<SEC-DOCUMENT>0000064803-21-000034.txt : 20211103
<SEC-HEADER>0000064803-21-000034.hdr.sgml : 20211103
<ACCEPTANCE-DATETIME>20211103064646
ACCESSION NUMBER:		0000064803-21-000034
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		79
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211103
DATE AS OF CHANGE:		20211103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		211373627

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cvs-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:25115a76-675c-4824-88fb-08e9720b17d2,g:63def5ee-f256-409d-94db-fc3f10f96be5,d:42a2ed4f4e484cdcb79747a1eeca0c55--><html xmlns:cvs="http://www.cvshealth.com/20210930" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cvs-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80L2ZyYWc6MGUyNjA0NWQxYzcyNDMyYWFmNGIwYjljMTA5ZWE4MDQvdGFibGU6Y2M1M2E0MWQzMjgyNGEzYmFlZTcwODFiNGQ3MjRmMjIvdGFibGVyYW5nZTpjYzUzYTQxZDMyODI0YTNiYWVlNzA4MWI0ZDcyNGYyMl8zLTEtMS0xLTA_1c3f9a3d-e1fa-405d-8747-e9d281707d4c">0000064803</ix:nonNumeric><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" format="ixt:date-month-day" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80L2ZyYWc6MGUyNjA0NWQxYzcyNDMyYWFmNGIwYjljMTA5ZWE4MDQvdGFibGU6Y2M1M2E0MWQzMjgyNGEzYmFlZTcwODFiNGQ3MjRmMjIvdGFibGVyYW5nZTpjYzUzYTQxZDMyODI0YTNiYWVlNzA4MWI0ZDcyNGYyMl80LTEtMS0xLTA_e92d698c-6b6d-4dca-8312-299db04fa9bd">12/31</ix:nonNumeric><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80L2ZyYWc6MGUyNjA0NWQxYzcyNDMyYWFmNGIwYjljMTA5ZWE4MDQvdGFibGU6Y2M1M2E0MWQzMjgyNGEzYmFlZTcwODFiNGQ3MjRmMjIvdGFibGVyYW5nZTpjYzUzYTQxZDMyODI0YTNiYWVlNzA4MWI0ZDcyNGYyMl81LTEtMS0xLTA_dfbedd34-6dc5-4c2b-ac1b-b7d8f0b761c2">2021</ix:nonNumeric><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80L2ZyYWc6MGUyNjA0NWQxYzcyNDMyYWFmNGIwYjljMTA5ZWE4MDQvdGFibGU6Y2M1M2E0MWQzMjgyNGEzYmFlZTcwODFiNGQ3MjRmMjIvdGFibGVyYW5nZTpjYzUzYTQxZDMyODI0YTNiYWVlNzA4MWI0ZDcyNGYyMl82LTEtMS0xLTA_2f28591d-93b9-4232-90fb-4af3e969cdd6">Q3</ix:nonNumeric><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80L2ZyYWc6MGUyNjA0NWQxYzcyNDMyYWFmNGIwYjljMTA5ZWE4MDQvdGFibGU6Y2M1M2E0MWQzMjgyNGEzYmFlZTcwODFiNGQ3MjRmMjIvdGFibGVyYW5nZTpjYzUzYTQxZDMyODI0YTNiYWVlNzA4MWI0ZDcyNGYyMl83LTEtMS0xLTA_d46fde7d-25b4-46dc-a734-2f53b4a7b7fa">false</ix:nonNumeric><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0wLTEtMS0w_51df1bf1-ea40-4dda-aacf-0790c85c5f35">http://fasb.org/us-gaap/2021-01-31#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0wLTEtMS0w_ce153847-f1d8-473f-ba33-7838efabea74">http://fasb.org/us-gaap/2021-01-31#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0wLTEtMS0w_d7e8ee36-962e-44b5-9405-217e509268a0">http://fasb.org/us-gaap/2021-01-31#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0wLTEtMS0w_ec68be8b-ec23-4ae8-b389-cfb8e2497555">http://fasb.org/us-gaap/2021-01-31#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i06e2801f1e8f4d4bb0ba64b129f8714a_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi0wLTEtMS0w_b7f503b3-72c7-47e0-954f-75dfffc049a2">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cvs-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i01397c0a67fe4cc788c55f7cf5e5d177_I20211027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ifdf12dfa1c48413dbb649aad32495c18_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc9deb51f5bb4f66aeeede8d66412ffa_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b9b6ee2abc8442796e1853380c5e295_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if40d51c00c3843f6a2791ae818b66480_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i198519b4ab0741be886e63579724dda2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd200dc7e8bf44ecaa5ed256c3e815d3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3312e30597dd4849b396d77a190ab38a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3ded585d03e4dee889ec0a76b1c3773_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2fdf49e58ef74885bcae89152e425b39_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie73ca519535e42989446d84c5cbfd99c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4adcddfef50d4237a36d95774c4b5e7f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie81f391964c947c2b2bd32278edef5e3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23ba03e375294644884d8e56a4a12ec8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9750e3f154044e0bf5e620a4abf5bc5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i551bc5b2e45e4537a35491b701e2bc6e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a860e1fdc9241a88d247676226a1743_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic102a7412e044e7dbb913688ea071de1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2054af963ad94d309c02720a2cfbe212_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92e4947a219a4f35b8b0e727a77bffa0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if831d75953f547bf91c30a4f27bf85e5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74a27263e55344aa87673203df970d6c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5ba9d09ff88466f96d748c706ada380_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22d23b76e1394040af9ea41449e89e30_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib469fa63d0a24fd3b8919d0471ce244c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86e55f5b316946bca272063c2c239038_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib76c2965654e4d27a7289e7d74a81285_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f8f1c6e4cf54f67a77ef5861fe75220_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebdfe2716bb1440b8056abf51feecbc7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0b07933938d4d1fb52659a2713205d8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c062bdcf0194ad8ab5933e999439363_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9c14939d5344d3b8c3ef6eb09b33da0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8781832d43cd4db79f8719e073082c68_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife449814992e43438e58bd3a5248451e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2d9c33c5d0445d4b7720d99637d30f0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i427a383940a94623a153c763b01bf61c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30c3d180e86948ca9c3beded789d010a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f39afeaa0164b9aaae2c4ad2a9488b3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide68db09236a41bd9e4db1ad61b5f1a7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice52c31f671142ff9c5da1e16b8b587c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i086fc8748c444262890e455770e0e120_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ed26699159f4e319ec98d041d5818f4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4687f5e592964cc2a694fd8d54353d81_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6540e87000648d19833b26522bbc190_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b84af36af2c42629e456c37a28e3938_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56f7b57e38ca4b558784c1d56f0aabcb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c1b85bddaae456e90d5a5399f3b4816_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17ed94c211de47da9c0bd88c599e60f2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab82a09b9c1a400d8e88219f37aea2de_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ed0ba20d2cd461099ef887e226c3e93_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e60a7d260c843d980920a5e304ae972_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a9f6159e4b14b72bff92db8236fd747_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6a97ebcb6674c2096965c9b22aaffc2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4ab8d4ce4d04aecb9a84bbfc6849284_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0265118fa568463fb1dfa52b691e2fca_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59307294db3d4cf4a1ad0f4df554aaf2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i186f27b850c7471dbc106faa8ac8974c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2aa020f1483426a991754c1bc8e4103_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d7fc2a5a2924d5991aedae343217836_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i082bfd21f3b045cbb0aaa7fba7f7804d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac37107e130b46c6b8fd2d7a2c171383_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9adf9f3e2e264684a8989823942612fc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic11ff217d030454db570ea0bc1a32ec6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64cb0760a3094aa686d8405ae705af26_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47ef065bc8ca45d686c76f5b4b47492d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69acde82d8db408eaa9ed7c6287a2301_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice9b45cfa6034116a0bb3a805bb25deb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63137494a1854ceeb7bd1ce433103833_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i949dda05f0274cf9b1746bbae441be84_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie19194eb945449b2be88388ede7f8337_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90f84206f61549279918a09332e58af8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06e2801f1e8f4d4bb0ba64b129f8714a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20bf1fd8851f4638bdd00a557c5f447b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0a7e1350bad4522a8484dd42ae70233_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id069616f8c3a471b9d0a7ef8e5adaa32_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1385ab29305c448a9c67d5770afb048e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida08eebb482d482f87035620abbf89d6_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i082608aa6b234f278b38aaf17009eb6e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id654c856e0c94aafa2fe19dc04299751_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48d4429acad1442ca35208e950d6b8a7_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fff271aac61427a93aace91fe11d093_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if946b6b5938546dcb10f22ed41a68dc9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dd00683a8f140fba68409bd3564961e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5ce1bd21a3640a79c7e024cab066d90_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i874e9eeb56a64352a7d096d7ecf784e3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08cf13c568a64de2a8c45a6b75813fc3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaae98d9e6fb345029082485700a2a279_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf4d73e8ce60495e83dd3d579a0a6635_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85fd60b1e5304049bca379f1eefb23a2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic26c88d8650047d8a0474834e8096a37_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87af6ecaa93148af93ee60a00e2bc5fc_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icace12a02237438d97c47d5283d91ee4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib368257cbb8a4dcc9f102a7125dff098_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe896c82eb7d48558a916c2226cdee18_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i619aa996f3d8498ab4f572d7da7b1ff7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibffe81af21c64c838090535f9633ed0a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20587aa2f9cc43dab807a6fd036d6ec6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b392878ff634b039bf5f8e8010826e5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81afc144424c4e4585c0d1c6720651e8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id11218ddb52b4b7889cb60e1b16b1edd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c2b0a74f321415ab4143fba6052d3fc_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida30c27c4c6849159ca6711a4c1037d2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd3c26ba9f894ca9a7da1af89a150bf8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0d552fb03c44883bdd9e4c09723809d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccddc7d61a62405bbd6126135b096cc4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac3c8def758f4306a0225b383df470e6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba7be38e83d341e093f4c569c8926177_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie66834e318c34f77b62a7489806c5c36_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04578fac9b784d489a884552dd60834b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2900b425253d40ca9ff265afb5d2e8ee_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb8d675420f0416490172136b95d4f77_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4b4ffbeaad7402bafb6efb81912f182_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64b99e857d05479fbde03dab04aacd4c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c4351afa1124647b74064aed3c9b1ed_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea10f7ec17074278bce5534f7460eebe_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9c67264f8554c16b088c68a6bf79e3e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i741f16a969ec4437b522117aeb1529bd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia94eca1fb7324209b95d6bcfa9878abc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i253d046d1d4543a0a2641f1e7e78877d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="location"><xbrli:measure>cvs:location</xbrli:measure></xbrli:unit><xbrli:context id="i7d765d02ede34e5fa56a51625a55c188_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="clinic"><xbrli:measure>cvs:clinic</xbrli:measure></xbrli:unit><xbrli:unit id="people"><xbrli:measure>cvs:people</xbrli:measure></xbrli:unit><xbrli:unit id="patient"><xbrli:measure>cvs:patient</xbrli:measure></xbrli:unit><xbrli:context id="i0c3ac878cf024e6d80d9917247d48b26_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cvs:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="state"><xbrli:measure>cvs:state</xbrli:measure></xbrli:unit><xbrli:context id="i9af0cc01cbc54c9f9e8615532da5bb0c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03ddd201af14457bbc83df4348f9bad1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i412e5ff6392245189b7c9456c23bf31a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia533baf499d04c8ca9ae5911bd795ab9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i290002d5729c495f8ac74f3b19d7d0fb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3894328a8f1466c8e456c94b93be275_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ab7ca31512a47f9b1c6b3868a809813_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdf2284c5d324dbc834c16b94260f82a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7eccee89ee34209972dbe04829f41a0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i625652e7d45b4702a574e3cc0bc9ee59_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ff4f742554a4022a187f1fa185cc04e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77b79029d3d0422f91971672e000f6b6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib390a8745a16401b9768897652fc449c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d3ec90dc0814b88b58bd914fedc0407_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic247236f845346c988b0332f27fa5573_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id372e9bfe6bb44eeba5d3ea51e988f33_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61c65f32eec4471868eff06cba27f89_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05ab8ae673ac4c12938a12847aa81a22_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i713ef3848ad542c18962c0cc34fc33eb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia630bb470ae642f8905431f2e294870b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25b37ce901e241a68a26af12fa5a391b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c910bf185e14abb8f843118e080650b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i583100df6a7145b9ad53eb0bc9fc4236_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f4c6beff36b46b0b7456de5c1600949_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91168981806a44fcada2dd00fcdacabe_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa6342f43a2c4bbaa5a4beabc6f6e0d9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i818171c70ff34861b15de5ffb456cd9d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69d20d815682465bb2bb57dc75692e06_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i713de0630b2c4ae48f9171b5d5051b83_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eef7665d65c4130b53d504334affcd0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dd05f21d6b243cb8fde4098a5393a14_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabd597abb76543afb656b9b04aa8e034_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05a987898eb94aac864574fe231e3a18_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf8640ff8c964e05b35cb76754034a11_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0da9396c07ac45aa88b14bb17a63332e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0b6b6a5a9634ad0b60f62d11118f057_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b1cb227ce25418f98cdb4c840a209b3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic02cc6173d9844a4af5efdc0fe2df7f5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6984fc17f7d8475f874f4de494cb3c48_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c255846afcd4865851ce574828f1003_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bfee72d1a0443d680828612b3a96710_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic576deaca0f04caea39ef63cbd517eeb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2893b2b18b814343a59acf92e7535ee6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4997bd10dafe4ccd9f92c679e0ffd1c1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5772c520e35f4b77b4c2c79644da46dd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ac823ba7ff34a13a62385beff1f8dba_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia22d065e2388491692af56f354d79db7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dc4395dff1d4c82a9760c20fceda344_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3576406107f47d7858dda78d75a6417_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42ba3552a810439d9832cae42b188533_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e4cd869c087429386704db934a61115_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c29ab4601174287b450f53152b36d36_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea31066dc7804044ae36620bede68059_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cdc8fa97da54c4a83f3e7c81196ef40_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aff50c37dc4454689af8f6f2c7cfa70_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3cbdb53e0614fd69d22b0611082a4fa_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63014255cc54440493b3c80ebe5cbf20_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib30ff9d3c92d44c69e87a939aee311b7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8e8ad852fbc47aca12f0dc2b4d1819d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f5439e4bb5845809fd326a3d2d9535b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia370cae5def349beaf1f0d98272cbc86_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i383e9e49c580468f96d67226826b3701_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fdbb1d0471e422b94075bd37bc906a7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa352e072fd64bac9be7da2a91adf04b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic11a639bc0634a7f934934ab6d3ea9e6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77461fd39fbd4219b11e33a2ae292268_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8f710bc255b4ddabb067c4df0121ed6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic48a2e72c0a444fd9aa88f429033c37f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id47a917ec1af4c5db06417fff5be5881_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if898d4a04a094d2fbda70a5bce06fbff_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5df45e3a2a5c4b17bf3ad60977af7588_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d918c713f67448682d7c685dc82da6b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34039126a3d845358fb813264ce5d92f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb505e76b20f4068b74c4b35f149f619_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib14d585750a94bcf85c1726868d8ed22_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad03227c933241798aeed098ed54ba11_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9901c4b8de6e4460ade56fa6d6a6c4df_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb4ce333dc4b4ac6a6db70a32f589fa0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d5483cd591a4ba29922131097dcc0a7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3777a80d7d548dd86f819a7a8c68626_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cc744230a544ead88ffab3c45d0c454_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b445faeec3845f6b11c9569be49f9fb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i472a8387964b45ec897885f8bc357e99_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f347f866918415994fa315bd6128224_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i009f875b81cb4be983f6d06abb32da71_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ce155a0217b4ef6b1d855626c01d3b7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ebd9dc275854c4faf090e45cccef77b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8111b2822cf741f59d35a0e165fda8f6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5082f90c86d41ae9be5d122e912ec22_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib50abeadc51e4faca566c3e8f770d30b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib624b26fc2464997942a122cf2a18d64_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9867d0a744a545c08b139379b67df848_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15d6678bc52c4b1b9a3992371795d9ba_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6674a9f6c2a41b19f32aefffb3a2dec_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idac5a4c6d4b94f628ed2cfe21a4d2421_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife3c76ab2d024ff4a261d3b4e14bdada_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04744a27d4fd4e3faadf43a927a7eb4a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3bf41b2dd03474394b5ac3c1e4407b9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45b3cd0569ac4039b5a66d8ac80b2c19_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b19f1d9ffbb4fe298e1f449c044db56_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25970c943ef246bf95009df4317e9dc3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icadb573d19cd422abcc090b691494ecc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c84847084804557b40086d59812ad68_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b2e395d22bf48aaa5e44c7091a81e15_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e829120f1fb4c1a9331bd53efd465d1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib32e95b570724a1f982834c296abc3e8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if97993cdf6bb48d99b74e00b854fff89_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie363563d839a430fa7d79ed6d41e5d06_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1ea3d7632384fe7b52a58c46f5bc52d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia07ca84334b34916a64718d4f3f0dadb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a95101c0a2547d68267b540d8eb8935_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0610bf8e796340e4b079b333dbc7453b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57164e4241fa4481b87fa534a3023d49_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0aa1900809b484188a9ccdf8c6792cd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc788eb85be74801ab161654330fe954_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1d2ef8361434b6e86e6d370a02b1d83_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c4d3d8eccee408d901f45c189ed9409_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if52efbf3b02a4086a4563b641c39020c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ea4f28e976a42eaad4bf6503fb394a6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64e9bda172dd402da851f2556c558b25_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a81285c245547c79d2a6cf01d1794e0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac2b3349c830449db89d0000b4259672_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dc635a1438340608f1c50ba4fdd86c9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21ee770549c949dcb40ae6f549cc3f40_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80a6996dadac4e8b8f355582234ddeb6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97c318d6cbb84ce1af4416e5e9e9e796_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i707fe789ecce4f57bbc13e85dcb9d128_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e088f53c1324f15a6ec9498f86c75ad_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6144005cd614c8aa06ca2e425c85859_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84071dd39d474caab85d1a67242c2886_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if27a76e953c04bb392f52d3e05778b01_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4167d58e660348f68004d45412fb002b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97c60203ad5c46589c94c32f921cb550_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf502564439b47e698e240fdd68a98f8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16162ee44bb9440284fbd19d6465d34c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib769dc9c21e142589bdcbe6161dc3506_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1bcbe85de984034b24a5e4fda18e485_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia73e717be6b54384b3a33a455727136e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3778b495d7b42c5a45cf242a88722cf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9ed33a6edcd4234b95ebdec84f83d90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb8aec5e18a44c75a0b64168efe52403_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>cvs:security</xbrli:measure></xbrli:unit><xbrli:context id="i1675bac7aaba429694ea0a6a1d6a3574_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cc96f7ad297439c9bd36cc63d9e3146_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0db856db0a1a4dc6b3fd81758f0ae424_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if24bb6ab7e694ecdb87149237d4c1602_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d2954c416de4b1e94f5fc8ec55a8415_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a9dc416181f40ecaf6b337fd9f9f867_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f12b69dec3e45bc83561d3148a11d4b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0879481908c44bb974f798733a18941_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81bd66dcd0c14391b7ca572896fce844_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic20457c673f444f7ad09370f0abc943f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie65d53b92fb04633bf47f5b64fe04237_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1005ea182f234733a5f7f072c2ab891b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i621480d3797b439aa77a9e7253861a59_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6bef302866f416f9a0761624eade678_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa59d496a4474b0f95a13c32d9357c35_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcad87c9dec641918b3c4b3bb560a7de_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f221174b2cc4c23bf352b6226458e50_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ccbb0e4dc92472684d9df86f46847c6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6b89ae1dbe540a4b314a9ffd00f3e91_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib99fbba707114103952918869f5d54e8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a096f78525a4f118bb1911a1d28e677_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i305483b9eb2c4a8995176a43a6032fc0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied8e395c6c584b45aadbedeab96bdde0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e4c260ac59344468042ee0c45e67651_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifacff69d92414346adfc278aca85cbab_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6bbe3fa4925463a965ddbfa2358fff7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i687923585ac246a3aeff8523198d5758_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8f440075a474904a22012bf5a0fa634_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37ba77da999a41fdb1d81252d6c8a441_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16e95dbb642b48db85e7e5bdff14e6e0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9969a7b4b4034a81bbe819b2eac5c9d6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42c00a9fab3d4285ae67e62b24f65277_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8be70fee5e364ac0b0e505aa20317bc3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i613b395302204b2d82957489697563c8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6adc5271a0f0419f838168a0b0c93dcf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3be55e2300ee48e49c912324e8d0adb5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5edd5e4487d4cde9d6f50a2574f3e8c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b52851fb9b94ea79df46ebaba85d992_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13f6a29f7e20449ca439559613ffdb02_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie16bfbf4e5d442348e7fbfc7fa8540f6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie54cb4fb85cc4c14ad9a8f690844eb1c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7336d9407ae74018bd8107c29553bc53_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i990fec2baf6c440d8151861169097a2d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bbb7234989e4a60815b6f61bbb10430_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic54ed38faf1840829ada4f19ee78708b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib458fd6ed94b4ec88122673b72dc2b86_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf1830b9927b403fb56106443f7e286a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic16faab668914c0b8f33d98455c26ca8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i299c35c4365f42e1bfcf88ec9516cd24_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89e754d40a6d447789aba510c1139f8c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i838e7866071a4f15bf5992c7b4d65771_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc3123160602429a9bf38bb156b7b80d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f211351ebd945b59851039aa7cd4aef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f8fc8c9444745159ca710fbe002a038_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34358d8265934eedae4d1ba649b53da2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b8c3d6759524f80acd74630696a9506_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i027a56206bf049918acb4cc292f57cf6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6be1325a1fd74472b0c1686a5b8bed29_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40eace95f50e4f4abe9ef0c982f565fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e6dcc78d1204e1a9a491939346531d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e2cf59a412346b49745f23c85ebdae7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e1433ec26e14619bce3f327630539e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad4028c79991465f8affd1c774924434_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i515f5ad673e841cbafd84da71411a3a4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdf7f501b4a04e6ab02d3946c1b2fcc7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifed08cdcd0ec4c51b9c44843b976a3fb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i141813623d8d47759168dc83deace4b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebcd200cf0d3431899420614fcc5f00d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeef2fe72a0e4db78d0c62aa5b990f64_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b884c52dc2140b8ad6a93ffb21a0ca8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7e1a05886ee4b2fb12e4f8922b90730_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib80106be43ca44388999d7b0f50726e1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf0870a5c62d42d0835c91ab95f6f879_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4a4db2857ba40af84f29186cfed8c8a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifebe5c48239d4acbbcfb816d06be3231_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41ef632b7d74402987f587828bb58743_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idca40fd7d89b44aeab59a2047d066ca6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i597b415b2bd6471fa91f8a8a2d582e58_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cf2d7ded1ee4ac3ad8f173a49ca5148_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i930f3c01703c43719b9d884430d891d8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i474200218c78432fae6cc7d8692546d7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59cbe9d0b1c14573aeee78a7f064a39c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42c6d3403b9b4becaa9ff959ccfe8f44_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ebe53271a07413f911296d1d7453a25_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaaa57ceba5d4481b694b7ba30c13b7b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72bbd414aabc447686e70f07f2d01a3f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id63cf05999ee4f44a681fc80a55eb52f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04638c4a1572491dab3ac08e4ad98438_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a39ccc3c07c44ed8a195c76b9e7e55d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c637804a3d2436ba9be1a2b270b4e53_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1067180474044cab8a4d973cdb2842e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i508e18defcad47008f1dab8d4f81dbdb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0563521c632f47179c829933333c3ddf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe7ab3f842154eeea4c328406a7ac83a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifda576b425f044eb953d6a347d279daa_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if06aeed222c24fe2b41407064d3593bd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49fc9d5b465f44abab9625a29fa0d38b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2af50b590ac44018a0222d8c3c2f4aa_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c1da65d86f7414da97ff4e9d8609420_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c144abf9d6c4c40ae0c2318a533d55b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib513a974552e403ca51acd78fcf5dde8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6e72b78b8754b94aaada037ca2420ee_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75c0f2cacc534be690f026d29bdfd858_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e2a3404bce24924ba593cb3d50a171f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia81d44c8f29a451a8615660915b19be0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9883998841414e459a14949384066c00_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4aee10007334dc08704544552884bc2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41c7bdff14cf4b519ad7ee30cc901f32_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5add9eb3c7da468c9b1a2863e2d79bf2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83f92ecb821d4bf7936caf73110c90ed_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6837264698c94d41988231e4099598b4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibab1f6f3b94e4f5fa5194e624f3698ef_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7db0731152d84288b010f872cd8a99e0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic04e7b60901742bcbc036ef80339246d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2025973837f14d479020bf7cc4499a72_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfa61eff06aa45fcab009a3adb153755_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92ad02b987304467b861021d6c699fee_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6d623b8d6a0424bb2669fd66020aafa_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94c9a1f84bba4080b2c3d4bef2b71e52_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i501877927dd54fbf93b7f49e999ee841_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c847c9a44124e7db070cb42a1a63f14_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9dd3149c06249a287ef6e26045fdd95_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadba8d3e3d8440528cfcc9c33445f682_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib29de6a09dcd46d9aeb48b72526eef8e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i999f68483084466e9e68712a6eafd08d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cfde730bc324d93b7009d7ab45141b6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89494621c37c4c219c62fdca2ec3a02c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc7910d366b94081aba8f7c036e31370_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d9073e6b5944376a12e7f42f106f789_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib122074ed9c9464eac823cc8d4819acb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia674f1ddc0d840b0aa42d18120ac12e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95327e52078a41a89444ec318828a7dd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic836b346282347908809f16a6eb5660c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34bec3f3434a41b7ab493984748deeae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc87715012e244f1a0941fc7f486bcb5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fa629d192414558a844c90838b9c4a1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ab2e48c06df4ca08a139917417a396f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie971ffe3a7844dc29d629c33684e8d32_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb69f5ffee80421c89348f37e2cb0f86_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf2f0f2fe2f045bda1c2226bbe6a8fd5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43c1eef1a6b448418547a06e29940d6d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc165d15f6804c64841a910becac3ed9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4c412a5ba874f98870341d7ea31c942_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib297eefdd01042809add61d2dd4010fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7de217ffec6c4548b78c7b2302f20377_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa404aec6f7740709c74a50e423f55c2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i694813f254844fc388cdc57b0282c552_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76a73d6716c549c5a3e574f5997c2627_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53410c2dbc4c4d39a65c4deba26b6c80_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23fa0bd51236409caabdfcaa76735c44_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d4071d9bde54949b0ab30e57b6d131b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5f20743700e4f5d90d0ace281e6184a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bd830bd2d0a49eb8ec02b1932b58722_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb2d516d37a44977806647d938c79d40_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cdd4cdd4ca546788f18be91782db91c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47fa10c381de44068b970898e3aa4e58_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96cb72db03134df09fb6aa81f2b1786b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9611cadb797e417db325edf33945b988_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i563011688aa349e7a1f32d722693061e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc355084ff424474b90262f9ba68cb4a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3904707e6a34e4e8e4ccfc85ced0bef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07c7bd30fcf945f7bae17c46fe84a1e0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafea971f2cd6419a915d40ecfdcc6853_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf087794476a45f1bafd4c1e6447c2a8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c049e51c8604a9183951023541454c3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i021c91d03c7945d4a5905a640d27996a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c135e138975479dbc208139f9ce925f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i147018bb8fcc4e0586edf2dde3e287c4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaad5be874c394c87a8151ea37f655ba4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaa2a9cf9df24d96a4910a7770e327b3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd49134c4a7f487a8cd469c1c1ffbe58_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if687d685f43147b8a54d5058142cdfc7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec2da8685e5443638fdf326121bfbf76_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c964868b4a547e1868068b2b01396dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0ecb6e4143541d38112288c2c2203a0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafa9567a6e1242cf9ae54c608091a142_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i612ca748550d489da66896239ad5b1c9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13473c0ae0c14361aa7e0e5b5809b5bd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie18b978d6a92462cb19e95c291464ff5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i557a10fe4b3943739f83a4f01347a36a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cd654f81de94c4ba6574ed395d10914_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f6debc0fdc84a0095ae738e034b2ce7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5b399af8f2c4b1494f420b54c395eab_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18d84e87420b4fdfb90748e9026f0c49_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if13f0350cddf45ffa223d9ec2d72053a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib46ae0b202514c6ba3af15017b7e230f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f2877a791e3491f9534edd67ed3e987_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad504c15b51c4049918b0ba3bf6aa35f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic424242c3bba48f9bbc125c6af13010d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib33c9671d5f046d79fce9e9901904688_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c04b19feb064cf1bf23bc7e65f7be4f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf82daed791d40cd93b600a3e62ef8cc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5aa8d204d59f4f928a510e6900cf939a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09fb9a5bef7f42428348726a2ff173f1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i685f457f55ed4bfdaf90fab6ce466d85_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60056bc19bb048b59c735005c438169b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a47aa4aaf384bc6a0e156ab09a449c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0cd80f6244e42fbab3150923c3c3ef6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id865ac262326451daffd0d3a056e96be_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d357538b6c0474aa7f475e2632e3e77_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bde8bbc8af2428fb013ae54651523b7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7abda2e513b34485baeda28fdbf8e4a1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic763372116b148e9a5a2904296c53f93_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79f3ba86d6354f07b5df6c1ffa8bbbe1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafc45f1d336740b0a1a8d911aac65229_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7733f5518c7645c4b56b68cccf6f76ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4652506a76c7489ca73ed1b4e3db819d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d5e67cc70504729944139279d44d713_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15df075bc2d04e759bf072636f0fd065_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8616075a3e1f47668b0ea71db5e5caf4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42ae767186744b45adac05f6feb0c37e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i750ac96cf4c64738af59810ad96e6411_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23c1f04677c042939927a68bb5fd9f65_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i869431e7abf74749b23dd3a1ed93e1ef_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05a9eb3fc13543189b612e1898a32241_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e788b4e17294696828048f3be438c9f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0f632a81048467cbde9502af1736d39_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0497b7413f024eccab9ca54d54ee0dac_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0118ee2d69441a7b3e211472508a35b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc05881978f94525b7d1199de70e7105_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3ecfefee0e642c0a78fc0131c0449c3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2db04fe0f832449baafb9d23de950513_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07fb4a28c1654faaa862b3d378de1c6c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ib62f2ee98dd644cd9bcc6e7fafb92659_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dbe9ff3e69946d3a25f666403b2d133_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6af42f85334840f8806360242558dac0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id10cfac743044c0b8d548cd557cd8836_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9597fa0131bc4e9887c9815a6cd88648_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59e7dd59a3b54a77b96c49edb48d86b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf27f7ccf52044a79068c5b1c21729a4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b3bd812b24f4f1eb1e8c8d5c0a75877_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i852a5e91e3b9468ba1cb2eb5f74b1b9d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6191e346def74ee2aea270383730ae08_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76f9788e25764f54b73f568ee5806646_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc41a17f6c774042b9fcf1afc65bbdde_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i137942ee3c634b5389f5afc0f8942bca_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if73d40a8e2434d0fa1ef103cc7698cc3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6b0b4743e034bb1bc3f258385746efd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99bd1157dbbe4945af1a81d0c21130ea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie17499a4aa5e4151b918eeea4df0de97_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d6ac400309247c5b66323fd368436e2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b0ee41eebc34bd180b2c69788165350_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99f11726422242bdae9d51047e1fbd8a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f47310960c144eaacb797297d97929d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d3712df84af449f83452fc8bc0a7e18_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i483ec33bdab247d48a38b7f13570e673_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia618ec5a27694900b1f7ba774ad68e8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff008f8fc0ee406881b35526798fa89d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19a79677cf9c4a2da09c14598934ad6e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1ab71b7baae485dba34f4f0eb636d02_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01e1bcf974684d3f8b8d8a88ddadfd46_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie08be45af7c046aaa32b288f6d0abe62_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec21c12c0eb1436d803f53d89f62fa05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72a7a16809e84d3b92e4bad0bac2262d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5d016793b9b42579b7bc6222e15baf6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i764944fd1b5e42008a5e99c7c609eed9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c92560f130b45779c8a95a020b233ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27806ca29bf844b3901fae3f691be398_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad404c84173a424d89258a6896c6cf7e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie935136890474a69910662f38d5b6b95_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17ee5f6b60d74d7e9832465d6c93a81d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i777d22b7a1214acf87d3902cab5fc684_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08366cfa41cf4ec09bb0df2075ab0906_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i501701dd672b47b79ce22cd7925e8550_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35c86118fbc64523a77d011172ead4d3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bf76349f2134b799b85e620ca017ce1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2c451a4fe964730babafb480988f0b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaae7c158e8fc423e95ac2bd644820bd4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i950c1c297c4a4358acd09c74ab566982_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62ccc6e98f4545a181d967e33f10d4df_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i857f5b369f4040fab9b2b410b0a79b73_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6bba02cee2944fbb480017e52082d76_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32452f38e22247ae967975fe6e98f407_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia409b9876a544297931507912b72df4f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75a9c983e179487b80338719c6654c2b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a4406c7b2f34949810aebaf45489f84_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8151e799d1c74f5c833144285cf01c69_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3182ba22cd594ccf9a8ae05b9078606d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib60002bca8e844649c542c4cc7f63f72_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba95d402ec9d49d28efe5abbbf533067_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6773fdec06dc4a40983a54841b13dda4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4916faa22d44187b36197276e047af9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueAugust2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73aea79ad2ba4f3fbca099d45fbd99ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueAugust2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeb8eac0c5ec472ea3a8d59c3be4564c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia10a7bda458947608ba95da5905bd9c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5a7d1903cee4bbe9e9caaee0f3997ea_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8be68adc97de4b3193304ca21babaad1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic715e236403845808ec274271d922531_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e414d119b874c97af3d40d143e3f394_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98d7f42792064db8af2bea27fe4217d6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9d87dfab2bc4779af52ac27db253497_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id61537d136804380900baa2205811e11_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f7e8dff237f43d0883eb5f73e112a29_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbe99d66375e4a84a14ca3cb9bd04463_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78303eac554f4ebaac80fbdb2ef497d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2bdbe81b56b433eb0b1abff2a8cf359_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7ad50bbcb824461968e1e224ceb45eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id19aa5c38de0498ba584e838008334eb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f0df169cc2a4329a01ff1661c5f6643_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia45c0682f66e4831a5e18003515863b7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44d5c108e0784a1baefe552607e68fbc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82d31c26e4d44623ae7b535f4961b40a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaca08c7669e84499a6b53f5fc209d8d1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaf0c3b289b94b89ba1558094a4e7fbb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7efa34741b14f12a2e1553830369efd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee85be27a3054609aeaa1f1291e5378b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4027fc5015314a28afdf00ece6eaa61d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia33e18e6e5cf4bca9278bb182bc5c16e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64ab274ab94e4fb0b97224d1979d31f7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic90e5382382f47f6a02d952c5ef3f35f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie01363b48cc748a8b4849e735b906bcb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57bd188e01604c998e340453dd1c10bc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9e00c491a58435bbe46b502dfc86a88_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7771d9a02ba1459fa65a6ed760132976_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1710183e3c7642969f8764f4a6bccb12_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2fe10dd7c524a25a46b3c5a30a4d149_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i498b74e1a6084982a704243062845c72_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf76f8b405534054bff48c947da24a34_I20210818"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueAugust2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec82b516316744c190f4a9f8856af906_D20210818-20210818"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueAugust2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-18</xbrli:startDate><xbrli:endDate>2021-08-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7001acb1c0940d18c4cb5e7df98ee1e_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ec50d6371f84eb3808d2b78b4f8710a_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcbf1d24a625419793f28cc2390b7c49_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4365454cfaf648c79ea4a5b95d9f8a4f_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8e59782bbf940fbb42fef683312041e_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f1e3af8e2a7433f93e2da46dedb4bae_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc2a92285efd424994eb094e0817bfc3_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f0b1fccad9c4d07b2db0f2507871783_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7898b0b327ab449eb16708ed5b14e472_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0de59d4f1eeb42f8bbb0fb2fe5621340_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie44679796a144c26b4b62a377639993f_I20161102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i191becb0a3c544ecaf8184ef7e8acb3d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6197d49ef31446ffacc35056221fecbf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b734952dace49dab51be5df71c2cdad_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45de384d4b8f4d4aa79185b3cf224a05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ddb5c89f1944d7f9dfa198754d529ee_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33239c1a09204337ad5c55fefd2f9d8c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf731d8db2514741951a6d08a5bf2340_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56a02a7778f5400493e2859f84b416f2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if38c0c0626334984872a2e8f0277dc2e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefa0cb672bf44372a091873f1dfe9120_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe641cc44c4a46438e0b7bfd4cc3622e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecd646f2764643b59a88988226c92eff_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4a67b4c90b54c758612bcb4085bec12_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12d2dcb1b92e4bcb94f40436329a7dd6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id52f8f655a4e45b28cdd084d28393f28_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47faa1c1728e4e11a77c17ac0400684b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idedf5740b04f4deea7f8b81566c50b36_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d8528d81dc241b8800e77a29be29f47_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1952024433d45cdb011fb1c5362e577_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic976b0752299464f9eb1c2e3a0466f84_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i537c6fd82b2d4484a4285287e0da5e8d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fcb54914f1448388da80fbfae61bf9b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89f5412889bb4704867c4db1cb7606ca_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80de0413731140859ba1fca6bbc151be_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e05796d442740d6b0e31e64c7579488_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22587a4dc04645edaa23ee4e6fe5309c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i320caa0f2438447eb917283e43737ae0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia60c00beb57f4d0aa1389f1cbd1b8aa9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46462aa1e76c440a848f1a6c4854fcbf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c8056adf6394fb8a935b96c8a1244bc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73d82d6008cf422f990c1967019b47ae_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38f0d7cd0319413a864c57d831aa6de9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5c9058389544d8f9fd0949b2df8c97e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fa36c1044d245bfa0fdac23491e04fe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5168781fe0f2491a9d873c5536902ff3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9a54e61594a4ce5afdb32319e63cfe5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d6fd9a3e6ba4affb174e7bf3606494f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd3134eb77504bf1a35552d9f49abbce_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd24288b5c4a41a39c5a91e91a8ef6bf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb78040186fa4e1aaee57c20ecf08ec1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeb02179387b4c138f3d16aecc35f88b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02e8e4d27b8640368de9694d52106ab1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38524abcd2514a1fb4737a87a7e66b81_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i744afac31d1c419187429ada2dec85cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cb66a72330944e6abe3847855220870_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i840219be56704e14b8dd4d1adb3ca119_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4d9088e966a40a68d31fc31fc7a2d2a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="store"><xbrli:measure>cvs:store</xbrli:measure></xbrli:unit><xbrli:unit id="member"><xbrli:measure>cvs:member</xbrli:measure></xbrli:unit><xbrli:context id="ida4612fe99b04ca2aa41bf1a2e73fe9a_D20120101-20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-01</xbrli:startDate><xbrli:endDate>2012-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>cvs:claim</xbrli:measure></xbrli:unit><xbrli:context id="i384f03c6d15c44d196ee290093383364_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:RadcliffeAndFlaimVAetnaIncEtAlMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c774f4ed3c4faabc1e5df119dd09f8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb5b7e4050464b31ba5e844cce234bd4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81f235791bca4dbc853d081abfa4d343_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1620dfc000424fd3b15b25a1ac9a1791_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc97d958fa084ddc939774b0bc91d620_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d900d4b1ca34915859e9703c35c8775_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic04e76d8cae84ec2a080a6f0fc22a523_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i307fb82e77314c8895bc793a68fe29dc_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d22088cdb00442b89bdd1fe6cf8a26b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b7044360fae43969a13838008e79bb1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacf5f0e00659493589182745e85a0e36_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedfff3121ba6469d9e77415864b5a41a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a7d151a028477481ac7f32edde55eb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28069fe437ba40d9b14e06d3899dbf60_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d7f4151778947ca96d8cb506330110a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8246339cd89c42688813a929c411f371_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i020d373f0ad2415aa7656c159c909537_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ac023dc2cf14e8aa8be582c9ee42c76_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a39cfe4d74743ff8499e3d09c93e0c5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i104116dd6efe40a7bb00f658c0ab14e3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0311b59b583f418eaccfec74aac1d61f_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0975e9ea8e5e480faf0a315905252457_D20200731-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-31</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjItNC0xLTEtMA_05331b88-e255-4dbf-8123-62f8f9e7a21b id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTUtNC0xLTEtMA_b48973fa-5b00-4cff-af94-b934b37c3d66 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNC0xLTEtMA_5ea3be2e-d67b-46af-b75e-45b93159eb93 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNC0xLTEtMA_8ff228aa-4d86-461e-9162-15397fc95b7b id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNC0xLTEtMA_d0c66a66-bc83-4916-a3ae-75e089f30f71 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS00LTEtMS0w_9fa121f2-d8c4-46e4-b66f-177184da942d id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOC00LTEtMS0w_ba871677-b90d-479d-9db2-be26b7fb580f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1Nw_b247c82e-4cdd-438b-8461-629d8e081d94" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS00LTEtMS0w_bcf6bb97-2a1f-4b9e-957f-9bdd06a9f486 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNC0xLTEtMA_628ff552-edb2-42b5-977f-39188ec396c1 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNC0xLTEtMA_bcaaf698-4b3f-4af4-9fcd-bf465e2d066f id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOS00LTEtMS0w_eff6e367-ca00-44e0-a822-573f8448fcb4 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTYtNC0xLTEtMA_47663ff0-bb33-42e2-8fda-5a986f4f2203 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNC0xLTEtMA_5e486fe4-2705-4eb0-9011-2efff2473d31 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjMtNC0xLTEtMA_36dd9700-2ab6-4371-9922-e173326f8a6f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OQ_7436366d-7ad1-482d-9dca-49b1e4c4ff23" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtNS0xLTEtMA_7a819f02-085e-4718-abf2-7b94f5c7e3e1 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNS0xLTEtMA_e93ad5c1-0d07-4d6a-8e38-4a12cc3d1d1a id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktMi0xLTEtMA_5a4b074b-11ab-42ef-b0cf-f71cf7ac3621 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNS0xLTEtMA_a5e3687d-cd13-4018-8344-29d72d6f0b22 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS0yLTEtMS0w_d174f413-fa0e-4e11-ab68-94ea32f3f8b9 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS01LTEtMS0w_95207aad-d4e2-4fbb-8d72-bca35abada02 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS01LTEtMS0w_3e47f73e-e459-43ba-8f5d-51743f0781f9 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtMi0xLTEtMA_bae16aa4-1ebf-46cd-a62c-af75a994bea5 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS0yLTEtMS0w_a3d36f42-c1ec-4ae6-bca4-0cb4bf194dfd id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtMi0xLTEtMA_706373f9-0140-4065-9f3d-5ee06f70df06 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItMi0xLTEtMA_d79af9bc-7b58-45a9-83e2-d1c57a6838eb id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtNS0xLTEtMA_2567cfd5-7634-4093-8d82-13ba8964cc47 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtMi0xLTEtMA_30ea49d0-0c4c-4253-8deb-c6b8ee4d1ff3 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNS0xLTEtMA_a2ccaa98-c808-436e-bc23-a18e347c6aef" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtMi0xLTEtMA_bdbd385d-1f8d-4b53-9278-ecdb4f1ca047 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctMi0xLTEtMA_b0287672-564a-41d3-bd32-0089b65be989 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNS0xLTEtMA_903d301d-a3f1-4b21-a771-9aec8812fe7e id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtMi0xLTEtMA_d2f3618f-ccb2-47ee-8a92-3983dd19fe58 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS0yLTEtMS0w_3c449d66-8194-4b73-b723-40167f9bc6ac id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctMi0xLTEtMA_0bb5398b-a386-4c1b-aa40-b5891a25a52d id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNS0xLTEtMA_b90fd349-d8e5-43ed-881b-24b77604464e id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctNS0xLTEtMA_9af71cce-2a15-49e5-b13c-b7c0458c9e0a id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtNS0xLTEtMA_2f70f4b2-1c71-4266-869e-ce63c3a83d4c id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtMi0xLTEtMA_360f5eeb-beba-40ed-8cca-0a920d5a120c id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtMi0xLTEtMA_5a7a6f94-71f1-49af-9f5a-c5337e491d60 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS01LTEtMS0w_0e722941-474c-452e-907a-9b9dfdc759d0 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNS0xLTEtMA_1b5f60bb-10d7-4399-bfbb-a23d0366a7f2 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtNS0xLTEtMA_3b76e1bd-f0c1-4144-80fd-b209578840b3" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi0xMC0xLTEtMA_bebec290-7fb8-47ed-ad52-695b1989a76b id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi04LTEtMS0w_024f2e1f-846c-4ae2-8f94-42293da62071 id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi02LTEtMS0w_6b55e493-0bf6-491f-b808-0bf50bf578a7" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA2MA_c3424baa-b3bf-46e8-ba70-dcb721cc4745" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_1"></div><div style="min-height:22.5pt;width:100%"><div style="padding-left:101.25pt;padding-right:101.25pt;text-align:center;text-indent:-184.5pt"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N184Nw_37aa6e89-a214-4268-9733-cdb58f9c720b">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Mark One)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDMx_cd1517cd-3033-454a-9f21-cf8769b8176b">&#9745;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMjU_61057fdd-68f1-4249-89fd-f2ce4ef40344">September&#160;30, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDMy_e5ccf0a3-4aa9-4219-ba53-b4420aaae24a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from _________ to_________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDMz_d9308d2c-078b-4568-b6e4-b355b469fdd0">001-01011</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="cvs-20210930_g1.jpg" alt="cvs-20210930_g1.jpg" style="height:18px;margin-bottom:5pt;vertical-align:text-bottom;width:104px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDM0_97c2c71d-94b0-41e3-b31e-8dabbb4bb75d">CVS HEALTH CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6NDVjODRiZmVjYzBiNGVkYmE0ZTlkMjY3MTRmNDY2NzgvdGFibGVyYW5nZTo0NWM4NGJmZWNjMGI0ZWRiYTRlOWQyNjcxNGY0NjY3OF8wLTAtMS0xLTA_3d0e855a-6e7b-45da-80d7-0d53dbe197cf">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6NDVjODRiZmVjYzBiNGVkYmE0ZTlkMjY3MTRmNDY2NzgvdGFibGVyYW5nZTo0NWM4NGJmZWNjMGI0ZWRiYTRlOWQyNjcxNGY0NjY3OF8wLTItMS0xLTA_c71a971c-b94f-42b6-b4b4-156d52f4614a">05-0494040</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:4.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.165%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6YzM3ZmQ5YWJhNTgxNDU2OWIyNWU0NjQ1MGQyOTgyNmMvdGFibGVyYW5nZTpjMzdmZDlhYmE1ODE0NTY5YjI1ZTQ2NDUwZDI5ODI2Y18wLTEtMS0xLTA_af11cd84-b10d-42e5-a927-f953ec52f95b">One CVS Drive,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6YzM3ZmQ5YWJhNTgxNDU2OWIyNWU0NjQ1MGQyOTgyNmMvdGFibGVyYW5nZTpjMzdmZDlhYmE1ODE0NTY5YjI1ZTQ2NDUwZDI5ODI2Y18wLTItMS0xLTA_8eae5ec0-500b-4bc1-8036-6c58200cdce5">Woonsocket,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6YzM3ZmQ5YWJhNTgxNDU2OWIyNWU0NjQ1MGQyOTgyNmMvdGFibGVyYW5nZTpjMzdmZDlhYmE1ODE0NTY5YjI1ZTQ2NDUwZDI5ODI2Y18wLTMtMS0xLTA_50434a68-4543-4520-ada9-b09bd5b29251">Rhode Island</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6YzM3ZmQ5YWJhNTgxNDU2OWIyNWU0NjQ1MGQyOTgyNmMvdGFibGVyYW5nZTpjMzdmZDlhYmE1ODE0NTY5YjI1ZTQ2NDUwZDI5ODI2Y18wLTUtMS0xLTA_c2d4b330-fb44-4988-ae90-8b6c39e358fa">02895</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Zip Code)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registrant&#8217;s telephone number, including area code: &#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6YzM3ZmQ5YWJhNTgxNDU2OWIyNWU0NjQ1MGQyOTgyNmMvdGFibGVyYW5nZTpjMzdmZDlhYmE1ODE0NTY5YjI1ZTQ2NDUwZDI5ODI2Y18zLTUtMS0xLTA_ab67452e-874f-4134-9456-e42463d35591">(401)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6YzM3ZmQ5YWJhNTgxNDU2OWIyNWU0NjQ1MGQyOTgyNmMvdGFibGVyYW5nZTpjMzdmZDlhYmE1ODE0NTY5YjI1ZTQ2NDUwZDI5ODI2Y18zLTYtMS0xLTA_c29f9a39-eed6-43be-81ad-ca269338a494">765-1500</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former name, former address and former fiscal year, if changed since last report:</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></div></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6ZDQyZGMyZTkzNTRlNGIxNmE1ZGFiNDQ2YTQ5OWZjNWEvdGFibGVyYW5nZTpkNDJkYzJlOTM1NGU0YjE2YTVkYWI0NDZhNDk5ZmM1YV8xLTAtMS0xLTA_29890012-9f8a-4143-82d4-a946473ab7ef">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6ZDQyZGMyZTkzNTRlNGIxNmE1ZGFiNDQ2YTQ5OWZjNWEvdGFibGVyYW5nZTpkNDJkYzJlOTM1NGU0YjE2YTVkYWI0NDZhNDk5ZmM1YV8xLTEtMS0xLTA_19d2abcd-873d-4468-a124-4aee95155be9">CVS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6ZDQyZGMyZTkzNTRlNGIxNmE1ZGFiNDQ2YTQ5OWZjNWEvdGFibGVyYW5nZTpkNDJkYzJlOTM1NGU0YjE2YTVkYWI0NDZhNDk5ZmM1YV8xLTItMS0xLTA_08e6cb02-7dc9-4046-92b6-d50d997c7ed0">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">                                                                            </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDI4_04748e76-e287-48d9-b64d-7fe3d66e0d2c">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">                                                                                                               &#160;&#160;&#160;&#160;                  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDI5_94dc8fcb-bff5-4e1d-b81d-c1cd59a8c80f">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6MDQwZGY2OWE0YzIyNDk4NDg5ZDJlODMzNjAwMjkwNzAvdGFibGVyYW5nZTowNDBkZjY5YTRjMjI0OTg0ODlkMmU4MzM2MDAyOTA3MF8wLTAtMS0xLTA_b06a7aeb-9b26-4a67-bb70-f1da2b5768dc">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt 2px 97.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer                     </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt 2px 97.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company    </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6MDQwZGY2OWE0YzIyNDk4NDg5ZDJlODMzNjAwMjkwNzAvdGFibGVyYW5nZTowNDBkZjY5YTRjMjI0OTg0ODlkMmU4MzM2MDAyOTA3MF8xLTMtMS0xLTA_dd8bd117-d5e9-4e40-9526-4e38cad6c29a">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 97.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company    </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6MDQwZGY2OWE0YzIyNDk4NDg5ZDJlODMzNjAwMjkwNzAvdGFibGVyYW5nZTowNDBkZjY5YTRjMjI0OTg0ODlkMmU4MzM2MDAyOTA3MF8yLTMtMS0xLTA_14e9933b-61ae-49ca-af92-4a35381cf667">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDMw_d15d8ab8-9f5b-412f-879d-7e58fb665eec">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Yes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;27, 2021, the registrant had <ix:nonFraction unitRef="shares" contextRef="i01397c0a67fe4cc788c55f7cf5e5d177_I20211027" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18xOTgw_55ee4e51-d79f-4c41-91d0-2964754df3a1">1,320,058,657</ix:nonFraction> shares of common stock issued and outstanding.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Information</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_13">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_70">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_70">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_103">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_103">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_106">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_106">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_112">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_112">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_115">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_115">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_118">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_118">62</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_121">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_121">62</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_124">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_124">62</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_127">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_127">62</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_130">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_130">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_133">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_133">64</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_7">Form 10-Q Table of Contents</a></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.25pt">Financial Information</span></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_13"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Financial Statements</span></div><div style="padding-left:27pt"><span><br/></span></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Condensed Consolidated Financial Statements</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Operations (Unaudited) for the three and nine months ended September 30, 2021 and 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_19">2</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three and nine months ended September 30, 2021 and 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_22">3</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Balance Sheets (Unaudited) as of September 30, 2021 and December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_25">4</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2021 and 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_28">5</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Shareholders&#8217; Equity (Unaudited) for the three months ended September 30, 2021 and 2020, the three months ended June 30, 2021 and 2020 and the three months ended March 31, 2021 and 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_31">7</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_34">9</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_67">37</a></span></div></td></tr></table></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_16"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf12dfa1c48413dbb649aad32495c18_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMy0xLTEtMS0w_6629c2da-45da-4f8b-98c3-b500e64a61d8">51,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc9deb51f5bb4f66aeeede8d66412ffa_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMy0zLTEtMS0w_3bc4243f-4c57-4a98-8808-1b8a3fdd3205">47,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b9b6ee2abc8442796e1853380c5e295_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMy01LTEtMS0w_c918ea43-a9a3-4078-95f4-79757f7e14c6">149,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if40d51c00c3843f6a2791ae818b66480_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMy03LTEtMS0w_357b1686-db7c-4f80-be6c-0cac04056537">141,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNC0xLTEtMS0w_d3c2eab5-aaa8-4303-9427-d869214341d6">18,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNC0zLTEtMS0w_57f77777-0165-424f-84f0-64df591e6dcf">17,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNC01LTEtMS0w_261b5a56-f0d9-4df4-a847-4b8d8ace0939">56,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNC03LTEtMS0w_0384e34c-50f5-4b1d-aa87-d20e80b15c0f">51,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198519b4ab0741be886e63579724dda2_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNS0xLTEtMS0w_65fbf207-5195-4085-b90d-e5bd0d7f8244">2,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd200dc7e8bf44ecaa5ed256c3e815d3_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNS0zLTEtMS0w_5b40b59a-7ed1-4de9-bc9c-d7a2bb2c5c1c">1,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3312e30597dd4849b396d77a190ab38a_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNS01LTEtMS0w_3a24ecac-a74d-4272-8d20-6f4f572d02a7">7,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3ded585d03e4dee889ec0a76b1c3773_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNS03LTEtMS0w_97444169-c3d5-4794-92c5-19ab7adbe348">5,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNi0xLTEtMS0w_286be67d-3624-4e43-a168-238766c77e79">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNi0zLTEtMS0w_cfc107c3-81f5-4a46-9950-d1c3380a91aa">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNi01LTEtMS0w_94e03f3d-116b-4998-96d8-70305a7b8d72">832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNi03LTEtMS0w_11f7d075-55fe-4e7a-aa45-9978baaeb64f">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNy0xLTEtMS0w_79ed0063-2ee9-493d-a3d2-1c8ddab8b2ed">73,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNy0zLTEtMS0w_50808680-ce7d-4710-b248-07fd3f06f00b">67,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNy01LTEtMS0w_1d52fb95-7b2b-485f-9be1-0e45f1e15127">215,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNy03LTEtMS0w_82e12bc2-1d68-491e-877d-7e0b5c60c3b9">199,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0wLTEtMS0w_51df1bf1-ea40-4dda-aacf-0790c85c5f35"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0wLTEtMS0w_ce153847-f1d8-473f-ba33-7838efabea74"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0wLTEtMS0w_d7e8ee36-962e-44b5-9405-217e509268a0"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0wLTEtMS0w_ec68be8b-ec23-4ae8-b389-cfb8e2497555">Cost of products sold</span></span></span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0xLTEtMS0w_4f37b59e-1475-48ea-af5b-ad0b8ef02466">45,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0zLTEtMS0w_b3e8f63e-4fcd-4e1b-a998-7c791267a7d7">40,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS01LTEtMS0w_f3f1e805-01b8-46d4-8e19-84fbcb11423b">129,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS03LTEtMS0w_620f9bb6-cd83-422c-bfaa-a08433d12b63">121,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTAtMS0xLTEtMA_a952b29c-ca51-410f-98fd-20703bf8853c">16,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTAtMy0xLTEtMA_82d4fb6a-0ba9-44e0-924a-e5d4619ce03a">14,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTAtNS0xLTEtMA_1f05d15d-205f-42d8-a4a7-e3bf49b9e884">47,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTAtNy0xLTEtMA_9e557163-ed75-4d5a-9793-a30eb66f29bd">40,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtMS0xLTEtNzU3MA_cd93a4d0-cffc-4940-bfa4-daa7a13da6ab">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtMy0xLTEtNzU4Nw_bdfe24f2-d2b6-4a59-994b-0e384e6835ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtNS0xLTEtNzYwNQ_226325f1-4e11-41bb-84a1-40d4c491afbb">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtNy0xLTEtNzYyMw_5e595806-cac4-4ec4-b413-997d786a3e2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:OperatingExpensesExcludingGoodwillImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtMS0xLTEtMA_2ad81d12-ad4c-4c3f-807f-836759305ac5">9,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:OperatingExpensesExcludingGoodwillImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtMy0xLTEtMA_c68f9672-2ffe-48ef-99e0-0b6a64f30160">8,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:OperatingExpensesExcludingGoodwillImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtNS0xLTEtMA_422c92d3-ae11-4848-8d84-7b7dc8cf2382">27,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:OperatingExpensesExcludingGoodwillImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtNy0xLTEtMA_b7788215-a856-4448-b9f1-63b8cdfb0b7c">25,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTItMS0xLTEtMA_43653d76-cc9a-4b4e-8cb5-9a70e617912b">70,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTItMy0xLTEtMA_4d03915d-887c-4171-a5ab-9567342768a6">63,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTItNS0xLTEtMA_e2b97ffb-ebc7-4ce0-acc6-2375c484fc41">204,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTItNy0xLTEtMA_aa233864-3e3f-4903-9a56-06cf233c1c87">187,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTMtMS0xLTEtMA_fb515f1e-cbdf-4efe-9e74-f76f969ab6b4">3,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTMtMy0xLTEtMA_258fc45e-d586-4789-b0c9-fd2806bd003f">3,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTMtNS0xLTEtMA_6e0a3ef2-0648-4854-a19b-cef4fc287b68">10,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTMtNy0xLTEtMA_cd62e712-ec73-4ceb-917c-bc57a0a1a9f8">11,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTQtMS0xLTEtMA_aef69925-7ffb-4c54-abc6-a1c9b80334eb">602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTQtMy0xLTEtMA_dec10a08-58ce-420e-a99a-ca4c2b647417">731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTQtNS0xLTEtMA_075f7293-eec6-4b8e-aa5c-7a70928ee7f4">1,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTQtNy0xLTEtMA_9b144179-2778-4845-9e90-04ef999806db">2,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTUtMS0xLTEtMA_42471213-bcf0-4d52-a59e-20959a5c1461">363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTUtMy0xLTEtMA_2e95b86c-263d-4ac7-8377-6f96bd3d8f7a">766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTUtNS0xLTEtMA_7d15fd29-e6fb-41ee-b78e-fbdee428475a">363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTUtNy0xLTEtMA_3ad9d89c-ed9f-48e6-a3bf-7bfe79963642">766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTYtMS0xLTEtMA_bffc3088-9334-413a-8836-e492ae9c7f79">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTYtMy0xLTEtMA_c552560c-51d6-4fd0-8fc1-9aa1be8c273d">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTYtNS0xLTEtMA_7c411f78-f92d-42a4-90f0-c0cc958d7b5e">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTYtNy0xLTEtMA_96185fe1-89c2-49a7-b6e2-b017f382a901">153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTctMS0xLTEtMA_15fdb3f9-2ddd-499b-b06d-eb96386bb06c">2,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTctMy0xLTEtMA_25f734a9-9751-4738-813b-df13a26db504">1,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTctNS0xLTEtMA_9ca4569d-a50d-45e5-9a1a-87e4f4e19cee">8,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTctNy0xLTEtMA_a8f61203-4f81-4c9e-9f7a-33259de8fb8e">8,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTgtMS0xLTEtMA_e7fecc86-fc8c-416c-b863-45fab9d45026">558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTgtMy0xLTEtMA_0a2193ae-3eff-498e-b63e-df8aa1071ffc">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTgtNS0xLTEtMA_f8e48888-8dfc-4589-acf1-c92f0318c623">2,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTgtNy0xLTEtMA_e310ec1f-5a12-4017-b416-9140bcc0ce46">2,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjEtMS0xLTEtMA_04b7018a-f80d-45cc-abdf-37ba23a50343">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjEtMy0xLTEtMA_9571d221-6493-4f7a-ae92-2d334e2678e5">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjEtNS0xLTEtMA_b308433f-42c9-4758-9c00-e08fe0e126b4">6,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjEtNy0xLTEtMA_75313df6-2c78-4e32-8331-cc4235bb0bdf">6,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjItMS0xLTEtMA_169a6204-5744-4527-9668-42c6fc500796">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjItMy0xLTEtMA_7325229e-a404-4353-8454-6a556879d333">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjItNS0xLTEtMA_5f0bbdc4-f657-40ff-bbce-00e3023babd5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjItNy0xLTEtMA_3422f3bb-0b94-4497-9721-6aa579ba57d0">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjMtMS0xLTEtMA_9667507d-dd5f-4bd4-b4fd-2039141e179b">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjMtMy0xLTEtMA_ba8af6f1-5d21-41c8-9aca-79d9c5ef5b3a">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjMtNS0xLTEtMA_37867f92-1b89-4642-b01d-4c597244e854">6,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjMtNy0xLTEtMA_2230d694-a7d3-47ab-88f1-c225eddc69a2">6,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to CVS Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjYtMS0xLTEtMA_db9f33a5-0fea-4a12-8cb1-f17153d7e84e">1.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjYtMy0xLTEtMA_6fdbec76-7491-4e88-b155-4a4770124752">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjYtNS0xLTEtMA_875e22ed-be5f-4d8f-8c31-229234c6963d">5.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjYtNy0xLTEtMA_a34e5024-4de4-498d-8413-b83048538f57">4.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjctMS0xLTEtMA_1af2d273-0d24-415e-ac25-3308350b6011">1.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjctMy0xLTEtMA_f10d6229-420c-4772-8e77-91917a9408b1">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjctNS0xLTEtMA_9b8f1777-19c8-4eb8-9ee9-6a9a34415aa3">4.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjctNy0xLTEtMA_5017157b-d68d-42a3-a7c6-eb0552e5e1f3">4.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjktMS0xLTEtMA_aa893404-d8e4-4b83-8757-4e821a499555">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjktMy0xLTEtMA_15139f95-6329-4a62-87a5-b42e9e1a052f">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjktNS0xLTEtMA_8e11ae59-2908-4a6a-a91b-6aba52e86a96">1,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjktNy0xLTEtMA_a431a1c5-5e1b-43b9-b42c-513fef60e9f1">1,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMzAtMS0xLTEtMA_aeff4377-92e1-429e-bdcf-ce0edd58e4fd">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMzAtMy0xLTEtMA_3cd277e1-bdfc-46d4-9617-a90ce2c49780">1,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMzAtNS0xLTEtMA_c6bd3212-f780-497e-a59a-777dfa1ca689">1,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMzAtNy0xLTEtMA_bf1af7bc-11e0-4c7a-8f65-ea27ea06b580">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNDEtMS0xLTEtMA_1d1b54c9-99ad-4ad3-96b3-c04f220207e0">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNDEtMy0xLTEtMA_2a65c530-e9ef-4b2b-b06c-a11f77b9c7fa">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNDEtNS0xLTEtMA_b9812c91-bbe6-4ae9-aa6b-f4f19eb9649d">1.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNDEtNy0xLTEtMA_b304f63f-1093-4fa4-96b2-fc816769dfe3">1.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMi0xLTEtMS0w_04b7018a-f80d-45cc-abdf-37ba23a50343">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMi0zLTEtMS0w_9571d221-6493-4f7a-ae92-2d334e2678e5">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMi01LTEtMS0w_b308433f-42c9-4758-9c00-e08fe0e126b4">6,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMi03LTEtMS0w_75313df6-2c78-4e32-8331-cc4235bb0bdf">6,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized investment gains (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNC0xLTEtMS0w_70c21c2a-21cb-4674-a8d3-22950d9ab9df">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNC0zLTEtMS0w_6cfb1ea0-4200-4a76-9d03-5cb2e0581dcd">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNC01LTEtMS0w_6b8ac751-d4f7-42de-8a86-81edd2bcb32e">310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNC03LTEtMS0w_1a70cb79-8825-4e62-b2cb-a55fb71e6a0f">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNS0xLTEtMS0w_de85d0cf-9357-411d-9c7a-c4dfc68063a2">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNS0zLTEtMS0w_fe663bd9-7ff3-40f7-8bf9-b20b7f006d79">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNS01LTEtMS0w_4bb883a3-6919-4b03-ac0d-fdc9e5860b3a">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNS03LTEtMS0w_a9ac12d7-f3d0-4c06-9bc5-e1c70deefe96">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNi0xLTEtMS0w_07112298-0c8f-4429-b3d0-d15591417348">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNi0zLTEtMS0w_715c0fc1-a2a9-44dd-90bf-0514043f6ad9">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNi01LTEtMS0w_3ccafdd4-052e-48b6-bf0a-cfd3ec877044">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNi03LTEtMS0w_1aba967a-ba3a-4b0f-bee7-4ed3eb2f8522">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNy0xLTEtMS0w_d4186b03-ccce-41b2-af53-4d86952c26c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNy0zLTEtMS0w_da9df924-f0e1-4b36-802d-7e286edd00a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNy01LTEtMS0w_5f0abcbd-7d46-4b17-95ca-d649db12a62f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNy03LTEtMS0w_173149af-a9fd-45d0-af63-a8e094602069">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOC0xLTEtMS0w_69bd7db9-c328-4987-b18e-56e97a7a4d8b">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOC0zLTEtMS0w_8900a25d-91cb-4f5c-85c4-189b868620f5">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOC01LTEtMS0w_cc20afdd-7ef0-4a8f-a5d6-a0cd1eae977a">337</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOC03LTEtMS0w_5cd58f5e-b5a7-4386-9898-97a24f39c682">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOS0xLTEtMS0w_23871e99-c730-4727-8a9f-c98b31c70f55">1,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOS0zLTEtMS0w_b9e8ec64-1ccb-4a6d-a0bb-4a9fd1eaa7af">1,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOS01LTEtMS0w_c7f53a28-bc60-4a08-92dc-af5f194e5c62">6,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOS03LTEtMS0w_e05eab05-4d94-4df9-9f75-eacf6279111e">6,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTAtMS0xLTEtMA_169a6204-5744-4527-9668-42c6fc500796">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTAtMy0xLTEtMA_e44f4d20-53cd-4ba7-b0ca-e208a54ae27f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTAtNS0xLTEtMA_5f0bbdc4-f657-40ff-bbce-00e3023babd5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTAtNy0xLTEtMA_3422f3bb-0b94-4497-9721-6aa579ba57d0">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to CVS Health</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTEtMS0xLTEtMA_9a8444ad-639c-41b4-bc2d-e9a3f8258110">1,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTEtMy0xLTEtMA_94fd55ad-9ddc-4905-855c-7322cdabd86a">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTEtNS0xLTEtMA_3049e63e-f02c-4d8b-91a9-bcc02af210c5">6,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTEtNy0xLTEtMA_0d5f9a5f-7071-4163-96b9-dc55927bf4a4">6,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_25"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">   CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMi0xLTEtMS0w_33f03c85-46e8-4fbd-b9ab-0667f6426329">9,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMi0zLTEtMS0w_5071ef91-838b-4554-bca2-137c7e4bd82a">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMy0xLTEtMS0w_34b9609d-b8d9-49bf-8294-8a9416925da9">3,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMy0zLTEtMS0w_e7dcbb48-8572-4dcc-9979-928a50524f97">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNC0xLTEtMS0w_7bb12d66-364f-48ee-b338-7de5623d1717">25,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNC0zLTEtMS0w_6d91d08d-b41b-42a4-baa6-4979d6f2acad">21,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNS0xLTEtMS0w_2a788bf0-b80d-4388-b3a8-930d644adfb8">17,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNS0zLTEtMS0w_ba227147-318e-4452-a44b-0c2df175c0d9">18,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNi0xLTEtMS0w_b175ecd7-2479-4226-a2a2-9cbc4518e20f">5,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNi0zLTEtMS0w_1ab508db-986b-4fba-8ff9-48e71ae6adaa">5,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNy0xLTEtMS0w_4a9fca7f-f36f-4d6b-8f27-dfba13a70fbb">60,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNy0zLTEtMS0w_0002787d-41bf-445d-acdb-19bc0fb8bedc">56,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfOC0xLTEtMS0w_e7fda66b-e800-457f-899e-77f3796c77da">22,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfOC0zLTEtMS0w_f1555326-7a90-49ee-98f3-ece9cf0d3519">20,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfOS0xLTEtMS0w_ff3fd2b0-962a-4b57-a2c9-d76aa6ffce9b">12,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfOS0zLTEtMS0w_cb0cfdb3-b2aa-4eea-b4e7-0ff284f21d81">12,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTAtMS0xLTEtMA_90fccc2d-032c-4919-a9f1-a3ea7c7491ba">20,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTAtMy0xLTEtMA_f476af67-cfa1-4306-93ac-0f435c76a6b5">20,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTEtMS0xLTEtMA_3a42c68d-9c73-44fe-9903-b4b9e684ba1e">79,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTEtMy0xLTEtMA_3ceb42bb-d0f5-488c-8a9c-3cc3eebf2920">79,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTItMS0xLTEtMA_1265c818-94ed-4da1-8602-c16ab9c3c10b">29,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTItMy0xLTEtMA_92d52a5f-1782-4992-893f-65192bfc58f9">31,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTMtMS0xLTEtMA_13705155-4a00-4368-bbd5-1010661ee18d">5,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTMtMy0xLTEtMA_31048ccd-6854-4aef-85d8-8b036a551e02">4,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTQtMS0xLTEtMA_41974607-aabc-4e3c-a734-a85b7a553e9c">4,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTQtMy0xLTEtMA_cf471b0f-6cf6-4bc8-aee2-1dd0175c71de">4,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTUtMS0xLTEtMA_53292201-7ebe-4576-89db-a494468be340">234,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTUtMy0xLTEtMA_da8f6c4e-ab92-4ff2-a436-1ee8e9fdf1b8">230,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTgtMS0xLTEtMA_90c1297e-0a04-41ca-ab0b-bc88f8cb9dc8">12,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTgtMy0xLTEtMA_6d4321b0-1938-4bbf-8607-ec25b0a50ecd">11,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PharmacyClaimsandDiscountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTktMS0xLTEtMA_8be28103-3d83-4557-b48a-783154c0ad9d">17,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PharmacyClaimsandDiscountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTktMy0xLTEtMA_fff9e7b2-a7b8-4ef1-9f63-524966155e0a">15,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjAtMS0xLTEtMA_9795ff5c-0057-45dd-a8d3-1c48ad18483f">8,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjAtMy0xLTEtMA_599bc77d-ee7b-468d-8681-c84bc9ccefa4">7,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherPolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjEtMS0xLTEtMA_0961f03c-aa1a-4fa1-bfaa-a3a22a2ce3c6">4,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherPolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjEtMy0xLTEtMA_8366140e-1ab7-4085-b3a3-5b66e95d1451">4,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjItMS0xLTEtMA_b0123346-d4f3-415f-b73e-ac7484d67d41">16,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjItMy0xLTEtMA_eda0e10f-c328-4b85-8cbd-f8abb26a2b1c">14,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:OtherInsuranceLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjMtMS0xLTEtMA_0b6facc8-5092-4138-b896-95a302e5ef96">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:OtherInsuranceLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjMtMy0xLTEtMA_8ed04520-2f2c-4753-97b0-ccb01d2c2fac">1,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjQtMS0xLTEtMA_0b52d326-d109-499e-a7db-1ff4f2bb175e">1,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjQtMy0xLTEtMA_e0d43086-ecf6-4a84-a672-4e06e35e7eaf">1,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjYtMS0xLTEtMA_11a6354c-713b-4104-8e84-df1059138e24">1,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjYtMy0xLTEtMA_25ab5884-3052-4c53-b172-e3e33967c55f">5,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjctMS0xLTEtMA_c58b9864-e7ab-4a91-aac8-b126a61b0179">64,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjctMy0xLTEtMA_afb50df6-1305-4534-8ff6-b96c588f58fa">62,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjgtMS0xLTEtMA_1d47066e-8b6a-4c8c-9612-6f03dd16626e">18,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjgtMy0xLTEtMA_114e1636-de43-4955-8002-728211eee9d2">18,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjktMS0xLTEtMA_b732eef5-857d-4fa5-9dc4-423e7a2fc7ff">56,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjktMy0xLTEtMA_5d8c119c-efaa-4919-8a68-6261e1955d6e">59,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzAtMS0xLTEtMA_2bec0f1a-063e-42c2-861b-40d1b8bcc911">6,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzAtMy0xLTEtMA_997014a1-38fa-41b6-8ab6-4a54741be4f5">6,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzEtMS0xLTEtMA_c81a1f88-d24f-4121-810d-646cb38f2ae9">5,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzEtMy0xLTEtMA_250aafbb-90fd-4991-8999-35983e8ba2f6">4,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:OtherInsuranceLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzItMS0xLTEtMA_1151ad1c-f96d-4eb9-a5d6-04fa4664a87d">6,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:OtherInsuranceLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzItMy0xLTEtMA_55b63974-6ba7-419a-87d8-52cdc0c2fdac">7,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzMtMS0xLTEtMA_61869863-b7bc-49f8-aefe-8d56a21231c8">2,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzMtMy0xLTEtMA_72998eb3-2643-4c67-aec7-a72a12144bda">2,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzQtMS0xLTEtMA_50739d3f-cba9-43a5-ae0f-8817b735e854">160,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzQtMy0xLTEtMA_0d997dee-7dba-4dd2-bea2-8282f29b5369">161,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzMx_25bb4194-7095-4911-843e-f16ab4744d80"><ix:nonFraction unitRef="usdPerShare" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzMx_b91e5266-54f2-4fb9-b834-a8bd05903adc">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzM1_6719fc3a-436a-4c8a-9c42-0ef14f4ff647"><ix:nonFraction unitRef="shares" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzM1_99be9ba0-b898-4953-834c-a3e2431253cc">0.1</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzU3_18698380-a36a-4ac2-9063-806d0b168906"><ix:nonFraction unitRef="shares" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzU3_45026aa3-a97e-49df-a33d-b0b7f831c070"><ix:nonFraction unitRef="shares" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzU3_a5638583-35bb-4136-8041-81434d4ee30a"><ix:nonFraction unitRef="shares" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzU3_c1b48e0c-c540-4ab7-8880-191b108f0c67">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>ne issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMS0xLTEtMA_64cbb992-0a07-4f5e-b8a9-3596293c11ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMy0xLTEtMA_3d18c188-8286-4d4e-b879-c3aacb535b0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzI4_625b89c1-cf70-4991-8cad-42a020abfa8a"><ix:nonFraction unitRef="usdPerShare" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzI4_e43dbed3-235f-4618-88c6-003e512ac6d4">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzMy_0591d2c1-0385-49dd-87be-9dd60d606376"><ix:nonFraction unitRef="shares" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzMy_d1cb71cc-5573-453c-8607-93fc2d51af47">3,200</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzU0_70a547b5-e865-499d-ab61-3694718f75eb">1,743</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4Xzc1_8d3a9898-ab08-43ae-9520-afed44210258">1,321</ix:nonFraction> shares outstanding at September&#160;30, 2021 and <ix:nonFraction unitRef="shares" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzEwNw_4cc38f6d-4d66-4d91-bd35-2f523b825836">1,733</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzEyOA_e46cfd50-cc35-4f74-99e8-30af3cda67da">1,310</ix:nonFraction> shares outstanding at December 31, 2020 and capital surplus</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMS0xLTEtMA_653cd1ac-a893-44b0-8dc6-2ce3c0e56894">47,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMy0xLTEtMA_44366385-289f-4163-9957-3eae48376a71">46,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost: <ix:nonFraction unitRef="shares" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzktMC0xLTEtMC90ZXh0cmVnaW9uOmE3ZGU0YzMyOWFkMTQwZmY4NDUzMjk4MmJjODA2NDQxXzI5_cbaf0338-18c1-4073-a9d3-02759490fc44">422</ix:nonFraction> shares at September&#160;30, 2021 and <ix:nonFraction unitRef="shares" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzktMC0xLTEtMC90ZXh0cmVnaW9uOmE3ZGU0YzMyOWFkMTQwZmY4NDUzMjk4MmJjODA2NDQxXzQ5_07db744d-3cc5-4ed2-9439-0cd76a49aff3">423</ix:nonFraction> shares at December&#160;31,&#160;2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzktMS0xLTEtMA_059fdd02-7601-4585-b9f1-8ca47518d373">28,166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzktMy0xLTEtMA_d6073f12-1edb-4f5c-9bdd-03ee4a2f9fd1">28,178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDAtMS0xLTEtMA_bcbc131b-f73d-4f85-b02e-8aea0c39055b">54,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDAtMy0xLTEtMA_b79c34e8-3750-4439-b995-3ea91e45500f">49,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDEtMS0xLTEtMA_cea55f51-d7dc-4ab2-bc62-d2d7148a3723">1,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDEtMy0xLTEtMA_16e79d86-b8f4-488f-a28a-612c49cdf1cc">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDItMS0xLTEtMA_21b9b902-0866-4a5d-b3c2-817c7623ae6d">74,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDItMy0xLTEtMA_e771bd4c-df13-4d67-80dc-df297ef5c8bd">69,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDMtMS0xLTEtMA_ae9f9e00-90d6-4757-9bc0-1c09c0ff0f0f">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDMtMy0xLTEtMA_d26e2540-b779-4cd0-8a06-f63140d7cfa3">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDQtMS0xLTEtMA_dd65c25b-3f1a-4393-91f5-0e737373a08f">74,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDQtMy0xLTEtMA_a52575d7-886f-4214-a487-a9678684bfb1">69,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDUtMS0xLTEtMA_4e3544ff-3f98-4db5-85be-22ca1d4eb9c7">234,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDUtMy0xLTEtMA_e8d592c7-ec6f-4fad-842a-7cdb848de9f8">230,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts from customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromCustomers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMy0xLTEtMS0w_e1a92d2b-b94a-408a-b5e6-73d51f922fdc">209,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromCustomers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMy0zLTEtMS0w_77a0b9bd-152b-42b3-9f43-8312b27fd868">195,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNC0xLTEtMS0w_b34ee109-bbf6-497a-8ce7-85b5fdebc9fe">122,129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNC0zLTEtMS0w_e0f33232-5880-4587-803d-eff29684c420">116,590</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance benefits paid </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PaymentsforInsuranceBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNS0xLTEtMS0w_1fb4bb08-d970-43eb-91ee-b1d8a10e5fc1">46,965</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PaymentsforInsuranceBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNS0zLTEtMS0w_d5d83caa-8055-48cd-a937-4c5e4d1364ef">40,221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid to other suppliers and employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToSuppliersAndEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNi0xLTEtMS0w_9ed87b0f-74ef-44ef-9380-01586dc80335">21,840</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToSuppliersAndEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNi0zLTEtMS0w_de0de563-c5c4-4900-8dde-b0291ba6c3e2">22,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and investment income received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNy0xLTEtMS0w_5ca17c5a-784f-4329-9e47-add3c2f90055">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNy0zLTEtMS0w_d56b5fdb-2e36-421d-a1fd-1bdec3ee4399">622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfOC0xLTEtMS0w_5228bf95-91e4-470f-bd8b-1334583fe9df">2,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfOC0zLTEtMS0w_d534281f-ef46-4aee-a140-0edd21310f9b">2,517</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfOS0xLTEtMS0w_30192316-2238-4784-b858-8930ca7e0791">2,397</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfOS0zLTEtMS0w_81623df3-e797-44d6-b7a2-1977a6851723">2,365</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTAtMS0xLTEtMA_a9c47c38-e018-4717-84d2-9ddfff107331">14,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTAtMy0xLTEtMA_19cd064d-cb35-4b1f-ac3f-93766790dcd0">12,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTMtMS0xLTEtMA_8d02e1e9-6b05-4742-9a7a-3cf1fe28d37d">5,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTMtMy0xLTEtMA_fcea0f89-d203-47f6-befd-b92d10baec9b">3,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTQtMS0xLTEtMA_cd455d9e-5d5d-44e2-aabf-94e935630a81">7,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTQtMy0xLTEtMA_be992064-54a1-43ce-846c-e88def1895e0">6,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTUtMS0xLTEtMA_11a77352-918c-46e0-9cf1-74670c1ffbce">1,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTUtMy0xLTEtMA_f7170f58-50ee-4b5b-9f86-99742acaa055">1,724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (net of cash acquired)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTYtMS0xLTEtMA_784d739e-3661-4a75-9352-bc6e42006e55">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTYtMy0xLTEtMA_d3760cb7-8f09-415a-9802-117d698c7621">828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTctMS0xLTEtMA_70b201a2-a17c-47a8-8a64-c16955baf5d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTctMy0xLTEtMA_79909922-e9b8-4471-bb81-7877edc43d1f">834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTgtMS0xLTEtMA_d89da939-3ae7-4668-b498-77d46f7c0694">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTgtMy0xLTEtMA_5ebd27eb-e59f-4cb4-8873-eb5ac0d0a6cf">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTktMS0xLTEtMA_94166b9f-0030-48e1-a281-d71f63d1cdca">3,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTktMy0xLTEtMA_0b4ea246-4e08-4680-940f-4a8a47d054e6">4,300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjMtMS0xLTEtMA_44181e46-04c2-4445-bd1d-2c2e794fd344">987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjMtMy0xLTEtMA_d34643cc-7501-4a46-b6b2-a33be045aa9d">7,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjQtMS0xLTEtMA_dedbc9c6-ca60-486c-8171-72a0064e9127">7,823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjQtMy0xLTEtMA_79aba4d2-7ea5-4a40-9443-b8e17416f84c">10,493</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjUtMS0xLTEtMA_444da234-a9a5-4e92-9949-cc8830b28bdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjUtMy0xLTEtMA_bd224428-913c-4a96-ac0a-4dbda7ccebd9">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjYtMS0xLTEtMA_839b8242-f5a9-4768-8fee-013e777932ad">1,965</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjYtMy0xLTEtMA_e4f0fa10-4bf1-4766-8331-2d8b96a2a597">1,980</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjctMS0xLTEtMA_158b5783-e1a7-4ce8-a32a-9800b8bef94f">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjctMy0xLTEtMA_7bcaac48-c349-4e5a-95d7-2e07e5d93781">249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjgtMS0xLTEtMA_276f0883-ef39-4d13-98bf-5f6c4dea7b10">161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjgtMy0xLTEtMA_23e06af9-6b03-462e-a45d-3f23bfa761a4">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjktMS0xLTEtMA_31cdd7a2-0772-4b6e-8f86-97ec6e4d5bf2">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjktMy0xLTEtMA_23e49611-2252-4dd5-958c-8885a3436c02">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzAtMS0xLTEtMA_b0e700fe-1b5b-4537-9587-af8f2c0ce072">8,525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzAtMy0xLTEtMA_bdd76422-4a47-4b52-ad2f-a71f557be113">4,420</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzEtMS0xLTEtMA_b8f7b375-abc7-48cd-9b04-cdd4c438710b">1,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzEtMy0xLTEtMA_ce21081d-7b7d-4c89-9af5-e141771a1f25">3,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzItMS0xLTEtMA_dc109b49-7e4f-4a4f-99b7-2aa84488247b">8,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adcddfef50d4237a36d95774c4b5e7f_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzItMy0xLTEtMA_f57a4668-24fe-46f9-b46e-32937111b783">5,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzMtMS0xLTEtMA_4d40a0d6-5feb-4cf1-850d-4f974529336e">10,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie81f391964c947c2b2bd32278edef5e3_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzMtMy0xLTEtMA_72463f01-aad0-4570-8368-7494a965530b">9,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMy0xLTEtMS0w_b308433f-42c9-4758-9c00-e08fe0e126b4">6,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMy0zLTEtMS0w_75313df6-2c78-4e32-8331-cc4235bb0bdf">6,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfNS0xLTEtMS0w_0b243ca8-814d-4c43-a588-d8ef661c96d8">3,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfNS0zLTEtMS0w_87a9ca6e-57b8-4656-bdc7-a2de117662e0">3,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfNi0xLTEtMS0w_bee35031-6215-4b5e-9c84-6581342ca8dd">431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfNi0zLTEtMS0w_f9ff4fa7-cb67-40d1-ab54-2a71e54cae22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfNy0xLTEtMS0w_beb287b7-a892-414d-beb0-e98574a53b25">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfNy0zLTEtMS0w_1441eb0d-304b-40d4-a90a-8303bf241473">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of subsidiary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfOC0xLTEtMS0w_101e563e-dbad-470a-9a01-e2ee1a6d677b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfOC0zLTEtMS0w_6973e305-3044-467e-a3d8-1b566bd1e362">271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfOS0xLTEtMS0w_2bde3106-79be-42e0-a2f4-9ec6fda0ddc4">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfOS0zLTEtMS0w_f65d2b1b-d553-4db7-908e-0be7157a3bb4">766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other noncash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" name="cvs:Deferredincometaxesandothernoncashitems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTAtMS0xLTEtMA_edb90b83-c327-4f0f-b599-a2badbadd491">645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" sign="-" name="cvs:Deferredincometaxesandothernoncashitems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTAtMy0xLTEtMA_0207bcff-06c6-4e9c-b6b1-bcc7d708169a">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTItMS0xLTEtMA_f0ba3c70-919e-4a6d-87b6-705bd4f1077f">3,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTItMy0xLTEtMA_f04b98d6-577a-49de-9cbe-254af29fe6db">3,564</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTMtMS0xLTEtMA_3f937569-99d5-481d-b68d-c9b2e20e5011">1,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTMtMy0xLTEtMA_82e37a44-42d9-47d6-819f-fdc849a28c41">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTQtMS0xLTEtMA_713b6aee-eeea-4b9c-b6c0-7305d6da030a">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTQtMy0xLTEtMA_74e271ce-c10e-4c32-8658-56fab38470ca">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTUtMS0xLTEtMA_4639fc9a-7576-404d-971c-0436e2e4daeb">3,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTUtMy0xLTEtMA_dfd82283-64f5-4499-859b-34f1ed0c9aa1">3,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTYtMS0xLTEtMA_186ec035-2b59-4ea3-ba6a-ba04bb742d95">348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTYtMy0xLTEtMA_d28dbfc5-8175-474c-b5ab-588d203bc895">474</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTctMS0xLTEtMA_79542b94-c181-4ab4-92f8-a386f969c64d">1,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTctMy0xLTEtMA_36cc494b-6989-40d8-9415-822776de6b0d">2,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTgtMS0xLTEtMA_53820a6a-2ef9-4fb8-b427-db946ffd4e39">14,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTgtMy0xLTEtMA_5c82dfda-44fb-437e-bee5-e62421c11716">12,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Shareholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to CVS Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares<br/>outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surplus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total <br/>CVS Health<br/>Shareholders&#8217;<br/>&#160;Equity</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Shares</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i23ba03e375294644884d8e56a4a12ec8_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS0xLTEtMS0w_ae7ae955-8cee-4a00-9933-c21ea0a7caae">1,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic9750e3f154044e0bf5e620a4abf5bc5_I20201231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS0yLTEtMS0w_d174f413-fa0e-4e11-ab68-94ea32f3f8b9">423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551bc5b2e45e4537a35491b701e2bc6e_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS00LTEtMS0w_9fa121f2-d8c4-46e4-b66f-177184da942d">46,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9750e3f154044e0bf5e620a4abf5bc5_I20201231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS01LTEtMS0w_95207aad-d4e2-4fbb-8d72-bca35abada02">28,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a860e1fdc9241a88d247676226a1743_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS02LTEtMS0w_e1de0d1e-ff2f-44a1-943c-7490a0f90f6c">49,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic102a7412e044e7dbb913688ea071de1_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS03LTEtMS0w_0ed4bfb7-a3ec-47b8-8be7-2cc28607a581">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2054af963ad94d309c02720a2cfbe212_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS04LTEtMS0w_4f1fecee-ba80-469d-8357-b028cf5f1862">69,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92e4947a219a4f35b8b0e727a77bffa0_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS05LTEtMS0w_cc4f2a8c-8e31-487f-b81e-85eef89c5ca3">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS0xMC0xLTEtMA_78edae45-b127-4909-9949-f3980233ae21">69,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if831d75953f547bf91c30a4f27bf85e5_D20210101-20210331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNi02LTEtMS0w_cd160d7a-7b6f-4979-8dc1-28932b0f9714">2,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a27263e55344aa87673203df970d6c_D20210101-20210331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNi04LTEtMS0w_495c8ef8-38a5-4789-9455-c63d8e084a46">2,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5ba9d09ff88466f96d748c706ada380_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNi05LTEtMS0w_09232207-a6ca-4a96-8ac8-48d288d21837">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNi0xMC0xLTEtMA_0cf1d2d7-165c-40fa-9c62-7e754e68cb23">2,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22d23b76e1394040af9ea41449e89e30_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNy03LTEtMS0w_6f300a09-3745-45b5-ac42-2ff3050f4159">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74a27263e55344aa87673203df970d6c_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNy04LTEtMS0w_e57b86c8-0f27-4e9d-a647-786b655a9581">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNy0xMC0xLTEtMA_f8b9a0f9-84d0-4c0e-a5b7-de9f2c19a4f6">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib469fa63d0a24fd3b8919d0471ce244c_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOC0xLTEtMS0w_3e0f2938-cc1a-4019-bac0-4531bfdfdc8f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86e55f5b316946bca272063c2c239038_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOC00LTEtMS0w_ba871677-b90d-479d-9db2-be26b7fb580f">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a27263e55344aa87673203df970d6c_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOC04LTEtMS0w_eb5c900e-0860-4fd2-9d5e-f9373f66bec9">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOC0xMC0xLTEtMA_ad3cba20-41ca-452d-9e48-b03a45ad55f9">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib76c2965654e4d27a7289e7d74a81285_D20210101-20210331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS0yLTEtMS0w_a3d36f42-c1ec-4ae6-bca4-0cb4bf194dfd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib76c2965654e4d27a7289e7d74a81285_D20210101-20210331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS01LTEtMS0w_3e47f73e-e459-43ba-8f5d-51743f0781f9">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a27263e55344aa87673203df970d6c_D20210101-20210331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS04LTEtMS0w_06a78138-46b5-44a2-a10e-57eb52dd707a">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS0xMC0xLTEtMA_b257dba3-c443-4f14-bd7f-70e54355ae7f">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if831d75953f547bf91c30a4f27bf85e5_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTAtNi0xLTEtMA_4c2c4525-e11c-47f0-866b-9a3d48727554">660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74a27263e55344aa87673203df970d6c_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTAtOC0xLTEtMA_2ae3a441-6854-4616-88a7-d8d7dcf8bf56">660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTAtMTAtMS0xLTA_94292405-4a6f-4fd0-89f5-72cbe27c0467">660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other increases in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5ba9d09ff88466f96d748c706ada380_D20210101-20210331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTEtOS0xLTEtMA_7fc6ad81-78b4-49ff-81e5-549d8e47ad0b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTEtMTAtMS0xLTA_0eee7a55-3e0d-496f-87df-5889e4c55923">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f8f1c6e4cf54f67a77ef5861fe75220_I20210331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItMS0xLTEtMA_eaa8c99d-c372-48f2-80a5-b1449652affb">1,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iebdfe2716bb1440b8056abf51feecbc7_I20210331" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItMi0xLTEtMA_d79af9bc-7b58-45a9-83e2-d1c57a6838eb">422</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0b07933938d4d1fb52659a2713205d8_I20210331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNC0xLTEtMA_8ff228aa-4d86-461e-9162-15397fc95b7b">46,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebdfe2716bb1440b8056abf51feecbc7_I20210331" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNS0xLTEtMA_a2ccaa98-c808-436e-bc23-a18e347c6aef">28,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c062bdcf0194ad8ab5933e999439363_I20210331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNi0xLTEtMA_ed2b954c-4f61-4947-8173-0d5347235f32">51,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9c14939d5344d3b8c3ef6eb09b33da0_I20210331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNy0xLTEtMA_06f0e1cd-37e1-4de8-a028-5878808e2a4b">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8781832d43cd4db79f8719e073082c68_I20210331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItOC0xLTEtMA_f3d26689-56f4-4421-bea6-3cd6eb3cc270">70,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife449814992e43438e58bd3a5248451e_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItOS0xLTEtMA_434a5531-771b-4424-af89-42040618ea42">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2d9c33c5d0445d4b7720d99637d30f0_I20210331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItMTAtMS0xLTA_3e573a7b-09ab-41c9-9628-c0c4632ad3f3">71,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i427a383940a94623a153c763b01bf61c_D20210401-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTMtNi0xLTEtMA_ba38f655-bb40-431a-93de-d23c30738e39">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c3d180e86948ca9c3beded789d010a_D20210401-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTMtOC0xLTEtMA_3fcfee77-98eb-4b17-bdf6-cc22d37f6b23">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f39afeaa0164b9aaae2c4ad2a9488b3_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTMtOS0xLTEtMA_3b0ff278-5a16-4072-9673-f5a4d462a333">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTMtMTAtMS0xLTA_4313deeb-358c-46c5-a4c0-ac247afb69a4">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide68db09236a41bd9e4db1ad61b5f1a7_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTQtNy0xLTEtMA_19b6030b-874a-48eb-b242-b3ecce140dfe">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c3d180e86948ca9c3beded789d010a_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTQtOC0xLTEtMA_8f307786-6a3d-4249-a6f9-de74ef515004">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTQtMTAtMS0xLTA_7827b529-bdea-414e-ac81-5e85c9e1ea7b">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice52c31f671142ff9c5da1e16b8b587c_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTUtMS0xLTEtMA_e4b7e3e5-8072-465e-a258-673719bcb985">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i086fc8748c444262890e455770e0e120_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTUtNC0xLTEtMA_b48973fa-5b00-4cff-af94-b934b37c3d66">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c3d180e86948ca9c3beded789d010a_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTUtOC0xLTEtMA_3fdb27d2-1b73-487d-a8a5-a3b9dd83eef0">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTUtMTAtMS0xLTA_a64ec4d6-d47b-4b46-b772-43fe808eb2d3">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1ed26699159f4e319ec98d041d5818f4_D20210401-20210630" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtMi0xLTEtMA_706373f9-0140-4065-9f3d-5ee06f70df06">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ed26699159f4e319ec98d041d5818f4_D20210401-20210630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtNS0xLTEtMA_7a819f02-085e-4718-abf2-7b94f5c7e3e1">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30c3d180e86948ca9c3beded789d010a_D20210401-20210630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtOC0xLTEtMA_6c58c92e-1ec0-4fd6-9d3c-02e9d95032b3">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtMTAtMS0xLTA_0e9773f7-9d98-4ae0-89c4-57f896271858">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i427a383940a94623a153c763b01bf61c_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTctNi0xLTEtMA_325d9f61-dc43-4190-b488-ec33e47f2fa6">655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30c3d180e86948ca9c3beded789d010a_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTctOC0xLTEtMA_99149a54-186d-4426-8eca-833edf62954f">655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTctMTAtMS0xLTA_90dd8608-e9ba-433f-b48f-87ab78e28884">655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f39afeaa0164b9aaae2c4ad2a9488b3_D20210401-20210630" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTgtOS0xLTEtMA_89fc906f-9eee-43ce-84c9-2edb863eb160">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTgtMTAtMS0xLTA_c7e911ec-cdeb-4f3c-953b-01cc1c2b5fe4">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4687f5e592964cc2a694fd8d54353d81_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktMS0xLTEtMA_d5f594ed-9113-4605-b088-260bc11bc1de">1,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id6540e87000648d19833b26522bbc190_I20210630" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktMi0xLTEtMA_5a4b074b-11ab-42ef-b0cf-f71cf7ac3621">424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b84af36af2c42629e456c37a28e3938_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNC0xLTEtMA_5ea3be2e-d67b-46af-b75e-45b93159eb93">46,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6540e87000648d19833b26522bbc190_I20210630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNS0xLTEtMA_a5e3687d-cd13-4018-8344-29d72d6f0b22">28,252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56f7b57e38ca4b558784c1d56f0aabcb_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNi0xLTEtMA_903ceb7b-71f7-4131-804c-3311890c460a">53,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c1b85bddaae456e90d5a5399f3b4816_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNy0xLTEtMA_b2d9d240-1890-4871-a87e-b5c651ebc371">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ed94c211de47da9c0bd88c599e60f2_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktOC0xLTEtMA_7c22cdad-9b02-44fb-a903-a56041bd888a">73,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab82a09b9c1a400d8e88219f37aea2de_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktOS0xLTEtMA_0146145f-7f34-4bbd-95c3-3e9126feedc3">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed0ba20d2cd461099ef887e226c3e93_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktMTAtMS0xLTA_5760f8c2-823d-4857-825d-4d3584cf72ad">73,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e60a7d260c843d980920a5e304ae972_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjAtNi0xLTEtMA_aa691208-8564-4c02-8190-77f99291b0a5">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a9f6159e4b14b72bff92db8236fd747_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjAtOC0xLTEtMA_dbf85a33-c844-40b8-896f-f1add302b261">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6a97ebcb6674c2096965c9b22aaffc2_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjAtOS0xLTEtMA_bf7caad8-8914-4d43-94b1-85ce3f8c7353">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjAtMTAtMS0xLTA_48aab240-64f4-4a73-8fdc-0b839b4fe087">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4ab8d4ce4d04aecb9a84bbfc6849284_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjEtNy0xLTEtMA_3d85c8e6-5070-4b29-81d0-09220e743200">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a9f6159e4b14b72bff92db8236fd747_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjEtOC0xLTEtMA_9e5df960-bc9e-486a-8f53-0e77e2b33099">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjEtMTAtMS0xLTA_194423b5-9384-44f3-b8c7-a23a16804afa">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0265118fa568463fb1dfa52b691e2fca_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjItMS0xLTEtMA_c5399910-2f71-44ec-a183-1eba118aa4a8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59307294db3d4cf4a1ad0f4df554aaf2_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjItNC0xLTEtMA_05331b88-e255-4dbf-8123-62f8f9e7a21b">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a9f6159e4b14b72bff92db8236fd747_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjItOC0xLTEtMA_f21ce29d-8749-466e-996e-1754c55cf514">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjItMTAtMS0xLTA_53e73e8d-c80a-4f36-be13-97a74195ac2e">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i186f27b850c7471dbc106faa8ac8974c_D20210701-20210930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtMi0xLTEtMA_bae16aa4-1ebf-46cd-a62c-af75a994bea5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i186f27b850c7471dbc106faa8ac8974c_D20210701-20210930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtNS0xLTEtMA_2567cfd5-7634-4093-8d82-13ba8964cc47">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a9f6159e4b14b72bff92db8236fd747_D20210701-20210930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtOC0xLTEtMA_576061dc-12da-4717-969a-4ce874a6abd0">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtMTAtMS0xLTA_d1c09cb0-bbbe-4c80-afca-e5ce96098783">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e60a7d260c843d980920a5e304ae972_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjQtNi0xLTEtMA_835756e1-72fb-4371-932a-f89d3a400305">665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a9f6159e4b14b72bff92db8236fd747_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjQtOC0xLTEtMA_d86b960b-0f5a-48a9-b99d-b0ba7ff829ff">665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjQtMTAtMS0xLTA_d6138027-f06d-4993-ac47-f402f7eb27f8">665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2aa020f1483426a991754c1bc8e4103_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtMS0xLTEtMA_69e14c89-bd6e-44b9-98bf-4e35adaf5916">1,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3d7fc2a5a2924d5991aedae343217836_I20210930" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtMi0xLTEtMA_30ea49d0-0c4c-4253-8deb-c6b8ee4d1ff3">422</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i082bfd21f3b045cbb0aaa7fba7f7804d_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNC0xLTEtMA_d0c66a66-bc83-4916-a3ae-75e089f30f71">47,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d7fc2a5a2924d5991aedae343217836_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNS0xLTEtMA_e93ad5c1-0d07-4d6a-8e38-4a12cc3d1d1a">28,166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac37107e130b46c6b8fd2d7a2c171383_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNi0xLTEtMA_02ffcb2b-52b5-4b0a-89eb-b638f5473b69">54,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9adf9f3e2e264684a8989823942612fc_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNy0xLTEtMA_c06f01cf-8cd9-4d4b-b8f7-d283fb684cb0">1,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11ff217d030454db570ea0bc1a32ec6_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtOC0xLTEtMA_44ebb3ba-078f-41c6-8b8d-070f02c1deb2">74,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64cb0760a3094aa686d8405ae705af26_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtOS0xLTEtMA_28aaf5b8-04ac-48bd-9f7d-94f7dfad7ac8">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtMTAtMS0xLTA_cbc959c7-270f-4466-ba03-473c420b95d2">74,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1" footnoteRole="http://www.xbrl.org/2003/role/footnote">Treasury shares include <ix:nonFraction unitRef="shares" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg4Ng_02fd537f-d763-4274-8780-7a66558f4edb"><ix:nonFraction unitRef="shares" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg4Ng_03b4edd3-6c78-4aca-b222-6b2c90213dc5"><ix:nonFraction unitRef="shares" contextRef="i7ed0ba20d2cd461099ef887e226c3e93_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg4Ng_46fdfc27-425e-4e22-b9f0-25abae5d1dfa"><ix:nonFraction unitRef="shares" contextRef="id2d9c33c5d0445d4b7720d99637d30f0_I20210331" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg4Ng_bd50908c-7a63-429a-86ab-a8c3d1a1dd35">1</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million shares held in trust and treasury stock includes $<ix:nonFraction unitRef="usd" contextRef="i7ed0ba20d2cd461099ef887e226c3e93_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Mg_4c36ba1f-92db-41ab-ab63-d665392e9b85"><ix:nonFraction unitRef="usd" contextRef="id2d9c33c5d0445d4b7720d99637d30f0_I20210331" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Mg_583bda1d-7ac2-4dba-ae87-ce195ae5ad84"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Mg_79270ca0-4751-49ca-8301-f452fd21917f"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Mg_e1a9a934-7ce1-497d-9a77-b523c4a909bb">29</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million related to shares held in trust as of September&#160;30, 2021, June&#160;30, 2021, March&#160;31, 2021 and December&#160;31, 2020. </ix:footnote></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1Nw_b247c82e-4cdd-438b-8461-629d8e081d94" footnoteRole="http://www.xbrl.org/2003/role/footnote">Common stock and capital surplus includes the par value of common stock of $<ix:nonFraction unitRef="usd" contextRef="i7ed0ba20d2cd461099ef887e226c3e93_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Nw_09656635-fc6b-4816-994f-38f800c96d1a"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Nw_1865c2b4-c54d-4afb-9ba9-9aa66a9d43cc"><ix:nonFraction unitRef="usd" contextRef="id2d9c33c5d0445d4b7720d99637d30f0_I20210331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Nw_252bb686-a84d-427e-8c1f-059535be1008"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Nw_9de6c227-b34f-4767-865b-5984d2f1c557">17</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million as of September&#160;30, 2021, June&#160;30, 2021, March&#160;31, 2021 and December&#160;31, 2020.</ix:footnote></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to CVS Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares<br/>outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surplus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total <br/>CVS Health<br/>Shareholders&#8217;<br/>&#160;Equity</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Shares</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47ef065bc8ca45d686c76f5b4b47492d_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS0xLTEtMS0w_961e8554-b46a-4b00-a710-ae6b89ca2aaa">1,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i69acde82d8db408eaa9ed7c6287a2301_I20191231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS0yLTEtMS0w_3c449d66-8194-4b73-b723-40167f9bc6ac">425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice9b45cfa6034116a0bb3a805bb25deb_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS00LTEtMS0w_bcf6bb97-2a1f-4b9e-957f-9bdd06a9f486">45,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69acde82d8db408eaa9ed7c6287a2301_I20191231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS01LTEtMS0w_0e722941-474c-452e-907a-9b9dfdc759d0">28,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63137494a1854ceeb7bd1ce433103833_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS02LTEtMS0w_6ac96658-13b5-4034-b220-73b141e3f808">45,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949dda05f0274cf9b1746bbae441be84_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS03LTEtMS0w_c5ee1989-6867-41a7-ae00-32a02743a096">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie19194eb945449b2be88388ede7f8337_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS04LTEtMS0w_93d82fbb-5191-4f4c-b83f-08b72fdb01fa">63,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90f84206f61549279918a09332e58af8_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS05LTEtMS0w_3c8c14f7-24ca-4e46-b16f-9b21a50878ec">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adcddfef50d4237a36d95774c4b5e7f_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS0xMC0xLTEtMA_7743e1bc-4238-4954-88e5-37ae3cc59c96">64,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi0wLTEtMS0w_b7f503b3-72c7-47e0-954f-75dfffc049a2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20bf1fd8851f4638bdd00a557c5f447b_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi02LTEtMS0w_6b55e493-0bf6-491f-b808-0bf50bf578a7">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0a7e1350bad4522a8484dd42ae70233_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi04LTEtMS0w_024f2e1f-846c-4ae2-8f94-42293da62071">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id069616f8c3a471b9d0a7ef8e5adaa32_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi0xMC0xLTEtMA_bebec290-7fb8-47ed-ad52-695b1989a76b">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1385ab29305c448a9c67d5770afb048e_D20200101-20200331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNy02LTEtMS0w_3b5cbdf0-455c-448d-840b-8418cba01f02">2,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida08eebb482d482f87035620abbf89d6_D20200101-20200331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNy04LTEtMS0w_b4bd5418-0d05-4f85-ba5f-d873e3b0ff1f">2,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i082608aa6b234f278b38aaf17009eb6e_D20200101-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNy05LTEtMS0w_01202f3b-48ab-4412-a7ad-f1a066b963bf">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNy0xMC0xLTEtMA_aa041094-5507-4ff9-a4a5-8bda4850e1f4">2,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id654c856e0c94aafa2fe19dc04299751_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOC03LTEtMS0w_6b800f03-6e5a-4bfc-ab78-0417f5db5b74">332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida08eebb482d482f87035620abbf89d6_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOC04LTEtMS0w_ecd6448b-a3f2-49a8-b5cc-56f0ea840aaa">332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOC0xMC0xLTEtMA_9505257a-7f1c-4984-acda-8d74a50e6539">332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48d4429acad1442ca35208e950d6b8a7_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOS0xLTEtMS0w_a7fb3e2d-6ec2-4487-aff3-b113f3ecad1d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fff271aac61427a93aace91fe11d093_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOS00LTEtMS0w_eff6e367-ca00-44e0-a822-573f8448fcb4">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida08eebb482d482f87035620abbf89d6_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOS04LTEtMS0w_f241bda7-57f1-46e4-b62d-c342f53b92c2">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOS0xMC0xLTEtMA_d04691db-4db9-40f8-8590-29afb9be0ce4">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if946b6b5938546dcb10f22ed41a68dc9_D20200101-20200331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtMi0xLTEtMA_d2f3618f-ccb2-47ee-8a92-3983dd19fe58">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if946b6b5938546dcb10f22ed41a68dc9_D20200101-20200331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtNS0xLTEtMA_2f70f4b2-1c71-4266-869e-ce63c3a83d4c">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida08eebb482d482f87035620abbf89d6_D20200101-20200331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtOC0xLTEtMA_f573c847-9cff-4e3b-928a-edb55caf1bf8">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtMTAtMS0xLTA_daf666e7-1eab-4b7b-9ddd-f6c0424f7a95">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1385ab29305c448a9c67d5770afb048e_D20200101-20200331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTEtNi0xLTEtMA_50465cbd-f27d-4474-86a5-e5fc4337f5bc">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida08eebb482d482f87035620abbf89d6_D20200101-20200331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTEtOC0xLTEtMA_55409cff-37a5-42d7-bad4-25f670bae02c">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTEtMTAtMS0xLTA_364fcd35-bc6a-44c9-9c71-8d8f0b96b7cd">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other increases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i082608aa6b234f278b38aaf17009eb6e_D20200101-20200331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTItOS0xLTEtMA_eaf5359c-3344-42bb-b43a-a60973464659">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTItMTAtMS0xLTA_9c1f8ebc-1425-4acc-a839-60579bbe0eec">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7dd00683a8f140fba68409bd3564961e_I20200331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtMS0xLTEtMA_97a22150-475c-4077-b690-26c4b72a19b9">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic5ce1bd21a3640a79c7e024cab066d90_I20200331" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtMi0xLTEtMA_5a7a6f94-71f1-49af-9f5a-c5337e491d60">424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i874e9eeb56a64352a7d096d7ecf784e3_I20200331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNC0xLTEtMA_628ff552-edb2-42b5-977f-39188ec396c1">46,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5ce1bd21a3640a79c7e024cab066d90_I20200331" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNS0xLTEtMA_b90fd349-d8e5-43ed-881b-24b77604464e">28,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08cf13c568a64de2a8c45a6b75813fc3_I20200331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNi0xLTEtMA_80c45186-4661-4602-bf1d-4501314c91f8">46,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae98d9e6fb345029082485700a2a279_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNy0xLTEtMA_1249ccfc-1e6c-4e0b-83a9-e76b6c5bfa11">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf4d73e8ce60495e83dd3d579a0a6635_I20200331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtOC0xLTEtMA_e5b93d89-67ab-4ac2-b442-05682f3fa5d1">65,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fd60b1e5304049bca379f1eefb23a2_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtOS0xLTEtMA_8a9cf761-48f1-4df7-b1b1-9105cc098216">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26c88d8650047d8a0474834e8096a37_I20200331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtMTAtMS0xLTA_f95e33bd-f305-44a6-87ce-3003f725adfc">65,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87af6ecaa93148af93ee60a00e2bc5fc_D20200401-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTQtNi0xLTEtMA_4b8d3859-d178-4852-b3a0-0a9867079bb3">2,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icace12a02237438d97c47d5283d91ee4_D20200401-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTQtOC0xLTEtMA_cc4525c5-6452-4103-b203-feac79be8f66">2,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib368257cbb8a4dcc9f102a7125dff098_D20200401-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTQtOS0xLTEtMA_de321a85-aabc-4cf1-8b2b-f8decceab33a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTQtMTAtMS0xLTA_94a6330c-9fa9-4207-a812-cc26912cff0a">2,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe896c82eb7d48558a916c2226cdee18_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTUtNy0xLTEtMA_0aea6f30-5bba-4faa-a013-9d21181290f7">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icace12a02237438d97c47d5283d91ee4_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTUtOC0xLTEtMA_65b52d2e-5b2d-4765-9479-1f037c744800">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTUtMTAtMS0xLTA_cf665d34-d7a2-4f57-a34e-89f73a29328b">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i619aa996f3d8498ab4f572d7da7b1ff7_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTYtMS0xLTEtMA_fb7aec88-9630-4521-a746-1b15fb90eda3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffe81af21c64c838090535f9633ed0a_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTYtNC0xLTEtMA_47663ff0-bb33-42e2-8fda-5a986f4f2203">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icace12a02237438d97c47d5283d91ee4_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTYtOC0xLTEtMA_c4aba8c9-aa09-4526-8d82-595553afd176">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTYtMTAtMS0xLTA_ddd93513-0407-4e16-9b08-b72306582aef">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i20587aa2f9cc43dab807a6fd036d6ec6_D20200401-20200630" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctMi0xLTEtMA_0bb5398b-a386-4c1b-aa40-b5891a25a52d">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20587aa2f9cc43dab807a6fd036d6ec6_D20200401-20200630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctNS0xLTEtMA_9af71cce-2a15-49e5-b13c-b7c0458c9e0a">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icace12a02237438d97c47d5283d91ee4_D20200401-20200630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctOC0xLTEtMA_21940468-77fa-4319-8b74-1a62f6895dc0">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctMTAtMS0xLTA_356aa2f7-7a89-48b7-8b92-f7e240b8832d">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87af6ecaa93148af93ee60a00e2bc5fc_D20200401-20200630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTgtNi0xLTEtMA_97a913a3-93bc-43df-ad54-122431ce8f59">662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icace12a02237438d97c47d5283d91ee4_D20200401-20200630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTgtOC0xLTEtMA_a658f509-9ca8-42a5-94a0-7e8d2e178dc3">662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTgtMTAtMS0xLTA_be2d4def-5d18-4b67-b7e4-5d7b94d86466">662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib368257cbb8a4dcc9f102a7125dff098_D20200401-20200630" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTktOS0xLTEtMA_ee87af54-a151-47d7-832a-e30194bc6f2a">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTktMTAtMS0xLTA_d40c9f3f-ab2c-4fa2-9dad-0d274afa4e24">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b392878ff634b039bf5f8e8010826e5_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtMS0xLTEtMA_f69bd105-6257-4186-9b36-195c90a78086">1,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i81afc144424c4e4585c0d1c6720651e8_I20200630" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtMi0xLTEtMA_bdbd385d-1f8d-4b53-9278-ecdb4f1ca047">425</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id11218ddb52b4b7889cb60e1b16b1edd_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNC0xLTEtMA_bcaaf698-4b3f-4af4-9fcd-bf465e2d066f">46,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81afc144424c4e4585c0d1c6720651e8_I20200630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNS0xLTEtMA_903d301d-a3f1-4b21-a771-9aec8812fe7e">28,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2b0a74f321415ab4143fba6052d3fc_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNi0xLTEtMA_8858cc98-2ecb-4b10-af03-2791e6de5d3b">48,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida30c27c4c6849159ca6711a4c1037d2_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNy0xLTEtMA_e37b813c-415b-4c3e-b32d-686903d01157">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd3c26ba9f894ca9a7da1af89a150bf8_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtOC0xLTEtMA_a56e8e1e-3d3f-451d-8f0a-a12d2050f501">68,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d552fb03c44883bdd9e4c09723809d_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtOS0xLTEtMA_48b4d894-c2d9-49de-8dbf-a762780723b9">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccddc7d61a62405bbd6126135b096cc4_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtMTAtMS0xLTA_bb352f11-9c9a-4540-9e22-aa023cce7d54">68,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac3c8def758f4306a0225b383df470e6_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjEtNi0xLTEtMA_02c126bf-1638-470d-9e5d-6dd9995280f6">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba7be38e83d341e093f4c569c8926177_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjEtOC0xLTEtMA_4ee5f70a-986c-4e0c-8a69-dc74c748956a">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie66834e318c34f77b62a7489806c5c36_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjEtOS0xLTEtMA_29cd5bc5-4df0-4639-8b0c-53f42222a1a3">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjEtMTAtMS0xLTA_6b65127a-5e01-4662-b10f-ab877b8d894d">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04578fac9b784d489a884552dd60834b_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjItNy0xLTEtMA_7658b002-805b-4029-81f0-655919fdfb63">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba7be38e83d341e093f4c569c8926177_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjItOC0xLTEtMA_e703f333-71dd-4644-9db1-b0adb7256f93">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjItMTAtMS0xLTA_2db780ad-bc2b-475e-b73e-319a275a3b17">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2900b425253d40ca9ff265afb5d2e8ee_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjMtNC0xLTEtMA_36dd9700-2ab6-4371-9922-e173326f8a6f">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba7be38e83d341e093f4c569c8926177_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjMtOC0xLTEtMA_0b1b021d-19d7-42f0-b33b-7502e63528a4">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjMtMTAtMS0xLTA_e38dd1c8-f8ce-4187-8a75-2e85a3631793">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb8d675420f0416490172136b95d4f77_D20200701-20200930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtMi0xLTEtMA_360f5eeb-beba-40ed-8cca-0a920d5a120c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8d675420f0416490172136b95d4f77_D20200701-20200930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtNS0xLTEtMA_3b76e1bd-f0c1-4144-80fd-b209578840b3">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba7be38e83d341e093f4c569c8926177_D20200701-20200930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtOC0xLTEtMA_c8c5388d-9d1a-4e20-87b0-f6e96e06647d">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtMTAtMS0xLTA_e2e27be2-864e-464b-875d-a7b51b4f9d3b">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac3c8def758f4306a0225b383df470e6_D20200701-20200930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjUtNi0xLTEtMA_cb40e00f-dda0-40ce-be89-856870c903aa">664</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba7be38e83d341e093f4c569c8926177_D20200701-20200930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjUtOC0xLTEtMA_a123a1e5-af37-489a-b8c4-54da0702445b">664</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjUtMTAtMS0xLTA_89454259-1c1e-4072-b2e3-8db10e438d80">664</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie66834e318c34f77b62a7489806c5c36_D20200701-20200930" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjYtOS0xLTEtMA_fe9c2db8-b018-498f-9450-201cd2c8871e">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjYtMTAtMS0xLTA_dec47102-d0fb-4344-854d-0ce206db37e0">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia4b4ffbeaad7402bafb6efb81912f182_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctMS0xLTEtMA_330b411d-f524-48c6-a81e-1400c8cdb0af">1,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i64b99e857d05479fbde03dab04aacd4c_I20200930" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctMi0xLTEtMA_b0287672-564a-41d3-bd32-0089b65be989">423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c4351afa1124647b74064aed3c9b1ed_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNC0xLTEtMA_5e486fe4-2705-4eb0-9011-2efff2473d31">46,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64b99e857d05479fbde03dab04aacd4c_I20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNS0xLTEtMA_1b5f60bb-10d7-4399-bfbb-a23d0366a7f2">28,164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea10f7ec17074278bce5534f7460eebe_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNi0xLTEtMA_65f68640-0384-455a-905d-4ea3fd2cc371">49,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9c67264f8554c16b088c68a6bf79e3e_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNy0xLTEtMA_b8c4c0f1-28dc-4d7d-b090-540a79820445">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i741f16a969ec4437b522117aeb1529bd_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctOC0xLTEtMA_b6418437-81e2-4d88-8ebe-a11f2f57ee28">68,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94eca1fb7324209b95d6bcfa9878abc_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctOS0xLTEtMA_5a49f646-ae09-4f9b-a94a-7bc9722c705e">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie81f391964c947c2b2bd32278edef5e3_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctMTAtMS0xLTA_cfe2bf0f-b4bc-4311-91e5-ca4e24cb842d">69,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b" footnoteRole="http://www.xbrl.org/2003/role/footnote">Treasury shares include <ix:nonFraction unitRef="shares" contextRef="ic26c88d8650047d8a0474834e8096a37_I20200331" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk2Ng_160bd428-88a1-449c-8531-a7494fc444e0"><ix:nonFraction unitRef="shares" contextRef="iccddc7d61a62405bbd6126135b096cc4_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk2Ng_b4e88ab2-ec4b-4af8-b96d-a48338470065"><ix:nonFraction unitRef="shares" contextRef="ie81f391964c947c2b2bd32278edef5e3_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk2Ng_d9f91d44-2de2-4ed8-91ff-40d1f4f589ac"><ix:nonFraction unitRef="shares" contextRef="i4adcddfef50d4237a36d95774c4b5e7f_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk2Ng_eb3f53ad-b972-4da1-9dae-8fc9ce404de7">1</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million shares held in trust and treasury stock includes $<ix:nonFraction unitRef="usd" contextRef="ic26c88d8650047d8a0474834e8096a37_I20200331" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk3Mw_480a1147-9755-4cfd-b7c7-0c5e263de478"><ix:nonFraction unitRef="usd" contextRef="i4adcddfef50d4237a36d95774c4b5e7f_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk3Mw_86217f0f-4801-4833-ba3e-c3e5b62b5c47"><ix:nonFraction unitRef="usd" contextRef="iccddc7d61a62405bbd6126135b096cc4_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk3Mw_bb608600-131a-457e-a2e3-d4f3ed6e9196"><ix:nonFraction unitRef="usd" contextRef="ie81f391964c947c2b2bd32278edef5e3_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk3Mw_e6d3eb4c-435d-492f-8991-ff7e70b0a0cb">29</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million related to shares held in trust as of September 30, 2020, June 30, 2020, March 31, 2020 and December 31, 2019. </ix:footnote></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OQ_7436366d-7ad1-482d-9dca-49b1e4c4ff23" footnoteRole="http://www.xbrl.org/2003/role/footnote">Common stock and capital surplus includes the par value of common stock of $<ix:nonFraction unitRef="usd" contextRef="i4adcddfef50d4237a36d95774c4b5e7f_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk4MA_065ef590-7321-4578-8c41-9a8cc78fa684"><ix:nonFraction unitRef="usd" contextRef="iccddc7d61a62405bbd6126135b096cc4_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk4MA_a653534c-e9a0-4db7-8e1f-53fe3a0b8bb9"><ix:nonFraction unitRef="usd" contextRef="ic26c88d8650047d8a0474834e8096a37_I20200331" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk4MA_d759832e-b130-4d83-b44c-057a76204355"><ix:nonFraction unitRef="usd" contextRef="ie81f391964c947c2b2bd32278edef5e3_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk4MA_d7b252f0-12f1-4d81-8780-2c544eedd414">17</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million as of  September 30, 2020, June 30, 2020, March 31, 2020 and December 31, 2019.</ix:footnote></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA2MA_c3424baa-b3bf-46e8-ba70-dcb721cc4745" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 326), which resulted in a decrease to retained earnings of $<ix:nonFraction unitRef="usd" contextRef="i253d046d1d4543a0a2641f1e7e78877d_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfOTE2_1a231f0e-4661-4166-93e0-2124f42e83e4">3</ix:nonFraction>&#160;million during the three months ended March 31, 2020.</span></ix:footnote></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_37"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzNDU_06487801-4ee7-4ac6-a914-ccfd3d0ecce5" continuedAt="if6e2871a667441b894f2dfa9842272bf" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if6e2871a667441b894f2dfa9842272bf" continuedAt="ieda322155b034e6a959274dc3e5e806e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (&#8220;CVS Health&#8221;), together with its subsidiaries (collectively, the &#8220;Company&#8221;), has more than <ix:nonFraction unitRef="location" contextRef="i7d765d02ede34e5fa56a51625a55c188_I20210930" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:NumberOfStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTgx_004205b2-e550-4007-b080-05ad31b41103">9,900</ix:nonFraction> retail locations, nearly <ix:nonFraction unitRef="clinic" contextRef="i7d765d02ede34e5fa56a51625a55c188_I20210930" decimals="-2" format="ixt:num-dot-decimal" name="cvs:NumberofWalkInMedicalClinics" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMjE2_844cac75-6712-407d-bdca-f4868e85fd3b">1,200</ix:nonFraction> walk-in medical clinics, a leading pharmacy benefits manager with approximately <ix:nonFraction unitRef="people" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:NumberofPharmacyPlanMembers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMjk5_a14f1874-8494-408f-bc2f-58333c7221d5">110</ix:nonFraction> million plan members, a dedicated senior pharmacy care business serving more than <ix:nonFraction unitRef="patient" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt-sec:numwordsen" name="cvs:NumberofPatientsServedperYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMzc2_714277c6-5210-402e-99ad-65bf2a826b72">one million</ix:nonFraction> patients per year and expanding specialty pharmacy services. The Company also serves an estimated <ix:nonFraction unitRef="people" contextRef="i0c3ac878cf024e6d80d9917247d48b26_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:NumberOfPeopleServed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfNDc3_e7c6e029-497f-4101-aac1-e02a12932922">35</ix:nonFraction> million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) continues to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTY0MTI_4ba7673c-9287-489f-b00a-febd8dee6452" continuedAt="i2cfbc5ca8cb84d108ae4a5f0caba2e75" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI2Nw_cc2110a0-c7c9-4415-8519-5424dc636492">four</ix:nonFraction> reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, the Company has submitted regulatory filings for a January 2022 entrance into the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in <ix:nonFraction unitRef="state" contextRef="i9af0cc01cbc54c9f9e8615532da5bb0c_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfNDk0NzgwMjM0MjE2NQ_a36741e3-4202-47dd-bcde-2a3ad28898ce">eight</ix:nonFraction> states.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Pharmacy Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of September&#160;30, 2021, the Retail/LTC segment operated more than <ix:nonFraction unitRef="location" contextRef="i7d765d02ede34e5fa56a51625a55c188_I20210930" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:NumberOfStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfNDY1NA_004205b2-e550-4007-b080-05ad31b41103">9,900</ix:nonFraction> retail locations, nearly <ix:nonFraction unitRef="clinic" contextRef="i7d765d02ede34e5fa56a51625a55c188_I20210930" decimals="-2" format="ixt:num-dot-decimal" name="cvs:NumberofWalkInMedicalClinics" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfNDY4OQ_844cac75-6712-407d-bdca-f4868e85fd3b">1,200</ix:nonFraction> MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ieda322155b034e6a959274dc3e5e806e" continuedAt="if40fc2da2e454b16882ffb3de3e718ca"><ix:continuation id="i2cfbc5ca8cb84d108ae4a5f0caba2e75"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzNTk_e45975ad-1074-4cff-83eb-d63b431ad251" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the &#8220;2020 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzODg_78420c52-7cf9-4476-8af3-2cea0973bf97" escape="true"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzODg_f207417a-888c-412d-8c9d-88b99d89d71b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if40fc2da2e454b16882ffb3de3e718ca" continuedAt="i4812f9bb908143e99de258318a31c6e5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzODM_2d8b385b-0215-4f88-bd4b-03a6e7754da9" continuedAt="i4578981f67aa4e22a8590c1d5ece73ce" escape="true">Restricted Cash</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4578981f67aa4e22a8590c1d5ece73ce">Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzOTc_ebb1651b-deb2-4a7d-881f-6e668b2ed9ab" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmI3ODE3Yzk4MDczYTRkY2E5NzQ3Mjc4MTk3ZWVjYzA3L3RhYmxlcmFuZ2U6Yjc4MTdjOTgwNzNhNGRjYTk3NDcyNzgxOTdlZWNjMDdfMS0xLTEtMS0w_33f03c85-46e8-4fbd-b9ab-0667f6426329">9,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmI3ODE3Yzk4MDczYTRkY2E5NzQ3Mjc4MTk3ZWVjYzA3L3RhYmxlcmFuZ2U6Yjc4MTdjOTgwNzNhNGRjYTk3NDcyNzgxOTdlZWNjMDdfMS0zLTEtMS0w_5071ef91-838b-4554-bca2-137c7e4bd82a">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmI3ODE3Yzk4MDczYTRkY2E5NzQ3Mjc4MTk3ZWVjYzA3L3RhYmxlcmFuZ2U6Yjc4MTdjOTgwNzNhNGRjYTk3NDcyNzgxOTdlZWNjMDdfMi0xLTEtMS0w_daeafe3e-8b8b-48cf-8986-24bdbddaa401">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmI3ODE3Yzk4MDczYTRkY2E5NzQ3Mjc4MTk3ZWVjYzA3L3RhYmxlcmFuZ2U6Yjc4MTdjOTgwNzNhNGRjYTk3NDcyNzgxOTdlZWNjMDdfMi0zLTEtMS0w_71e6de45-694a-4019-a877-d8a3b70e1a73">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmI3ODE3Yzk4MDczYTRkY2E5NzQ3Mjc4MTk3ZWVjYzA3L3RhYmxlcmFuZ2U6Yjc4MTdjOTgwNzNhNGRjYTk3NDcyNzgxOTdlZWNjMDdfMy0xLTEtMS0w_2b37856a-299d-4fbf-9360-b40ca9ec5793">10,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmI3ODE3Yzk4MDczYTRkY2E5NzQ3Mjc4MTk3ZWVjYzA3L3RhYmxlcmFuZ2U6Yjc4MTdjOTgwNzNhNGRjYTk3NDcyNzgxOTdlZWNjMDdfMy0zLTEtMS0w_cc03bc2f-fe2d-487d-b549-5542544bfcfa">8,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzNzc_85e2a1ca-8415-47a5-a55a-5c34ccca5bb9" continuedAt="i01facb0a4e2246e9acf67a64ab63ea86" escape="true">Accounts Receivable</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i01facb0a4e2246e9acf67a64ab63ea86">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations</ix:continuation>. <ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzODQ_94f3ac13-d8ca-4693-b9d6-3cdf366d59a7" continuedAt="iad0f1d63ed9a440bb3358672bd96f161" escape="true">Accounts receivable, net is composed of the following:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="iad0f1d63ed9a440bb3358672bd96f161"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfMS0xLTEtMS0w_1f6f5f70-9145-4017-b673-8d2719c178ae">8,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfMS0zLTEtMS0w_997eb991-6b2a-4409-bc93-5fce3369285b">7,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:VendorandManufacturerReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfMi0xLTEtMS0w_90b8b622-f700-4063-800c-7a51887fb7d1">11,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:VendorandManufacturerReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfMi0zLTEtMS0w_59d94add-f0a9-4aef-b5c0-bea9ae219712">9,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PremiumsReceivableAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfMy0xLTEtMS0w_5f214981-4c8e-4bb1-86d6-b0b864ae392c">2,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PremiumsReceivableAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfMy0zLTEtMS0w_76acc15e-484a-40b4-9795-a493c708da5f">2,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfNC0xLTEtMS0w_c1eccdaa-6515-4377-9541-1af4787b6fe1">2,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfNC0zLTEtMS0w_0060aae0-074f-466d-8464-77cae90e99c2">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfNS0xLTEtMS0w_4553aacb-0539-44c4-ae77-2bdc97e5bdb7">25,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfNS0zLTEtMS0w_1118360b-45e0-483c-85b0-f4403a8f0538">21,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $<ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfOTAyOA_69960806-9e69-40c7-9960-eb4cba858645">364</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfOTAzNQ_26e5e2c2-07e7-4818-9f00-ea19b34eef25">358</ix:nonFraction> million as of September&#160;30, 2021 and December&#160;31,<br/>2020, respectively. <ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzODk_55ac3363-5bd8-4938-9f0d-03d1fb8f852e" escape="true">When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4812f9bb908143e99de258318a31c6e5" continuedAt="ic114efc2685343beb4c133313fccc7eb"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTY0MDQ_3104779d-7c39-4fa8-9304-067d0bfb6b1e" continuedAt="i1dc3d89b27124898bf623f5f6e0a682a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue by major source in each segment for the three and nine months ended September 30, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03ddd201af14457bbc83df4348f9bad1_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMy0xLTEtMS0w_c7677a46-28c1-4eb4-85c5-f46a59b3335e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i412e5ff6392245189b7c9456c23bf31a_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMy0zLTEtMS0w_326c8910-d948-4aea-998c-906df6847832">38,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia533baf499d04c8ca9ae5911bd795ab9_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMy01LTEtMS0w_5eee6bd7-c812-49cb-b77d-6302ef26ab8e">19,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i290002d5729c495f8ac74f3b19d7d0fb_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMy03LTEtMS0w_6ebd10f0-4300-4327-b5dc-c42bf2ebad36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3894328a8f1466c8e456c94b93be275_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMy05LTEtMS0w_8139a42b-63b9-4993-9dc4-48e2e8c0d38b">10,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab7ca31512a47f9b1c6b3868a809813_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMy0xMS0xLTEtMA_8d909931-83bd-42f7-bf36-8c68ae9a0122">47,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf2284c5d324dbc834c16b94260f82a_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNC0xLTEtMS0w_966925e2-5dd4-4cbf-9f62-627fbef3878e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7eccee89ee34209972dbe04829f41a0_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNC0zLTEtMS0w_5165c909-7fa0-4776-b887-dfe104eee23a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i625652e7d45b4702a574e3cc0bc9ee59_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNC01LTEtMS0w_e86984e4-5927-439d-a5fb-f23df7cc4361">5,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ff4f742554a4022a187f1fa185cc04e_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNC03LTEtMS0w_c00b7e23-5301-4d97-92f2-129913d98370">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b79029d3d0422f91971672e000f6b6_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNC05LTEtMS0w_228afb41-4dac-44eb-a989-eee703e284d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib390a8745a16401b9768897652fc449c_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNC0xMS0xLTEtMA_1389b602-e8bc-4cc6-9edf-92d99d9f863e">5,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3ec90dc0814b88b58bd914fedc0407_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNS0xLTEtMS0w_8cf8588e-7db9-4241-bda4-0e350875daff">18,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic247236f845346c988b0332f27fa5573_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNS0zLTEtMS0w_37941299-7fa8-48f9-9996-7a3c77846838">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id372e9bfe6bb44eeba5d3ea51e988f33_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNS01LTEtMS0w_640ea7f1-829e-4261-8385-f440b6c81929">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61c65f32eec4471868eff06cba27f89_D20210701-20210930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNS03LTEtMS0w_8e5addd7-d7d6-480e-8fc1-652995643266">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ab8ae673ac4c12938a12847aa81a22_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNS05LTEtMS0w_718c9f46-1d64-4e57-9876-3358fb81985f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i713ef3848ad542c18962c0cc34fc33eb_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNS0xMS0xLTEtMA_8f23b40a-fa04-436c-87bb-c3c711f394d2">18,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia630bb470ae642f8905431f2e294870b_D20210701-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNi0xLTEtMS0w_4a048e00-0e58-494f-a38b-3b12da4f2acb">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNi0zLTEtMS0w_6ac8a6f1-ecfa-4436-9f7e-28085f117166">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25b37ce901e241a68a26af12fa5a391b_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNi01LTEtMS0w_a3a7dff5-fadf-4c8e-b4f5-240e24da5451">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c910bf185e14abb8f843118e080650b_D20210701-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNi03LTEtMS0w_d0212144-e256-447e-a202-64c5c0727ed6">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNi05LTEtMS0w_feeaa530-be87-40c9-ad0b-d5d4cca491ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNi0xMS0xLTEtMA_c09f8661-055d-4347-aece-1b7dd8aaf574">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i583100df6a7145b9ad53eb0bc9fc4236_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNy0xLTEtMS0w_67f07158-da98-483d-bc1b-d88bd34af9c2">1,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4c6beff36b46b0b7456de5c1600949_D20210701-20210930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNy0zLTEtMS0w_70aeee9e-6931-47e2-aa17-b98f4d237e8c">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91168981806a44fcada2dd00fcdacabe_D20210701-20210930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNy01LTEtMS0w_c597724e-4dda-4908-b0ad-b86230c5b347">643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa6342f43a2c4bbaa5a4beabc6f6e0d9_D20210701-20210930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNy03LTEtMS0w_aed1140b-ddcb-467c-ad6e-11d59bebdfc8">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i818171c70ff34861b15de5ffb456cd9d_D20210701-20210930" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNy05LTEtMS0w_da29dd4d-d746-43ab-826b-7e948c40b53d">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d20d815682465bb2bb57dc75692e06_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNy0xMS0xLTEtMA_aceabe4d-f4e6-4a6f-a5fb-91816e3c7ada">2,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia630bb470ae642f8905431f2e294870b_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfOC0xLTEtMS0w_80a3b066-10c4-4c2f-94cd-09822785ec5c">20,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfOC0zLTEtMS0w_c102abfb-e8d1-40f1-9712-f5cf4a5754b8">39,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25b37ce901e241a68a26af12fa5a391b_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfOC01LTEtMS0w_8aad4bc0-fe12-4ee8-8a4b-20b90443cd38">24,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c910bf185e14abb8f843118e080650b_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfOC03LTEtMS0w_febba8a2-f935-476e-b752-4e961a8771ff">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfOC05LTEtMS0w_8217b983-9c35-4f0d-ae72-b21fdaf16109">10,894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfOC0xMS0xLTEtMA_19a09a67-48bc-4d41-8cf9-4541d32aa4a5">73,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i713de0630b2c4ae48f9171b5d5051b83_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTEtMy0xLTEtMA_7d8c95f2-680c-4c8e-b171-58c17b7c8851">23,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eef7665d65c4130b53d504334affcd0_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTItMy0xLTEtMA_0adce520-62bb-4bd0-b05a-c57a92af56f8">15,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dd05f21d6b243cb8fde4098a5393a14_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTMtMy0xLTEtMA_b5ea04d9-799f-44cf-8ea3-669cb23a5f38">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTQtMy0xLTEtMA_4dcff8b8-1e6f-4454-8a0b-15297acb9d91">39,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabd597abb76543afb656b9b04aa8e034_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTgtMS0xLTEtMA_e54101cc-0f6e-45b0-88e6-591aaf71418c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05a987898eb94aac864574fe231e3a18_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTgtMy0xLTEtMA_9d9a698f-0781-4794-acff-5ad4d13ffced">35,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf8640ff8c964e05b35cb76754034a11_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTgtNS0xLTEtMA_3d129ca1-0794-4486-a2a8-dce68b9e5cb8">17,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0da9396c07ac45aa88b14bb17a63332e_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTgtNy0xLTEtMA_458db50d-8a3b-4f36-b995-23fca51e3d55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0b6b6a5a9634ad0b60f62d11118f057_D20200701-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTgtOS0xLTEtMA_8b5230db-8c18-49f0-a96e-bb54b9f5d3f5">10,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1cb227ce25418f98cdb4c840a209b3_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTgtMTEtMS0xLTA_77e632f8-fdbe-42f6-8fbe-407a5a140c2e">43,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic02cc6173d9844a4af5efdc0fe2df7f5_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTktMS0xLTEtMA_42c84ba3-e39f-484d-bf6f-2d3725cfe8fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6984fc17f7d8475f874f4de494cb3c48_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTktMy0xLTEtMA_47ba7a1c-dbf5-4ef2-b76f-c9e89108ed1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c255846afcd4865851ce574828f1003_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTktNS0xLTEtMA_a47ab361-b2d2-4abd-b698-97e686038a48">4,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfee72d1a0443d680828612b3a96710_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTktNy0xLTEtMA_30c94a2b-90ed-4fcb-be0a-531db73ca560">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic576deaca0f04caea39ef63cbd517eeb_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTktOS0xLTEtMA_523ee587-01cd-4a4d-864b-c468f2f02cf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2893b2b18b814343a59acf92e7535ee6_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTktMTEtMS0xLTA_0e5c06aa-cb4c-4cda-83c3-d0f191ceaee4">4,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4997bd10dafe4ccd9f92c679e0ffd1c1_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjAtMS0xLTEtMA_bfe0e1a4-f572-483c-91b6-84b6dfe7a4b4">17,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5772c520e35f4b77b4c2c79644da46dd_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjAtMy0xLTEtMA_f1304983-0d1b-49ce-86a0-9631283aa5dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ac823ba7ff34a13a62385beff1f8dba_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjAtNS0xLTEtMA_df9af2b0-b243-4c7b-8753-cfceb41aa799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia22d065e2388491692af56f354d79db7_D20200701-20200930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjAtNy0xLTEtMA_b76ff342-cb1c-4538-8363-e0f59253ce66">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dc4395dff1d4c82a9760c20fceda344_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjAtOS0xLTEtMA_e110f58d-2d43-47b0-9ad7-432d2a4e8036">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3576406107f47d7858dda78d75a6417_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjAtMTEtMS0xLTA_60cf9da7-23f9-4a8a-b0ab-cf5e3ec5f68e">17,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42ba3552a810439d9832cae42b188533_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjEtMS0xLTEtMA_18d9f52a-ed44-4a13-aa10-a6644f296612">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjEtMy0xLTEtMA_a1d122a5-6a2c-43ac-bfa5-a0b2648b80f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c29ab4601174287b450f53152b36d36_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjEtNS0xLTEtMA_fc4e4fea-bd85-47e6-ad5e-ecc62e571ca8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjEtNy0xLTEtMA_79c73f1a-7689-4616-8f99-fd365995a444">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea31066dc7804044ae36620bede68059_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjEtOS0xLTEtMA_706e26f0-04b6-4776-bc31-1244d544ad45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjEtMTEtMS0xLTA_28db1d3f-bd76-478a-8c9c-c686cad3d768">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cdc8fa97da54c4a83f3e7c81196ef40_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjItMS0xLTEtMA_e90ccae6-4875-42c0-b894-38690bc6234f">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aff50c37dc4454689af8f6f2c7cfa70_D20200701-20200930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjItMy0xLTEtMA_5369985a-fdc0-45fe-951e-da3abf56125f">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3cbdb53e0614fd69d22b0611082a4fa_D20200701-20200930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjItNS0xLTEtMA_e60628b5-9afd-4983-ab2d-444451f4dd8e">377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63014255cc54440493b3c80ebe5cbf20_D20200701-20200930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjItNy0xLTEtMA_29ed019b-7773-41ae-8231-5fc1932af81c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib30ff9d3c92d44c69e87a939aee311b7_D20200701-20200930" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjItOS0xLTEtMA_4c3d0e42-790e-4be4-8be4-3603aafab3f9">143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e8ad852fbc47aca12f0dc2b4d1819d_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjItMTEtMS0xLTA_91602a4c-3a16-41ab-9638-da6d5260b272">1,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42ba3552a810439d9832cae42b188533_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjMtMS0xLTEtMA_709d31e2-873b-41e7-ab1d-62870ae9efa9">18,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjMtMy0xLTEtMA_6474a4f2-258a-4a33-8fce-af869173f834">35,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c29ab4601174287b450f53152b36d36_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjMtNS0xLTEtMA_e521699a-1b72-4409-b687-d92fd8518897">22,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjMtNy0xLTEtMA_955581f1-a7aa-4fe0-b7f6-97938938dfd8">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea31066dc7804044ae36620bede68059_D20200701-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjMtOS0xLTEtMA_98b3381a-af00-4971-861c-8a016e41d00a">10,194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjMtMTEtMS0xLTA_dd871b32-a593-46af-ad96-da06fa9fe359">67,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5439e4bb5845809fd326a3d2d9535b_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjYtMy0xLTEtMA_0078c9c6-b5ef-44c5-a1d4-f6260fe0506e">21,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia370cae5def349beaf1f0d98272cbc86_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjctMy0xLTEtMA_9682fe74-fd6a-40d4-8eac-905ebeabf562">14,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383e9e49c580468f96d67226826b3701_D20200701-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjgtMy0xLTEtMA_37481c93-5cba-49ab-8db2-ca39122d08cf">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjktMy0xLTEtMA_c7bb5b2a-e7e2-4297-8e55-baca7e147b49">35,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic114efc2685343beb4c133313fccc7eb" continuedAt="ie041cd655e524f8c8756ce07cd0b063d"><ix:continuation id="i1dc3d89b27124898bf623f5f6e0a682a"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdbb1d0471e422b94075bd37bc906a7_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMy0xLTEtMS0w_faea34aa-72a8-4164-a4d4-981bfcad2fa3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa352e072fd64bac9be7da2a91adf04b_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMy0zLTEtMS0w_6e02ea38-0e63-4739-87d2-d6537d70ae35">113,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11a639bc0634a7f934934ab6d3ea9e6_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMy01LTEtMS0w_ac1a5604-939a-4e50-be98-0aea0280d3e7">55,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77461fd39fbd4219b11e33a2ae292268_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMy03LTEtMS0w_5b6ed579-38a4-40f4-8522-9682d35326a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8f710bc255b4ddabb067c4df0121ed6_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMy05LTEtMS0w_623291e4-7749-4f15-94a5-b3b45db2740d">33,025</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic48a2e72c0a444fd9aa88f429033c37f_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMy0xMS0xLTEtMA_844084a9-13df-41e7-8ef7-fc7a9333fdb8">135,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47a917ec1af4c5db06417fff5be5881_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNC0xLTEtMS0w_2b934f92-1ed9-4016-8fe8-24f24870dd2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if898d4a04a094d2fbda70a5bce06fbff_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNC0zLTEtMS0w_e9a892ef-90f6-49c2-93f3-337d068bda19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df45e3a2a5c4b17bf3ad60977af7588_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNC01LTEtMS0w_6845a8ee-3b21-455e-8aef-4d932b748c4c">15,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d918c713f67448682d7c685dc82da6b_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNC03LTEtMS0w_4fa53ef2-23c6-4eb4-bbd1-a0ca75023d78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34039126a3d845358fb813264ce5d92f_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNC05LTEtMS0w_3465906a-2d7d-4cce-9bd0-e681b033c5c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb505e76b20f4068b74c4b35f149f619_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNC0xMS0xLTEtMA_5f8481ce-9afd-4be6-9cdf-52a11a294ac9">15,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib14d585750a94bcf85c1726868d8ed22_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNS0xLTEtMS0w_53d7ae55-ea79-418a-9f09-78809dc04be9">56,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad03227c933241798aeed098ed54ba11_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNS0zLTEtMS0w_879c91a8-d1f0-4c35-b9ca-d4765b6f8cd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9901c4b8de6e4460ade56fa6d6a6c4df_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNS01LTEtMS0w_b4fc7e09-7930-4244-828a-693fafbba07e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb4ce333dc4b4ac6a6db70a32f589fa0_D20210101-20210930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNS03LTEtMS0w_607f1372-23dc-40ef-b6b3-ae69c9cc5fb5">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d5483cd591a4ba29922131097dcc0a7_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNS05LTEtMS0w_039463b5-b991-4742-9272-3c613704bc09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3777a80d7d548dd86f819a7a8c68626_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNS0xMS0xLTEtMA_3635a0e4-7071-499c-a656-1465bbf04860">56,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc744230a544ead88ffab3c45d0c454_D20210101-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNi0xLTEtMS0w_0ebc7173-d883-42ba-b473-7a6c205452ad">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNi0zLTEtMS0w_e96bad39-080c-4473-84ac-e370c87d46df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b445faeec3845f6b11c9569be49f9fb_D20210101-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNi01LTEtMS0w_69269f94-0217-49cb-ac2f-5830db95f9f4">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNi03LTEtMS0w_57fece00-1749-4e7f-b6ec-6695bac8d1fd">387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i472a8387964b45ec897885f8bc357e99_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNi05LTEtMS0w_02c64a20-9aa3-45df-8a82-c1759da384d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNi0xMS0xLTEtMA_0940a4bb-9370-4566-b476-b976716f4639">832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f347f866918415994fa315bd6128224_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNy0xLTEtMS0w_2e70ac17-d783-42c1-82c9-c4214c8fd8ff">4,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009f875b81cb4be983f6d06abb32da71_D20210101-20210930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNy0zLTEtMS0w_88673af7-856f-4dbf-9777-0dbe1467e7aa">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ce155a0217b4ef6b1d855626c01d3b7_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNy01LTEtMS0w_eef07f41-f566-4aae-a8fa-c41d79b018c8">1,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebd9dc275854c4faf090e45cccef77b_D20210101-20210930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNy03LTEtMS0w_6a88a787-8ded-4a73-b3ba-b6e9dba0a653">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8111b2822cf741f59d35a0e165fda8f6_D20210101-20210930" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNy05LTEtMS0w_074ff14b-c02e-4b44-b6df-3b9f866e1c54">118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5082f90c86d41ae9be5d122e912ec22_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNy0xMS0xLTEtMA_c5b4d510-b870-4cf2-ab85-98140a6ab266">6,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc744230a544ead88ffab3c45d0c454_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfOC0xLTEtMS0w_76b9c7f3-7fae-498c-bf04-11a7b2e6c859">61,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfOC0zLTEtMS0w_395fc2c9-aeb9-4418-9c8d-4c442a50b65b">113,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b445faeec3845f6b11c9569be49f9fb_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfOC01LTEtMS0w_0ed354a2-a5a9-47fa-aab2-12fb661916ee">72,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfOC03LTEtMS0w_e194472b-a77e-495a-94c9-d53f462c0f5d">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i472a8387964b45ec897885f8bc357e99_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfOC05LTEtMS0w_73c1f934-7fe0-45a4-8ae2-28207770b738">33,143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfOC0xMS0xLTEtMA_648c09e2-19d2-4409-8698-783ad36c5984">215,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib50abeadc51e4faca566c3e8f770d30b_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTEtMy0xLTEtMA_cbd7feec-915b-4d96-a6c3-a3c7d08754df">68,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib624b26fc2464997942a122cf2a18d64_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTItMy0xLTEtMA_08f88d92-fc51-4f97-9ca1-fee7bdd7aefa">44,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9867d0a744a545c08b139379b67df848_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTMtMy0xLTEtMA_35573d52-5191-4ab7-8f34-fe25cc538367">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTQtMy0xLTEtMA_2a47b9c2-815d-4986-8dc0-75942c24188e">113,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020   </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15d6678bc52c4b1b9a3992371795d9ba_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTgtMS0xLTEtMA_568fcf78-093f-4387-840c-01383d1bec9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6674a9f6c2a41b19f32aefffb3a2dec_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTgtMy0xLTEtMA_e1031ac9-7775-409b-8896-b592b4548781">104,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac5a4c6d4b94f628ed2cfe21a4d2421_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTgtNS0xLTEtMA_6bdb6a1c-6581-4b0d-a4b7-d682d82f2846">51,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife3c76ab2d024ff4a261d3b4e14bdada_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTgtNy0xLTEtMA_7095e5f1-7439-40ce-a14b-2ccae33aa340">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04744a27d4fd4e3faadf43a927a7eb4a_D20200101-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTgtOS0xLTEtMA_c4ed8770-26b6-4d55-a100-79638abfa26b">30,032</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3bf41b2dd03474394b5ac3c1e4407b9_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTgtMTEtMS0xLTA_6e115301-34bb-4085-bcf8-efc8b9b7010a">126,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45b3cd0569ac4039b5a66d8ac80b2c19_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTktMS0xLTEtMA_f7738b75-cd15-481e-b95e-0e2e661b156c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b19f1d9ffbb4fe298e1f449c044db56_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTktMy0xLTEtMA_15261519-6b45-4d13-8a91-e771e800b4a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25970c943ef246bf95009df4317e9dc3_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTktNS0xLTEtMA_4c9d0ef8-312a-4fff-9431-c9cc32cc00e9">14,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icadb573d19cd422abcc090b691494ecc_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTktNy0xLTEtMA_e6b193e5-42f4-4f3e-9ed3-f788bd0b6adf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c84847084804557b40086d59812ad68_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTktOS0xLTEtMA_3628e213-b662-48c6-b5f5-abc9c0b7fe8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b2e395d22bf48aaa5e44c7091a81e15_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTktMTEtMS0xLTA_f5ca1d04-2a42-4d00-9e0a-f79cd22b3437">14,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e829120f1fb4c1a9331bd53efd465d1_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjAtMS0xLTEtMA_fcd1ee01-2e70-460a-ac1a-75de7fcd6c0d">51,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib32e95b570724a1f982834c296abc3e8_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjAtMy0xLTEtMA_8c4be631-79b9-4dab-aa86-bd6f8299c2de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if97993cdf6bb48d99b74e00b854fff89_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjAtNS0xLTEtMA_7f887175-48d8-48fb-a03a-71fb6f48fd87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie363563d839a430fa7d79ed6d41e5d06_D20200101-20200930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjAtNy0xLTEtMA_fb62dc24-9c16-4d7d-a842-fecde0bf6b34">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1ea3d7632384fe7b52a58c46f5bc52d_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjAtOS0xLTEtMA_3c823997-483a-406a-81e1-4d0721ce7971">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07ca84334b34916a64718d4f3f0dadb_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjAtMTEtMS0xLTA_6d1e7407-6327-4bec-aaa4-88d8eeccf347">51,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a95101c0a2547d68267b540d8eb8935_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjEtMS0xLTEtMA_a3b5bced-1117-4905-8825-33b84e9174fe">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjEtMy0xLTEtMA_df7383ab-adae-429f-ad35-4733468e8420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0610bf8e796340e4b079b333dbc7453b_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjEtNS0xLTEtMA_13a67722-daea-4366-842c-ff3e0de788c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjEtNy0xLTEtMA_af78f06b-57f9-481f-89cd-60627632dc7c">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjEtOS0xLTEtMA_5a63839a-6205-40eb-a301-af1bf03b4e78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjEtMTEtMS0xLTA_f954e24e-e97a-43c6-a8cc-71b986fee162">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57164e4241fa4481b87fa534a3023d49_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjItMS0xLTEtMA_6d0dffdb-3e91-4e4c-bd3f-ed076bcbcd30">4,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0aa1900809b484188a9ccdf8c6792cd_D20200101-20200930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjItMy0xLTEtMA_da4d9576-db52-4973-8d0d-b5e56e01b05b">659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc788eb85be74801ab161654330fe954_D20200101-20200930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjItNS0xLTEtMA_6bc10feb-9a27-4aa2-8611-38ee78daefca">702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d2ef8361434b6e86e6d370a02b1d83_D20200101-20200930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjItNy0xLTEtMA_23b87f76-1d91-4822-b010-9ecc159af12f">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c4d3d8eccee408d901f45c189ed9409_D20200101-20200930" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjItOS0xLTEtMA_1373448d-f3e1-40aa-a296-af97e257d559">191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52efbf3b02a4086a4563b641c39020c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjItMTEtMS0xLTA_a974e85c-de6b-4a78-80c2-71ec6e33595e">5,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a95101c0a2547d68267b540d8eb8935_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjMtMS0xLTEtMA_7d02adb0-1023-4ad4-b2ab-626cc9ca44e7">56,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjMtMy0xLTEtMA_71df2c0e-26f3-4725-91a7-30b0314893c2">105,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0610bf8e796340e4b079b333dbc7453b_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjMtNS0xLTEtMA_faaae4b5-7587-45b7-b1ad-aeef6a2a4935">67,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjMtNy0xLTEtMA_dcd0935a-34fa-4d13-a509-dbe79e58046d">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjMtOS0xLTEtMA_106d104a-8653-401b-ae17-1441824df338">30,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjMtMTEtMS0xLTA_1e2d6e24-1cae-467b-b205-4b9fd39a68bb">199,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea4f28e976a42eaad4bf6503fb394a6_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjYtMy0xLTEtMA_e749f130-4549-4e00-9e1b-e71a52debe2b">63,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e9bda172dd402da851f2556c558b25_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjctMy0xLTEtMA_11a60a1d-79f8-4685-bcbc-446dfaf9592e">41,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a81285c245547c79d2a6cf01d1794e0_D20200101-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjgtMy0xLTEtMA_3cd0eac6-cb66-4f76-9253-c0b6cb202cb4">659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjktMy0xLTEtMA_0d068625-e705-4eff-b599-4bb73154b26c">105,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzNzg_840f4e9f-6c1d-493a-b7d4-77d1f0b7e56d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzOTU_cf436098-9d9b-40fc-a69d-7843318dda9c" continuedAt="ib1f35ef0892448ba9618f6098aa768c4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjg5NDUwMzUxZTc1NTQ1MTBiMGRmZjgzYzJkMjgwNWRhL3RhYmxlcmFuZ2U6ODk0NTAzNTFlNzU1NDUxMGIwZGZmODNjMmQyODA1ZGFfMS0xLTEtMS0w_1f6f5f70-9145-4017-b673-8d2719c178ae">8,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjg5NDUwMzUxZTc1NTQ1MTBiMGRmZjgzYzJkMjgwNWRhL3RhYmxlcmFuZ2U6ODk0NTAzNTFlNzU1NDUxMGIwZGZmODNjMmQyODA1ZGFfMS0zLTEtMS0w_04b71c9c-b550-444d-91e9-8bb6105f51b7">7,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjg5NDUwMzUxZTc1NTQ1MTBiMGRmZjgzYzJkMjgwNWRhL3RhYmxlcmFuZ2U6ODk0NTAzNTFlNzU1NDUxMGIwZGZmODNjMmQyODA1ZGFfMi0xLTEtMS0w_823cba8e-1bb5-49f4-8abb-7f7527ec5d73">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjg5NDUwMzUxZTc1NTQ1MTBiMGRmZjgzYzJkMjgwNWRhL3RhYmxlcmFuZ2U6ODk0NTAzNTFlNzU1NDUxMGIwZGZmODNjMmQyODA1ZGFfMi0zLTEtMS0w_b3975110-d15f-4c8f-b411-6586833b242d">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie041cd655e524f8c8756ce07cd0b063d" continuedAt="i2ba412dbae3d4088961757e82f5cc877"><ix:continuation id="ib1f35ef0892448ba9618f6098aa768c4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021 and 2020, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfMi0xLTEtMS0w_b3975110-d15f-4c8f-b411-6586833b242d">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adcddfef50d4237a36d95774c4b5e7f_I20191231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfMi0zLTEtMS0w_d2765690-aec4-4a77-bb49-f02c6bbe1fe3">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfMy0xLTEtMS0w_8d168ce2-be82-4380-8708-7e6ffdf80f95">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfMy0zLTEtMS0w_e2427da8-3570-40ef-861a-658c3264c6ea">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="cvs:ContractwithCustomerLiabilityRedemptionandBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfNC0xLTEtMS0w_7c65040d-3530-477d-b07e-2ea8497068a8">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="cvs:ContractwithCustomerLiabilityRedemptionandBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfNC0zLTEtMS0w_bcd87e5f-0da1-467c-b422-de61f8c35ae2">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfNS0xLTEtMS0w_823cba8e-1bb5-49f4-8abb-7f7527ec5d73">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie81f391964c947c2b2bd32278edef5e3_I20200930" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfNS0zLTEtMS0w_34c5abf1-313f-4d3b-b513-937e169958ff">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:HealthCareEntitiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzNDg_278d1ded-8d2b-45f6-95de-94e3f04e7f5e" continuedAt="ied93c9b7b8454eabb02304fa0f61fa04" escape="true">Health Insurer Fee</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ied93c9b7b8454eabb02304fa0f61fa04">Since January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) has imposed an annual premium-based health insurer fee (the &#8220;HIF&#8221;). The HIF, which is payable each September, is not deductible for federal income tax purposes.</ix:continuation> In December 2019, the HIF was repealed for calendar years after 2020, therefore there was <ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="INF" format="ixt:fixed-zero" name="cvs:HealthInsurerFee" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTE4OTk_51f77a18-d457-4dd5-a27c-0b5fe7452572"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="cvs:HealthInsurerFee" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTE4OTk_a2ee9430-e24c-478c-988f-3584a238d09c">no</ix:nonFraction></ix:nonFraction> expense related to the HIF in the three and nine months ended September&#160;30, 2021. In the three and nine months ended September&#160;30, 2020, operating expenses included $<ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:HealthInsurerFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTE5ODU_3882b728-f3a1-4756-9b3f-196f45d163fd">255</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:HealthInsurerFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTE5OTI_c1fc11ac-b2d3-425a-aad2-b77ec487e0b7">774</ix:nonFraction> million, respectively, related to the Company&#8217;s estimated share of the 2020 HIF. The Company paid approximately $<ix:nonFraction unitRef="usd" contextRef="iac2b3349c830449db89d0000b4259672_D20200101-20201231" decimals="-8" format="ixt:num-dot-decimal" name="cvs:PaymentsToHealthInsurerFee" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMzI5ODUzNDkwMDA3NA_6b4eff88-cfa1-4cc3-ba4f-53d55a52ada5">1.0</ix:nonFraction>&#160;billion, representing the Company&#8217;s portion of the non tax-deductible HIF in 2020.</span></div><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzNTM_dced6e4f-9bac-426c-860b-9ee2896d98de" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $<ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI0MjI_b370f22d-1f39-49bd-a96e-190ee05a65eb">16</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI0Mjk_b0acc57b-2c9c-47af-bd50-e376a53ce416">5</ix:nonFraction> million in the three months ended September&#160;30, 2021 and 2020, respectively, and expensed fees for the use of this network of approximately $<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI1NDY_688bbb7b-822b-4c81-9fcd-d1822898062e">35</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI1NTM_939b19c4-2c8b-481c-9069-e5e230e6af10">28</ix:nonFraction> million in the nine months ended September&#160;30, 2021 and 2020, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in <ix:nonFraction unitRef="state" contextRef="i4dc635a1438340608f1c50ba4fdd86c9_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfStatesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI4NDU_e581957c-5e83-4b83-81d5-64b0884fb109">four</ix:nonFraction> states. Heartland paid the Company $<ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI4ODM_cb5185bd-0a91-4240-8a19-dd1114b65b2c">20</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI4OTA_1aae189c-6a48-4200-b4a7-cf90bdd4dde3">15</ix:nonFraction> million for pharmaceutical inventory purchases during the three months ended September&#160;30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI5OTE_a291f382-010f-4f63-87e5-7aa5d308a442">57</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI5OTg_03e918d6-341f-418f-b966-2043fb715f90">58</ix:nonFraction> million for pharmaceutical inventory purchases during the nine months ended September&#160;30, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzODY_14ab63d0-a5ec-4643-9e90-2a7fec0add21" continuedAt="iaf49fe4162754916bf7352063050c9de" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2ba412dbae3d4088961757e82f5cc877"><ix:continuation id="iaf49fe4162754916bf7352063050c9de">comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the existing guidance.</ix:continuation></ix:continuation></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_40"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDkxNg_fd57c260-7369-47fd-9f72-430f1b191665" continuedAt="i6b2722073e3b45ed8ce619ee1f5812d0" escape="true">Investments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6b2722073e3b45ed8ce619ee1f5812d0" continuedAt="ie4c076f7c92048ca91babb3634838ad6"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="cvs:TotalInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDk3MA_ee596593-77d6-46f5-b719-298012e99a32" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at September&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ee770549c949dcb40ae6f549cc3f40_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMi0xLTEtMS0w_250f67dc-648a-41be-bc9d-dacae7913cda">2,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ee770549c949dcb40ae6f549cc3f40_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMi0zLTEtMS0w_8c1ada5d-9ef1-4f29-96fc-7990c78661c6">19,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ee770549c949dcb40ae6f549cc3f40_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMi01LTEtMS0w_663814b5-04c0-45b4-8790-9fabe9a60b24">22,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80a6996dadac4e8b8f355582234ddeb6_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMi03LTEtMS0w_3a75656b-32b4-4ecf-817d-fc03351eec9c">2,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80a6996dadac4e8b8f355582234ddeb6_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMi05LTEtMS0w_2ea01091-0258-4df3-adbd-fa80a1671290">18,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80a6996dadac4e8b8f355582234ddeb6_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMi0xMS0xLTEtMA_89929f8c-73e6-4324-9ea8-1cc321143217">21,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c318d6cbb84ce1af4416e5e9e9e796_I20210930" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMy0xLTEtMS0w_bb1f7a1a-ace9-4627-bca7-9af8858f525c">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c318d6cbb84ce1af4416e5e9e9e796_I20210930" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMy0zLTEtMS0w_4b5a3d8a-10f5-4e6c-8440-5658e13f1977">824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c318d6cbb84ce1af4416e5e9e9e796_I20210930" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMy01LTEtMS0w_67c93395-e0f6-4b8b-8bc8-9f20c0235ad7">934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i707fe789ecce4f57bbc13e85dcb9d128_I20201231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMy03LTEtMS0w_3578e537-e7ae-4dcd-8c57-a2e142ae6657">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i707fe789ecce4f57bbc13e85dcb9d128_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMy05LTEtMS0w_3fd4a749-fe36-45a2-b727-4c1a0b5fd818">821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i707fe789ecce4f57bbc13e85dcb9d128_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMy0xMS0xLTEtMA_f6c59fde-1ad9-471f-bb75-48336e2f04ac">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e088f53c1324f15a6ec9498f86c75ad_I20210930" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNC0xLTEtMS0w_d429e606-3f3f-4a93-afe8-d822fc3eadd0">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e088f53c1324f15a6ec9498f86c75ad_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNC0zLTEtMS0w_983d2ba8-861b-4b1c-89b5-4a160d00fc75">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e088f53c1324f15a6ec9498f86c75ad_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNC01LTEtMS0w_2023f88d-b224-4541-8534-14b7f7cfa7dc">1,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6144005cd614c8aa06ca2e425c85859_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNC03LTEtMS0w_8c0970b4-4f70-49de-95f3-13dbea38f2d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6144005cd614c8aa06ca2e425c85859_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNC05LTEtMS0w_d6365e56-e295-40a7-9d4d-e55d5ae82f62">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6144005cd614c8aa06ca2e425c85859_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNC0xMS0xLTEtMA_53f3799b-7a1c-44e4-b427-b7ac420e0f4d">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNS0xLTEtMS0w_9f3c03df-9569-4b46-9e66-237b989ed5df">3,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNS0zLTEtMS0w_0dd59856-bf9e-4275-b0c9-c76e6a202e1e">22,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNS01LTEtMS0w_dbda76c8-353e-43bc-b6e4-843422c8d8c8">25,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNS03LTEtMS0w_e1a95d65-ad75-4aa6-a77e-1092941dfc04">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNS05LTEtMS0w_31122afc-f7d7-44d3-999a-b19d5a01a926">20,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNS0xMS0xLTEtMA_181de5f7-f518-4329-8576-4cfe2e4cc830">23,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDkzMA_9513acff-8fd8-46cd-90ac-a49e9ffe58b4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at September&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMy01LTEtMS0w_e85c06fc-e6ba-4491-bf32-7223a7c6e58d">2,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMy03LTEtMS0w_a52b9f03-5363-4b95-bc25-4be231053301">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMy05LTEtMS0w_21e299cd-3819-49a4-a578-a070db3fef36">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMy0xMS0xLTEtMA_3221c993-02d0-4f59-9593-79d27eacb952">2,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNC01LTEtMS0w_fded7a7a-30ab-4b0a-b3ec-4d04dacd7ca8">2,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNC03LTEtMS0w_081780ab-c529-485e-8652-1964b88cdf3e">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNC05LTEtMS0w_691919a0-bd0d-42f0-9e56-b53f92db294b">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNC0xMS0xLTEtMA_7ed79b94-6680-45f7-b8c8-bfb689287072">3,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84071dd39d474caab85d1a67242c2886_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNS01LTEtMS0w_81571bfd-8de8-4afa-bc56-923958845e8a">8,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84071dd39d474caab85d1a67242c2886_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNS03LTEtMS0w_b160e288-c3ac-4504-897a-f1ddbd6c6207">757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84071dd39d474caab85d1a67242c2886_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNS05LTEtMS0w_64c6f6e3-3829-4715-b0f7-687b16c7e9da">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84071dd39d474caab85d1a67242c2886_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNS0xMS0xLTEtMA_09d8c658-211c-4708-9c12-3ed6a7c09724">9,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNi01LTEtMS0w_47e90fd7-4c46-49cc-8515-9fe141463111">2,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNi03LTEtMS0w_69da3434-4aeb-42b1-9dc4-047127a6dcdb">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNi05LTEtMS0w_fb2a1eda-5f78-488e-b9f4-49c54640d40e">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNi0xMS0xLTEtMA_b709bf38-383c-4182-98fe-81bf63a28f1c">2,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNy01LTEtMS0w_b67de901-52bf-4391-a9ca-55aa94ede9a5">849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNy03LTEtMS0w_46f6c1a3-42a2-43b6-a790-e6a9dcf71f5d">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNy05LTEtMS0w_3b3e4637-76b5-4f7c-bdfb-925fcaa099f7">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNy0xMS0xLTEtMA_22674af9-b1c0-400e-ac0f-919013e6a9b8">863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOC01LTEtMS0w_5a4d55d7-da88-4a0d-8f6b-7d9aebf263e7">1,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOC03LTEtMS0w_99ec6363-6834-4067-bb1e-5762aae56233">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOC05LTEtMS0w_0fdd0429-1f0c-4af9-b59b-75e75cd351a0">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOC0xMS0xLTEtMA_c9dc424c-bf54-4c2b-ace6-9e674d894431">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOS01LTEtMS0w_c4c9c365-f0c6-4d2e-84af-44be7c20462c">2,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOS03LTEtMS0w_c26946ff-e9b4-46a3-8a24-9e5a20e05aed">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOS05LTEtMS0w_a9e74c8a-8289-4566-89bc-8696265a2c1a">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOS0xMS0xLTEtMA_cd8bb2d6-5d96-44c2-99e3-681b7d28e39d">2,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf502564439b47e698e240fdd68a98f8_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTAtNS0xLTEtMA_ee36636c-b16c-4440-9b8d-c5de81a0bf91">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf502564439b47e698e240fdd68a98f8_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTAtNy0xLTEtMA_82f982a2-b30a-46ff-b1eb-7ce8b51fb87e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf502564439b47e698e240fdd68a98f8_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTAtOS0xLTEtMA_6ee7415e-2fa8-4b6c-8f61-e1d54ab36e0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf502564439b47e698e240fdd68a98f8_I20210930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTAtMTEtMS0xLTA_e65f044c-4391-4ecf-bbbb-1149e9b95621">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTEtNS0xLTEtMA_336ac941-4f8b-4d3b-811e-e2e83531e119">21,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTEtNy0xLTEtMA_09adaa2b-c5a1-46a3-a207-e51b751b81e6">1,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTEtOS0xLTEtMA_a93f5279-5940-458b-a41b-729d7335df62">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTEtMTEtMS0xLTA_85aeda2e-53d8-446f-a6b9-cc943142aae1">22,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTUtNS0xLTEtMA_9be3be62-0cca-4928-bb61-ee85761ab84b">2,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTUtNy0xLTEtMA_adf712ad-9fd5-4124-ab11-5de2f9607e57">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTUtOS0xLTEtMA_5ec01bcb-626e-4765-a7ed-5b13cd9d532c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTUtMTEtMS0xLTA_c7586209-c72d-4ae9-a089-08ff20afe3b3">2,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTYtNS0xLTEtMA_a13066e1-b0d4-4b42-a724-e9980a959405">2,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTYtNy0xLTEtMA_49d5d6ee-9115-4671-a48e-c91f666ed3b3">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTYtOS0xLTEtMA_a3c87522-3ade-4b77-ae85-410daf9157bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTYtMTEtMS0xLTA_04a41cee-d05e-4902-985b-133891c4b99c">2,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTctNS0xLTEtMA_3429ba3e-46ea-4aba-8141-95a2dce27bda">7,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTctNy0xLTEtMA_a4d828e4-7f6b-4d76-9945-3af56202294f">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTctOS0xLTEtMA_e1f9e12b-bc1d-4e2c-8caa-8847ca167d05">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTctMTEtMS0xLTA_4c983864-427d-4fef-b87d-70133d756820">8,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTgtNS0xLTEtMA_e9c09ad8-efed-42cb-8951-f9776c584764">2,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTgtNy0xLTEtMA_b98256f3-7327-41f2-a7a8-bfaf715baf8f">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTgtOS0xLTEtMA_b794a248-12d9-4909-8aab-eb0aa016b61d">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTgtMTEtMS0xLTA_dfe6e66d-a34c-499c-8c4c-ae3889819981">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e717be6b54384b3a33a455727136e_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTktNS0xLTEtMA_4cd21c00-fd59-4024-a788-12e4c55dd31e">673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e717be6b54384b3a33a455727136e_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTktNy0xLTEtMA_375cad43-9edd-4784-9f5b-a64759934d56">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e717be6b54384b3a33a455727136e_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTktOS0xLTEtMA_ea912f77-2382-48b7-9d93-c77887294cac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e717be6b54384b3a33a455727136e_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTktMTEtMS0xLTA_9d3f971a-b068-4152-b1a2-8489cae591ca">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjAtNS0xLTEtMA_e54e7894-3f73-4f83-b6aa-9ec857ac0d23">962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjAtNy0xLTEtMA_034d7ee0-cb95-420d-9837-9d43e2d8c982">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjAtOS0xLTEtMA_d67e69ba-6d44-4511-b0c4-fcef6fbd6b5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjAtMTEtMS0xLTA_9fe43176-726f-4b9d-a7bc-020b144d7d50">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjEtNS0xLTEtMA_6ba7b829-68c1-4ba7-a2d4-e2d742e37fd9">2,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjEtNy0xLTEtMA_4cff8454-9b8a-412b-a50e-504d296a1cb7">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjEtOS0xLTEtMA_678b82f1-800b-4aa6-9bae-e0e6b03cbd3d">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjEtMTEtMS0xLTA_a2460ff1-e2cc-4ee1-9449-ac90c3f6b157">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9ed33a6edcd4234b95ebdec84f83d90_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjItNS0xLTEtMA_0a51e0da-3727-4fd8-a109-436f5a5ba11c">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9ed33a6edcd4234b95ebdec84f83d90_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjItNy0xLTEtMA_808f48a7-d01e-4236-9a0a-c581d55e87ff">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9ed33a6edcd4234b95ebdec84f83d90_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjItOS0xLTEtMA_f0919ef5-838a-401f-9d94-84f8ed61a1f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9ed33a6edcd4234b95ebdec84f83d90_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjItMTEtMS0xLTA_4ca2b6a7-bac8-4290-86f3-db7311c77564">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjMtNS0xLTEtMA_1c67a0e2-8069-44c0-adc5-cf6560d13d26">19,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjMtNy0xLTEtMA_361819f4-6bbb-4eed-b680-b51ba0ed2a95">1,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjMtOS0xLTEtMA_b54ea77d-3b28-4fd3-a1a1-651467be0200">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjMtMTEtMS0xLTA_33147939-7656-4134-af10-cc22f13818bb">21,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">There was <ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfMjEx_68526fba-fbe6-459c-aee5-a15bd122d1b5"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfMjEx_d3027883-7016-45c2-836e-61f2c888dc79">no</ix:nonFraction></ix:nonFraction> allowance for expected credit losses recorded on available-for-sale debt securities at September&#160;30, 2021 or December&#160;31, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At September&#160;30, 2021, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDk4_a851fd24-ccd5-4319-9e26-294a6ef61276">882</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNTM2_88cef85f-925a-448b-95d8-4ff3747f9340">101</ix:nonFraction> million and gross unrealized capital losses of $<ix:nonFraction unitRef="usd" contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNTc4_79e7c443-3ee5-4802-a2e5-50f607e86426">1</ix:nonFraction> million and at December&#160;31, 2020, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="ibb8aec5e18a44c75a0b64168efe52403_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNjI5_f7621c21-f7f1-4a94-9fbb-d908c19c6200">919</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="ibb8aec5e18a44c75a0b64168efe52403_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNjY3_bd7a7d2b-45ca-46e8-bad9-998c58831561">135</ix:nonFraction> million and <ix:nonFraction unitRef="usd" contextRef="ibb8aec5e18a44c75a0b64168efe52403_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNjc0_9a711e2f-4d33-4416-9b15-22f0798153ef">no</ix:nonFraction> gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie4c076f7c92048ca91babb3634838ad6" continuedAt="ic38bd9b04c6a4be9a1abf085dc1ff4ca"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDk4Mg_0d8f0115-6902-4dd6-8381-30d807fa75bd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at September&#160;30, 2021 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.690%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfMi0xLTEtMS0w_eb97941a-7a68-4f44-94f0-0582050bb1cc">1,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfMi0zLTEtMS0w_bb3f169e-26b7-4852-be32-a100b96da1bc">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfMy0xLTEtMS0w_4f004648-672e-4a24-8e72-f5dd9a5a8f3f">7,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfMy0zLTEtMS0w_c67b26eb-0c56-4692-9a5e-5dba3e6e1518">7,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNC0xLTEtMS0w_11dcac9b-ab31-4e62-bbe9-622af34544c3">4,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNC0zLTEtMS0w_65cfa699-fb0a-44ea-b7f0-1804711a92c6">4,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNS0xLTEtMS0w_17c2eeff-0dab-45fb-b360-716a55f6e4d9">4,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNS0zLTEtMS0w_fbb35d13-07fc-4f30-bc70-8a73adfac05a">4,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNi0xLTEtMS0w_882aa935-2582-4ff0-a960-08fb0fedb50a">849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNi0zLTEtMS0w_fc20bd4d-7595-4387-8e68-b969000ddb30">863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNy0xLTEtMS0w_59ee7266-3b07-406e-b3f6-47fa5f8ad0e7">1,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNy0zLTEtMS0w_fb1a9eed-c70e-4b7f-8107-8546d02c8236">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfOC0xLTEtMS0w_01517c39-13ec-490a-8f10-a23bc47cb0f9">2,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfOC0zLTEtMS0w_37c9415b-201a-423c-a671-3791e72e4f36">2,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfOS0xLTEtMS0w_af10c56e-8bb9-455f-880d-9f3ae9217bc7">21,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfOS0zLTEtMS0w_e247f416-97d2-4abc-b05a-590a12774dd3">22,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic38bd9b04c6a4be9a1abf085dc1ff4ca" continuedAt="iacc2b23fce4c479584014152b3dcff58"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDg5OA_233f1b8f-fa94-4922-b20d-8936f18a57ec" continuedAt="ic6ebb7e7d1984e49a8fa10e77d446703" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at September&#160;30, 2021 and December&#160;31, 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC0xLTEtMS0w_49a3e297-7e48-4e47-abc9-3229d8e07869">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC0zLTEtMS0w_030a3568-bebf-4d74-950b-0af57354b94d">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC01LTEtMS0w_a8c35abb-5008-4562-a130-3c8aa39b7b37">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC03LTEtMS0w_2120bebb-bb55-4f9d-a73f-e5e4b1947755">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC05LTEtMS0w_2c215e83-e7ec-4444-b5a6-42474ece5e1e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC0xMS0xLTEtMA_cfeae266-eee6-42cc-8277-1288aa27c3f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC0xMy0xLTEtMA_f19953bc-1da6-44f0-823d-88fa9bb0721d">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC0xNS0xLTEtMA_caf8675e-4b62-4cac-91c0-e2c9270d5fa6">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC0xNy0xLTEtMA_83915881-b8f5-441f-9d97-b081bf3675ba">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS0xLTEtMS0w_f77ba1f9-40c9-43cf-abb4-7fa1ff446f35">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS0zLTEtMS0w_ff112a1e-9048-4e83-934e-ae7cebc28caf">464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS01LTEtMS0w_de486785-276e-4fbf-a898-d6e74697eac6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS03LTEtMS0w_6ddf35b3-4b85-4f39-9aad-a10290f93996">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS05LTEtMS0w_25e25427-e8d0-4fcc-b2e0-55c8120e6f3a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS0xMS0xLTEtMA_645dba41-5a28-4911-bf2b-9486a75ff662">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS0xMy0xLTEtMA_1f1bf0be-a911-4d7d-a755-4c65b7d2863b">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS0xNS0xLTEtMA_a109aff8-cd83-4235-9b63-527f5fc8f75d">468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS0xNy0xLTEtMA_7cb162df-1f8e-4a56-a01d-6ee84e63f90c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i84071dd39d474caab85d1a67242c2886_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi0xLTEtMS0w_3476b2d2-db63-476d-bd6d-8262bbc3df2b">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84071dd39d474caab85d1a67242c2886_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi0zLTEtMS0w_62f2ef9d-82c0-4360-92f3-32ee74e85a14">1,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84071dd39d474caab85d1a67242c2886_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi01LTEtMS0w_8b272e3a-dd0d-4f0f-a950-824c5aee566f">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i84071dd39d474caab85d1a67242c2886_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi03LTEtMS0w_d419de39-0999-423a-901e-bf39b6f6b2ed">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84071dd39d474caab85d1a67242c2886_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi05LTEtMS0w_5c8c2d47-12a6-4fd5-a0e1-ae1b3eed03e8">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84071dd39d474caab85d1a67242c2886_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi0xMS0xLTEtMA_6162cf37-d587-49ba-81a2-5f908c9c461a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i84071dd39d474caab85d1a67242c2886_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi0xMy0xLTEtMA_1ad4224f-7d36-44f5-8eda-c85393d9e479">1,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84071dd39d474caab85d1a67242c2886_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi0xNS0xLTEtMA_fff5524c-69fa-4cc1-9917-4048f0309dcf">1,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84071dd39d474caab85d1a67242c2886_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi0xNy0xLTEtMA_40ed76f6-7896-4d62-a49e-96297df9a4ea">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy0xLTEtMS0w_f1ad2f06-b7ef-4c80-827e-fdd0bc529409">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy0zLTEtMS0w_99f1f412-55c3-4f01-b024-0be5a7fa9c38">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy01LTEtMS0w_5b5fbc02-f281-4220-b30b-a00a60fc8d2b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy03LTEtMS0w_51c7ebb5-a1a4-411f-9e8f-b479e3dc08a9">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy05LTEtMS0w_b4e5a8ca-1fc2-4f0a-bc16-108432fc3b31">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy0xMS0xLTEtMA_311d6676-51b3-422c-a352-c153fb49c5c8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy0xMy0xLTEtMA_539108bb-1d9c-4049-8237-fb78cf3a99fb">332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy0xNS0xLTEtMA_0f3dab49-3a6d-467e-95bf-d49dccc8aeec">589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy0xNy0xLTEtMA_a669fa73-3dc3-4ef9-8b6b-343f2d0692e6">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC0xLTEtMS0w_ae1b848a-5c5c-4d37-a540-1de7d9907655">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC0zLTEtMS0w_575f2f18-7f22-4c80-bfb5-26d2a927d700">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC01LTEtMS0w_b0094fed-d653-48fa-9970-18216b7d9014">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC03LTEtMS0w_3e70b054-645e-4b41-9661-3c7ec512b835">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC05LTEtMS0w_9503c65f-df89-4b51-8552-0a22cf2da248">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC0xMS0xLTEtMA_201237a3-b904-44b8-aecd-2417ac2773f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC0xMy0xLTEtMA_8aad08f8-a522-4e63-812f-d780e451612d">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC0xNS0xLTEtMA_3082763b-7e62-48f0-8805-5f6f94330572">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC0xNy0xLTEtMA_f3faf251-cda8-4b2d-b62b-711cccf749e1">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS0xLTEtMS0w_24a5ff0f-fc15-461e-87a2-f71bc7e2dc64">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS0zLTEtMS0w_c5960a0a-087d-4c5c-a75c-acb7b76c8a94">342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS01LTEtMS0w_9cfc1925-108a-4b92-bdbb-99a6a8cb9ec9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS03LTEtMS0w_b29f69cc-ae40-4cb8-951c-50c3a7dbeb26">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS05LTEtMS0w_a6d89e1b-7ee4-4ade-b5a4-dd7b129bb0a3">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS0xMS0xLTEtMA_326fc4b4-876d-4fc4-921e-f326ca2e3f39">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS0xMy0xLTEtMA_44aff4fa-1ebc-46a0-8f95-43d8c84af39b">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS0xNS0xLTEtMA_076d92aa-3913-4710-87d4-2d89245e3d1a">389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS0xNy0xLTEtMA_16d36e40-fd27-4221-9810-7b6e00aaa1af">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtMS0xLTEtMA_d5d65c3e-29da-4845-9ae2-f07c11fad06f">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtMy0xLTEtMA_0422a551-3635-4cd9-97e7-93a17ecc7442">652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtNS0xLTEtMA_ed22c6ab-9f87-46d2-b846-b64c88e4d431">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtNy0xLTEtMA_cfac04b7-4e28-4f35-af2b-134bfa6d5bcc">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtOS0xLTEtMA_9612dc92-3c2d-4a35-878a-12d4608804b2">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtMTEtMS0xLTA_925fa759-786f-4283-8421-4d6d32af13b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtMTMtMS0xLTA_c10dae5c-9672-4c8d-94df-50d492b3e0a0">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtMTUtMS0xLTA_0710a751-440a-4430-ab38-076b3d225b46">669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtMTctMS0xLTA_f0483d94-88b0-4263-8ebf-ed72acc6173f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="idf502564439b47e698e240fdd68a98f8_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtMS0xLTEtMA_751007f1-f881-476c-9f92-656535fb781d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf502564439b47e698e240fdd68a98f8_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtMy0xLTEtMA_51b7e290-049e-4c8b-aeff-4e53455f368b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf502564439b47e698e240fdd68a98f8_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtNS0xLTEtMA_1e803c58-8b84-4b16-86bc-9ec898c5f564">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="idf502564439b47e698e240fdd68a98f8_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtNy0xLTEtMA_0fcb4243-5c92-423b-89da-8cd67716855b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf502564439b47e698e240fdd68a98f8_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtOS0xLTEtMA_f41cef68-c74d-4106-9ae7-30e9dbbd4c13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf502564439b47e698e240fdd68a98f8_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtMTEtMS0xLTA_c7761b65-8cc9-442f-a6af-5dc4f08aecc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="idf502564439b47e698e240fdd68a98f8_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtMTMtMS0xLTA_76db7052-6335-4357-b371-ada2feac9adb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf502564439b47e698e240fdd68a98f8_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtMTUtMS0xLTA_7ce6fb19-f9ba-446f-8955-7e0faa2ffd18">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf502564439b47e698e240fdd68a98f8_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtMTctMS0xLTA_a383291a-a3f5-4af9-ada2-bcd4cca9e080">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItMS0xLTEtMA_6750c8f7-9812-471b-b83f-b8e944272262">2,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItMy0xLTEtMA_c205ad1c-69c1-4cf6-99b5-75dbb82b6efa">4,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItNS0xLTEtMA_5a4e4ec0-a869-4849-903d-5494344b135a">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItNy0xLTEtMA_a338ded4-3a37-41b1-a70e-f13985de7b65">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItOS0xLTEtMA_55646628-f384-44ce-af37-fffc2163621a">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItMTEtMS0xLTA_fd907f85-e332-464a-aea9-80b557ef5296">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItMTMtMS0xLTA_9d9ccde1-4ff7-444f-929c-a84a86f69f2c">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItMTUtMS0xLTA_9a79c81e-b6ef-402e-a51c-a7bc1b6b5c4e">4,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItMTctMS0xLTA_36804098-9c6c-4438-9562-6c1678d44ca5">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtMS0xLTEtMA_f073dd10-947a-4234-b4a0-e5433c997986">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtMy0xLTEtMA_cd651f50-a392-457e-84c7-ee73e91a0fcd">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtNS0xLTEtMA_1ffa0cd8-14b4-4d95-96ec-4dde36ad4d12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtNy0xLTEtMA_d7b7062d-e2cf-4871-808a-5f3b63af1c94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtOS0xLTEtMA_62f7cd66-d007-4a4c-890a-4c857851a72d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtMTEtMS0xLTA_1dd13fda-9c54-4ccd-b86c-6c4a8cb48a76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtMTMtMS0xLTA_50fb8304-9b09-47d7-b225-17a0d2e7595c">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtMTUtMS0xLTA_bc98d211-ba48-4f45-bd57-44172f534548">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtMTctMS0xLTA_2cd4fbe3-dbe4-4297-adce-f46b3334d385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctMS0xLTEtMA_e27e9003-c075-4cff-a99c-877395505023">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctMy0xLTEtMA_fb5de1df-9cfc-49f3-ba1d-4f787408c2b8">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctNS0xLTEtMA_5c731271-9e04-45a3-9ba7-e727f331ea10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctNy0xLTEtMA_fc500533-500e-421a-85f4-138380d5d149">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctOS0xLTEtMA_8bd635da-dbad-41ea-8d76-80c3050f5a5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctMTEtMS0xLTA_7ac0aa6c-035f-4451-82be-04a4142bf3ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctMTMtMS0xLTA_f8ba63a1-2000-49c4-887e-7a7de87d18d4">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctMTUtMS0xLTA_166dfaf9-19de-48a2-9add-a4cd42088548">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctMTctMS0xLTA_34fd6c59-f724-4035-8f57-38deb69fcf66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtMS0xLTEtMA_b845cd2f-cbfa-4bb1-a62a-a2a6c0b01679">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtMy0xLTEtMA_fb846737-47e2-40ec-92c8-9e87413cc87e">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtNS0xLTEtMA_6fc6fed8-4a31-4ea0-b6b8-b08383db62f1">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtNy0xLTEtMA_cc4586d7-990e-49d5-ac8c-f655bee30bb5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtOS0xLTEtMA_f4a00757-273b-4423-b050-36492a6593c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtMTEtMS0xLTA_ce79757e-3bff-407b-b81a-00e3dafc2a86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtMTMtMS0xLTA_034555a7-6b38-4745-ba66-f43dc80c0db2">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtMTUtMS0xLTA_94afbecc-c76d-482b-bba1-3455638b7814">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtMTctMS0xLTA_9b3a2697-8914-4ce1-acaa-bb758fa414dd">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktMS0xLTEtMA_89a0923a-e7d1-4ced-98e0-9b54ba9a9925">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktMy0xLTEtMA_67a72ce7-fbf0-47da-a2f9-fe198160487f">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktNS0xLTEtMA_4bebd5c2-0d70-4c79-8ef1-e64536520e90">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktNy0xLTEtMA_de3f369d-3ccd-4844-b412-df0a3abc0b71">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktOS0xLTEtMA_260df1e0-921f-42d7-922f-74a794b331de">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktMTEtMS0xLTA_0b6a1f2c-bd3b-4e1f-ad8e-2dd74828d7e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktMTMtMS0xLTA_f2c9eec0-aa19-460c-8411-ec043e3e1fe5">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktMTUtMS0xLTA_971a28da-2566-40c7-a44b-abbab6418347">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktMTctMS0xLTA_2fb56ede-4006-4486-9483-83b147e36582">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ia73e717be6b54384b3a33a455727136e_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtMS0xLTEtMA_4f64912c-c0e5-4f65-b17e-07a29a187e58">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e717be6b54384b3a33a455727136e_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtMy0xLTEtMA_e03e3954-7334-42b1-8c4d-67ddab045022">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e717be6b54384b3a33a455727136e_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtNS0xLTEtMA_a2305228-feb6-4233-bac3-73be1f24d037">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ia73e717be6b54384b3a33a455727136e_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtNy0xLTEtMA_8dd50d56-2e5f-453b-9be7-5404f041e2f2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e717be6b54384b3a33a455727136e_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtOS0xLTEtMA_b394a292-318d-4dc0-80c1-4e7470e67db2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e717be6b54384b3a33a455727136e_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtMTEtMS0xLTA_46c57e76-2cee-4728-bfb4-b97c747018c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ia73e717be6b54384b3a33a455727136e_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtMTMtMS0xLTA_f5f753cf-ec9b-43c9-9076-1865dc7e5c13">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e717be6b54384b3a33a455727136e_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtMTUtMS0xLTA_1caf5dd7-541e-4991-bbf5-408ebaa71aae">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e717be6b54384b3a33a455727136e_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtMTctMS0xLTA_248007fe-7753-4430-8b15-1bebacda6e82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtMS0xLTEtMA_806173ba-bbd4-480b-b4d0-6333aa131226">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtMy0xLTEtMA_aa6a9ce2-feef-4444-a6a9-f7a74450a8e3">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtNS0xLTEtMA_df9d701c-a334-4d16-8359-f2cb91a193c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtNy0xLTEtMA_ee21e88d-bcda-4433-a2f4-ee93f1a51ae3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtOS0xLTEtMA_aad7690e-e232-49f9-bfeb-5974f20c025e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtMTEtMS0xLTA_9ffa2896-4914-4240-8af1-c6ccd0712c95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtMTMtMS0xLTA_7aef05d5-fe3d-45dd-9895-e863600a92c1">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtMTUtMS0xLTA_fe9812b6-b173-4e5a-a8af-a79bd4aa8b55">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtMTctMS0xLTA_632effce-4bee-48cf-9498-53d167e7fea4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItMS0xLTEtMA_50ad818a-31e6-4c32-8a3c-64144a33072a">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItMy0xLTEtMA_4c94bc36-2dad-4c9b-a7d2-b90b7eccb4c2">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItNS0xLTEtMA_4096d407-7bbe-46eb-b880-5909743e79ce">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItNy0xLTEtMA_988038e4-f6bb-48f0-b557-f9e3619afad1">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItOS0xLTEtMA_a822268f-2b24-415a-a20b-ff78f885bb5e">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItMTEtMS0xLTA_6a1efd79-41e4-48c1-9ed4-eff13bd91af0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItMTMtMS0xLTA_2fc1213c-3ba3-4021-bef6-f2afb58acc8f">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItMTUtMS0xLTA_6f2d370d-82d6-4dbe-89c0-61a911554b7b">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItMTctMS0xLTA_64df2be3-798f-47b8-bd08-0638df6b9e2f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtMS0xLTEtMA_34d4fb87-39df-4e9f-ac20-e9ef62f8bde6">468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtMy0xLTEtMA_774df60a-adf2-4086-91e0-d38007e9b843">869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtNS0xLTEtMA_dd072b3a-e46d-4392-81f5-c156f3ec9433">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtNy0xLTEtMA_4c1fceb7-634f-4040-bdd1-5aa579f850d7">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtOS0xLTEtMA_44e2cc18-b8de-403e-9f82-61ad36e0de40">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtMTEtMS0xLTA_e7b70e60-d6d0-4b11-b948-08341bd47241">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtMTMtMS0xLTA_502336e0-050d-48df-b711-341decbc0bfe">527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtMTUtMS0xLTA_6b5e1fbe-500a-44c8-8b78-fe33320b6aea">915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtMTctMS0xLTA_e89d3123-0939-4123-a508-22782c633482">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at September&#160;30, 2021 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of September&#160;30, 2021, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iacc2b23fce4c479584014152b3dcff58" continuedAt="i740eb1835fdb40068d2d1c46eec50d5e"><ix:continuation id="ic6ebb7e7d1984e49a8fa10e77d446703"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at September&#160;30, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.948%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMy0xLTEtMS0w_060e493c-ac51-424d-be75-dc7f167f3710">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMy0zLTEtMS0w_fe204396-da41-4975-add3-d67fd2177377">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMy01LTEtMS0w_bc6c01be-ec21-45e5-9af5-f97bed37f669">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMy03LTEtMS0w_de658b29-5cbe-485b-a6ba-6edd77ac9fef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMy05LTEtMS0w_0a007f5d-f1fc-474e-afcb-1b78efccd5cf">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMy0xMS0xLTEtMA_06f5c6b7-b815-4bc6-a8b3-8e43fd5b362f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNC0xLTEtMS0w_fc299269-68c4-4534-b87d-18807c236aa3">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNC0zLTEtMS0w_1e4e6a10-436f-478f-8870-3d9026df7c9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNC01LTEtMS0w_8c06a953-c799-43ca-b792-8b94f13b339d">1,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNC03LTEtMS0w_217a0d47-ae91-4c9b-89da-dfbd28c032db">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNC05LTEtMS0w_d9c65c68-9cb6-4ba3-aefe-a205d05db342">1,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNC0xMS0xLTEtMA_a46ca547-30ae-48bc-a705-001afc46bf62">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNS0xLTEtMS0w_5dfb5ff0-0b5e-44e8-9fa6-ecb8f18e93fe">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNS0zLTEtMS0w_0f432a1f-0eed-4a18-a925-5dd011a394b0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNS01LTEtMS0w_f975433d-438f-43e5-8299-4fdbe5751897">920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNS03LTEtMS0w_2bb5e5f4-1db8-43fc-9244-bea323de6ca2">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNS05LTEtMS0w_e659d6a7-9577-4fb8-9912-98ac974a7f04">949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNS0xMS0xLTEtMA_4fc3e65c-d657-43da-b351-6ab4a75a6e9b">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNi0xLTEtMS0w_529504b5-6c05-47a5-8468-38f7ac060505">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNi0zLTEtMS0w_dca3953e-493a-40b6-b494-b43970f127d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNi01LTEtMS0w_33e72495-48d1-4445-992c-dc34fd9cf273">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNi03LTEtMS0w_5a960fa3-4a3a-45fc-9b5c-71c65bf6d15d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNi05LTEtMS0w_52cbf82f-51de-426b-a535-8a33b48daeea">605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNi0xMS0xLTEtMA_4cb8508b-b221-4f13-90a1-0d80194a2650">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc96f7ad297439c9bd36cc63d9e3146_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNy0xLTEtMS0w_834ee2cc-4276-44cd-8855-218734e54a37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc96f7ad297439c9bd36cc63d9e3146_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNy0zLTEtMS0w_9e15bb47-1a9e-4b1b-924a-d41ca651fecc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0db856db0a1a4dc6b3fd81758f0ae424_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNy01LTEtMS0w_cc0db4b8-4cf3-40b8-947b-79e1e0235be7">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0db856db0a1a4dc6b3fd81758f0ae424_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNy03LTEtMS0w_96279ea6-048e-43b8-ab5c-d5c60d661e4c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNy05LTEtMS0w_e5253464-2b88-4228-8c1e-0fa4a217bf98">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167d58e660348f68004d45412fb002b_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNy0xMS0xLTEtMA_11fdb03a-a79b-412c-94b2-a5079d54c774">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if24bb6ab7e694ecdb87149237d4c1602_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOC0xLTEtMS0w_28277044-8f4c-4b87-bd42-7f0bc2193ca3">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if24bb6ab7e694ecdb87149237d4c1602_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOC0zLTEtMS0w_ad0da237-ed23-4d86-9fca-e6231dfbeda9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d2954c416de4b1e94f5fc8ec55a8415_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOC01LTEtMS0w_0a23df98-cd76-45c9-a1c3-5efc13deee8a">383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d2954c416de4b1e94f5fc8ec55a8415_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOC03LTEtMS0w_c1141449-e7d5-415f-805e-b52bf17adc1f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOC05LTEtMS0w_4f98daf7-4739-488b-8c99-af9904363881">389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOC0xMS0xLTEtMA_7f96a888-de80-45f1-aad6-ddc950398a92">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9dc416181f40ecaf6b337fd9f9f867_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOS0xLTEtMS0w_7a3423af-66f6-4b0d-914f-4fd87c3a7551">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9dc416181f40ecaf6b337fd9f9f867_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOS0zLTEtMS0w_5d146aac-8683-4448-820f-407798b36044">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f12b69dec3e45bc83561d3148a11d4b_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOS01LTEtMS0w_80bc2b25-5852-4ec7-8ff9-5f801d2c15ff">669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f12b69dec3e45bc83561d3148a11d4b_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOS03LTEtMS0w_50c893f2-0545-48e5-a32d-48f0bae0c06e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOS05LTEtMS0w_5232017a-765f-4ba3-96f2-78e589b2e987">669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOS0xMS0xLTEtMA_f819a9ce-f0fd-4985-a773-9ca0b548c2cb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMTAtMS0xLTEtMA_da309e68-b732-4ad9-aba4-bb46ca098002">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMTAtMy0xLTEtMA_3f7d7799-74f7-4418-a8c5-9b61c5e0d1a0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMTAtNS0xLTEtMA_532d7074-7b06-4218-825b-57cc4a1b8a10">4,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMTAtNy0xLTEtMA_b8d342ca-daf4-4f65-aa3b-01cab9c8a34b">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMTAtOS0xLTEtMA_f2c2c878-6d8f-4931-9270-b5cf84f3d390">4,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMTAtMTEtMS0xLTA_87baf74a-ac42-4055-abee-0c2a2997f9a5">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;<ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="cvs:ActivityInMortgageLoanPortfolioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDk3Mg_4bfa2e2a-23fc-4b21-8d08-28a6bc595a62" continuedAt="ib3654997d288468ca4b598fc6a2b21dd" escape="true">During the three and nine months ended September&#160;30, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ib3654997d288468ca4b598fc6a2b21dd"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0879481908c44bb974f798733a18941_D20210701-20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMi0xLTEtMS0w_311519ec-e611-4a0a-8b59-46e1bb1591aa">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81bd66dcd0c14391b7ca572896fce844_D20200701-20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMi0zLTEtMS0w_82c21570-d43d-4d6a-b87b-985e90e1b7dc">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic20457c673f444f7ad09370f0abc943f_D20210101-20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMi01LTEtMS0w_ceb7b14d-6422-44e5-ac5d-b107dd9dc035">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie65d53b92fb04633bf47f5b64fe04237_D20200101-20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMi03LTEtMS0w_7297fdac-876e-49a0-b6d3-149851381aa5">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0879481908c44bb974f798733a18941_D20210701-20210930" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMy0xLTEtMS0w_6abcdd87-14cb-4b09-9000-34a730aacd62">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81bd66dcd0c14391b7ca572896fce844_D20200701-20200930" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMy0zLTEtMS0w_2096da06-34ec-4288-8e68-a4656221d1f3">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic20457c673f444f7ad09370f0abc943f_D20210101-20210930" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMy01LTEtMS0w_ad6bf5c1-1f5c-4e67-b84d-08b7e92a6801">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie65d53b92fb04633bf47f5b64fe04237_D20200101-20200930" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMy03LTEtMS0w_74231e54-a613-48f1-a86d-3ced5e1f6699">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0879481908c44bb974f798733a18941_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfNC0xLTEtMS0w_e4df3a33-f5b3-4dd7-a07f-22ee46ab4772">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81bd66dcd0c14391b7ca572896fce844_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfNC0zLTEtMS0w_5e91330c-11ff-46c1-8d65-dcb095c39498">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic20457c673f444f7ad09370f0abc943f_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfNC01LTEtMS0w_0fa5746a-6464-4c5e-b479-1a1ed6578b2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie65d53b92fb04633bf47f5b64fe04237_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfNC03LTEtMS0w_e5893b0d-6fa5-4563-ad01-28eade9cfb96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i740eb1835fdb40068d2d1c46eec50d5e"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDk2NA_281d8edc-9ae2-4a20-a690-82ab7eb9c24e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at September&#160;30, 2021 and December&#160;31, 2020, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1005ea182f234733a5f7f072c2ab891b_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy0xLTEtMS0w_76002a62-4bc3-4dc8-b3aa-06ebbe5a9954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i621480d3797b439aa77a9e7253861a59_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy0zLTEtMS0w_8299976a-0873-44ef-8211-25508e63b2d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bef302866f416f9a0761624eade678_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy01LTEtMS0w_2bfa048e-00f1-484c-8bbd-cac900920b1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa59d496a4474b0f95a13c32d9357c35_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy03LTEtMS0w_cb53e6c6-dd6a-462a-a484-0bb6b6c487df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcad87c9dec641918b3c4b3bb560a7de_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy05LTEtMS0w_c4d8f5a8-f986-442d-85ec-4518e0d53a2b">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f221174b2cc4c23bf352b6226458e50_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy0xMS0xLTEtMA_9d8211b0-5dae-44fa-b23e-1ee157d36f91">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ccbb0e4dc92472684d9df86f46847c6_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy0xMy0xLTEtMA_e0a89984-24f9-4b67-9b89-a7dbcad07e4a">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6b89ae1dbe540a4b314a9ffd00f3e91_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC0xLTEtMS0w_9d4fb6b1-996b-4318-bbb4-165015483106">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99fbba707114103952918869f5d54e8_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC0zLTEtMS0w_cfc140eb-37b6-490f-867c-f139222934cd">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a096f78525a4f118bb1911a1d28e677_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC01LTEtMS0w_75c9c1cf-bc92-4cdc-9ce5-21499d6229dd">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i305483b9eb2c4a8995176a43a6032fc0_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC03LTEtMS0w_33e4def2-3ce4-4f4d-b854-1a474a481168">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8e395c6c584b45aadbedeab96bdde0_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC05LTEtMS0w_ecec8125-cbec-4b51-a297-de42d8c4201c">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4c260ac59344468042ee0c45e67651_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC0xMS0xLTEtMA_2192b7e1-27ab-4ee7-ae1d-b22dc9981fba">443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifacff69d92414346adfc278aca85cbab_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC0xMy0xLTEtMA_59ed3d9b-ab57-42cd-bbf4-bf6b7aaab930">870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bbe3fa4925463a965ddbfa2358fff7_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS0xLTEtMS0w_81f80a30-cced-4904-b136-598a696955c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i687923585ac246a3aeff8523198d5758_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS0zLTEtMS0w_cc303497-0bf0-402a-b520-fde1e628de67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f440075a474904a22012bf5a0fa634_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS01LTEtMS0w_3f54781c-d318-4a5d-a2d6-2a059f6040e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37ba77da999a41fdb1d81252d6c8a441_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS03LTEtMS0w_09f074ac-5fe3-4425-ae98-e7f3efc13da2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e95dbb642b48db85e7e5bdff14e6e0_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS05LTEtMS0w_c129f10a-8e8f-4043-9267-7ba88a4821ee">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9969a7b4b4034a81bbe819b2eac5c9d6_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS0xMS0xLTEtMA_c7f2937f-dd28-4954-a3f2-9454b7d16598">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42c00a9fab3d4285ae67e62b24f65277_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS0xMy0xLTEtMA_1a9884bc-4092-4170-b07c-74d3f0af85c2">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8be70fee5e364ac0b0e505aa20317bc3_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi0xLTEtMS0w_b2105793-9905-49ee-86a7-203b835d83a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i613b395302204b2d82957489697563c8_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi0zLTEtMS0w_d97bda07-c541-4f92-866d-cbf8e022bc0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6adc5271a0f0419f838168a0b0c93dcf_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi01LTEtMS0w_c7fcf0c7-379c-4856-80f7-81d4dde3dd92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3be55e2300ee48e49c912324e8d0adb5_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi03LTEtMS0w_f848fea8-7369-4d1a-b0f1-6c67aa355511">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5edd5e4487d4cde9d6f50a2574f3e8c_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi05LTEtMS0w_b4ebe61e-2eca-4086-8541-b3856476cf48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b52851fb9b94ea79df46ebaba85d992_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi0xMS0xLTEtMA_39cc2797-9162-42e3-81c7-1bea12636331">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13f6a29f7e20449ca439559613ffdb02_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi0xMy0xLTEtMA_b36ea46e-68ff-4ff8-9510-f45e87f6c9e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie16bfbf4e5d442348e7fbfc7fa8540f6_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy0xLTEtMS0w_b80c5355-41d0-4f60-adbb-56465438adb5">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie54cb4fb85cc4c14ad9a8f690844eb1c_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy0zLTEtMS0w_9297707d-cca2-4bcb-bd75-dffce312bc4e">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7336d9407ae74018bd8107c29553bc53_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy01LTEtMS0w_acccb5f7-258c-4386-a66d-5ad5c1180223">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i990fec2baf6c440d8151861169097a2d_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy03LTEtMS0w_f002b866-90be-4bd7-8e5e-0a413ac43a87">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bbb7234989e4a60815b6f61bbb10430_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy05LTEtMS0w_16ca2b60-e0b0-4533-9b4d-7f0827df70db">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic54ed38faf1840829ada4f19ee78708b_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy0xMS0xLTEtMA_dabc61af-3a09-4888-be36-d82f06c25d7d">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib458fd6ed94b4ec88122673b72dc2b86_I20210930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy0xMy0xLTEtMA_84e779eb-22df-43e9-bb92-1212c7e455c6">934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf1830b9927b403fb56106443f7e286a_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTAtMy0xLTEtMA_43d390aa-574a-4b75-a7a3-f061abd36e85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic16faab668914c0b8f33d98455c26ca8_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTAtNS0xLTEtMA_8f55e123-9656-4437-aa48-55644696512b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299c35c4365f42e1bfcf88ec9516cd24_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTAtNy0xLTEtMA_939e534c-3455-4924-ab1c-801c77814995">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e754d40a6d447789aba510c1139f8c_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTAtOS0xLTEtMA_b997f290-0b9c-40f3-ad9f-0b2238ba2af9">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838e7866071a4f15bf5992c7b4d65771_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTAtMTEtMS0xLTA_b5bcba71-44e3-465a-95ef-c14f3ac9cf81">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc3123160602429a9bf38bb156b7b80d_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTAtMTMtMS0xLTA_192d2385-2c67-4722-98cb-862449405184">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f211351ebd945b59851039aa7cd4aef_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTEtMy0xLTEtMA_8d4a164a-ae54-41e1-9149-199eae99803d">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f8fc8c9444745159ca710fbe002a038_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTEtNS0xLTEtMA_d94759e7-f3f4-461e-861d-c0cc409b15ba">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34358d8265934eedae4d1ba649b53da2_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTEtNy0xLTEtMA_f113a3a3-abdf-46a4-b5ab-f44ff9148db3">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b8c3d6759524f80acd74630696a9506_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTEtOS0xLTEtMA_d8c98394-ba79-475d-bca4-4d381e892916">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027a56206bf049918acb4cc292f57cf6_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTEtMTEtMS0xLTA_0a506e1a-346d-4e5c-9950-18ff34dd0b71">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6be1325a1fd74472b0c1686a5b8bed29_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTEtMTMtMS0xLTA_b3442183-ebeb-49c8-8a22-084823ed934b">952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40eace95f50e4f4abe9ef0c982f565fd_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTItMy0xLTEtMA_8d21a07d-33ff-4199-bb09-630d9cd831b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e6dcc78d1204e1a9a491939346531d7_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTItNS0xLTEtMA_cd5de697-1223-42c3-af37-b921bfc3f5b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e2cf59a412346b49745f23c85ebdae7_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTItNy0xLTEtMA_c5f59607-dfe5-422f-a3f5-1ffe688b4ec3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e1433ec26e14619bce3f327630539e5_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTItOS0xLTEtMA_f1826ca3-ec49-4cc4-9644-08137af19d52">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad4028c79991465f8affd1c774924434_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTItMTEtMS0xLTA_3c79802e-b76d-412c-9240-192f91a4d199">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i515f5ad673e841cbafd84da71411a3a4_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTItMTMtMS0xLTA_e5d3931c-51ec-4aa2-9156-07c50a91dad3">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf7f501b4a04e6ab02d3946c1b2fcc7_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTMtMy0xLTEtMA_be7bbf31-12b8-43ee-852e-777abab4b230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifed08cdcd0ec4c51b9c44843b976a3fb_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTMtNS0xLTEtMA_4de268ad-02e1-4e90-a1b0-fa99d27c5f2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141813623d8d47759168dc83deace4b8_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTMtNy0xLTEtMA_06deb08f-5599-4af5-b086-0dd1b3094ad1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebcd200cf0d3431899420614fcc5f00d_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTMtOS0xLTEtMA_24053cf9-ca6a-42ba-b324-bc456d37db05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeef2fe72a0e4db78d0c62aa5b990f64_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTMtMTEtMS0xLTA_182afbf1-4b04-43d0-a3eb-3b3a750a82da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b884c52dc2140b8ad6a93ffb21a0ca8_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTMtMTMtMS0xLTA_c96d70d1-3f8c-46bb-818b-97f6d5883ffe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7e1a05886ee4b2fb12e4f8922b90730_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTQtMy0xLTEtMA_b4ffbd3f-f086-45d7-aca3-24dc0fa19cd8">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib80106be43ca44388999d7b0f50726e1_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTQtNS0xLTEtMA_8feed5d8-f407-4ad6-8248-1bbc92b0f182">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0870a5c62d42d0835c91ab95f6f879_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTQtNy0xLTEtMA_09db6ca9-0d05-4e7d-b422-0197ece27f8e">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4a4db2857ba40af84f29186cfed8c8a_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTQtOS0xLTEtMA_3412f0ef-b732-45a4-9c03-4edf12f72304">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebe5c48239d4acbbcfb816d06be3231_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTQtMTEtMS0xLTA_b41b3333-dba3-471c-b18d-6bec524bef02">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ef632b7d74402987f587828bb58743_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTQtMTMtMS0xLTA_a35c184b-0bac-4c50-8a2b-3ce2a76fdbfa">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:InvestmentIncomeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDkxNA_3b9c14cf-825e-4a90-a1ab-f0c0e9662536" continuedAt="i33edf14933bc4318a8e5ce6074fb7b8c" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three and nine months ended September&#160;30, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca40fd7d89b44aeab59a2047d066ca6_D20210701-20210930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMi0xLTEtMS0w_7f2ce8a4-1497-4ae3-8036-a648ced8c5cb">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i597b415b2bd6471fa91f8a8a2d582e58_D20200701-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMi0zLTEtMS0w_abdfa148-08ab-4a53-be16-d1a62957ac7b">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf2d7ded1ee4ac3ad8f173a49ca5148_D20210101-20210930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMi01LTEtMS0w_b603ad70-6b54-4992-a48a-ee6427a36399">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i930f3c01703c43719b9d884430d891d8_D20200101-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMi03LTEtMS0w_47bbe51a-f7d5-4394-96cd-847ed4b67eec">441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i474200218c78432fae6cc7d8692546d7_D20210701-20210930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMy0xLTEtMS0w_4f7c9a99-4514-4630-8b62-f6de025963d2">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59cbe9d0b1c14573aeee78a7f064a39c_D20200701-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMy0zLTEtMS0w_d0413e15-c472-46a5-a67a-9fc55b6b3607">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42c6d3403b9b4becaa9ff959ccfe8f44_D20210101-20210930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMy01LTEtMS0w_99d38b49-8ab5-45dc-bc0e-debc2d5cc047">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebe53271a07413f911296d1d7453a25_D20200101-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMy03LTEtMS0w_838cdfac-bff2-4979-ba84-aa514aad6ddc">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaaa57ceba5d4481b694b7ba30c13b7b_D20210701-20210930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNC0xLTEtMS0w_caf779bf-458c-4294-a4f4-0dc11119f2f8">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72bbd414aabc447686e70f07f2d01a3f_D20200701-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNC0zLTEtMS0w_21c82095-5257-43e0-8837-0667bff60bcd">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id63cf05999ee4f44a681fc80a55eb52f_D20210101-20210930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNC01LTEtMS0w_dcb0f61b-7863-4f0e-971f-45222ab2a694">307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04638c4a1572491dab3ac08e4ad98438_D20200101-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNC03LTEtMS0w_94727aec-89a4-4b82-b469-7e563eef7313">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNS0xLTEtMS0w_43fb21dc-f3ee-4a8e-b205-fd5484ab9045">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNS0zLTEtMS0w_5b22bcf7-865e-44e7-bfdc-7c004d777caa">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNS01LTEtMS0w_a8440df8-7bdf-49bf-9ffb-b81ef440ae96">822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNS03LTEtMS0w_694812ef-4a18-4a3e-bae8-5e19770d1740">550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNi0xLTEtMS0w_30964080-bef8-4752-a854-d77badbd9658">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNi0zLTEtMS0w_59f28413-8ba4-4baf-81f9-77cc74fc542a">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNi01LTEtMS0w_4273a5d8-6f72-4ea7-80ab-9562ada43778">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNi03LTEtMS0w_da97e5a0-da63-4359-bd10-b47b6e24eff2">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNy0xLTEtMS0w_f555691c-5d7a-4bfd-938d-e9390f583685">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNy0zLTEtMS0w_8c13efd8-4b46-486b-b3df-b443b93bf935">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNy01LTEtMS0w_acb93d0b-2d85-4be5-894c-d6b754b5e235">794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNy03LTEtMS0w_b4d04cf5-6d52-474c-ba49-fa1e0c896eb9">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOC0xLTEtMS0w_b4a84a87-b2ab-4116-8b00-0f33abf2e273">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOC0zLTEtMS0w_4293fa73-91e9-4b9e-8635-ef9974af6fbb">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOC01LTEtMS0w_84268d3a-cabd-4659-bd43-470e026e60eb">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOC03LTEtMS0w_174826e2-8d09-460e-9500-51990e0b9b49">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOS0xLTEtMS0w_c4c501b1-1f49-4d04-aabf-a937c86365e4">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOS0zLTEtMS0w_e96e47ae-cd2b-4fe7-b430-422ccc620aa9">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOS01LTEtMS0w_2e771001-9a56-4b57-9c0e-376178bbc158">832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOS03LTEtMS0w_d7200dcb-39c1-43d7-98ec-b8b5718e6ceb">550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital losses include yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfMzk1MQ_19fe0f3a-5e63-443f-838e-87fe4046f466">3</ix:nonFraction> million in the three months ended September&#160;30, 2021. Net realized capital gains are net of yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfMzk1OA_8905d401-799e-45d8-9078-41f4a8aa8cf1">35</ix:nonFraction> million in the nine months ended September&#160;30, 2021. There were <ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDAyNQ_2c88994e-fb07-4694-939b-d81b870ba6ca"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDAyNQ_7751eb3d-7eb4-4506-a598-74107bfd1b87">no</ix:nonFraction></ix:nonFraction> credit-related losses on debt securities in the three and nine months ended September&#160;30, 2021. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDIzMw_f897b0d7-7472-4e6f-bf0e-34f3c77831d4">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfMTA5OTUxMTYzMjg4Ng_d8004d32-087d-42c0-8433-bf386585e0c2">2</ix:nonFraction> million, respectively, in the three months ended September&#160;30, 2020. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDQzOA_af1450da-f99a-4b88-8812-67a827c173ce">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDQ0NQ_1b1a7a6e-c81e-4ec1-8f30-fd620b4d24b2">44</ix:nonFraction> million, respectively, in the nine months ended September&#160;30, 2020. </span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i33edf14933bc4318a8e5ce6074fb7b8c" continuedAt="icd1cc5b70ff14b718a2d56f0ee31020b">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="icd1cc5b70ff14b718a2d56f0ee31020b">Net investment income includes $<ix:nonFraction unitRef="usd" contextRef="i6a39ccc3c07c44ed8a195c76b9e7e55d_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDUyMw_f5aa2a67-ff26-4476-952e-5a8d0ae2aa0f">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3c637804a3d2436ba9be1a2b270b4e53_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDUzMA_77b25e24-745c-44a7-8fce-e8ef1a67f7bf">28</ix:nonFraction> million for the three and nine months ended September&#160;30, 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="if1067180474044cab8a4d973cdb2842e_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDU2Ng_c2566fe6-96a9-4c94-be74-644a2406453e">10</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i508e18defcad47008f1dab8d4f81dbdb_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDU3Mw_e756d3db-c83c-4a95-ba3a-9878c92fc567">31</ix:nonFraction> million for the three and nine months ended September&#160;30, 2020, respectively, related to investments supporting experience-rated products.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDkxMQ_70d86a6c-6646-43cf-8e4f-b1b5172266af" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and nine months ended September&#160;30, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMi0xLTEtMS0w_ca68b88d-ad41-4b71-af2f-9a8c04b20094">668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMi0zLTEtMS0w_6a262b70-d313-494d-b3ce-03a6ae389323">905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMi01LTEtMS0w_c95074c5-b7ce-43d1-b212-5782980d065c">2,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMi03LTEtMS0w_ec393c6c-ee3f-4bf5-8353-a3751e7173d8">2,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMy0xLTEtMS0w_28d6e07c-132b-4794-bacf-4659163853a0">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMy0zLTEtMS0w_de2661a2-7e9f-4330-975f-36d0a2447cf5">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMy01LTEtMS0w_7dcf3d5d-c822-4455-a8e6-8b91690b1ce0">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMy03LTEtMS0w_9a8a7dd1-6c14-4053-801d-3bca0d4e1fb1">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfNC0xLTEtMS0w_6dd06608-b77f-4a66-9dae-a20b0fbd2343">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfNC0zLTEtMS0w_48186d50-0df0-4466-8747-4c290dc439ef">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfNC01LTEtMS0w_e475161f-2e66-42c2-8968-8bc9c9811da2">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfNC03LTEtMS0w_05b389cc-c28f-41bf-b3ed-0a00f875b48b">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_43"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMjc0NA_ecc791ae-416b-4449-8c69-9de1d0a6dfbe" continuedAt="if0bb705dc4b84441884ee0149136952d" escape="true">Fair Value</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if0bb705dc4b84441884ee0149136952d" continuedAt="ib37768e0041c44fe932cbb031f8b2f1c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#8217;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#8220;Fair Value&#8221; in the 2020 Form 10-K.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib37768e0041c44fe932cbb031f8b2f1c" continuedAt="ia66edc3264d54e9f9581dec23099d494"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i0563521c632f47179c829933333c3ddf_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMTQzNQ_5d6ffac6-4f6c-4374-9234-8021243c1fad"><ix:nonFraction unitRef="usd" contextRef="ibe7ab3f842154eeea4c328406a7ac83a_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMTQzNQ_bbce314c-cd4d-4710-870d-7342a5237c24">no</ix:nonFraction></ix:nonFraction> financial liabilities measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2021 or December&#160;31, 2020. <ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMjc0Mw_ce109eb8-0e11-442b-80cf-ef15bda9e158" continuedAt="i884e67c59578442cba15b25b2d286147" escape="true">Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2021 and December&#160;31, 2020 were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i884e67c59578442cba15b25b2d286147"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda576b425f044eb953d6a347d279daa_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMi0xLTEtMS0w_e1124896-22c3-4021-8760-b79ab1599059">4,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06aeed222c24fe2b41407064d3593bd_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMi0zLTEtMS0w_a182c1c5-6ebf-445b-8d5d-bba973f03794">4,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fc9d5b465f44abab9625a29fa0d38b_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMi01LTEtMS0w_70cf2947-11aa-44ae-92fd-ab01ed440d5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7ab3f842154eeea4c328406a7ac83a_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMi03LTEtMS0w_04c0a635-4076-47e6-8390-91b4b0016757">9,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2af50b590ac44018a0222d8c3c2f4aa_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNC0xLTEtMS0w_9d6a0f23-e978-4a30-a334-e0a4b0821a54">2,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c1da65d86f7414da97ff4e9d8609420_I20210930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNC0zLTEtMS0w_e76a715f-f8c7-4d54-869e-f158446f30af">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c144abf9d6c4c40ae0c2318a533d55b_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNC01LTEtMS0w_763052af-a37a-43d1-a158-8ee289104fc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib513a974552e403ca51acd78fcf5dde8_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNC03LTEtMS0w_9ea75b8d-bc94-468a-b925-3b99236a339d">2,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6e72b78b8754b94aaada037ca2420ee_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNS0xLTEtMS0w_02289bcf-aa25-4573-84f8-317ea1513b6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75c0f2cacc534be690f026d29bdfd858_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNS0zLTEtMS0w_9437e509-cbdc-4ede-af71-f3b6b04327bf">3,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e2a3404bce24924ba593cb3d50a171f_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNS01LTEtMS0w_a3a21f8f-8c8e-4ce4-b400-fb0bd4b02791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81d44c8f29a451a8615660915b19be0_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNS03LTEtMS0w_1dd7e92c-dbb4-4a1e-bac2-9a8ff0f66b73">3,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9883998841414e459a14949384066c00_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNi0xLTEtMS0w_9dca7528-6325-4821-b911-e4a18c135009">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4aee10007334dc08704544552884bc2_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNi0zLTEtMS0w_cee44ba5-b740-40a6-8c50-c61bf1c2fe1f">9,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c7bdff14cf4b519ad7ee30cc901f32_I20210930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNi01LTEtMS0w_0337c5cf-b391-415f-a5b6-19a1e7466294">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5add9eb3c7da468c9b1a2863e2d79bf2_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNi03LTEtMS0w_fef378c8-97ed-4dd9-a992-fbcd2059f849">9,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83f92ecb821d4bf7936caf73110c90ed_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNy0xLTEtMS0w_747f41bf-670c-4258-8211-e75945122445">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6837264698c94d41988231e4099598b4_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNy0zLTEtMS0w_4504258f-ad40-4b0c-84f6-76bae10485f5">2,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibab1f6f3b94e4f5fa5194e624f3698ef_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNy01LTEtMS0w_6ebf9f82-664b-4c7a-881b-c086288b62e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7db0731152d84288b010f872cd8a99e0_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNy03LTEtMS0w_dd513304-2fb5-4b16-b487-f0212bfc7b74">2,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic04e7b60901742bcbc036ef80339246d_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOC0xLTEtMS0w_052b8fd6-fa93-42ca-a0e3-0a051acc71dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2025973837f14d479020bf7cc4499a72_I20210930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOC0zLTEtMS0w_fe7cd51b-523a-45ae-9d95-63760a89fada">863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfa61eff06aa45fcab009a3adb153755_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOC01LTEtMS0w_cd29a29e-065c-4a1e-98ad-887fb858b34c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ad02b987304467b861021d6c699fee_I20210930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOC03LTEtMS0w_66482a56-265e-4d8b-9e58-3c30e428678f">863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d623b8d6a0424bb2669fd66020aafa_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOS0xLTEtMS0w_597a1f2c-b8a4-4d1b-a504-f7f96bf8c619">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c9a1f84bba4080b2c3d4bef2b71e52_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOS0zLTEtMS0w_9cc74f74-10c3-4179-9ab6-edd1c880c4d8">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501877927dd54fbf93b7f49e999ee841_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOS01LTEtMS0w_7b6978e0-d7ee-451a-ae49-56c05d91e552">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c847c9a44124e7db070cb42a1a63f14_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOS03LTEtMS0w_2523acc6-3739-4cec-9ac4-e678e270b97d">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9dd3149c06249a287ef6e26045fdd95_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTAtMS0xLTEtMA_f33435e5-09c2-4928-8e7f-3669974663a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadba8d3e3d8440528cfcc9c33445f682_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTAtMy0xLTEtMA_9d0da4de-2c96-4d99-af0d-246fd96c706d">2,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib29de6a09dcd46d9aeb48b72526eef8e_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTAtNS0xLTEtMA_17e17b98-76be-4dea-92dc-2e8bb0154c2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999f68483084466e9e68712a6eafd08d_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTAtNy0xLTEtMA_35d6d1cd-2028-4e0c-93d9-c5b7824c4d79">2,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfde730bc324d93b7009d7ab45141b6_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTEtMS0xLTEtMA_537731d5-cb5b-4739-891a-2df502645b8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89494621c37c4c219c62fdca2ec3a02c_I20210930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTEtMy0xLTEtMA_cee14d46-41f0-4c94-a563-3f369bb6ea74">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7910d366b94081aba8f7c036e31370_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTEtNS0xLTEtMA_f2f21e30-0075-4598-ad7f-deb8406ce5ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9073e6b5944376a12e7f42f106f789_I20210930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTEtNy0xLTEtMA_7dc7ff2a-254a-48cc-a513-621edac971f7">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda576b425f044eb953d6a347d279daa_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTItMS0xLTEtMA_9f68cc13-4c45-4bc1-8c1c-592a248db5b2">2,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06aeed222c24fe2b41407064d3593bd_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTItMy0xLTEtMA_1967ee62-bff1-4ddb-8d70-cd3ab3633ac6">20,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fc9d5b465f44abab9625a29fa0d38b_I20210930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTItNS0xLTEtMA_2944d3b6-7e88-4f55-9600-01db4c1b6c55">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7ab3f842154eeea4c328406a7ac83a_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTItNy0xLTEtMA_3dbc90e3-db50-4771-b6d2-a7af9d7dbd23">22,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda576b425f044eb953d6a347d279daa_I20210930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTMtMS0xLTEtMA_210030bb-f37e-4234-98c9-fafd988c056c">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06aeed222c24fe2b41407064d3593bd_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTMtMy0xLTEtMA_aa6c672a-bad6-41d3-bc73-02d4f03eda24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fc9d5b465f44abab9625a29fa0d38b_I20210930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTMtNS0xLTEtMA_3d947c6c-f419-418d-bc14-40e2bdccefe8">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7ab3f842154eeea4c328406a7ac83a_I20210930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTMtNy0xLTEtMA_70ac57f7-eaee-49f6-a228-079b70e56bdc">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda576b425f044eb953d6a347d279daa_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTQtMS0xLTEtMA_844a0cce-d3ee-4352-b807-1d38011d0871">7,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06aeed222c24fe2b41407064d3593bd_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTQtMy0xLTEtMA_8b0e5f04-40e1-4a5e-a396-1e4f82e02262">25,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fc9d5b465f44abab9625a29fa0d38b_I20210930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTQtNS0xLTEtMA_3b3ed289-351c-4e33-af56-5a2d1ea3c0cd">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7ab3f842154eeea4c328406a7ac83a_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTQtNy0xLTEtMA_61b18d3a-25db-4acc-add4-a93270244761">32,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib122074ed9c9464eac823cc8d4819acb_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTctMS0xLTEtMA_7e3d80ba-913d-48cf-bc5d-1bbabac94acc">3,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia674f1ddc0d840b0aa42d18120ac12e5_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTctMy0xLTEtMA_458f0139-d30d-47f3-a1c8-5b8db501ab14">3,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95327e52078a41a89444ec318828a7dd_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTctNS0xLTEtMA_b4c28d31-8d2b-47f0-97e1-4390c5f5d76a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0563521c632f47179c829933333c3ddf_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTctNy0xLTEtMA_7a8abe23-a1ac-4d5b-a532-d8f882a7951a">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic836b346282347908809f16a6eb5660c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTktMS0xLTEtMA_b6c9b825-7ec4-4f37-bcaf-05907d82d58f">2,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34bec3f3434a41b7ab493984748deeae_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTktMy0xLTEtMA_f3fbe449-22f8-4f81-9af1-123dfb706083">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc87715012e244f1a0941fc7f486bcb5_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTktNS0xLTEtMA_38472441-e339-43df-8ee5-13201174c01e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fa629d192414558a844c90838b9c4a1_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTktNy0xLTEtMA_383b800d-7efd-4f6c-92cf-0ac37044cac0">2,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ab2e48c06df4ca08a139917417a396f_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjAtMS0xLTEtMA_73bf45d6-b11b-42f0-81f2-2dca2f663aec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie971ffe3a7844dc29d629c33684e8d32_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjAtMy0xLTEtMA_c4919bba-8b03-4fa2-a26c-e0bf603fabac">2,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb69f5ffee80421c89348f37e2cb0f86_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjAtNS0xLTEtMA_03eae8a7-0ff9-4f8d-97f4-3750a975e162">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2f0f2fe2f045bda1c2226bbe6a8fd5_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjAtNy0xLTEtMA_101eeddf-22c2-475f-bf2c-f76b287db929">2,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c1eef1a6b448418547a06e29940d6d_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjEtMS0xLTEtMA_cfef7e41-b34e-4372-a7bd-3a5b72325f2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc165d15f6804c64841a910becac3ed9_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjEtMy0xLTEtMA_62ee9c0b-183b-43e8-8fdc-51f3fa8bfad2">8,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c412a5ba874f98870341d7ea31c942_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjEtNS0xLTEtMA_3c3868b9-b7df-4492-93a2-5718ac601a8c">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib297eefdd01042809add61d2dd4010fa_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjEtNy0xLTEtMA_b4253983-e1d1-441a-9ebb-1218ea4d9f82">8,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de217ffec6c4548b78c7b2302f20377_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjItMS0xLTEtMA_9d2f27ef-1a77-4898-bad8-acb26b8574c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa404aec6f7740709c74a50e423f55c2_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjItMy0xLTEtMA_0b3432b3-fcf0-4bce-a518-8e5328472296">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i694813f254844fc388cdc57b0282c552_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjItNS0xLTEtMA_b3d09ded-6a74-447d-8bc6-59f6c051bcc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76a73d6716c549c5a3e574f5997c2627_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjItNy0xLTEtMA_192766cf-4e7b-4451-89f4-fb2ac5f7f522">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53410c2dbc4c4d39a65c4deba26b6c80_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjMtMS0xLTEtMA_4aa72ed3-e308-405a-a3f2-f7ca1b16dc4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fa0bd51236409caabdfcaa76735c44_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjMtMy0xLTEtMA_7bb97df2-fc0f-4b90-bd73-ea81cba7d491">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d4071d9bde54949b0ab30e57b6d131b_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjMtNS0xLTEtMA_8be7b672-e169-4bb8-b251-d77b1ee16382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f20743700e4f5d90d0ace281e6184a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjMtNy0xLTEtMA_f6a73c3e-e59c-4eb6-92cf-55d6f0dddc32">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bd830bd2d0a49eb8ec02b1932b58722_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjQtMS0xLTEtMA_1b6f1bc1-c9f0-4dd0-b86f-828084433eb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb2d516d37a44977806647d938c79d40_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjQtMy0xLTEtMA_f9030ed7-9d6e-4795-b956-8f2b7a43cd01">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cdd4cdd4ca546788f18be91782db91c_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjQtNS0xLTEtMA_d866d9d5-f063-4bf8-8c4f-6ae5de04e1e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47fa10c381de44068b970898e3aa4e58_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjQtNy0xLTEtMA_04c08e99-c5ed-4521-8a31-61415ed987e7">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96cb72db03134df09fb6aa81f2b1786b_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjUtMS0xLTEtMA_13f295d4-1148-46fa-9fac-a7167ef628c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9611cadb797e417db325edf33945b988_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjUtMy0xLTEtMA_0d5b0cbe-69d0-4b67-8672-d761676f447a">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563011688aa349e7a1f32d722693061e_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjUtNS0xLTEtMA_b1cbbdc0-6152-4d34-93ff-65381d6f40e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc355084ff424474b90262f9ba68cb4a_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjUtNy0xLTEtMA_affc7af2-03dd-415d-87ff-4cc6a6b5d2f7">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3904707e6a34e4e8e4ccfc85ced0bef_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjYtMS0xLTEtMA_0ae2f50b-2d09-4a96-9b71-04e6db06c2ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07c7bd30fcf945f7bae17c46fe84a1e0_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjYtMy0xLTEtMA_9ca5cec9-a71c-4baa-8c60-5639a011a332">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafea971f2cd6419a915d40ecfdcc6853_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjYtNS0xLTEtMA_3b43aeac-150e-441e-aa36-82020b9fc34e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf087794476a45f1bafd4c1e6447c2a8_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjYtNy0xLTEtMA_d5071754-cac1-4642-8dfc-d6a9ce01105e">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib122074ed9c9464eac823cc8d4819acb_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjctMS0xLTEtMA_bc58f1fb-ba65-4cf8-b082-6b304a7d2f62">2,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia674f1ddc0d840b0aa42d18120ac12e5_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjctMy0xLTEtMA_799f80f6-26cd-4835-ac07-1388b163c075">18,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95327e52078a41a89444ec318828a7dd_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjctNS0xLTEtMA_4d690416-bca5-4aac-96fc-c019d80b6fd0">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0563521c632f47179c829933333c3ddf_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjctNy0xLTEtMA_a4601a82-c014-45cf-9665-bfb904794157">21,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib122074ed9c9464eac823cc8d4819acb_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjgtMS0xLTEtMA_c7f69e3f-b880-4128-92be-fcffbc4743f9">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia674f1ddc0d840b0aa42d18120ac12e5_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjgtMy0xLTEtMA_7398d120-f391-4f76-8043-9821eec10d3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95327e52078a41a89444ec318828a7dd_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjgtNS0xLTEtMA_fb6d2088-fe6f-4924-8353-8e5058baf079">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0563521c632f47179c829933333c3ddf_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjgtNy0xLTEtMA_cd40bc06-dd38-4a75-ae70-54fe898287bc">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib122074ed9c9464eac823cc8d4819acb_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjktMS0xLTEtMA_acf4843c-5a02-4afa-a730-92d364abdd5f">6,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia674f1ddc0d840b0aa42d18120ac12e5_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjktMy0xLTEtMA_7e5f39b5-4bd3-467b-b77f-296ded9803cf">22,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95327e52078a41a89444ec318828a7dd_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjktNS0xLTEtMA_4e2ef0b5-90df-4e76-a9f7-cfa90f00e244">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0563521c632f47179c829933333c3ddf_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjktNy0xLTEtMA_1d671840-eb17-4ee5-a5a3-8374cca3b1c5">29,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2021 and 2020, there were no transfers into or out of Level 3.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia66edc3264d54e9f9581dec23099d494"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMjc3NQ_1f303984-f111-44b0-a665-0629f58adf3f" continuedAt="i2b4ee64d698f420abb40b8e6aa8e626e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at September&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c049e51c8604a9183951023541454c3_I20210930" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfNC0xLTEtMS0w_4517e7a4-93d1-44c3-b49f-9465b6f6714d">934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i021c91d03c7945d4a5905a640d27996a_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfNC0zLTEtMS0w_8fa8fc3a-2d68-4a35-b69f-f944eef607d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c135e138975479dbc208139f9ce925f_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfNC01LTEtMS0w_db4e083c-5780-4f51-8d18-f2103823948a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i147018bb8fcc4e0586edf2dde3e287c4_I20210930" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfNC03LTEtMS0w_86307a15-230c-403b-8929-6ddf5e11564c">945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaad5be874c394c87a8151ea37f655ba4_I20210930" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfNC05LTEtMS0w_507354cc-3f69-4c6c-93a1-1c62fa53c7e9">945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c049e51c8604a9183951023541454c3_I20210930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfNS0xLTEtMS0w_487294e1-37e2-43a2-8828-eaab54a6ae7c">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c049e51c8604a9183951023541454c3_I20210930" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOC0xLTEtMS0w_65d5a294-089e-4031-a584-9949c056291f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i021c91d03c7945d4a5905a640d27996a_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOC0zLTEtMS0w_0dd2db1d-85a5-4caa-84a9-ba613b64cd79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c135e138975479dbc208139f9ce925f_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOC01LTEtMS0w_661bb3e7-7799-4e32-afe6-b0c056534985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i147018bb8fcc4e0586edf2dde3e287c4_I20210930" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOC03LTEtMS0w_e5fe68b6-8c05-4000-9d40-0da4e8f1520c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaad5be874c394c87a8151ea37f655ba4_I20210930" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOC05LTEtMS0w_5f399113-4b87-4d24-8454-a5f3bedb7ad9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c049e51c8604a9183951023541454c3_I20210930" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOS0xLTEtMS0w_6211777b-2b62-47c8-b2c3-d754e45395ee">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i021c91d03c7945d4a5905a640d27996a_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOS0zLTEtMS0w_07f655ec-a268-425d-9b21-377be61bb472">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c135e138975479dbc208139f9ce925f_I20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOS01LTEtMS0w_e272747a-9005-4bd1-b615-e02697229b7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i147018bb8fcc4e0586edf2dde3e287c4_I20210930" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOS03LTEtMS0w_ca448555-7671-4856-a879-36cb77329496">378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaad5be874c394c87a8151ea37f655ba4_I20210930" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOS05LTEtMS0w_4ef0d360-1055-4c91-9aa1-b6cf08fb368f">378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c049e51c8604a9183951023541454c3_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTAtMS0xLTEtMA_8d7d4509-512f-42c1-b0a3-c1f1cf2ad537">58,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i021c91d03c7945d4a5905a640d27996a_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTAtMy0xLTEtMA_07b2a5d1-c524-4591-b441-541bfdc79f65">66,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c135e138975479dbc208139f9ce925f_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTAtNS0xLTEtMA_334b8d9b-abd4-44d5-8d91-3e525d567f73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i147018bb8fcc4e0586edf2dde3e287c4_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTAtNy0xLTEtMA_dcd8ba32-26eb-4134-a5cf-c5564e6b4a0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaad5be874c394c87a8151ea37f655ba4_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTAtOS0xLTEtMA_474269f9-fb65-41c9-adde-e8f1ad49dcdd">66,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa2a9cf9df24d96a4910a7770e327b3_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTQtMS0xLTEtMA_e33644a0-ac46-4d0a-a9c0-dd1a1aff12cc">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd49134c4a7f487a8cd469c1c1ffbe58_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTQtMy0xLTEtMA_1db39eb9-47af-4336-b0bd-5acdff237f0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if687d685f43147b8a54d5058142cdfc7_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTQtNS0xLTEtMA_ef59e5b0-f84f-4a52-893e-5f0065106441">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2da8685e5443638fdf326121bfbf76_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTQtNy0xLTEtMA_9424406e-00f4-4a48-ae9b-8343623ff799">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c964868b4a547e1868068b2b01396dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTQtOS0xLTEtMA_5e19a9ca-c08f-4741-955d-06c2deb1887d">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa2a9cf9df24d96a4910a7770e327b3_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTUtMS0xLTEtMA_3aebc571-a0c3-4a52-a1db-f944ad513b6b">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa2a9cf9df24d96a4910a7770e327b3_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTgtMS0xLTEtMA_38cd0cae-9962-4f89-a2a7-089b25e63df5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd49134c4a7f487a8cd469c1c1ffbe58_I20201231" decimals="-6" format="ixt:fixed-zero" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTgtMy0xLTEtMA_04eac8c1-b354-467e-b254-f8c744b73a25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if687d685f43147b8a54d5058142cdfc7_I20201231" decimals="-6" format="ixt:fixed-zero" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTgtNS0xLTEtMA_e945b36a-18d5-4f19-88e7-43c0adddbc40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2da8685e5443638fdf326121bfbf76_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTgtNy0xLTEtMA_e94a1fc9-4b78-4b31-92ec-391c27a41d7a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c964868b4a547e1868068b2b01396dc_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTgtOS0xLTEtMA_605c1d6c-91f3-4305-99ac-ebdcff43f96b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa2a9cf9df24d96a4910a7770e327b3_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTktMS0xLTEtMA_0f037744-d232-4c1e-b078-f91f00eeb641">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd49134c4a7f487a8cd469c1c1ffbe58_I20201231" decimals="-6" format="ixt:fixed-zero" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTktMy0xLTEtMA_ff02b28a-b2ff-4588-bd42-83d20c49fcc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if687d685f43147b8a54d5058142cdfc7_I20201231" decimals="-6" format="ixt:fixed-zero" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTktNS0xLTEtMA_f8efd463-4dca-4b24-aa71-b31ca02c809e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2da8685e5443638fdf326121bfbf76_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTktNy0xLTEtMA_9eac2b67-774e-4f8c-a57e-9ff0a2054b00">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c964868b4a547e1868068b2b01396dc_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTktOS0xLTEtMA_26c738ba-8fa1-4dba-83e0-671bf25f7b08">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa2a9cf9df24d96a4910a7770e327b3_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMjAtMS0xLTEtMA_825cc3fe-0ab4-486c-9da8-768b109cc0fd">64,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd49134c4a7f487a8cd469c1c1ffbe58_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMjAtMy0xLTEtMA_f560d4cc-37a5-4e2e-a957-734a2b4c3b1b">75,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if687d685f43147b8a54d5058142cdfc7_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMjAtNS0xLTEtMA_1e2a96f3-9992-42c9-82fb-5c5961a33d02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2da8685e5443638fdf326121bfbf76_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMjAtNy0xLTEtMA_fc764dd5-8f15-4e60-99e1-9200e5c57938">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c964868b4a547e1868068b2b01396dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMjAtOS0xLTEtMA_00578a66-e38e-4a95-87ac-564c780bac23">75,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i2b4ee64d698f420abb40b8e6aa8e626e" continuedAt="i9e6b890685e740cfa74fb866ce8bd46c">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i9e6b890685e740cfa74fb866ce8bd46c">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;<ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMjc1NQ_a95bd28a-7f9b-4152-933d-135f699abd3b" continuedAt="icadfd217492d43778176b4a2b3d6da3b" escape="true">Separate Accounts financial assets as of September&#160;30, 2021 and December&#160;31, 2020 were as follows:</ix:nonNumeric></span></div><ix:continuation id="icadfd217492d43778176b4a2b3d6da3b"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.243%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ecb6e4143541d38112288c2c2203a0_I20210930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi0yLTEtMS0w_d0d463ed-98d1-4dd4-a46f-980344916fb7">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa9567a6e1242cf9ae54c608091a142_I20210930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi00LTEtMS0w_c19e40e3-f367-4854-bbe2-b9168e91d9c7">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i612ca748550d489da66896239ad5b1c9_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi02LTEtMS0w_5cc8c1bb-d6fe-4e90-b68c-03b8aa9587e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13473c0ae0c14361aa7e0e5b5809b5bd_I20210930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi04LTEtMS0w_1d4116e5-aa21-4909-8bcd-e6c51f0127ba">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18b978d6a92462cb19e95c291464ff5_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi0xMC0xLTEtMA_07b14e20-454a-48f2-8c5d-e5a34306aa30">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i557a10fe4b3943739f83a4f01347a36a_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi0xMi0xLTEtMA_0f1b603c-fa4f-4119-b184-857960c4b05b">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cd654f81de94c4ba6574ed395d10914_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi0xNC0xLTEtMA_1878e05c-d94e-4b6c-850d-9afc6fce9384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f6debc0fdc84a0095ae738e034b2ce7_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi0xNi0xLTEtMA_0250c6be-fdd9-4f19-a77c-094016d855a7">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5b399af8f2c4b1494f420b54c395eab_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy0yLTEtMS0w_65211a66-ba7d-47a6-ae70-5ed981de170f">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d84e87420b4fdfb90748e9026f0c49_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy00LTEtMS0w_22a14631-fcd3-4ce2-84f0-351dd89eb015">3,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if13f0350cddf45ffa223d9ec2d72053a_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy02LTEtMS0w_45d1f1f9-ff4c-4754-a056-e71b6c76e1af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib46ae0b202514c6ba3af15017b7e230f_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy04LTEtMS0w_21c46913-5f2b-4c99-a753-6f35dc8c98de">4,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f2877a791e3491f9534edd67ed3e987_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy0xMC0xLTEtMA_c5659b30-9853-4357-9813-023ba9fbd7d3">1,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad504c15b51c4049918b0ba3bf6aa35f_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy0xMi0xLTEtMA_5a8e5d10-d931-4d4f-817c-07d64a9f97b4">2,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic424242c3bba48f9bbc125c6af13010d_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy0xNC0xLTEtMA_f60eb9ab-0017-45a5-b5e5-b64e2e3713cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib33c9671d5f046d79fce9e9901904688_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy0xNi0xLTEtMA_3e14004a-0e2b-42c9-8afe-c19d75216ab4">4,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c04b19feb064cf1bf23bc7e65f7be4f_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC0yLTEtMS0w_5a297af8-bfdb-4353-89e9-a0536ac6704f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf82daed791d40cd93b600a3e62ef8cc_I20210930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC00LTEtMS0w_1cf94c46-e9b2-4dda-bf9a-2de4b8ad7143">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5aa8d204d59f4f928a510e6900cf939a_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC02LTEtMS0w_f23cb1a7-fb44-4068-9dee-118f0b44b8eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09fb9a5bef7f42428348726a2ff173f1_I20210930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC04LTEtMS0w_6546d9ca-e40f-44c1-bd24-3b5340213bee">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685f457f55ed4bfdaf90fab6ce466d85_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC0xMC0xLTEtMA_39618a9d-de16-4451-ae3c-a62af2a25c63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60056bc19bb048b59c735005c438169b_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC0xMi0xLTEtMA_d402a4c1-5275-49ca-a4f0-d31ec4e36564">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a47aa4aaf384bc6a0e156ab09a449c7_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC0xNC0xLTEtMA_11151afd-ffa9-4fb7-9405-f727b111a2e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cd80f6244e42fbab3150923c3c3ef6_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC0xNi0xLTEtMA_9f38a9e9-f268-4516-9a85-ce57d365f9a9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id865ac262326451daffd0d3a056e96be_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS0yLTEtMS0w_74a14869-f08f-4f6a-a8b1-a1028ff0bf8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d357538b6c0474aa7f475e2632e3e77_I20210930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS00LTEtMS0w_95d77a20-e81f-4bab-b30f-648dbba7e352">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bde8bbc8af2428fb013ae54651523b7_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS02LTEtMS0w_6c2d9f7f-9c6e-4f73-9370-c3936db42084">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7abda2e513b34485baeda28fdbf8e4a1_I20210930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS04LTEtMS0w_13af22ba-824e-44d8-8e9a-ed9a9c372277">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic763372116b148e9a5a2904296c53f93_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS0xMC0xLTEtMA_4dac21b7-3a47-46ef-a279-77af429d05ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79f3ba86d6354f07b5df6c1ffa8bbbe1_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS0xMi0xLTEtMA_4c6a447c-d7ef-44bc-956d-14af82d883f6">563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc45f1d336740b0a1a8d911aac65229_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS0xNC0xLTEtMA_943232a9-37b8-4ec2-9621-02a0412f486c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7733f5518c7645c4b56b68cccf6f76ff_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS0xNi0xLTEtMA_f21faad7-4221-4710-af5a-51ba2be4aad1">563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda576b425f044eb953d6a347d279daa_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi0yLTEtMS0w_43ec6768-2553-4906-bb1f-a7ef90b9511a">1,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06aeed222c24fe2b41407064d3593bd_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi00LTEtMS0w_7eb2e03b-2e00-4157-bb32-65997e3b2804">3,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49fc9d5b465f44abab9625a29fa0d38b_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi02LTEtMS0w_176b1746-ba89-4b55-8050-e544d405427e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7ab3f842154eeea4c328406a7ac83a_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi04LTEtMS0w_90a1a349-b08f-4efb-a04c-e95c6e64222e">5,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib122074ed9c9464eac823cc8d4819acb_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi0xMC0xLTEtMA_83db812f-5234-4572-9de4-c9c6bbf4cbc1">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia674f1ddc0d840b0aa42d18120ac12e5_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi0xMi0xLTEtMA_d4c2b59f-72f4-46ce-a853-8cf0a3f68ab8">3,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95327e52078a41a89444ec318828a7dd_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi0xNC0xLTEtMA_b22e7afe-3249-4fa7-8b2e-0c8e0e535ced">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0563521c632f47179c829933333c3ddf_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi0xNi0xLTEtMA_c34f9646-0b92-4f8b-9ec6-7980165fbdda">4,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $<ix:nonFraction unitRef="usd" contextRef="i4652506a76c7489ca73ed1b4e3db819d_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMjY3OQ_ff5198df-c5c0-4025-a4f1-c97f03bd1d72">9</ix:nonFraction> million of other payables at September&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i1d5e67cc70504729944139279d44d713_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMjY4Ng_f8f050f9-566d-4d99-bdd3-c10076a23b84">29</ix:nonFraction> million of other receivables at December&#160;31, 2020.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_1099511628970"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGV4dHJlZ2lvbjozOTdkNGNkZjdjMWQ0ODI1YTk3ZmViYjRjMWZjNGJiM18zMjk4NTM0OTA3MzU0_43c3ad8b-701f-45e5-a1e2-8747f8d0c63a" continuedAt="i2022881f509445b1982d35613c91aa30" escape="true">Goodwill</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2022881f509445b1982d35613c91aa30"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is not amortized, but is subject to annual impairment reviews, or more frequent reviews if events or circumstances indicate there may be impairment. Goodwill is evaluated for possible impairment by comparing the fair value of a reporting unit to its carrying value, including the goodwill assigned to that reporting unit.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated an impairment of the goodwill associated with the LTC reporting unit, as the reporting unit&#8217;s carrying value exceeded its fair value as of the testing date. The results of the impairment tests of the remaining reporting units indicated that there was no impairment of goodwill as of the testing date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2021, the LTC reporting unit has continued to face challenges that have impacted the Company&#8217;s ability to grow the LTC reporting unit&#8217;s business at the rate estimated when its 2020 goodwill impairment test was performed. These challenges include lower net facility admissions, net long-term care facility customer losses and the prolonged adverse impact of the COVID-19 pandemic and the emerging new variants, which resulted in more significant declines in occupancy rates experienced by the Company&#8217;s long-term care facility customers than previously anticipated. During the third quarter of 2021, LTC management updated their 2021 annual forecast and submitted their long-term plan which showed deterioration in the financial results for the remainder of 2021 and beyond. The Company utilized these updated projections in performing its annual impairment test, which indicated that the fair value of the LTC reporting unit was lower than its carrying value, resulting in a $<ix:nonFraction unitRef="usd" contextRef="i15df075bc2d04e759bf072636f0fd065_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGV4dHJlZ2lvbjozOTdkNGNkZjdjMWQ0ODI1YTk3ZmViYjRjMWZjNGJiM181NDk3NTU4MTY2NjAz_3de0b2da-ef8d-4745-b200-6c84f50da442">431</ix:nonFraction>&#160;million goodwill impairment charge in the third quarter of 2021. The fair value of the LTC reporting unit was determined using a combination of a discounted cash flow method and a market multiple method. As of September&#160;30, 2021, there was <ix:nonFraction unitRef="usd" contextRef="i8616075a3e1f47668b0ea71db5e5caf4_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:Goodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGV4dHJlZ2lvbjozOTdkNGNkZjdjMWQ0ODI1YTk3ZmViYjRjMWZjNGJiM180OTQ3ODAyMzUzMzIw_45cd995f-b90a-436a-a18f-036ccdd34cc1">no</ix:nonFraction> remaining goodwill balance in the LTC reporting unit. The Company also performed an impairment test of the intangible assets of the LTC reporting unit and concluded these assets were not impaired as of September 30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative goodwill impairments were $<ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGV4dHJlZ2lvbjozOTdkNGNkZjdjMWQ0ODI1YTk3ZmViYjRjMWZjNGJiM180OTQ3ODAyMzQ2OTI5_0a2fa305-bc07-42db-8056-f882a5522532">6.6</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGV4dHJlZ2lvbjozOTdkNGNkZjdjMWQ0ODI1YTk3ZmViYjRjMWZjNGJiM180OTQ3ODAyMzQ2OTc4_919f9496-2b81-48a2-b273-7475a561a70a">6.1</ix:nonFraction>&#160;billion at September&#160;30, 2021 and December 31, 2020, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGV4dHJlZ2lvbjozOTdkNGNkZjdjMWQ0ODI1YTk3ZmViYjRjMWZjNGJiM18zMjk4NTM0OTA3MzU2_1428aba3-102d-42ee-bb96-79c96e9390c7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Below is a summary of the changes in the carrying value of goodwill by segment for the nine months ended September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.455%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42ae767186744b45adac05f6feb0c37e_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18xLTEtMS0xLTg5OTg_20f8e4f6-3535-4903-9f8b-3660e6de46c4">45,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750ac96cf4c64738af59810ad96e6411_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18xLTMtMS0xLTg4MjQ_3687c7e9-eeeb-422a-8359-3c1ce3544ca3">23,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23c1f04677c042939927a68bb5fd9f65_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18xLTUtMS0xLTg5MTQ_e894e86b-729a-40f9-8bd6-6815f438026a">10,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18xLTctMS0xLTkwOTA_038d934b-f11e-46bd-9764-901d9abe100d">79,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af0cc01cbc54c9f9e8615532da5bb0c_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18zLTEtMS0xLTkwNDI_92569ff0-0cae-49ca-9b52-250da5d47ffa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869431e7abf74749b23dd3a1ed93e1ef_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18zLTMtMS0xLTg4Njg_baf969e9-3156-489c-8429-500f50071b0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05a9eb3fc13543189b612e1898a32241_D20210101-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18zLTUtMS0xLTg5NjA_c56af83a-1d3d-43a6-8078-7d172d562bec">431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18zLTctMS0xLTkxNDk_7289980f-be53-4f1b-898b-d53a0a43e19d">431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c3ac878cf024e6d80d9917247d48b26_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY182LTEtMS0xLTkwNjM_60268560-923f-4811-b1f8-9c13dc2ad5e8">45,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e788b4e17294696828048f3be438c9f_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY182LTMtMS0xLTg4OTM_b209ce2e-e557-45db-95da-57925c32b9dd">23,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d765d02ede34e5fa56a51625a55c188_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY182LTUtMS0xLTg5ODM_0fbfa77e-f5c5-43da-b80b-5f798888c686">10,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY182LTctMS0xLTkxNjM_444bb764-ff80-4851-a101-f134d86cb29a">79,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMTgwOQ_b5fe14a2-b833-4b90-b849-1cb41498512e" continuedAt="i8b94d2da94774b949fe2d55eddc80b91" escape="true">Health Care Costs Payable</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8b94d2da94774b949fe2d55eddc80b91"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMTgxNQ_0b8d09fe-f2d6-466e-8a0f-8301a033ec72" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the nine months ended September&#160;30, 2021 and 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0f632a81048467cbde9502af1736d39_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMi0xLTEtMS0w_a642b422-7446-44f7-b2aa-f55581eece79">7,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0497b7413f024eccab9ca54d54ee0dac_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMi0zLTEtMS0w_1f19c85c-105c-4fd5-9ea2-15e8c8a37366">6,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0f632a81048467cbde9502af1736d39_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMy0xLTEtMS0w_97d090a3-0090-4a77-8240-3fb40a17bf7a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0497b7413f024eccab9ca54d54ee0dac_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMy0zLTEtMS0w_ce185657-a7f0-4b5b-bee9-7461afdfe301">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0f632a81048467cbde9502af1736d39_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfNC0xLTEtMS0w_fc315a9f-c77d-4bcb-be12-f54aaa13ae25">7,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0497b7413f024eccab9ca54d54ee0dac_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfNC0zLTEtMS0w_839d540e-0c53-4bcb-8123-3315b1a71b24">6,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfNS0xLTEtMS0w_7b37ba2f-405a-43eb-9fdd-1f5187f500b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfNS0zLTEtMS0w_c770dd20-f317-462b-8079-624d9422ed74">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfNy0xLTEtMS0w_2c77bc32-0b89-40dc-9cf7-91b2cda525c1">48,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfNy0zLTEtMS0w_f7f16c22-25c7-4d38-965f-c050249a9d0b">40,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfOC0xLTEtMS0w_029b22e9-d5cd-4414-b5e7-151c6d0abb23">771</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfOC0zLTEtMS0w_88829a82-658d-477d-af4c-975559b8df99">448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfOS0xLTEtMS0w_a8427918-bf89-41b8-b006-a26be0e9d11b">47,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfOS0zLTEtMS0w_8771738d-d41b-4e2c-8df8-1093cf604cdf">40,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTEtMS0xLTEtMA_402e6700-3f57-4a92-a7e3-118a020f61ad">39,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTEtMy0xLTEtMA_cb583b12-ae81-46ce-9568-4cebc8158629">34,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTItMS0xLTEtMA_741ebbb4-175e-4994-b295-65c2e0e80a31">6,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTItMy0xLTEtMA_7470be55-d33b-4f97-9c32-ef944073775d">5,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTMtMS0xLTEtMA_dd31d35c-46fc-48d8-bd35-d6b1b62eb486">46,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTMtMy0xLTEtMA_d4b08d1a-7472-432d-9244-8cfb4114b217">40,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0118ee2d69441a7b3e211472508a35b_I20210930" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTQtMS0xLTEtMA_4ea9ee96-a4f5-41ff-9e5c-33ae6f15729c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc05881978f94525b7d1199de70e7105_I20200930" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTQtMy0xLTEtMA_00d850b3-6e8e-42b4-b22e-0fbdcb847793">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0118ee2d69441a7b3e211472508a35b_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTUtMS0xLTEtMA_29079a5c-e4ab-49c4-b16c-b56e87aec47b">8,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc05881978f94525b7d1199de70e7105_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTUtMy0xLTEtMA_6fbc9997-fa8d-4deb-a83d-766bbb04857d">7,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0118ee2d69441a7b3e211472508a35b_I20210930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTYtMS0xLTEtMA_a3d9102c-33ec-4180-a80c-9c0e5ea99ee0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc05881978f94525b7d1199de70e7105_I20200930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTYtMy0xLTEtMA_b8c132ef-372f-4ba9-8fa5-3abf9406b595">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0118ee2d69441a7b3e211472508a35b_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTctMS0xLTEtMA_036c40c2-8458-460c-b94c-0392a983fef7">8,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc05881978f94525b7d1199de70e7105_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTctMy0xLTEtMA_b9a8b974-fd39-4104-9a26-555f1dc04020">7,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the nine months ended September&#160;30, 2021 and 2020 in the table above exclude (i) $<ix:nonFraction unitRef="usd" contextRef="ic0118ee2d69441a7b3e211472508a35b_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMjc2_4ea9ee96-a4f5-41ff-9e5c-33ae6f15729c">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibc05881978f94525b7d1199de70e7105_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMjgz_00d850b3-6e8e-42b4-b22e-0fbdcb847793">1</ix:nonFraction> million, respectively, for a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $<ix:nonFraction unitRef="usd" contextRef="i9af0cc01cbc54c9f9e8615532da5bb0c_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMzkw_f7ee8a04-37ee-4983-a3f1-52ee4478ca3e">45</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id3ecfefee0e642c0a78fc0131c0449c3_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMzk3_b3316eae-f60a-4ea4-b68d-19b3d94e4d4e">31</ix:nonFraction> million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets and (iii) $<ix:nonFraction unitRef="usd" contextRef="i2db04fe0f832449baafb9d23de950513_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfNjAx_a6350169-bfa4-4e97-bad1-46d64ecc3d9f">168</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i07fb4a28c1654faaa862b3d378de1c6c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfNjA4_f18d3c49-c13b-4a07-9a78-b083256eb148">173</ix:nonFraction> million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $<ix:nonFraction unitRef="usd" contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfODc4_029b22e9-d5cd-4414-b5e7-151c6d0abb23">771</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfODg1_88829a82-658d-477d-af4c-975559b8df99">448</ix:nonFraction> million, respectively, in the nine months ended September&#160;30, 2021 and 2020, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, the Company&#8217;s liabilities for the ultimate cost of (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#8220;IBNR&#8221;) plus expected development on reported claims totaled approximately $<ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMTY1OA_f004ef9f-b7d7-41a3-bc8d-b497aad8682b">6.8</ix:nonFraction> billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at September&#160;30, 2021 related to the current year.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_1185"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8zMjk4NTM0ODkwNTI0_23259b07-902b-46fa-ac2c-e9ff8aa3af76" continuedAt="i38497caf120443ceb2dc5cbeb7c8d8ad" escape="true">Borrowings</ix:nonNumeric></span></div><ix:continuation id="i38497caf120443ceb2dc5cbeb7c8d8ad" continuedAt="if0d7127a7c87421d9972e5e5339b3e86"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8zMjk4NTM0ODkwNTI2_a30df100-f62d-41c5-be8a-e308c8717bfa" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings at September&#160;30, 2021 and December&#160;31, 2020: </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib62f2ee98dd644cd9bcc6e7fafb92659_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81LTAtMS0xLTEzMTAvdGV4dHJlZ2lvbjoxODNlMjkxODQ0ODY0YTYzYWNlNzJiZmRhNWMwMjAzYl80_92fbf718-05ca-4caa-9cca-ad0e0f721988">3.35</ix:nonFraction>% senior notes due March 2021</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib62f2ee98dd644cd9bcc6e7fafb92659_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81LTEtMS0xLTEzMTA_6ad7c7fc-c2fd-42c6-bf7c-6a8d6faa3194">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dbe9ff3e69946d3a25f666403b2d133_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81LTMtMS0xLTEzMTA_ae2a825b-1328-4a72-aac9-6da86151be3a">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Floating rate notes due March 2021 (<ix:nonFraction unitRef="number" contextRef="i6af42f85334840f8806360242558dac0_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl82LTAtMS0xLTEzMTAvdGV4dHJlZ2lvbjoyOGVjZmM2OGEzZTU0OGFhYWEwMTgyOGE2MmE0MzQ2MV82Ng_630eed45-4d00-4aed-b67e-61e1a05f8869">0.950</ix:nonFraction>% at December 31, 2020)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10cfac743044c0b8d548cd557cd8836_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl82LTEtMS0xLTEzMTA_4fbd08e4-456a-4405-a532-b74886e69a66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af42f85334840f8806360242558dac0_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl82LTMtMS0xLTEzMTA_ef8cb4b6-721f-4924-aad3-a2c7fa110f50">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9597fa0131bc4e9887c9815a6cd88648_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl83LTAtMS0xLTEzMTAvdGV4dHJlZ2lvbjo2YWEzMjAxNzhmMTc0MDE2YTY2NmRkODJjMDI4NTgyOF80_a7c1d924-4583-441d-b7c2-bca883b9ce28">4.125</ix:nonFraction>% senior notes due May 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9597fa0131bc4e9887c9815a6cd88648_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl83LTEtMS0xLTEzMTA_e47843e7-d1f5-44d2-b55b-a8fd9e588785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59e7dd59a3b54a77b96c49edb48d86b0_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl83LTMtMS0xLTEzMTA_d62e4a56-1d2b-4e5b-83c2-aaa7f7c580c3">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf27f7ccf52044a79068c5b1c21729a4_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl84LTAtMS0xLTEzMTAvdGV4dHJlZ2lvbjpmNmU1MTc0MWJkOTY0MmE0ODQzY2QxNTE2NzY2Y2NhM180_fc9e8ffe-452d-41dc-935e-9f87455bd3f3">2.125</ix:nonFraction>% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf27f7ccf52044a79068c5b1c21729a4_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl84LTEtMS0xLTEzMTA_c4f8112e-512c-4327-ace5-088e43114fa6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b3bd812b24f4f1eb1e8c8d5c0a75877_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl84LTMtMS0xLTEzMTA_f11e08ad-b7e8-4ee3-ae04-6dd14e270f85">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i852a5e91e3b9468ba1cb2eb5f74b1b9d_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl85LTAtMS0xLTEzMTAvdGV4dHJlZ2lvbjowMDhiYWQ2NzIyMGU0ZDcwYjI5YmRmN2ZkZDZhMGU0N180_32dc4296-08e9-4f51-aaae-fb1c8640c9ae">4.125</ix:nonFraction>% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852a5e91e3b9468ba1cb2eb5f74b1b9d_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl85LTEtMS0xLTEzMTA_7a5f30e1-6cea-490a-9751-194b538136bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6191e346def74ee2aea270383730ae08_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl85LTMtMS0xLTEzMTA_28de9102-6849-4f68-a5de-38adce3fa4d8">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i76f9788e25764f54b73f568ee5806646_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMC0wLTEtMS0xMzEwL3RleHRyZWdpb246M2QzOWMyMTIxMjMzNGQwYjhhZWY4N2NlNTA5ZjFkYjNfNA_4196023b-9e74-48c9-9710-c69f2d9b35a0">5.45</ix:nonFraction>% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f9788e25764f54b73f568ee5806646_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMC0xLTEtMS0xMzEw_2a1d240f-1acd-4eb5-acce-74d9a439547b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc41a17f6c774042b9fcf1afc65bbdde_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMC0zLTEtMS0xMzEw_d0483a62-c27d-4373-9159-ef924e7e2a7a">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i137942ee3c634b5389f5afc0f8942bca_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMS0wLTEtMS0xMzEwL3RleHRyZWdpb246YTljNDg2NGMxYWI2NDQ2Zjk4OGViNzA4MmY4ZjFjY2NfNA_b53b1912-9fcf-4923-8a63-a0963b00cd62">3.5</ix:nonFraction>% senior notes due July 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i137942ee3c634b5389f5afc0f8942bca_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMS0xLTEtMS0xMzEw_020187b4-1106-44cb-95a5-fe778f9f98f3">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if73d40a8e2434d0fa1ef103cc7698cc3_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMS0zLTEtMS0xMzEw_4b0d4cd8-202d-40fb-8639-b013bab52af8">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib6b0b4743e034bb1bc3f258385746efd_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMi0wLTEtMS0xMzEwL3RleHRyZWdpb246Zjk2ODUwOTAyZWJjNDI4Mzg2ZTZiMTE4ODNiZjA2Y2JfNA_8c8eec0c-a586-4dc1-a35e-bf1006b94ce1">2.75</ix:nonFraction>% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6b0b4743e034bb1bc3f258385746efd_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMi0xLTEtMS0xMzEw_4f0b05fb-dbbe-41a6-90f0-02e5f55602ba">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99bd1157dbbe4945af1a81d0c21130ea_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMi0zLTEtMS0xMzEw_89b0144f-8c34-4560-b6ba-5acfd11ace09">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie17499a4aa5e4151b918eeea4df0de97_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMy0wLTEtMS0xMzEwL3RleHRyZWdpb246N2M4YzJmMzhiMmNhNGExNDgzOTRjOGU3Y2UyMjE5OTZfNA_ddeb41c7-8061-4218-a941-465c0a5a35be">2.75</ix:nonFraction>% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie17499a4aa5e4151b918eeea4df0de97_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMy0xLTEtMS0xMzEw_47c6f7dc-ad34-49d8-87ad-9e8ce3530796">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d6ac400309247c5b66323fd368436e2_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMy0zLTEtMS0xMzEw_f81bc442-b0ff-42d3-9962-8eca0a970d2b">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8b0ee41eebc34bd180b2c69788165350_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNC0wLTEtMS0xMzEwL3RleHRyZWdpb246ZDNjNWM4MjA2MTU3NDIwZjhhZjViNTA0NTY5ODMzMGRfNA_e211cb40-1496-435a-a4d1-006f1a942410">4.75</ix:nonFraction>% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ee41eebc34bd180b2c69788165350_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNC0xLTEtMS0xMzEw_e9103ef3-6ba9-4125-b38f-5e29681164ae">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f11726422242bdae9d51047e1fbd8a_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNC0zLTEtMS0xMzEw_453a5eeb-44d4-425b-8166-5d29922b7500">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f47310960c144eaacb797297d97929d_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNS0wLTEtMS0xMzEwL3RleHRyZWdpb246OGJhZjE3ZGMyYmUyNDU0ZjkwZjJmNzdjZTIxN2NiNDZfNA_d81ec0d4-acb8-48ad-9e82-8a1f6e8d5c3c">3.7</ix:nonFraction>% senior notes due March 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f47310960c144eaacb797297d97929d_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNS0xLTEtMS0xMzEw_21a0d154-bd14-42a5-862c-dea4a219d5b5">2,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3712df84af449f83452fc8bc0a7e18_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNS0zLTEtMS0xMzEw_80201db1-3647-4768-8885-af22dff3159b">2,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i483ec33bdab247d48a38b7f13570e673_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNi0wLTEtMS0xMzEwL3RleHRyZWdpb246Yzc5MWNkMWZkNTczNGM2MWFiM2NiM2RkMGUxNjcwMjFfNA_84069088-cad3-4757-ae62-1649597617e8">2.8</ix:nonFraction>% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i483ec33bdab247d48a38b7f13570e673_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNi0xLTEtMS0xMzEw_6a038c98-3354-4b02-9ee9-5b8bb1beabc6">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia618ec5a27694900b1f7ba774ad68e8e_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNi0zLTEtMS0xMzEw_20c2a428-8907-4d58-a01d-5012fe81703b">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff008f8fc0ee406881b35526798fa89d_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNy0wLTEtMS0xMzEwL3RleHRyZWdpb246YjY5YWJjNzUzN2Y2NDQ5Nzk4NmM5ZGM4NzlhZmRiNzNfNA_810cf834-535f-4643-a711-8a3b452f3c35">4</ix:nonFraction>% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff008f8fc0ee406881b35526798fa89d_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNy0xLTEtMS0xMzEw_e9181ae3-e3b4-484b-9954-ed8813f6b44d">414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19a79677cf9c4a2da09c14598934ad6e_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNy0zLTEtMS0xMzEw_0e834866-b4b6-4c76-aad5-736b0b085bc2">414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia1ab71b7baae485dba34f4f0eb636d02_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xOC0wLTEtMS0xMzEwL3RleHRyZWdpb246MjViODA2OTAzODdmNDIzYTg3YmM2NTkxMGFmNjI4NDdfMTA5OTUxMTYyNzgxMg_55d8f079-aefa-49a4-821b-424f84183989">3.375</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ab71b7baae485dba34f4f0eb636d02_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xOC0xLTEtMS0xMzEw_fd88d2e8-1fd3-4d83-ac8f-f89532da4210">650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e1bcf974684d3f8b8d8a88ddadfd46_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xOC0zLTEtMS0xMzEw_c6527246-d6ce-41a3-b325-30e1dfa4884c">650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie08be45af7c046aaa32b288f6d0abe62_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xOS0wLTEtMS0xMzEwL3RleHRyZWdpb246MDRjNWE1MjgxZjQzNGFiMGE1YzY0NzA4Y2M2OWFjNTdfMTA5OTUxMTYyNzgxMg_c9c1ffb3-be8e-4f63-834f-1bbb47e58c5c">2.625</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie08be45af7c046aaa32b288f6d0abe62_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xOS0xLTEtMS0xMzEw_a3fb8828-d33d-45d3-8969-82c764ce88a3">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec21c12c0eb1436d803f53d89f62fa05_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xOS0zLTEtMS0xMzEw_a37858e1-65b5-44db-b42b-a9a56e093917">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i72a7a16809e84d3b92e4bad0bac2262d_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMC0wLTEtMS0xMzEwL3RleHRyZWdpb246ZDNmZjBiNGI1OTQ4NDg2M2E3OGZhZDBjYTY3N2ZjNjFfNA_a37fe543-39a0-4d3d-bd6f-82333a003893">3.5</ix:nonFraction>% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72a7a16809e84d3b92e4bad0bac2262d_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMC0xLTEtMS0xMzEw_cd69c6e1-c921-4c0b-b6cc-2f7f4cb01dad">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5d016793b9b42579b7bc6222e15baf6_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMC0zLTEtMS0xMzEw_5ba786dd-c4c9-4f0c-af20-5232d016357f">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i764944fd1b5e42008a5e99c7c609eed9_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMS0wLTEtMS0xMzEwL3RleHRyZWdpb246YzhmZmYyNmQwNzgwNDRlOTg0YTI1YzM1OGM3N2IzNDBfNA_a98e3c80-35d0-4029-bda7-6c91aa19666c">5</ix:nonFraction>% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i764944fd1b5e42008a5e99c7c609eed9_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMS0xLTEtMS0xMzEw_275ad229-8ab2-498d-b3df-004182e3cb22">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c92560f130b45779c8a95a020b233ed_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMS0zLTEtMS0xMzEw_8f7ee85b-3bd7-4576-807c-81aab70c8512">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27806ca29bf844b3901fae3f691be398_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMi0wLTEtMS0xMzEwL3RleHRyZWdpb246YTIzZmY5ZWM5ZTA3NDhlODk3MDU1YjE1MWYxZDY2N2NfNA_2982779e-9fc1-4171-9de0-80ddffc3622f">4.1</ix:nonFraction>% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27806ca29bf844b3901fae3f691be398_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMi0xLTEtMS0xMzEw_01cfe7e6-fa16-4ddd-8b14-8f78a59e12b7">950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad404c84173a424d89258a6896c6cf7e_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMi0zLTEtMS0xMzEw_d4c10852-64b7-4c93-9520-d6a9df6ce20a">950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie935136890474a69910662f38d5b6b95_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMy0wLTEtMS0xMzEwL3RleHRyZWdpb246YjZjYWFmMjVkNGQ1NGNiOThjNzNhMDQ2Yjc3MTAzNDBfNA_87f9a12b-6a7a-48d7-9925-2349bb41c639">3.875</ix:nonFraction>% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie935136890474a69910662f38d5b6b95_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMy0xLTEtMS0xMzEw_03ce9900-c3f4-40b6-a54e-1b68e7fac6bc">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ee5f6b60d74d7e9832465d6c93a81d_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMy0zLTEtMS0xMzEw_82c3b65a-3fdb-499c-90d4-9d0c5ca79aaa">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i777d22b7a1214acf87d3902cab5fc684_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNC0wLTEtMS0xMzEwL3RleHRyZWdpb246ZDcxNGI3MTYwZjgxNDRiZmFmODQzYzM3YjA5ZjllNGVfNA_91c3cdf4-500b-49a7-8c6f-9117ce72313e">2.875</ix:nonFraction>% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i777d22b7a1214acf87d3902cab5fc684_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNC0xLTEtMS0xMzEw_e28142e3-30d4-40b1-acd6-4196351622cf">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08366cfa41cf4ec09bb0df2075ab0906_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNC0zLTEtMS0xMzEw_75f84f0a-0f88-4c35-a36c-e2dd59f0c66a">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i501701dd672b47b79ce22cd7925e8550_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNS0wLTEtMS0xMzEwL3RleHRyZWdpb246YTJjZjkxZGM1ZjU3NDI4MTkwN2I0ZWM2ZjA2NzE3MzhfNA_3ff281ac-855f-478b-8901-d261b6cbf36d">3</ix:nonFraction>% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501701dd672b47b79ce22cd7925e8550_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNS0xLTEtMS0xMzEw_1dcb56db-8599-4acd-a85f-0e7f1f5c34cc">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c86118fbc64523a77d011172ead4d3_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNS0zLTEtMS0xMzEw_57abf0d6-8933-4c13-93b2-a1c6bae89946">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6bf76349f2134b799b85e620ca017ce1_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNi0wLTEtMS0xMzEwL3RleHRyZWdpb246YWVjYTEyMWM5YzdmNGMwOGE3MGIzNTVhZWI2MGIzMmNfNA_fbf5a635-3d57-4ee5-bcc0-ba1af27abd0b">3.625</ix:nonFraction>% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf76349f2134b799b85e620ca017ce1_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNi0xLTEtMS0xMzEw_d7c89865-96b0-4531-8c3a-094f0e640395">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2c451a4fe964730babafb480988f0b2_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNi0zLTEtMS0xMzEw_0b64fa7f-ab79-4b97-a54c-1feb10bfb924">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaae7c158e8fc423e95ac2bd644820bd4_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNy0wLTEtMS0xMzEwL3RleHRyZWdpb246ZDJhOTU5M2NmNzExNDI3Y2FjMzc1OTdlZjU1ZjYzZDRfNA_e9e470ae-739d-4dde-a76b-a929b3fe6d4c">6.25</ix:nonFraction>% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae7c158e8fc423e95ac2bd644820bd4_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNy0xLTEtMS0xMzEw_09200d0f-cfc1-486f-bbaf-9104c0f5cff7">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950c1c297c4a4358acd09c74ab566982_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNy0zLTEtMS0xMzEw_9472e30a-cc9e-4f73-a6dc-4efefcda2857">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62ccc6e98f4545a181d967e33f10d4df_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yOC0wLTEtMS0xMzEwL3RleHRyZWdpb246NjM1YzkzZTZmZTQwNDQwMDkyYTkxYjI4ZGUwOTg1NjZfNA_7bcca18f-10c2-414e-a265-e7ebe99f8a06">1.3</ix:nonFraction>% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62ccc6e98f4545a181d967e33f10d4df_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yOC0xLTEtMS0xMzEw_2d2c2bf2-02f1-4b7a-a378-9dfe4e6be579">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i857f5b369f4040fab9b2b410b0a79b73_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yOC0zLTEtMS0xMzEw_c53f5a9b-2a8d-440f-9a97-e57adab6d869">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if6bba02cee2944fbb480017e52082d76_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yOS0wLTEtMS0xMzEwL3RleHRyZWdpb246MDlhZWU5N2FjZWRmNGFmNWJlNmM0NDUwZTlmZWYyNGVfNA_178a6dfe-dbee-4d54-862c-1c5135596366">4.3</ix:nonFraction>% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bba02cee2944fbb480017e52082d76_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yOS0xLTEtMS0xMzEw_23fce254-5bad-48b2-9df8-2866cd184d96">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32452f38e22247ae967975fe6e98f407_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yOS0zLTEtMS0xMzEw_711faedb-6823-4609-ac69-dcec20d5af39">7,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia409b9876a544297931507912b72df4f_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMC0wLTEtMS0xMzEwL3RleHRyZWdpb246ODVkMmExZDkyMGMwNDgwMGJlNmEwNWI5NDJiOWU5NjFfNA_7b769033-6daf-4771-8f0d-1a40830e34b0">3.25</ix:nonFraction>% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia409b9876a544297931507912b72df4f_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMC0xLTEtMS0xMzEw_758278ce-d819-4f4e-b2ef-fe4734efbf54">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a9c983e179487b80338719c6654c2b_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMC0zLTEtMS0xMzEw_12dd6aa0-4cdb-4a1c-860f-773d8a139672">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7a4406c7b2f34949810aebaf45489f84_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMS0wLTEtMS0xMzEwL3RleHRyZWdpb246ODQ0ODNjM2NlZmYxNDA4MmFmY2VmOTE1MjQxMmZiNzhfNA_cc99a98d-7bfe-4a3d-9ee3-a4f8b8e10652">3.75</ix:nonFraction>% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a4406c7b2f34949810aebaf45489f84_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMS0xLTEtMS0xMzEw_ec4ca56b-e981-4fc2-b9a0-31e1b2e937d5">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8151e799d1c74f5c833144285cf01c69_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMS0zLTEtMS0xMzEw_e9b08a25-b3b8-4b47-99ef-cb20b9d56a0f">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3182ba22cd594ccf9a8ae05b9078606d_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMi0wLTEtMS0xMzEwL3RleHRyZWdpb246YjJjYjU0OWJiYTc2NGYyODg2NjBjNzVkMjJhYmE4MzZfNA_4a89ce83-0a2a-4404-a535-584295c1a049">1.75</ix:nonFraction>% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3182ba22cd594ccf9a8ae05b9078606d_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMi0xLTEtMS0xMzEw_c6ddc586-4dd5-41a4-9ac8-74cffc39f92d">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60002bca8e844649c542c4cc7f63f72_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMi0zLTEtMS0xMzEw_74521df4-7f63-41ad-b1fa-8a5974666323">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba95d402ec9d49d28efe5abbbf533067_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMy0wLTEtMS0xMzEwL3RleHRyZWdpb246ZDgxYjZlMTA0ODQyNDg5ZGJkMmQ0YWQwNTIzYzViODNfNA_12033622-adf2-407c-ba1b-c0a441fef014">1.875</ix:nonFraction>% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba95d402ec9d49d28efe5abbbf533067_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMy0xLTEtMS0xMzEw_2ab3fe54-c642-4a50-804a-17e82d7210a6">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773fdec06dc4a40983a54841b13dda4_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMy0zLTEtMS0xMzEw_989fc6ae-fb61-4132-8452-63ed56f85a3a">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic4916faa22d44187b36197276e047af9_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNC0wLTEtMS0xNzA2L3RleHRyZWdpb246N2RjY2YzMDU0NjQ2NDZmOGE0NmJjYzU1NDU3NDc3NTZfMTA5OTUxMTYyNzgyMQ_390d8049-94b2-43d0-9e16-87e040b340b4">2.125</ix:nonFraction>% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4916faa22d44187b36197276e047af9_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNC0xLTEtMS0xNzE1_0e8bf54a-3f16-44e8-bf4c-5012965df96b">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73aea79ad2ba4f3fbca099d45fbd99ca_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNC0zLTEtMS0xNzIy_1dd3eb93-aeea-4c4d-8d34-c8736696d80b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibeb8eac0c5ec472ea3a8d59c3be4564c_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNC0wLTEtMS0xMzEwL3RleHRyZWdpb246MWI4YTIxMjU1ODlhNDY1ZjhjNzRmZWY0MzA3ZmJkYTVfNA_710b3925-9c09-4d42-94ff-0790b35d0011">4.875</ix:nonFraction>% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb8eac0c5ec472ea3a8d59c3be4564c_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNC0xLTEtMS0xMzEw_5e2ec58c-8ca1-4535-93da-577156f5e45a">652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia10a7bda458947608ba95da5905bd9c4_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNC0zLTEtMS0xMzEw_07f5b40a-3188-4245-ab16-55bd0910fcbb">652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5a7d1903cee4bbe9e9caaee0f3997ea_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNS0wLTEtMS0xMzEwL3RleHRyZWdpb246YzgzODYyYjkzNjAwNGMxZWI5YWUxZDc0NTE3MGUxM2VfNA_e077eebd-62be-4d91-89fd-c775557995b2">6.625</ix:nonFraction>% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5a7d1903cee4bbe9e9caaee0f3997ea_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNS0xLTEtMS0xMzEw_fb8fe3bc-d04f-4ba1-9401-15e2b74ec133">771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8be68adc97de4b3193304ca21babaad1_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNS0zLTEtMS0xMzEw_467a7034-8972-40bd-8f3c-5173b99e74b9">771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic715e236403845808ec274271d922531_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNi0wLTEtMS0xMzEwL3RleHRyZWdpb246NjhjNDY0Yjk3OGU4NDI5NzkxMTllNzU3MDNmZTEwYWNfNA_e37e0542-5bad-4548-8ec1-e2e367c32a6a">6.75</ix:nonFraction>% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic715e236403845808ec274271d922531_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNi0xLTEtMS0xMzEw_4d973a00-de36-470f-83a3-2866d3bbda89">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e414d119b874c97af3d40d143e3f394_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNi0zLTEtMS0xMzEw_699c66f5-ee67-4725-8ba8-b6acdb233c14">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i98d7f42792064db8af2bea27fe4217d6_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNy0wLTEtMS0xMzEwL3RleHRyZWdpb246NDVhNjA4ZGE2MDIwNGI0NDllMmYxNjlmMTg1OGQ0YmRfNA_37a77a32-3fe0-4af0-8a22-31cdc08dfafa">4.78</ix:nonFraction>% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98d7f42792064db8af2bea27fe4217d6_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNy0xLTEtMS0xMzEw_3b24f32a-76c9-415a-9cf6-eea17361bd4b">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d87dfab2bc4779af52ac27db253497_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNy0zLTEtMS0xMzEw_9a4a7867-b9d8-4184-ac5a-8e67d5abf4bd">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id61537d136804380900baa2205811e11_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zOC0wLTEtMS0xMzEwL3RleHRyZWdpb246MjU0NGMyYzM2OGU4NGEzYTg2MGVhY2ZhMWYyNTBhMThfNA_5eece932-c91c-4739-b178-8daf7b5e20cc">6.125</ix:nonFraction>% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61537d136804380900baa2205811e11_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zOC0xLTEtMS0xMzEw_71013fcd-f718-4128-b9d8-0755ddacde7a">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7e8dff237f43d0883eb5f73e112a29_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zOC0zLTEtMS0xMzEw_85884adb-ed3e-46e4-aae0-6e44a75e1f96">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icbe99d66375e4a84a14ca3cb9bd04463_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zOS0wLTEtMS0xMzEwL3RleHRyZWdpb246YmQxYmZhZDIzODlkNGRkMWI1YTZiZWU3ODg4N2QwZGJfNA_18b6df4a-0d50-41c0-93c3-0531d8ca1889">4.125</ix:nonFraction>% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbe99d66375e4a84a14ca3cb9bd04463_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zOS0xLTEtMS0xMzEw_460b4938-f96c-49de-abb4-b5b38324756d">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78303eac554f4ebaac80fbdb2ef497d2_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zOS0zLTEtMS0xMzEw_82b9473d-84c7-41e3-b92a-95c1d1edf083">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic2bdbe81b56b433eb0b1abff2a8cf359_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80MC0wLTEtMS0xMzEwL3RleHRyZWdpb246NzI0YzQ1YzFhY2JmNDQ0ZTlhMjM2MjZiMWJhZWRjNzZfNA_edd603d2-4221-4272-bea0-89965cfaba7b">2.7</ix:nonFraction>% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2bdbe81b56b433eb0b1abff2a8cf359_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80MC0xLTEtMS0xMzEw_abe4f6cc-c9e8-4edf-952f-657926ccd3c4">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7ad50bbcb824461968e1e224ceb45eb_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80MC0zLTEtMS0xMzEw_3e012232-9089-42e6-b14a-71821ebf105e">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id19aa5c38de0498ba584e838008334eb_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80MS0wLTEtMS0xMzEwL3RleHRyZWdpb246M2EzYTIwNzdkNTY0NDdkNmFhNjU4MzAwMDhiNzBjMzRfNA_3430e50a-4e8c-4d3f-b11c-f1f392802d43">5.75</ix:nonFraction>% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19aa5c38de0498ba584e838008334eb_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80MS0xLTEtMS0xMzEw_23748e96-c204-4469-a2c6-27c2e6a19f95">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0df169cc2a4329a01ff1661c5f6643_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80MS0zLTEtMS0xMzEw_da57fb8f-1d90-4e7d-91c4-9ba238680802">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia45c0682f66e4831a5e18003515863b7_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Mi0wLTEtMS0xMzEwL3RleHRyZWdpb246ZDM4Nzc0OTQ0YTdmNDAwMWFlOGNiZTY1MDE1ZWRiYzRfNA_27f6bd2e-40f8-4e91-9cbf-361e888c6340">4.5</ix:nonFraction>% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia45c0682f66e4831a5e18003515863b7_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Mi0xLTEtMS0xMzEw_b2bffb3b-ff0c-45b6-a9ab-19fbaa585777">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44d5c108e0784a1baefe552607e68fbc_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Mi0zLTEtMS0xMzEw_de492c4e-1c8f-40d4-a4c4-ac02a44ab155">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i82d31c26e4d44623ae7b535f4961b40a_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80My0wLTEtMS0xMzEwL3RleHRyZWdpb246MjY2NmVlYjYzNmU2NDNiMzlmYjczNDBiMDNlYTM3MTBfNA_24fc195b-de1d-445f-bf0f-653a46fbf922">4.125</ix:nonFraction>% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82d31c26e4d44623ae7b535f4961b40a_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80My0xLTEtMS0xMzEw_d4959907-40ff-45d9-bb2d-19899166c3ca">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaca08c7669e84499a6b53f5fc209d8d1_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80My0zLTEtMS0xMzEw_3b4b1d57-ada6-4d99-85e0-7ae20cdcbe63">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieaf0c3b289b94b89ba1558094a4e7fbb_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80NC0wLTEtMS0xMzEwL3RleHRyZWdpb246ODMyYzc3MmM0YTRjNDY3ZGJiYTI4NTkxYmQ2NTAwOWVfNA_ad172e0c-4f69-430c-b045-60ac9ec1ac4d">5.3</ix:nonFraction>% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaf0c3b289b94b89ba1558094a4e7fbb_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80NC0xLTEtMS0xMzEw_c8bd60ce-7409-47b2-8de1-1ad7308e3a21">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7efa34741b14f12a2e1553830369efd_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80NC0zLTEtMS0xMzEw_1d180e7b-0ee9-4ab1-8f0e-e5a8d4f68c68">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee85be27a3054609aeaa1f1291e5378b_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80NS0wLTEtMS0xMzEwL3RleHRyZWdpb246MDczNTYwYzVjMDg3NGQ5ZGFlNmUyZGE3YzQwZjY4MjFfNA_88313b26-9cdd-4d63-9e93-4ed77b6f28cc">4.75</ix:nonFraction>% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee85be27a3054609aeaa1f1291e5378b_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80NS0xLTEtMS0xMzEw_f76f3ad9-5c9a-4426-b544-11d1ec606702">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4027fc5015314a28afdf00ece6eaa61d_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80NS0zLTEtMS0xMzEw_4b81d870-54c5-448c-b36f-a574e0628f1b">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia33e18e6e5cf4bca9278bb182bc5c16e_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Ni0wLTEtMS0xMzEwL3RleHRyZWdpb246MDMwYzhkYmI3YTliNDZiN2JhNmNmZjkzNmIwZWRlM2VfNA_8cb1e888-5f2f-40ae-a50a-b07e7263b19a">5.125</ix:nonFraction>% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33e18e6e5cf4bca9278bb182bc5c16e_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Ni0xLTEtMS0xMzEw_267c9648-78df-4d7e-ac55-c3b43d9e4c60">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64ab274ab94e4fb0b97224d1979d31f7_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Ni0zLTEtMS0xMzEw_56722df6-479a-4ead-a0f8-f3082d15bbe1">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic90e5382382f47f6a02d952c5ef3f35f_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Ny0wLTEtMS0xMzEwL3RleHRyZWdpb246YjkyMmM1MmU3ZmEwNDMyMGJiODk0NzdlMmY3ODM1ZGRfNA_ed21b581-6ffa-4271-8589-4a092e00346e">3.875</ix:nonFraction>% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic90e5382382f47f6a02d952c5ef3f35f_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Ny0xLTEtMS0xMzEw_d4ca8494-fc43-4070-b87d-748e0a5cf9a1">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie01363b48cc748a8b4849e735b906bcb_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Ny0zLTEtMS0xMzEw_456837d4-e9aa-43b9-abbf-53d1b4325ebf">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i57bd188e01604c998e340453dd1c10bc_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80OC0wLTEtMS0xMzEwL3RleHRyZWdpb246ZGE3MTE3NTA5M2MzNGNlYThlYTA0NmNlMjVmMDIwZDVfNA_5f750f04-00ce-4b10-a6c8-7da15b5c7d2f">5.05</ix:nonFraction>% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57bd188e01604c998e340453dd1c10bc_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80OC0xLTEtMS0xMzEw_fda9fdd0-756c-4513-86a8-aac052509eee">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e00c491a58435bbe46b502dfc86a88_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80OC0zLTEtMS0xMzEw_2277babf-2934-4a78-9ba6-4581cc2ab397">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7771d9a02ba1459fa65a6ed760132976_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80OS0wLTEtMS0xMzEwL3RleHRyZWdpb246MmUwYjVkNGI1NmMzNDNmZTlmOTYzMmQ3YzI3NzM4N2FfNA_1e71d92c-e830-4c2e-8aed-fed4bb58413f">4.25</ix:nonFraction>% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7771d9a02ba1459fa65a6ed760132976_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80OS0xLTEtMS0xMzEw_c7c219bd-3b4d-444d-aad3-8e3cee3caea5">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1710183e3c7642969f8764f4a6bccb12_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80OS0zLTEtMS0xMzEw_5d8aec9c-6973-4cc7-b06b-ed3f5c63eb25">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81MC0xLTEtMS0xMzEw_1f8e53a5-c8bd-47a7-b17f-d009e6547981">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81MC0zLTEtMS0xMzEw_b5cd7b3d-a09c-46f2-9ad4-dd8e8dffea70">1,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2fe10dd7c524a25a46b3c5a30a4d149_I20210930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81MS0xLTEtMS0xMzEw_ae5e6983-1fe7-4eca-85fb-64f806b7e803">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i498b74e1a6084982a704243062845c72_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81MS0zLTEtMS0xMzEw_e7da1c09-adca-4a0b-81e7-096d1a232094">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:LongtermDebtGrossAndLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81Mi0xLTEtMS0xMzEw_fd3b970c-232a-49ea-bf0f-9d356d5904f6">58,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="cvs:LongtermDebtGrossAndLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81Mi0zLTEtMS0xMzEw_5523b4e9-d5ec-4076-a7eb-4d758ad049fc">65,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81My0xLTEtMS0xMzEw_76a2576d-cf4a-444c-b8f4-f187cb7e400c">224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81My0zLTEtMS0xMzEw_b38356aa-4753-4b4d-b9aa-9e8edb735e56">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" name="cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81NC0xLTEtMS0xMzEw_534b25a2-d809-4b29-8710-527b0fe524d3">818</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" name="cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81NC0zLTEtMS0xMzEw_ff7223a6-6f59-4488-a82d-961909a312a4">909</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81NS0xLTEtMS0xMzEw_3a818d5d-c99e-4d71-8b9d-bf5cd44197b1">58,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81NS0zLTEtMS0xMzEw_b32d671a-c197-4b01-bd35-79f24326d16b">64,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81OC0xLTEtMS0xMzEw_aeda3ab0-cf10-487e-8d82-450bd8f50223">1,561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81OC0zLTEtMS0xMzEw_ba1ccbc8-8810-4a7f-95b2-8438a31e0dce">5,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81OS0xLTEtMS0xMzEw_5924c1b6-d0e6-4175-839f-484e35f64927">56,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81OS0zLTEtMS0xMzEw_a85ead01-54e6-4358-a369-32759091ec8c">59,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if0d7127a7c87421d9972e5e5339b3e86"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 18, 2021, the Company issued $<ix:nonFraction unitRef="usd" contextRef="iaf76f8b405534054bff48c947da24a34_I20210818" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NDkz_1cd6eafb-cf93-4b69-b681-81f52cc601dc">1.0</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="iaf76f8b405534054bff48c947da24a34_I20210818" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTA4_6908df96-12ff-4627-8346-49113f3668e7">2.125</ix:nonFraction>% unsecured senior notes due September 15, 2031 for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="iec82b516316744c190f4a9f8856af906_D20210818-20210818" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTcx_0ae49e88-c293-45bd-839d-60e4a1a6fe00">987</ix:nonFraction>&#160;million, net of discounts, underwriting fees and offering expenses. The net proceeds of this offering were used for the purchase of senior notes in connection with the Company&#8217;s cash tender offer in August 2021 as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company purchased approximately $<ix:nonFraction unitRef="usd" contextRef="ib7001acb1c0940d18c4cb5e7df98ee1e_D20210801-20210831" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTIy_f20a2998-f6ef-4323-9a32-eaa84607f73d">2.0</ix:nonFraction>&#160;billion of its outstanding <ix:nonFraction unitRef="number" contextRef="i5ec50d6371f84eb3808d2b78b4f8710a_I20210831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTM3_24d7b24c-1dc6-4615-898d-11ef2ad022bf">4.3</ix:nonFraction>% senior notes due 2028 through a cash tender offer. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="ib7001acb1c0940d18c4cb5e7df98ee1e_D20210801-20210831" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTg2_bdab15b6-9bf0-44aa-86dd-012697b56165">332</ix:nonFraction>&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $<ix:nonFraction unitRef="usd" contextRef="ib7001acb1c0940d18c4cb5e7df98ee1e_D20210801-20210831" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTk5_24112595-c71d-4521-8253-3560cbabd930">26</ix:nonFraction>&#160;million of unamortized deferred financing costs and incurred $<ix:nonFraction unitRef="usd" contextRef="ib7001acb1c0940d18c4cb5e7df98ee1e_D20210801-20210831" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtExtinguishmentFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NjEy_ab649c3b-ea9a-4e65-ab65-cb52194552e7">5</ix:nonFraction>&#160;million in fees, for a total loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="ib7001acb1c0940d18c4cb5e7df98ee1e_D20210801-20210831" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTU4_955624d4-9ca8-43ef-9688-4e43cfd28a8b">363</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $<ix:nonFraction unitRef="usd" contextRef="ifcbf1d24a625419793f28cc2390b7c49_D20200801-20200831" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NjI1_4d090376-78a5-489a-9097-b298fbd586d8">6.0</ix:nonFraction>&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $<ix:nonFraction unitRef="usd" contextRef="i4365454cfaf648c79ea4a5b95d9f8a4f_D20200801-20200831" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NjUy_9ebd55aa-96ea-47c9-bff7-bd26c4315fa3">723</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="ib8e59782bbf940fbb42fef683312041e_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4NzEz_ba50144d-68f3-4e02-ba94-e98caa119d21">4.0</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="i9f1e3af8e2a7433f93e2da46dedb4bae_D20200801-20200831" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4NzIw_a1d77ee0-464e-4a68-bd66-f1e1ba9202c8">2.3</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="idc2a92285efd424994eb094e0817bfc3_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4NzM1_d95601f1-fd96-4c4f-b884-5681007346b0">3.7</ix:nonFraction>% senior notes due 2023 and $<ix:nonFraction unitRef="usd" contextRef="i7f0b1fccad9c4d07b2db0f2507871783_D20200801-20200831" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4NzQy_bc2812cc-2c10-4b24-9d61-17ff080145c2">3.0</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i7898b0b327ab449eb16708ed5b14e472_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4NzU3_81825dea-e2f6-43ed-8139-a6223525acfc">4.1</ix:nonFraction>% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="i0de59d4f1eeb42f8bbb0fb2fe5621340_D20200801-20200831" decimals="INF" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4NzY0_89635dff-6e1f-4650-8114-dc66027195d1">706</ix:nonFraction>&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $<ix:nonFraction unitRef="usd" contextRef="i0de59d4f1eeb42f8bbb0fb2fe5621340_D20200801-20200831" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4Nzc5_8cc3ed47-1522-42cf-a48f-840f2c53253b">47</ix:nonFraction>&#160;million of unamortized deferred financing costs and incurred $<ix:nonFraction unitRef="usd" contextRef="i0de59d4f1eeb42f8bbb0fb2fe5621340_D20200801-20200831" decimals="-6" format="ixt:num-dot-decimal" name="cvs:DebtExtinguishmentFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4Nzkz_c3686bd0-bfe1-495c-8bc1-6f90826bac4c">13</ix:nonFraction>&#160;million in fees, for a total loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="i0de59d4f1eeb42f8bbb0fb2fe5621340_D20200801-20200831" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4ODA3_df967558-380b-4451-865c-016f7e7331a5">766</ix:nonFraction>&#160;million.</span></div></ix:continuation><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_49"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfMTMxOQ_81ee366f-25b6-4289-9aa4-f32aed617c30" continuedAt="i9c825d6c7c214d24a4e26af65343bdca" escape="true">Shareholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9c825d6c7c214d24a4e26af65343bdca" continuedAt="i621d35b1c88142479412ae736e768883"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2016, CVS Health&#8217;s Board of Directors (the &#8220;Board&#8221;) authorized the 2016 share repurchase program (&#8220;2016 Repurchase Program&#8221;) for up to&#160;$<ix:nonFraction unitRef="usd" contextRef="ie44679796a144c26b4b62a377639993f_I20161102" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfMTk3_922a2736-cc7c-4ab8-8fef-51aed1dc1363">15.0</ix:nonFraction> billion of the Company&#8217;s common shares. The 2016 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2016 Repurchase Program can be modified or terminated by the Board at any time.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021 and 2020, the Company did <ix:nonFraction unitRef="shares" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfNjI4_327f2bc6-5503-4360-b079-7b9125da842e"><ix:nonFraction unitRef="shares" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfNjI4_82fbaf21-64a5-45e3-ac78-36154054e0d4">no</ix:nonFraction></ix:nonFraction>t repurchase any shares of its common stock. At September&#160;30, 2021, the Company had remaining authorization to repurchase an aggregate of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i191becb0a3c544ecaf8184ef7e8acb3d_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfNzcy_03ddb333-143b-4fdd-a1b5-7f7f56b01399">13.9</ix:nonFraction> billion of its common shares under the 2016 Repurchase Program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i621d35b1c88142479412ae736e768883">The quarterly cash dividend declared by the Board was $<ix:nonFraction unitRef="usdPerShare" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfODk4_1ee9794f-5caf-4b92-ad99-8da21f46e48f"><ix:nonFraction unitRef="usdPerShare" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfODk4_3dddc327-dcdc-41e2-a2b3-04fc7794f95d">0.50</ix:nonFraction></ix:nonFraction> per share in each of the three-month periods ended September&#160;30, 2021 and 2020. Cash dividends declared by the Board were $<ix:nonFraction unitRef="usdPerShare" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfMTAwNQ_1689aaef-f210-42c9-8fa3-931073004229"><ix:nonFraction unitRef="usdPerShare" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfMTAwNQ_a631876a-78fa-4e4f-8fd2-8d91445a83df">1.50</ix:nonFraction></ix:nonFraction> per share in each of the nine-month periods ended September&#160;30, 2021 and 2020. CVS Health has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_52"></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RleHRyZWdpb246ODE2MzAwOTEyNTdiNGYwOGFkNWU3NGYwNzg4MWVhNDNfMTAyMw_1098dc44-a89a-4abd-a61a-aed83913b6fa" continuedAt="ia90f8cc5050745d1b548a4bc396fa9b4" escape="true">Other Comprehensive Income</ix:nonNumeric></span></div><ix:continuation id="ia90f8cc5050745d1b548a4bc396fa9b4" continuedAt="i432dc664d80c4800b223ee550f6420c5"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RleHRyZWdpb246ODE2MzAwOTEyNTdiNGYwOGFkNWU3NGYwNzg4MWVhNDNfMTAyNQ_9117faa7-4c69-4095-9bea-059b09762a99" continuedAt="ie555c4c3117c4d359665f87cd01364b0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income for the three and nine months ended September&#160;30, 2021 and 2020:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6197d49ef31446ffacc35056221fecbf_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMy0xLTEtMS0w_bccdb420-67e5-443e-ac9a-3e23ceab7994">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b734952dace49dab51be5df71c2cdad_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMy0zLTEtMS0w_208d623f-ebe9-4e38-abb9-c82754dac9eb">987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45de384d4b8f4d4aa79185b3cf224a05_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMy01LTEtMS0w_96648d2b-e9be-4934-8a11-9e7fba35112a">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ddb5c89f1944d7f9dfa198754d529ee_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMy03LTEtMS0w_021e3c82-fc3b-442b-a1ec-b104d7ab1868">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i33239c1a09204337ad5c55fefd2f9d8c_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC0wLTEtMS0wL3RleHRyZWdpb246OTgxMDkyZDMwNWU4NGY0ZWE5M2E3ZDNiYjdmMDM0NzBfNjQ_8822f829-4f94-4d3b-898d-5e947232321c">73</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="idf731d8db2514741951a6d08a5bf2340_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC0wLTEtMS0wL3RleHRyZWdpb246OTgxMDkyZDMwNWU4NGY0ZWE5M2E3ZDNiYjdmMDM0NzBfNjg_579eae9d-8c0d-4c33-9c83-1d1833b98e39">83</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i56a02a7778f5400493e2859f84b416f2_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC0wLTEtMS0wL3RleHRyZWdpb246OTgxMDkyZDMwNWU4NGY0ZWE5M2E3ZDNiYjdmMDM0NzBfNzI_d743918c-350f-42ab-9ca5-2ee99c718d86">346</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="if38c0c0626334984872a2e8f0277dc2e_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC0wLTEtMS0wL3RleHRyZWdpb246OTgxMDkyZDMwNWU4NGY0ZWE5M2E3ZDNiYjdmMDM0NzBfNzY_96813989-eabf-4383-af99-d77334838f0e">278</ix:nonFraction> pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33239c1a09204337ad5c55fefd2f9d8c_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC0xLTEtMS0w_d076ed1e-eca0-44ba-977b-7df5b29910fa">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf731d8db2514741951a6d08a5bf2340_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC0zLTEtMS0w_7d7b1baa-c3ce-44bd-9c50-1a34ba355121">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56a02a7778f5400493e2859f84b416f2_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC01LTEtMS0w_e0c105b0-ba3c-4fcc-a794-bef7f3743770">297</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if38c0c0626334984872a2e8f0277dc2e_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC03LTEtMS0w_85597734-786e-4f12-b890-a69e5e696d23">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="i33239c1a09204337ad5c55fefd2f9d8c_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS0wLTEtMS0wL3RleHRyZWdpb246MzJiYzY1OGFlOWRkNDdmNDlkMjVmOWFjZGJmMGJmM2FfNzA_f3c54b9c-ac5f-455a-8477-614877e05b9e">14</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="idf731d8db2514741951a6d08a5bf2340_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS0wLTEtMS0wL3RleHRyZWdpb246MzJiYzY1OGFlOWRkNDdmNDlkMjVmOWFjZGJmMGJmM2FfNzQ_76b8022d-a527-406d-926c-ab617b1b4f02">10</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i56a02a7778f5400493e2859f84b416f2_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS0wLTEtMS0wL3RleHRyZWdpb246MzJiYzY1OGFlOWRkNDdmNDlkMjVmOWFjZGJmMGJmM2FfNzg_e534ea61-846a-4ad1-8c8d-3e6b686b5f2e">15</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="if38c0c0626334984872a2e8f0277dc2e_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS0wLTEtMS0wL3RleHRyZWdpb246MzJiYzY1OGFlOWRkNDdmNDlkMjVmOWFjZGJmMGJmM2FfODI_89336955-5ab9-4c7f-8311-73eea95c876d">47</ix:nonFraction> pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33239c1a09204337ad5c55fefd2f9d8c_D20210701-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS0xLTEtMS0w_c1d4b052-4ed4-4b4c-92f9-68b9e7107066">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf731d8db2514741951a6d08a5bf2340_D20200701-20200930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS0zLTEtMS0w_6342ba77-4ed8-4362-902a-8196722e6d6f">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56a02a7778f5400493e2859f84b416f2_D20210101-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS01LTEtMS0w_6bd3a9a6-1272-4bec-8d53-6726d56fe5e9">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if38c0c0626334984872a2e8f0277dc2e_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS03LTEtMS0w_5777da12-265e-426a-bbe3-d00554cc5872">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33239c1a09204337ad5c55fefd2f9d8c_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNi0xLTEtMS0w_44ed1293-a93d-43b2-8444-84c6c065a77d">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf731d8db2514741951a6d08a5bf2340_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNi0zLTEtMS0w_fa93d64c-8945-41dd-af8e-c6f1931a7d09">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56a02a7778f5400493e2859f84b416f2_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNi01LTEtMS0w_7fbb1e1f-706c-4cda-8743-1b306c7a15bd">310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if38c0c0626334984872a2e8f0277dc2e_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNi03LTEtMS0w_69539672-c330-46cd-8f04-fe435e783e51">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefa0cb672bf44372a091873f1dfe9120_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNy0xLTEtMS0w_d7d21d65-9008-4344-b958-1d742865706f">904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe641cc44c4a46438e0b7bfd4cc3622e_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNy0zLTEtMS0w_eb90b377-22fd-454a-8378-78156cb0e8fb">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefa0cb672bf44372a091873f1dfe9120_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNy01LTEtMS0w_7af04df6-84e2-4702-82d0-fcb86a3a648b">904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe641cc44c4a46438e0b7bfd4cc3622e_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNy03LTEtMS0w_29416be9-7e9a-466c-bf5e-f76a8f0cecda">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecd646f2764643b59a88988226c92eff_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTAtMS0xLTEtMA_5f141332-db93-4a90-9d51-08ada834fe07">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a67b4c90b54c758612bcb4085bec12_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTAtMy0xLTEtMA_2e22417d-d6a3-4b10-824f-669fdddd44f3">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12d2dcb1b92e4bcb94f40436329a7dd6_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTAtNS0xLTEtMA_5fce2da4-3a28-4e5c-af9e-077bd5c5c8be">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52f8f655a4e45b28cdd084d28393f28_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTAtNy0xLTEtMA_59629fcc-10a5-495b-a318-bb9e3b78b0f6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47faa1c1728e4e11a77c17ac0400684b_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTEtMS0xLTEtMA_05c291f7-19b3-415f-ad94-79b4799f94c6">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idedf5740b04f4deea7f8b81566c50b36_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTEtMy0xLTEtMA_47d018d5-e505-4ed2-94d7-93cc0339498d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d8528d81dc241b8800e77a29be29f47_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTEtNS0xLTEtMA_da54f601-4b43-434c-a9f6-fbdbed16b81d">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1952024433d45cdb011fb1c5362e577_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTEtNy0xLTEtMA_829b2e06-1891-49d8-8d73-cbfcceee7428">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47faa1c1728e4e11a77c17ac0400684b_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTMtMS0xLTEtMA_990d3cea-d48c-40b1-8936-82d8771c34c7">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idedf5740b04f4deea7f8b81566c50b36_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTMtMy0xLTEtMA_158c30eb-7493-472c-9ba5-57218591e3c9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d8528d81dc241b8800e77a29be29f47_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTMtNS0xLTEtMA_39ded0b9-cc99-4174-bc6c-3a36106ceee5">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1952024433d45cdb011fb1c5362e577_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTMtNy0xLTEtMA_19dc5e7e-76c3-4b6f-953d-7897a9216a4f">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic976b0752299464f9eb1c2e3a0466f84_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTQtMS0xLTEtMA_682c834c-1987-4132-8144-3cf24632acc0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i537c6fd82b2d4484a4285287e0da5e8d_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTQtMy0xLTEtMA_ae0627c2-0b90-4097-858b-01f07541804f">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic976b0752299464f9eb1c2e3a0466f84_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTQtNS0xLTEtMA_480ea90a-f897-4cae-833a-02de97addd9e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i537c6fd82b2d4484a4285287e0da5e8d_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTQtNy0xLTEtMA_57e3a781-67e0-4af2-af13-8e61da83e92c">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fcb54914f1448388da80fbfae61bf9b_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTctMS0xLTEtMA_240529bf-ac4a-4679-96e5-45d08588ef0b">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89f5412889bb4704867c4db1cb7606ca_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTctMy0xLTEtMA_d387b3ea-aed6-4160-8019-431b6d249c2b">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80de0413731140859ba1fca6bbc151be_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTctNS0xLTEtMA_fe4fafda-7947-4159-a093-24d8e7b11a9c">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e05796d442740d6b0e31e64c7579488_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTctNy0xLTEtMA_4447c333-2ae2-4972-8e6a-8e75c30e9606">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i22587a4dc04645edaa23ee4e6fe5309c_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM4ZDgwYjdmOWE2NjRmYjM5Njg5MWUwNjI0M2QyNjE2XzU1_c30d2be7-0fbf-400a-b5ac-4661eb556411">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i320caa0f2438447eb917283e43737ae0_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM4ZDgwYjdmOWE2NjRmYjM5Njg5MWUwNjI0M2QyNjE2XzU5_db692759-990e-407e-88cd-66be36f85cba">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ia60c00beb57f4d0aa1389f1cbd1b8aa9_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM4ZDgwYjdmOWE2NjRmYjM5Njg5MWUwNjI0M2QyNjE2XzYz_f8046566-2b4d-4f10-9833-1a116dfe0d2f">0</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i46462aa1e76c440a848f1a6c4854fcbf_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM4ZDgwYjdmOWE2NjRmYjM5Njg5MWUwNjI0M2QyNjE2XzY3_ed223937-06a5-4a8b-9a6e-b918cf82a7ac">7</ix:nonFraction>) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22587a4dc04645edaa23ee4e6fe5309c_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtMS0xLTEtMA_f4566d99-26a2-41f0-8fd9-bb3abde9d1b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i320caa0f2438447eb917283e43737ae0_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtMy0xLTEtMA_be6e3c66-fdfe-4737-98da-f04560fcb0e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia60c00beb57f4d0aa1389f1cbd1b8aa9_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtNS0xLTEtMA_9144392a-ceb4-43b2-9043-67d3d02dbf97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46462aa1e76c440a848f1a6c4854fcbf_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtNy0xLTEtMA_fe41d19d-1c7b-4eca-b075-65cd179e52d7">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="i22587a4dc04645edaa23ee4e6fe5309c_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktMC0xLTEtMC90ZXh0cmVnaW9uOmY4NGQxYjE2NmFiNTRmZDliZTJhMTYyZTExYmM2ZmZhXzcw_5b291621-c670-4dd2-bcc9-3c4c781c73d9">20</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i320caa0f2438447eb917283e43737ae0_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktMC0xLTEtMC90ZXh0cmVnaW9uOmY4NGQxYjE2NmFiNTRmZDliZTJhMTYyZTExYmM2ZmZhXzc0_04c7ecf9-4ce3-4921-bf84-5c06b0473adf">4</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="ia60c00beb57f4d0aa1389f1cbd1b8aa9_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktMC0xLTEtMC90ZXh0cmVnaW9uOmY4NGQxYjE2NmFiNTRmZDliZTJhMTYyZTExYmM2ZmZhXzc4_3624f564-20b8-43db-b146-e8410cafb7fc">29</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i46462aa1e76c440a848f1a6c4854fcbf_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktMC0xLTEtMC90ZXh0cmVnaW9uOmY4NGQxYjE2NmFiNTRmZDliZTJhMTYyZTExYmM2ZmZhXzgy_1a1c4122-0f7c-49cb-8be4-6b99b48aeeb0">14</ix:nonFraction>) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22587a4dc04645edaa23ee4e6fe5309c_D20210701-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktMS0xLTEtMA_233bf244-2c14-4733-bcc3-ff68ba8cbae3">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i320caa0f2438447eb917283e43737ae0_D20200701-20200930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktMy0xLTEtMA_c9823881-33df-41e2-a5d9-731cf4952eac">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia60c00beb57f4d0aa1389f1cbd1b8aa9_D20210101-20210930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktNS0xLTEtMA_b4d378b7-f4d4-4253-bb0d-518fd6503a12">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46462aa1e76c440a848f1a6c4854fcbf_D20200101-20200930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktNy0xLTEtMA_97af32d8-d3af-4b23-ac0c-65d122a2eef4">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22587a4dc04645edaa23ee4e6fe5309c_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjAtMS0xLTEtMA_05faaa86-f76f-439c-945b-0f3b8f149a56">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i320caa0f2438447eb917283e43737ae0_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjAtMy0xLTEtMA_6f1eb972-78f3-4fb4-aabb-b8b9e53f35e3">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia60c00beb57f4d0aa1389f1cbd1b8aa9_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjAtNS0xLTEtMA_2764b696-8a08-491f-b304-af466b90ec52">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46462aa1e76c440a848f1a6c4854fcbf_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjAtNy0xLTEtMA_a862867d-3eca-4d20-a961-245fc0e6bf3b">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8056adf6394fb8a935b96c8a1244bc_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjEtMS0xLTEtMA_97bdb363-ff3a-4b4c-b905-70c455b2fed5">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d82d6008cf422f990c1967019b47ae_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjEtMy0xLTEtMA_9443abe1-72ed-45e4-b200-ddf5911ccddd">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8056adf6394fb8a935b96c8a1244bc_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjEtNS0xLTEtMA_e23c8c0c-3f79-406f-a43d-21ca1b93097b">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d82d6008cf422f990c1967019b47ae_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjEtNy0xLTEtMA_78599408-b634-4e11-a459-17761c68d57d">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38f0d7cd0319413a864c57d831aa6de9_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjQtMS0xLTEtMA_9fa0de12-f15e-4eae-841e-9bcfb3f2bbc5">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5c9058389544d8f9fd0949b2df8c97e_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjQtMy0xLTEtMA_5d02324a-24d2-4ed4-82cc-e45a853602a9">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fa36c1044d245bfa0fdac23491e04fe_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjQtNS0xLTEtMA_0205ea2b-d211-4c9c-846e-d439e16e4dd9">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5168781fe0f2491a9d873c5536902ff3_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjQtNy0xLTEtMA_5b205f66-4e04-4578-8c37-6bf189561655">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="ia9a54e61594a4ce5afdb32319e63cfe5_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjE0NTNjZTU2MTlmNjQzZjRiZWZlYmU3ZDNjMjQ2NTRkXzU1_bf00ba5a-e9a5-4ed4-9453-095b86ce5f5e">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i7d6fd9a3e6ba4affb174e7bf3606494f_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjE0NTNjZTU2MTlmNjQzZjRiZWZlYmU3ZDNjMjQ2NTRkXzU5_033f252d-e38b-4abc-bf2d-d9df1ab885b0">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ibd3134eb77504bf1a35552d9f49abbce_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjE0NTNjZTU2MTlmNjQzZjRiZWZlYmU3ZDNjMjQ2NTRkXzYz_b684e7a2-a597-4b59-8a86-727d0b9476d4">0</ix:nonFraction>, and $(<ix:nonFraction unitRef="usd" contextRef="ifd24288b5c4a41a39c5a91e91a8ef6bf_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjE0NTNjZTU2MTlmNjQzZjRiZWZlYmU3ZDNjMjQ2NTRkXzcx_ccddf74a-606a-44de-842c-8b97cd6cacd0">8</ix:nonFraction>) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a54e61594a4ce5afdb32319e63cfe5_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtMS0xLTEtMA_792135b7-dd49-4544-a075-f9387ce06468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d6fd9a3e6ba4affb174e7bf3606494f_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtMy0xLTEtMA_9fa2e411-bfa8-4962-9a14-e585ffed65fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd3134eb77504bf1a35552d9f49abbce_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtNS0xLTEtMA_bcd99a79-1e37-4d9d-9291-71025e91c06b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd24288b5c4a41a39c5a91e91a8ef6bf_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtNy0xLTEtMA_9f97843d-207b-4a0c-b55f-765a083b7068">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="ia9a54e61594a4ce5afdb32319e63cfe5_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA0MTc1ZWEzNDA2NTRmN2ViYjY1NGI5NTdhM2JiZDJiXzY4_d1b13d9c-a921-4791-8fbf-50c8d41a1f7d">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i7d6fd9a3e6ba4affb174e7bf3606494f_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA0MTc1ZWEzNDA2NTRmN2ViYjY1NGI5NTdhM2JiZDJiXzcy_3f6e7de7-b119-4a93-bbf5-5c1865a26ae3">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ibd3134eb77504bf1a35552d9f49abbce_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA0MTc1ZWEzNDA2NTRmN2ViYjY1NGI5NTdhM2JiZDJiXzc2_777562f9-2d84-447e-a25f-9092785d32c5">1</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifd24288b5c4a41a39c5a91e91a8ef6bf_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA0MTc1ZWEzNDA2NTRmN2ViYjY1NGI5NTdhM2JiZDJiXzgz_2a7ca8c1-95cf-48ad-9d2f-030bf2b1dd2b">7</ix:nonFraction> pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a54e61594a4ce5afdb32319e63cfe5_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtMS0xLTEtMA_1c356969-c540-4d6b-a121-48288badff90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d6fd9a3e6ba4affb174e7bf3606494f_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtMy0xLTEtMA_d022dc6b-aa1f-47d6-a0ac-0f05f50581c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd3134eb77504bf1a35552d9f49abbce_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtNS0xLTEtMA_62174c98-e084-4870-900b-e1e392b810b0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd24288b5c4a41a39c5a91e91a8ef6bf_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtNy0xLTEtMA_edb375fa-ff44-43da-92fb-586929a4cfab">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a54e61594a4ce5afdb32319e63cfe5_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjctMS0xLTEtMA_694c92c3-7fdb-4fa7-82db-1beb086feeef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d6fd9a3e6ba4affb174e7bf3606494f_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjctMy0xLTEtMA_37b032ad-23c2-43fe-8b3d-42a81440497a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd3134eb77504bf1a35552d9f49abbce_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjctNS0xLTEtMA_dcdef228-f6d8-4f58-92d8-18820e84ff15">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd24288b5c4a41a39c5a91e91a8ef6bf_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjctNy0xLTEtMA_20b64d92-fde7-4ca2-aa10-5478c14110bf">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb78040186fa4e1aaee57c20ecf08ec1_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjgtMS0xLTEtMA_3ac81044-1db0-410f-80fc-52137e54ca9a">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaeb02179387b4c138f3d16aecc35f88b_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjgtMy0xLTEtMA_7c63208e-72d6-4825-8c80-aacc52174e3a">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb78040186fa4e1aaee57c20ecf08ec1_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjgtNS0xLTEtMA_bf385afd-6350-4f33-9107-2ff3005470ff">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaeb02179387b4c138f3d16aecc35f88b_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjgtNy0xLTEtMA_65ad627b-0b50-40cc-9683-b47f335966ea">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e8e4d27b8640368de9694d52106ab1_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzAtMS0xLTEtMA_4b9c5016-e3f3-422c-b071-8c1498be523b">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38524abcd2514a1fb4737a87a7e66b81_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzAtMy0xLTEtMA_a49e0441-c9b6-4f66-a22f-4d8f29847f7f">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744afac31d1c419187429ada2dec85cb_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzAtNS0xLTEtMA_a735cc75-e1c8-411c-960a-1f97738f40af">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb66a72330944e6abe3847855220870_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzAtNy0xLTEtMA_6f01702c-ae46-4c0b-8b92-011275b039d1">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4ab8d4ce4d04aecb9a84bbfc6849284_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzEtMS0xLTEtMA_3d85c8e6-5070-4b29-81d0-09220e743200">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzEtMy0xLTEtMA_6d0ede36-87d1-488d-b39c-a10588fbb4ac">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzEtNS0xLTEtMA_435fd22b-304d-474a-a3ed-d99faa107bc4">337</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzEtNy0xLTEtMA_304cf154-2f69-4d46-bbeb-e897c841a1c8">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive income </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i840219be56704e14b8dd4d1adb3ca119_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzItMS0xLTEtMA_a5649950-6822-4933-be98-6b7be2ba2731">1,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4d9088e966a40a68d31fc31fc7a2d2a_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzItMy0xLTEtMA_3e3a63ca-137b-4903-b818-82c8198d28b5">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i840219be56704e14b8dd4d1adb3ca119_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzItNS0xLTEtMA_d8380852-b67c-4962-9695-a84624a532d9">1,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4d9088e966a40a68d31fc31fc7a2d2a_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzItNy0xLTEtMA_528fe796-9c27-4275-a480-4ff0090593fc">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i4c8056adf6394fb8a935b96c8a1244bc_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RleHRyZWdpb246ODE2MzAwOTEyNTdiNGYwOGFkNWU3NGYwNzg4MWVhNDNfNjY5_b1caf58b-5ef4-4788-ae4a-6d03db4154bb">11</ix:nonFraction> million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i432dc664d80c4800b223ee550f6420c5" continuedAt="i6fc7330b74af44dc8beac74383f6ef10"><ix:continuation id="ie555c4c3117c4d359665f87cd01364b0" continuedAt="i31f5941fa4634448bb3faecede0f0e73">(3)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i6fc7330b74af44dc8beac74383f6ef10"><ix:continuation id="i31f5941fa4634448bb3faecede0f0e73">Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.</ix:continuation></ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RleHRyZWdpb246ZjliZTY2YTIxNzkxNDhkYjkxMzUzNmQ1NGVhNzk5M2ZfNzYw_2a3d9d1c-aaec-47b9-af35-5c7946c85d13" continuedAt="i0c22b424657b419d82dd462bc250734c" escape="true">Earnings Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0c22b424657b419d82dd462bc250734c"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the two-class method. Stock appreciation rights and options to purchase <ix:nonFraction unitRef="shares" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RleHRyZWdpb246ZjliZTY2YTIxNzkxNDhkYjkxMzUzNmQ1NGVhNzk5M2ZfMTM1_4f01645c-4064-4f89-a1c6-b03c597aa458"><ix:nonFraction unitRef="shares" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RleHRyZWdpb246ZjliZTY2YTIxNzkxNDhkYjkxMzUzNmQ1NGVhNzk5M2ZfMTM1_65607586-288c-49c1-a1c4-21ea8cf2a3c6">8</ix:nonFraction></ix:nonFraction> million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share in each of the three and nine-month periods ended September&#160;30, 2021, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, stock appreciation rights and options to purchase <ix:nonFraction unitRef="shares" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RleHRyZWdpb246ZjliZTY2YTIxNzkxNDhkYjkxMzUzNmQ1NGVhNzk5M2ZfNTAw_26fbab07-5aea-42aa-92d0-bf392b313917">17</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RleHRyZWdpb246ZjliZTY2YTIxNzkxNDhkYjkxMzUzNmQ1NGVhNzk5M2ZfNTA3_186ccc15-8a56-47f9-a447-9e94bc99ea40">16</ix:nonFraction> million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and nine months ended September&#160;30, 2020, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RleHRyZWdpb246ZjliZTY2YTIxNzkxNDhkYjkxMzUzNmQ1NGVhNzk5M2ZfNzk0_783904ed-fe66-44e0-834f-e8e984a68ed6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfNi0xLTEtMS0w_8c08a933-40c1-4e1d-959d-13fe2521eb59">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfNi0zLTEtMS0w_1ea8efb2-2d47-434d-a862-1587bd2ae860">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfNi01LTEtMS0w_83c753c4-93e9-4074-a429-b1821518f47f">6,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfNi03LTEtMS0w_6fa3200d-add9-42ef-9196-6d411c4dfa07">6,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfOS0xLTEtMS0w_aa893404-d8e4-4b83-8757-4e821a499555">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfOS0zLTEtMS0w_15139f95-6329-4a62-87a5-b42e9e1a052f">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfOS01LTEtMS0w_8e11ae59-2908-4a6a-a91b-6aba52e86a96">1,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfOS03LTEtMS0w_a431a1c5-5e1b-43b9-b42c-513fef60e9f1">1,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTAtMS0xLTEtMA_d75f28b6-5933-4d96-a5ef-6cad2abeec16">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTAtMy0xLTEtMA_7a1088bc-928b-410a-9103-354093f6a1a7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTAtNS0xLTEtMA_71f5b656-acef-4b15-a1cd-7a2fa42f65b4">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTAtNy0xLTEtMA_6e3e3a88-acfd-4cf8-b28a-465ecb50837e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTEtMS0xLTEtMA_aeff4377-92e1-429e-bdcf-ce0edd58e4fd">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTEtMy0xLTEtMA_3cd277e1-bdfc-46d4-9617-a90ce2c49780">1,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTEtNS0xLTEtMA_c6bd3212-f780-497e-a59a-777dfa1ca689">1,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTEtNy0xLTEtMA_bf1af7bc-11e0-4c7a-8f65-ea27ea06b580">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTQtMS0xLTEtMA_4a6d78c9-98ee-41b2-ac3f-a459c24e94c8">1.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTQtMy0xLTEtMA_930b9546-8c9d-4875-91ac-9b959ec61ba5">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTQtNS0xLTEtMA_b13b0d80-559b-4267-9f46-5acb5ffb3457">5.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTQtNy0xLTEtMA_815a2300-8593-40b2-a550-371deea65147">4.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTUtMS0xLTEtMA_d0e836bd-44b0-40e3-bc91-ab307c39d6d7">1.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTUtMy0xLTEtMA_ecc0d294-6d9e-4e84-bb98-1340097c3ee2">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTUtNS0xLTEtMA_73242c83-a1ab-46ae-a7b4-c8f8b370027e">4.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTUtNy0xLTEtMA_7a610ec8-f699-4175-9c64-2c85edd578e6">4.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_58"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81OC9mcmFnOjY0M2Y3NDA2Njc1OTQxMTJhYTRiMThlOTU1MDVjYWYyL3RleHRyZWdpb246NjQzZjc0MDY2NzU5NDExMmFhNGIxOGU5NTUwNWNhZjJfMjgyMzY_1457f91f-e69f-43c2-9abe-d23a5149001d" continuedAt="ief374af8e6cf4d98ad3c662b909ab19b" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ief374af8e6cf4d98ad3c662b909ab19b" continuedAt="i47756b0452844ae295459f38353895dd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. The Company believes COVID-19&#8217;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company&#8217;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#8217;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of September&#160;30, 2021, the Company guaranteed <ix:nonFraction unitRef="store" contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930" decimals="INF" name="cvs:GuarantorObligationsNumberofLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81OC9mcmFnOjY0M2Y3NDA2Njc1OTQxMTJhYTRiMThlOTU1MDVjYWYyL3RleHRyZWdpb246NjQzZjc0MDY2NzU5NDExMmFhNGIxOGU5NTUwNWNhZjJfMjAxNA_cfabef9b-f90e-4e1f-a803-9636c3a1721d">72</ix:nonFraction> such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2030. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i47756b0452844ae295459f38353895dd" continuedAt="i979c9337264b42d596f9524f51bbc6f0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), state insurance and health and welfare departments, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the U.S. Department of Justice (the &#8220;DOJ&#8221;), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">state attorneys general, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i979c9337264b42d596f9524f51bbc6f0" continuedAt="ia349dc346da54cb0a153df10a9864b21"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including by a State Attorney General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;) and other requests for documents and information from, and is being investigated by, Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information. In June 2021, prior to the start of the New York State Court bellwether trial, the Company reached a settlement with Nassau and Suffolk Counties for an immaterial amount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations in connection with an investigation concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The Company has been providing documents and information in response to this subpoena.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia349dc346da54cb0a153df10a9864b21" continuedAt="i688d394ada3c40b698c1cd3fe51f0ed0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed a complaint-in-intervention in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#8217;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#8220;HHS-OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i688d394ada3c40b698c1cd3fe51f0ed0" continuedAt="i88859fed44544c10883bdcd11771799d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately <ix:nonFraction unitRef="member" contextRef="ida4612fe99b04ca2aa41bf1a2e73fe9a_D20120101-20121231" decimals="-2" name="cvs:LossContingencyAuditMethodologySampleSize" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81OC9mcmFnOjY0M2Y3NDA2Njc1OTQxMTJhYTRiMThlOTU1MDVjYWYyL3RleHRyZWdpb246NjQzZjc0MDY2NzU5NDExMmFhNGIxOGU5NTUwNWNhZjJfMTgwNjg_a92adda0-a6a7-4776-87a4-d7d643a1afdf">200</ix:nonFraction> members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, HHS-OIG or otherwise, including audits of the Company&#8217;s minimum medical loss ratio (&#8220;MLR&#8221;) rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">), was dismissed with prejudice in February 2021. Plaintiffs have appealed that decision to the First Circuit after their motion for reconsideration was denied. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Waterford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In re CVS Health Corp. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">City of Warren</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Freundlich</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) have been stayed pending the outcome of the First Circuit appeal. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, <ix:nonFraction unitRef="claim" contextRef="i384f03c6d15c44d196ee290093383364_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81OC9mcmFnOjY0M2Y3NDA2Njc1OTQxMTJhYTRiMThlOTU1MDVjYWYyL3RleHRyZWdpb246NjQzZjc0MDY2NzU5NDExMmFhNGIxOGU5NTUwNWNhZjJfMjI0NTg_746191ee-7c4e-44aa-a969-c6908c1f96fd">two</ix:nonFraction> ERISA class actions were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna Inc. (&#8220;Aetna&#8221;), and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The district court consolidated the actions and the Company is defending itself against these claims. In October 2021, the consolidated case was dismissed without prejudice. Plaintiffs may seek leave to file an amended complaint. The Company also received a related document request pursuant to ERISA &#167; 104(b), to which the Company has responded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i88859fed44544c10883bdcd11771799d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health care services company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div></ix:continuation><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_61"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMzQzMA_e0988b15-8344-4019-be9f-70a81872e947" continuedAt="i3e645617f58e41088f162daf31658872" escape="true">Segment Reporting</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3e645617f58e41088f162daf31658872" continuedAt="i98a30b6c66b94cce887bb7b61e57a886">The Company has <ix:nonFraction unitRef="segment" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfNDE_8bdec9bd-d467-4952-ace1-6ed30f95e9b9">three</ix:nonFraction> operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. </ix:continuation></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i98a30b6c66b94cce887bb7b61e57a886" continuedAt="ibaea4c49a26947eeaf5da41ccb274893"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMzQyNg_3909d17d-00e3-44e7-80ad-b35fd5771fb8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia630bb470ae642f8905431f2e294870b_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMy0xLTEtMS0w_6e9f5b6b-f205-476b-8494-eef344ce8072">20,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMy0zLTEtMS0w_96a11781-629d-4b06-89fe-573637c0e036">36,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25b37ce901e241a68a26af12fa5a391b_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMy01LTEtMS0w_2daf23cf-f245-45b5-aa42-5a4131b1de83">16,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c910bf185e14abb8f843118e080650b_D20210701-20210930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMy03LTEtMS0w_e8930c54-c93e-44af-b8d3-f7afeebd8b2a">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMy0xMS0xLTEtMA_8bb0a90a-79aa-437a-ae58-5be9a7900689">73,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c774f4ed3c4faabc1e5df119dd09f8_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNC0xLTEtMS0w_35bc5233-8623-4d32-960f-4ac8402a80dc">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb5b7e4050464b31ba5e844cce234bd4_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNC0zLTEtMS0w_410d89e3-b911-46b3-93da-c16d2d1c3c52">2,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f235791bca4dbc853d081abfa4d343_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNC01LTEtMS0w_fc06756a-67d3-4688-b6f2-18ee2e02ff41">8,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNC05LTEtMS0w_9f514e3f-1801-4e37-b191-1ce28b128996">10,894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia630bb470ae642f8905431f2e294870b_D20210701-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNS0xLTEtMS0w_4a048e00-0e58-494f-a38b-3b12da4f2acb">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNS0zLTEtMS0w_6ac8a6f1-ecfa-4436-9f7e-28085f117166">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25b37ce901e241a68a26af12fa5a391b_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNS01LTEtMS0w_a3a7dff5-fadf-4c8e-b4f5-240e24da5451">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c910bf185e14abb8f843118e080650b_D20210701-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNS03LTEtMS0w_d0212144-e256-447e-a202-64c5c0727ed6">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNS05LTEtMS0w_feeaa530-be87-40c9-ad0b-d5d4cca491ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNS0xMS0xLTEtMA_c09f8661-055d-4347-aece-1b7dd8aaf574">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1620dfc000424fd3b15b25a1ac9a1791_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNi0xLTEtMS0w_0c7408fc-8845-4091-aa91-d178d5ad0e1c">20,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc97d958fa084ddc939774b0bc91d620_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNi0zLTEtMS0w_bae5b639-b37b-43bc-ac06-82e642ebae6b">39,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d900d4b1ca34915859e9703c35c8775_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNi01LTEtMS0w_95392129-c03d-4f29-8965-6a9a4ba7228d">24,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c910bf185e14abb8f843118e080650b_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNi03LTEtMS0w_07ed4d20-e5fa-4a33-8593-7d47a4611a80">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNi05LTEtMS0w_af2a7715-62b3-46cf-9b3f-c5c74ad1cdd6">10,894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNi0xMS0xLTEtMA_5bf2616f-77c3-4061-b2f2-58632071e446">73,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia630bb470ae642f8905431f2e294870b_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNy0xLTEtMS0w_07a944af-c9f6-487b-ad40-8a500b711a3a">1,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNy0zLTEtMS0w_23658bea-a7d9-4d90-af44-f4545751d301">1,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25b37ce901e241a68a26af12fa5a391b_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNy01LTEtMS0w_c34059bd-cc09-435f-8663-6f3bf2ae6607">1,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c910bf185e14abb8f843118e080650b_D20210701-20210930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNy03LTEtMS0w_e2ac92bd-63f8-4d19-94e3-679f077331d3">343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNy05LTEtMS0w_03b3f4da-305f-493c-a061-0f398050f7b3">186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNy0xMS0xLTEtMA_9b23f0e4-08eb-498b-a025-66672a3afc89">4,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42ba3552a810439d9832cae42b188533_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTAtMS0xLTEtMA_59d1d263-d181-4ce9-8df5-d1f153cab33a">18,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTAtMy0xLTEtMA_1d9809f5-e350-4b78-adce-c343a9c6f139">33,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c29ab4601174287b450f53152b36d36_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTAtNS0xLTEtMA_907a12d2-8d05-4724-9df7-95cd4b0e0458">14,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTAtNy0xLTEtMA_2515b483-152a-45a6-8f3e-240c057edf6e">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTAtMTEtMS0xLTA_ce42a07e-d1c0-43e9-a80c-58e3f98dbaf0">66,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic04e76d8cae84ec2a080a6f0fc22a523_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTEtMS0xLTEtMA_f3cb30bc-6793-48e3-af0c-5b64e5bc9934">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i307fb82e77314c8895bc793a68fe29dc_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTEtMy0xLTEtMA_4e18eb03-f30e-47f3-afa5-6128d4e2a376">2,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d22088cdb00442b89bdd1fe6cf8a26b_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTEtNS0xLTEtMA_bc974854-426e-46c0-ad03-cd67ed91589c">7,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea31066dc7804044ae36620bede68059_D20200701-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTEtOS0xLTEtMA_0e3b6960-a257-40ab-b353-4c7d160a50b0">10,194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42ba3552a810439d9832cae42b188533_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTItMS0xLTEtMA_18d9f52a-ed44-4a13-aa10-a6644f296612">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTItMy0xLTEtMA_a1d122a5-6a2c-43ac-bfa5-a0b2648b80f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c29ab4601174287b450f53152b36d36_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTItNS0xLTEtMA_fc4e4fea-bd85-47e6-ad5e-ecc62e571ca8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTItNy0xLTEtMA_79c73f1a-7689-4616-8f99-fd365995a444">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea31066dc7804044ae36620bede68059_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTItOS0xLTEtMA_706e26f0-04b6-4776-bc31-1244d544ad45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTItMTEtMS0xLTA_cfc107c3-81f5-4a46-9950-d1c3380a91aa">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b7044360fae43969a13838008e79bb1_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTMtMS0xLTEtMA_acc036da-c8de-4d33-9985-aaa3993b6156">18,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacf5f0e00659493589182745e85a0e36_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTMtMy0xLTEtMA_d9651373-c3c0-4e15-a28c-fe5086d6a0c5">35,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedfff3121ba6469d9e77415864b5a41a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTMtNS0xLTEtMA_4090e3a4-9ba2-468b-b7af-baf7ccf6fe05">22,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTMtNy0xLTEtMA_09279d01-73a5-467c-b617-0bc8db000a88">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea31066dc7804044ae36620bede68059_D20200701-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTMtOS0xLTEtMA_6d82e080-7e4e-432f-9877-79de9ff06397">10,194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTMtMTEtMS0xLTA_bad30cb8-7078-44f7-a542-568fcced4f11">67,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42ba3552a810439d9832cae42b188533_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTQtMS0xLTEtMA_2d8ce8cf-5c8d-451e-a514-11d4ef52b82a">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTQtMy0xLTEtMA_845ab551-d738-4e35-a98f-23d422230cf9">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c29ab4601174287b450f53152b36d36_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTQtNS0xLTEtMA_0364ffc3-b5c6-4d5f-8df7-31441ec4f4a3">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTQtNy0xLTEtMA_d05b5798-a5e0-488a-bd05-916fa97c002d">303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea31066dc7804044ae36620bede68059_D20200701-20200930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTQtOS0xLTEtMA_8140246e-7ac0-40fd-9c99-7da417a037e5">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTQtMTEtMS0xLTA_2dbb4eaf-2c24-4dbe-bf60-9518615360b7">3,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc744230a544ead88ffab3c45d0c454_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTgtMS0xLTEtMA_6de5e315-ce27-4442-a515-3e63f099f9dc">60,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTgtMy0xLTEtMA_2bc4615a-fe53-4371-a694-aa3bdb30b0a6">105,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b445faeec3845f6b11c9569be49f9fb_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTgtNS0xLTEtMA_6155e72c-81e2-4299-a7ee-b1e41c426abf">47,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTgtNy0xLTEtMA_34b31357-281b-49ae-a60b-9a29917a93da">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTgtMTEtMS0xLTA_6bf77804-a3e8-4017-aac0-923786856ce3">214,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a7d151a028477481ac7f32edde55eb_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTktMS0xLTEtMA_eb32e0dd-c16d-4feb-91b2-95b53e1f0ddb">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28069fe437ba40d9b14e06d3899dbf60_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTktMy0xLTEtMA_d0d2d5df-4787-4b02-b8b6-b027c4e99ace">7,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d7f4151778947ca96d8cb506330110a_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTktNS0xLTEtMA_480ebb67-ebb1-4388-926b-5ebb9540a75a">25,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i472a8387964b45ec897885f8bc357e99_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTktOS0xLTEtMA_434f887a-2832-46c6-bfdb-bfa7ac301dd2">33,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc744230a544ead88ffab3c45d0c454_D20210101-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjAtMS0xLTEtMA_e4936f2a-0f80-4a7c-987b-6e958ee38576">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjAtMy0xLTEtMA_e96bad39-080c-4473-84ac-e370c87d46df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b445faeec3845f6b11c9569be49f9fb_D20210101-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjAtNS0xLTEtMA_69269f94-0217-49cb-ac2f-5830db95f9f4">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjAtNy0xLTEtMA_57fece00-1749-4e7f-b6ec-6695bac8d1fd">387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i472a8387964b45ec897885f8bc357e99_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjAtOS0xLTEtMA_02c64a20-9aa3-45df-8a82-c1759da384d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjAtMTEtMS0xLTA_94e03f3d-116b-4998-96d8-70305a7b8d72">832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af0cc01cbc54c9f9e8615532da5bb0c_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjEtMS0xLTEtMA_67264a3b-368e-4132-b2f7-6874ba25ff75">61,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869431e7abf74749b23dd3a1ed93e1ef_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjEtMy0xLTEtMA_f01b6cf5-c90e-4292-ba8f-1754ea574472">113,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05a9eb3fc13543189b612e1898a32241_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjEtNS0xLTEtMA_70af9416-8d16-4db0-be76-33c9580b0680">72,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjEtNy0xLTEtMA_2f91f078-a19f-4ccc-b739-a889cc5b667d">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i472a8387964b45ec897885f8bc357e99_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjEtOS0xLTEtMA_c80ece34-5d00-41c2-83ac-cfb0a4f36e81">33,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjEtMTEtMS0xLTA_ceeabcdf-126e-4e8d-b33e-a512dd691116">215,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc744230a544ead88ffab3c45d0c454_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjItMS0xLTEtMA_82d6306f-ed3e-438f-ba00-61aa03d1264d">4,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjItMy0xLTEtMA_8c930c16-84b3-454d-b37f-210a762a1f04">5,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b445faeec3845f6b11c9569be49f9fb_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjItNS0xLTEtMA_50c5087b-2bbb-4122-a96b-28e71218571e">5,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjItNy0xLTEtMA_9701e8bb-0e5e-4f0d-b22b-4a0c69592bb6">1,015</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i472a8387964b45ec897885f8bc357e99_D20210101-20210930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjItOS0xLTEtMA_4977f141-000d-4ae5-a1f6-efef4a3c253a">523</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjItMTEtMS0xLTA_1924aa10-3a74-4e92-8861-1dae4218bde9">13,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a95101c0a2547d68267b540d8eb8935_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjUtMS0xLTEtMA_a774a704-a443-44bf-9447-eabeb798e8d5">55,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjUtMy0xLTEtMA_da149e04-09c6-4eaa-b0d8-154df9b62b39">98,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0610bf8e796340e4b079b333dbc7453b_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjUtNS0xLTEtMA_50b95ed4-43d9-4600-94a7-e951afd13722">44,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjUtNy0xLTEtMA_e5c93692-55cf-4790-9b0d-b5675ca26d0c">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjUtMTEtMS0xLTA_67c7e61a-1a3e-445a-b90d-a210fef395a5">198,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8246339cd89c42688813a929c411f371_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjYtMS0xLTEtMA_6f9fda40-45c1-41eb-8a7a-974aebf04259">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i020d373f0ad2415aa7656c159c909537_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjYtMy0xLTEtMA_90b04d5d-8846-44d4-ab39-281d42424f20">7,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac023dc2cf14e8aa8be582c9ee42c76_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjYtNS0xLTEtMA_b2ee14c7-f59e-4365-95f5-d663d819aea4">22,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjYtOS0xLTEtMA_2ce09ea4-3555-42f0-a6a6-4bff41b50fd5">30,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a95101c0a2547d68267b540d8eb8935_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjctMS0xLTEtMA_80f85948-933c-4a46-ae64-1455f26d5550">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjctMy0xLTEtMA_df7383ab-adae-429f-ad35-4733468e8420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0610bf8e796340e4b079b333dbc7453b_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjctNS0xLTEtMA_13a67722-daea-4366-842c-ff3e0de788c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjctNy0xLTEtMA_af78f06b-57f9-481f-89cd-60627632dc7c">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjctOS0xLTEtMA_5a63839a-6205-40eb-a301-af1bf03b4e78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjctMTEtMS0xLTA_11f7d075-55fe-4e7a-aa45-9978baaeb64f">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3ecfefee0e642c0a78fc0131c0449c3_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjgtMS0xLTEtMA_d95553ad-6d83-422c-9845-105d8492f291">56,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a39cfe4d74743ff8499e3d09c93e0c5_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjgtMy0xLTEtMA_1c308964-49a9-4ad5-bbfa-dc01fd106a7f">105,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i104116dd6efe40a7bb00f658c0ab14e3_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjgtNS0xLTEtMA_269d8fbf-0125-4e78-b759-0c97a89f4490">67,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjgtNy0xLTEtMA_674fea92-6a37-4a6a-b72a-415fde8a14c3">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjgtOS0xLTEtMA_51c53097-e6b7-4a94-9911-9a2cf1e3f4d5">30,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjgtMTEtMS0xLTA_d9690697-70c4-451b-9785-acb09136366c">199,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a95101c0a2547d68267b540d8eb8935_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjktMS0xLTEtMA_5aae679b-f215-4f02-ba60-52622f1c98e8">6,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjktMy0xLTEtMA_b998bcff-7b5a-4e64-ae6d-91402c9a9899">4,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0610bf8e796340e4b079b333dbc7453b_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjktNS0xLTEtMA_43a12775-a7f9-4b7d-89bf-2eec9e18196e">4,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjktNy0xLTEtMA_7da122b9-8c7f-4b44-ac22-1d6b057cfcf9">931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjktOS0xLTEtMA_0a52d716-9cff-4ad5-98a9-94f3d9d6e593">539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjktMTEtMS0xLTA_b4d33d5b-3afc-4a73-a50c-78e1492d7f9f">13,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $<ix:nonFraction unitRef="usd" contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930" decimals="-8" format="ixt:num-dot-decimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMTczOQ_0eb0d5a2-09e8-440c-a646-2eadaeaf1a53">2.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930" decimals="-8" format="ixt:num-dot-decimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMTc0Ng_b61f7c6d-a1af-42ed-82eb-ad0970513f53">2.5</ix:nonFraction> billion of retail co-payments for the three months ended  September&#160;30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930" decimals="-8" format="ixt:num-dot-decimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMTgyOA_68ed2989-19ae-4f6d-b8db-5e7b581faa66">9.0</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930" decimals="-8" format="ixt:num-dot-decimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMTgzNQ_cb3c8039-3781-48d6-9e8a-7c9bf3b10776">8.5</ix:nonFraction> billion of retail co-payments for the nine months ended September&#160;30, 2021 and 2020, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibaea4c49a26947eeaf5da41ccb274893" continuedAt="ibcb7f7d46de840fb828b31dbf684d527"><ix:nonNumeric contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMzQyMg_e503137d-b6e5-43c2-b63d-e6d40d30064d" continuedAt="i9b3c6c33be2e4ef096ddc688d3423e3b" escape="true"><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three and nine months ended September&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMi0xLTEtMS0w_fb515f1e-cbdf-4efe-9e74-f76f969ab6b4">3,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMi0zLTEtMS0w_258fc45e-d586-4789-b0c9-fd2806bd003f">3,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMi01LTEtMS0w_6e0a3ef2-0648-4854-a19b-cef4fc287b68">10,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMi03LTEtMS0w_cd62e712-ec73-4ceb-917c-bc57a0a1a9f8">11,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMy0xLTEtMS0w_920a91e5-5811-4d73-8722-7dc51087af51">561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMy0zLTEtMS0w_28a9be3b-48fc-4788-aa6d-1d7555fa2981">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMy01LTEtMS0w_a46c5586-8bec-410c-abe0-5c0f417f79ea">1,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMy03LTEtMS0w_c287d3e4-8386-4132-bddf-6e44f52f9918">1,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNC0xLTEtMS0w_20b2d44f-b126-46b0-a5f1-03d3e1436267">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNC0zLTEtMS0w_54f22c88-10ba-4b77-a010-dab447e48c08">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNC01LTEtMS0w_afbc6a7a-a1f0-4ce4-b8de-9a76e54abdf5">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNC03LTEtMS0w_13b22aa5-63d5-4b37-adb1-beac1daa8ed2">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS0xLTEtMS03NjY3_3d00fe2a-0c74-4bcd-89ef-e03684a8084d">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS0zLTEtMS03Njgx_666f3b01-8f39-4046-8cc8-6a51fbff8d16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS01LTEtMS03Njk1_8590df23-4f0f-483e-a4e9-01b4d73bb326">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS03LTEtMS03NzE1_23831557-3ecb-454a-8704-b9d629044461">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS0xLTEtMS00MDgx_16106766-036a-4d3f-b78b-8d3d6512a096">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS01LTEtMS00MTI4_f878ac64-a134-4d80-bfe8-7fc3f818f7cd">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS0zLTEtMS0w_11cfbb6b-1668-4c96-924f-970bee6e8e8a">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS03LTEtMS0w_3e797961-d989-4b3e-bbdd-8bef4e0455a2">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNy0xLTEtMS0w_9b23f0e4-08eb-498b-a025-66672a3afc89">4,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNy0zLTEtMS0w_2dbb4eaf-2c24-4dbe-bf60-9518615360b7">3,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNy01LTEtMS0w_1924aa10-3a74-4e92-8861-1dae4218bde9">13,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNy03LTEtMS0w_b4d33d5b-3afc-4a73-a50c-78e1492d7f9f">13,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September 30, 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:8.68pt">During the three and nine months ended September 30, 2021, the goodwill impairment charge relates to the LTC reporting unit within the Retail/LTC segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In June 2021, the Company received $<ix:nonFraction unitRef="usd" contextRef="i0311b59b583f418eaccfec74aac1d61f_D20210601-20210630" decimals="-6" format="ixt:num-dot-decimal" name="cvs:ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMTA5OTUxMTYzMzE1Mw_c51b5cb8-1448-4dc6-8f37-32a66733708d">61</ix:nonFraction>&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statement of operations for the nine months ended September&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment. </span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ibcb7f7d46de840fb828b31dbf684d527" continuedAt="if250fe3456de4f0ab7eaa9c803dcc1b9"><ix:continuation id="i9b3c6c33be2e4ef096ddc688d3423e3b" continuedAt="i9b0c9448678e4eafb19fe10c8674e2c8">(5)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="if250fe3456de4f0ab7eaa9c803dcc1b9"><ix:continuation id="i9b0c9448678e4eafb19fe10c8674e2c8">During the three and nine months ended September 30, 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $<ix:nonFraction unitRef="usd" contextRef="i0975e9ea8e5e480faf0a315905252457_D20200731-20200731" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMzI5ODUzNDg4OTQ5Nw_58528beb-1b74-4650-9258-246cef5daedc">850</ix:nonFraction>&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations within the Health Care Benefits segment.</ix:continuation></ix:continuation> </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Review of Interim Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reviewed the accompanying condensed consolidated balance sheet of CVS Health Corporation (the Company) as of September&#160;30, 2021, the related condensed consolidated statements of operations and comprehensive income for the three-month and nine-month periods ended September&#160;30, 2021 and 2020, the related condensed consolidated statements of shareholders&#8217; equity for the three-month periods ended March 31, 2021 and 2020, June&#160;30, 2021 and 2020, and September&#160;30, 2021 and 2020, the related condensed consolidated statements of cash flows for the nine-month periods ended September&#160;30, 2021 and 2020, and the related notes (collectively referred to as the &#8220;condensed consolidated interim financial statements&#8221;). Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated interim financial statements for them to be in conformity with U.S. generally accepted accounting principles.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December&#160;31, 2020,  the related consolidated statements of operations, comprehensive income (loss), shareholders&#8217; equity and cash flows for the year then ended, and the related notes (not presented herein); and in our report dated February 16, 2021, we expressed an unqualified audit opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December&#160;31, 2020, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Review Results</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These financial statements are the responsibility of the Company&#8217;s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the SEC and the PCAOB. We conducted our review in accordance with the standards of the PCAOB. A review of interim financial statements consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November&#160;3, 2021</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;)</span></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (&#8220;CVS Health&#8221;), together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;), is a diversified health services company united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. The Company has more than 9,900 retail locations, nearly 1,200 walk-in medical clinics, a leading pharmacy benefits manager with approximately 110 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services, and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, the Company has submitted regulatory filings for a January 2022 entrance into the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Overview of the Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and Covered Entities. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, coronavirus disease 2019 (&#8220;COVID-19&#8221;) and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of September&#160;30, 2021, the Retail/LTC segment operated more than 9,900 retail locations, nearly 1,200 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and onsite pharmacies.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Current Trends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also face trends and uncertainties specific to our reportable segments, certain of which are summarized below and also discussed in the review of our segment results. For the remainder of the year, the Company believes you should consider the following important information:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The COVID-19 pandemic continues to impact the economies of the U.S. and other countries around the world. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic, as well as the pandemic&#8217;s impact on the U.S. and global economies, global supply chain, consumer behavior, and health care utilization patterns. In addition, as described in the &#8220;Government Regulation&#8221; section of the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the &#8220;2020 Form 10-K&#8221;), federal, state and local governmental policies and initiatives designed to reduce the transmission of COVID-19 and emerging new variants may not effectively combat the severity and/or duration of the COVID-19 pandemic, and have resulted in a myriad of impacts on our businesses. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. Specific COVID-19 related impacts on the Company during the three and nine months ended September 30, 2021 and 2020 are further described below. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Care Benefits segment is expected to experience lower Medicare risk adjustment revenue and elevated medical costs during the fourth quarter, with non-COVID-19 related utilization returning towards baseline levels and continued COVID-19 related costs, largely related to treatment, testing and the administration of the vaccine. The Company also expects to incur higher operating expenses during the fourth quarter related to investments to support future growth and readiness for the start of the 2022 plan year.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy Services segment is expected to continue to benefit from our ability to drive improvements in purchasing economics and growth in specialty pharmacy, partially offset by continued price compression. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Retail/LTC segment is expected to continue to benefit from increased prescription volume and improved generic drug purchasing, partially offset by continued pharmacy reimbursement pressure. While COVID-19 vaccinations, diagnostic testing and over-the-counter (&#8220;OTC&#8221;) test kit sales are expected to continue for the remainder of 2021, we expect vaccinations to slow in the fourth quarter of the year. The extent of COVID-19 vaccinations and diagnostic testing will be dependent upon various factors including vaccine hesitancy, the emergence of new variants and the availability and administration of pediatric and booster vaccinations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company is expected to continue to benefit from its cost savings initiatives, including ongoing digitalization and technology improvements, a reduction in non-retail real estate associated with workforce management changes and initiatives to increase productivity and operational efficiency. The Company also expects to incur higher operating expenses during the fourth quarter related to incremental investments in compensation and benefits, including the increase in the minimum wage for store, warehouse and call center colleagues in support of its initiatives to retain and attract talent for its community health destinations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Results</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion explains the material changes in the Company&#8217;s operating results for the three and nine months ended September&#160;30, 2021 and 2020, and the significant developments affecting the Company&#8217;s financial condition since December&#160;31, 2020. We strongly recommend that you read our audited consolidated financial statements and notes thereto and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, which are included in the 2020 Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Consolidated Financial Results</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,<br/>2021 vs 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,<br/>2021 vs 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">149,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">73,794&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">67,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">215,507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">199,152&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,738&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">129,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">121,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">27,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">70,733&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,807&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">204,543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">187,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,778&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(423)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(52.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(52.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,545&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">120.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,206&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended September&#160;30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $6.7 billion, or 10.0%, in the three months ended September&#160;30, 2021 compared to the prior year driven by growth across all segments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the revenues of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $739 million, or 8.7%, in the three months ended September&#160;30, 2021 compared to the prior year. The increase in operating expenses was primarily due to incremental costs associated with growth in the business, including costs associated with the administration of COVID-19 vaccinations and diagnostic testing in the Retail/LTC segment, as well as the absence of a $271 million gain on the sale of the Workers&#8217; Compensation business recorded in the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended September&#160;30, 2020. The increase was partially offset by the repeal of the non-deductible health insurer fee (&#8220;HIF&#8221;) for 2021. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained relatively consistent at 12.5% and 12.6% in the three months ended September&#160;30, 2021 and September&#160;30, 2020, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating expenses of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income decreased $188 million, or 5.8%, in the three months ended September&#160;30, 2021 compared to the prior year primarily due to a $431 million goodwill impairment charge recorded in the Retail/LTC segment in the three months ended September&#160;30, 2021 (see Note 4 &#8216;&#8216;Goodwill&#8217;&#8217; to the unaudited condensed consolidated financial statements for additional information) and the absence of the $271 million gain on the sale of the Workers&#8217; Compensation business recorded in the three months ended September&#160;30, 2020. These decreases were partially offset by the administration of COVID-19 vaccinations and diagnostic testing and increased front store volume in the Retail/LTC segment, as well as improved purchasing economics and growth in specialty pharmacy in the Pharmacy Services segment during the three months ended September&#160;30, 2021.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating results of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense decreased $129 million, or 17.6%, in the three months ended September&#160;30, 2021 compared to the prior year due to lower debt in the three months ended September&#160;30, 2021. See &#8220;Liquidity and Capital Resources&#8221; later in this report for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on early extinguishment of debt</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the three months ended September&#160;30, 2021, the loss on early extinguishment of debt relates to the Company&#8217;s repayment of approximately $2.0&#160;billion of its outstanding senior notes pursuant to its tender offer for such notes in August 2021, which resulted in a loss on early extinguishment of debt of $363&#160;million. During the three months ended September&#160;30, 2020, the loss on early extinguishment of debt relates to the Company&#8217;s repayment of $6.0&#160;billion of its outstanding senior notes pursuant to its tender offers for such notes in August 2020, which resulted in a loss on early extinguishment of debt of $766&#160;million. See Note 6 &#8216;&#8216;Borrowings&#8217;&#8217; to the unaudited condensed consolidated financial statements for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effective income tax rate was 26.0% for the three months ended September&#160;30, 2021 compared to 32.5% for the three months ended September&#160;30, 2020. The decrease in the effective income tax rate was primarily due to the absence of the impact of the sale of the Workers&#8217; Compensation business in the three months ended September&#160;30, 2020 and the repeal of the non-deductible HIF for 2021.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Nine Months Ended September 30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $16.4 billion, or 8.2%, in the nine months ended September&#160;30, 2021 compared to the prior year driven by growth across all segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the revenues of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $1.3 billion, or 5.1%, in the nine months ended September&#160;30, 2021 compared to the prior year. The increase in operating expenses was primarily due to incremental costs associated with growth in the business, including costs associated with the administration of COVID-19 vaccinations and diagnostic testing in the Retail/LTC segment and the absence of the $271 million gain on the sale of the Workers&#8217; Compensation business in the nine months ended September&#160;30, 2020. The increase was partially offset by the repeal of the HIF for 2021 and the favorable impact of company-wide cost savings initiatives in 2021. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues were 12.5% in the nine months ended September&#160;30, 2021, a decrease of 40 basis points compared to the prior year. The decrease in operating expenses as a percentage of total revenues was primarily due to the increases in total revenues described above.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating expenses of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income decreased $423 million, or 3.7%, in the nine months ended September&#160;30, 2021 compared to the prior year. The decrease in operating income was primarily driven by higher COVID-19 related costs in the Health Care Benefits segment in the nine months ended September&#160;30, 2021 compared to the prior year, including the impact of the deferral of elective procedures and other discretionary utilization in response to the COVID-19 pandemic during the nine months ended September&#160;30, 2020, the $431 million goodwill impairment charge recorded in the Retail/LTC segment in the nine months ended September&#160;30, 2021 and the absence of the $271 million gain on the sale of the Workers&#8217; Compensation business in the nine months ended September&#160;30, 2020. These decreases were partially offset by improved purchasing economics and growth in specialty pharmacy in the Pharmacy Services segment, as well as the administration of COVID-19 vaccinations and diagnostic testing and increased front store volume in the Retail/LTC segment in the nine months ended September&#160;30, 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating results of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense decreased $334 million, or 15.0%, in the nine months ended September&#160;30, 2021 compared to the prior year due to lower debt in the nine months ended September&#160;30, 2021. See &#8220;Liquidity and Capital Resources&#8221; later in this report for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on early extinguishment of debt</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the nine months ended September&#160;30, 2021, the loss on early extinguishment of debt relates to the Company&#8217;s repayment of approximately $2.0&#160;billion of its outstanding senior notes pursuant to its tender offer for such notes in August 2021, which resulted in a loss on early extinguishment of debt of $363&#160;million. During the nine months ended September&#160;30, 2020, the loss on early extinguishment of debt relates to the Company&#8217;s repayment of $6.0&#160;billion of its outstanding senior notes pursuant to its tender offers for such notes in August 2020, which resulted in a loss on early extinguishment of debt of $766&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effective income tax rate was 25.4% for the nine months ended September&#160;30, 2021 compared to 27.2% for the nine months ended September&#160;30, 2020. The decrease in the effective income tax rate in the nine months ended September&#160;30, 2021 was primarily due to the repeal of the non-deductible HIF for 2021 and the absence of the impact of the sale of the Workers&#8217; Compensation business in the nine months ended September&#160;30, 2020.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Analysis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of segment operating results is presented based on the Company&#8217;s reportable segments in accordance with the accounting guidance for segment reporting and is consistent with the segment disclosure in Note 11 &#8216;&#8216;Segment Reporting&#8217;&#8217; to the unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,894)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(539)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $2.8 billion and $2.5 billion of retail co-payments for the three months ended  September&#160;30, 2021 and 2020, respectively, and $9.0 billion and $8.5 billion of retail co-payments for the nine months ended September&#160;30, 2021 and 2020, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income, as well as reconciliations of segment GAAP operating income to segment adjusted operating income:</span></div><div style="margin-bottom:0.3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(364)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss) </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,073&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.3pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.792%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.3pt"><span><br/></span></div><div style="margin-bottom:0.3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,118)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(523)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss) </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,502&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,035&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,166&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(523)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,165&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.3pt"><span><br/></span></div><div style="margin-bottom:0.3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.792%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(539)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,371&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(931)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(539)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,063&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September&#160;30, 2021 and 2020, acquisition-related integration costs relate to the Company&#8217;s acquisition (the &#8220;Aetna Acquisition&#8221;) of Aetna Inc. (&#8220;Aetna&#8221;). The acquisition-related integration costs are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September&#160;30, 2021, the goodwill impairment charge relates to the LTC reporting unit within the Retail/LTC segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September 30, 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations within the Health Care Benefits segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statement of operations for the nine months ended September&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s performance for the respective periods:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.949%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,<br/>2021 vs 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,<br/>2021 vs 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages and basis points (&#8220;bps&#8221;)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,959</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,165</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,869</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,699</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,186</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,324</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,479</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,698</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,487</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,364</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,260</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,416</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,971</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,816</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MBR </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,503</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,333</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,147</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,438</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,369</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,110</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,741)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,502</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,035</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenues (by business):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,903</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,181</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,717</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,626</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,056</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,984</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,152</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,073</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Health Care Benefits segment operating income (GAAP measure) to adjusted operating income, which represents the Company&#8217;s principal measure of segment performance.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended September&#160;30, 2021 vs. 2020</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $1.8 billion, or 9.5%, to $20.5 billion in the three months ended September&#160;30, 2021 compared to the prior year primarily driven by growth in the Government Services business, partially offset by the unfavorable impact of the repeal of the HIF for 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Ratio (&#8220;MBR&#8221;)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical benefit ratio is calculated as benefit costs divided by premium revenues and represents the percentage of premium revenues spent on medical benefits for the Company&#8217;s Insured members. Management uses MBR to assess the underlying business performance and underwriting of its insurance products, understand variances between actual results and expected results and identify trends in period-over-period results. MBR provides management and investors with information useful in assessing the operating results of the Company&#8217;s Insured Health Care Benefits products. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The MBR increased from 84.0% to 85.8% in the three months ended September&#160;30, 2021 compared to the prior year primarily driven by higher COVID-19 related costs, net of deferred care, in the three months ended September&#160;30, 2021 compared to the prior year and the repeal of the HIF for 2021. These increases were partially offset by higher favorable development of prior-periods&#8217; health care cost estimates in the three months ended September 30, 2021 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Health Care Benefits segment include selling, general and administrative expenses and depreciation and amortization expenses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $170 million, or 5.1%, in the three months ended September&#160;30, 2021 compared to the prior year. The increase in operating expenses was primarily due to the absence of the $271 million gain on the sale of the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Workers&#8217; Compensation business in the three months ended September&#160;30, 2020 and incremental operating expenses to support the growth in the Government Services business described above. These increases were partially offset by the repeal of the HIF for 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 17.1% in the three months ended September&#160;30, 2021 compared to 17.8% in the prior year. The decrease in operating expenses as a percentage of total revenues was primarily due to the repeal of the HIF for 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $26 million, or 2.4%, in the three months ended September&#160;30, 2021 compared to the prior year. The increase in adjusted operating income was primarily driven by improved performance in the underlying Government Services business, largely offset by higher COVID-19 related costs, net of deferred care, in the three months ended September&#160;30, 2021 compared to the prior year.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Nine Months Ended September 30, 2021 vs. 2020</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $5.1 billion, or 9.1%, to $61.5 billion in the nine months ended September&#160;30, 2021 compared to the prior year primarily driven by growth in the Government Services business, partially offset by the unfavorable impact of the repeal of the HIF for 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Ratio </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The MBR increased from 78.9% to 84.4% in the nine months ended September&#160;30, 2021 compared to the prior year primarily driven by higher COVID-19 related costs in the nine months ended September&#160;30, 2021 compared to the prior year, including the impact of the deferral of elective procedures and other discretionary utilization in response to the COVID-19 pandemic during the nine months ended September&#160;30, 2020, as well as the repeal of the HIF for 2021. These increases were partially offset by improved performance in the underlying Government Services business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses decreased $291 million, or 2.8%, in the nine months ended September&#160;30, 2021 compared to the prior year. The decrease in operating expenses was primarily due to the repeal of the HIF for 2021 and the impact of cost savings initiatives in the nine months ended September&#160;30, 2021. These decreases were partially offset by incremental operating expenses to support the growth in the Government Services business described above and the net impact of the sale of the Workers&#8217; Compensation business sold on July 31, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 16.5% in the nine months ended September&#160;30, 2021 compared to 18.5% in the prior year. The decrease in operating expenses as a percentage of total revenues was primarily due to the repeal of the HIF for 2021 and continued revenue growth described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income decreased $1.5 billion, or 25.4%, in the nine months ended September&#160;30, 2021 compared to the prior year. The decrease in adjusted operating income was primarily driven by higher COVID-19 related costs in the nine months ended September&#160;30, 2021 compared to the prior year, including the impact of the deferral of elective procedures and other discretionary utilization in response to the COVID-19 pandemic during the nine months ended September&#160;30, 2020. The decrease was partially offset by improved performance in the underlying Government Services business and the impact of cost savings initiatives in the nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s medical membership for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.203%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medical membership:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,902&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total medical membership</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">9,708&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,989&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">23,697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">9,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,992&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">23,510&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">9,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,267&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">23,412&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">8,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">23,270&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Supplemental membership information: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicare Prescription Drug Plan (standalone)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Membership</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership represents the number of members covered by the Company&#8217;s Insured and ASC medical products and related services at a specified point in time. Management uses this metric to understand variances between actual medical membership and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of medical membership on segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership as of September&#160;30, 2021 of 23.7 million increased 187,000 members compared with June&#160;30, 2021, reflecting increases across all product lines.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership as of September&#160;30, 2021 of 23.7 million increased 427,000 members compared with September&#160;30, 2020 primarily reflecting increases in the Medicare and Medicaid product lines, partially offset by a decline in the Commercial product line.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Update</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 15, 2021, the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) issued its final notice detailing final 2022 Medicare Advantage benchmark payment rates. Final 2022 Medicare Advantage rates resulted in an increase in industry benchmark rates of approximately 4.1%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA ties a portion of each Medicare Advantage plan&#8217;s reimbursement to the plan&#8217;s &#8220;star ratings.&#8221; Plans must have a star rating of four or higher (out of five) to qualify for bonus payments. CMS released the Company&#8217;s 2022 star ratings in October 2021. The Company&#8217;s 2022 star ratings will be used to determine which of the Company&#8217;s Medicare Advantage plans have ratings of four stars or higher and qualify for bonus payments in 2023. Based on the Company&#8217;s membership at September 1, 2021, 87% of the Company&#8217;s Medicare Advantage members were in plans with 2022 star ratings of at least 4.0 stars, compared to 83% of the Company&#8217;s Medicare Advantage members being in plans with 2021 star ratings of at least 4.0 stars based on the Company&#8217;s membership at September 1, 2020.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Pharmacy Services segment&#8217;s performance for the respective periods:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,<br/>2021 vs 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,<br/>2021 vs 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,739</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,461</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,816</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">865</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,046</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,681</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,335&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,925</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,809</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,714</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,583</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,730</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,564</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,949</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,035</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by distribution channel): </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,665</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,473</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,476</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,109</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,202</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,685</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,815</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims processed: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,662.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,575.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Pharmacy Services segment operating income (GAAP measure) to adjusted operating income, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended September&#160;30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $3.3 billion, or 9.3%, to $39.0 billion in the three months ended September&#160;30, 2021 compared to the prior year primarily driven by increased pharmacy claims volume, growth in specialty pharmacy and brand inflation, partially offset by continued price compression.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Pharmacy Services segment include selling, general and administrative expenses; depreciation and amortization expense; and expenses related to specialty retail pharmacies, which include store and administrative payroll, employee benefits and occupancy costs.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained relatively consistent at 1.0% and 0.9% in the three-month periods ended September&#160;30, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $154 million, or 9.5%, in the three months ended September&#160;30, 2021 compared to the prior year. The increase in adjusted operating income was primarily driven by improved purchasing economics which reflected increased contributions from the products and services of the Company&#8217;s group purchasing organization and specialty pharmacy (including pharmacy and/or administrative services for providers and Covered Entities). These increases were partially offset by continued price compression.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Pharmacy Services segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s efforts to (i)&#160;retain existing clients, (ii)&#160;obtain new business and (iii)&#160;maintain or improve the rebates, fees and/or discounts the Company receives from manufacturers, wholesalers and retail pharmacies continue to have an impact on adjusted operating income. In particular, competitive pressures in the PBM industry have caused the Company and other PBMs to continue to share with clients a larger portion of rebates, fees and/or discounts received from pharmaceutical manufacturers. In addition, marketplace dynamics and regulatory changes have limited the Company&#8217;s ability to offer plan sponsors pricing that includes retail network &#8220;differential&#8221; or &#8220;spread,&#8221; and the Company expects these trends to continue. The &#8220;differential&#8221; or &#8220;spread&#8221; is any difference between the drug price charged to plan sponsors, including Medicare Part&#160;D plan sponsors, by a PBM and the price paid for the drug by the PBM to the dispensing provider. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy claims processed</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total pharmacy claims processed represents the number of prescription claims processed through our pharmacy benefits manager and dispensed by either our retail network pharmacies or our own mail and specialty pharmacies. Management uses this metric to understand variances between actual claims processed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of pharmacy claim volume on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s pharmacy network claims processed on a 30-day equivalent basis increased 7.5% to 481.1 million claims in the three months ended September&#160;30, 2021 compared to 447.7 million claims in the prior year primarily driven by net new business, COVID-19 vaccinations and increased new therapy prescriptions, which were adversely impacted by the COVID-19 pandemic during the three months ended September&#160;30, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s mail choice claims processed on a 30-day equivalent basis increased 3.5% to 83.3 million claims in the three months ended September&#160;30, 2021 compared to 80.5 million claims in the prior year primarily driven by net new business and the continued adoption of Maintenance Choice offerings.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Excluding the impact of COVID-19 vaccinations, total pharmacy claims processed increased 5.3% on a 30-day equivalent basis for the three months ended September&#160;30, 2021 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Pharmacy Services segment&#8217;s generic drug prescriptions processed or filled by its total prescriptions processed or filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Pharmacy Services segment&#8217;s total generic dispensing rate decreased to 87.1% in the three months ended September&#160;30, 2021 compared to 87.9% in the prior year. The decrease in the segment&#8217;s generic dispensing rate was primarily driven by an increase in brand prescriptions, largely attributable to COVID-19 vaccinations in the three months ended September&#160;30, 2021. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate increased to 88.4% in the three months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Nine Months Ended September 30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $8.1 billion, or 7.7%, to $113.7 billion in the nine months ended September&#160;30, 2021 compared to the prior year primarily driven by increased pharmacy claims volume, growth in specialty pharmacy and brand inflation, partially offset by continued price compression.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained consistent at 1.0% in each of the nine-month periods ended September&#160;30, 2021 and 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $908 million, or 22.0% in the nine months ended September&#160;30, 2021 compared to the prior year. The increase in adjusted operating income was primarily driven by improved purchasing economics which reflected increased contributions from the products and services of the Company&#8217;s group purchasing organization that was launched in the second quarter of 2020 and specialty pharmacy (including pharmacy and/or administrative services for providers and Covered Entities), partially offset by continued price compression.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy claims processed</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The Company&#8217;s pharmacy network claims processed on a 30-day equivalent basis increased 6.1% to 1.4 billion claims in the nine months ended September&#160;30, 2021 compared to 1.3 billion claims in the prior year primarily driven by net new business and COVID-19 vaccinations. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The Company&#8217;s mail choice claims processed on a 30-day equivalent basis increased 2.3% to 246.7 million claims in the nine months ended September&#160;30, 2021 compared to 241.1 million claims in the prior year primarily driven by net new business and the continued adoption of Maintenance Choice offerings.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Excluding the impact of COVID-19 vaccinations, total pharmacy claims processed increased 3.8% on a 30-day equivalent basis for the nine months ended September&#160;30, 2021 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Pharmacy Services segment&#8217;s total generic dispensing rate decreased to 87.3% in the nine months ended September&#160;30, 2021 compared to 88.5% in the prior year. The decrease in the segment&#8217;s generic dispensing rate was primarily driven by an increase in brand prescriptions, largely attributable to COVID-19 vaccinations in the nine months ended September&#160;30, 2021. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate increased to 88.8% in the nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Retail/LTC segment&#8217;s performance for the respective periods:</span></div><div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,<br/>2021 vs 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,<br/>2021 vs 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,971</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,424</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,974</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,422</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,992</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,725</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,994</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,136</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,381</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,899</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,375</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,697</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,543</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,839</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,443</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,283</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,349</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,996</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,166</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,371</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by major goods/service lines):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,608</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,781</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,833</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,359</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,255</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,601</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescriptions filled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same store sales increase: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Retail/LTC segment operating income (GAAP measure) to adjusted operating income, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Same store sales and prescription volume represent the change in revenues and prescriptions filled in the Company&#8217;s retail pharmacy stores that have been operating for greater than one year, expressed as a percentage that indicates the increase or decrease relative to the comparable prior period. Same store metrics exclude revenues from MinuteClinic, revenues and prescriptions from LTC operations. Management uses these metrics to evaluate the performance of existing stores on a comparable basis and to inform future decisions regarding existing stores and new locations. Same-store metrics provide management and investors with information useful&#160;in understanding the portion of current revenues and prescriptions resulting from organic growth in existing locations versus the portion resulting from opening new stores.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended September&#160;30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $2.3 billion, or 10.0%, to $25.0 billion in the three months ended September&#160;30, 2021 compared to the prior year primarily driven by the administration of COVID-19 vaccinations and diagnostic testing, increased prescription and front store volume, both of which were adversely impacted by the COVID-19 pandemic during the three months ended September&#160;30, 2020, as well as brand inflation. These increases were partially offset by continued pharmacy </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reimbursement pressure and the impact of recent generic introductions. COVID-19 vaccinations, diagnostic testing and OTC test kit sales contributed approximately 40% of the increase in the segment&#8217;s revenues for the three months ended September&#160;30, 2021 compared to the prior year, as the prior year reflected the ongoing expansion of the Company&#8217;s diagnostic testing program which began in April 2020 and no COVID-19 vaccinations or OTC test kit sales.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy same store sales increased 8.8% in the three months ended September&#160;30, 2021 compared to the prior year. The increase was primarily driven by the 9.0% increase in pharmacy same store prescription volume on a 30-day equivalent basis and brand inflation. These increases were partially offset by continued pharmacy reimbursement pressure and the impact of recent generic introductions.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Front store same store sales increased 12.3% in the three months ended September&#160;30, 2021 compared to the prior year. The increase was primarily due to reduced customer traffic in the segment&#8217;s retail pharmacies as a result of the COVID-19 pandemic in the three months ended September&#160;30, 2020 as well as strength in consumer health sales, including the sale of OTC test kits, in the three months ended September&#160;30, 2021. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other revenues increased $266 million in the three months ended September&#160;30, 2021 compared to the prior year. The increase was primarily due to increased COVID-19 diagnostic testing in the three months ended September&#160;30, 2021, partially offset by the absence of revenues associated with the fulfillment of consumer health product boxes to support the Health Care Benefits segment&#8217;s Medicare members in response to the COVID-19 pandemic in the three months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the three months ended September&#160;30, 2021, the Company recorded a $431 million goodwill impairment charge related to the LTC reporting unit within the Retail/LTC segment. See Note 4 &#8216;&#8216;Goodwill&#8217;&#8217; to the unaudited condensed consolidated financial statements for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Retail/LTC segment include store payroll, store employee benefits, store occupancy costs, selling expenses, advertising expenses, depreciation and amortization expense and certain administrative expenses. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $472 million, or 10.4%, in the three months ended September&#160;30, 2021 compared to the prior year. The increase was primarily due to incremental costs associated with increased volume including COVID-19 vaccinations and diagnostic testing, as well as increased investments in the segment&#8217;s capabilities and colleague compensation and benefits. These increases were partially offset by the impact of cost savings initiatives in the three months ended September&#160;30, 2021 and the absence of incremental expenses associated with the Company&#8217;s COVID-19 pandemic mitigation efforts incurred in the three months ended September&#160;30, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained relatively consistent at 20.1% and 20.0% in the three-month periods ended September&#160;30, 2021 and September&#160;30, 2020, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $311 million, or 22.0% in the three months ended September&#160;30, 2021 compared to the prior year. The increase in adjusted operating income was primarily driven by the administration of COVID-19 vaccinations and diagnostic testing, the increased prescription and front store volume described above and improved generic drug purchasing. These increases were partially offset by continued pharmacy reimbursement pressure and investments in the segment&#8217;s capabilities and colleague compensation and benefits.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Retail/LTC segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The segment&#8217;s adjusted operating income benefited from the administration of COVID-19 vaccinations, diagnostic testing and OTC test kit sales which contributed approximately one-third of the segment&#8217;s adjusted operating income for the three months ended September&#160;30, 2021.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The segment&#8217;s adjusted operating income has been adversely affected by the efforts of managed care organizations, PBMs and governmental and other third-party payors to reduce their prescription drug costs, including the use of restrictive networks, as well as changes in the mix of business within the pharmacy portion of the Retail/LTC segment. If the pharmacy reimbursement pressure accelerates, the segment may not be able grow revenues, and its adjusted operating income could be adversely affected.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The increased use of generic drugs has positively impacted the segment&#8217;s adjusted operating income but has resulted in third-party payors augmenting their efforts to reduce reimbursement payments to retail pharmacies for prescriptions. This trend, which the Company expects to continue, reduces the benefit the segment realizes from brand to generic drug conversions.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prescriptions filled</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled represents the number of prescriptions dispensed through the Retail/LTC segment&#8217;s pharmacies. Management uses this metric to understand variances between actual prescriptions dispensed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of prescription volume on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Prescriptions filled increased 8.0% on a 30-day equivalent basis in the three months ended September&#160;30, 2021 compared to the prior year primarily driven by COVID-19 vaccinations, as well as the continued adoption of patient care programs and increased new therapy prescriptions, both of which were adversely impacted by the COVID-19 pandemic during the three months ended September&#160;30, 2020. Excluding the impact of COVID-19 vaccinations, prescriptions filled increased 4.9% on a 30-day equivalent basis for the three months ended September&#160;30, 2021 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Retail/LTC segment&#8217;s generic drug prescriptions filled by its total prescriptions filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Retail/LTC segment&#8217;s generic dispensing rate decreased to 86.6% in the three months ended September&#160;30, 2021 compared to 87.7% in the prior year. The decrease in the segment&#8217;s generic dispensing rate was primarily driven by an increase in brand prescriptions, largely attributable to COVID-19 vaccinations in the three months ended September&#160;30, 2021. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate increased to 89.1% in the three months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Nine Months Ended September 30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $5.9 billion, or 8.7%, to $73.0 billion in the nine months ended September&#160;30, 2021 compared to the prior year primarily driven by the administration of COVID-19 vaccinations and diagnostic testing, increased prescription and front store volume and brand inflation. These increases were partially offset by continued pharmacy reimbursement pressure and the impact of recent generic introductions. COVID-19 vaccinations, diagnostic testing and OTC test kit sales contributed approximately 45% of the increase in the segment&#8217;s revenues for the nine months ended September&#160;30, 2021, as the prior year reflected the ongoing expansion of the Company&#8217;s diagnostic testing program which began in April 2020 and no COVID-19 vaccinations or OTC test kit sales.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy same store sales increased 8.4% in the nine months ended September&#160;30, 2021 compared to the prior year. The increase was primarily driven by the 8.1% increase in pharmacy same store prescription volume on a 30-day equivalent basis and brand inflation. These increases were partially offset by continued pharmacy reimbursement pressure and the impact of recent generic introductions. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Front store same store sales increased 3.7% in the nine months ended September&#160;30, 2021 compared to the prior year. The increase was primarily due to strength in consumer health, including the sale of OTC test kits, and beauty care sales in the nine months ended September&#160;30, 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other revenues increased $1.2 billion in the nine months ended September&#160;30, 2021 compared to the prior year. The increase was primarily due to increased COVID-19 diagnostic testing in the nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the nine months ended September&#160;30, 2021, the Company recorded a $431 million goodwill impairment charge related to the LTC reporting unit within the Retail/LTC segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $1.4 billion, or 10.4%, in the nine months ended September&#160;30, 2021 compared to the prior year. The increase was primarily due to incremental costs associated with increased volume including COVID-19 vaccinations and diagnostic testing. These increases were partially offset by the absence of incremental expenses associated with the Company&#8217;s initial COVID-19 pandemic mitigation efforts incurred in the nine months ended September&#160;30, 2020 and the impact of cost savings initiatives in the nine months ended September&#160;30, 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues increased to 20.3% in the nine months ended September&#160;30, 2021 compared to 20.0% in the prior year. The increase in operating expenses as a percentage of total revenues was primarily driven by the increases in operating expenses described above.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $795 million, or 18.2% in the nine months ended September&#160;30, 2021 compared to the prior year. The increase in adjusted operating income was primarily driven by the administration of COVID-19 vaccinations and diagnostic testing, the increased prescription and front store volume described above and improved generic drug purchasing. These increases were partially offset by continued pharmacy reimbursement pressure. COVID-19 vaccinations, diagnostic testing and OTC test kit sales contributed approximately 25% of the segment&#8217;s adjusted operating income for the nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prescriptions filled</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Prescriptions filled increased 7.2% on a 30-day equivalent basis in the nine months ended September&#160;30, 2021 compared to the prior year primarily driven by COVID-19 vaccinations, as well as the continued adoption of patient care programs and increased new therapy prescriptions, both of which were adversely impacted by the COVID-19 pandemic during the nine months ended September&#160;30, 2020. Excluding the impact of COVID-19 vaccinations, prescriptions filled increased 3.7% on a 30-day equivalent basis for the nine months ended September&#160;30, 2021 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Retail/LTC segment&#8217;s generic dispensing rate decreased to 86.6% in the nine months ended September&#160;30, 2021 compared to 88.7% in the prior year. The decrease in the segment&#8217;s generic dispensing rate was primarily driven by an increase in brand prescriptions, largely attributable to COVID-19 vaccinations in the nine months ended September&#160;30, 2021. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate increased to 89.4% in the nine months ended September&#160;30, 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Corporate/Other segment&#8217;s performance for the respective periods:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,<br/>2021 vs 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,<br/>2021 vs 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(364)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,118)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(931)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Corporate/Other segment operating loss (GAAP measure) to adjusted operating loss, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended September&#160;30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues primarily relate to products for which the Company no longer solicits or accepts new customers, such as large case pensions and long-term care insurance products.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $55 million, or 47.4%, to $171 million in the three months ended September&#160;30, 2021 compared to the prior year primarily driven by higher net investment income, largely related to private equity investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating loss </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating loss increased $40 million in the three months ended September&#160;30, 2021 compared to the prior year. The increase was primarily driven by higher employee benefit costs and incremental operating expenses associated with the Company&#8217;s investments in transformation, partially offset by the increase in net investment income in the three months ended September&#160;30, 2021 described above.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Nine Months Ended September 30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $196 million, or 67.1%, to $488 million in the nine months ended September&#160;30, 2021 compared to the prior year primarily driven by higher net investment income, largely related to private equity investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating loss </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating loss increased $84 million in the nine months ended September&#160;30, 2021 compared to the prior year. The increase was primarily driven by higher employee benefit costs and incremental operating expenses associated with the Company&#8217;s investments in transformation, partially offset by the increase in net investment income in the nine months ended September&#160;30, 2021 described above.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a level of liquidity sufficient to allow it to meet its cash needs in the short-term. Over the long term, the Company manages its cash and capital structure to maximize shareholder return, maintain its financial condition and maintain flexibility for future strategic initiatives. The Company continuously assesses its regulatory capital requirements, working capital needs, debt and leverage levels, debt maturity schedule, capital expenditure requirements, dividend payouts, potential share repurchases and future investments or acquisitions. The Company believes its operating cash flows, commercial paper program, credit facilities, as well as any potential future borrowings, will be sufficient to fund these future payments and long-term initiatives. As of September&#160;30, 2021, the Company had approximately $9.8 billion in cash and cash equivalents, approximately $3.6 billion of which was held by the parent company or nonrestricted subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in cash, cash equivalents and restricted cash during the nine months ended September&#160;30, 2021 and 2020 was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,260&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,420)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,914&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,578&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,664)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash provided by operating activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $2.0 billion in the nine months ended September&#160;30, 2021 compared to the prior year. The increase was primarily due to the timing of payments and higher operating income in the Retail/LTC segment. The increase was partially offset by reduced benefit costs due to the deferral of elective procedures and other discretionary utilization in the Health Care Benefits segment as a result of the COVID-19 pandemic, which favorably impacted operating cash flows in the nine months ended September&#160;30, 2020 and did not recur during the current year.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in investing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased by $479 million in the nine months ended September&#160;30, 2021 compared to the prior year primarily due to a decrease in cash used for acquisitions and decreased net purchases of investments and property and equipment in the nine months ended September&#160;30, 2021, partially offset by the absence of $834 million in proceeds from the sale of the Workers&#8217; Compensation business in the nine months ended September&#160;30, 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in financing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $8.5 billion in the nine months ended September&#160;30, 2021 compared to net cash used in financing activities of $4.4 billion in the prior year. The increase in cash used in financing activities primarily related to an increase in net repayments of long-term debt during the nine months ended September&#160;30, 2021 compared to the prior year. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any commercial paper outstanding as of September&#160;30, 2021. In connection with its commercial paper program, the Company maintains a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 17, 2023, a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May&#160;16, 2024, and a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 11, 2026. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately 0.03%, regardless of usage. As of September&#160;30, 2021, there were no borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary of the Company is a member of the Federal Home Loan Bank of Boston (the &#8220;FHLBB&#8221;). As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of September&#160;30, 2021 was approximately $1.0 billion. As of September&#160;30, 2021, there were no outstanding advances from the FHLBB.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 18, 2021, the Company issued $1.0&#160;billion aggregate principal amount of 2.125% unsecured senior notes due September 15, 2031 for total proceeds of $987&#160;million, net of discounts, underwriting fees and offering expenses. The net proceeds of this offering were used for the purchase of senior notes in connection with the Company&#8217;s cash tender offer in August 2021 as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company purchased approximately $2.0&#160;billion of its outstanding 4.3% senior notes due 2028 through a cash tender offer. In connection with the purchase of such senior notes, the Company paid a premium of $332&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $26&#160;million of unamortized deferred financing costs and incurred $5&#160;million in fees, for a total loss on early extinguishment of debt of $363&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities and unsecured senior notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities in the event of a downgrade in the Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of September&#160;30, 2021, the Company was in compliance with all of its debt covenants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company&#8217;s long-term debt was rated &#8220;Baa2&#8221; by Moody&#8217;s Investor Service, Inc. (&#8220;Moody&#8217;s&#8221;) and &#8220;BBB&#8221; by Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;), and its commercial paper program was rated &#8220;P-2&#8221; by Moody&#8217;s and &#8220;A-2&#8221; by S&amp;P. The outlook on the Company&#8217;s long-term debt is &#8220;Stable&#8221; by Moody&#8217;s and &#8220;Positive&#8221; by S&amp;P. In assessing the Company&#8217;s credit strength, the Company believes that both Moody&#8217;s and S&amp;P considered, among other things, the Company&#8217;s capital structure and financial policies as well as its consolidated balance sheet, its historical acquisition activity and other financial information. Although the Company currently believes its long-term debt ratings will remain investment grade, it cannot guarantee the future actions of Moody&#8217;s and/or S&amp;P. The Company&#8217;s debt ratings have a direct impact on its future borrowing costs, access to capital markets and new store operating lease costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021 and 2020, the Company did not repurchase any shares of common stock. See Note 7 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; to the unaudited condensed consolidated financial statements for additional information on the Company&#8217;s share repurchase program.</span></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles, which require management to make certain estimates and apply judgment. Estimates and judgments are based on historical experience, current trends and other factors that management believes to be important at the time the unaudited condensed consolidated financial statements are prepared. On a regular basis, the Company reviews its accounting policies and how they are applied and disclosed in the unaudited condensed consolidated financial statements. While the Company believes the historical experience, current trends and other factors considered by management support the preparation of the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles, actual results could differ from estimates, and such differences could be material.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recoverability of Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company performed its required annual impairment test of goodwill. The results of the impairment tests indicated an impairment of the goodwill associated with the LTC reporting unit, as the reporting unit&#8217;s carrying value exceeded its fair value as of the testing date. The results of the impairment tests of the remaining reporting units indicated that there was no impairment of goodwill as of the testing date. The fair values of the reporting units with goodwill exceeded their carrying values by significant margins, with the exception of the Commercial Business reporting unit, which exceeded its carrying value by approximately 3%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the reporting units is estimated using a combination of a discounted cash flow method and a market multiple method. The determination of the fair value of the reporting units requires the Company to make significant assumptions and estimates. These assumptions and estimates primarily include the selection of appropriate peer group companies; control premiums and valuation multiples appropriate for acquisitions in the industries in which the Company competes; discount rates; terminal growth rates; and forecasts of revenue, operating income, depreciation and amortization, income taxes, capital expenditures and future working capital requirements. When determining these assumptions and preparing these estimates, the Company considers each reporting unit&#8217;s historical results and current operating trends; consolidated revenues, profitability and cash flow results and forecasts; and industry trends. The Company&#8217;s estimates can be affected by a number of factors, including general economic and regulatory conditions; the risk-free interest rate environment; the Company&#8217;s market capitalization; efforts of customers and payers to reduce costs, including their prescription drug costs, and/or increase member co-payments; the continued efforts of competitors to gain market share, consumer spending patterns and the Company&#8217;s ability to achieve its revenue growth projections and execute on its cost reduction initiatives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the LTC reporting unit has continued to face challenges that have impacted the Company&#8217;s ability to grow the LTC reporting unit&#8217;s business at the rate estimated when its 2020 goodwill impairment test was performed. These challenges include lower net facility admissions, net long-term care facility customer losses and the prolonged adverse impact of the COVID-19 pandemic and the emerging new variants, which resulted in more significant declines in occupancy rates experienced by the Company&#8217;s long-term care facility customers than previously anticipated. During the third quarter of 2021, LTC management updated their 2021 annual forecast and submitted their long-term plan which showed deterioration in the financial results for the remainder of 2021 and beyond. The Company utilized these updated projections in performing its annual impairment test, which indicated that the fair value of the LTC reporting unit was lower than its carrying value, resulting in a $431&#160;million goodwill impairment charge in the third quarter of 2021. The fair value of the LTC reporting unit was determined using a combination of a discounted cash flow method and a market multiple method.  As of September&#160;30, 2021, there was no remaining goodwill balance in the LTC reporting unit.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has experienced declines in its Commercial Insured medical membership subsequent to the closing date of the Aetna Acquisition and may continue to do so for a number of reasons, including as a result of the competitive Commercial business environment. In addition, COVID-19 and the emerging new variants have had and may continue to have an adverse impact on medical membership in the Commercial business due to reductions in workforce at existing customers (including due to business failures) as well as reduced willingness to change benefit providers by prospective customers. The Company&#8217;s fair value estimate is sensitive to significant assumptions including changes in medical membership, revenue growth rate, operating income and the discount rate. Although the Company believes the financial projections used to determine the fair value of the Commercial Business reporting unit in the third quarter of 2021 were reasonable and achievable, the challenges described above may affect the Company&#8217;s ability to increase medical membership or operating income in the Commercial Business reporting unit at the rate estimated when such goodwill impairment test was performed and may continue to do so. As of September 30, 2021, the goodwill balance in the Commercial Business reporting unit was $26.5 billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a full description of the Company&#8217;s other critical accounting policies, see &#8220;Critical Accounting Policies&#8221; in Item 7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; of the 2020 Form 10-K.</span></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement Concerning Forward-Looking Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Private Securities Litigation Reform Act of 1995 (the &#8220;Reform Act&#8221;) provides a &#8220;safe harbor&#8221; for forward-looking statements, so long as (1) those statements are identified as forward-looking and (2) the statements are accompanied by meaningful cautionary statements that identify important factors that could cause actual results to differ materially from those discussed in the statement. We want to take advantage of these safe harbor provisions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain information contained in this Quarterly Report on Form 10-Q (this &#8220;report&#8221;) is forward-looking within the meaning of the Reform Act or SEC rules. This information includes, but is not limited to the forward-looking information in Management&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) included in Part I, Item 2 of this report. In addition, throughout this report and our other reports and communications, we use the following words or variations or negatives of these words and similar expressions when we intend to identify forward-looking statements:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Anticipates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Believes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Can</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Continue</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Could</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Estimates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Evaluate</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Expects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Explore</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Forecast</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Guidance</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Intends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Likely</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">May</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Might</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Outlook</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Potential</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Predict</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Probable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Projects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Seeks</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Should</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">View</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Will</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">All statements addressing the future operating performance of CVS Health or any segment or any subsidiary and/or future events or developments, including statements relating to the projected impact of COVID-19 on the Company&#8217;s businesses, investment portfolio, operating results, cash flows and/or financial condition, statements relating to corporate strategy, statements relating to future revenue, operating income or adjusted operating income, earnings per share or adjusted earnings per share, Health Care Benefits segment business, sales results and/or trends, medical cost trends, medical membership, Medicare Part D membership, medical benefit ratios and/or operations, Pharmacy Services segment business, sales results and/or trends and/or operations, Retail/LTC segment business, sales results and/or trends and/or operations, incremental investment spending, interest expense, effective tax rate, weighted-average share count, cash flow from operations, net capital expenditures, cash available for debt repayment, integration synergies, net synergies, integration costs, enterprise modernization, transformation, leverage ratio, cash available for enhancing shareholder value, inventory reduction, turn rate and/or loss rate, debt ratings, the Company&#8217;s ability to attract or retain customers and clients, store development and/or relocations, new product development, and the impact of industry and regulatory developments as well as statements expressing optimism or pessimism about future operating results or events, are forward-looking statements within the meaning of the Reform Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-looking statements rely on a number of estimates, assumptions and projections concerning future events, and are subject to a number of significant risks and uncertainties and other factors that could cause actual results to differ materially from those statements. Many of these risks and uncertainties and other factors are outside our control. Certain of these risks and uncertainties and other factors are described under &#8220;Risk Factors&#8221; included in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and under &#8220;Risk Factors&#8221; included in Part II, Item 1A of this report; these are not the only risks and uncertainties we face. There can be no assurance that the Company has identified all the risks that affect it. Additional risks and uncertainties not presently known to the Company or that the Company currently believes to be immaterial also may adversely affect the Company&#8217;s businesses. If any of those risks or uncertainties develops into actual events, those events or circumstances could have a material adverse effect on the Company&#8217;s businesses, operating results, cash flows, financial condition and/or stock price, among other effects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should not put undue reliance on forward-looking statements. Any forward-looking statement speaks only as of the date of this report, and we disclaim any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.</span></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_103"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has not experienced any material changes in exposures to market risk since December 31, 2020. See the information contained in Part II, Item 7A &#8220;Quantitative and Qualitative Disclosures About Market Risk&#8221; of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 for a discussion of the Company&#8217;s exposures to market risk. </span></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_106"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures (as defined in Securities Exchange Act Rules&#160;13a&#8209;15(f) and 15d&#8209;15(f)) as of September&#160;30, 2021, have concluded that as of such date the Company&#8217;s disclosure controls and procedures were adequate and effective and designed to provide reasonable assurance that material information relating to the Company and its subsidiaries would be made known to such officers on a timely basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in internal control over financial reporting:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There has been no change in the Company&#8217;s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 that </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">occurred in the three months ended&#160;September&#160;30, 2021 that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_109"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:40.36pt">Other Information</span></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_112"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in Note 10 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; contained in &#8220;Notes to Condensed Consolidated Financial Statements (Unaudited)&#8221; in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated by reference herein. </span></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_115"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:34.8pt">Risk Factors</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information supplements the risk factors described in Part I, Item 1A of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the &#8220;2020 10-K&#8221;) and should be read in conjunction with the risk factors described in the 2020 10-K. Together, these risk factors could adversely affect the Company&#8217;s businesses, operating results, cash flows and/or financial condition as well as the market price of the Company&#8217;s common shares.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We can provide no assurance that we will be able to compete successfully on individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) or that our pricing or other actions will result in the profitability of our Public Exchange products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have submitted our regulatory filings for a January 2022 entrance into the Public Exchanges in eight states and have begun the open enrollment period. To compete effectively on Public Exchanges, we have developed or acquired the technology, systems, tools and talent necessary to interact with Public Exchanges and engage Public Exchange consumers through enhanced consumer-focused sales and marketing channels and customer interfaces. We have also created new customer service programs and product offerings. While participating on the Public Exchanges, we will have to respond to pricing and other actions taken by existing competitors and regulators as well as potentially disruptive new entrants which could reduce our profit margins. Due to the price transparency provided by Public Exchanges, when we market products we face competitive pressures from existing and new competitors who may have lower cost structures. Our competitors may bring their Public Exchange and other consumer products to market more quickly, have greater experience marketing to consumers and/or may be targeting the higher margin portions of our business. We can provide no assurance that we will be able to compete successfully or profitably on Public Exchanges or that we will be able to benefit from any opportunities presented by Public Exchanges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there can be no assurance that our pricing or other actions will result in the profitability of our Public Exchange products in 2022 or any future year. We have set 2022 premium rates for our Public Exchange products based on our projections, including as to the health status and quantity of membership and utilization of medical and/or other covered services by members. The accuracy of the projections reflected in our pricing may be impacted by (i) adverse selection among individuals who require or utilize more expensive medical and/or other covered services, (ii) other plans&#8217; withdrawals from participation in the Public Exchanges we serve and (iii) legislation, regulations, enforcement activity and/or judicial decisions that cause Public Exchanges to operate in a manner different than what we projected in setting our premium rates.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_7">Form 10-Q Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Stock Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total number of shares purchased in the three months ended September&#160;30, 2021, the average price paid per share and the approximate dollar value of shares that still could have been purchased at the end of the applicable fiscal period, pursuant to the share repurchase program authorized by CVS Health Corporation&#8217;s Board of Directors on November 2, 2016. See Note 7 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; contained in &#8220;Notes to Condensed Consolidated Financial Statements (Unaudited)&#8221; in Part I, Item 1 of this Quarterly Report on Form&#160;10-Q for additional information.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Fiscal&#160;Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total&#160;Number<br/>of&#160;Shares<br/>Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Average<br/>Price&#160;Paid&#160;per<br/>Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of&#160;Shares<br/>Purchased&#160;as&#160;Part&#160;of<br/>Publicly&#160;Announced<br/>Plans&#160;or&#160;Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Approximate&#160;Dollar<br/>Value&#160;of&#160;Shares&#160;that<br/>May&#160;Yet&#160;Be<br/>Purchased&#160;Under&#160;the<br/>Plans&#160;or&#160;Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2021 through July 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,869,392,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2021 through August 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,869,392,446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2021 through September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,869,392,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mine Safety Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_7">Form 10-Q Table of Contents</a></span></div></div><div><span><br/></span></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_130"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed in this Item 6 are filed as part of this Quarterly Report on Form 10-Q. Exhibits marked with an asterisk (*) are management contracts or compensatory plans or arrangements. Exhibits other than those listed are omitted because they are not required to be listed or are not applicable. Pursuant to Item 601(b)(4)(iii) of Regulation S-K, the Registrant hereby agrees to furnish to the Securities and Exchange Commission a copy of any omitted instrument that is not required to be listed. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO EXHIBITS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Instruments defining the rights of security holders, including indentures </span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000064803/000119312521250356/d209728dex41.htm">Form of the Registrant</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000064803/000119312521250356/d209728dex41.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000064803/000119312521250356/d209728dex41.htm">s 2031 Note (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on August 18, 2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000064803/000119312521250356/d209728dex41.htm">)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000064803/000119312521250356/d209728dex41.htm">.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000064803/000119312521250356/d209728dex41.htm"> </a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Letter re: unaudited interim financial information</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09302021ex151.htm">Letter from Ernst &amp; Young LLP acknowledging awareness of the use of a report dated November 3, 2021 related to their reviews of interim financial information.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rule 13a-14(a)/15d-14(a) Certifications</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09302021ex311.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09302021ex312.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Section 1350 Certifications</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09302021ex321.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09302021ex322.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the CVS Health Corporation Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2021 formatted in Inline XBRL: (i) the Condensed Consolidated Statements of Operations, (ii) the Condensed Consolidated Statements of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Cash Flows, (v) the Condensed Consolidated Statements of Shareholders&#8217; Equity and (vi) the related Notes to Condensed Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2021, formatted in Inline XBRL (included as Exhibit 101).</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="i42a2ed4f4e484cdcb79747a1eeca0c55_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i42a2ed4f4e484cdcb79747a1eeca0c55_7">Form 10-Q Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CVS HEALTH CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Shawn M. Guertin</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shawn M. Guertin</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>2
<FILENAME>a09302021ex151.htm
<DESCRIPTION>EX-15.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i487c9e8c492e4b9a8fd1dc6ccbd9d02f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 15.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Letter re&#58; Unaudited Interim Financial Information</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">November&#160;3, 2021 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We are aware of the incorporation by reference in the Registration Statements (Form S-3ASR No. 333-238506 and Form S-8 Nos. 333-238507, 333-230035, 333-228622, 333-167746, 333-217853, 333-208805, 333-141481, 333-139470, 333-63664, 333-91253, 333-49407, 333-34927, and 333-28043) of CVS Health Corporation of our report dated November&#160;3, 2021, relating to the unaudited condensed consolidated interim financial statements of CVS Health Corporation that is included in its Form 10-Q for the quarter ended September&#160;30, 2021.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Boston, Massachusetts</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>a09302021ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3de4217aa1c6444fbd166248a0901976_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen S. Lynch, President and Chief Executive Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of CVS Health Corporation&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:10pt;margin-top:8pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;&#160;KAREN S. LYNCH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karen S. Lynch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>a09302021ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ica72b1cec63a4f65be4ad89c881b6190_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Shawn M. Guertin, Executive Vice President and Chief Financial Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of CVS Health Corporation&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;&#160;SHAWN M. GUERTIN</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shawn M. Guertin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>a09302021ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib6caafe5dc2b4d31922c5f98b9792003_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report of CVS Health Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2021 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen S. Lynch, President and Chief Executive Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:10pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;KAREN S. LYNCH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karen S. Lynch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>a09302021ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i8f166e9fea2f47d3a4997590dffb69d8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report of CVS Health Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2021 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="margin-top:5pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Shawn M. Guertin, Executive Vice President and Chief Financial Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;SHAWN M. GUERTIN</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shawn M. Guertin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial&#160;Officer</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>cvs-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:25115a76-675c-4824-88fb-08e9720b17d2,g:63def5ee-f256-409d-94db-fc3f10f96be5-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cvshealth.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cvshealth.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited">
        <link:definition>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>1004005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited_1" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquityUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquityParentheticals" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesTables" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404401 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails">
        <link:definition>2405402 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesAccountsReceivableDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails">
        <link:definition>2406403 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDisaggregationofRevenueDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails">
        <link:definition>2407404 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails">
        <link:definition>2408405 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesContractBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails">
        <link:definition>2409406 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.cvshealth.com/role/Investments">
        <link:definition>2110102 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.cvshealth.com/role/InvestmentsTables">
        <link:definition>2311302 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTotalInvestmentScheduleDetails" roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails">
        <link:definition>2412407 - Disclosure - Investments - Total Investment Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails">
        <link:definition>2413408 - Disclosure - Investments - Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesbyMaturityDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails">
        <link:definition>2414409 - Disclosure - Investments - Debt Securities by Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails">
        <link:definition>2415410 - Disclosure - Investments - Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionMaturitiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails">
        <link:definition>2416411 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails">
        <link:definition>2417412 - Disclosure - Investments - Mortgage Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansCreditRatingsIndicatorDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
        <link:definition>2418413 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNetInvestmentIncomeDetails" roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails">
        <link:definition>2419414 - Disclosure - Investments - Net Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsRealizedGainsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails">
        <link:definition>2420415 - Disclosure - Investments - Realized Gains (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.cvshealth.com/role/FairValue">
        <link:definition>2121103 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.cvshealth.com/role/FairValueTables">
        <link:definition>2322303 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementonaRecurringBasisDetails" roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails">
        <link:definition>2423416 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueCarryingValueandFairValueClassifiedbyLevelDetails" roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
        <link:definition>2424417 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueSeparateAccountsFairValueDetails" roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails">
        <link:definition>2425418 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.cvshealth.com/role/Goodwill">
        <link:definition>2126104 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesTables" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables">
        <link:definition>2327304 - Disclosure - Goodwill and Other Intangibles (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesNarrativeDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails">
        <link:definition>2428419 - Disclosure - Goodwill and Other Intangibles - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesGoodwillDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails">
        <link:definition>2429420 - Disclosure - Goodwill and Other Intangibles - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayable" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable">
        <link:definition>2130105 - Disclosure - Health Care Costs Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableTables" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables">
        <link:definition>2331305 - Disclosure - Health Care Costs Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails">
        <link:definition>2432421 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableNarrativeDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails">
        <link:definition>2433422 - Disclosure - Health Care Costs Payable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Borrowings" roleURI="http://www.cvshealth.com/role/Borrowings">
        <link:definition>2134106 - Disclosure - Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsTables" roleURI="http://www.cvshealth.com/role/BorrowingsTables">
        <link:definition>2335306 - Disclosure - Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsScheduleofBorrowingsDetails" roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails">
        <link:definition>2436423 - Disclosure - Borrowings - Schedule of Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsNarrativeDetails" roleURI="http://www.cvshealth.com/role/BorrowingsNarrativeDetails">
        <link:definition>2437424 - Disclosure - Borrowings - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cvshealth.com/role/ShareholdersEquity">
        <link:definition>2138107 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityDetails">
        <link:definition>2439425 - Disclosure - Shareholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncome" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome">
        <link:definition>2140108 - Disclosure - Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeTables" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables">
        <link:definition>2341307 - Disclosure - Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeDetails" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails">
        <link:definition>2442426 - Disclosure - Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.cvshealth.com/role/EarningsPerShare">
        <link:definition>2143109 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.cvshealth.com/role/EarningsPerShareTables">
        <link:definition>2344308 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails">
        <link:definition>2445427 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies">
        <link:definition>2146110 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2447428 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.cvshealth.com/role/SegmentReporting">
        <link:definition>2148111 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.cvshealth.com/role/SegmentReportingTables">
        <link:definition>2349309 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails">
        <link:definition>2450429 - Disclosure - Segment Reporting - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
        <link:definition>2451430 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails">
        <link:definition>2452431 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" abstract="false" name="ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2.75DueDecember2022Member" abstract="true" name="SeniorNotes2.75DueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PharmacyClaimsandDiscountsPayableCurrent" abstract="false" name="PharmacyClaimsandDiscountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.3DueMarch2028Member" abstract="true" name="SeniorNotes4.3DueMarch2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ContractwithCustomerLiabilityRedemptionandBreakage" abstract="false" name="ContractwithCustomerLiabilityRedemptionandBreakage" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" abstract="true" name="HealthCareandOtherInsuranceLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_CorporateOtherMember" abstract="true" name="CorporateOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FloatingRateNotesDueMarch2021Member" abstract="true" name="FloatingRateNotesDueMarch2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.5DueJuly2022Member" abstract="true" name="SeniorNotes3.5DueJuly2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodThreeMember" abstract="true" name="YearOfOriginationPeriodThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes6.75DueDecember2037Member" abstract="true" name="SeniorNotes6.75DueDecember2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_VendorandManufacturerReceivables" abstract="false" name="VendorandManufacturerReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueAugust2047Member" abstract="true" name="SeniorNotes3.875DueAugust2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PharmacyRevenueMember" abstract="true" name="PharmacyRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsLineItems" abstract="true" name="TotalInvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2125PercentDueAugust2031Member" abstract="true" name="SeniorNotes2125PercentDueAugust2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OperatingExpensesExcludingGoodwillImpairments" abstract="false" name="OperatingExpensesExcludingGoodwillImpairments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TreasuryStockSharesHeldinTrust" abstract="false" name="TreasuryStockSharesHeldinTrust" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_NumeratorForEarningsPerShareCalculationAbstract" abstract="true" name="NumeratorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" abstract="false" name="ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFiveMember" abstract="true" name="YearOfOriginationPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.78DueMarch2038Member" abstract="true" name="SeniorNotes4.78DueMarch2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_Category1Member" abstract="true" name="Category1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SupportingExperienceRatedProductsMember" abstract="true" name="SupportingExperienceRatedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" abstract="false" name="NoncontrollinginterestOtherPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HeartlandHealthcareServicesMember" abstract="true" name="HeartlandHealthcareServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.375DueAugust2024Member" abstract="true" name="SeniorNotes3.375DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherAssetBackedSecuritiesMember" abstract="true" name="OtherAssetBackedSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OutstandingSeniorNotesMember" abstract="true" name="OutstandingSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_SeniorNotes5.75DueMay2041Member" abstract="true" name="SeniorNotes5.75DueMay2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" abstract="false" name="ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.875DueJuly2035Member" abstract="true" name="SeniorNotes4.875DueJuly2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueJuly2025Member" abstract="true" name="SeniorNotes3.875DueJuly2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LossContingencyAuditMethodologySampleSize" abstract="false" name="LossContingencyAuditMethodologySampleSize" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" abstract="false" name="PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2.125June2021Member" abstract="true" name="SeniorNotes2.125June2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.5DueNovember2024Member" abstract="true" name="SeniorNotes3.5DueNovember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3DueAugust2026Member" abstract="true" name="SeniorNotes3DueAugust2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" abstract="false" name="IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" abstract="false" name="DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberofPharmacyPlanMembers" abstract="false" name="NumberofPharmacyPlanMembers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_A2016RepurchaseProgramMember" abstract="true" name="A2016RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.25DueAugust2029Member" abstract="true" name="SeniorNotes3.25DueAugust2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RetailLongTermCareSegmentMember" abstract="true" name="RetailLongTermCareSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.8DueJune2023Member" abstract="true" name="SeniorNotes2.8DueJune2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes5DueDecember2024Member" abstract="true" name="SeniorNotes5DueDecember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HealthCareBenefitsSegmentMember" abstract="true" name="HealthCareBenefitsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4DueDecember2023Member" abstract="true" name="SeniorNotes4DueDecember2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesCurrent" abstract="false" name="OtherInsuranceLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DenominatorForEarningsPerShareCalculationAbstract" abstract="true" name="DenominatorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes4.75DueMarch2044Member" abstract="true" name="SeniorNotes4.75DueMarch2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_Categories5and6Member" abstract="true" name="Categories5and6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsDomain" abstract="true" name="TotalInvestmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFourMember" abstract="true" name="YearOfOriginationPeriodFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PaymentsToHealthInsurerFee" abstract="false" name="PaymentsToHealthInsurerFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueMay2021Member" abstract="true" name="SeniorNotes4.125DueMay2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsTableTextBlock" abstract="false" name="TotalInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_SeniorNotes4.25DueApril2050Member" abstract="true" name="SeniorNotes4.25DueApril2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.125DueJuly2045Member" abstract="true" name="SeniorNotes5.125DueJuly2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" abstract="true" name="MortgageLoansOnRealEstateCreditQualityIndicatorDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithoutFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LongtermDebtGrossAndLeaseObligation" abstract="false" name="LongtermDebtGrossAndLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes43Due2028Member" abstract="true" name="SeniorNotes43Due2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodOneMember" abstract="true" name="YearOfOriginationPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodTwoMember" abstract="true" name="YearOfOriginationPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateLoansFullyRepaid" abstract="false" name="MortgageLoansOnRealEstateLoansFullyRepaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" abstract="true" name="DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_DebtAndEquitySecuritiesAvailableForSaleMember" abstract="true" name="DebtAndEquitySecuritiesAvailableForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_Deferredincometaxesandothernoncashitems" abstract="false" name="Deferredincometaxesandothernoncashitems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.5DueMay2042Member" abstract="true" name="SeniorNotes4.5DueMay2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtExtinguishmentFees" abstract="false" name="DebtExtinguishmentFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TreasuryStockValueSharesHeldInTrust" abstract="false" name="TreasuryStockValueSharesHeldInTrust" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes6.25DueJune2027Member" abstract="true" name="SeniorNotes6.25DueJune2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueApril2040Member" abstract="true" name="SeniorNotes4.125DueApril2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" abstract="false" name="BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueNovember2042Member" abstract="true" name="SeniorNotes4.125DueNovember2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumberofWalkInMedicalClinics" abstract="false" name="NumberofWalkInMedicalClinics" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_NumberOfPeopleServed" abstract="false" name="NumberOfPeopleServed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_YearOfOriginationPriorToPeriodFiveMember" abstract="true" name="YearOfOriginationPriorToPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" abstract="true" name="ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes3.35DueMarch2021Member" abstract="true" name="SeniorNotes3.35DueMarch2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" abstract="true" name="ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_TotalInvestmentsAxis" abstract="true" name="TotalInvestmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_InvestmentIncomeExcludingCapitalGainsorLosses" abstract="false" name="InvestmentIncomeExcludingCapitalGainsorLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FrontStoreRevenueMember" abstract="true" name="FrontStoreRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes13DueAugust2027Member" abstract="true" name="SeniorNotes13DueAugust2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.3DueDecember2043Member" abstract="true" name="SeniorNotes5.3DueDecember2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HealthInsurerFee" abstract="false" name="HealthInsurerFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SupportingRemainingProductsMember" abstract="true" name="SupportingRemainingProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ChangeinContractwithCustomerLiabilityRollForward" abstract="true" name="ChangeinContractwithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes4.1DueMarch2025Member" abstract="true" name="SeniorNotes4.1DueMarch2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" abstract="false" name="DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesNoncurrent" abstract="false" name="OtherInsuranceLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" abstract="true" name="MortgageLoansOnRealEstateCreditQualityIndicatorAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes2.875DueJune2026Member" abstract="true" name="SeniorNotes2.875DueJune2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_Category2To4Member" abstract="true" name="Category2To4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" abstract="false" name="ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_LongTermCareReportingUnitMember" abstract="true" name="LongTermCareReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueJune2021Member" abstract="true" name="SeniorNotes4.125DueJune2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NetRevenuesRetailCoPayments" abstract="false" name="NetRevenuesRetailCoPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PremiumDeficiencyReserveLiability" abstract="false" name="PremiumDeficiencyReserveLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes1875DueFebruary2031Member" abstract="true" name="SeniorNotes1875DueFebruary2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.7DueMarch2023Member" abstract="true" name="SeniorNotes3.7DueMarch2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_Category7Member" abstract="true" name="Category7Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_CommonAndCollectiveTrustsMember" abstract="true" name="CommonAndCollectiveTrustsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.75DueDecember2022Member" abstract="true" name="SeniorNotes4.75DueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsTable" abstract="true" name="TotalInvestmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_CoventryHealthCareWorkersCompensationBusinessMember" abstract="true" name="CoventryHealthCareWorkersCompensationBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PharmacyServicesSegmentMember" abstract="true" name="PharmacyServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes175DueAugust2030Member" abstract="true" name="SeniorNotes175DueAugust2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes5.05DueMarch2048Member" abstract="true" name="SeniorNotes5.05DueMarch2048Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SalesChannelOtherMember" abstract="true" name="SalesChannelOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.75DueApril2030Member" abstract="true" name="SeniorNotes3.75DueApril2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" abstract="true" name="RadcliffeAndFlaimVAetnaIncEtAlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_GuarantorObligationsNumberofLeases" abstract="false" name="GuarantorObligationsNumberofLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_AdjustedOperatingIncomeLoss" abstract="false" name="AdjustedOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberofPatientsServedperYear" abstract="false" name="NumberofPatientsServedperYear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes6.125DueSeptember2039Member" abstract="true" name="SeniorNotes6.125DueSeptember2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherReceivablesMember" abstract="true" name="OtherReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PaymentsforInsuranceBenefits" abstract="false" name="PaymentsforInsuranceBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" abstract="true" name="AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" abstract="false" name="DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ActivityInMortgageLoanPortfolioTableTextBlock" abstract="false" name="ActivityInMortgageLoanPortfolioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_SeniorNotes6.625DueJune2036Member" abstract="true" name="SeniorNotes6.625DueJune2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PremiumsMember" abstract="true" name="PremiumsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansMember" abstract="true" name="MortgageLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" abstract="false" name="PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2.75DueNovember2022Member" abstract="true" name="SeniorNotes2.75DueNovember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes27DueAugust2040Member" abstract="true" name="SeniorNotes27DueAugust2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.625DueAugust2024Member" abstract="true" name="SeniorNotes2.625DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes5.45DueJune2021Member" abstract="true" name="SeniorNotes5.45DueJune2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.625DueApril2027Member" abstract="true" name="SeniorNotes3.625DueApril2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>cvs-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:25115a76-675c-4824-88fb-08e9720b17d2,g:63def5ee-f256-409d-94db-fc3f10f96be5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7f2e7660-5fb9-4812-8bfa-bb106f6a63d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_092c5aa4-16f9-4099-8dbe-75be5cc10bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_7f2e7660-5fb9-4812-8bfa-bb106f6a63d6" xlink:to="loc_us-gaap_NetInvestmentIncome_092c5aa4-16f9-4099-8dbe-75be5cc10bc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_e37538df-8c40-4d2e-8c0e-846cb47ad8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_7f2e7660-5fb9-4812-8bfa-bb106f6a63d6" xlink:to="loc_us-gaap_PremiumsEarnedNet_e37538df-8c40-4d2e-8c0e-846cb47ad8cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5e9466e2-5580-40f6-a09b-39fbe0c82b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_7f2e7660-5fb9-4812-8bfa-bb106f6a63d6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5e9466e2-5580-40f6-a09b-39fbe0c82b30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_cb6451ec-50d7-4551-a613-a5b8909630d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bcc07b89-a4e5-4433-9872-917ddabaa41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_cb6451ec-50d7-4551-a613-a5b8909630d6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bcc07b89-a4e5-4433-9872-917ddabaa41b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d7a5e015-33f3-4095-820c-06684a2b97e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_cb6451ec-50d7-4551-a613-a5b8909630d6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d7a5e015-33f3-4095-820c-06684a2b97e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f580e5bc-f163-48a4-9d14-12669ae25c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairments_24dfd53b-3944-46cb-97b3-b7684b4d0a7e" xlink:href="cvs-20210930.xsd#cvs_OperatingExpensesExcludingGoodwillImpairments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f580e5bc-f163-48a4-9d14-12669ae25c23" xlink:to="loc_cvs_OperatingExpensesExcludingGoodwillImpairments_24dfd53b-3944-46cb-97b3-b7684b4d0a7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_4230550c-6fa4-47f0-ab1d-df2315330de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f580e5bc-f163-48a4-9d14-12669ae25c23" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_4230550c-6fa4-47f0-ab1d-df2315330de0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_debc5a45-f476-4c66-826f-e81fe04bd2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f580e5bc-f163-48a4-9d14-12669ae25c23" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_debc5a45-f476-4c66-826f-e81fe04bd2ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bd2a1662-51f8-4a5a-848b-a7dc49f484dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f580e5bc-f163-48a4-9d14-12669ae25c23" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bd2a1662-51f8-4a5a-848b-a7dc49f484dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c1702fd2-5c4a-4ef4-96b9-c08e69fd8ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_8a713777-a529-4c7a-a07b-3d3bc3ffa86b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c1702fd2-5c4a-4ef4-96b9-c08e69fd8ce0" xlink:to="loc_us-gaap_CostsAndExpenses_8a713777-a529-4c7a-a07b-3d3bc3ffa86b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6461782f-944f-4fda-90bf-5abc7a7ee806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c1702fd2-5c4a-4ef4-96b9-c08e69fd8ce0" xlink:to="loc_us-gaap_Revenues_6461782f-944f-4fda-90bf-5abc7a7ee806" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ce951d09-594b-4b29-b4cf-78ed28a64873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_257672ad-d3ee-44fe-8328-300eb7313eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ce951d09-594b-4b29-b4cf-78ed28a64873" xlink:to="loc_us-gaap_OperatingIncomeLoss_257672ad-d3ee-44fe-8328-300eb7313eec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3c8a27d0-6100-4860-a570-8f7e76d308d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ce951d09-594b-4b29-b4cf-78ed28a64873" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3c8a27d0-6100-4860-a570-8f7e76d308d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_dff47cb2-12a8-4420-8305-4cf59d390df4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ce951d09-594b-4b29-b4cf-78ed28a64873" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_dff47cb2-12a8-4420-8305-4cf59d390df4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d5d1c92c-59a0-4b5a-b570-5a6461d88e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ce951d09-594b-4b29-b4cf-78ed28a64873" xlink:to="loc_us-gaap_InterestExpense_d5d1c92c-59a0-4b5a-b570-5a6461d88e58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_93279280-0255-4900-834a-73a85758143c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_07c94ae2-37a5-4832-9031-4099160495f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_93279280-0255-4900-834a-73a85758143c" xlink:to="loc_us-gaap_ProfitLoss_07c94ae2-37a5-4832-9031-4099160495f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f02cedc9-66ab-465e-ac91-3c16da0a26d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_93279280-0255-4900-834a-73a85758143c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f02cedc9-66ab-465e-ac91-3c16da0a26d1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f68fe71a-310e-46c8-92d6-bbd0c0870f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d1afad9b-9383-4df1-865b-77e3f665fd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f68fe71a-310e-46c8-92d6-bbd0c0870f62" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d1afad9b-9383-4df1-865b-77e3f665fd9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_89f3489b-fd50-4a66-b06b-d1ab3d48d888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f68fe71a-310e-46c8-92d6-bbd0c0870f62" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_89f3489b-fd50-4a66-b06b-d1ab3d48d888" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_266353d3-cf7d-4efe-99c3-f83b4ffdc4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_23196176-d6f3-42f3-8869-db6807c4b37c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_266353d3-cf7d-4efe-99c3-f83b4ffdc4a2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_23196176-d6f3-42f3-8869-db6807c4b37c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b6ab07b4-0250-4974-a946-1c7f08a7447c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_266353d3-cf7d-4efe-99c3-f83b4ffdc4a2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b6ab07b4-0250-4974-a946-1c7f08a7447c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_09480bb6-3647-4336-b538-b199ab999dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_266353d3-cf7d-4efe-99c3-f83b4ffdc4a2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_09480bb6-3647-4336-b538-b199ab999dfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e65e15c8-f421-44d1-9f96-ec5e42efe305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_266353d3-cf7d-4efe-99c3-f83b4ffdc4a2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e65e15c8-f421-44d1-9f96-ec5e42efe305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c0050e23-076c-4c4f-aa94-a45282d63feb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_125abbe9-85b0-4620-8b4e-3725c3dc4e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c0050e23-076c-4c4f-aa94-a45282d63feb" xlink:to="loc_us-gaap_ProfitLoss_125abbe9-85b0-4620-8b4e-3725c3dc4e03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_14da50ab-e8df-4fc2-a4b8-cadca0454dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c0050e23-076c-4c4f-aa94-a45282d63feb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_14da50ab-e8df-4fc2-a4b8-cadca0454dce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_536dcf7b-86fa-4478-bee4-146538677cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_6c5f3b41-cfb2-4d24-800c-b7eace420701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_536dcf7b-86fa-4478-bee4-146538677cc7" xlink:to="loc_us-gaap_LongTermInvestments_6c5f3b41-cfb2-4d24-800c-b7eace420701" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1a4f04c1-dd46-4f54-80ea-c36c36bd359c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_536dcf7b-86fa-4478-bee4-146538677cc7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1a4f04c1-dd46-4f54-80ea-c36c36bd359c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1db0d711-1038-42fe-9985-956214332c35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_536dcf7b-86fa-4478-bee4-146538677cc7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1db0d711-1038-42fe-9985-956214332c35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1063a51c-0a3e-4abc-a820-88f391188b04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_536dcf7b-86fa-4478-bee4-146538677cc7" xlink:to="loc_us-gaap_Goodwill_1063a51c-0a3e-4abc-a820-88f391188b04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_de0ef946-b10d-4450-bd5e-6b956d2c1221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_536dcf7b-86fa-4478-bee4-146538677cc7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_de0ef946-b10d-4450-bd5e-6b956d2c1221" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_0ded8657-c5bb-4577-88a6-7fd14a3c5ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_536dcf7b-86fa-4478-bee4-146538677cc7" xlink:to="loc_us-gaap_SeparateAccountAssets_0ded8657-c5bb-4577-88a6-7fd14a3c5ba1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ef58d1c0-16d3-48f9-b1d2-4a23bac212c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_536dcf7b-86fa-4478-bee4-146538677cc7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ef58d1c0-16d3-48f9-b1d2-4a23bac212c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7b7eb905-1397-489e-b28f-b877ece9f163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_536dcf7b-86fa-4478-bee4-146538677cc7" xlink:to="loc_us-gaap_AssetsCurrent_7b7eb905-1397-489e-b28f-b877ece9f163" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_16ceff5f-6ea9-45fb-8254-d569e821dd57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_420594fd-6378-42ab-b4f4-c8c1c919ece6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_16ceff5f-6ea9-45fb-8254-d569e821dd57" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_420594fd-6378-42ab-b4f4-c8c1c919ece6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_17c1f232-c42f-4ccc-af5f-3a03b5312d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_16ceff5f-6ea9-45fb-8254-d569e821dd57" xlink:to="loc_us-gaap_Liabilities_17c1f232-c42f-4ccc-af5f-3a03b5312d5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ee07ede7-7f90-4b88-8e0b-69e033780e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_fbbd41bc-6fa7-4ae3-93e7-33fadc0aa688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ee07ede7-7f90-4b88-8e0b-69e033780e5f" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_fbbd41bc-6fa7-4ae3-93e7-33fadc0aa688" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8318265d-f1f5-4f82-a5f3-7f9c36cdf9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ee07ede7-7f90-4b88-8e0b-69e033780e5f" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8318265d-f1f5-4f82-a5f3-7f9c36cdf9e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_4f13a0c9-e2fb-42da-891f-d752dcd32fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ee07ede7-7f90-4b88-8e0b-69e033780e5f" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_4f13a0c9-e2fb-42da-891f-d752dcd32fa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_59e6edb2-200d-4f1a-95a3-5c3d93ed99ed" xlink:href="cvs-20210930.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ee07ede7-7f90-4b88-8e0b-69e033780e5f" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_59e6edb2-200d-4f1a-95a3-5c3d93ed99ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_b7dceeea-1c4e-4a28-8514-f78c95f09a34" xlink:href="cvs-20210930.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ee07ede7-7f90-4b88-8e0b-69e033780e5f" xlink:to="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_b7dceeea-1c4e-4a28-8514-f78c95f09a34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_c1f702ab-20c1-4399-9b53-b627dbef5ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ee07ede7-7f90-4b88-8e0b-69e033780e5f" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_c1f702ab-20c1-4399-9b53-b627dbef5ad6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_f2c581db-7ac8-40c3-9a94-0af64673f342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ee07ede7-7f90-4b88-8e0b-69e033780e5f" xlink:to="loc_us-gaap_OtherPolicyholderFunds_f2c581db-7ac8-40c3-9a94-0af64673f342" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f4d89995-ef1c-4a26-bfe2-daa8446f10f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ee07ede7-7f90-4b88-8e0b-69e033780e5f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f4d89995-ef1c-4a26-bfe2-daa8446f10f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b3e6ff26-7c3b-4ef6-93d2-ac24014200bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_68b7a9e9-0799-42c2-91ee-f359c20dac61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b3e6ff26-7c3b-4ef6-93d2-ac24014200bb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_68b7a9e9-0799-42c2-91ee-f359c20dac61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_76bc51b8-7ddb-4463-a0ff-a1181767b816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b3e6ff26-7c3b-4ef6-93d2-ac24014200bb" xlink:to="loc_us-gaap_ShortTermInvestments_76bc51b8-7ddb-4463-a0ff-a1181767b816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_501c1317-2858-475d-8adf-2d365a6bf496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b3e6ff26-7c3b-4ef6-93d2-ac24014200bb" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_501c1317-2858-475d-8adf-2d365a6bf496" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_21111c65-2d21-4c3d-9bcb-b8f71bc00152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b3e6ff26-7c3b-4ef6-93d2-ac24014200bb" xlink:to="loc_us-gaap_InventoryNet_21111c65-2d21-4c3d-9bcb-b8f71bc00152" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_4a428812-1917-46f0-a5a4-a2f8765a8828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b3e6ff26-7c3b-4ef6-93d2-ac24014200bb" xlink:to="loc_us-gaap_OtherAssetsCurrent_4a428812-1917-46f0-a5a4-a2f8765a8828" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_af2c8893-c590-4ebd-9c92-1441c69b8ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_5ab9813b-bfc0-470e-b1d1-9c17e75fe72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af2c8893-c590-4ebd-9c92-1441c69b8ca9" xlink:to="loc_us-gaap_PreferredStockValue_5ab9813b-bfc0-470e-b1d1-9c17e75fe72b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_950da1ff-a4e0-43db-a92a-cb4dd9262650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af2c8893-c590-4ebd-9c92-1441c69b8ca9" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_950da1ff-a4e0-43db-a92a-cb4dd9262650" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_d873673a-ece9-4090-ab97-ac6094903ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af2c8893-c590-4ebd-9c92-1441c69b8ca9" xlink:to="loc_us-gaap_TreasuryStockValue_d873673a-ece9-4090-ab97-ac6094903ae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ec588b93-85ec-4d8f-927d-80facc86acce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af2c8893-c590-4ebd-9c92-1441c69b8ca9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ec588b93-85ec-4d8f-927d-80facc86acce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_84ba8ea7-3a7e-4946-b842-873930c0e059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_af2c8893-c590-4ebd-9c92-1441c69b8ca9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_84ba8ea7-3a7e-4946-b842-873930c0e059" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_933944b4-5b05-42d9-a94d-cd5ebd3d75bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e423dd91-0223-4fd0-a7fa-89c4bbf85bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_933944b4-5b05-42d9-a94d-cd5ebd3d75bc" xlink:to="loc_us-gaap_StockholdersEquity_e423dd91-0223-4fd0-a7fa-89c4bbf85bdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_cb197a07-5290-42dc-b178-6e44d810656d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_933944b4-5b05-42d9-a94d-cd5ebd3d75bc" xlink:to="loc_us-gaap_MinorityInterest_cb197a07-5290-42dc-b178-6e44d810656d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_bdc47bc7-1403-494d-9ee7-7e25f1bd837f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d48d4b6a-d965-412a-a7b2-0fe0e3712746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bdc47bc7-1403-494d-9ee7-7e25f1bd837f" xlink:to="loc_us-gaap_LiabilitiesCurrent_d48d4b6a-d965-412a-a7b2-0fe0e3712746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_23df685b-fb79-417f-b3f6-90a035b2f20f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bdc47bc7-1403-494d-9ee7-7e25f1bd837f" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_23df685b-fb79-417f-b3f6-90a035b2f20f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8fa793fe-963d-4842-94b8-45392bd87b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bdc47bc7-1403-494d-9ee7-7e25f1bd837f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8fa793fe-963d-4842-94b8-45392bd87b6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_81047d21-dbc9-4b42-b815-aad273cd300b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bdc47bc7-1403-494d-9ee7-7e25f1bd837f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_81047d21-dbc9-4b42-b815-aad273cd300b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_6c28b3a4-6520-4ab2-9f5a-7ba5526197d0" xlink:href="cvs-20210930.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bdc47bc7-1403-494d-9ee7-7e25f1bd837f" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_6c28b3a4-6520-4ab2-9f5a-7ba5526197d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_570a3516-a096-4800-a8cf-317a6e909a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bdc47bc7-1403-494d-9ee7-7e25f1bd837f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_570a3516-a096-4800-a8cf-317a6e909a8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_951dd7fe-8379-4fb5-b19d-a98ae9240766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bdc47bc7-1403-494d-9ee7-7e25f1bd837f" xlink:to="loc_us-gaap_SeparateAccountsLiability_951dd7fe-8379-4fb5-b19d-a98ae9240766" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82dfe8b5-cd72-4a37-ba68-f16041df3c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_f1cb5c77-eeb9-4781-a667-903409012e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82dfe8b5-cd72-4a37-ba68-f16041df3c91" xlink:to="loc_us-gaap_InterestPaidNet_f1cb5c77-eeb9-4781-a667-903409012e29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_92ba0bff-ca5f-4562-9cfe-32dcb8b5b203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82dfe8b5-cd72-4a37-ba68-f16041df3c91" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_92ba0bff-ca5f-4562-9cfe-32dcb8b5b203" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_f970fec0-9c76-4167-9f0f-c5924f40cb80" xlink:href="cvs-20210930.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82dfe8b5-cd72-4a37-ba68-f16041df3c91" xlink:to="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_f970fec0-9c76-4167-9f0f-c5924f40cb80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_b004ee1e-a406-46c1-8c4b-fcb134ada37f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82dfe8b5-cd72-4a37-ba68-f16041df3c91" xlink:to="loc_us-gaap_ProceedsFromCustomers_b004ee1e-a406-46c1-8c4b-fcb134ada37f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits_35a6e03d-d75e-40f3-a5a5-52ca0f5e2e68" xlink:href="cvs-20210930.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82dfe8b5-cd72-4a37-ba68-f16041df3c91" xlink:to="loc_cvs_PaymentsforInsuranceBenefits_35a6e03d-d75e-40f3-a5a5-52ca0f5e2e68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_801779b7-a1b5-4810-aa06-129ea2d52030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82dfe8b5-cd72-4a37-ba68-f16041df3c91" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_801779b7-a1b5-4810-aa06-129ea2d52030" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_db0f00c6-eb21-43dc-9cde-818271d3bdf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82dfe8b5-cd72-4a37-ba68-f16041df3c91" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_db0f00c6-eb21-43dc-9cde-818271d3bdf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_05b66f8b-c46b-4398-a0d2-fb335f2cb1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e10f9bbb-598b-4066-b1ef-2d06331ae29e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_05b66f8b-c46b-4398-a0d2-fb335f2cb1c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e10f9bbb-598b-4066-b1ef-2d06331ae29e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cc7a9ed5-96da-43f6-84b3-a50d534c3c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_05b66f8b-c46b-4398-a0d2-fb335f2cb1c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cc7a9ed5-96da-43f6-84b3-a50d534c3c0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_893091c6-58dd-4d54-8609-92ed1814338f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_05b66f8b-c46b-4398-a0d2-fb335f2cb1c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_893091c6-58dd-4d54-8609-92ed1814338f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75db7b2-6379-4a66-94af-5019bf743b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_17a28231-a348-4e3f-a41b-bd7319ea2c18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75db7b2-6379-4a66-94af-5019bf743b9b" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_17a28231-a348-4e3f-a41b-bd7319ea2c18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_13defa9a-a507-432f-ba43-c09e608dba06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75db7b2-6379-4a66-94af-5019bf743b9b" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_13defa9a-a507-432f-ba43-c09e608dba06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3b172a6d-9eb2-4b04-920f-7cab19232525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75db7b2-6379-4a66-94af-5019bf743b9b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3b172a6d-9eb2-4b04-920f-7cab19232525" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_26d47ad5-6d34-4c06-8558-20ae74d2ede0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75db7b2-6379-4a66-94af-5019bf743b9b" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_26d47ad5-6d34-4c06-8558-20ae74d2ede0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_0925fac1-72bb-4a71-9559-3e7f480ed9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75db7b2-6379-4a66-94af-5019bf743b9b" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_0925fac1-72bb-4a71-9559-3e7f480ed9fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_e3d756fc-7063-4774-8908-55ad02dbc2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75db7b2-6379-4a66-94af-5019bf743b9b" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_e3d756fc-7063-4774-8908-55ad02dbc2a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0341ec9a-0b34-4d97-a022-eac45cab39db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_dcf09c7c-cdc4-4c7a-84e8-692b08d26e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0341ec9a-0b34-4d97-a022-eac45cab39db" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_dcf09c7c-cdc4-4c7a-84e8-692b08d26e34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_cdc3c3ea-cc1f-465b-8f54-7797d7c6492a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0341ec9a-0b34-4d97-a022-eac45cab39db" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_cdc3c3ea-cc1f-465b-8f54-7797d7c6492a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0ed1a2a7-7249-4e7a-9768-de0021d6cb50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0341ec9a-0b34-4d97-a022-eac45cab39db" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0ed1a2a7-7249-4e7a-9768-de0021d6cb50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9cf19f7c-3c63-4c3c-be43-2c9d638b6771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0341ec9a-0b34-4d97-a022-eac45cab39db" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9cf19f7c-3c63-4c3c-be43-2c9d638b6771" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_fa8ee616-c0e7-4d2e-8527-2797f7ce06e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0341ec9a-0b34-4d97-a022-eac45cab39db" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_fa8ee616-c0e7-4d2e-8527-2797f7ce06e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_bd22f464-00a7-4cd8-a5ba-87d14fa99761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0341ec9a-0b34-4d97-a022-eac45cab39db" xlink:to="loc_us-gaap_PaymentsOfDividends_bd22f464-00a7-4cd8-a5ba-87d14fa99761" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2a0b8317-9c95-4653-98ba-7d42ccb3b2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0341ec9a-0b34-4d97-a022-eac45cab39db" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2a0b8317-9c95-4653-98ba-7d42ccb3b2e4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_50e6982b-ae11-4102-93d7-f863cd4a1b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_50e6982b-ae11-4102-93d7-f863cd4a1b9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5b345916-011a-43f4-9ab7-23eda4b546ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5b345916-011a-43f4-9ab7-23eda4b546ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c80bea01-0c05-4872-8a0a-4907b3fd0e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c80bea01-0c05-4872-8a0a-4907b3fd0e6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_1d6ba658-031e-4836-8acb-5e3a452e4158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_1d6ba658-031e-4836-8acb-5e3a452e4158" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8c23308c-dd5b-4642-9d2e-1c3f72cf92b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8c23308c-dd5b-4642-9d2e-1c3f72cf92b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_979cb5c7-ec17-4743-a4a1-bb1a22deffe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_979cb5c7-ec17-4743-a4a1-bb1a22deffe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Deferredincometaxesandothernoncashitems_92564a81-1f48-44b0-8502-0c0ea6b49af2" xlink:href="cvs-20210930.xsd#cvs_Deferredincometaxesandothernoncashitems"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:to="loc_cvs_Deferredincometaxesandothernoncashitems_92564a81-1f48-44b0-8502-0c0ea6b49af2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_640e2c2a-70b1-4dec-a0eb-6b3b729d23ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_640e2c2a-70b1-4dec-a0eb-6b3b729d23ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2b5e880e-4c10-4d4e-b442-7cdc1814c9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:to="loc_us-gaap_ShareBasedCompensation_2b5e880e-4c10-4d4e-b442-7cdc1814c9a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3b1b8779-c9eb-49bb-b5c6-9b21355dd060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3b1b8779-c9eb-49bb-b5c6-9b21355dd060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_07b6e992-f842-45f1-a78f-6b07bb465e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_07b6e992-f842-45f1-a78f-6b07bb465e92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_509b735a-207e-4810-bba9-0c9c6df63dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_509b735a-207e-4810-bba9-0c9c6df63dea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a1af8290-0566-47f5-ae85-a3f53a45bb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e03785d9-999c-48a2-af9b-5a50e0d35f26" xlink:to="loc_us-gaap_ProfitLoss_a1af8290-0566-47f5-ae85-a3f53a45bb6b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b151ea08-55d4-4dce-a2e9-b8a53dbf1cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_48c1adca-50f6-4efd-bb2d-d306aa4846c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b151ea08-55d4-4dce-a2e9-b8a53dbf1cf2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_48c1adca-50f6-4efd-bb2d-d306aa4846c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_7d7f844c-ac82-405f-ad34-4349ef5af851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b151ea08-55d4-4dce-a2e9-b8a53dbf1cf2" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_7d7f844c-ac82-405f-ad34-4349ef5af851" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5c044503-fbba-427a-812f-eda71e2d215c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_78a8061d-3d91-4790-b6da-5ce7438e7f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_5c044503-fbba-427a-812f-eda71e2d215c" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_78a8061d-3d91-4790-b6da-5ce7438e7f6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_0942fba8-4a63-4958-a826-aaaf7543907c" xlink:href="cvs-20210930.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_5c044503-fbba-427a-812f-eda71e2d215c" xlink:to="loc_cvs_VendorandManufacturerReceivables_0942fba8-4a63-4958-a826-aaaf7543907c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_36af3459-7eb8-4c7e-9ec3-3525b85ea320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_5c044503-fbba-427a-812f-eda71e2d215c" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_36af3459-7eb8-4c7e-9ec3-3525b85ea320" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_190e74a4-94f9-47cd-8889-a38064990981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_5c044503-fbba-427a-812f-eda71e2d215c" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_190e74a4-94f9-47cd-8889-a38064990981" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsTotalInvestmentScheduleDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_a1a98b41-46d4-4af8-a41a-1232c2cdc8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_c2457104-ec58-43ff-bece-b24a35c4bc4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_a1a98b41-46d4-4af8-a41a-1232c2cdc8a8" xlink:to="loc_us-gaap_ShortTermInvestments_c2457104-ec58-43ff-bece-b24a35c4bc4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_af52044f-fcc3-43d0-8081-824df5a7f70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_a1a98b41-46d4-4af8-a41a-1232c2cdc8a8" xlink:to="loc_us-gaap_LongTermInvestments_af52044f-fcc3-43d0-8081-824df5a7f70e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_f156af23-e57b-4b2c-909b-da5a479bde11" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_f54254c9-356e-46d6-a363-4aecf27e7268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_f156af23-e57b-4b2c-909b-da5a479bde11" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_f54254c9-356e-46d6-a363-4aecf27e7268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4f4b0eee-cc62-4a85-a9c0-84cf098d5363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_f156af23-e57b-4b2c-909b-da5a479bde11" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4f4b0eee-cc62-4a85-a9c0-84cf098d5363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a9024741-937f-40d2-a684-1564cf6866e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_f156af23-e57b-4b2c-909b-da5a479bde11" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a9024741-937f-40d2-a684-1564cf6866e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_89dfa9ff-1c36-429d-ba83-661fff21f4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9b1d813d-7ed7-4a60-bc32-04f012bb2170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_89dfa9ff-1c36-429d-ba83-661fff21f4d2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9b1d813d-7ed7-4a60-bc32-04f012bb2170" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_8e31fb65-1362-47d1-8669-f110fe120e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_89dfa9ff-1c36-429d-ba83-661fff21f4d2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_8e31fb65-1362-47d1-8669-f110fe120e67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_88efe684-c945-4619-87ff-5a0ff36b63e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_89dfa9ff-1c36-429d-ba83-661fff21f4d2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_88efe684-c945-4619-87ff-5a0ff36b63e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_c3b5cb3b-c22f-48d6-a971-abe1c0b4af78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_89dfa9ff-1c36-429d-ba83-661fff21f4d2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_c3b5cb3b-c22f-48d6-a971-abe1c0b4af78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_b102e6f0-3e03-40b8-89a1-87267c807be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_89dfa9ff-1c36-429d-ba83-661fff21f4d2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_b102e6f0-3e03-40b8-89a1-87267c807be8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3d9db699-0b4e-4a47-80fc-7e8ee07e6ca6" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_6b59514f-dd2f-4e0b-8fcb-2160f2b4c988" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3d9db699-0b4e-4a47-80fc-7e8ee07e6ca6" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_6b59514f-dd2f-4e0b-8fcb-2160f2b4c988" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_9a4d75ea-c1b4-4332-9966-6b9f76349fd5" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3d9db699-0b4e-4a47-80fc-7e8ee07e6ca6" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_9a4d75ea-c1b4-4332-9966-6b9f76349fd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_51da91a2-7ae0-45bb-a338-6c70d331b03f" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3d9db699-0b4e-4a47-80fc-7e8ee07e6ca6" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_51da91a2-7ae0-45bb-a338-6c70d331b03f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_57c678fb-556f-4e1f-b103-1d0cb5bd9f14" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3d9db699-0b4e-4a47-80fc-7e8ee07e6ca6" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_57c678fb-556f-4e1f-b103-1d0cb5bd9f14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_d754b420-177e-4721-9c0c-f4f914b86cbb" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3d9db699-0b4e-4a47-80fc-7e8ee07e6ca6" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_d754b420-177e-4721-9c0c-f4f914b86cbb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ecfe5380-1ad2-4524-bc6a-98483541f65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6fa222a9-3c05-46f0-ad9f-8101025c7da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ecfe5380-1ad2-4524-bc6a-98483541f65f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6fa222a9-3c05-46f0-ad9f-8101025c7da8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_2936ef18-680f-4bf3-a20e-0e25951d6caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ecfe5380-1ad2-4524-bc6a-98483541f65f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_2936ef18-680f-4bf3-a20e-0e25951d6caa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_cbee5d95-968d-44a0-933f-fe182b75fbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_c4991782-6cb4-42f6-914d-afc60401d101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_cbee5d95-968d-44a0-933f-fe182b75fbf3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_c4991782-6cb4-42f6-914d-afc60401d101" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_d90b2d44-295d-4a2d-8059-b56d215321c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_cbee5d95-968d-44a0-933f-fe182b75fbf3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_d90b2d44-295d-4a2d-8059-b56d215321c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_baaa5cbf-cff8-44f2-9a3c-d3d8cb525ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_cca28de7-3cd9-4c09-8781-8da7b04771a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_baaa5cbf-cff8-44f2-9a3c-d3d8cb525ae6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_cca28de7-3cd9-4c09-8781-8da7b04771a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_6b08fdb0-6e5e-443a-bdcf-641acf149105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_baaa5cbf-cff8-44f2-9a3c-d3d8cb525ae6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_6b08fdb0-6e5e-443a-bdcf-641acf149105" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5de92349-4463-4e07-8b7d-535cedbae976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_610802df-081c-4717-a370-30d584576389" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5de92349-4463-4e07-8b7d-535cedbae976" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_610802df-081c-4717-a370-30d584576389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_73917df1-4afd-4abb-8132-e0a63b6467e6" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5de92349-4463-4e07-8b7d-535cedbae976" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_73917df1-4afd-4abb-8132-e0a63b6467e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_386d672d-e468-4af6-9d02-b6f3ea4787c2" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5de92349-4463-4e07-8b7d-535cedbae976" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_386d672d-e468-4af6-9d02-b6f3ea4787c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_55f2c9c6-c5aa-410a-bbaf-9daf62cc94da" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5de92349-4463-4e07-8b7d-535cedbae976" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_55f2c9c6-c5aa-410a-bbaf-9daf62cc94da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_461a0075-69f5-4143-ad2c-ce35b1726e57" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5de92349-4463-4e07-8b7d-535cedbae976" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_461a0075-69f5-4143-ad2c-ce35b1726e57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e2bad742-9ca8-4c97-bb56-0b5b841fef21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_a1d041e0-f15f-4aba-84be-35d53d5522aa" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e2bad742-9ca8-4c97-bb56-0b5b841fef21" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_a1d041e0-f15f-4aba-84be-35d53d5522aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_0fa6f325-b2a6-452a-a80e-d39c1091929e" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e2bad742-9ca8-4c97-bb56-0b5b841fef21" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_0fa6f325-b2a6-452a-a80e-d39c1091929e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_975d96e2-6d4a-4c57-a181-9b24bcc95cde" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e2bad742-9ca8-4c97-bb56-0b5b841fef21" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_975d96e2-6d4a-4c57-a181-9b24bcc95cde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_e527a3c0-e39e-4291-b881-e0bbfa750aa5" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e2bad742-9ca8-4c97-bb56-0b5b841fef21" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_e527a3c0-e39e-4291-b881-e0bbfa750aa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_fd1ee9dc-f630-4761-9ba1-617a4b12f165" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e2bad742-9ca8-4c97-bb56-0b5b841fef21" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_fd1ee9dc-f630-4761-9ba1-617a4b12f165" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_dc9411c7-ffd2-4676-9e1d-91d95d53beb4" xlink:href="cvs-20210930.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_2ce91dc4-2e88-479c-8ec0-f9a32a816135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_dc9411c7-ffd2-4676-9e1d-91d95d53beb4" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_2ce91dc4-2e88-479c-8ec0-f9a32a816135" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_1d7024f5-68b1-44fc-97f3-085ad4b113d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_dc9411c7-ffd2-4676-9e1d-91d95d53beb4" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_1d7024f5-68b1-44fc-97f3-085ad4b113d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_8051f4ee-d1cc-43e7-b04f-6f57f3792233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_1f9feef7-ace4-4e44-84d8-56cb25dbde16" xlink:href="cvs-20210930.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_8051f4ee-d1cc-43e7-b04f-6f57f3792233" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_1f9feef7-ace4-4e44-84d8-56cb25dbde16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_8587d5b6-4777-4f45-8de7-b23b2c63e828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_8051f4ee-d1cc-43e7-b04f-6f57f3792233" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_8587d5b6-4777-4f45-8de7-b23b2c63e828" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_32e00952-65e9-498b-a74d-dd32a22c6b04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b98a24e1-6085-47f9-8b03-baf733472e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_32e00952-65e9-498b-a74d-dd32a22c6b04" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b98a24e1-6085-47f9-8b03-baf733472e86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_bc96e3d9-57a0-477b-8a4d-5e04d8750041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_32e00952-65e9-498b-a74d-dd32a22c6b04" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_bc96e3d9-57a0-477b-8a4d-5e04d8750041" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_600852ac-6958-4935-94c8-a57862dd5657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_32e00952-65e9-498b-a74d-dd32a22c6b04" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_600852ac-6958-4935-94c8-a57862dd5657" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e02d15db-3419-4776-a036-1f3c791a9cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_cfad4a58-59bf-4304-afee-bdec37c6ac7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e02d15db-3419-4776-a036-1f3c791a9cdf" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_cfad4a58-59bf-4304-afee-bdec37c6ac7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_4b5fbbe4-fdb5-473a-aa58-53b7c09c3532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e02d15db-3419-4776-a036-1f3c791a9cdf" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_4b5fbbe4-fdb5-473a-aa58-53b7c09c3532" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_c9023729-cefe-40ee-9ea0-8d6040549dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_7b68b22f-df20-4c97-9139-fe909118b33c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_c9023729-cefe-40ee-9ea0-8d6040549dd6" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_7b68b22f-df20-4c97-9139-fe909118b33c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_0cdd48c1-f17a-47c8-8fd3-09503d5aeac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_c9023729-cefe-40ee-9ea0-8d6040549dd6" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_0cdd48c1-f17a-47c8-8fd3-09503d5aeac0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_60f75332-24b3-4413-9b51-d3bc21a9c1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_9e522fe5-7c3f-4b9f-a539-b6acf5538bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_60f75332-24b3-4413-9b51-d3bc21a9c1a4" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_9e522fe5-7c3f-4b9f-a539-b6acf5538bb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_500f883c-7fa2-43ce-9abf-92383a85604c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_60f75332-24b3-4413-9b51-d3bc21a9c1a4" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_500f883c-7fa2-43ce-9abf-92383a85604c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#BorrowingsScheduleofBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_ce57e50b-3506-4ae0-ba79-af80d26589e2" xlink:href="cvs-20210930.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_aad568b2-a41e-4600-9930-12cbafa9bfcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation_ce57e50b-3506-4ae0-ba79-af80d26589e2" xlink:to="loc_us-gaap_FinanceLeaseLiability_aad568b2-a41e-4600-9930-12cbafa9bfcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_aae06173-2ee6-404d-9ec5-4049a5818ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation_ce57e50b-3506-4ae0-ba79-af80d26589e2" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_aae06173-2ee6-404d-9ec5-4049a5818ad2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_6ddae98d-fec3-42a9-bfdc-e5f44a46f073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_1b7de7f6-4f01-47a5-9dc0-80f7e1ef3710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_6ddae98d-fec3-42a9-bfdc-e5f44a46f073" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_1b7de7f6-4f01-47a5-9dc0-80f7e1ef3710" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_b5fe392c-0302-4315-b77f-5da8d38ecab9" xlink:href="cvs-20210930.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_6ddae98d-fec3-42a9-bfdc-e5f44a46f073" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_b5fe392c-0302-4315-b77f-5da8d38ecab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_e1af70ae-7215-4eed-b583-62a77eaef6bd" xlink:href="cvs-20210930.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_6ddae98d-fec3-42a9-bfdc-e5f44a46f073" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_e1af70ae-7215-4eed-b583-62a77eaef6bd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#OtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_198b0716-890f-4214-aec8-245a09ab57d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8f3ba3a0-decd-443c-8295-1d502c5cf223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_198b0716-890f-4214-aec8-245a09ab57d1" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8f3ba3a0-decd-443c-8295-1d502c5cf223" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_42be9932-f185-4789-97a3-ac7dc6aa491a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_198b0716-890f-4214-aec8-245a09ab57d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_42be9932-f185-4789-97a3-ac7dc6aa491a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#EarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a31fdf8f-3548-4c06-bbdb-c32de402e7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_94cdfc7e-5bf9-4cf9-b512-bdaefc99f9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a31fdf8f-3548-4c06-bbdb-c32de402e7e6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_94cdfc7e-5bf9-4cf9-b512-bdaefc99f9a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f6620f6a-182b-4143-b73c-4ab36618a6f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a31fdf8f-3548-4c06-bbdb-c32de402e7e6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f6620f6a-182b-4143-b73c-4ab36618a6f8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0eac0845-c000-4fac-8e70-522c3c6e1683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_c7be15aa-fe09-4bae-9132-3fd0b230065d" xlink:href="cvs-20210930.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0eac0845-c000-4fac-8e70-522c3c6e1683" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_c7be15aa-fe09-4bae-9132-3fd0b230065d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a5a1e196-cc15-46e4-9acd-912d8e730088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0eac0845-c000-4fac-8e70-522c3c6e1683" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a5a1e196-cc15-46e4-9acd-912d8e730088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_831bbe7f-b2bc-4485-829c-4f068a55916e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0eac0845-c000-4fac-8e70-522c3c6e1683" xlink:to="loc_us-gaap_NetInvestmentIncome_831bbe7f-b2bc-4485-829c-4f068a55916e" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>cvs-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:25115a76-675c-4824-88fb-08e9720b17d2,g:63def5ee-f256-409d-94db-fc3f10f96be5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended" id="if36545185c884e8197f8afbdda1fb456_CondensedConsolidatedStatementsofOperationsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_0adb472b-a455-4506-86ac-2b736c97920a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_RevenuesAbstract_0adb472b-a455-4506-86ac-2b736c97920a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e5068219-6190-4efa-8695-f6b981e36307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_0adb472b-a455-4506-86ac-2b736c97920a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e5068219-6190-4efa-8695-f6b981e36307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_2b4cab86-7aaa-4a16-83a1-817e8cb58c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_0adb472b-a455-4506-86ac-2b736c97920a" xlink:to="loc_us-gaap_PremiumsEarnedNet_2b4cab86-7aaa-4a16-83a1-817e8cb58c77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_99f4500d-97c4-416d-943b-4cf050ad780d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_0adb472b-a455-4506-86ac-2b736c97920a" xlink:to="loc_us-gaap_NetInvestmentIncome_99f4500d-97c4-416d-943b-4cf050ad780d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_90a46210-c4ca-4706-b12a-82e7a26e62c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_0adb472b-a455-4506-86ac-2b736c97920a" xlink:to="loc_us-gaap_Revenues_90a46210-c4ca-4706-b12a-82e7a26e62c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ed04b044-be4b-4bab-ad3b-86dbdff36394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ed04b044-be4b-4bab-ad3b-86dbdff36394" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_f6cf296f-2dd1-487d-ad83-6bd79ced9ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_f6cf296f-2dd1-487d-ad83-6bd79ced9ec6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_512b0ef7-d68c-4dd2-a10b-92dde44d8fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_512b0ef7-d68c-4dd2-a10b-92dde44d8fea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_fd47be17-4cef-44b7-baf5-fe5951735428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_fd47be17-4cef-44b7-baf5-fe5951735428" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairments_e2a209c9-c90e-4a76-a80d-f99fc0835031" xlink:href="cvs-20210930.xsd#cvs_OperatingExpensesExcludingGoodwillImpairments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:to="loc_cvs_OperatingExpensesExcludingGoodwillImpairments_e2a209c9-c90e-4a76-a80d-f99fc0835031" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_1005289b-4372-46cb-a98c-eadf36f71f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:to="loc_us-gaap_CostsAndExpenses_1005289b-4372-46cb-a98c-eadf36f71f0f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_420b1bd1-02aa-46d1-9231-a7d4806afa30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_OperatingIncomeLoss_420b1bd1-02aa-46d1-9231-a7d4806afa30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_bb589d33-ee24-4c36-add3-a20deb5dbf48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_InterestExpense_bb589d33-ee24-4c36-add3-a20deb5dbf48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b9fbcb35-5b50-4e88-8984-5db65086c289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b9fbcb35-5b50-4e88-8984-5db65086c289" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f8cdbef0-80f5-4b9e-9b0b-ff122802b394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f8cdbef0-80f5-4b9e-9b0b-ff122802b394" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e6568b16-ca04-4e50-9890-d481293cd57b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e6568b16-ca04-4e50-9890-d481293cd57b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cfc56948-63e5-4484-9447-5435d34be6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cfc56948-63e5-4484-9447-5435d34be6c8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e7fb6301-7986-4718-a61f-93cad802cf63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_ProfitLoss_e7fb6301-7986-4718-a61f-93cad802cf63" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3b70a5c5-c575-468e-ba17-65a919426500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3b70a5c5-c575-468e-ba17-65a919426500" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_40cc6e47-24da-4a5a-9d13-c537bc4c677e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_NetIncomeLoss_40cc6e47-24da-4a5a-9d13-c537bc4c677e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b5a823f2-92d8-4cf5-8422-55fc675eb60d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_EarningsPerShareAbstract_b5a823f2-92d8-4cf5-8422-55fc675eb60d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_46c2476d-188f-4f20-9fb4-124933a65ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b5a823f2-92d8-4cf5-8422-55fc675eb60d" xlink:to="loc_us-gaap_EarningsPerShareBasic_46c2476d-188f-4f20-9fb4-124933a65ab2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_802524ee-3d8a-40e1-bc2c-495ae9a611be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b5a823f2-92d8-4cf5-8422-55fc675eb60d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_802524ee-3d8a-40e1-bc2c-495ae9a611be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8093ade8-28d9-46ec-8fee-97ed9aabb8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8093ade8-28d9-46ec-8fee-97ed9aabb8e7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f90fe43c-64ac-47ee-90dc-42bb6e8348ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8093ade8-28d9-46ec-8fee-97ed9aabb8e7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f90fe43c-64ac-47ee-90dc-42bb6e8348ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8fade3b8-b947-4359-b3e0-99377d6e2ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8093ade8-28d9-46ec-8fee-97ed9aabb8e7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8fade3b8-b947-4359-b3e0-99377d6e2ed0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_c12d5c73-9d2c-48ca-8bf4-76f717bafbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_c12d5c73-9d2c-48ca-8bf4-76f717bafbbd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2d00b2e8-dc57-4249-a1c0-ef3ff4caef8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_StatementTable_2d00b2e8-dc57-4249-a1c0-ef3ff4caef8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_71db7144-917c-4916-8500-44043f18da27" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2d00b2e8-dc57-4249-a1c0-ef3ff4caef8f" xlink:to="loc_srt_ProductOrServiceAxis_71db7144-917c-4916-8500-44043f18da27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_71db7144-917c-4916-8500-44043f18da27_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_71db7144-917c-4916-8500-44043f18da27" xlink:to="loc_srt_ProductsAndServicesDomain_71db7144-917c-4916-8500-44043f18da27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_623f3dda-efa3-4cb2-8d7e-5e464c98f973" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_71db7144-917c-4916-8500-44043f18da27" xlink:to="loc_srt_ProductsAndServicesDomain_623f3dda-efa3-4cb2-8d7e-5e464c98f973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_991cfa10-3a27-4233-b61f-f4adf22cb38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_623f3dda-efa3-4cb2-8d7e-5e464c98f973" xlink:to="loc_us-gaap_ProductMember_991cfa10-3a27-4233-b61f-f4adf22cb38d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_8d1f22a9-243f-4687-998d-a8bc86e7431e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_623f3dda-efa3-4cb2-8d7e-5e464c98f973" xlink:to="loc_us-gaap_ServiceMember_8d1f22a9-243f-4687-998d-a8bc86e7431e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedStatementsofShareholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="extended" id="i86ac3d4e7755462ca1b3f0d483841bc6_CondensedConsolidatedStatementsofShareholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2f2e37ec-6274-416d-861a-a99602370832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2f2e37ec-6274-416d-861a-a99602370832" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_353b4c6f-b584-4f9f-95c9-fe9f1738bb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_SharesOutstanding_353b4c6f-b584-4f9f-95c9-fe9f1738bb0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ffd1823c-adef-4699-8230-367a474c298c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ffd1823c-adef-4699-8230-367a474c298c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8eddb3a7-a7a8-4b88-8caf-d3c6035e52b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_ProfitLoss_8eddb3a7-a7a8-4b88-8caf-d3c6035e52b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d05b3d28-7d14-42d0-bb91-6e7490312d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d05b3d28-7d14-42d0-bb91-6e7490312d5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_63cc92fb-e856-4a7c-86e9-fc800237e1da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_63cc92fb-e856-4a7c-86e9-fc800237e1da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a8f3e8bc-b609-43ac-8bab-a5a7776f5df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a8f3e8bc-b609-43ac-8bab-a5a7776f5df9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_4accdc71-9c73-45f7-9664-12fad01aa5cf" xlink:href="cvs-20210930.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_4accdc71-9c73-45f7-9664-12fad01aa5cf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_1e81d3a5-c1eb-4d09-9627-896ba30634f5" xlink:href="cvs-20210930.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_1e81d3a5-c1eb-4d09-9627-896ba30634f5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_1f8b8ac2-375c-493c-b397-ce7c92e4813d" xlink:href="cvs-20210930.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_1f8b8ac2-375c-493c-b397-ce7c92e4813d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_a449aa17-3c77-454f-81d0-4ebef324d701" xlink:href="cvs-20210930.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_a449aa17-3c77-454f-81d0-4ebef324d701" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_3d9b5a44-5ab6-4238-b964-62e1ba9de182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_DividendsCommonStock_3d9b5a44-5ab6-4238-b964-62e1ba9de182" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_fcab9446-de30-4fbf-9ea0-e375b8e0b157" xlink:href="cvs-20210930.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_fcab9446-de30-4fbf-9ea0-e375b8e0b157" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_40c54677-7de6-4a5e-8a67-9f726a25d362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dabdb433-89f7-4282-84b5-95aa5b48fa15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0f699b4c-60d5-4620-a46a-c5c63fd8dcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2f2e37ec-6274-416d-861a-a99602370832" xlink:to="loc_us-gaap_StatementTable_0f699b4c-60d5-4620-a46a-c5c63fd8dcc5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3484739e-ffdc-4dfc-b592-3c0d589a569d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0f699b4c-60d5-4620-a46a-c5c63fd8dcc5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3484739e-ffdc-4dfc-b592-3c0d589a569d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3484739e-ffdc-4dfc-b592-3c0d589a569d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3484739e-ffdc-4dfc-b592-3c0d589a569d" xlink:to="loc_us-gaap_EquityComponentDomain_3484739e-ffdc-4dfc-b592-3c0d589a569d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9ddd1d11-f401-4ea7-adc2-6af50084e503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3484739e-ffdc-4dfc-b592-3c0d589a569d" xlink:to="loc_us-gaap_EquityComponentDomain_9ddd1d11-f401-4ea7-adc2-6af50084e503" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9ddd1d11-f401-4ea7-adc2-6af50084e503" xlink:to="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b7ff924e-0472-4251-a923-5a4d6b4115d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:to="loc_us-gaap_CommonStockMember_b7ff924e-0472-4251-a923-5a4d6b4115d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_251d61b1-869e-41da-88c9-7380bfd91154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:to="loc_us-gaap_TreasuryStockMember_251d61b1-869e-41da-88c9-7380bfd91154" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_d5b82aed-90b5-4bbc-83a1-ab1fef36f14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_d5b82aed-90b5-4bbc-83a1-ab1fef36f14a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_53c3f264-8606-49f3-bba3-d3828cdef018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:to="loc_us-gaap_RetainedEarningsMember_53c3f264-8606-49f3-bba3-d3828cdef018" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_244aee92-2b7d-4312-ab1c-c55cd549d33f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_244aee92-2b7d-4312-ab1c-c55cd549d33f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b2642efa-3705-4918-9cf4-968681b71bee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9ddd1d11-f401-4ea7-adc2-6af50084e503" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b2642efa-3705-4918-9cf4-968681b71bee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_50aa68ce-989d-4b76-a428-e5fb416bb693" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0f699b4c-60d5-4620-a46a-c5c63fd8dcc5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_50aa68ce-989d-4b76-a428-e5fb416bb693" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_50aa68ce-989d-4b76-a428-e5fb416bb693_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_50aa68ce-989d-4b76-a428-e5fb416bb693" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_50aa68ce-989d-4b76-a428-e5fb416bb693_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d78c069d-8043-4ff1-b4fe-076bb2bfc659" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_50aa68ce-989d-4b76-a428-e5fb416bb693" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d78c069d-8043-4ff1-b4fe-076bb2bfc659" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_31e2967d-59c3-4186-a1c8-f45c4b3f4afb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d78c069d-8043-4ff1-b4fe-076bb2bfc659" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_31e2967d-59c3-4186-a1c8-f45c4b3f4afb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended" id="i107291b3f6a44de2aa5d6bf9ba1a0950_CondensedConsolidatedStatementsofShareholdersEquityParentheticals">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_8d9b6577-25a7-48e2-9820-7c16451609a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_8d9b6577-25a7-48e2-9820-7c16451609a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_04c35944-bec0-4712-a49f-50e183f825bd" xlink:href="cvs-20210930.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_04c35944-bec0-4712-a49f-50e183f825bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_9d40c3d2-a42f-4589-815d-1cef9b4644cb" xlink:href="cvs-20210930.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_9d40c3d2-a42f-4589-815d-1cef9b4644cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d2781cf6-d2b6-445d-aec3-6a34d8005297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:to="loc_us-gaap_CommonStockValue_d2781cf6-d2b6-445d-aec3-6a34d8005297" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f7d7da42-2c5e-408a-81d8-70e72256650a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f7d7da42-2c5e-408a-81d8-70e72256650a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_eb51a7b0-54ae-45ee-85a2-3708f35e0a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:to="loc_us-gaap_StatementTable_eb51a7b0-54ae-45ee-85a2-3708f35e0a3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f2de8b08-2f24-4a4a-b02e-de762e6f2f99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_eb51a7b0-54ae-45ee-85a2-3708f35e0a3d" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f2de8b08-2f24-4a4a-b02e-de762e6f2f99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f2de8b08-2f24-4a4a-b02e-de762e6f2f99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f2de8b08-2f24-4a4a-b02e-de762e6f2f99" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f2de8b08-2f24-4a4a-b02e-de762e6f2f99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_270cbe38-c244-4d85-9cab-c94503d06652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f2de8b08-2f24-4a4a-b02e-de762e6f2f99" xlink:to="loc_us-gaap_TypeOfAdoptionMember_270cbe38-c244-4d85-9cab-c94503d06652" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_b8229459-f2cf-4b2e-9f71-ab96dd886fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_270cbe38-c244-4d85-9cab-c94503d06652" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_b8229459-f2cf-4b2e-9f71-ab96dd886fc6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i95ba5aac88d94205a3c447c7982e9658_SignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_8478284b-c783-4b72-af1a-21a1d8f1ae5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_us-gaap_NumberOfStores_8478284b-c783-4b72-af1a-21a1d8f1ae5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_77979a8c-8368-4f19-be43-e3d37142143c" xlink:href="cvs-20210930.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_77979a8c-8368-4f19-be43-e3d37142143c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPharmacyPlanMembers_4a4e763b-5cc3-4f7b-88e2-e8425b2ef343" xlink:href="cvs-20210930.xsd#cvs_NumberofPharmacyPlanMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_NumberofPharmacyPlanMembers_4a4e763b-5cc3-4f7b-88e2-e8425b2ef343" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear_09545f92-bc6a-4aa4-82df-1e4788b50f4c" xlink:href="cvs-20210930.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_NumberofPatientsServedperYear_09545f92-bc6a-4aa4-82df-1e4788b50f4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_c16d16bd-e4e6-4d09-9e57-05e024402111" xlink:href="cvs-20210930.xsd#cvs_NumberOfPeopleServed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_NumberOfPeopleServed_c16d16bd-e4e6-4d09-9e57-05e024402111" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_948396d7-b499-4d5e-9ebd-e2b31d8dd818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_us-gaap_NumberOfReportableSegments_948396d7-b499-4d5e-9ebd-e2b31d8dd818" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee_ffd843f7-c53c-413e-92a5-8fc9c093c720" xlink:href="cvs-20210930.xsd#cvs_HealthInsurerFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_HealthInsurerFee_ffd843f7-c53c-413e-92a5-8fc9c093c720" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsToHealthInsurerFee_1845b96b-d039-4a96-879d-8aa85e2384d5" xlink:href="cvs-20210930.xsd#cvs_PaymentsToHealthInsurerFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_PaymentsToHealthInsurerFee_1845b96b-d039-4a96-879d-8aa85e2384d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_51035412-6193-4723-ac21-f4246b14b103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_51035412-6193-4723-ac21-f4246b14b103" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_5ec4d6ea-9c86-438c-ad3d-fd978e99350f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_5ec4d6ea-9c86-438c-ad3d-fd978e99350f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_b61772a9-b7f8-4d27-a121-650a17d1752e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_b61772a9-b7f8-4d27-a121-650a17d1752e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_9e88730e-4151-48a1-b74c-9bbee7aee1c6" xlink:href="cvs-20210930.xsd#cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_9e88730e-4151-48a1-b74c-9bbee7aee1c6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d97b87f7-ec56-42a0-b6ae-ebc1d56c52c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d97b87f7-ec56-42a0-b6ae-ebc1d56c52c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_20ace0e0-bca3-4630-ab09-d3cbb0dc6d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d97b87f7-ec56-42a0-b6ae-ebc1d56c52c8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_20ace0e0-bca3-4630-ab09-d3cbb0dc6d7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_20ace0e0-bca3-4630-ab09-d3cbb0dc6d7e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_20ace0e0-bca3-4630-ab09-d3cbb0dc6d7e" xlink:to="loc_us-gaap_SegmentDomain_20ace0e0-bca3-4630-ab09-d3cbb0dc6d7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_476207ae-e5b5-4d98-beb2-0444730eda4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_20ace0e0-bca3-4630-ab09-d3cbb0dc6d7e" xlink:to="loc_us-gaap_SegmentDomain_476207ae-e5b5-4d98-beb2-0444730eda4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_7ab7505c-bcc2-4a43-a61c-2f610366ad2c" xlink:href="cvs-20210930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_476207ae-e5b5-4d98-beb2-0444730eda4a" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_7ab7505c-bcc2-4a43-a61c-2f610366ad2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_52f118de-7033-4b18-b31a-c60ccdb0b446" xlink:href="cvs-20210930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_476207ae-e5b5-4d98-beb2-0444730eda4a" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_52f118de-7033-4b18-b31a-c60ccdb0b446" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0dfd5808-b2b1-4d30-ad31-b67f53162488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d97b87f7-ec56-42a0-b6ae-ebc1d56c52c8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0dfd5808-b2b1-4d30-ad31-b67f53162488" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0dfd5808-b2b1-4d30-ad31-b67f53162488_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0dfd5808-b2b1-4d30-ad31-b67f53162488" xlink:to="loc_us-gaap_RelatedPartyDomain_0dfd5808-b2b1-4d30-ad31-b67f53162488_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7a86f84a-9bb0-4840-aa02-533a00b66eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0dfd5808-b2b1-4d30-ad31-b67f53162488" xlink:to="loc_us-gaap_RelatedPartyDomain_7a86f84a-9bb0-4840-aa02-533a00b66eaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_c5256c9c-768a-49cb-8cb2-ac06614259a2" xlink:href="cvs-20210930.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_7a86f84a-9bb0-4840-aa02-533a00b66eaf" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_c5256c9c-768a-49cb-8cb2-ac06614259a2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended" id="i79e234f3182a48e29a642b2bf8367ae2_SignificantAccountingPoliciesDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_808f5be4-2502-4b70-ab3f-99884362fb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_4b46c534-39db-40f3-8345-e4eee4eac9b2" xlink:href="cvs-20210930.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_808f5be4-2502-4b70-ab3f-99884362fb8b" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_4b46c534-39db-40f3-8345-e4eee4eac9b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_d6ae029a-62ca-4087-89e0-af417f291c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_808f5be4-2502-4b70-ab3f-99884362fb8b" xlink:to="loc_us-gaap_NetInvestmentIncome_d6ae029a-62ca-4087-89e0-af417f291c5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_33d379cb-0e6b-452f-ab22-43a77f58aa80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_808f5be4-2502-4b70-ab3f-99884362fb8b" xlink:to="loc_us-gaap_Revenues_33d379cb-0e6b-452f-ab22-43a77f58aa80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d5d91387-5aa1-4a86-97f7-f25755b5c8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_808f5be4-2502-4b70-ab3f-99884362fb8b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d5d91387-5aa1-4a86-97f7-f25755b5c8fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_95349013-8d11-4c76-9c1f-b79c001d97d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d5d91387-5aa1-4a86-97f7-f25755b5c8fa" xlink:to="loc_srt_ConsolidationItemsAxis_95349013-8d11-4c76-9c1f-b79c001d97d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_95349013-8d11-4c76-9c1f-b79c001d97d6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_95349013-8d11-4c76-9c1f-b79c001d97d6" xlink:to="loc_srt_ConsolidationItemsDomain_95349013-8d11-4c76-9c1f-b79c001d97d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d97daf68-75f0-4987-b23d-62b95891bdfd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_95349013-8d11-4c76-9c1f-b79c001d97d6" xlink:to="loc_srt_ConsolidationItemsDomain_d97daf68-75f0-4987-b23d-62b95891bdfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f846916f-fbaf-443d-a901-802e1028066e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d97daf68-75f0-4987-b23d-62b95891bdfd" xlink:to="loc_us-gaap_OperatingSegmentsMember_f846916f-fbaf-443d-a901-802e1028066e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9c431a62-2115-416d-b29f-013dfead8cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d97daf68-75f0-4987-b23d-62b95891bdfd" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9c431a62-2115-416d-b29f-013dfead8cad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_7df286be-3f3a-4d47-a1b7-adf39a7f78b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d97daf68-75f0-4987-b23d-62b95891bdfd" xlink:to="loc_us-gaap_IntersegmentEliminationMember_7df286be-3f3a-4d47-a1b7-adf39a7f78b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fc7f5cd1-28da-4f8f-8072-efdcf1a3832a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d5d91387-5aa1-4a86-97f7-f25755b5c8fa" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fc7f5cd1-28da-4f8f-8072-efdcf1a3832a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fc7f5cd1-28da-4f8f-8072-efdcf1a3832a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fc7f5cd1-28da-4f8f-8072-efdcf1a3832a" xlink:to="loc_us-gaap_SegmentDomain_fc7f5cd1-28da-4f8f-8072-efdcf1a3832a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d5caa8f3-bf28-4fd6-bd4d-9710e8e28b15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fc7f5cd1-28da-4f8f-8072-efdcf1a3832a" xlink:to="loc_us-gaap_SegmentDomain_d5caa8f3-bf28-4fd6-bd4d-9710e8e28b15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_c66dc409-6eaa-477f-a48c-d9862ccbcf18" xlink:href="cvs-20210930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d5caa8f3-bf28-4fd6-bd4d-9710e8e28b15" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_c66dc409-6eaa-477f-a48c-d9862ccbcf18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_e58a2f8b-0609-41c6-af88-d4821f0bc24d" xlink:href="cvs-20210930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d5caa8f3-bf28-4fd6-bd4d-9710e8e28b15" xlink:to="loc_cvs_PharmacyServicesSegmentMember_e58a2f8b-0609-41c6-af88-d4821f0bc24d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_d0b549fd-a427-458a-947f-50145fb129ec" xlink:href="cvs-20210930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d5caa8f3-bf28-4fd6-bd4d-9710e8e28b15" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_d0b549fd-a427-458a-947f-50145fb129ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a90c8071-c7ae-4344-a3ca-fee232a7cdfb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d5d91387-5aa1-4a86-97f7-f25755b5c8fa" xlink:to="loc_srt_ProductOrServiceAxis_a90c8071-c7ae-4344-a3ca-fee232a7cdfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a90c8071-c7ae-4344-a3ca-fee232a7cdfb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a90c8071-c7ae-4344-a3ca-fee232a7cdfb" xlink:to="loc_srt_ProductsAndServicesDomain_a90c8071-c7ae-4344-a3ca-fee232a7cdfb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_64039913-18a9-4cb1-ab9b-508bb551e1cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a90c8071-c7ae-4344-a3ca-fee232a7cdfb" xlink:to="loc_srt_ProductsAndServicesDomain_64039913-18a9-4cb1-ab9b-508bb551e1cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_f19b5919-4f9d-4944-a6df-64c1fa616b89" xlink:href="cvs-20210930.xsd#cvs_PharmacyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64039913-18a9-4cb1-ab9b-508bb551e1cc" xlink:to="loc_cvs_PharmacyRevenueMember_f19b5919-4f9d-4944-a6df-64c1fa616b89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_922f2bd0-4290-4770-bdad-9394831bf303" xlink:href="cvs-20210930.xsd#cvs_FrontStoreRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64039913-18a9-4cb1-ab9b-508bb551e1cc" xlink:to="loc_cvs_FrontStoreRevenueMember_922f2bd0-4290-4770-bdad-9394831bf303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_e6fa4777-29e2-4d9d-bde9-bcd68aa93785" xlink:href="cvs-20210930.xsd#cvs_PremiumsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64039913-18a9-4cb1-ab9b-508bb551e1cc" xlink:to="loc_cvs_PremiumsMember_e6fa4777-29e2-4d9d-bde9-bcd68aa93785" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_14d69ae7-1aba-402e-a46a-2b874e5d82db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64039913-18a9-4cb1-ab9b-508bb551e1cc" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_14d69ae7-1aba-402e-a46a-2b874e5d82db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_c4bf306d-219f-4d8b-a420-4b8b8913640e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d5d91387-5aa1-4a86-97f7-f25755b5c8fa" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_c4bf306d-219f-4d8b-a420-4b8b8913640e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_c4bf306d-219f-4d8b-a420-4b8b8913640e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_c4bf306d-219f-4d8b-a420-4b8b8913640e" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_c4bf306d-219f-4d8b-a420-4b8b8913640e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7ab2f1d3-0af2-4158-a1c2-933ec7b529df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_c4bf306d-219f-4d8b-a420-4b8b8913640e" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7ab2f1d3-0af2-4158-a1c2-933ec7b529df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_1bd4361e-645a-4792-9414-3bb0ce357783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7ab2f1d3-0af2-4158-a1c2-933ec7b529df" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_1bd4361e-645a-4792-9414-3bb0ce357783" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_fba82521-26ef-4eba-ac72-e90c611f8ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7ab2f1d3-0af2-4158-a1c2-933ec7b529df" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_fba82521-26ef-4eba-ac72-e90c611f8ebe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_4757e4a9-e58d-44b9-8ba8-48d762026d6c" xlink:href="cvs-20210930.xsd#cvs_SalesChannelOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7ab2f1d3-0af2-4158-a1c2-933ec7b529df" xlink:to="loc_cvs_SalesChannelOtherMember_4757e4a9-e58d-44b9-8ba8-48d762026d6c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsTotalInvestmentScheduleDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="extended" id="icd212826fe05490da08722f8538f6379_InvestmentsTotalInvestmentScheduleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_619f0e99-424a-4f6f-b3df-9656cae86175" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_574b8c04-007b-4bf4-a597-fab3db92a035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_619f0e99-424a-4f6f-b3df-9656cae86175" xlink:to="loc_us-gaap_ShortTermInvestments_574b8c04-007b-4bf4-a597-fab3db92a035" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_49faf92b-e595-4a26-87c6-ce58d82a07db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_619f0e99-424a-4f6f-b3df-9656cae86175" xlink:to="loc_us-gaap_LongTermInvestments_49faf92b-e595-4a26-87c6-ce58d82a07db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_50d154d0-c424-4698-b92a-7aed3045f094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_619f0e99-424a-4f6f-b3df-9656cae86175" xlink:to="loc_us-gaap_Investments_50d154d0-c424-4698-b92a-7aed3045f094" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_ee7b0f43-767b-482e-a6b3-c5d4ac846f97" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cvs_TotalInvestmentsLineItems_619f0e99-424a-4f6f-b3df-9656cae86175" xlink:to="loc_cvs_TotalInvestmentsTable_ee7b0f43-767b-482e-a6b3-c5d4ac846f97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_322f76f3-f8b6-458d-91d4-d4aa480094ea" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_TotalInvestmentsTable_ee7b0f43-767b-482e-a6b3-c5d4ac846f97" xlink:to="loc_cvs_TotalInvestmentsAxis_322f76f3-f8b6-458d-91d4-d4aa480094ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_322f76f3-f8b6-458d-91d4-d4aa480094ea_default" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_TotalInvestmentsAxis_322f76f3-f8b6-458d-91d4-d4aa480094ea" xlink:to="loc_cvs_TotalInvestmentsDomain_322f76f3-f8b6-458d-91d4-d4aa480094ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_9a16f55e-4678-4fa9-909b-e38061116cf2" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_TotalInvestmentsAxis_322f76f3-f8b6-458d-91d4-d4aa480094ea" xlink:to="loc_cvs_TotalInvestmentsDomain_9a16f55e-4678-4fa9-909b-e38061116cf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_a9c76f51-25a6-49b9-8c2e-8e02a240f7bc" xlink:href="cvs-20210930.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_9a16f55e-4678-4fa9-909b-e38061116cf2" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_a9c76f51-25a6-49b9-8c2e-8e02a240f7bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_ace92b43-f8e3-4e85-aea5-03891a41e404" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_9a16f55e-4678-4fa9-909b-e38061116cf2" xlink:to="loc_cvs_MortgageLoansMember_ace92b43-f8e3-4e85-aea5-03891a41e404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_6483fff9-d1e7-4a13-9759-d2317f113414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_9a16f55e-4678-4fa9-909b-e38061116cf2" xlink:to="loc_us-gaap_OtherInvestmentsMember_6483fff9-d1e7-4a13-9759-d2317f113414" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended" id="i00bb8e1fd1c84d4c9c40208cf38fdc3a_InvestmentsDebtSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_8da9d36b-8fc5-4db5-9b59-6ae166455e49" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_8da9d36b-8fc5-4db5-9b59-6ae166455e49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_257e9f2b-48a3-4020-ab73-154bdf06fc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_257e9f2b-48a3-4020-ab73-154bdf06fc1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_cfc981d4-f201-422d-947a-92bf2cddd3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_cfc981d4-f201-422d-947a-92bf2cddd3cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cbe24ddc-5028-403b-88f8-408c47c00b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cbe24ddc-5028-403b-88f8-408c47c00b9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_2c88a641-a50f-4c43-880d-1fa23828cd55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_2c88a641-a50f-4c43-880d-1fa23828cd55" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2c071bd8-f14d-466a-b149-a3ca40f94211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2c071bd8-f14d-466a-b149-a3ca40f94211" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ee674efb-7109-4029-9926-54afc4f3535b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2c071bd8-f14d-466a-b149-a3ca40f94211" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ee674efb-7109-4029-9926-54afc4f3535b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ee674efb-7109-4029-9926-54afc4f3535b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ee674efb-7109-4029-9926-54afc4f3535b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ee674efb-7109-4029-9926-54afc4f3535b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9aa43fdf-2d07-441a-80b4-836bbbfe08fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ee674efb-7109-4029-9926-54afc4f3535b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9aa43fdf-2d07-441a-80b4-836bbbfe08fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9aa43fdf-2d07-441a-80b4-836bbbfe08fb" xlink:to="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4febc233-700f-462e-982a-99318f936bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4febc233-700f-462e-982a-99318f936bf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_7d448d4f-844f-4f11-9d13-abccd017959b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_7d448d4f-844f-4f11-9d13-abccd017959b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_4aded417-278a-4832-b54c-c267be936392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_4aded417-278a-4832-b54c-c267be936392" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_e4aeb7d6-3de5-401c-8a83-6dae1f91b399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_e4aeb7d6-3de5-401c-8a83-6dae1f91b399" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d3cf0d2d-41b2-444b-b06b-a1263714f251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d3cf0d2d-41b2-444b-b06b-a1263714f251" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8d9ec6a0-1298-4bee-8040-78c60c1bc83a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8d9ec6a0-1298-4bee-8040-78c60c1bc83a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_c7ebeb1d-480a-4cac-9cf2-e0a50fdd2e26" xlink:href="cvs-20210930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_c7ebeb1d-480a-4cac-9cf2-e0a50fdd2e26" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_028e03d5-1e15-4a26-a197-d71d88bbb9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_028e03d5-1e15-4a26-a197-d71d88bbb9f9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5323ba8b-9925-4c83-a4e9-c1a9b0b5a4ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2c071bd8-f14d-466a-b149-a3ca40f94211" xlink:to="loc_srt_ProductOrServiceAxis_5323ba8b-9925-4c83-a4e9-c1a9b0b5a4ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5323ba8b-9925-4c83-a4e9-c1a9b0b5a4ea_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5323ba8b-9925-4c83-a4e9-c1a9b0b5a4ea" xlink:to="loc_srt_ProductsAndServicesDomain_5323ba8b-9925-4c83-a4e9-c1a9b0b5a4ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d308884e-3b68-4fe1-8b41-cb1fdbcedb6f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5323ba8b-9925-4c83-a4e9-c1a9b0b5a4ea" xlink:to="loc_srt_ProductsAndServicesDomain_d308884e-3b68-4fe1-8b41-cb1fdbcedb6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_a190709d-3a45-465c-b25f-5a7df484f420" xlink:href="cvs-20210930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d308884e-3b68-4fe1-8b41-cb1fdbcedb6f" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_a190709d-3a45-465c-b25f-5a7df484f420" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended" id="i860322676dc242bf8e0f6650e9f09473_InvestmentsDebtSecuritiesbyMaturityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_bb465807-b4e0-47ac-bd6b-ef11481ec0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_bb465807-b4e0-47ac-bd6b-ef11481ec0ec" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_0d99c431-a6d3-4676-a9a1-a32364fba8bd" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_0d99c431-a6d3-4676-a9a1-a32364fba8bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_b1a97f59-a444-4c12-b7d6-3bfb838d94f7" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_b1a97f59-a444-4c12-b7d6-3bfb838d94f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_99220582-373d-485f-8f44-083e53917ebd" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_99220582-373d-485f-8f44-083e53917ebd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_515ae94b-26d0-4aac-8ed0-670e4b7ccbe5" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_515ae94b-26d0-4aac-8ed0-670e4b7ccbe5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_42fbba5b-b69c-4cf6-965f-293fcd16a2aa" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_42fbba5b-b69c-4cf6-965f-293fcd16a2aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_0d5b0fc8-1419-435d-9a97-4c4d36663c48" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_0d5b0fc8-1419-435d-9a97-4c4d36663c48" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_bb465807-b4e0-47ac-bd6b-ef11481ec0ec" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5d5ff0c8-7ec1-4935-af0d-77e1de1c7a64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5d5ff0c8-7ec1-4935-af0d-77e1de1c7a64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0d6c14d5-7a31-48f7-b3ed-b5bc78f15c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0d6c14d5-7a31-48f7-b3ed-b5bc78f15c9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_bbd0d018-e6d6-4a83-bba6-9e4c80ddeaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_bbd0d018-e6d6-4a83-bba6-9e4c80ddeaa8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_cfab2cca-6d5e-4dae-8d88-7a2e162b7063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_cfab2cca-6d5e-4dae-8d88-7a2e162b7063" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_00a8e2cc-b685-464a-8d17-3971c66fbb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_00a8e2cc-b685-464a-8d17-3971c66fbb3d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ab6dca7e-5d0e-45d3-acba-479a775ec39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ab6dca7e-5d0e-45d3-acba-479a775ec39e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ad30d06b-c533-4274-b10b-59e5859ab105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_bb465807-b4e0-47ac-bd6b-ef11481ec0ec" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ad30d06b-c533-4274-b10b-59e5859ab105" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b3e70b80-7e4e-469e-ba80-8be3c7beff9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ad30d06b-c533-4274-b10b-59e5859ab105" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b3e70b80-7e4e-469e-ba80-8be3c7beff9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3e70b80-7e4e-469e-ba80-8be3c7beff9c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b3e70b80-7e4e-469e-ba80-8be3c7beff9c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3e70b80-7e4e-469e-ba80-8be3c7beff9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bdfab320-d46d-4926-8a86-853505f02da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b3e70b80-7e4e-469e-ba80-8be3c7beff9c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bdfab320-d46d-4926-8a86-853505f02da9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_cc3df7aa-83a3-4500-bf9a-7e7dc57792a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bdfab320-d46d-4926-8a86-853505f02da9" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_cc3df7aa-83a3-4500-bf9a-7e7dc57792a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_77ef3bf1-a169-49eb-8d25-a46c39c4fe2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bdfab320-d46d-4926-8a86-853505f02da9" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_77ef3bf1-a169-49eb-8d25-a46c39c4fe2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_5967106e-2e71-45d7-9c97-b9d3c2c52157" xlink:href="cvs-20210930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bdfab320-d46d-4926-8a86-853505f02da9" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_5967106e-2e71-45d7-9c97-b9d3c2c52157" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended" id="i6279ea49078e4a2d9f12a21017786991_InvestmentsUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_53ce674b-e78b-4be6-9b1f-4f931effb2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_eaa45e08-87e4-480b-9c92-1b47fd1f3892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_53ce674b-e78b-4be6-9b1f-4f931effb2b7" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_eaa45e08-87e4-480b-9c92-1b47fd1f3892" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0af349c7-f0bf-496c-ae21-614d5f641264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_eaa45e08-87e4-480b-9c92-1b47fd1f3892" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0af349c7-f0bf-496c-ae21-614d5f641264" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_ab5c9542-1eea-4bcd-871e-aec1684246d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_eaa45e08-87e4-480b-9c92-1b47fd1f3892" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_ab5c9542-1eea-4bcd-871e-aec1684246d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_14caf2c3-7d23-4b1c-8425-f5e8ada14a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_eaa45e08-87e4-480b-9c92-1b47fd1f3892" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_14caf2c3-7d23-4b1c-8425-f5e8ada14a52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_8a57e0b8-327b-4e88-b0e8-b8be42386f5e" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_53ce674b-e78b-4be6-9b1f-4f931effb2b7" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_8a57e0b8-327b-4e88-b0e8-b8be42386f5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_92504034-fafc-433f-a4e7-7a0b89f90ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_8a57e0b8-327b-4e88-b0e8-b8be42386f5e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_92504034-fafc-433f-a4e7-7a0b89f90ebb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_898df459-d120-4980-bd0f-7fec7c0df975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_8a57e0b8-327b-4e88-b0e8-b8be42386f5e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_898df459-d120-4980-bd0f-7fec7c0df975" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ad4ee5a3-5d55-42f0-a189-c1827d0b9a15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_8a57e0b8-327b-4e88-b0e8-b8be42386f5e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ad4ee5a3-5d55-42f0-a189-c1827d0b9a15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f500bd1a-aca9-47a5-b3bb-294f824b2015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_53ce674b-e78b-4be6-9b1f-4f931effb2b7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f500bd1a-aca9-47a5-b3bb-294f824b2015" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_79fc5ea1-75a2-424d-913d-510c933169c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f500bd1a-aca9-47a5-b3bb-294f824b2015" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_79fc5ea1-75a2-424d-913d-510c933169c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_5a3945aa-2719-4ba2-950a-38552f2f0b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f500bd1a-aca9-47a5-b3bb-294f824b2015" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_5a3945aa-2719-4ba2-950a-38552f2f0b3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f59c106d-117b-4cd7-b57e-c268696baae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f500bd1a-aca9-47a5-b3bb-294f824b2015" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f59c106d-117b-4cd7-b57e-c268696baae6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_bebfe43d-f527-442c-a801-8eefc1c1d41d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_53ce674b-e78b-4be6-9b1f-4f931effb2b7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_bebfe43d-f527-442c-a801-8eefc1c1d41d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5733ff07-edd1-42c9-a558-9ada632d1009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_bebfe43d-f527-442c-a801-8eefc1c1d41d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5733ff07-edd1-42c9-a558-9ada632d1009" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5733ff07-edd1-42c9-a558-9ada632d1009_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5733ff07-edd1-42c9-a558-9ada632d1009" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5733ff07-edd1-42c9-a558-9ada632d1009_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5733ff07-edd1-42c9-a558-9ada632d1009" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_25cd3b6b-5a45-4c18-9ba3-4d437f8f4604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_25cd3b6b-5a45-4c18-9ba3-4d437f8f4604" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_75d6fa79-2a00-4024-bc63-6014efe3b84c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_75d6fa79-2a00-4024-bc63-6014efe3b84c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_8773dc5f-1af9-4542-94fe-da7b1ad270c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_8773dc5f-1af9-4542-94fe-da7b1ad270c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_fcf60d0b-bbd7-469b-9083-42a10fdd9d52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_fcf60d0b-bbd7-469b-9083-42a10fdd9d52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_61837fae-bfee-45ac-ada1-37c895ac85ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_61837fae-bfee-45ac-ada1-37c895ac85ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_19d01be6-17dd-4b1b-97b1-ccbf924f9caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_19d01be6-17dd-4b1b-97b1-ccbf924f9caa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_b9d925ae-ca50-47b0-891e-1497a082ad5e" xlink:href="cvs-20210930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_b9d925ae-ca50-47b0-891e-1497a082ad5e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_8d7afdc0-b7af-43b9-a980-dbc2f56740b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_8d7afdc0-b7af-43b9-a980-dbc2f56740b8" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended" id="ia62986c9e784430495ab3fa78276509d_InvestmentsUnrealizedLossPositionMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c356f14b-a093-4e94-b7fe-e789fbfbd52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c356f14b-a093-4e94-b7fe-e789fbfbd52b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_d66d9cc9-eec5-47fb-9fb0-d8205dea9f13" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_d66d9cc9-eec5-47fb-9fb0-d8205dea9f13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_f603565e-dda4-4d70-92ab-a734e1ba11bb" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_f603565e-dda4-4d70-92ab-a734e1ba11bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_e1fe60da-a151-4aa4-a027-002ac29a844a" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_e1fe60da-a151-4aa4-a027-002ac29a844a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_3192bf8a-0266-4d7f-9630-cc10e685fd18" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_3192bf8a-0266-4d7f-9630-cc10e685fd18" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_bf96a679-8310-4e67-aa53-35afd0d9989b" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_bf96a679-8310-4e67-aa53-35afd0d9989b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_49a00ff2-d96e-4474-958a-662c3f194169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_49a00ff2-d96e-4474-958a-662c3f194169" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c356f14b-a093-4e94-b7fe-e789fbfbd52b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_63e5c1d4-7cd1-463c-bd46-df2550d754df" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_63e5c1d4-7cd1-463c-bd46-df2550d754df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_a9b0f2c2-2dd2-4d77-9e44-eecd6f92dbad" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_a9b0f2c2-2dd2-4d77-9e44-eecd6f92dbad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_d8ded535-bc25-4f16-be5d-8819a2ab13e0" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_d8ded535-bc25-4f16-be5d-8819a2ab13e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_b3239599-3fa6-42d9-aebe-f8d8677bbb96" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_b3239599-3fa6-42d9-aebe-f8d8677bbb96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_aa4d70ea-3ac1-43d6-ad55-b88bdc68bbca" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_aa4d70ea-3ac1-43d6-ad55-b88bdc68bbca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ecf09dc0-58eb-4665-a10c-fe53d7b02714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ecf09dc0-58eb-4665-a10c-fe53d7b02714" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_474c1081-2fae-4246-9950-9ff79f814790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c356f14b-a093-4e94-b7fe-e789fbfbd52b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_474c1081-2fae-4246-9950-9ff79f814790" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f8cf470d-adbe-4a78-b725-5430a464b2e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_474c1081-2fae-4246-9950-9ff79f814790" xlink:to="loc_srt_ProductOrServiceAxis_f8cf470d-adbe-4a78-b725-5430a464b2e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f8cf470d-adbe-4a78-b725-5430a464b2e3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f8cf470d-adbe-4a78-b725-5430a464b2e3" xlink:to="loc_srt_ProductsAndServicesDomain_f8cf470d-adbe-4a78-b725-5430a464b2e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c90955e2-af38-4a76-a626-2e620a2767b0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f8cf470d-adbe-4a78-b725-5430a464b2e3" xlink:to="loc_srt_ProductsAndServicesDomain_c90955e2-af38-4a76-a626-2e620a2767b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_315e8adc-b917-49d0-8db3-39cd466f206e" xlink:href="cvs-20210930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c90955e2-af38-4a76-a626-2e620a2767b0" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_315e8adc-b917-49d0-8db3-39cd466f206e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_ea724d11-dfb1-4124-be89-95a06bfa01b4" xlink:href="cvs-20210930.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c90955e2-af38-4a76-a626-2e620a2767b0" xlink:to="loc_cvs_SupportingRemainingProductsMember_ea724d11-dfb1-4124-be89-95a06bfa01b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6acd048d-0f04-4b80-966f-271d3abd5455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_474c1081-2fae-4246-9950-9ff79f814790" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6acd048d-0f04-4b80-966f-271d3abd5455" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6acd048d-0f04-4b80-966f-271d3abd5455_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6acd048d-0f04-4b80-966f-271d3abd5455" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6acd048d-0f04-4b80-966f-271d3abd5455_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_06a72bb5-be10-4bbf-9251-a420b0bb2cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6acd048d-0f04-4b80-966f-271d3abd5455" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_06a72bb5-be10-4bbf-9251-a420b0bb2cb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3c3befb7-7c5f-47f1-888b-5df604853a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_06a72bb5-be10-4bbf-9251-a420b0bb2cb1" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3c3befb7-7c5f-47f1-888b-5df604853a7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_70c643ea-e427-4889-ad7d-7277237cf8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_06a72bb5-be10-4bbf-9251-a420b0bb2cb1" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_70c643ea-e427-4889-ad7d-7277237cf8a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_de070762-fe70-4fa5-941a-44d775b8e2df" xlink:href="cvs-20210930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_06a72bb5-be10-4bbf-9251-a420b0bb2cb1" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_de070762-fe70-4fa5-941a-44d775b8e2df" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsMortgageLoansDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended" id="i78de7540517d4147a3014b7069f75cdc_InvestmentsMortgageLoansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_843876f0-61c9-4c8b-abca-723b03ba7c3c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_a4d9be65-81a7-4370-9df9-d834a7055ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_843876f0-61c9-4c8b-abca-723b03ba7c3c" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_a4d9be65-81a7-4370-9df9-d834a7055ccd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_1b6010cd-0e1d-45c2-81be-6b99a52cced7" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_843876f0-61c9-4c8b-abca-723b03ba7c3c" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_1b6010cd-0e1d-45c2-81be-6b99a52cced7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_73a71d6c-2d8a-41d1-80cd-952c93c404cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_843876f0-61c9-4c8b-abca-723b03ba7c3c" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_73a71d6c-2d8a-41d1-80cd-952c93c404cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_862cf1a7-db67-4334-91ce-f62489b4f252" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_843876f0-61c9-4c8b-abca-723b03ba7c3c" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_862cf1a7-db67-4334-91ce-f62489b4f252" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_6489a453-4851-4261-bd98-358c7eab37d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_862cf1a7-db67-4334-91ce-f62489b4f252" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_6489a453-4851-4261-bd98-358c7eab37d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_6489a453-4851-4261-bd98-358c7eab37d1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_6489a453-4851-4261-bd98-358c7eab37d1" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_6489a453-4851-4261-bd98-358c7eab37d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_50d6d818-d4f4-4e86-aa15-7ef3aa51ea2a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_6489a453-4851-4261-bd98-358c7eab37d1" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_50d6d818-d4f4-4e86-aa15-7ef3aa51ea2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_dcbb8658-88af-4a62-b1a9-a1c10c6da673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_50d6d818-d4f4-4e86-aa15-7ef3aa51ea2a" xlink:to="loc_us-gaap_CommercialRealEstateMember_dcbb8658-88af-4a62-b1a9-a1c10c6da673" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended" id="i9b4feca5142a4772be87ab7847e76af1_InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_7c5464ab-309d-45da-b1a6-3c43ed2ff12f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_5a95d565-8ec7-4eb6-80fa-ab4dfa8f88a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_7c5464ab-309d-45da-b1a6-3c43ed2ff12f" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_5a95d565-8ec7-4eb6-80fa-ab4dfa8f88a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_81f4b36f-2970-4303-b3a1-3d02c6bf1d7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_7c5464ab-309d-45da-b1a6-3c43ed2ff12f" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_81f4b36f-2970-4303-b3a1-3d02c6bf1d7a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_a44a0dc8-0378-4f1b-9fb8-684fcd1e786b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_81f4b36f-2970-4303-b3a1-3d02c6bf1d7a" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_a44a0dc8-0378-4f1b-9fb8-684fcd1e786b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_a44a0dc8-0378-4f1b-9fb8-684fcd1e786b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_a44a0dc8-0378-4f1b-9fb8-684fcd1e786b" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_a44a0dc8-0378-4f1b-9fb8-684fcd1e786b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d862314d-dfda-47e8-864e-87553b9eab30" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_a44a0dc8-0378-4f1b-9fb8-684fcd1e786b" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d862314d-dfda-47e8-864e-87553b9eab30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_56c5f6f5-6605-4cfe-9934-f77659ddd97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d862314d-dfda-47e8-864e-87553b9eab30" xlink:to="loc_us-gaap_CommercialRealEstateMember_56c5f6f5-6605-4cfe-9934-f77659ddd97c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_e74d0b52-15c3-421e-88a8-e7d133545788" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_81f4b36f-2970-4303-b3a1-3d02c6bf1d7a" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_e74d0b52-15c3-421e-88a8-e7d133545788" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_e74d0b52-15c3-421e-88a8-e7d133545788_default" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_e74d0b52-15c3-421e-88a8-e7d133545788" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_e74d0b52-15c3-421e-88a8-e7d133545788_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_e74d0b52-15c3-421e-88a8-e7d133545788" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_c272eb71-b62c-4017-86b2-bdab96814088" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_c272eb71-b62c-4017-86b2-bdab96814088" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_2fbedf7f-389d-4a45-9e07-9e91bd53deeb" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_2fbedf7f-389d-4a45-9e07-9e91bd53deeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_0b582e5a-da5d-4f8d-af80-094b6a336f20" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_0b582e5a-da5d-4f8d-af80-094b6a336f20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_0337de41-0725-43ce-83db-6d35fe2213bd" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_0337de41-0725-43ce-83db-6d35fe2213bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_999791dd-60e4-44bb-aabc-899d74eb2e05" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_999791dd-60e4-44bb-aabc-899d74eb2e05" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_67fc7358-04c1-40cb-8ad0-3d793e207f2b" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_67fc7358-04c1-40cb-8ad0-3d793e207f2b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_c1fe0549-d994-42b0-b656-a0f083e9de73" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_81f4b36f-2970-4303-b3a1-3d02c6bf1d7a" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_c1fe0549-d994-42b0-b656-a0f083e9de73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_c1fe0549-d994-42b0-b656-a0f083e9de73_default" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_c1fe0549-d994-42b0-b656-a0f083e9de73" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_c1fe0549-d994-42b0-b656-a0f083e9de73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_75ec03c1-61a1-4dbb-a65a-fcf8ea3d1f7b" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_c1fe0549-d994-42b0-b656-a0f083e9de73" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_75ec03c1-61a1-4dbb-a65a-fcf8ea3d1f7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_11f504df-7b01-458a-aa68-5885602bc966" xlink:href="cvs-20210930.xsd#cvs_Category1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_75ec03c1-61a1-4dbb-a65a-fcf8ea3d1f7b" xlink:to="loc_cvs_Category1Member_11f504df-7b01-458a-aa68-5885602bc966" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_0f04b6ca-7928-4c92-8c9a-5774dda6f690" xlink:href="cvs-20210930.xsd#cvs_Category2To4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_75ec03c1-61a1-4dbb-a65a-fcf8ea3d1f7b" xlink:to="loc_cvs_Category2To4Member_0f04b6ca-7928-4c92-8c9a-5774dda6f690" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_a2fd9eb7-cb6d-48bb-988a-90b353f4ef13" xlink:href="cvs-20210930.xsd#cvs_Categories5and6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_75ec03c1-61a1-4dbb-a65a-fcf8ea3d1f7b" xlink:to="loc_cvs_Categories5and6Member_a2fd9eb7-cb6d-48bb-988a-90b353f4ef13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_064ec7b6-31c2-4d7d-9b36-c8289c7caa73" xlink:href="cvs-20210930.xsd#cvs_Category7Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_75ec03c1-61a1-4dbb-a65a-fcf8ea3d1f7b" xlink:to="loc_cvs_Category7Member_064ec7b6-31c2-4d7d-9b36-c8289c7caa73" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended" id="i5f10273d41c545d984e87ad4899adfee_InvestmentsNetInvestmentIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_542e55ee-3c13-4dbe-9463-2248a01cc347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_542e55ee-3c13-4dbe-9463-2248a01cc347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_b1fcd77d-40df-4e72-b575-cb69024e82c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_b1fcd77d-40df-4e72-b575-cb69024e82c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_b4763d41-573e-4f0b-959e-5b38fd666593" xlink:href="cvs-20210930.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_b4763d41-573e-4f0b-959e-5b38fd666593" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_8334970d-4485-4134-a22d-3935cee29ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_8334970d-4485-4134-a22d-3935cee29ef8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_f71af3c1-9fff-4606-8036-487d59513b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_us-gaap_InvestmentIncomeNet_f71af3c1-9fff-4606-8036-487d59513b5a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_df4768c2-b851-4062-9960-7cd12a1db1c3" xlink:href="cvs-20210930.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_df4768c2-b851-4062-9960-7cd12a1db1c3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_65ce98df-06dc-4eeb-884c-e2b651e9e069" xlink:href="cvs-20210930.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_65ce98df-06dc-4eeb-884c-e2b651e9e069" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_512f728b-33ce-4506-8c21-b0850b2d7c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_512f728b-33ce-4506-8c21-b0850b2d7c28" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4a4f86c6-deb8-40cb-b8b9-a8a402377e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_512f728b-33ce-4506-8c21-b0850b2d7c28" xlink:to="loc_us-gaap_InvestmentTypeAxis_4a4f86c6-deb8-40cb-b8b9-a8a402377e54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_4a4f86c6-deb8-40cb-b8b9-a8a402377e54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_4a4f86c6-deb8-40cb-b8b9-a8a402377e54" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_4a4f86c6-deb8-40cb-b8b9-a8a402377e54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_cebfb96f-db2d-470a-a063-3fd240621799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_4a4f86c6-deb8-40cb-b8b9-a8a402377e54" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_cebfb96f-db2d-470a-a063-3fd240621799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_2ef14ec0-1328-46c5-a9b4-efc31cbb6f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_cebfb96f-db2d-470a-a063-3fd240621799" xlink:to="loc_us-gaap_DebtSecuritiesMember_2ef14ec0-1328-46c5-a9b4-efc31cbb6f97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_f06f2063-804e-4cc2-ab68-c4f121996b9d" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_cebfb96f-db2d-470a-a063-3fd240621799" xlink:to="loc_cvs_MortgageLoansMember_f06f2063-804e-4cc2-ab68-c4f121996b9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_4a8e0c13-171d-48c3-8db2-a331f5d856b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_cebfb96f-db2d-470a-a063-3fd240621799" xlink:to="loc_us-gaap_OtherInvestmentsMember_4a8e0c13-171d-48c3-8db2-a331f5d856b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_706ce3ea-c35c-45e5-9d3d-945b1ffdc7cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_512f728b-33ce-4506-8c21-b0850b2d7c28" xlink:to="loc_srt_ProductOrServiceAxis_706ce3ea-c35c-45e5-9d3d-945b1ffdc7cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_706ce3ea-c35c-45e5-9d3d-945b1ffdc7cb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_706ce3ea-c35c-45e5-9d3d-945b1ffdc7cb" xlink:to="loc_srt_ProductsAndServicesDomain_706ce3ea-c35c-45e5-9d3d-945b1ffdc7cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8514258a-3447-44c7-a733-c27413c09ae0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_706ce3ea-c35c-45e5-9d3d-945b1ffdc7cb" xlink:to="loc_srt_ProductsAndServicesDomain_8514258a-3447-44c7-a733-c27413c09ae0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_d37faef5-cbf1-460f-9634-8471d7590cf4" xlink:href="cvs-20210930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8514258a-3447-44c7-a733-c27413c09ae0" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_d37faef5-cbf1-460f-9634-8471d7590cf4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended" id="id57906f276964597a5dd6b34eeca07f3_FairValueMeasurementonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_3fed392f-9d92-41ef-8b55-32cd1375413d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_3fed392f-9d92-41ef-8b55-32cd1375413d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_930fe4c3-1ea7-40e6-a557-f98fdc6b921d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_930fe4c3-1ea7-40e6-a557-f98fdc6b921d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7ae79207-daf4-47a2-80ba-0ae617251cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7ae79207-daf4-47a2-80ba-0ae617251cb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_cd6d2844-8310-40a6-83b2-bda6e96a1d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_cd6d2844-8310-40a6-83b2-bda6e96a1d3e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9e9fc698-d527-4617-a3a3-dccc21a475d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_9e9fc698-d527-4617-a3a3-dccc21a475d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4265076d-51fd-4480-9823-7fc12c53b626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4265076d-51fd-4480-9823-7fc12c53b626" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e1926fd-a4f2-4dc7-baba-cae3ce98d1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4265076d-51fd-4480-9823-7fc12c53b626" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e1926fd-a4f2-4dc7-baba-cae3ce98d1d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6e1926fd-a4f2-4dc7-baba-cae3ce98d1d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e1926fd-a4f2-4dc7-baba-cae3ce98d1d4" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6e1926fd-a4f2-4dc7-baba-cae3ce98d1d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b036bf9c-2bec-4202-9d34-b987da96b22b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e1926fd-a4f2-4dc7-baba-cae3ce98d1d4" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b036bf9c-2bec-4202-9d34-b987da96b22b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_95f31cdb-f06b-4323-bdf1-aecf301a8a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b036bf9c-2bec-4202-9d34-b987da96b22b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_95f31cdb-f06b-4323-bdf1-aecf301a8a52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b265b504-dd13-4331-9709-fee86b5337b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4265076d-51fd-4480-9823-7fc12c53b626" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b265b504-dd13-4331-9709-fee86b5337b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b265b504-dd13-4331-9709-fee86b5337b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b265b504-dd13-4331-9709-fee86b5337b9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b265b504-dd13-4331-9709-fee86b5337b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b265b504-dd13-4331-9709-fee86b5337b9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_48f1e100-b8e2-4cf4-b7d9-4d6716e80e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_48f1e100-b8e2-4cf4-b7d9-4d6716e80e26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_459914ec-5536-4564-8015-5816a8a3b2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_459914ec-5536-4564-8015-5816a8a3b2e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_0d2268cb-e9ca-4bef-93e4-5bfb9fbecd2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_0d2268cb-e9ca-4bef-93e4-5bfb9fbecd2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_ac319efc-26dd-4b8f-939d-54564f818a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_ac319efc-26dd-4b8f-939d-54564f818a4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_cf8c25d6-72b0-448c-af48-c879ebfb6775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_cf8c25d6-72b0-448c-af48-c879ebfb6775" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_7264bbdb-dd38-46c1-a1e3-fc441b8c842b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_7264bbdb-dd38-46c1-a1e3-fc441b8c842b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_47f71d2c-93e8-4509-b29d-7f7994c6e955" xlink:href="cvs-20210930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_47f71d2c-93e8-4509-b29d-7f7994c6e955" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_eb1c66a5-3d7b-48d1-9781-ad02a340fa09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_eb1c66a5-3d7b-48d1-9781-ad02a340fa09" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9ff9b61-f531-408c-a628-e6354be7becd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4265076d-51fd-4480-9823-7fc12c53b626" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9ff9b61-f531-408c-a628-e6354be7becd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9ff9b61-f531-408c-a628-e6354be7becd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9ff9b61-f531-408c-a628-e6354be7becd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9ff9b61-f531-408c-a628-e6354be7becd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94191bfb-d687-4673-857a-5a1ef150dfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9ff9b61-f531-408c-a628-e6354be7becd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94191bfb-d687-4673-857a-5a1ef150dfd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_119436be-ef79-4eb5-8299-e6623ce73e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94191bfb-d687-4673-857a-5a1ef150dfd5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_119436be-ef79-4eb5-8299-e6623ce73e8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_15040309-4072-49d8-8475-7b1444f70de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94191bfb-d687-4673-857a-5a1ef150dfd5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_15040309-4072-49d8-8475-7b1444f70de9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_308091a5-8bd1-498b-9c93-ab581c365cae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94191bfb-d687-4673-857a-5a1ef150dfd5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_308091a5-8bd1-498b-9c93-ab581c365cae" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended" id="i7dc6c252c1ad48bb836376cdf464c3f3_FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6d1d5752-1493-4974-ad8c-53a34d776a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_aa0b0b3e-e53e-48d4-b05b-df8e33095d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6d1d5752-1493-4974-ad8c-53a34d776a7c" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_aa0b0b3e-e53e-48d4-b05b-df8e33095d3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_a21c8e94-2cc6-4c7d-ae3b-922a6ecfbc93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_aa0b0b3e-e53e-48d4-b05b-df8e33095d3a" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_a21c8e94-2cc6-4c7d-ae3b-922a6ecfbc93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_98f045d6-d78b-4820-ad84-9b280e4373e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_aa0b0b3e-e53e-48d4-b05b-df8e33095d3a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_98f045d6-d78b-4820-ad84-9b280e4373e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_bce5a6b5-3b18-4e4b-9e56-515325be6e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6d1d5752-1493-4974-ad8c-53a34d776a7c" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_bce5a6b5-3b18-4e4b-9e56-515325be6e24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_7e6ce08a-3266-432d-9cff-48ee5b8b2a4b" xlink:href="cvs-20210930.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_bce5a6b5-3b18-4e4b-9e56-515325be6e24" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_7e6ce08a-3266-432d-9cff-48ee5b8b2a4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_98c59df1-62d1-4c69-9a99-0a86a8515048" xlink:href="cvs-20210930.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_bce5a6b5-3b18-4e4b-9e56-515325be6e24" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_98c59df1-62d1-4c69-9a99-0a86a8515048" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_1f04c108-99e3-4fea-86d1-ed5641bd9518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_bce5a6b5-3b18-4e4b-9e56-515325be6e24" xlink:to="loc_us-gaap_DebtInstrumentFairValue_1f04c108-99e3-4fea-86d1-ed5641bd9518" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_aa88d89e-ca59-41e1-8bf6-11701155620f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6d1d5752-1493-4974-ad8c-53a34d776a7c" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_aa88d89e-ca59-41e1-8bf6-11701155620f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28da8fec-ede4-4825-97ec-8305b0023101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_aa88d89e-ca59-41e1-8bf6-11701155620f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28da8fec-ede4-4825-97ec-8305b0023101" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_28da8fec-ede4-4825-97ec-8305b0023101_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28da8fec-ede4-4825-97ec-8305b0023101" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_28da8fec-ede4-4825-97ec-8305b0023101_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_cac37923-e792-4143-bd7d-ee36b213dbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28da8fec-ede4-4825-97ec-8305b0023101" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_cac37923-e792-4143-bd7d-ee36b213dbb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_edc3dddb-1f87-4652-b685-bb1d539fa198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_cac37923-e792-4143-bd7d-ee36b213dbb7" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_edc3dddb-1f87-4652-b685-bb1d539fa198" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a4cceaf-84ae-445b-960a-502b1a7256f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_aa88d89e-ca59-41e1-8bf6-11701155620f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a4cceaf-84ae-445b-960a-502b1a7256f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a4cceaf-84ae-445b-960a-502b1a7256f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a4cceaf-84ae-445b-960a-502b1a7256f1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a4cceaf-84ae-445b-960a-502b1a7256f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be10da61-2d18-417b-95f3-dc070e6ac9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a4cceaf-84ae-445b-960a-502b1a7256f1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be10da61-2d18-417b-95f3-dc070e6ac9fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_af299dd3-346d-488f-843b-920ff311b6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be10da61-2d18-417b-95f3-dc070e6ac9fe" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_af299dd3-346d-488f-843b-920ff311b6d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0139d0c3-25ef-4a93-8d40-9c0f705fe4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be10da61-2d18-417b-95f3-dc070e6ac9fe" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0139d0c3-25ef-4a93-8d40-9c0f705fe4eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_99fea7fd-925d-4b68-9dd6-7f58790950fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be10da61-2d18-417b-95f3-dc070e6ac9fe" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_99fea7fd-925d-4b68-9dd6-7f58790950fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_7cb389d7-cdf5-4e9e-916a-81c740fa4d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be10da61-2d18-417b-95f3-dc070e6ac9fe" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_7cb389d7-cdf5-4e9e-916a-81c740fa4d22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_9190776d-b3f8-4c24-8082-569f1afafbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_aa88d89e-ca59-41e1-8bf6-11701155620f" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_9190776d-b3f8-4c24-8082-569f1afafbd3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9190776d-b3f8-4c24-8082-569f1afafbd3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_9190776d-b3f8-4c24-8082-569f1afafbd3" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9190776d-b3f8-4c24-8082-569f1afafbd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0bcc25bb-ec9d-45ec-88fc-eeed074ff9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_9190776d-b3f8-4c24-8082-569f1afafbd3" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0bcc25bb-ec9d-45ec-88fc-eeed074ff9cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_c5e16c35-c42e-43bc-826e-640828bd95fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0bcc25bb-ec9d-45ec-88fc-eeed074ff9cb" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_c5e16c35-c42e-43bc-826e-640828bd95fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d26d0bb9-8015-4ec3-8b83-e38114e28398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_c5e16c35-c42e-43bc-826e-640828bd95fc" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d26d0bb9-8015-4ec3-8b83-e38114e28398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8afba158-f675-4d7c-a71a-603638c3d24c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_c5e16c35-c42e-43bc-826e-640828bd95fc" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8afba158-f675-4d7c-a71a-603638c3d24c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended" id="ic168124e5e6e4ce1910178f55ed5a1f8_FairValueSeparateAccountsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9619ac2d-fecc-40b3-9697-90e5a68d4903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_e298fe30-196e-41be-8733-84919e2dfbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9619ac2d-fecc-40b3-9697-90e5a68d4903" xlink:to="loc_us-gaap_SeparateAccountAssets_e298fe30-196e-41be-8733-84919e2dfbc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b2cfa37e-a807-498d-9d47-2d5581c11601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9619ac2d-fecc-40b3-9697-90e5a68d4903" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b2cfa37e-a807-498d-9d47-2d5581c11601" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_13a6fc89-4b67-4f67-8d0a-370f2f702902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b2cfa37e-a807-498d-9d47-2d5581c11601" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_13a6fc89-4b67-4f67-8d0a-370f2f702902" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_13a6fc89-4b67-4f67-8d0a-370f2f702902_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_13a6fc89-4b67-4f67-8d0a-370f2f702902" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_13a6fc89-4b67-4f67-8d0a-370f2f702902_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2b18c16b-027c-47a9-9aeb-821360be4a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_13a6fc89-4b67-4f67-8d0a-370f2f702902" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2b18c16b-027c-47a9-9aeb-821360be4a4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_bd91f22a-bb55-446c-8224-f18a671c78de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_2b18c16b-027c-47a9-9aeb-821360be4a4f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_bd91f22a-bb55-446c-8224-f18a671c78de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f28e096-24b0-4098-adb3-519e5909040f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b2cfa37e-a807-498d-9d47-2d5581c11601" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f28e096-24b0-4098-adb3-519e5909040f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f28e096-24b0-4098-adb3-519e5909040f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f28e096-24b0-4098-adb3-519e5909040f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f28e096-24b0-4098-adb3-519e5909040f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d4a4408e-e4ec-43c2-a00b-e696347c666b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f28e096-24b0-4098-adb3-519e5909040f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d4a4408e-e4ec-43c2-a00b-e696347c666b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4daf98af-ee26-4812-8edc-883e3666e60d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d4a4408e-e4ec-43c2-a00b-e696347c666b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4daf98af-ee26-4812-8edc-883e3666e60d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_525d828e-a95a-41f7-bf1f-6580ba902997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d4a4408e-e4ec-43c2-a00b-e696347c666b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_525d828e-a95a-41f7-bf1f-6580ba902997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_cf82be65-e13a-4218-82d4-ea877f7c4600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d4a4408e-e4ec-43c2-a00b-e696347c666b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_cf82be65-e13a-4218-82d4-ea877f7c4600" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4745bf77-8115-4d84-bc6a-26a5b0395396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b2cfa37e-a807-498d-9d47-2d5581c11601" xlink:to="loc_us-gaap_InvestmentTypeAxis_4745bf77-8115-4d84-bc6a-26a5b0395396" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_4745bf77-8115-4d84-bc6a-26a5b0395396_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_4745bf77-8115-4d84-bc6a-26a5b0395396" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_4745bf77-8115-4d84-bc6a-26a5b0395396_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_e56c73a3-21ad-4102-8938-c51b8c852b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_4745bf77-8115-4d84-bc6a-26a5b0395396" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_e56c73a3-21ad-4102-8938-c51b8c852b3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_e440b231-3637-4d51-b5ee-87720930e79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e56c73a3-21ad-4102-8938-c51b8c852b3e" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_e440b231-3637-4d51-b5ee-87720930e79c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_337a89f3-4346-4ff2-a085-cac63765971d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e56c73a3-21ad-4102-8938-c51b8c852b3e" xlink:to="loc_us-gaap_DebtSecuritiesMember_337a89f3-4346-4ff2-a085-cac63765971d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_3acb2d4a-7719-4909-a13c-214e7e60ef47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e56c73a3-21ad-4102-8938-c51b8c852b3e" xlink:to="loc_us-gaap_EquitySecuritiesMember_3acb2d4a-7719-4909-a13c-214e7e60ef47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_7e2942af-2030-40d9-b142-0370a97f306f" xlink:href="cvs-20210930.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e56c73a3-21ad-4102-8938-c51b8c852b3e" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_7e2942af-2030-40d9-b142-0370a97f306f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_daef5618-57a7-4f06-9886-aec9c127d798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b2cfa37e-a807-498d-9d47-2d5581c11601" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_daef5618-57a7-4f06-9886-aec9c127d798" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_daef5618-57a7-4f06-9886-aec9c127d798_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_daef5618-57a7-4f06-9886-aec9c127d798" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_daef5618-57a7-4f06-9886-aec9c127d798_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e39e81a3-01f4-4dc3-9cbb-d69fc974aef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_daef5618-57a7-4f06-9886-aec9c127d798" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e39e81a3-01f4-4dc3-9cbb-d69fc974aef7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_19fde89d-3937-4a93-8f19-c24376dbd138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e39e81a3-01f4-4dc3-9cbb-d69fc974aef7" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_19fde89d-3937-4a93-8f19-c24376dbd138" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember_9fa8596d-b8b3-4e50-9467-5e79807125ad" xlink:href="cvs-20210930.xsd#cvs_OtherReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e39e81a3-01f4-4dc3-9cbb-d69fc974aef7" xlink:to="loc_cvs_OtherReceivablesMember_9fa8596d-b8b3-4e50-9467-5e79807125ad" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#GoodwillandOtherIntangiblesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="extended" id="if0a24ce5cc93432daadeb807d91fa300_GoodwillandOtherIntangiblesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_3120d28c-4df8-43fc-9781-be3991bdc1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_06e5ccda-d718-400d-b7e0-4ae896e5ac04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3120d28c-4df8-43fc-9781-be3991bdc1d0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_06e5ccda-d718-400d-b7e0-4ae896e5ac04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_aa8bbb09-a70d-42e0-88d1-f85c31bd9ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3120d28c-4df8-43fc-9781-be3991bdc1d0" xlink:to="loc_us-gaap_Goodwill_aa8bbb09-a70d-42e0-88d1-f85c31bd9ff4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c265f91a-d846-4b63-b900-5bfaf9561725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3120d28c-4df8-43fc-9781-be3991bdc1d0" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c265f91a-d846-4b63-b900-5bfaf9561725" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_aa645d7c-f270-4be1-b40e-42e6354a61bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_3120d28c-4df8-43fc-9781-be3991bdc1d0" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_aa645d7c-f270-4be1-b40e-42e6354a61bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d185710a-2df1-4118-8d57-0bfb5ecfb2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_aa645d7c-f270-4be1-b40e-42e6354a61bd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d185710a-2df1-4118-8d57-0bfb5ecfb2c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d185710a-2df1-4118-8d57-0bfb5ecfb2c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d185710a-2df1-4118-8d57-0bfb5ecfb2c3" xlink:to="loc_us-gaap_SegmentDomain_d185710a-2df1-4118-8d57-0bfb5ecfb2c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b8817ae8-4d34-46fb-9bb8-9c8db6897d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d185710a-2df1-4118-8d57-0bfb5ecfb2c3" xlink:to="loc_us-gaap_SegmentDomain_b8817ae8-4d34-46fb-9bb8-9c8db6897d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_1b140bc1-235c-4220-aa11-7771b14ed1aa" xlink:href="cvs-20210930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b8817ae8-4d34-46fb-9bb8-9c8db6897d9d" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_1b140bc1-235c-4220-aa11-7771b14ed1aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_81c45124-0132-4090-a02d-328bee44a86e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_aa645d7c-f270-4be1-b40e-42e6354a61bd" xlink:to="loc_us-gaap_ReportingUnitAxis_81c45124-0132-4090-a02d-328bee44a86e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_81c45124-0132-4090-a02d-328bee44a86e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_81c45124-0132-4090-a02d-328bee44a86e" xlink:to="loc_us-gaap_ReportingUnitDomain_81c45124-0132-4090-a02d-328bee44a86e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_e0e8e0e2-6d17-4986-8645-0f4eddb5e491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_81c45124-0132-4090-a02d-328bee44a86e" xlink:to="loc_us-gaap_ReportingUnitDomain_e0e8e0e2-6d17-4986-8645-0f4eddb5e491" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember_dda32a6a-21a4-4a3c-a898-cee418b73672" xlink:href="cvs-20210930.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_e0e8e0e2-6d17-4986-8645-0f4eddb5e491" xlink:to="loc_cvs_LongTermCareReportingUnitMember_dda32a6a-21a4-4a3c-a898-cee418b73672" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#GoodwillandOtherIntangiblesGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="extended" id="i98818db7e3854b30b900aaa5921e2544_GoodwillandOtherIntangiblesGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_c501b50d-a202-48f2-a796-fc5f97deb858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_06b92025-d907-4938-909e-56e3de49ac46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_c501b50d-a202-48f2-a796-fc5f97deb858" xlink:to="loc_us-gaap_GoodwillRollForward_06b92025-d907-4938-909e-56e3de49ac46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_74ec628a-ed7e-4249-b3f2-1a423f5d3665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_06b92025-d907-4938-909e-56e3de49ac46" xlink:to="loc_us-gaap_Goodwill_74ec628a-ed7e-4249-b3f2-1a423f5d3665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_7baadc2a-feae-4666-b4db-c5fcf5056c67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_06b92025-d907-4938-909e-56e3de49ac46" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_7baadc2a-feae-4666-b4db-c5fcf5056c67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ac70495e-45c9-4d6b-b789-67a703884677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_68a6e43a-900c-4db8-809c-5ccdcdefd9df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_c501b50d-a202-48f2-a796-fc5f97deb858" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_68a6e43a-900c-4db8-809c-5ccdcdefd9df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_43259a69-78f4-4e83-bfb0-6200fcdb7205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_68a6e43a-900c-4db8-809c-5ccdcdefd9df" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_43259a69-78f4-4e83-bfb0-6200fcdb7205" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_43259a69-78f4-4e83-bfb0-6200fcdb7205_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_43259a69-78f4-4e83-bfb0-6200fcdb7205" xlink:to="loc_us-gaap_SegmentDomain_43259a69-78f4-4e83-bfb0-6200fcdb7205_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_202fc427-321e-4424-86fb-ac441c6dde5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_43259a69-78f4-4e83-bfb0-6200fcdb7205" xlink:to="loc_us-gaap_SegmentDomain_202fc427-321e-4424-86fb-ac441c6dde5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_d8dc3748-b859-4fe0-8232-f22413617964" xlink:href="cvs-20210930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_202fc427-321e-4424-86fb-ac441c6dde5c" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_d8dc3748-b859-4fe0-8232-f22413617964" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_728bfec9-d943-4dec-829b-875fc59374a1" xlink:href="cvs-20210930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_202fc427-321e-4424-86fb-ac441c6dde5c" xlink:to="loc_cvs_PharmacyServicesSegmentMember_728bfec9-d943-4dec-829b-875fc59374a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_5ed4d873-74a5-44e0-b7a4-b77ef3176bf3" xlink:href="cvs-20210930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_202fc427-321e-4424-86fb-ac441c6dde5c" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_5ed4d873-74a5-44e0-b7a4-b77ef3176bf3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended" id="id0930b0e56c74bc289c92fc77fcd47a2_HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_80d2bae3-fdb2-4593-bd83-46484ae129a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_80d2bae3-fdb2-4593-bd83-46484ae129a8" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f864f023-02dd-49bd-b055-6cdc7a13e863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f864f023-02dd-49bd-b055-6cdc7a13e863" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_020d8fd2-7a2f-4c9d-ab5f-1fcf733303ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_020d8fd2-7a2f-4c9d-ab5f-1fcf733303ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_3e95a070-f246-45e6-a130-cd3c7ac98198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_3e95a070-f246-45e6-a130-cd3c7ac98198" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_82b51d25-4e0a-410f-9d07-9c9f30e66d06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_82b51d25-4e0a-410f-9d07-9c9f30e66d06" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_50e85b29-2013-4340-b62b-0e9eb31f7f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_50e85b29-2013-4340-b62b-0e9eb31f7f0b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_1ddadfdc-d0a3-482a-ad92-aecde567c19c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_50e85b29-2013-4340-b62b-0e9eb31f7f0b" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_1ddadfdc-d0a3-482a-ad92-aecde567c19c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_1d88dc13-49af-4396-a212-48ea6e77e747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_50e85b29-2013-4340-b62b-0e9eb31f7f0b" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_1d88dc13-49af-4396-a212-48ea6e77e747" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_72011a44-4d53-44b6-a27d-1a13066f3af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_50e85b29-2013-4340-b62b-0e9eb31f7f0b" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_72011a44-4d53-44b6-a27d-1a13066f3af7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d7d47fb-5ca0-4258-a97f-34834419fc95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d7d47fb-5ca0-4258-a97f-34834419fc95" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_4a6a5caf-a203-411f-ba0f-7d7f7c9fc621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d7d47fb-5ca0-4258-a97f-34834419fc95" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_4a6a5caf-a203-411f-ba0f-7d7f7c9fc621" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_1a58332c-585a-46ac-b46f-1a14fa674863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d7d47fb-5ca0-4258-a97f-34834419fc95" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_1a58332c-585a-46ac-b46f-1a14fa674863" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_8f27536a-8891-4edf-8835-ad1507229771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d7d47fb-5ca0-4258-a97f-34834419fc95" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_8f27536a-8891-4edf-8835-ad1507229771" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_5e6aebf0-62d8-4091-b9f7-b5ed1873d6e1" xlink:href="cvs-20210930.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_5e6aebf0-62d8-4091-b9f7-b5ed1873d6e1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_ea16312d-52a2-441b-a939-fcfa2b93d2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_352908d7-6e75-4894-83e4-fc9f67aee873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_10a1c21d-092e-4914-ac09-38cb94ad1468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_5d2fe156-7c44-412b-bf30-624e6efd0719" xlink:href="cvs-20210930.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_abf52695-0658-4e60-ae47-5d8e5e147ab5" xlink:href="cvs-20210930.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_80d2bae3-fdb2-4593-bd83-46484ae129a8" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_abf52695-0658-4e60-ae47-5d8e5e147ab5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_1591e7ad-ed60-499c-90fd-c659d87dc186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_80d2bae3-fdb2-4593-bd83-46484ae129a8" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_1591e7ad-ed60-499c-90fd-c659d87dc186" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e3ac4dd0-38a3-42ad-801f-909239fcc4da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_1591e7ad-ed60-499c-90fd-c659d87dc186" xlink:to="loc_srt_ProductOrServiceAxis_e3ac4dd0-38a3-42ad-801f-909239fcc4da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e3ac4dd0-38a3-42ad-801f-909239fcc4da_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e3ac4dd0-38a3-42ad-801f-909239fcc4da" xlink:to="loc_srt_ProductsAndServicesDomain_e3ac4dd0-38a3-42ad-801f-909239fcc4da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_96eb5b23-5b69-4910-b5eb-3479bbec7b98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e3ac4dd0-38a3-42ad-801f-909239fcc4da" xlink:to="loc_srt_ProductsAndServicesDomain_96eb5b23-5b69-4910-b5eb-3479bbec7b98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_7a0399a3-3f26-49d9-acc1-6d3719769f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_96eb5b23-5b69-4910-b5eb-3479bbec7b98" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_7a0399a3-3f26-49d9-acc1-6d3719769f90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1b800ed0-a7bd-46e2-be32-98e9a5c24237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_1591e7ad-ed60-499c-90fd-c659d87dc186" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1b800ed0-a7bd-46e2-be32-98e9a5c24237" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1b800ed0-a7bd-46e2-be32-98e9a5c24237_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1b800ed0-a7bd-46e2-be32-98e9a5c24237" xlink:to="loc_us-gaap_SegmentDomain_1b800ed0-a7bd-46e2-be32-98e9a5c24237_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_16bf73c5-6101-431e-9a8c-54bbd5dbd7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1b800ed0-a7bd-46e2-be32-98e9a5c24237" xlink:to="loc_us-gaap_SegmentDomain_16bf73c5-6101-431e-9a8c-54bbd5dbd7a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_4624d7c0-6dbf-4a07-a7dd-313701f6cfbc" xlink:href="cvs-20210930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_16bf73c5-6101-431e-9a8c-54bbd5dbd7a2" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_4624d7c0-6dbf-4a07-a7dd-313701f6cfbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember_47b83ca5-faeb-419f-95ba-5d9d254a06d1" xlink:href="cvs-20210930.xsd#cvs_CorporateOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_16bf73c5-6101-431e-9a8c-54bbd5dbd7a2" xlink:to="loc_cvs_CorporateOtherMember_47b83ca5-faeb-419f-95ba-5d9d254a06d1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended" id="i7f01178d9f1f4d9d9045e73fe21d6f9b_HealthCareCostsPayableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_addc72b5-7b4d-4f89-8225-d5001b567003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_8af23ddc-327a-4caf-8ef3-a14e56ec319d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_addc72b5-7b4d-4f89-8225-d5001b567003" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_8af23ddc-327a-4caf-8ef3-a14e56ec319d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_5bce3286-89c1-4b75-9f16-e85a13bb353b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_addc72b5-7b4d-4f89-8225-d5001b567003" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_5bce3286-89c1-4b75-9f16-e85a13bb353b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_0569576d-7e8a-48f2-bd17-8d587fb9b107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_addc72b5-7b4d-4f89-8225-d5001b567003" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_0569576d-7e8a-48f2-bd17-8d587fb9b107" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_78546df9-077e-40cd-a105-08bd90852262" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_0569576d-7e8a-48f2-bd17-8d587fb9b107" xlink:to="loc_srt_ProductOrServiceAxis_78546df9-077e-40cd-a105-08bd90852262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_78546df9-077e-40cd-a105-08bd90852262_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_78546df9-077e-40cd-a105-08bd90852262" xlink:to="loc_srt_ProductsAndServicesDomain_78546df9-077e-40cd-a105-08bd90852262_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47bdca7a-2768-4004-84bb-4e99a72a283b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_78546df9-077e-40cd-a105-08bd90852262" xlink:to="loc_srt_ProductsAndServicesDomain_47bdca7a-2768-4004-84bb-4e99a72a283b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_497742b1-df37-4921-94be-7b4b92b4f7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_47bdca7a-2768-4004-84bb-4e99a72a283b" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_497742b1-df37-4921-94be-7b4b92b4f7ae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#BorrowingsScheduleofBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="extended" id="iffcf9770a192452794fd33cc9e77b220_BorrowingsScheduleofBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f983735f-d8b1-4cbf-bc9e-4af1e6c3e766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f983735f-d8b1-4cbf-bc9e-4af1e6c3e766" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_0838c302-18bd-42ee-82c9-d7fbb6a8abaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_0838c302-18bd-42ee-82c9-d7fbb6a8abaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_5a6aa1aa-9d11-4f80-b31c-6b3437433067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_FinanceLeaseLiability_5a6aa1aa-9d11-4f80-b31c-6b3437433067" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_b2a4536e-8513-4318-8306-1e0892d430d0" xlink:href="cvs-20210930.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_b2a4536e-8513-4318-8306-1e0892d430d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_0ee151e7-3fcb-4644-9e8d-30e81851c833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_0ee151e7-3fcb-4644-9e8d-30e81851c833" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_61ccd1e8-a40d-4def-a8d8-3b16cea3937e" xlink:href="cvs-20210930.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_61ccd1e8-a40d-4def-a8d8-3b16cea3937e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_a923a0b6-6634-4724-8c00-ced1a656b0be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_a923a0b6-6634-4724-8c00-ced1a656b0be" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_690a0570-8110-407f-976d-a9640e5215ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_690a0570-8110-407f-976d-a9640e5215ab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f39f1020-8c7f-488b-85ad-70a66557e99d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f39f1020-8c7f-488b-85ad-70a66557e99d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_875ad796-089c-472d-aaeb-bbf925ad5c53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_DebtInstrumentTable_875ad796-089c-472d-aaeb-bbf925ad5c53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a54eb335-e167-4acd-98f4-f1eb39827ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_875ad796-089c-472d-aaeb-bbf925ad5c53" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a54eb335-e167-4acd-98f4-f1eb39827ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a54eb335-e167-4acd-98f4-f1eb39827ce0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a54eb335-e167-4acd-98f4-f1eb39827ce0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a54eb335-e167-4acd-98f4-f1eb39827ce0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_22bd9002-f4e1-4334-b7e1-9166fafefb08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a54eb335-e167-4acd-98f4-f1eb39827ce0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_22bd9002-f4e1-4334-b7e1-9166fafefb08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_739b3f8b-f7d5-46c3-84f2-144955b528a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_22bd9002-f4e1-4334-b7e1-9166fafefb08" xlink:to="loc_us-gaap_SeniorNotesMember_739b3f8b-f7d5-46c3-84f2-144955b528a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_d227283b-dc73-4e7b-a36c-52138784be29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_22bd9002-f4e1-4334-b7e1-9166fafefb08" xlink:to="loc_us-gaap_NotesPayableToBanksMember_d227283b-dc73-4e7b-a36c-52138784be29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_b0d7c6a5-10d1-4352-b97f-d63976722eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_22bd9002-f4e1-4334-b7e1-9166fafefb08" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_b0d7c6a5-10d1-4352-b97f-d63976722eb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_aadaa5c2-ed75-485f-bddd-e1afcf920d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_875ad796-089c-472d-aaeb-bbf925ad5c53" xlink:to="loc_us-gaap_DebtInstrumentAxis_aadaa5c2-ed75-485f-bddd-e1afcf920d74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_aadaa5c2-ed75-485f-bddd-e1afcf920d74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_aadaa5c2-ed75-485f-bddd-e1afcf920d74" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_aadaa5c2-ed75-485f-bddd-e1afcf920d74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_aadaa5c2-ed75-485f-bddd-e1afcf920d74" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_de3c8631-0a5a-4910-a672-fc14510a22f2" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_de3c8631-0a5a-4910-a672-fc14510a22f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2021Member_076768b2-efd0-4299-88fe-bddf84c884d7" xlink:href="cvs-20210930.xsd#cvs_FloatingRateNotesDueMarch2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_FloatingRateNotesDueMarch2021Member_076768b2-efd0-4299-88fe-bddf84c884d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_456d09cb-0d4c-4b68-a794-97332bd6d094" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_456d09cb-0d4c-4b68-a794-97332bd6d094" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.125June2021Member_5540aa68-f987-4e98-85f1-fba84c57c875" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.125June2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2.125June2021Member_5540aa68-f987-4e98-85f1-fba84c57c875" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_874856ba-2051-442b-904d-e9d6d418adeb" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_874856ba-2051-442b-904d-e9d6d418adeb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_61187780-ea9f-41c9-b6ce-9b3bad09d83c" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_61187780-ea9f-41c9-b6ce-9b3bad09d83c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_2fbe6d10-d2cb-43b7-a4d6-2c52ca4ab01d" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_2fbe6d10-d2cb-43b7-a4d6-2c52ca4ab01d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_2f5ff10a-a5cf-4106-b345-bf919fb8ff71" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_2f5ff10a-a5cf-4106-b345-bf919fb8ff71" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_ed657bf1-cc6a-46fa-bd44-77115b1eab02" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_ed657bf1-cc6a-46fa-bd44-77115b1eab02" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_195f4c59-bb61-4c9e-b395-cd4064ed3caa" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_195f4c59-bb61-4c9e-b395-cd4064ed3caa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_917a13de-5e57-4635-b988-22aa166a7adc" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_917a13de-5e57-4635-b988-22aa166a7adc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_05f4798e-d382-46ea-ae2c-c3f4450e3729" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_05f4798e-d382-46ea-ae2c-c3f4450e3729" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_d91fdf24-0a37-4875-9fdd-0a5578cc2cb6" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_d91fdf24-0a37-4875-9fdd-0a5578cc2cb6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_98480b58-641b-49f3-940f-a49d072a686b" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_98480b58-641b-49f3-940f-a49d072a686b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_aa10d701-4a44-49a8-9240-b6f3e3a86914" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_aa10d701-4a44-49a8-9240-b6f3e3a86914" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_95ea71dd-c88e-4f12-93ca-391b58114397" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_95ea71dd-c88e-4f12-93ca-391b58114397" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_f68bb33e-d104-40d1-8d6c-5f3130f5a0e7" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_f68bb33e-d104-40d1-8d6c-5f3130f5a0e7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_09a4d6d7-8d4c-4479-82cb-dffaa0341c7e" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_09a4d6d7-8d4c-4479-82cb-dffaa0341c7e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_6ae4822d-c036-4e5c-a3c0-0ff3835affb5" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_6ae4822d-c036-4e5c-a3c0-0ff3835affb5" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_eb1d7631-06b0-4bb5-be79-abfd444cadb1" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_eb1d7631-06b0-4bb5-be79-abfd444cadb1" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_9e3bbb01-956d-41e9-9d6e-92907edc9716" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_9e3bbb01-956d-41e9-9d6e-92907edc9716" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member_e13644cf-239f-49ae-a1f3-318e15f20c1b" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.625DueApril2027Member_e13644cf-239f-49ae-a1f3-318e15f20c1b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_17731dcf-be42-4646-8f4a-3e2edfc417e9" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_17731dcf-be42-4646-8f4a-3e2edfc417e9" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_27f5da16-358b-48c8-b95e-f7c6fa022839" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_27f5da16-358b-48c8-b95e-f7c6fa022839" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_99d58372-db4b-4cd1-9742-d49f983f56c4" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_99d58372-db4b-4cd1-9742-d49f983f56c4" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_02664356-3153-4906-a5f8-8314e0c680e9" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_02664356-3153-4906-a5f8-8314e0c680e9" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member_8b9660ad-9574-4ecf-934b-db1fd34113e4" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.75DueApril2030Member_8b9660ad-9574-4ecf-934b-db1fd34113e4" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_c5d6038c-e426-4870-a108-16f68e1c2db5" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_c5d6038c-e426-4870-a108-16f68e1c2db5" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member_e6f3b4cc-c1ce-42d8-b867-d2b66e58820e" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes1875DueFebruary2031Member_e6f3b4cc-c1ce-42d8-b867-d2b66e58820e" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2125PercentDueAugust2031Member_f5336bd4-190e-4d59-a18b-fb09e9cf850d" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2125PercentDueAugust2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2125PercentDueAugust2031Member_f5336bd4-190e-4d59-a18b-fb09e9cf850d" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_743e2337-9881-43ee-9484-5060fa012b55" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_743e2337-9881-43ee-9484-5060fa012b55" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_f05b3b22-e216-4cb4-904a-b69850db2cf9" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_f05b3b22-e216-4cb4-904a-b69850db2cf9" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_abddb498-d798-47b9-9405-91fbf1f41892" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_abddb498-d798-47b9-9405-91fbf1f41892" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_4dc58610-8496-4844-88bc-25b39f358b68" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_4dc58610-8496-4844-88bc-25b39f358b68" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_bc0debda-7189-4b6e-9f18-828af284c96a" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_bc0debda-7189-4b6e-9f18-828af284c96a" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member_75956750-4422-426e-9809-d6491be5ccf4" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.125DueApril2040Member_75956750-4422-426e-9809-d6491be5ccf4" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_9b83656e-f82d-4309-9d18-d9493fb2872d" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_9b83656e-f82d-4309-9d18-d9493fb2872d" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_26eca057-e383-4988-ad81-0e8d864aed70" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_26eca057-e383-4988-ad81-0e8d864aed70" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_7ef52499-b3cb-4006-993e-93fb98c085ae" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_7ef52499-b3cb-4006-993e-93fb98c085ae" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_527bbd55-8120-4edd-be56-e07c3bf31057" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_527bbd55-8120-4edd-be56-e07c3bf31057" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_54be20f5-2c0b-4dd8-899f-555c6dbed006" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_54be20f5-2c0b-4dd8-899f-555c6dbed006" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_179f8ecf-42ee-4445-a9e2-14f7146d345a" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_179f8ecf-42ee-4445-a9e2-14f7146d345a" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_4d15fb6e-6706-4e36-b033-02c51844465a" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_4d15fb6e-6706-4e36-b033-02c51844465a" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_fd6fc897-92c3-49c0-bfa6-a50d88b88668" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_fd6fc897-92c3-49c0-bfa6-a50d88b88668" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_c227e301-1f00-43e2-a576-d20e16417fac" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_c227e301-1f00-43e2-a576-d20e16417fac" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member_f52b90f4-59a6-4c3e-a688-25e2cf4f2649" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.25DueApril2050Member_f52b90f4-59a6-4c3e-a688-25e2cf4f2649" xlink:type="arc" order="45"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#BorrowingsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="extended" id="iedf8b202966d49e9a77fe246476f8ff8_BorrowingsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9a3b7b6d-1e29-43e5-9bab-b577ed09575e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9a3b7b6d-1e29-43e5-9bab-b577ed09575e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4b12558a-0b61-48b2-8341-ad16e814ef97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4b12558a-0b61-48b2-8341-ad16e814ef97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_10174390-049c-4fa4-a43e-fe386b9e72c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_10174390-049c-4fa4-a43e-fe386b9e72c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_7776ccb7-fcef-4e76-9970-301bc1ab58dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_7776ccb7-fcef-4e76-9970-301bc1ab58dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_45c2d50f-1936-41f1-a7ac-88c899c79958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_45c2d50f-1936-41f1-a7ac-88c899c79958" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_c226fb79-b26b-47fa-8057-3c448ac8c28a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_c226fb79-b26b-47fa-8057-3c448ac8c28a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees_b5825cda-ae47-4e83-831c-0a200b522152" xlink:href="cvs-20210930.xsd#cvs_DebtExtinguishmentFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_cvs_DebtExtinguishmentFees_b5825cda-ae47-4e83-831c-0a200b522152" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b0446085-192f-4d00-b082-01aaefb9a730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b0446085-192f-4d00-b082-01aaefb9a730" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_086bb192-4044-43e7-a532-70cae51db78e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_DebtInstrumentTable_086bb192-4044-43e7-a532-70cae51db78e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1997c1cf-5da0-4689-9ee9-b54bcdb09652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_086bb192-4044-43e7-a532-70cae51db78e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1997c1cf-5da0-4689-9ee9-b54bcdb09652" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1997c1cf-5da0-4689-9ee9-b54bcdb09652_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1997c1cf-5da0-4689-9ee9-b54bcdb09652" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1997c1cf-5da0-4689-9ee9-b54bcdb09652_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_95beb255-3d44-41bb-a405-fa4ebf9c8405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1997c1cf-5da0-4689-9ee9-b54bcdb09652" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_95beb255-3d44-41bb-a405-fa4ebf9c8405" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3751fdb8-b5fd-409c-9b81-8ce561e4dc36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95beb255-3d44-41bb-a405-fa4ebf9c8405" xlink:to="loc_us-gaap_SeniorNotesMember_3751fdb8-b5fd-409c-9b81-8ce561e4dc36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_13c1c373-db30-4810-bad6-0aaaa29fc510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_086bb192-4044-43e7-a532-70cae51db78e" xlink:to="loc_us-gaap_DebtInstrumentAxis_13c1c373-db30-4810-bad6-0aaaa29fc510" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_13c1c373-db30-4810-bad6-0aaaa29fc510_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_13c1c373-db30-4810-bad6-0aaaa29fc510" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_13c1c373-db30-4810-bad6-0aaaa29fc510_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_13c1c373-db30-4810-bad6-0aaaa29fc510" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2125PercentDueAugust2031Member_f3be53c1-2157-4869-8389-8144fa3686ad" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2125PercentDueAugust2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:to="loc_cvs_SeniorNotes2125PercentDueAugust2031Member_f3be53c1-2157-4869-8389-8144fa3686ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes43Due2028Member_819015fb-7ff1-4be5-982f-cf1be08aeee5" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes43Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:to="loc_cvs_SeniorNotes43Due2028Member_819015fb-7ff1-4be5-982f-cf1be08aeee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember_5c8212a4-46b5-4d81-b070-fbde5c8a031a" xlink:href="cvs-20210930.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:to="loc_cvs_OutstandingSeniorNotesMember_5c8212a4-46b5-4d81-b070-fbde5c8a031a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_9e40375e-843a-459b-9bd7-76f7c9730345" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_9e40375e-843a-459b-9bd7-76f7c9730345" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_72b6e4ca-7615-4349-8bab-361d1c3fe552" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_72b6e4ca-7615-4349-8bab-361d1c3fe552" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_1e62e666-579a-4e4b-846e-185acbbf0682" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_1e62e666-579a-4e4b-846e-185acbbf0682" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#ShareholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="extended" id="id3a6a8f04cf3403eb50b70d0c371dd89_ShareholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_8e9034fb-5e1b-4b87-a165-a9d05af61513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c3507509-2271-4931-9dda-54b32fa8bba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_8e9034fb-5e1b-4b87-a165-a9d05af61513" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c3507509-2271-4931-9dda-54b32fa8bba6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_b76f5866-f5f0-4cb2-b7de-e3e1074eb33a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_8e9034fb-5e1b-4b87-a165-a9d05af61513" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_b76f5866-f5f0-4cb2-b7de-e3e1074eb33a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7b030c0d-3ca7-450a-8a0d-180c73711b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_8e9034fb-5e1b-4b87-a165-a9d05af61513" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7b030c0d-3ca7-450a-8a0d-180c73711b2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_424be890-b2a1-446a-998f-c8ab2d11d074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_8e9034fb-5e1b-4b87-a165-a9d05af61513" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_424be890-b2a1-446a-998f-c8ab2d11d074" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_e6628c25-79af-4b32-bc1f-92314ec4c9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_8e9034fb-5e1b-4b87-a165-a9d05af61513" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_e6628c25-79af-4b32-bc1f-92314ec4c9f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_892a98ff-61a0-47b3-9ec3-7014eea9242e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_e6628c25-79af-4b32-bc1f-92314ec4c9f5" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_892a98ff-61a0-47b3-9ec3-7014eea9242e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_892a98ff-61a0-47b3-9ec3-7014eea9242e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_892a98ff-61a0-47b3-9ec3-7014eea9242e" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_892a98ff-61a0-47b3-9ec3-7014eea9242e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_328c8ee5-9e67-4f0a-b394-54dd6274b2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_892a98ff-61a0-47b3-9ec3-7014eea9242e" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_328c8ee5-9e67-4f0a-b394-54dd6274b2e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember_4773259e-3c3a-4500-9fb6-92840e696c5a" xlink:href="cvs-20210930.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_328c8ee5-9e67-4f0a-b394-54dd6274b2e8" xlink:to="loc_cvs_A2016RepurchaseProgramMember_4773259e-3c3a-4500-9fb6-92840e696c5a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#OtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended" id="i8d86974a888046cfb9bfbd8f85c1df9e_OtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d3afd3aa-443c-4946-b6d3-04b562abe736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_64f07725-9e66-4724-b9cd-8f81e9612de8" xlink:href="cvs-20210930.xsd#cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d3afd3aa-443c-4946-b6d3-04b562abe736" xlink:to="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_64f07725-9e66-4724-b9cd-8f81e9612de8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3dceb808-7e6b-4bd7-b915-ff5827e04ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_64f07725-9e66-4724-b9cd-8f81e9612de8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3dceb808-7e6b-4bd7-b915-ff5827e04ea0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d401f566-16e1-45d2-a65b-cdc97cbfec0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_64f07725-9e66-4724-b9cd-8f81e9612de8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d401f566-16e1-45d2-a65b-cdc97cbfec0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1d1b33ef-8935-49c8-8a0e-08fb0b399ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_64f07725-9e66-4724-b9cd-8f81e9612de8" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1d1b33ef-8935-49c8-8a0e-08fb0b399ac7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85e14075-8003-4d70-ad06-7b948301b0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_64f07725-9e66-4724-b9cd-8f81e9612de8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85e14075-8003-4d70-ad06-7b948301b0e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_053415f9-ea4b-4545-980f-92083aebc926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_81cf403e-1cdc-41f1-8d4a-a8b8e461875c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d3afd3aa-443c-4946-b6d3-04b562abe736" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_81cf403e-1cdc-41f1-8d4a-a8b8e461875c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_496e42af-9b94-444c-950c-fa8795e87a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d3afd3aa-443c-4946-b6d3-04b562abe736" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_496e42af-9b94-444c-950c-fa8795e87a04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_fa481e8e-1b71-49bb-a5a3-91aa1b337aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d3afd3aa-443c-4946-b6d3-04b562abe736" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_fa481e8e-1b71-49bb-a5a3-91aa1b337aad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e3acbc5-fdb5-45d9-9809-aed0770a1446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d3afd3aa-443c-4946-b6d3-04b562abe736" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e3acbc5-fdb5-45d9-9809-aed0770a1446" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c0799fd5-c3f1-42be-be4a-59c37d858993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e3acbc5-fdb5-45d9-9809-aed0770a1446" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c0799fd5-c3f1-42be-be4a-59c37d858993" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c0799fd5-c3f1-42be-be4a-59c37d858993_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c0799fd5-c3f1-42be-be4a-59c37d858993" xlink:to="loc_us-gaap_EquityComponentDomain_c0799fd5-c3f1-42be-be4a-59c37d858993_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c0799fd5-c3f1-42be-be4a-59c37d858993" xlink:to="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_81fe2d6e-669e-400c-b0d0-af0bf42bde42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_81fe2d6e-669e-400c-b0d0-af0bf42bde42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_4dfc214a-ac78-479e-9cee-a60e9e09cae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_4dfc214a-ac78-479e-9cee-a60e9e09cae1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_1c890b90-fc55-4e7a-81c4-cd71f5b01e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_1c890b90-fc55-4e7a-81c4-cd71f5b01e5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_debc87b2-2a05-454d-95e3-46da4cd95ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_debc87b2-2a05-454d-95e3-46da4cd95ce9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_d22953ed-00d4-422c-b703-8a33c7d5928a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_d22953ed-00d4-422c-b703-8a33c7d5928a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i986b1f0c61cd4ce398efe05f2263973a_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_6ca7395d-c43c-4087-a740-b09cf4600646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_091d7990-9f56-43f9-960d-585c30b6c2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ca7395d-c43c-4087-a740-b09cf4600646" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_091d7990-9f56-43f9-960d-585c30b6c2e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_003e922c-dfba-40e0-b493-2d4dd7642928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ca7395d-c43c-4087-a740-b09cf4600646" xlink:to="loc_us-gaap_LossContingenciesTable_003e922c-dfba-40e0-b493-2d4dd7642928" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_0b70d845-5ef7-4ec6-9777-0fe4b753886e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_003e922c-dfba-40e0-b493-2d4dd7642928" xlink:to="loc_srt_LitigationCaseAxis_0b70d845-5ef7-4ec6-9777-0fe4b753886e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_0b70d845-5ef7-4ec6-9777-0fe4b753886e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_0b70d845-5ef7-4ec6-9777-0fe4b753886e" xlink:to="loc_srt_LitigationCaseTypeDomain_0b70d845-5ef7-4ec6-9777-0fe4b753886e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_75f265c1-35f7-456e-9984-3b1f2a294bb1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_0b70d845-5ef7-4ec6-9777-0fe4b753886e" xlink:to="loc_srt_LitigationCaseTypeDomain_75f265c1-35f7-456e-9984-3b1f2a294bb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_766e65d3-653e-4387-bc89-b9774bacc4a4" xlink:href="cvs-20210930.xsd#cvs_RadcliffeAndFlaimVAetnaIncEtAlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_75f265c1-35f7-456e-9984-3b1f2a294bb1" xlink:to="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_766e65d3-653e-4387-bc89-b9774bacc4a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d2ed05bc-89d3-4fa8-99f4-665ec69da2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_003e922c-dfba-40e0-b493-2d4dd7642928" xlink:to="loc_us-gaap_LitigationStatusAxis_d2ed05bc-89d3-4fa8-99f4-665ec69da2f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d2ed05bc-89d3-4fa8-99f4-665ec69da2f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_d2ed05bc-89d3-4fa8-99f4-665ec69da2f5" xlink:to="loc_us-gaap_LitigationStatusDomain_d2ed05bc-89d3-4fa8-99f4-665ec69da2f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_c7f2e2fc-f6d7-4b6b-9cad-21e88cde5799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_d2ed05bc-89d3-4fa8-99f4-665ec69da2f5" xlink:to="loc_us-gaap_LitigationStatusDomain_c7f2e2fc-f6d7-4b6b-9cad-21e88cde5799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_d383ae96-7a38-46de-8c56-e92a531cb9ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_c7f2e2fc-f6d7-4b6b-9cad-21e88cde5799" xlink:to="loc_us-gaap_PendingLitigationMember_d383ae96-7a38-46de-8c56-e92a531cb9ea" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended" id="i949bc4b404854c25a32101ea28cafa01_SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_e43dd802-e9bc-47c7-906d-e07253a73f4f" xlink:href="cvs-20210930.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_e43dd802-e9bc-47c7-906d-e07253a73f4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eaf57fb2-85bc-4966-a44b-fced753b451b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eaf57fb2-85bc-4966-a44b-fced753b451b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_7a064d4b-a063-4457-b85e-48cf6d7da2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:to="loc_us-gaap_NetInvestmentIncome_7a064d4b-a063-4457-b85e-48cf6d7da2bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5cd940b9-e0fe-4e7d-a0e3-259a6316ded0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:to="loc_us-gaap_Revenues_5cd940b9-e0fe-4e7d-a0e3-259a6316ded0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_84a94b25-d89d-4f72-945c-0ac5485380c7" xlink:href="cvs-20210930.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_84a94b25-d89d-4f72-945c-0ac5485380c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_57d2288d-6ce0-4b03-85c2-e6fcdd55179f" xlink:href="cvs-20210930.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_57d2288d-6ce0-4b03-85c2-e6fcdd55179f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d2c05863-66d7-42b5-a678-b4e07da4aebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d2c05863-66d7-42b5-a678-b4e07da4aebb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_81ad6ab8-1bd6-496c-9f57-889c5b2a5260" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d2c05863-66d7-42b5-a678-b4e07da4aebb" xlink:to="loc_srt_ConsolidationItemsAxis_81ad6ab8-1bd6-496c-9f57-889c5b2a5260" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_81ad6ab8-1bd6-496c-9f57-889c5b2a5260_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_81ad6ab8-1bd6-496c-9f57-889c5b2a5260" xlink:to="loc_srt_ConsolidationItemsDomain_81ad6ab8-1bd6-496c-9f57-889c5b2a5260_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_419df8e3-b55f-4a7a-9b22-492a2714404e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_81ad6ab8-1bd6-496c-9f57-889c5b2a5260" xlink:to="loc_srt_ConsolidationItemsDomain_419df8e3-b55f-4a7a-9b22-492a2714404e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_96edf236-db03-4656-963e-e8810c5d903f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_419df8e3-b55f-4a7a-9b22-492a2714404e" xlink:to="loc_us-gaap_OperatingSegmentsMember_96edf236-db03-4656-963e-e8810c5d903f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_d0b011a3-87d5-4eec-93bf-8baacb0a40cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_419df8e3-b55f-4a7a-9b22-492a2714404e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_d0b011a3-87d5-4eec-93bf-8baacb0a40cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_01c2ae85-e3ef-4b31-862e-d079703a7587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_419df8e3-b55f-4a7a-9b22-492a2714404e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_01c2ae85-e3ef-4b31-862e-d079703a7587" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0fb81236-2d3e-45de-8771-f67e146eced6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d2c05863-66d7-42b5-a678-b4e07da4aebb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0fb81236-2d3e-45de-8771-f67e146eced6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0fb81236-2d3e-45de-8771-f67e146eced6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0fb81236-2d3e-45de-8771-f67e146eced6" xlink:to="loc_us-gaap_SegmentDomain_0fb81236-2d3e-45de-8771-f67e146eced6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_189e3f89-2e6e-47ef-8e03-50fcd17ee238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0fb81236-2d3e-45de-8771-f67e146eced6" xlink:to="loc_us-gaap_SegmentDomain_189e3f89-2e6e-47ef-8e03-50fcd17ee238" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_3dfcb9e4-f57e-4efc-bec0-a5d8d079d1a2" xlink:href="cvs-20210930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_189e3f89-2e6e-47ef-8e03-50fcd17ee238" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_3dfcb9e4-f57e-4efc-bec0-a5d8d079d1a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_5716e651-06db-4ec6-8cc2-c36757d9c0c9" xlink:href="cvs-20210930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_189e3f89-2e6e-47ef-8e03-50fcd17ee238" xlink:to="loc_cvs_PharmacyServicesSegmentMember_5716e651-06db-4ec6-8cc2-c36757d9c0c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_0b9133eb-fde6-472b-b616-72dfc87affe4" xlink:href="cvs-20210930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_189e3f89-2e6e-47ef-8e03-50fcd17ee238" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_0b9133eb-fde6-472b-b616-72dfc87affe4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended" id="i5a2ffd5f556e4a6190b32a13785c2c4f_SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_69c4264e-9e49-4f22-adc3-d5d42d752d54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_f21b8a15-6721-48dd-91ef-9ea2db01d320" xlink:href="cvs-20210930.xsd#cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_69c4264e-9e49-4f22-adc3-d5d42d752d54" xlink:to="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_f21b8a15-6721-48dd-91ef-9ea2db01d320" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_60e44ba8-c554-4bd6-a24c-8d251949fc77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_69c4264e-9e49-4f22-adc3-d5d42d752d54" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_60e44ba8-c554-4bd6-a24c-8d251949fc77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_0b05ed39-b334-4bac-8dfd-4a234a6a1a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_69c4264e-9e49-4f22-adc3-d5d42d752d54" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_0b05ed39-b334-4bac-8dfd-4a234a6a1a82" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6daa26d3-79ce-4372-980c-5d6d835fb8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_0b05ed39-b334-4bac-8dfd-4a234a6a1a82" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6daa26d3-79ce-4372-980c-5d6d835fb8e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6daa26d3-79ce-4372-980c-5d6d835fb8e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6daa26d3-79ce-4372-980c-5d6d835fb8e9" xlink:to="loc_us-gaap_SegmentDomain_6daa26d3-79ce-4372-980c-5d6d835fb8e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_abcd8e69-2e6d-4dc8-8ab7-79337306fe63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6daa26d3-79ce-4372-980c-5d6d835fb8e9" xlink:to="loc_us-gaap_SegmentDomain_abcd8e69-2e6d-4dc8-8ab7-79337306fe63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_34f1fa90-a0a1-4f96-b9d3-acee88fa1db3" xlink:href="cvs-20210930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_abcd8e69-2e6d-4dc8-8ab7-79337306fe63" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_34f1fa90-a0a1-4f96-b9d3-acee88fa1db3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e868e05f-649c-4122-82da-1c6156fdb222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_0b05ed39-b334-4bac-8dfd-4a234a6a1a82" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e868e05f-649c-4122-82da-1c6156fdb222" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e868e05f-649c-4122-82da-1c6156fdb222_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e868e05f-649c-4122-82da-1c6156fdb222" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e868e05f-649c-4122-82da-1c6156fdb222_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_383388c3-2437-41aa-b7b6-1764dee41486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e868e05f-649c-4122-82da-1c6156fdb222" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_383388c3-2437-41aa-b7b6-1764dee41486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_9aba2d2e-af8c-4d72-8ccb-a45e20a5c968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_383388c3-2437-41aa-b7b6-1764dee41486" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_9aba2d2e-af8c-4d72-8ccb-a45e20a5c968" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_374f4682-e789-474a-854b-e08be7b7f34e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_0b05ed39-b334-4bac-8dfd-4a234a6a1a82" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_374f4682-e789-474a-854b-e08be7b7f34e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_374f4682-e789-474a-854b-e08be7b7f34e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_374f4682-e789-474a-854b-e08be7b7f34e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_374f4682-e789-474a-854b-e08be7b7f34e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a4ee116e-d53d-4624-96b2-1851a5c8f56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_374f4682-e789-474a-854b-e08be7b7f34e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a4ee116e-d53d-4624-96b2-1851a5c8f56f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_137a24ef-e09f-4949-8f9c-aac2870de5ac" xlink:href="cvs-20210930.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a4ee116e-d53d-4624-96b2-1851a5c8f56f" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_137a24ef-e09f-4949-8f9c-aac2870de5ac" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>cvs-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:25115a76-675c-4824-88fb-08e9720b17d2,g:63def5ee-f256-409d-94db-fc3f10f96be5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1cdaeae7-f94c-4b1a-9d4e-daabc853341b_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1959891c-e3d4-4f8b-8823-eb171648c768_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_6f89db72-d3c8-417e-9cd6-8973c63a3b7c_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_f000b04d-571f-4139-92c6-18f3c6d994d7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Separate Accounts by Major Category of Investment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_e68d6712-d754-463e-813d-17a9767be8d9_terseLabel_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_label_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset-Backed Securities [Member]</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:href="cvs-20210930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:to="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_67325e04-7f0c-45ab-8c11-19658ad90acc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_87822f87-cc56-4831-bc6d-8f86845b48de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_80b5aa60-7b7b-4d72-b92b-b88236b6f506_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_4f444ee5-6add-4d2e-872a-0424bc6a2bbd_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6269003f-d483-4cf9-a16e-b5ce57f4ed72_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_41788d76-ee2b-4e4e-9f75-d0beee212893_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueMay2021Member_4a32b736-4824-45c7-b93b-f965732a7946_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due May 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueMay2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due May 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueMay2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due May 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueMay2021Member" xlink:to="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_290691e2-98c4-4782-95d0-3796ba687e31_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_8bc6afa0-fa20-4ac4-ad10-c1df9c8d5145_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1bd6865f-c6a1-4068-a172-15584c98a7cf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_d3922697-719e-40e5-878d-b71d156edda0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_a6b78f62-2301-4efd-a0ff-3e5b22270af9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueJune2021Member_51bb9d3a-493a-45f0-97fc-1d10feb7d94c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due June 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueJune2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due June 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueJune2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due June 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueJune2021Member" xlink:to="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_14abcce2-ed70-466c-9118-8704fd27f58c_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_3e6c91e3-e1c0-4728-9277-1d5e0b37acef_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of receivables and contract liabilities from contracts with customers</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d5494d5a-55ea-459a-a55c-a41f38216404_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_83aaecbb-0f02-4d17-be03-d578cf644676_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01: 3,200 shares authorized; 1,743 shares issued and 1,321 shares outstanding at September&#160;30, 2021 and 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and capital surplus</link:label>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stocks, Including Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:to="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_11efcb82-3ced-4cc2-bda8-5b949db7f828_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.05% senior notes due March 2048</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:to="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_06cc366a-db26-4eea-90a7-97304eac14d5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_386f1839-52a1-45d2-87c7-1f61ca61c8e2_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% senior notes due July 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due July 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due July 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.5DueJuly2022Member" xlink:to="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_59ae6ff4-43e4-4937-b53f-c4ad57c9cc54_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_54381b8b-c420-4cf4-8804-bd5392593fe2_terseLabel_en-US" xlink:label="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt related purchase price adjustment from acquisition</link:label>
    <link:label id="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_label_en-US" xlink:label="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:label id="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_documentation_en-US" xlink:label="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:href="cvs-20210930.xsd#cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:to="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_801cb3f6-4941-437c-8a11-75b550287128_totalLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_27392124-99d6-4f3f-b5e3-70886dc57a7a_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category7Member_bd73d60b-9feb-4bfb-b6cd-fc26dc65a095_terseLabel_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 7</link:label>
    <link:label id="lab_cvs_Category7Member_label_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 7 [Member]</link:label>
    <link:label id="lab_cvs_Category7Member_documentation_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Category 7</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member" xlink:href="cvs-20210930.xsd#cvs_Category7Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category7Member" xlink:to="lab_cvs_Category7Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_05b6a4d9-ea6f-494a-91a9-eac6e35676d6_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ebbcbba5-34d5-40e2-ae3d-87052e7ae96c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Securities Available For Sale</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_ac0793f3-6179-49a7-8800-031b08f2678b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_7e37d2bc-c08a-4cd9-af08-03d687b18223_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingExpensesExcludingGoodwillImpairments_83e2c68c-7cbe-4368-8ab4-348951158bd6_terseLabel_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingGoodwillImpairments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_cvs_OperatingExpensesExcludingGoodwillImpairments_label_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingGoodwillImpairments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Goodwill Impairments</link:label>
    <link:label id="lab_cvs_OperatingExpensesExcludingGoodwillImpairments_documentation_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingGoodwillImpairments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Goodwill Impairments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairments" xlink:href="cvs-20210930.xsd#cvs_OperatingExpensesExcludingGoodwillImpairments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingExpensesExcludingGoodwillImpairments" xlink:to="lab_cvs_OperatingExpensesExcludingGoodwillImpairments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_c773a9cb-297a-49f6-ad9b-58cdfe6474ba_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_3092780d-99b8-4d45-953c-0010f814a3fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_7b90bafe-b7d8-4e6a-a60a-ef28a8fd2480_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares (in shares)</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:href="cvs-20210930.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6d77c04f-826c-48ee-9168-30a785ae7384_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_9158acfa-f9d2-4b11-8054-d315b1195dba_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bfd82c0e-7b7f-4f4b-b325-f3597ab76001_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_7aa27c0d-8e07-4b34-b28b-69f7d5afd7ac_terseLabel_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail/ LTC</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_label_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_documentation_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember" xlink:href="cvs-20210930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RetailLongTermCareSegmentMember" xlink:to="lab_cvs_RetailLongTermCareSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_d6d62ca6-3d84-4a34-8ecd-875082eab053_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_391b7b23-0cc9-4b34-b35b-b495d01ef56e_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_8793bbb1-8323-49d9-869b-c65b7bb8cfe4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_48a4591a-41f3-4f3f-8a30-3d7676065542_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee</link:label>
    <link:label id="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareEntitiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:to="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_127e7b25-dcec-48e0-91bf-00a18324a6fe_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy network</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_d91a2223-e525-4d92-821e-528bc4d874bd_terseLabel_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20210930.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bc84d593-5d32-4b75-9cc6-90d96b4f00ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_71a522e9-c772-4133-b8cf-3c9b3705c562_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% senior notes due December 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due December 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.75DueDecember2022Member" xlink:to="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_14f627c8-f763-45c9-80d8-a039b23ab96a_terseLabel_en-US" xlink:label="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_label_en-US" xlink:label="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]</link:label>
    <link:label id="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_documentation_en-US" xlink:label="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:href="cvs-20210930.xsd#cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:to="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_fa8e2cdc-34b0-4126-8e0b-629e7839d399_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_8a319acb-6097-455b-8c08-e3f5def4c036_terseLabel_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20210930.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_66e8dae4-867f-4353-9eff-3b1d4a67fbdd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_2faa982c-2fdf-4436-ac08-69e82dc8d4a1_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.125% senior notes due September 2039</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:to="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.625DueApril2027Member_f33ce773-5ca9-42d5-ab39-50173506c2a5_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% senior notes due April 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes3.625DueApril2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.625%, Due April 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.625DueApril2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.625%, Due April 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.625DueApril2027Member" xlink:to="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_b243ef94-1544-4ebe-9bee-c1accfda744f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_02aa919b-11f5-426f-88a4-dde8fb70cdf8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_2fe47343-49f4-4dd9-8dae-2cb8f3e07b2a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative goodwill impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherReceivablesMember_93c75263-c035-47d1-b33b-c525b1ba38b8_terseLabel_en-US" xlink:label="lab_cvs_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:label id="lab_cvs_OtherReceivablesMember_label_en-US" xlink:label="lab_cvs_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables [Member]</link:label>
    <link:label id="lab_cvs_OtherReceivablesMember_documentation_en-US" xlink:label="lab_cvs_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember" xlink:href="cvs-20210930.xsd#cvs_OtherReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherReceivablesMember" xlink:to="lab_cvs_OtherReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_85c05e64-1c4c-45f2-87a0-9ff2a219e6ac_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts liabilities without a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:href="cvs-20210930.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_8a7fa40b-004f-4784-a564-d550b70baed4_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States, municipalities and political subdivisions</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_854d602f-6ef7-469f-8bac-377fc4e970e5_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amortized Cost and Fair Value of Debt Securities by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_cc9887d6-b11e-4012-a997-652617ed4482_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_72e907ed-cac5-4fe8-b589-9b496b264006_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_07511250-95aa-4b41-ba9c-07633b923918_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_7f0cfa85-c910-41c4-b003-1f9302e810b3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8550fa2b-aac4-4c98-baa6-aa187df60f6c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7d0725e-28c0-4812-a511-60ac44b92bc0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_277a595c-d442-4227-958d-83fdd764c143_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_a3fb08a5-180a-4946-a7b2-d7b3533b8a47_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_8c79643e-3aab-4faa-8e47-8096f6dc9626_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_c6679ab4-8df4-4224-bb89-a526cdc40a0b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_3ac5d29b-482e-47a1-82e7-8410d6379b33_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate</link:label>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_label_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialRealEstateMember" xlink:to="lab_us-gaap_CommercialRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpensesAbstract_82ae7a49-5f29-4189-aa3d-8504b298a13b_verboseLabel_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs:</link:label>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits, Losses and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:to="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_bf48d39d-a0f5-4371-82a4-cc15aec08761_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_a8ac0831-0643-42ca-af05-f5639d6fb7b4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_6132931e-17b9-42ee-8757-4ca500badf6f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:to="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_18851044-c105-46b4-a28b-e5266fdcb4f4_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstate" xlink:to="lab_us-gaap_MortgageLoansOnRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8c645860-08d4-42a5-9afb-c55042914241_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_5fa01b57-55ab-44f7-919c-283403f9b96d_terseLabel_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-related impairment loss</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20210930.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_bb394746-99f4-4830-b989-990bdfcad3b4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_071d2032-8967-4223-9a12-9fda6d0773dc_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_a30ffe91-438f-4624-8e11-ebd84149b442_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts liabilities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_label_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountsLiability" xlink:to="lab_us-gaap_SeparateAccountsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category2To4Member_90be809d-e812-4de0-8349-8545d008f17e_terseLabel_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 2 to 4</link:label>
    <link:label id="lab_cvs_Category2To4Member_label_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 2 to 4 [Member]</link:label>
    <link:label id="lab_cvs_Category2To4Member_documentation_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member" xlink:href="cvs-20210930.xsd#cvs_Category2To4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category2To4Member" xlink:to="lab_cvs_Category2To4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_ee1e30f6-3cbf-46b4-a440-ccb091d90172_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.3% senior notes due December 2043</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:to="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_411584b5-bd9a-4d49-b735-949f534909f7_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.25% senior notes due August 2029</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:to="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_26c0d03b-140d-4f24-9e18-3a8a08c75e1e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_9f1de1c7-6174-4053-a501-3da599ca51f0_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5% senior notes due December 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:to="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_9b5deae5-b33f-4fb0-9244-0e2966c0f2d2_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a3444508-a5ab-4295-9a5b-a34170f38b52_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_c2089dcc-bfaa-47c8-b2ca-02b509798152_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_1e345f05-83da-4bd7-8591-d046f399fb44_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount expected to be reclassified</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_5c07f089-05f9-4f0b-a0d3-9bfbdf520d37_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_ce4533fb-54b2-4a06-a33b-111103a590eb_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_2f38851c-c78a-4466-a018-dbca254193d0_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in prior years' healthcare costs payable</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_78a95dcd-02ad-4a2d-b6a7-d00ae6f28459_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of subsidiary</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8b0d28e7-529f-40f7-a14d-eef4f2fbd0a0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to CVS Health, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_e5d5a6c9-24f9-41a1-b915-5c3e20821e00_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_5923e4bf-852d-48ca-8028-db3a16e9a176_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_21217975-f32a-45f7-9566-a6100c9f6050_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7b968e7b-eae5-4146-bb86-0540f0f3614b_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b563978d-362f-4fe8-9775-b3b85360ee23_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_112a369a-849c-4c18-a804-ca7b8628ba1b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_afe97dbc-eff1-40ab-a77a-d0bc36cc73e7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_f732db8a-a879-4e0d-af00-005378ca71fd_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_76e6c3bc-8463-498d-ac46-0ff1a8075956_terseLabel_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:href="cvs-20210930.xsd#cvs_ChangeinContractwithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:to="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsDomain_aadbd188-50eb-4fb9-98c1-26badfceb8be_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsDomain_label_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsDomain" xlink:to="lab_cvs_TotalInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_f560d907-251f-4369-8eb9-88929193c02e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_c8e59771-7567-42a4-a77c-a9b1147f4bdf_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, fair value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:to="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_61a9af0e-c18e-426c-9086-5b1321c021eb_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_ffb611a7-d917-43cc-a42d-975710f412ec_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_25679717-2b1a-4ad6-9123-559f7044091d_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Prior To Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Prior To Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e38cf050-47f8-4457-8017-501f21b1dc30_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Categories5and6Member_44dc38d2-b032-47b3-b71b-e5a4e8c60dd8_terseLabel_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories 5 and 6</link:label>
    <link:label id="lab_cvs_Categories5and6Member_label_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories 5 and 6 [Member]</link:label>
    <link:label id="lab_cvs_Categories5and6Member_documentation_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Categories 5 and 6</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member" xlink:href="cvs-20210930.xsd#cvs_Categories5and6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Categories5and6Member" xlink:to="lab_cvs_Categories5and6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_484f7eb5-0727-43d3-87ad-c0b580056c0e_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury shares, net of ESPP issuances (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20210930.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStores_6841dc6d-bea4-4d72-b3fb-d121c1747bd2_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stores</link:label>
    <link:label id="lab_us-gaap_NumberOfStores_label_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStores" xlink:to="lab_us-gaap_NumberOfStores" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_a159713c-2f93-4cac-aac3-0151290fff2e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_625cb320-543a-45fb-8a16-2b9f51b866cd_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_055799b4-e259-4d07-b668-bb4a2b4880d4_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3% senior notes due August 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:to="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_5dd8f769-6d4b-4d5a-a696-b842bdddb7ee_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.875% senior notes due July 2035</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:to="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_1bfb11cf-dbad-4ba5-96ff-ef0e45a960a1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_8c4e7b6e-1740-459a-87a8-ff73dc38de34_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_4aa3af9f-f7dc-47b2-ba44-eda2688b4c21_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_0d210a99-34bc-4f77-9dd6-9e14c3168b69_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_94d0ca7b-335b-47de-8fdd-14d3bfa72854_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_f33f4fdd-c054-4e3a-93b1-95396bb2d3a1_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.25% senior notes due June 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:to="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_9ad6cd1e-e218-4d4f-817f-9375c8aec002_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2125PercentDueAugust2031Member_9c143856-ce2b-4652-ba68-c2ce4049a078_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2125PercentDueAugust2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% senior notes due September 2031</link:label>
    <link:label id="lab_cvs_SeniorNotes2125PercentDueAugust2031Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2125PercentDueAugust2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125 Percent, Due August 2031 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2125PercentDueAugust2031Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2125PercentDueAugust2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125 Percent, Due August 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2125PercentDueAugust2031Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2125PercentDueAugust2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2125PercentDueAugust2031Member" xlink:to="lab_cvs_SeniorNotes2125PercentDueAugust2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_ea6740ae-24a0-42a3-a2ae-51d05a3647c2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_042f187e-38be-475d-a968-90f340fb8ed4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_97b8de30-d378-46de-a4d9-3b664c788a6f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_6b2a6e8b-5e57-498b-b21c-eb4c7022d670_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_df0428e5-70bc-46d0-8a28-eb6653d45ba6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.75DueApril2030Member_a2365ae0-fbef-4c29-8b93-55d5c87fb6f9_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% senior notes due April 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes3.75DueApril2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.75%, Due April 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.75DueApril2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.75%, Due April 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.75DueApril2030Member" xlink:to="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_7289fe54-8909-4fa4-af22-b753f52493d7_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_eb294083-84af-4f0f-814b-13b44d842519_terseLabel_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor obligations, number of leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_label_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number of Leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_documentation_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number of Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberofLeases" xlink:href="cvs-20210930.xsd#cvs_GuarantorObligationsNumberofLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_GuarantorObligationsNumberofLeases" xlink:to="lab_cvs_GuarantorObligationsNumberofLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_5f36465b-c3ea-48a8-9b07-21f1f8f81b2b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_c077e9fd-9fdb-448a-a68e-d434b436aa9f_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:to="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyRevenueMember_6fd1b72e-83bd-439b-bbda-0ca701b1c463_terseLabel_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_label_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_documentation_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember" xlink:href="cvs-20210930.xsd#cvs_PharmacyRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyRevenueMember" xlink:to="lab_cvs_PharmacyRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueApril2040Member_75c68d52-7d5d-4620-b433-b8095dec4e2a_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due April 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueApril2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due April 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueApril2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due April 2040 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueApril2040Member" xlink:to="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_ca746c3e-ec4c-4d73-aba2-5de115c81c8c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_97de19db-c9a5-4545-a8c2-2422889f0070_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_ef23c1b4-7556-4140-b365-afaf741db62f_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2eb0c38e-2a8b-4116-817e-c282baec65ba_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_ea221c74-0f23-4fc6-a6e0-768352a2f285_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities (included in accrued expenses)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_45661938-cecc-4bb7-8867-a37287559acf_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities, beginning of the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_d5bd116c-91b6-4305-aa11-6d32baecf2df_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities, end of the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_d40d55e1-348c-4525-b3c9-dfa30df517b6_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.7% senior notes due March 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.7%, Due March 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.7%, Due March 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.7DueMarch2023Member" xlink:to="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_ada31193-495b-43da-96c3-79db7c50881c_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_d9debd4b-9140-4b61-bfa3-5938155eca98_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_33b23b5f-9213-42a5-ae44-312191a496d6_terseLabel_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services</link:label>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_label_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services Segment [Member]</link:label>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_documentation_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember" xlink:href="cvs-20210930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyServicesSegmentMember" xlink:to="lab_cvs_PharmacyServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_77ae4253-6230-422c-967b-f0a371a40e4a_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FrontStoreRevenueMember_92d1666d-bc71-4a58-bc27-0f4cca91f5e7_terseLabel_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_label_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_documentation_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember" xlink:href="cvs-20210930.xsd#cvs_FrontStoreRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FrontStoreRevenueMember" xlink:to="lab_cvs_FrontStoreRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_bc7e0bc2-dca4-4d0d-8bd7-578bf3fb74fa_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.7% senior notes due August 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.7%, Due August 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.7%, Due August 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes27DueAugust2040Member" xlink:to="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_8c1afa07-49d7-49c1-bd15-9fb1237b2ef3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_be3e6b35-3135-482b-ade8-d4427a84f77f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and pharmacy claims and discounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_0bd78936-6241-499c-b87e-3d868c82f66e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_65160445-d62f-43c1-97cf-9077f243864c_terseLabel_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting experience-rated products</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_label_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Experience Rated Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting discontinued and experience-rated products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember" xlink:href="cvs-20210930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingExperienceRatedProductsMember" xlink:to="lab_cvs_SupportingExperienceRatedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_7d478aa1-1de7-44f3-8175-194acaaefc1a_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance benefits paid</link:label>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_label_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Insurance Benefits</link:label>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_documentation_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Insurance Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits" xlink:href="cvs-20210930.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsforInsuranceBenefits" xlink:to="lab_cvs_PaymentsforInsuranceBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_586b35c2-3926-4612-b38d-8b86d1790f53_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_31968810-f435-4184-92f7-48133edcd431_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital gains</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthInsurerFee_80b02f76-63d2-4bdf-a8e2-e8565c97e7c6_terseLabel_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurer fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFee_label_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFee_documentation_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee" xlink:href="cvs-20210930.xsd#cvs_HealthInsurerFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthInsurerFee" xlink:to="lab_cvs_HealthInsurerFee" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_2447746a-bac2-44ce-935e-87fb83cd8a50_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_cd127081-ca89-4886-9c64-f46a5617b066_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_6d34d952-ee87-460b-bf6e-4ec89608dfaa_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_label_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_documentation_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:href="cvs-20210930.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:to="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_5252f32f-bea8-49f5-b8b6-990f686999e5_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_08a6f29f-0e0f-4517-9edd-600438951757_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_80fbfc78-7527-40fd-bbcb-85256c3405dd_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, unrealized losses</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:to="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_4ae92a89-2320-4010-9d51-17ff01680dbd_verboseLabel_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_label_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:href="cvs-20210930.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:to="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_54e35228-6e76-4f19-86f3-50a416d77cbc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_20e23426-9934-49ab-aa24-301612d285af_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% senior notes due June 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:to="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_4c8924ae-76af-4b6a-85c9-4c2b0b3b587b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_7b0ebb94-1e46-4e69-b6ee-1774ce13968c_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_ac27e072-8a16-44a7-b400-f71dee1cf53f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI before Reclass, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_2ee657c0-41dd-4f8a-94cc-3e15b6220462_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0d01b22f-fd36-417c-8e83-c049aa32786e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_fd1255fb-95da-4240-8389-6075ef1fe510_terseLabel_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-related impairment loss</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20210930.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e22c5f99-cee9-4417-baee-f44326ca916e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions (net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_36d21f08-ea1b-4f82-8eb3-769d80f249b0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_506184a4-bcde-4b16-aa79-388eda3ef4cd_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_b22b760b-23f8-4e2f-a3c0-bdff481bf7e4_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_2a816bdd-f225-411e-af49-58497b098a34_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.3% senior notes due March 2028</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:to="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_189e952d-05f4-48e7-a418-db17641180e0_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_ee2dd11c-71e6-4ce3-a980-a0ca8ac7ed02_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_b10040f1-5d55-4570-bf81-837f158774f7_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_3682d580-78f7-40c7-9bcb-d4e76f708eff_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium receivables</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:to="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_9cfe4297-9c49-4f5e-97e9-8710c605e8ea_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_d6528f76-56e0-4ccf-b635-d88fa61ec0ba_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due August 2047</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:to="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_025233e3-0a60-4a53-9526-1576ef0f28d6_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_f8b63c66-ee28-427a-ae91-3a17484572d4_totalLabel_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_label_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross And Lease Obligation</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_documentation_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross And Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation" xlink:href="cvs-20210930.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation" xlink:to="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_dd1c749a-1e87-4abf-b93c-8a0a10431029_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.125% senior notes due July 2045</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:to="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_e7eb62e2-2a12-49c5-ac31-51e5c8d2bd42_terseLabel_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_label_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_documentation_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember" xlink:href="cvs-20210930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareBenefitsSegmentMember" xlink:to="lab_cvs_HealthCareBenefitsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_dd87aea3-d65b-4b96-af7c-47845d23574c_totalLabel_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (excluding net realized capital gains or losses)</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_label_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains or Losses</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_documentation_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains or Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:href="cvs-20210930.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:to="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_e041a279-02a4-4d86-85a1-0ead645f9d5f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_3538cab5-d650-46fd-89ad-a3cd9ad92b42_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d3475b45-2ef2-42e5-940b-a7f0095e4111_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Deferredincometaxesandothernoncashitems_4dd945b9-7efe-4dab-956c-bcbd8c3405ad_terseLabel_en-US" xlink:label="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other noncash items</link:label>
    <link:label id="lab_cvs_Deferredincometaxesandothernoncashitems_label_en-US" xlink:label="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other noncash items</link:label>
    <link:label id="lab_cvs_Deferredincometaxesandothernoncashitems_documentation_en-US" xlink:label="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Deferredincometaxesandothernoncashitems" xlink:href="cvs-20210930.xsd#cvs_Deferredincometaxesandothernoncashitems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Deferredincometaxesandothernoncashitems" xlink:to="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_02d90bcf-ceb6-4e1f-b767-57e98cdd7d32_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable and other insurance liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_74ef21a1-f6a2-4824-a73e-7020d021046b_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_750e0489-ccf7-4283-a229-ac25f2eb5302_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_537e6216-52d2-4050-90f1-0783c33c4e25_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_ede20b7a-6bf0-45b0-a0b8-2fab29458885_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_20d6c5cf-1a1e-4b58-acc0-391609da6fb2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b54ddc0a-957c-4161-b269-afafecaad6b9_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofPharmacyPlanMembers_acb43a24-db3e-41b1-ba48-3adba3016c93_terseLabel_en-US" xlink:label="lab_cvs_NumberofPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of pharmacy plan members</link:label>
    <link:label id="lab_cvs_NumberofPharmacyPlanMembers_label_en-US" xlink:label="lab_cvs_NumberofPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Pharmacy Plan Members</link:label>
    <link:label id="lab_cvs_NumberofPharmacyPlanMembers_documentation_en-US" xlink:label="lab_cvs_NumberofPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Pharmacy Plan Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPharmacyPlanMembers" xlink:href="cvs-20210930.xsd#cvs_NumberofPharmacyPlanMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofPharmacyPlanMembers" xlink:to="lab_cvs_NumberofPharmacyPlanMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_457142db-315a-471f-8f3e-63b613361ae9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_321dae9e-5a1c-4a7d-9504-79f237b61d80_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_c1b88797-9593-4ed2-9ae6-cd6319655d87_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_8909b6c4-3079-4acc-976c-a8f8ea630317_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.625% senior notes due June 2036</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:to="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_9c72a3b4-b32a-4915-a8c7-902ba4fa6b78_terseLabel_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_label_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common and Collective Trusts [Member]</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_documentation_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember" xlink:href="cvs-20210930.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CommonAndCollectiveTrustsMember" xlink:to="lab_cvs_CommonAndCollectiveTrustsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_4b03b9cf-820b-4072-9ab0-169347b5a564_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_daf75066-efd2-4cc0-abd3-96259891e011_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_f7412906-9b9c-4fa7-82e1-7b310a60da5a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred but not reported (IBNR) claims liability, net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_bf5aaff3-32dd-4e3d-ba71-43972dee38ad_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_c5c3ae8e-9215-456b-9006-120f299af28e_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_08c0c7a7-2b94-4015-b6bf-3451f2e84bce_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive income (loss) before reclassifications, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9a6965b5-6ce3-4625-b09a-cb3acbb4c545_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_1a489c78-46c0-4fe5-8dae-8f46e64e0989_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_dde86489-c83a-42bb-bca0-cd8bd22110e4_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Securities In An Unrealized Capital Loss Position</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_eefd6d73-1ccd-419f-9516-7cfd40a9ea34_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_4b4267c6-86ac-4c2a-a23e-c292814c2d6d_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:to="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_3e0ac631-fe58-4cec-af65-0d267236521e_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares held in trust (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:href="cvs-20210930.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:to="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_1b1a1e3a-64e7-4d52-a1d2-5e7cc0828873_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_90bfd141-2930-4341-a5a9-0f4e4369f3c3_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of the period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_0ace6578-f408-4d83-89ea-a47b25e0bda9_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of the period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_7df6fdc8-27bb-4566-8b27-40486b5a5362_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_32fb3db0-9b08-446e-b6e5-535df514e719_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_d5e11a54-7307-4124-a8d8-02cf31e67b44_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_260f1857-97fc-4f4b-9521-c23555bef9ff_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_fecccb43-96c0-467e-ad7b-d1fe57276b0f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash receipts from customers</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCustomers" xlink:to="lab_us-gaap_ProceedsFromCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_5697a744-7baf-46be-8d58-c2a39e181521_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_2e6069b4-996f-4ded-b29c-e3806b24cad0_terseLabel_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes</link:label>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_label_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes [Member]</link:label>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_documentation_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember" xlink:href="cvs-20210930.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OutstandingSeniorNotesMember" xlink:to="lab_cvs_OutstandingSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsToHealthInsurerFee_377d7fa6-90cb-499e-97d0-a305e9bcba32_terseLabel_en-US" xlink:label="lab_cvs_PaymentsToHealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to HIF</link:label>
    <link:label id="lab_cvs_PaymentsToHealthInsurerFee_label_en-US" xlink:label="lab_cvs_PaymentsToHealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Health Insurer Fee</link:label>
    <link:label id="lab_cvs_PaymentsToHealthInsurerFee_documentation_en-US" xlink:label="lab_cvs_PaymentsToHealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Health Insurer Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsToHealthInsurerFee" xlink:href="cvs-20210930.xsd#cvs_PaymentsToHealthInsurerFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsToHealthInsurerFee" xlink:to="lab_cvs_PaymentsToHealthInsurerFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_b9ebe6b6-071d-48b4-b428-f6b048d8c5b2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_dd2cbd0f-33c6-452c-ac94-84970f1cb7ab_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_917c9b91-9896-4507-b73b-d292ea460b34_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_9f647dcd-eb66-4e08-a7b2-1a451346d2f3_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CorporateOtherMember_0ee911e1-4ad5-4e75-a4df-8d886f74d649_terseLabel_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other</link:label>
    <link:label id="lab_cvs_CorporateOtherMember_label_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other [Member]</link:label>
    <link:label id="lab_cvs_CorporateOtherMember_documentation_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember" xlink:href="cvs-20210930.xsd#cvs_CorporateOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CorporateOtherMember" xlink:to="lab_cvs_CorporateOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_e9da264b-9bf0-45e2-8e16-b1f832da1032_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Payables</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_3f721a1a-d7c7-4a8d-9649-b8c1920fe973_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_6bdb0219-ba0b-4eb7-9f2c-8bf75c1cea4e_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_4ae95b2e-2057-47be-bfd4-7d3bd6e99f0c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_f1a38476-485f-4ffa-a5a3-b4f843df55aa_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Claims paid</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_6ffbedbe-5628-499a-a3f9-ceeb22df6ecf_terseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_bffa0a87-ec2a-4bf2-9048-5f60b9dedc4c_verboseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from external customers</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_documentation_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="cvs-20210930.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_afb0acf9-3711-4114-824f-2973b04f7c23_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8bc2626d-b98d-4eda-8279-a5fc34c1c7d7_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_4e187e9f-e292-4364-9bba-22ff343c9866_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (GAAP measure)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_a3c47b5d-fcc6-4582-84c4-5ef505edf4e2_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and lease obligation</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cf5ff5e8-4924-4935-b7bf-eeaffe29323a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_55b860da-b113-47b7-be2d-986a5562e37e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_cce76c9f-6994-4592-994f-c3b6bd1631cf_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3e590e4b-d114-4dbb-a158-a75db664d599_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_990adc9d-217f-427a-ad62-0af948075090_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_4ddfae3a-d0ec-43af-a6cc-2837941f1979_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_f7169669-a2d2-4225-b380-4278d33d79f1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_e951ef79-7b58-424a-9b2f-e1ee0b5abb7d_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mail choice</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_9f825ce4-b58e-4afe-afd7-5d4cc8d153be_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_0e0ed10e-c0ee-47a4-8a65-3abd9c35ad53_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_3111d909-2dbf-4cdd-bbe8-985d0cf23e95_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. corporate securities</link:label>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_13e9785c-6db4-4697-98ab-2a6392cf0b2e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongTermCareReportingUnitMember_28340dac-66d7-42f2-a82d-4e7863f30a06_terseLabel_en-US" xlink:label="lab_cvs_LongTermCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care Reporting Unit</link:label>
    <link:label id="lab_cvs_LongTermCareReportingUnitMember_label_en-US" xlink:label="lab_cvs_LongTermCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care Reporting Unit [Member]</link:label>
    <link:label id="lab_cvs_LongTermCareReportingUnitMember_documentation_en-US" xlink:label="lab_cvs_LongTermCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember" xlink:href="cvs-20210930.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongTermCareReportingUnitMember" xlink:to="lab_cvs_LongTermCareReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_debf28e6-e361-47a4-833f-af17421299c5_terseLabel_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions:</link:label>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_label_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</link:label>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_documentation_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:href="cvs-20210930.xsd#cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:to="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e7059545-7a54-4b4c-acee-3eaee87ea4fe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_e586240f-a8d8-4d62-91d6-78f12b0d699e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_019a2511-c043-4d0d-9a9c-0d925a2e7bcc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d83e961a-b490-4614-8de0-1ba04d4eb644_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_9bc54c40-8bf5-4546-a3ba-ed7f4a26997c_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_53c6d445-1c06-428e-8678-6c6718dde48a_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2676dd3f-d0bc-4190-a65e-7026e4ffb5ee_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_e5165898-c858-449a-890c-6cc948ae70fd_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_f2cfbe9b-4f48-4dae-97d1-15bc10ab7d75_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Three [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:to="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_1d990e56-4ba0-47b2-8cac-f5821a6fe46d_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_eb8e0c88-cf41-48d6-bbaa-948ae776bb5c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_033830f6-dc89-4828-97ca-4214dfe4d790_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_22b8c838-2b15-49fc-8cac-e62b3effae91_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_133e0992-6883-4aef-8130-2e890cbfd6e9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_47d73c9d-3d63-473a-9c22-a86205b4557c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_f0c55942-3311-4a24-8ff5-656d3084586e_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.75% senior notes due November 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due November 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due November 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.75DueNovember2022Member" xlink:to="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_fdfde660-21e3-446b-8c9b-fad8fb9d90bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_d3c5c63c-2ad9-4197-81f6-3d78b9a2ace5_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred securities</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemablePreferredStockMember" xlink:to="lab_us-gaap_RedeemablePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_319338ad-7d9e-4c1d-8bd8-210cbd45dc44_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_207c1b3b-5d3e-46b5-b5b7-027d76c96d64_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_0e2cc132-e75d-4630-b471-a2855dd4f3f1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_44db9324-0d97-46ea-80f2-543e7c6ae87b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_a5425cc1-4171-4de6-ace9-58432b5d14e3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_8091d065-c0dc-42d2-9c61-316e2a70eaa7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_7dcfbe4c-4c2d-4052-ac11-5d0c5f4b1dab_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_f097d5ac-0ff0-4f81-98d1-95439802f69b_terseLabel_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rewards earnings and gift card issuances</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_label_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_documentation_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:href="cvs-20210930.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:to="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_e1ee9a82-80d8-48e6-840a-cde1b7423633_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_9e1773f5-9578-456f-bf1a-3182d30dfede_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_02ce605d-93c3-4d26-a078-5cad9c9bc128_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_a272ab16-80ef-43ec-9c34-ecc9a17f30f1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_630afe08-6913-4141-94ef-439f51496ea5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_43259aab-652b-4d76-8a57-a3bd0929a47d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_be9e96da-0779-42fe-91bb-24d4e3ba5b83_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_6b6e9bb8-a010-46e7-84b5-f510795ccef4_terseLabel_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_label_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_documentation_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:href="cvs-20210930.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:to="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d9e3c93c-94a4-4e58-8de7-8b7d35f6ff2b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_7bebd803-eb17-4aca-9d79-d4a09df7ad2c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_6748f222-4ec2-4775-87d1-882bd3871d7e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_839ec392-de52-48fd-85e9-0a3c29a09cd0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_bad3d83f-098f-4ffa-935b-0a660f6085e0_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_c1ae5234-edce-406b-bcf3-33267c65b6b3_terseLabel_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients served per year</link:label>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_label_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Patients Served per Year</link:label>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_documentation_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Patients Served per Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear" xlink:href="cvs-20210930.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofPatientsServedperYear" xlink:to="lab_cvs_NumberofPatientsServedperYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_dbf4053f-b500-4acd-ae28-8dc65e7636bc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6364acd7-7642-46c7-ad4e-4080d5f2a46e_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_b66cb7de-00c0-4ce9-814f-cbe8e4965f1a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_ff406ca4-e9e8-43d5-8908-170cb63adf53_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_38acf71e-7fe4-415d-ac47-2711964e58b0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_cb4fd123-59ee-4136-8ca7-7b28e7806d2d_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_166ab33e-df19-43a5-bcf2-a580e3503f24_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:to="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_3ff9a636-e6f0-4de7-a456-35395b73304c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.875% senior notes due February 2031</link:label>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.875%, Due February 2031 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.875%, Due February 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1875DueFebruary2031Member" xlink:to="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_bf6629d8-3e2d-44c1-87d8-ab92905e40d1_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4% senior notes due December 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:to="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category1Member_ad25beaf-199e-4bff-9323-7e4349769d52_terseLabel_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 1</link:label>
    <link:label id="lab_cvs_Category1Member_label_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 1 [Member]</link:label>
    <link:label id="lab_cvs_Category1Member_documentation_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 1 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member" xlink:href="cvs-20210930.xsd#cvs_Category1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category1Member" xlink:to="lab_cvs_Category1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_67bdc4ee-018b-4fb3-bf6c-aabf2c3e53d9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_12b10954-4869-4c0d-a2c3-044cf5f6f703_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_989fcdd3-fba8-4f5d-ad11-aad781e4dd44_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_1c3fff5f-895b-4b7a-bfdd-528081585813_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6ef01e29-b48f-4d0b-bb86-d4ac037e8bfc_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70383d1a-000c-4a5f-98ee-5ea61f5bf950_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_672dda18-23fc-455f-9a76-f54e472b1829_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_20a3a5ab-60d8-4027-8530-c3eeb2d1934b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_3d12db7a-7b56-4f62-812f-55a7367e106f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_581804c3-65a4-4a02-bcbe-c6ff12a51e44_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_bd95f0a5-ed17-471d-bcd2-fe727adb7467_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs recorded in other insurance liabilities</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_label_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_documentation_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:href="cvs-20210930.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:to="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_339d39a1-068f-4758-8553-55c69ba49721_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_1900ad86-4f18-4d36-99d3-6089e2935b3f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_49811fb7-ad70-412d-9a5e-db6f1f144d6f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_cbd4e654-3959-44ed-b6a3-1376e85d3ac7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_41e0a02c-cda6-4696-8350-172c5870896b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_4763658d-567a-4540-bb7c-d48de473d577_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium paid in excess of debt principal</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_375f2973-3cd5-41d6-aa0e-71927b27ef97_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_4e4f32c5-e774-4fba-9ab2-1bad1f7e8d06_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_c5ecc5c5-4b24-4a71-9389-b1bf71e4aef9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Components of incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_679ede8f-35ba-4276-9119-f155aa229a00_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarized Financial Information Of Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ba094af6-7213-4cb8-99bb-4c7057aecbd4_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_a8aaba0c-871d-4b9a-a1e9-e8178d6c41eb_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2dfcca32-1cc5-4d37-8e9e-76359c343678_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_5d01e40d-4b1f-4ed0-b58f-45c97894588b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ad700347-04bb-4ed6-819c-a6cd6498ce7f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_025b1006-607d-4ce0-9a3b-f4c460bcaaae_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% senior notes due August 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.3%, Due August 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.3%, Due August 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes13DueAugust2027Member" xlink:to="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_0cd5ddaa-c60c-4c41-bec2-6251c256ba1d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% senior notes due March 2044</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:to="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_8f53b12b-b5e1-4951-8320-a1091db10103_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_dd3b6508-ea2f-450f-99d4-cccecdc54c06_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_0ab5bd96-c590-4c61-b412-8fee7aac4bb4_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_715ccd5c-2ae1-49d9-9d98-7103d0edbb19_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_534e6cd6-6623-494c-b48e-64559a710a09_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:href="cvs-20210930.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_a28a93d1-71d9-4a2a-af52-5e2a86a12091_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_f6e29f1e-ab2e-420e-87fd-4eb625decce2_negatedTerseLabel_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discounts and deferred financing costs</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_label_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_documentation_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:href="cvs-20210930.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:to="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_90f4b71a-12b3-4069-b02c-a669615c7938_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_149c7c78-ab2e-41e8-aa91-ab425f834ea8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_8bca230e-c8dc-4ce0-af01-08d1c6166975_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansMember_01aff429-f673-4092-b989-dcc276d5bae1_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_label_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans [Member]</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_documentation_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansMember" xlink:to="lab_cvs_MortgageLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_a46eb07b-2e7d-47b6-9826-e37a23e11317_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_9ad5e0ff-61fd-48f7-bcb2-6349fc5770ee_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f9776305-501a-4e07-9272-75b87ed50128_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7ca58c0e-4cd2-4661-a9f9-cc7d464756b0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_0886feea-1254-4dfc-8afe-9bd0597a652b_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes</link:label>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable to Banks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableToBanksMember" xlink:to="lab_us-gaap_NotesPayableToBanksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_8bd4544b-ff93-4221-85ea-0addf38b508a_terseLabel_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted operating income (loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_label_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_documentation_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss" xlink:href="cvs-20210930.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss" xlink:to="lab_cvs_AdjustedOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_770e2b71-a742-4f95-97f4-c72c03bc1c4f_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.75% senior notes due August 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.75%, Due August 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.75%, Due August 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes175DueAugust2030Member" xlink:to="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_3c77cc2f-0917-4f63-9371-100e7bc4f27c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_a758843f-2808-47c9-84ea-fe18095cdfce_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_03855972-6e44-44a1-8472-2f1df4bcde7c_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes43Due2028Member_605ec30c-52df-4aa3-8070-cab4b9b48a0a_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes43Due2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due 2028</link:label>
    <link:label id="lab_cvs_SeniorNotes43Due2028Member_label_en-US" xlink:label="lab_cvs_SeniorNotes43Due2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due 2028 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes43Due2028Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes43Due2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes43Due2028Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes43Due2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes43Due2028Member" xlink:to="lab_cvs_SeniorNotes43Due2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_acfca56e-3b9c-453f-8aff-34f51f4e440c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2021Member_b0414203-6ff2-4930-aed6-f1e3a0feaf65_terseLabel_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes due March 2021 (0.950% at December 31, 2020)</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2021Member_label_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2021 [Member]</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2021Member_documentation_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2021Member" xlink:href="cvs-20210930.xsd#cvs_FloatingRateNotesDueMarch2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FloatingRateNotesDueMarch2021Member" xlink:to="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_a1044afe-ef72-4e2c-ab6d-a10e8a22490d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (included in other assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_0cf1ed6f-77a8-4c74-a21a-06072e315053_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_label_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsLineItems" xlink:to="lab_cvs_TotalInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_f3bc813b-3191-483e-8153-0cb354413dba_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_2685cf98-1693-45c6-b76e-47c4c87e098a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_43b46d3f-8cee-4b12-ab31-a1bf668bd447_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.35DueMarch2021Member_a97f7c33-3c53-4df4-8295-a6f127954270_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.35% senior notes due March 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes3.35DueMarch2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.35%, Due March 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.35DueMarch2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.35%, Due March 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.35DueMarch2021Member" xlink:to="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_607b61a8-5981-4bb9-a30d-f37769f57217_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6274026e-594d-48d6-b85a-18f41c699e3d_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_423862cb-21f7-4669-8ed3-3e435e6628eb_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_d4ac80f6-a32c-465e-b638-e79e8f80aaa9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_b6866a8d-1751-4e44-ab72-87618dafb0f4_terseLabel_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other increases (decreases) in noncontrolling interests</link:label>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_label_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, Other Period Increase (Decrease)</link:label>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, Other Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:href="cvs-20210930.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:to="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_58739aba-1af7-4642-96cf-6b0bde7a0109_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_a0f32bf2-ba00-4e22-b158-adc49e791742_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_25e5a6c0-931e-4fc6-97da-0cb1080bec71_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_361319d9-ec81-498e-ba00-d7fd3007e549_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_2002345a-bf57-41a3-95c3-b7c0cfa9e354_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_3069b39f-a66c-475d-bec7-c512b228974c_terseLabel_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and manufacturer receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_label_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_documentation_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables" xlink:href="cvs-20210930.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VendorandManufacturerReceivables" xlink:to="lab_cvs_VendorandManufacturerReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e394e83c-9ccb-4672-a05f-b0901a8137ed_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_9e9a54c2-ebb7-44bf-875c-91ee2881257b_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate/ Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_5205098e-a538-4c2f-acc6-b9e58289ea6b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_14c96731-e17a-400f-ae5c-db29815d1b08_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_a834efee-0cfe-4f99-8036-7224eedc3774_terseLabel_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available for sale</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_label_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities Available For Sale [Member]</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_documentation_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:href="cvs-20210930.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:to="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cea6919f-b29e-4456-b841-8402b71d60b1_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_016a81c1-e252-4f42-94ee-ef69e6740668_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e48a8793-6a9a-4829-ab7e-3b0878e2ff23_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_55c7942c-dc8b-443a-8c57-2054e5343ed4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b5d17abb-df33-44a6-8f86-8842da4d7deb_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_d8ad29a6-9109-4a50-8199-be6e868588e6_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_e780f76b-02a0-40f1-a64c-794d26a19144_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized capital gains (losses)</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_6eb36b57-8dc3-4db3-9c4b-cf0a9b21c4ac_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_6f009a45-c9ac-430d-a473-95b136129bd9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0e6b33be-e0a7-44cb-815d-fdc65b2f5c21_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_da8be615-6de8-405f-a7fd-75ccac609180_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_81ade4ae-7559-49d3-b492-6a14b0b7c0eb_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_b04604b5-8dce-46fe-9971-962d78300fb4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_5653fcdf-409e-460c-8ca0-b30e887f30db_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_fd18889c-717f-4158-b291-80406a036f3f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_263c4a07-3ea2-41e1-afef-6b3f91262d35_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.75% senior notes due December 2037</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:to="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0585990a-0984-46e2-9199-e4f373108575_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_900d87d2-df17-41ae-b0a7-99a52cb82e84_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_fc4044eb-b1ef-4194-ae8b-a81df9de4216_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_a04f9733-b448-4be8-8862-bbc414a20dea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_69e96747-d8fa-4bc5-9edb-8f87be6b0805_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.8% senior notes due June 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:to="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_561e4aa8-4728-4b38-b8e5-794b3a9e71fa_terseLabel_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sample size</link:label>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_label_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Audit Methodology Sample Size</link:label>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_documentation_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Audit Methodology Sample Size</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyAuditMethodologySampleSize" xlink:href="cvs-20210930.xsd#cvs_LossContingencyAuditMethodologySampleSize"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LossContingencyAuditMethodologySampleSize" xlink:to="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_e36c477d-dc05-48a7-83df-d41950db290c_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_42a785cc-728c-45f5-8591-005e847e37d6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_548823e9-c50d-401f-9c77-738d53a764c7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_b72de369-015c-4344-a382-7e461d6f6bad_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b994a6cd-2b4b-4c0e-9177-12f9c7032452_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_83ce3480-3c25-4c92-8a37-841c107b3f37_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance and Deposit Contracts [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:to="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e087bf50-784b-410f-a88c-dded40af567c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_b116846e-89c9-4533-832c-c7e4c8c08376_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due July 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:to="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_16865b66-c953-40d7-83b4-0acf6cb85fe2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_7d67944f-950c-450b-a737-4e858ca007a8_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_5669a265-38e7-4980-835a-b652aab312e5_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign securities</link:label>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_147ae5d8-899a-4540-97f0-59086d57b3f8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_d3b02f4e-e7f4-4dbf-94c5-14f1cb1ae75b_terseLabel_en-US" xlink:label="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income (Loss) by Component</link:label>
    <link:label id="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_label_en-US" xlink:label="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_documentation_en-US" xlink:label="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:href="cvs-20210930.xsd#cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:to="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_eb10e2c6-ab30-496a-a9e2-a8970e4b6466_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8fd52894-ec1a-41d6-8e47-fda4b128269b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average basic shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1e98094a-e0dd-416f-9d9a-ecd9989db3db_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_8b32262a-274d-4e40-9389-2bce015fd3b0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to CVS Health, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_dc626307-0aa8-4c68-baaa-b4dcdee24eaf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.45DueJune2021Member_dc481f09-1d9b-4917-99ee-c9818c25a8d6_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.45% senior notes due June 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes5.45DueJune2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.45%, Due June 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.45DueJune2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents senior notes due 2021 with a coupon rate of 5.45%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.45DueJune2021Member" xlink:to="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_ec2fa47f-cc15-4ef0-9b98-63f258f39d79_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans fully repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Loans Fully Repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertains to amount of mortgage loans fully repaid.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:to="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_d374b14a-9879-4f35-a59f-b64d6122b8c8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_e154f825-4d8b-49ee-8e51-fbd787c68384_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Four [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFourMember" xlink:to="lab_cvs_YearOfOriginationPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_f877a2ba-3031-4a2f-9e0a-17a41aee6f29_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_7b6f24a4-a9f7-470b-842a-d3207a32203f_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liabilities at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_f810b344-0f99-4003-acb8-4f7ed65e45ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_7a72c615-53db-44a9-9da8-dcf1edc23439_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:to="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_774c955b-8152-4af9-9ae0-81a936fd3e5e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_cd64dc56-9f59-4916-93b5-f0e5cec921be_negatedTerseLabel_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and breakage</link:label>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_label_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer Liability Redemption and Breakage</link:label>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_documentation_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer Liability Redemption and Breakage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:href="cvs-20210930.xsd#cvs_ContractwithCustomerLiabilityRedemptionandBreakage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:to="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfPeopleServed_f5ec8847-7f9a-4707-86d6-36e357c985cb_terseLabel_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of people served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_label_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_documentation_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed" xlink:href="cvs-20210930.xsd#cvs_NumberOfPeopleServed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfPeopleServed" xlink:to="lab_cvs_NumberOfPeopleServed" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_7576020c-63a2-4082-8f68-f484ef16730b_terseLabel_en-US" xlink:label="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliffe and Flaim v. Aetna Inc., et al</link:label>
    <link:label id="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_label_en-US" xlink:label="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliffe and Flaim v. Aetna Inc., et al [Member]</link:label>
    <link:label id="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_documentation_en-US" xlink:label="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliffe and Flaim v. Aetna Inc., et al</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:href="cvs-20210930.xsd#cvs_RadcliffeAndFlaimVAetnaIncEtAlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:to="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b9742f65-30d2-48e1-ac26-316a9eaf981b_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_bb5874dc-245f-4100-a6d7-ed37113ad069_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f8705f57-0d3f-4d69-b4e6-69062679e053_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_c42161f9-ca88-49db-8619-1d0c29ea9b5d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost: 422 shares at September&#160;30, 2021 and 423 shares at December&#160;31,&#160;2020</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_14ea72fd-d132-4cb9-8e47-90b6c061e9f9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_84ab3f65-495e-4a1a-885c-5e6fe994def6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_47077c62-a140-4151-9104-0371ed830456_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and OPEB plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_c77ce13c-3c5b-4896-949c-5bf809a7670e_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts liabilities with a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:href="cvs-20210930.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_918a5d05-a6a2-43c8-9dbc-3b27f304bca5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_17f6f05d-706d-43f6-a1a6-fab42fe8ee34_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% senior notes due November 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:to="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_f1f87ac2-02d3-43fb-bea4-0ae07ebe70e0_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.1% senior notes due March 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:to="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_b716c12b-2303-43a2-8289-9f815803a86f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_3d26491b-c68f-4571-903f-0be827ab899d_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:href="cvs-20210930.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_19b08a7c-8740-4e99-92d3-42007b188b14_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_157ce113-cfee-4d5b-9ac0-e989e83a4a59_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_5e1be33d-fbd6-449e-9c7e-893bc62e950d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.75% senior notes due December 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due December 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.75DueDecember2022Member" xlink:to="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_7b3a8437-2558-41a7-b407-10eccc0c5bd2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_92134325-fb04-4564-ba6c-11a7544ca318_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_8a52bca6-4c52-49fe-a437-7963f979a609_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Derivative Instrument, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_7ca9dd02-b655-483f-ab0e-5c73f6074d04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_21987641-c759-4e42-ad97-2d5983e22585_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_ebcdeffa-6012-41d9-9879-90eec8c6663b_terseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_263b1ff9-9d43-446f-ab76-0a9abf9c246e_verboseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_label_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Deficiency Reserve Liability</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_documentation_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability" xlink:href="cvs-20210930.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumDeficiencyReserveLiability" xlink:to="lab_cvs_PremiumDeficiencyReserveLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d77c834f-48bd-4790-8fac-78e297bb9542_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_7e5adf1d-9f41-4b9a-ba1e-2c56c965c67c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9d81e975-4e00-45fd-ac4b-2314ab756a37_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_f46f6610-c69c-4102-a796-9928a35e1f3e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, other revenues from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Other Revenues from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_0eefe472-3fdc-42be-8043-aa8faa5b1e4c_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_ba8d6bbf-382e-4c5d-88b6-ba196141f9d8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_37c09a93-e2d2-4857-bbd9-946941f5f9b6_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_1aa0bfe5-d4aa-4576-af80-536b28284a29_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_c7a995b2-f2e5-41f1-9ea1-5b6027ba7e2c_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_5947534c-47a6-4efa-ab44-196fe60dd31b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_defc698a-387f-4701-a763-2a1f8c0dc4c1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_96ababc1-584c-421f-a42f-cdff3514317b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of subsidiary</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_07da0153-3b3a-4dc8-8036-8bc564ebd689_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury share held in trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:href="cvs-20210930.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:to="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_f1330b91-7891-4549-9e48-fc623f70ce54_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due November 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due November 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents senior notes due 2042 with a coupon rate of 4.125%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:to="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_8fe95b67-99ee-4092-969f-2a57679b533d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, 2 and 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:to="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_425965cc-5f09-45b0-a32b-b8ec07f47f0d_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_74172d62-3fed-4cc8-8acc-5b9bd5ab620c_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_9279423d-23ec-4cbe-a7d9-42ffce58fbe8_terseLabel_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Copayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_label_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_documentation_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments" xlink:href="cvs-20210930.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NetRevenuesRetailCoPayments" xlink:to="lab_cvs_NetRevenuesRetailCoPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_d184f92c-657a-4b59-8d66-43875c8f64cd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SalesChannelOtherMember_4adbdbe3-77fa-4b8b-a578-544fa9b19469_terseLabel_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_label_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_documentation_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember" xlink:href="cvs-20210930.xsd#cvs_SalesChannelOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SalesChannelOtherMember" xlink:to="lab_cvs_SalesChannelOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentIncome_75e4a3fd-b6d6-42c5-89a8-7aa624d86223_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_4d191aee-bcc8-4d9f-996d-1f02280694bc_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (loss)</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_22e4d34d-09d6-4402-944b-df6223a34f8d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_08fc483a-8cf5-4067-beca-1e120ebba741_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_19506647-c1c6-4636-b14f-5658679de518_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_83348a62-3b87-42ac-80c9-daecbad78bdd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_27c3bb4d-6feb-48e8-86e6-ff58e784fc8b_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_c0c1d681-efdc-4419-8055-2aea8abf4bdb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_5cd69419-ada5-4850-9e3d-6792eb80b1f2_terseLabel_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.125June2021Member_3387ea34-d7bd-4dc0-af4b-9e52710c4333_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.125June2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% senior notes due June 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes2.125June2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.125June2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125%, June 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.125June2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.125June2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125%, June 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.125June2021Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.125June2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.125June2021Member" xlink:to="lab_cvs_SeniorNotes2.125June2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_48ac4eab-d523-422d-93f9-2c6d5bc1e6fc_terseLabel_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages Held-for-sale, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:to="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_2fcf2f24-3c6a-46af-95a4-5a3bedd33ec9_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_5b2cbbf2-7563-425f-b457-f09289f1d13b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Company's Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_fd577627-3f23-44c5-a53b-f95a14265837_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_c2a48e27-a07a-4820-9800-bd8ab6bee826_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_d6f88c97-b3b1-4b69-abcc-bc7dad672bc6_terseLabel_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line</link:label>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthInsuranceProductLineMember" xlink:to="lab_us-gaap_HealthInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_3f37789b-cd69-4f4d-95e4-c4f57d0cdccc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to CVS Health:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_36a1c8cd-9b27-4665-b7d3-f16c1fdedf5f_verboseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_86dfd569-11a4-4ee3-aa20-ce76c389cf90_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.25DueApril2050Member_dd528b28-5ee3-4c06-8ade-670422a5bdba_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.25% senior notes due April 2050</link:label>
    <link:label id="lab_cvs_SeniorNotes4.25DueApril2050Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.25%, Due April 2050 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.25DueApril2050Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.25%, Due April 2050 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.25DueApril2050Member" xlink:to="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_5c298e5f-1bab-4d86-8cae-0d30a62a0951_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_833407c3-a222-477f-a931-18041d3d20e3_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_68a57a99-f8f3-4ec5-803e-3cb85925fd4b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_f5622b0e-a0c3-431b-b4d8-703fb6256cdf_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_75d54c8a-597e-4210-8a27-9585a06d403f_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_c71fda48-65d7-4fc6-86e1-5b158d7cac5d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e6a93d30-37f4-4e00-927f-590b8effc6e9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_5d0add3e-0f12-4e7c-ab7b-8c7eaffdf17b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premiums</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_78142e3a-d22c-4b80-90a5-52e660462e07_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares, net of ESPP issuances</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20210930.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_b16844c2-ae78-4e44-a600-50ed34b2e57e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_825de9db-b1bd-44ce-89bb-74b659e7b7a5_terseLabel_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy claims and discounts payable</link:label>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_label_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims and Discounts Payable, Current</link:label>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_documentation_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims and Discounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:href="cvs-20210930.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:to="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0395b129-3fb9-4606-a824-eb45eea4a487_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8da8e6d5-967a-4252-bd99-ff799da7f87a_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_4be2ba09-7742-4da4-96f7-8d5a37cc5b50_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_74d48d29-a2fb-4b8e-8660-2076ea1e68a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_6423172a-fb51-421c-aaeb-81b552e3c34c_terseLabel_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting remaining products</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_label_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Remaining Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities in an unrealized capital loss position supporting remaining products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember" xlink:href="cvs-20210930.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingRemainingProductsMember" xlink:to="lab_cvs_SupportingRemainingProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtExtinguishmentFees_f2e90546-bf83-4e2a-9790-dac9722175da_terseLabel_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Extinguishment Fees</link:label>
    <link:label id="lab_cvs_DebtExtinguishmentFees_label_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Extinguishment Fees</link:label>
    <link:label id="lab_cvs_DebtExtinguishmentFees_documentation_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Extinguishment Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees" xlink:href="cvs-20210930.xsd#cvs_DebtExtinguishmentFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtExtinguishmentFees" xlink:to="lab_cvs_DebtExtinguishmentFees" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_133a66e8-4389-4897-aa54-04e02c39b1ca_terseLabel_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_label_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_documentation_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:href="cvs-20210930.xsd#cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:to="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_c33aa1ed-f1ad-446d-a9d5-02e4f5c93392_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_3b80ade7-a5d0-4455-a578-313f74968483_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsMember_a880bed2-a491-4988-a4f9-f8c860c83c8e_terseLabel_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_cvs_PremiumsMember_label_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:label id="lab_cvs_PremiumsMember_documentation_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember" xlink:href="cvs-20210930.xsd#cvs_PremiumsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsMember" xlink:to="lab_cvs_PremiumsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_4f908863-9d40-4896-9fe0-cf2bf87fac81_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.75% senior notes due May 2041</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:to="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_0007c2e6-72a1-4604-849b-639bbcd37344_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period One [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodOneMember" xlink:to="lab_cvs_YearOfOriginationPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_97ac9033-a24e-4701-9c4c-5836a4a7ee2d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_242db881-eabf-43b6-b9c8-c2e4f46c0098_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_86c9e42a-6875-4c39-8c7d-7c0aaed51943_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_5fadd19e-7da0-471b-aec5-35917e3021dc_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_a6e2d4d2-4f9c-4d58-b235-d65d93490ba3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_9b16e9ea-4fe2-49e8-9cf8-0274adbee776_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_7c83e912-fddb-4b2f-9ede-2597e80598b5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_286d4b5d-f713-45ed-9c71-5d3cbfd80f21_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_bf62ba69-b8f6-4c4c-81bb-43194114c87e_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables (included in accounts receivable, net)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_105ec324-33af-429b-b922-196ab7c668f8_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_acda3385-516b-4acf-b768-3218c691c1cc_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bd704efd-4202-423d-b53f-d8b06ebcfeba_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash in the statements of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_765f9a7b-97ef-4c00-9749-096dce1b393a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_a124927f-90ce-414d-a8cc-9af739ae2176_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses recorded</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_77dedb39-8b05-450d-875d-720fa36e926a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b3f49ebe-64ba-4935-9c60-b48065928e87_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_9ad83e60-a222-409c-9058-7f79978e2be9_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_8d32daa8-5a85-4122-8d9c-8012aac13703_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_fc102ba2-3301-4497-ac30-c83354c42c82_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_ff2999a5-16ba-406e-882a-3a700a37add7_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of the period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_220c8444-b540-4fd0-b44b-d3597d059a3f_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of the period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_12975086-7d04-4f0a-9ee7-c508e6ece423_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_9d2e0883-a4e5-4979-89f0-358e30c38a9d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_14f382c5-ee26-4ef9-83b8-ec05099d3b08_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Balances</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_dbec5439-d9df-448c-a55f-aa00aebc5e7a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_032f8ec4-824e-4881-a0d4-8cb62b5a7c42_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.78% senior notes due March 2038</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:to="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d178cdaf-b233-4709-89e6-844d412e9c1a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b8deff0f-65b6-4167-8e0e-d4669aba4c8e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_96900c5b-4721-4cf2-8a55-95146586da0e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cee55139-52dc-4683-a3a8-476661b5e1a9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive Income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_ed5c23c4-638d-4884-a218-4404c63ea285_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_58aaaa80-9ebc-4798-87b9-fb3871dc6767_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_e483e8c6-ca91-4b44-8742-830d6e73850d_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_38c0c81d-ec2a-4bd6-8677-1128f8d9538b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_6faad3b5-691b-46a8-8069-b621d5dfac33_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_79c17ab1-2c06-45dc-a491-dac680313955_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_aa38462a-7ab9-465f-9480-e790ad73f182_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_f6d36683-52e7-4fba-a397-bd81e6fd43ab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_a948392f-14ba-45aa-a815-fa0cc7a04f37_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_e638402c-78f0-4c8f-b335-87384b5a2e9f_negatedLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment expenses</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Investment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:to="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_0ed5911e-587a-493e-b256-43715732c673_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsAxis_5ef9eb1c-98bd-49a1-896c-de647152e49b_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsAxis_label_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsAxis" xlink:to="lab_cvs_TotalInvestmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ab81cd2-7a9e-4a3d-8584-9dd3b94886d3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_9bb07c2c-4228-44d0-8103-7da8e67f2e1e_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Earnings to Net Income</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_0499bfff-9e84-4b1c-a56d-3d996dddc9d7_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_7c1b15f4-31d0-49d2-9065-19a0396038f3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dafd8f18-94e5-497d-8f7e-329456c21009_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_06141c93-4e0c-437c-b182-9dea725c7c02_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:href="cvs-20210930.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_a8eca862-9fe0-4bd3-a107-0b789bb52dbb_verboseLabel_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Mortgage Loan Portfolio</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_label_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity in mortgage loan portfolio [Table Text Block]</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Table representing activities in mortgage loan portfolio during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:href="cvs-20210930.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:to="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_a4d9921e-7cbd-4d22-89b3-e6fbd892f96b_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_3d9406d6-8e63-450f-8a3e-d5259900c737_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_782b0558-a2d6-47de-a3eb-aad0835c947c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f950d8c5-4671-4084-b13b-2e003ffc65c6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for taxes related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssets_2a2efbd2-ac22-49da-b325-d19d8515eaaa_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts assets</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssets_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssets" xlink:to="lab_us-gaap_SeparateAccountAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_2d481ffe-819c-42f9-ad5c-6e24e1b92ef2_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_6ca9c3b7-c81b-4d49-8da4-00f26943038a_terseLabel_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of walk in medical clinics</link:label>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_label_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Walk In Medical Clinics</link:label>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_documentation_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Walk In Medical Clinics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics" xlink:href="cvs-20210930.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofWalkInMedicalClinics" xlink:to="lab_cvs_NumberofWalkInMedicalClinics" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_c1c60ad9-d2e0-4c04-9b15-2f15705c5d3f_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_24e96d13-4b6f-42d9-8784-4cd25115a49c_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Table]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:to="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_e8ff0e4d-8a39-46cb-9b5f-e2c44784790b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_ba4a1a6b-9191-4517-a15b-4c1f9b0a5c63_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c336aaa0-0803-4d66-b598-23bcd70ff06b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_8ed14b25-eb4a-42f9-bf92-58595798d5f0_verboseLabel_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_label_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:href="cvs-20210930.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:to="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTable_75d4d665-60fc-412a-8393-333e0daf4a85_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTable_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTable" xlink:to="lab_cvs_TotalInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_231bf9e6-5f46-460c-9a8d-65daf6389b61_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Two [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:to="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_ea17f5b0-046e-490f-9061-1619bd7b91f7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_3e936130-c0cb-43e0-99da-20cc953fe126_verboseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Investments</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table Text Block]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes total investments, both current and long-term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTableTextBlock" xlink:to="lab_cvs_TotalInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_2d96c71b-a66a-4002-8a37-287699f76f26_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_f19a9f52-c471-4928-bd84-64c57ad5a8cf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e4996743-9b8b-468f-acda-49ad8c124be3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_e0dddb76-9c4e-4838-b63a-0e2796af57db_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total claims paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_9484db97-1e33-489f-bed9-904aa30d6172_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeTextBlock" xlink:to="lab_us-gaap_InvestmentIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9dae5c6d-0a1f-4cc3-9e34-0a628091593f_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements Recently Adopted and Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_3c151574-91ae-4302-a059-61280027116d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_02444478-cca4-46d1-b43c-2307a71c003d_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans foreclosed</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_88ddcec8-73df-49bc-87ad-b15bcfa9cfc9_terseLabel_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation business</link:label>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_label_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation Business [Member]</link:label>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_documentation_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:href="cvs-20210930.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:to="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_a14e0c20-e90f-4b57-9761-a974c5b81d43_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_1e56b8c5-0c62-463c-8e86-c8bfa8392a08_terseLabel_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_label_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_documentation_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember" xlink:href="cvs-20210930.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HeartlandHealthcareServicesMember" xlink:to="lab_cvs_HeartlandHealthcareServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_91ba6df1-aae6-4d4d-93d1-1297d2ec3ed3_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.5% senior notes due May 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:to="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_6c1df970-09d9-4757-941f-8532ca86eb01_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_f59731b7-b14e-4cd6-bacc-040d4e311e76_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of the period</link:label>
    <link:label id="lab_us-gaap_Goodwill_e94515ee-e95a-4349-b3c0-9cbc394261cf_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of the period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_4f49c52b-ce15-48c6-aa6f-b690320aa836_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal of debt extinguished</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_b9564c98-8e4d-4102-8f75-bc8a08b35271_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and investment income received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Interest and Dividends Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:to="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_a2b0a675-1009-48b9-b995-397f3e580e9f_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_3675c317-4e9d-495f-a15d-483b9bf052e0_terseLabel_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program</link:label>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_label_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program [Member]</link:label>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_documentation_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember" xlink:href="cvs-20210930.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_A2016RepurchaseProgramMember" xlink:to="lab_cvs_A2016RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_453145fb-df9c-43fc-a0b6-a518e0925bcd_negatedTerseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition purchase price adjustment outside of measurement period</link:label>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_label_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:href="cvs-20210930.xsd#cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:to="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_c8e361e6-b6ad-4392-bd76-2b74a0dc192b_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_9a999fca-c5b0-4cbf-9dd2-3d04bc2671a8_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of deferred debt issuance cost</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_78e8b858-ab4c-41b3-977d-987f24f7568b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders&#8217; funds</link:label>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_label_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Policyholder Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPolicyholderFunds" xlink:to="lab_us-gaap_OtherPolicyholderFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_fd1d9987-ca5f-4911-81d0-61666c924916_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_d94365e9-e049-46ec-90b1-b53932e508a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_cb0d55a8-d081-4763-96c7-2c6c43f16403_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_334f72c6-1d6e-4de0-b5e9-f0629c3997ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_9a435f77-a272-42c5-a9e9-32ee933a4b0f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_f70f6fd7-b1a0-4c60-9004-655d1015fe04_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to other suppliers and employees</link:label>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_label_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Suppliers and Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:to="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_dd3f9a3a-0167-4ec8-8635-d9df450b9229_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_6c75240d-4fb5-484f-9ee8-ee9843d0df53_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Including Capital Surplus</link:label>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Including Additional Paid in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>cvs-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:25115a76-675c-4824-88fb-08e9720b17d2,g:63def5ee-f256-409d-94db-fc3f10f96be5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CoverPage" xlink:type="simple" xlink:href="cvs-20210930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ee2b1c43-d6c1-4698-a4fb-61b63756bc59" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_DocumentType_ee2b1c43-d6c1-4698-a4fb-61b63756bc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_8fedb0e3-1f5d-40cb-9e77-01c31b20872f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_DocumentQuarterlyReport_8fedb0e3-1f5d-40cb-9e77-01c31b20872f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d65cfcec-af35-4da1-82b4-55cecd8248f2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_DocumentPeriodEndDate_d65cfcec-af35-4da1-82b4-55cecd8248f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_15264523-13c2-4531-ad08-64a7db6dfd31" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_DocumentTransitionReport_15264523-13c2-4531-ad08-64a7db6dfd31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d840cdf5-a52d-4df7-b090-a3e3f61027b6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityFileNumber_d840cdf5-a52d-4df7-b090-a3e3f61027b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2b21ad1e-6d48-4c03-b517-ccc3c0dc9a31" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityRegistrantName_2b21ad1e-6d48-4c03-b517-ccc3c0dc9a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_15f2d127-e9ba-47fa-bcad-033d59ada22a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityIncorporationStateCountryCode_15f2d127-e9ba-47fa-bcad-033d59ada22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_11aa5d03-0f59-48df-b2a8-5cca960b441a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityTaxIdentificationNumber_11aa5d03-0f59-48df-b2a8-5cca960b441a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_006d0058-d571-43b4-b32a-d0ea01878d40" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityAddressAddressLine1_006d0058-d571-43b4-b32a-d0ea01878d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7aa46841-b090-4b1d-b397-4f123b75fcab" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityAddressCityOrTown_7aa46841-b090-4b1d-b397-4f123b75fcab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4488fd56-c980-411b-8053-eb7ffae08403" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityAddressStateOrProvince_4488fd56-c980-411b-8053-eb7ffae08403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_116b2b41-f109-43cd-b8d0-f1dea59e616e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityAddressPostalZipCode_116b2b41-f109-43cd-b8d0-f1dea59e616e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_22041467-eabc-41dd-82ea-dce5589f1301" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_CityAreaCode_22041467-eabc-41dd-82ea-dce5589f1301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_9988a614-001c-45b2-8114-d9616c2a1c9e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_LocalPhoneNumber_9988a614-001c-45b2-8114-d9616c2a1c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_72cccf0b-7ab3-4592-9237-f4d8ab07a8cf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_Security12bTitle_72cccf0b-7ab3-4592-9237-f4d8ab07a8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_0cefa4a5-a9d0-4902-9a14-b58f0dbc1dbf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_TradingSymbol_0cefa4a5-a9d0-4902-9a14-b58f0dbc1dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_96e301a6-a376-468b-b5b6-371a70e6b44f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_SecurityExchangeName_96e301a6-a376-468b-b5b6-371a70e6b44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_d9382ab6-73af-4161-9ce9-175deffaa6ef" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityCurrentReportingStatus_d9382ab6-73af-4161-9ce9-175deffaa6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_10fd42fe-f9fc-4f84-91b6-82c888239681" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityInteractiveDataCurrent_10fd42fe-f9fc-4f84-91b6-82c888239681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_716320f1-75c8-45a7-8bd0-37d411598b80" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityFilerCategory_716320f1-75c8-45a7-8bd0-37d411598b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a33774f6-40dd-4372-8d12-9e3e41b83464" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntitySmallBusiness_a33774f6-40dd-4372-8d12-9e3e41b83464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_bc975e62-5404-410a-90a0-bfa78a1db227" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityEmergingGrowthCompany_bc975e62-5404-410a-90a0-bfa78a1db227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_c4b4d1dc-058e-420a-88f7-98ac52c68bd5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityShellCompany_c4b4d1dc-058e-420a-88f7-98ac52c68bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_e32cf484-f360-42f8-8a88-5728f7b240ed" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_e32cf484-f360-42f8-8a88-5728f7b240ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_96e2c399-9c7f-4d28-90be-4f6f809acfcd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_EntityCentralIndexKey_96e2c399-9c7f-4d28-90be-4f6f809acfcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7948d7cb-2678-42ef-b8e8-5ad62bec4e83" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_CurrentFiscalYearEndDate_7948d7cb-2678-42ef-b8e8-5ad62bec4e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_0eb1334d-1d5a-43a3-b9f1-c5c61e7c3377" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_DocumentFiscalYearFocus_0eb1334d-1d5a-43a3-b9f1-c5c61e7c3377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_14eac27d-7b0d-4adb-a322-a5ae6da7a6f3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_DocumentFiscalPeriodFocus_14eac27d-7b0d-4adb-a322-a5ae6da7a6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_272c4667-5ff6-4c30-b8fc-9ad499ffeed8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_41f5a3f3-11f2-4788-9d12-634e442a6ddb" xlink:to="loc_dei_AmendmentFlag_272c4667-5ff6-4c30-b8fc-9ad499ffeed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_a8338e66-3d3e-46df-9431-bb4ff48e0e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2d00b2e8-dc57-4249-a1c0-ef3ff4caef8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a8338e66-3d3e-46df-9431-bb4ff48e0e58" xlink:to="loc_us-gaap_StatementTable_2d00b2e8-dc57-4249-a1c0-ef3ff4caef8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_71db7144-917c-4916-8500-44043f18da27" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2d00b2e8-dc57-4249-a1c0-ef3ff4caef8f" xlink:to="loc_srt_ProductOrServiceAxis_71db7144-917c-4916-8500-44043f18da27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_623f3dda-efa3-4cb2-8d7e-5e464c98f973" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_71db7144-917c-4916-8500-44043f18da27" xlink:to="loc_srt_ProductsAndServicesDomain_623f3dda-efa3-4cb2-8d7e-5e464c98f973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_991cfa10-3a27-4233-b61f-f4adf22cb38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_623f3dda-efa3-4cb2-8d7e-5e464c98f973" xlink:to="loc_us-gaap_ProductMember_991cfa10-3a27-4233-b61f-f4adf22cb38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_8d1f22a9-243f-4687-998d-a8bc86e7431e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_623f3dda-efa3-4cb2-8d7e-5e464c98f973" xlink:to="loc_us-gaap_ServiceMember_8d1f22a9-243f-4687-998d-a8bc86e7431e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2d00b2e8-dc57-4249-a1c0-ef3ff4caef8f" xlink:to="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_0adb472b-a455-4506-86ac-2b736c97920a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_RevenuesAbstract_0adb472b-a455-4506-86ac-2b736c97920a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e5068219-6190-4efa-8695-f6b981e36307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_0adb472b-a455-4506-86ac-2b736c97920a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e5068219-6190-4efa-8695-f6b981e36307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_2b4cab86-7aaa-4a16-83a1-817e8cb58c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_0adb472b-a455-4506-86ac-2b736c97920a" xlink:to="loc_us-gaap_PremiumsEarnedNet_2b4cab86-7aaa-4a16-83a1-817e8cb58c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_99f4500d-97c4-416d-943b-4cf050ad780d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_0adb472b-a455-4506-86ac-2b736c97920a" xlink:to="loc_us-gaap_NetInvestmentIncome_99f4500d-97c4-416d-943b-4cf050ad780d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_90a46210-c4ca-4706-b12a-82e7a26e62c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_0adb472b-a455-4506-86ac-2b736c97920a" xlink:to="loc_us-gaap_Revenues_90a46210-c4ca-4706-b12a-82e7a26e62c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ed04b044-be4b-4bab-ad3b-86dbdff36394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ed04b044-be4b-4bab-ad3b-86dbdff36394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_f6cf296f-2dd1-487d-ad83-6bd79ced9ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_f6cf296f-2dd1-487d-ad83-6bd79ced9ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_512b0ef7-d68c-4dd2-a10b-92dde44d8fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_512b0ef7-d68c-4dd2-a10b-92dde44d8fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_fd47be17-4cef-44b7-baf5-fe5951735428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_fd47be17-4cef-44b7-baf5-fe5951735428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairments_e2a209c9-c90e-4a76-a80d-f99fc0835031" xlink:href="cvs-20210930.xsd#cvs_OperatingExpensesExcludingGoodwillImpairments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:to="loc_cvs_OperatingExpensesExcludingGoodwillImpairments_e2a209c9-c90e-4a76-a80d-f99fc0835031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_1005289b-4372-46cb-a98c-eadf36f71f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_ebb41454-f260-4cb9-a9ff-a31e5ffc8c95" xlink:to="loc_us-gaap_CostsAndExpenses_1005289b-4372-46cb-a98c-eadf36f71f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_420b1bd1-02aa-46d1-9231-a7d4806afa30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_OperatingIncomeLoss_420b1bd1-02aa-46d1-9231-a7d4806afa30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_bb589d33-ee24-4c36-add3-a20deb5dbf48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_InterestExpense_bb589d33-ee24-4c36-add3-a20deb5dbf48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b9fbcb35-5b50-4e88-8984-5db65086c289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b9fbcb35-5b50-4e88-8984-5db65086c289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f8cdbef0-80f5-4b9e-9b0b-ff122802b394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f8cdbef0-80f5-4b9e-9b0b-ff122802b394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e6568b16-ca04-4e50-9890-d481293cd57b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e6568b16-ca04-4e50-9890-d481293cd57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cfc56948-63e5-4484-9447-5435d34be6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cfc56948-63e5-4484-9447-5435d34be6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e7fb6301-7986-4718-a61f-93cad802cf63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_ProfitLoss_e7fb6301-7986-4718-a61f-93cad802cf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3b70a5c5-c575-468e-ba17-65a919426500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3b70a5c5-c575-468e-ba17-65a919426500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_40cc6e47-24da-4a5a-9d13-c537bc4c677e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_NetIncomeLoss_40cc6e47-24da-4a5a-9d13-c537bc4c677e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b5a823f2-92d8-4cf5-8422-55fc675eb60d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_EarningsPerShareAbstract_b5a823f2-92d8-4cf5-8422-55fc675eb60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_46c2476d-188f-4f20-9fb4-124933a65ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b5a823f2-92d8-4cf5-8422-55fc675eb60d" xlink:to="loc_us-gaap_EarningsPerShareBasic_46c2476d-188f-4f20-9fb4-124933a65ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_802524ee-3d8a-40e1-bc2c-495ae9a611be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b5a823f2-92d8-4cf5-8422-55fc675eb60d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_802524ee-3d8a-40e1-bc2c-495ae9a611be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8093ade8-28d9-46ec-8fee-97ed9aabb8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8093ade8-28d9-46ec-8fee-97ed9aabb8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f90fe43c-64ac-47ee-90dc-42bb6e8348ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8093ade8-28d9-46ec-8fee-97ed9aabb8e7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f90fe43c-64ac-47ee-90dc-42bb6e8348ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8fade3b8-b947-4359-b3e0-99377d6e2ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8093ade8-28d9-46ec-8fee-97ed9aabb8e7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8fade3b8-b947-4359-b3e0-99377d6e2ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_c12d5c73-9d2c-48ca-8bf4-76f717bafbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_54a3e90c-98b5-4aed-ace2-18c69c6020b4" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_c12d5c73-9d2c-48ca-8bf4-76f717bafbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ff2ccb9a-16e6-4f9c-9fe7-3460197ba700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_271dc878-3ea3-4200-9887-e227eb85c31d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ff2ccb9a-16e6-4f9c-9fe7-3460197ba700" xlink:to="loc_us-gaap_ProfitLoss_271dc878-3ea3-4200-9887-e227eb85c31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67761fca-1e8b-4d91-abfa-2b1cccd3c8de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ff2ccb9a-16e6-4f9c-9fe7-3460197ba700" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67761fca-1e8b-4d91-abfa-2b1cccd3c8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_72caf7c8-f842-4a5b-a37a-0bef743bb803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67761fca-1e8b-4d91-abfa-2b1cccd3c8de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_72caf7c8-f842-4a5b-a37a-0bef743bb803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0bfc9057-fd35-4ff2-8b8b-24e9dfdddfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67761fca-1e8b-4d91-abfa-2b1cccd3c8de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0bfc9057-fd35-4ff2-8b8b-24e9dfdddfa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_01663fca-1bb6-4718-8a34-c0a5612f6f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67761fca-1e8b-4d91-abfa-2b1cccd3c8de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_01663fca-1bb6-4718-8a34-c0a5612f6f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a1f272ce-bebe-47b8-bfca-8796c6b0d935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67761fca-1e8b-4d91-abfa-2b1cccd3c8de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a1f272ce-bebe-47b8-bfca-8796c6b0d935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f83b4b69-774f-443e-95c7-7c8f6fb0c8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67761fca-1e8b-4d91-abfa-2b1cccd3c8de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f83b4b69-774f-443e-95c7-7c8f6fb0c8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4f802916-5616-4671-8507-7f2de66177b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ff2ccb9a-16e6-4f9c-9fe7-3460197ba700" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4f802916-5616-4671-8507-7f2de66177b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_52e000ba-191e-488c-9be7-dd066714f1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ff2ccb9a-16e6-4f9c-9fe7-3460197ba700" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_52e000ba-191e-488c-9be7-dd066714f1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5fb7a690-01fc-44bd-b500-f99fec8fb671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ff2ccb9a-16e6-4f9c-9fe7-3460197ba700" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_5fb7a690-01fc-44bd-b500-f99fec8fb671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_60105709-0b92-43a4-b4a7-0bc0a2e92f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_60105709-0b92-43a4-b4a7-0bc0a2e92f26" xlink:to="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bc5cc60e-d0ee-41bf-94a8-52199e84498e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bc5cc60e-d0ee-41bf-94a8-52199e84498e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_9eb01876-120c-4c05-898f-0908c870b0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_ShortTermInvestments_9eb01876-120c-4c05-898f-0908c870b0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e73a0b08-71cb-4dc1-9519-9f26e992d66d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e73a0b08-71cb-4dc1-9519-9f26e992d66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_99bda655-73e5-4ab6-9d12-0d0a87220661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_InventoryNet_99bda655-73e5-4ab6-9d12-0d0a87220661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_1dadbb81-eae7-4705-9866-bfc6fc14f7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_OtherAssetsCurrent_1dadbb81-eae7-4705-9866-bfc6fc14f7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_242c94cf-ca3d-4cad-99f5-4b9d7b2d62cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_AssetsCurrent_242c94cf-ca3d-4cad-99f5-4b9d7b2d62cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_f3187049-a2e7-43d0-890d-765fc5cddeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_LongTermInvestments_f3187049-a2e7-43d0-890d-765fc5cddeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f71e0dbb-abc6-4dad-b7a9-4fbce6d7a08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f71e0dbb-abc6-4dad-b7a9-4fbce6d7a08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ed5f2319-cc2a-4b5f-b74d-dcfba580c031" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ed5f2319-cc2a-4b5f-b74d-dcfba580c031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7a5c9f90-868d-477d-9e42-86105b13fa7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_Goodwill_7a5c9f90-868d-477d-9e42-86105b13fa7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_92e3ec01-5359-4ef8-a8fe-8c9888c6397d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_92e3ec01-5359-4ef8-a8fe-8c9888c6397d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_b0c85774-2be6-45bf-ab41-8b304e304a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_SeparateAccountAssets_b0c85774-2be6-45bf-ab41-8b304e304a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f2cab61b-c5f5-4978-aaab-e6fc819e1bac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f2cab61b-c5f5-4978-aaab-e6fc819e1bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7ff73455-edbf-4194-8890-cbd8a9ee1609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_867d8ea6-eb61-4012-8b70-400447d41ab0" xlink:to="loc_us-gaap_Assets_7ff73455-edbf-4194-8890-cbd8a9ee1609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_60105709-0b92-43a4-b4a7-0bc0a2e92f26" xlink:to="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_07aa2643-c0d7-4e66-a5f5-aef205e3b972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_07aa2643-c0d7-4e66-a5f5-aef205e3b972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_5ca0e1e4-8264-4670-bffd-9457380f53cd" xlink:href="cvs-20210930.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_5ca0e1e4-8264-4670-bffd-9457380f53cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_5f48e9b3-29cd-4380-9eac-feb4621f770c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_5f48e9b3-29cd-4380-9eac-feb4621f770c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_8851f4a0-11d6-479c-8f83-f71ed218967b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_us-gaap_OtherPolicyholderFunds_8851f4a0-11d6-479c-8f83-f71ed218967b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_bafff417-f198-46dc-8810-98c39f2ee3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_bafff417-f198-46dc-8810-98c39f2ee3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_5e35aece-8fba-41f9-8bd6-744912296664" xlink:href="cvs-20210930.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_5e35aece-8fba-41f9-8bd6-744912296664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_06740a2b-a3ea-492a-97a4-2e9ceb998c52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_06740a2b-a3ea-492a-97a4-2e9ceb998c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9b01cb46-eb45-487d-8b98-edb1b3d22749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9b01cb46-eb45-487d-8b98-edb1b3d22749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_858c3cef-75fc-4b2d-9f17-b3ed5a0e1879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_us-gaap_LiabilitiesCurrent_858c3cef-75fc-4b2d-9f17-b3ed5a0e1879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8b3bcb4c-33aa-4345-a51a-2000802e5dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8b3bcb4c-33aa-4345-a51a-2000802e5dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_24ebba80-c981-466d-a5dc-1b026cd89724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_24ebba80-c981-466d-a5dc-1b026cd89724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9673d752-16d3-4ea9-b22b-b3f9d969ddb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9673d752-16d3-4ea9-b22b-b3f9d969ddb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_f9da2122-860b-4932-84e9-7728f2e6ee1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_us-gaap_SeparateAccountsLiability_f9da2122-860b-4932-84e9-7728f2e6ee1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_ce2956b7-c11c-4895-a713-230cdaa3a5ac" xlink:href="cvs-20210930.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_ce2956b7-c11c-4895-a713-230cdaa3a5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b65a2f51-7421-4843-9d60-94a06139595e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b65a2f51-7421-4843-9d60-94a06139595e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d91b7dda-84b8-48a1-b4d1-0e06a149a835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28aede6a-007c-42a9-a0dc-5826937cc350" xlink:to="loc_us-gaap_Liabilities_d91b7dda-84b8-48a1-b4d1-0e06a149a835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_467a8721-b7a9-4bca-aa6c-f4861d5687fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_60105709-0b92-43a4-b4a7-0bc0a2e92f26" xlink:to="loc_us-gaap_StockholdersEquityAbstract_467a8721-b7a9-4bca-aa6c-f4861d5687fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_93478de5-09d7-49d6-b743-4da222ce94d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_467a8721-b7a9-4bca-aa6c-f4861d5687fa" xlink:to="loc_us-gaap_PreferredStockValue_93478de5-09d7-49d6-b743-4da222ce94d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_5b6ec1d3-7394-406c-9443-81e35de93646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_467a8721-b7a9-4bca-aa6c-f4861d5687fa" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_5b6ec1d3-7394-406c-9443-81e35de93646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_d15a69b6-d8db-435f-976c-5253a8024fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_467a8721-b7a9-4bca-aa6c-f4861d5687fa" xlink:to="loc_us-gaap_TreasuryStockValue_d15a69b6-d8db-435f-976c-5253a8024fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d6b6f658-e64f-459a-baf0-b84faa013825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_467a8721-b7a9-4bca-aa6c-f4861d5687fa" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d6b6f658-e64f-459a-baf0-b84faa013825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ed59e963-d936-4cd5-a047-4f518bcb9eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_467a8721-b7a9-4bca-aa6c-f4861d5687fa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ed59e963-d936-4cd5-a047-4f518bcb9eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f71259eb-9f05-4517-ba3e-6bf2cc58fe47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_467a8721-b7a9-4bca-aa6c-f4861d5687fa" xlink:to="loc_us-gaap_StockholdersEquity_f71259eb-9f05-4517-ba3e-6bf2cc58fe47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_61eeb2aa-429d-4133-bb06-b94ebcfdbc75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_60105709-0b92-43a4-b4a7-0bc0a2e92f26" xlink:to="loc_us-gaap_MinorityInterest_61eeb2aa-429d-4133-bb06-b94ebcfdbc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8199701c-2bd9-4470-8538-488d4e3e5bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_60105709-0b92-43a4-b4a7-0bc0a2e92f26" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8199701c-2bd9-4470-8538-488d4e3e5bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_341cedd9-ec4d-4239-8b81-3d695f3f0b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_60105709-0b92-43a4-b4a7-0bc0a2e92f26" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_341cedd9-ec4d-4239-8b81-3d695f3f0b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f2a9759f-74b7-488b-b745-002070241f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8e3eb181-77f7-4436-af0d-3baa9e138df4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f2a9759f-74b7-488b-b745-002070241f1a" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8e3eb181-77f7-4436-af0d-3baa9e138df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b8634331-b27f-46cc-9bbc-adb6975980e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f2a9759f-74b7-488b-b745-002070241f1a" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b8634331-b27f-46cc-9bbc-adb6975980e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_280b3837-4886-473d-880c-cad7fc4cb03a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f2a9759f-74b7-488b-b745-002070241f1a" xlink:to="loc_us-gaap_PreferredStockSharesIssued_280b3837-4886-473d-880c-cad7fc4cb03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1be209f6-f2d0-45f1-bce4-9697804e6c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f2a9759f-74b7-488b-b745-002070241f1a" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1be209f6-f2d0-45f1-bce4-9697804e6c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_7129c073-8a02-454a-9889-fb506772f98b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f2a9759f-74b7-488b-b745-002070241f1a" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_7129c073-8a02-454a-9889-fb506772f98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_32340ddf-6aae-4828-b7f0-a60407b6624e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f2a9759f-74b7-488b-b745-002070241f1a" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_32340ddf-6aae-4828-b7f0-a60407b6624e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_41283026-3b90-418f-b959-91ab09daacb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f2a9759f-74b7-488b-b745-002070241f1a" xlink:to="loc_us-gaap_CommonStockSharesIssued_41283026-3b90-418f-b959-91ab09daacb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_fc4e04fc-cc0b-4a48-a0d1-9759951bba21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f2a9759f-74b7-488b-b745-002070241f1a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_fc4e04fc-cc0b-4a48-a0d1-9759951bba21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_73b06167-f7c5-481f-b4b8-f6c03c6a12d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f2a9759f-74b7-488b-b745-002070241f1a" xlink:to="loc_us-gaap_TreasuryStockShares_73b06167-f7c5-481f-b4b8-f6c03c6a12d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_02866973-122b-49c0-9d32-0ef8f6a06938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c19a1dba-f820-4bbe-9f9f-83532508e285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02866973-122b-49c0-9d32-0ef8f6a06938" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c19a1dba-f820-4bbe-9f9f-83532508e285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_56a4ea08-44a1-48f7-b458-a53f17b0e0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c19a1dba-f820-4bbe-9f9f-83532508e285" xlink:to="loc_us-gaap_ProceedsFromCustomers_56a4ea08-44a1-48f7-b458-a53f17b0e0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_f2473016-985c-4a19-8952-b114d023c1db" xlink:href="cvs-20210930.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c19a1dba-f820-4bbe-9f9f-83532508e285" xlink:to="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_f2473016-985c-4a19-8952-b114d023c1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits_52759acf-d0a2-4366-8091-b18b4f68ea3c" xlink:href="cvs-20210930.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c19a1dba-f820-4bbe-9f9f-83532508e285" xlink:to="loc_cvs_PaymentsforInsuranceBenefits_52759acf-d0a2-4366-8091-b18b4f68ea3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_33290ae5-9256-48ce-82d7-1e917302dad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c19a1dba-f820-4bbe-9f9f-83532508e285" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_33290ae5-9256-48ce-82d7-1e917302dad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_cdc129c6-26a8-46f7-9c36-b5ded18b3939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c19a1dba-f820-4bbe-9f9f-83532508e285" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_cdc129c6-26a8-46f7-9c36-b5ded18b3939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_703edfff-fc54-44fe-aa38-c366678e9db5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c19a1dba-f820-4bbe-9f9f-83532508e285" xlink:to="loc_us-gaap_InterestPaidNet_703edfff-fc54-44fe-aa38-c366678e9db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_f4cfd7dd-8f27-4d4e-8695-d2068a3e325e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c19a1dba-f820-4bbe-9f9f-83532508e285" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_f4cfd7dd-8f27-4d4e-8695-d2068a3e325e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a638e3fa-dd76-4e9a-9069-8956e55532e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c19a1dba-f820-4bbe-9f9f-83532508e285" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a638e3fa-dd76-4e9a-9069-8956e55532e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_70690ff1-5cf6-4613-8bf5-cc5106ac7881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02866973-122b-49c0-9d32-0ef8f6a06938" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_70690ff1-5cf6-4613-8bf5-cc5106ac7881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_89c8f382-83f6-4038-b2f1-28a68872f07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_70690ff1-5cf6-4613-8bf5-cc5106ac7881" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_89c8f382-83f6-4038-b2f1-28a68872f07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_f2a392fa-0411-4a9c-97ef-f80131d64145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_70690ff1-5cf6-4613-8bf5-cc5106ac7881" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_f2a392fa-0411-4a9c-97ef-f80131d64145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_72c1cc67-8f1d-49a2-8678-ff70c0aae6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_70690ff1-5cf6-4613-8bf5-cc5106ac7881" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_72c1cc67-8f1d-49a2-8678-ff70c0aae6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7b49364b-6ded-417b-89e8-2b70ce051475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_70690ff1-5cf6-4613-8bf5-cc5106ac7881" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7b49364b-6ded-417b-89e8-2b70ce051475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_96109f14-608a-4122-8ed0-de538e7ba003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_70690ff1-5cf6-4613-8bf5-cc5106ac7881" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_96109f14-608a-4122-8ed0-de538e7ba003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9c3f3469-5f35-4e8d-bb74-ff443ae67722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_70690ff1-5cf6-4613-8bf5-cc5106ac7881" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9c3f3469-5f35-4e8d-bb74-ff443ae67722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2982d19e-0da3-4b7b-a9c1-24301603544d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_70690ff1-5cf6-4613-8bf5-cc5106ac7881" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2982d19e-0da3-4b7b-a9c1-24301603544d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20143dac-0fac-4c66-8ed4-89bf04fc37d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02866973-122b-49c0-9d32-0ef8f6a06938" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20143dac-0fac-4c66-8ed4-89bf04fc37d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b4cea9a3-c887-449d-b14e-e806179f4d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20143dac-0fac-4c66-8ed4-89bf04fc37d4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b4cea9a3-c887-449d-b14e-e806179f4d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_ac9a376d-7855-49da-95c0-a13da5b614c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20143dac-0fac-4c66-8ed4-89bf04fc37d4" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_ac9a376d-7855-49da-95c0-a13da5b614c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_512a7c9f-a741-464b-9ef1-05006632a72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20143dac-0fac-4c66-8ed4-89bf04fc37d4" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_512a7c9f-a741-464b-9ef1-05006632a72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_04eab5d6-3feb-4ea5-89aa-097457f0c783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20143dac-0fac-4c66-8ed4-89bf04fc37d4" xlink:to="loc_us-gaap_PaymentsOfDividends_04eab5d6-3feb-4ea5-89aa-097457f0c783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_4a0df075-b89e-4b2c-9b96-51128015b022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20143dac-0fac-4c66-8ed4-89bf04fc37d4" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_4a0df075-b89e-4b2c-9b96-51128015b022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e5a33d2a-c795-4a48-b966-a98bfad4de1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20143dac-0fac-4c66-8ed4-89bf04fc37d4" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e5a33d2a-c795-4a48-b966-a98bfad4de1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a32dabeb-dc04-4979-90e6-414ecae42197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20143dac-0fac-4c66-8ed4-89bf04fc37d4" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a32dabeb-dc04-4979-90e6-414ecae42197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a9cfe58e-0209-49f0-91a3-b3080a7617f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20143dac-0fac-4c66-8ed4-89bf04fc37d4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a9cfe58e-0209-49f0-91a3-b3080a7617f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ae7e79a3-8a4d-4d45-a527-cdaaff018a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02866973-122b-49c0-9d32-0ef8f6a06938" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ae7e79a3-8a4d-4d45-a527-cdaaff018a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d7bbb89b-23dd-488c-9ba5-022cb0d87516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02866973-122b-49c0-9d32-0ef8f6a06938" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d7bbb89b-23dd-488c-9ba5-022cb0d87516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aaab876e-ad61-46ff-88a4-b4b6e85835fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02866973-122b-49c0-9d32-0ef8f6a06938" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aaab876e-ad61-46ff-88a4-b4b6e85835fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_c03c36d1-c5df-45b8-bf57-60ce69c44ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02866973-122b-49c0-9d32-0ef8f6a06938" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_c03c36d1-c5df-45b8-bf57-60ce69c44ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ff772140-1b9d-41d2-b05a-00f539344624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c03c36d1-c5df-45b8-bf57-60ce69c44ef9" xlink:to="loc_us-gaap_ProfitLoss_ff772140-1b9d-41d2-b05a-00f539344624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_120f3b86-c949-478a-a7c7-406e86dad4d1" xlink:href="cvs-20210930.xsd#cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c03c36d1-c5df-45b8-bf57-60ce69c44ef9" xlink:to="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_120f3b86-c949-478a-a7c7-406e86dad4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f9cbb68b-1d11-4a6e-8c1c-3754e6261929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_120f3b86-c949-478a-a7c7-406e86dad4d1" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f9cbb68b-1d11-4a6e-8c1c-3754e6261929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_041fa3ee-8675-49d2-8bae-10acbff534a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_120f3b86-c949-478a-a7c7-406e86dad4d1" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_041fa3ee-8675-49d2-8bae-10acbff534a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_0dbebb2c-2055-4b5a-9ca4-d84a0df2bcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_120f3b86-c949-478a-a7c7-406e86dad4d1" xlink:to="loc_us-gaap_ShareBasedCompensation_0dbebb2c-2055-4b5a-9ca4-d84a0df2bcb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_ac5108e7-a7e9-4693-b413-833147291878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_120f3b86-c949-478a-a7c7-406e86dad4d1" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_ac5108e7-a7e9-4693-b413-833147291878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3be20783-6b70-4dd5-92bf-65960efa1918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_120f3b86-c949-478a-a7c7-406e86dad4d1" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3be20783-6b70-4dd5-92bf-65960efa1918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Deferredincometaxesandothernoncashitems_a6b1a50e-7f59-4dfe-ad9d-af46e28c77b3" xlink:href="cvs-20210930.xsd#cvs_Deferredincometaxesandothernoncashitems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_120f3b86-c949-478a-a7c7-406e86dad4d1" xlink:to="loc_cvs_Deferredincometaxesandothernoncashitems_a6b1a50e-7f59-4dfe-ad9d-af46e28c77b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_22c549cd-0df0-4729-a86f-93d2730ee2c6" xlink:href="cvs-20210930.xsd#cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_120f3b86-c949-478a-a7c7-406e86dad4d1" xlink:to="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_22c549cd-0df0-4729-a86f-93d2730ee2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fec0551c-63e8-4e08-9015-6f3296b257bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_22c549cd-0df0-4729-a86f-93d2730ee2c6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fec0551c-63e8-4e08-9015-6f3296b257bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_00c1e372-a497-4332-bee1-ac2c9f0622de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_22c549cd-0df0-4729-a86f-93d2730ee2c6" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_00c1e372-a497-4332-bee1-ac2c9f0622de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_caedbe12-3f94-4f03-b4c0-267250fe2ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_22c549cd-0df0-4729-a86f-93d2730ee2c6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_caedbe12-3f94-4f03-b4c0-267250fe2ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_856a1657-1675-4055-a099-f84ae6fbf3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_22c549cd-0df0-4729-a86f-93d2730ee2c6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_856a1657-1675-4055-a099-f84ae6fbf3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_b9fb4139-57d9-44c8-b5f7-3f8c472696ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_22c549cd-0df0-4729-a86f-93d2730ee2c6" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_b9fb4139-57d9-44c8-b5f7-3f8c472696ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_a98d2cf1-d3d2-4cc0-8564-f74b955ed57b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_22c549cd-0df0-4729-a86f-93d2730ee2c6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_a98d2cf1-d3d2-4cc0-8564-f74b955ed57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6232ee38-7a84-4bc0-871c-8de467369b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_22c549cd-0df0-4729-a86f-93d2730ee2c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6232ee38-7a84-4bc0-871c-8de467369b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedStatementsofShareholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c62532de-2d14-4f16-99e7-f3a608b5cf17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0f699b4c-60d5-4620-a46a-c5c63fd8dcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c62532de-2d14-4f16-99e7-f3a608b5cf17" xlink:to="loc_us-gaap_StatementTable_0f699b4c-60d5-4620-a46a-c5c63fd8dcc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3484739e-ffdc-4dfc-b592-3c0d589a569d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0f699b4c-60d5-4620-a46a-c5c63fd8dcc5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3484739e-ffdc-4dfc-b592-3c0d589a569d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9ddd1d11-f401-4ea7-adc2-6af50084e503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3484739e-ffdc-4dfc-b592-3c0d589a569d" xlink:to="loc_us-gaap_EquityComponentDomain_9ddd1d11-f401-4ea7-adc2-6af50084e503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9ddd1d11-f401-4ea7-adc2-6af50084e503" xlink:to="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b7ff924e-0472-4251-a923-5a4d6b4115d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:to="loc_us-gaap_CommonStockMember_b7ff924e-0472-4251-a923-5a4d6b4115d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_251d61b1-869e-41da-88c9-7380bfd91154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:to="loc_us-gaap_TreasuryStockMember_251d61b1-869e-41da-88c9-7380bfd91154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_d5b82aed-90b5-4bbc-83a1-ab1fef36f14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_d5b82aed-90b5-4bbc-83a1-ab1fef36f14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_53c3f264-8606-49f3-bba3-d3828cdef018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:to="loc_us-gaap_RetainedEarningsMember_53c3f264-8606-49f3-bba3-d3828cdef018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_244aee92-2b7d-4312-ab1c-c55cd549d33f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_58cfc1a7-c13c-45c4-b032-587dfa3388cd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_244aee92-2b7d-4312-ab1c-c55cd549d33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b2642efa-3705-4918-9cf4-968681b71bee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9ddd1d11-f401-4ea7-adc2-6af50084e503" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b2642efa-3705-4918-9cf4-968681b71bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_50aa68ce-989d-4b76-a428-e5fb416bb693" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0f699b4c-60d5-4620-a46a-c5c63fd8dcc5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_50aa68ce-989d-4b76-a428-e5fb416bb693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d78c069d-8043-4ff1-b4fe-076bb2bfc659" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_50aa68ce-989d-4b76-a428-e5fb416bb693" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d78c069d-8043-4ff1-b4fe-076bb2bfc659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_31e2967d-59c3-4186-a1c8-f45c4b3f4afb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d78c069d-8043-4ff1-b4fe-076bb2bfc659" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_31e2967d-59c3-4186-a1c8-f45c4b3f4afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2f2e37ec-6274-416d-861a-a99602370832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0f699b4c-60d5-4620-a46a-c5c63fd8dcc5" xlink:to="loc_us-gaap_StatementLineItems_2f2e37ec-6274-416d-861a-a99602370832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2f2e37ec-6274-416d-861a-a99602370832" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_353b4c6f-b584-4f9f-95c9-fe9f1738bb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_SharesOutstanding_353b4c6f-b584-4f9f-95c9-fe9f1738bb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ffd1823c-adef-4699-8230-367a474c298c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ffd1823c-adef-4699-8230-367a474c298c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8eddb3a7-a7a8-4b88-8caf-d3c6035e52b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_ProfitLoss_8eddb3a7-a7a8-4b88-8caf-d3c6035e52b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d05b3d28-7d14-42d0-bb91-6e7490312d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d05b3d28-7d14-42d0-bb91-6e7490312d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_63cc92fb-e856-4a7c-86e9-fc800237e1da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_63cc92fb-e856-4a7c-86e9-fc800237e1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a8f3e8bc-b609-43ac-8bab-a5a7776f5df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a8f3e8bc-b609-43ac-8bab-a5a7776f5df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_4accdc71-9c73-45f7-9664-12fad01aa5cf" xlink:href="cvs-20210930.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_4accdc71-9c73-45f7-9664-12fad01aa5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_1e81d3a5-c1eb-4d09-9627-896ba30634f5" xlink:href="cvs-20210930.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_1e81d3a5-c1eb-4d09-9627-896ba30634f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_1f8b8ac2-375c-493c-b397-ce7c92e4813d" xlink:href="cvs-20210930.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_1f8b8ac2-375c-493c-b397-ce7c92e4813d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_a449aa17-3c77-454f-81d0-4ebef324d701" xlink:href="cvs-20210930.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_a449aa17-3c77-454f-81d0-4ebef324d701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_3d9b5a44-5ab6-4238-b964-62e1ba9de182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_DividendsCommonStock_3d9b5a44-5ab6-4238-b964-62e1ba9de182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_fcab9446-de30-4fbf-9ea0-e375b8e0b157" xlink:href="cvs-20210930.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_fcab9446-de30-4fbf-9ea0-e375b8e0b157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_40c54677-7de6-4a5e-8a67-9f726a25d362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_SharesOutstanding_40c54677-7de6-4a5e-8a67-9f726a25d362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dabdb433-89f7-4282-84b5-95aa5b48fa15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_650a258b-dea8-438d-8676-14d02afd2938" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dabdb433-89f7-4282-84b5-95aa5b48fa15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20210930.xsd#CondensedConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_ff48bd0d-e1b8-48ef-8039-e732a9257af6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_eb51a7b0-54ae-45ee-85a2-3708f35e0a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_ff48bd0d-e1b8-48ef-8039-e732a9257af6" xlink:to="loc_us-gaap_StatementTable_eb51a7b0-54ae-45ee-85a2-3708f35e0a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f2de8b08-2f24-4a4a-b02e-de762e6f2f99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_eb51a7b0-54ae-45ee-85a2-3708f35e0a3d" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f2de8b08-2f24-4a4a-b02e-de762e6f2f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_270cbe38-c244-4d85-9cab-c94503d06652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f2de8b08-2f24-4a4a-b02e-de762e6f2f99" xlink:to="loc_us-gaap_TypeOfAdoptionMember_270cbe38-c244-4d85-9cab-c94503d06652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_b8229459-f2cf-4b2e-9f71-ab96dd886fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_270cbe38-c244-4d85-9cab-c94503d06652" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_b8229459-f2cf-4b2e-9f71-ab96dd886fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_eb51a7b0-54ae-45ee-85a2-3708f35e0a3d" xlink:to="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_8d9b6577-25a7-48e2-9820-7c16451609a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_8d9b6577-25a7-48e2-9820-7c16451609a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_04c35944-bec0-4712-a49f-50e183f825bd" xlink:href="cvs-20210930.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_04c35944-bec0-4712-a49f-50e183f825bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_9d40c3d2-a42f-4589-815d-1cef9b4644cb" xlink:href="cvs-20210930.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_9d40c3d2-a42f-4589-815d-1cef9b4644cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d2781cf6-d2b6-445d-aec3-6a34d8005297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:to="loc_us-gaap_CommonStockValue_d2781cf6-d2b6-445d-aec3-6a34d8005297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f7d7da42-2c5e-408a-81d8-70e72256650a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2d4d9c49-ab67-408d-9bbe-a28590ed0e97" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f7d7da42-2c5e-408a-81d8-70e72256650a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="cvs-20210930.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1566149f-c62c-41db-841f-a47acb533ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e5f4607f-9721-4b1f-9a52-2b1589dc14e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1566149f-c62c-41db-841f-a47acb533ddc" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e5f4607f-9721-4b1f-9a52-2b1589dc14e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cvs-20210930.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_60bec5fe-200b-4074-ad18-92bc59818457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_7cde04c6-cd51-4ce9-b418-e3227f02eaa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_60bec5fe-200b-4074-ad18-92bc59818457" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_7cde04c6-cd51-4ce9-b418-e3227f02eaa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ab0b4ff2-8419-4eaf-a080-a293e4123a19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_60bec5fe-200b-4074-ad18-92bc59818457" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ab0b4ff2-8419-4eaf-a080-a293e4123a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_d07270ec-63ce-4bed-b931-37ddaa9d2d24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_60bec5fe-200b-4074-ad18-92bc59818457" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_d07270ec-63ce-4bed-b931-37ddaa9d2d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b90b9091-bf04-4961-a7f8-a95cc03b5f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_60bec5fe-200b-4074-ad18-92bc59818457" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b90b9091-bf04-4961-a7f8-a95cc03b5f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_4ed08ff5-b272-4182-9dab-59a60bd69bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_60bec5fe-200b-4074-ad18-92bc59818457" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_4ed08ff5-b272-4182-9dab-59a60bd69bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_8a85fb83-2010-4175-bdbe-0a75e64fe270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_60bec5fe-200b-4074-ad18-92bc59818457" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_8a85fb83-2010-4175-bdbe-0a75e64fe270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_1741d2bc-d308-4eee-b7b5-7b6622b8e7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_60bec5fe-200b-4074-ad18-92bc59818457" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_1741d2bc-d308-4eee-b7b5-7b6622b8e7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_6512e32d-eb7c-4a1d-8ba4-d8c4701f8e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareEntitiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_60bec5fe-200b-4074-ad18-92bc59818457" xlink:to="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_6512e32d-eb7c-4a1d-8ba4-d8c4701f8e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_6ed3f202-836c-405c-bc1a-181c44a6b666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_60bec5fe-200b-4074-ad18-92bc59818457" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_6ed3f202-836c-405c-bc1a-181c44a6b666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6fafa7a3-e445-4b17-aaa9-3f70fe028df7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_60bec5fe-200b-4074-ad18-92bc59818457" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6fafa7a3-e445-4b17-aaa9-3f70fe028df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cvs-20210930.xsd#SignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4d4d5728-eb6e-40ff-9865-801aac541a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_20ce8aba-4266-485f-a427-48bd819e7690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4d4d5728-eb6e-40ff-9865-801aac541a0a" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_20ce8aba-4266-485f-a427-48bd819e7690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_1cd7675d-d08e-41d5-ae19-fb006d2da36a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4d4d5728-eb6e-40ff-9865-801aac541a0a" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_1cd7675d-d08e-41d5-ae19-fb006d2da36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e9ef0ec4-bab8-42f5-b765-79a8de7e5e84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4d4d5728-eb6e-40ff-9865-801aac541a0a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e9ef0ec4-bab8-42f5-b765-79a8de7e5e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_e0fed105-7db4-419e-89ac-6db14deca003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4d4d5728-eb6e-40ff-9865-801aac541a0a" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_e0fed105-7db4-419e-89ac-6db14deca003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bf738451-a4cb-4519-9ef6-54a0a57d4857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d97b87f7-ec56-42a0-b6ae-ebc1d56c52c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf738451-a4cb-4519-9ef6-54a0a57d4857" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d97b87f7-ec56-42a0-b6ae-ebc1d56c52c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_20ace0e0-bca3-4630-ab09-d3cbb0dc6d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d97b87f7-ec56-42a0-b6ae-ebc1d56c52c8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_20ace0e0-bca3-4630-ab09-d3cbb0dc6d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_476207ae-e5b5-4d98-beb2-0444730eda4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_20ace0e0-bca3-4630-ab09-d3cbb0dc6d7e" xlink:to="loc_us-gaap_SegmentDomain_476207ae-e5b5-4d98-beb2-0444730eda4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_7ab7505c-bcc2-4a43-a61c-2f610366ad2c" xlink:href="cvs-20210930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_476207ae-e5b5-4d98-beb2-0444730eda4a" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_7ab7505c-bcc2-4a43-a61c-2f610366ad2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_52f118de-7033-4b18-b31a-c60ccdb0b446" xlink:href="cvs-20210930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_476207ae-e5b5-4d98-beb2-0444730eda4a" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_52f118de-7033-4b18-b31a-c60ccdb0b446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0dfd5808-b2b1-4d30-ad31-b67f53162488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d97b87f7-ec56-42a0-b6ae-ebc1d56c52c8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0dfd5808-b2b1-4d30-ad31-b67f53162488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7a86f84a-9bb0-4840-aa02-533a00b66eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0dfd5808-b2b1-4d30-ad31-b67f53162488" xlink:to="loc_us-gaap_RelatedPartyDomain_7a86f84a-9bb0-4840-aa02-533a00b66eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_c5256c9c-768a-49cb-8cb2-ac06614259a2" xlink:href="cvs-20210930.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_7a86f84a-9bb0-4840-aa02-533a00b66eaf" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_c5256c9c-768a-49cb-8cb2-ac06614259a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d97b87f7-ec56-42a0-b6ae-ebc1d56c52c8" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_8478284b-c783-4b72-af1a-21a1d8f1ae5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_us-gaap_NumberOfStores_8478284b-c783-4b72-af1a-21a1d8f1ae5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_77979a8c-8368-4f19-be43-e3d37142143c" xlink:href="cvs-20210930.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_77979a8c-8368-4f19-be43-e3d37142143c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPharmacyPlanMembers_4a4e763b-5cc3-4f7b-88e2-e8425b2ef343" xlink:href="cvs-20210930.xsd#cvs_NumberofPharmacyPlanMembers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_NumberofPharmacyPlanMembers_4a4e763b-5cc3-4f7b-88e2-e8425b2ef343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear_09545f92-bc6a-4aa4-82df-1e4788b50f4c" xlink:href="cvs-20210930.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_NumberofPatientsServedperYear_09545f92-bc6a-4aa4-82df-1e4788b50f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_c16d16bd-e4e6-4d09-9e57-05e024402111" xlink:href="cvs-20210930.xsd#cvs_NumberOfPeopleServed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_NumberOfPeopleServed_c16d16bd-e4e6-4d09-9e57-05e024402111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_948396d7-b499-4d5e-9ebd-e2b31d8dd818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_us-gaap_NumberOfReportableSegments_948396d7-b499-4d5e-9ebd-e2b31d8dd818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee_ffd843f7-c53c-413e-92a5-8fc9c093c720" xlink:href="cvs-20210930.xsd#cvs_HealthInsurerFee"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_HealthInsurerFee_ffd843f7-c53c-413e-92a5-8fc9c093c720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsToHealthInsurerFee_1845b96b-d039-4a96-879d-8aa85e2384d5" xlink:href="cvs-20210930.xsd#cvs_PaymentsToHealthInsurerFee"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_PaymentsToHealthInsurerFee_1845b96b-d039-4a96-879d-8aa85e2384d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_51035412-6193-4723-ac21-f4246b14b103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_51035412-6193-4723-ac21-f4246b14b103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_5ec4d6ea-9c86-438c-ad3d-fd978e99350f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_5ec4d6ea-9c86-438c-ad3d-fd978e99350f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_b61772a9-b7f8-4d27-a121-650a17d1752e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_b61772a9-b7f8-4d27-a121-650a17d1752e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_9e88730e-4151-48a1-b74c-9bbee7aee1c6" xlink:href="cvs-20210930.xsd#cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9d28cd02-76f3-495b-be78-b51ee28f319c" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_9e88730e-4151-48a1-b74c-9bbee7aee1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fb48ea07-0baa-486a-96c7-32788681bbf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ad603b3a-070b-43e7-8063-e82b5ee80b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fb48ea07-0baa-486a-96c7-32788681bbf2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ad603b3a-070b-43e7-8063-e82b5ee80b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_38cdd8c5-d8b9-4e3c-843f-72528e886104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fb48ea07-0baa-486a-96c7-32788681bbf2" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_38cdd8c5-d8b9-4e3c-843f-72528e886104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8b63fabc-3cfa-422d-9439-72e5c0f2b7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fb48ea07-0baa-486a-96c7-32788681bbf2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8b63fabc-3cfa-422d-9439-72e5c0f2b7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_df1334aa-837e-426d-afae-17201e58d532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_a9da2275-1f41-4061-aac8-28fbf33c7f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_df1334aa-837e-426d-afae-17201e58d532" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_a9da2275-1f41-4061-aac8-28fbf33c7f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_e40265b9-ebce-402f-869b-178f8e34dba0" xlink:href="cvs-20210930.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_df1334aa-837e-426d-afae-17201e58d532" xlink:to="loc_cvs_VendorandManufacturerReceivables_e40265b9-ebce-402f-869b-178f8e34dba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_8a3580c9-532f-4450-9f42-9b146e52e157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_df1334aa-837e-426d-afae-17201e58d532" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_8a3580c9-532f-4450-9f42-9b146e52e157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_a3ecc96b-b68e-4470-ad29-74784bed8bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_df1334aa-837e-426d-afae-17201e58d532" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_a3ecc96b-b68e-4470-ad29-74784bed8bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_27d10f7f-7e64-4985-8ff7-c6455744ab1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_df1334aa-837e-426d-afae-17201e58d532" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_27d10f7f-7e64-4985-8ff7-c6455744ab1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_c7518dc4-1137-40a9-bc15-d68771428fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_df1334aa-837e-426d-afae-17201e58d532" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_c7518dc4-1137-40a9-bc15-d68771428fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0480f929-418e-4a10-8638-f5d08a827081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d5d91387-5aa1-4a86-97f7-f25755b5c8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0480f929-418e-4a10-8638-f5d08a827081" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d5d91387-5aa1-4a86-97f7-f25755b5c8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_95349013-8d11-4c76-9c1f-b79c001d97d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d5d91387-5aa1-4a86-97f7-f25755b5c8fa" xlink:to="loc_srt_ConsolidationItemsAxis_95349013-8d11-4c76-9c1f-b79c001d97d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d97daf68-75f0-4987-b23d-62b95891bdfd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_95349013-8d11-4c76-9c1f-b79c001d97d6" xlink:to="loc_srt_ConsolidationItemsDomain_d97daf68-75f0-4987-b23d-62b95891bdfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f846916f-fbaf-443d-a901-802e1028066e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d97daf68-75f0-4987-b23d-62b95891bdfd" xlink:to="loc_us-gaap_OperatingSegmentsMember_f846916f-fbaf-443d-a901-802e1028066e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9c431a62-2115-416d-b29f-013dfead8cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d97daf68-75f0-4987-b23d-62b95891bdfd" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9c431a62-2115-416d-b29f-013dfead8cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_7df286be-3f3a-4d47-a1b7-adf39a7f78b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d97daf68-75f0-4987-b23d-62b95891bdfd" xlink:to="loc_us-gaap_IntersegmentEliminationMember_7df286be-3f3a-4d47-a1b7-adf39a7f78b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fc7f5cd1-28da-4f8f-8072-efdcf1a3832a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d5d91387-5aa1-4a86-97f7-f25755b5c8fa" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fc7f5cd1-28da-4f8f-8072-efdcf1a3832a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d5caa8f3-bf28-4fd6-bd4d-9710e8e28b15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fc7f5cd1-28da-4f8f-8072-efdcf1a3832a" xlink:to="loc_us-gaap_SegmentDomain_d5caa8f3-bf28-4fd6-bd4d-9710e8e28b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_c66dc409-6eaa-477f-a48c-d9862ccbcf18" xlink:href="cvs-20210930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d5caa8f3-bf28-4fd6-bd4d-9710e8e28b15" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_c66dc409-6eaa-477f-a48c-d9862ccbcf18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_e58a2f8b-0609-41c6-af88-d4821f0bc24d" xlink:href="cvs-20210930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d5caa8f3-bf28-4fd6-bd4d-9710e8e28b15" xlink:to="loc_cvs_PharmacyServicesSegmentMember_e58a2f8b-0609-41c6-af88-d4821f0bc24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_d0b549fd-a427-458a-947f-50145fb129ec" xlink:href="cvs-20210930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d5caa8f3-bf28-4fd6-bd4d-9710e8e28b15" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_d0b549fd-a427-458a-947f-50145fb129ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a90c8071-c7ae-4344-a3ca-fee232a7cdfb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d5d91387-5aa1-4a86-97f7-f25755b5c8fa" xlink:to="loc_srt_ProductOrServiceAxis_a90c8071-c7ae-4344-a3ca-fee232a7cdfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_64039913-18a9-4cb1-ab9b-508bb551e1cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a90c8071-c7ae-4344-a3ca-fee232a7cdfb" xlink:to="loc_srt_ProductsAndServicesDomain_64039913-18a9-4cb1-ab9b-508bb551e1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_f19b5919-4f9d-4944-a6df-64c1fa616b89" xlink:href="cvs-20210930.xsd#cvs_PharmacyRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64039913-18a9-4cb1-ab9b-508bb551e1cc" xlink:to="loc_cvs_PharmacyRevenueMember_f19b5919-4f9d-4944-a6df-64c1fa616b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_922f2bd0-4290-4770-bdad-9394831bf303" xlink:href="cvs-20210930.xsd#cvs_FrontStoreRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64039913-18a9-4cb1-ab9b-508bb551e1cc" xlink:to="loc_cvs_FrontStoreRevenueMember_922f2bd0-4290-4770-bdad-9394831bf303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_e6fa4777-29e2-4d9d-bde9-bcd68aa93785" xlink:href="cvs-20210930.xsd#cvs_PremiumsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64039913-18a9-4cb1-ab9b-508bb551e1cc" xlink:to="loc_cvs_PremiumsMember_e6fa4777-29e2-4d9d-bde9-bcd68aa93785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_14d69ae7-1aba-402e-a46a-2b874e5d82db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64039913-18a9-4cb1-ab9b-508bb551e1cc" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_14d69ae7-1aba-402e-a46a-2b874e5d82db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_c4bf306d-219f-4d8b-a420-4b8b8913640e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d5d91387-5aa1-4a86-97f7-f25755b5c8fa" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_c4bf306d-219f-4d8b-a420-4b8b8913640e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7ab2f1d3-0af2-4158-a1c2-933ec7b529df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_c4bf306d-219f-4d8b-a420-4b8b8913640e" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7ab2f1d3-0af2-4158-a1c2-933ec7b529df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_1bd4361e-645a-4792-9414-3bb0ce357783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7ab2f1d3-0af2-4158-a1c2-933ec7b529df" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_1bd4361e-645a-4792-9414-3bb0ce357783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_fba82521-26ef-4eba-ac72-e90c611f8ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7ab2f1d3-0af2-4158-a1c2-933ec7b529df" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_fba82521-26ef-4eba-ac72-e90c611f8ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_4757e4a9-e58d-44b9-8ba8-48d762026d6c" xlink:href="cvs-20210930.xsd#cvs_SalesChannelOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7ab2f1d3-0af2-4158-a1c2-933ec7b529df" xlink:to="loc_cvs_SalesChannelOtherMember_4757e4a9-e58d-44b9-8ba8-48d762026d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_808f5be4-2502-4b70-ab3f-99884362fb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d5d91387-5aa1-4a86-97f7-f25755b5c8fa" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_808f5be4-2502-4b70-ab3f-99884362fb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_4b46c534-39db-40f3-8345-e4eee4eac9b2" xlink:href="cvs-20210930.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_808f5be4-2502-4b70-ab3f-99884362fb8b" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_4b46c534-39db-40f3-8345-e4eee4eac9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_d6ae029a-62ca-4087-89e0-af417f291c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_808f5be4-2502-4b70-ab3f-99884362fb8b" xlink:to="loc_us-gaap_NetInvestmentIncome_d6ae029a-62ca-4087-89e0-af417f291c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_33d379cb-0e6b-452f-ab22-43a77f58aa80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_808f5be4-2502-4b70-ab3f-99884362fb8b" xlink:to="loc_us-gaap_Revenues_33d379cb-0e6b-452f-ab22-43a77f58aa80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e2b61da7-6d17-473f-a993-4f57c8872ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_82634efc-0073-42c5-a319-9f1583b01208" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2b61da7-6d17-473f-a993-4f57c8872ba6" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_82634efc-0073-42c5-a319-9f1583b01208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6e312e5b-8f3d-41f3-a63c-1219981183cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2b61da7-6d17-473f-a993-4f57c8872ba6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6e312e5b-8f3d-41f3-a63c-1219981183cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c4004bcc-9016-455c-9af0-33ea9935647a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_8fc03e06-db54-48c6-b906-afcacb5cfa33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c4004bcc-9016-455c-9af0-33ea9935647a" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_8fc03e06-db54-48c6-b906-afcacb5cfa33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_4ad9c286-09a1-4397-b378-fb7f058b080f" xlink:href="cvs-20210930.xsd#cvs_ChangeinContractwithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_8fc03e06-db54-48c6-b906-afcacb5cfa33" xlink:to="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_4ad9c286-09a1-4397-b378-fb7f058b080f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c20bff0f-32b4-4b21-b463-99f7a90b95b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_4ad9c286-09a1-4397-b378-fb7f058b080f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c20bff0f-32b4-4b21-b463-99f7a90b95b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_d39cf4a6-f88c-4f77-8a98-6b0ca370b5e3" xlink:href="cvs-20210930.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_4ad9c286-09a1-4397-b378-fb7f058b080f" xlink:to="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_d39cf4a6-f88c-4f77-8a98-6b0ca370b5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_25480183-334b-4f0a-a41f-08c7e097e9e5" xlink:href="cvs-20210930.xsd#cvs_ContractwithCustomerLiabilityRedemptionandBreakage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_4ad9c286-09a1-4397-b378-fb7f058b080f" xlink:to="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_25480183-334b-4f0a-a41f-08c7e097e9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_148a8555-39ac-4bdd-850b-2c8fd950e895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_4ad9c286-09a1-4397-b378-fb7f058b080f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_148a8555-39ac-4bdd-850b-2c8fd950e895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Investments" xlink:type="simple" xlink:href="cvs-20210930.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_cc3ef1d6-6c76-4033-b81e-50ecd86cc146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7be0c54a-fab9-4f0c-8c42-37698b951a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_cc3ef1d6-6c76-4033-b81e-50ecd86cc146" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7be0c54a-fab9-4f0c-8c42-37698b951a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_9f25ee92-f54e-49f6-ab84-3eab977690ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock_b8aebdc1-299c-4181-a438-c9ae50b30b84" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9f25ee92-f54e-49f6-ab84-3eab977690ca" xlink:to="loc_cvs_TotalInvestmentsTableTextBlock_b8aebdc1-299c-4181-a438-c9ae50b30b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ac2b24a9-4517-4e99-8b5f-61be7140bb38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9f25ee92-f54e-49f6-ab84-3eab977690ca" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ac2b24a9-4517-4e99-8b5f-61be7140bb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_eb32b34f-8973-4f33-bab0-782ab7c49998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9f25ee92-f54e-49f6-ab84-3eab977690ca" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_eb32b34f-8973-4f33-bab0-782ab7c49998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_f318b260-39f1-4482-b8dc-8343a07f5903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9f25ee92-f54e-49f6-ab84-3eab977690ca" xlink:to="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_f318b260-39f1-4482-b8dc-8343a07f5903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_a4774c4f-4fc0-4207-8b77-d56c1b1a55bf" xlink:href="cvs-20210930.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9f25ee92-f54e-49f6-ab84-3eab977690ca" xlink:to="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_a4774c4f-4fc0-4207-8b77-d56c1b1a55bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_91199870-4722-4183-acd8-689ccc3459ae" xlink:href="cvs-20210930.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9f25ee92-f54e-49f6-ab84-3eab977690ca" xlink:to="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_91199870-4722-4183-acd8-689ccc3459ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock_b787b590-2410-4f41-af1c-f2c72b361e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9f25ee92-f54e-49f6-ab84-3eab977690ca" xlink:to="loc_us-gaap_InvestmentIncomeTextBlock_b787b590-2410-4f41-af1c-f2c72b361e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_6abcf61d-4f4d-4a20-9773-cc7f8d430764" xlink:href="cvs-20210930.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9f25ee92-f54e-49f6-ab84-3eab977690ca" xlink:to="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_6abcf61d-4f4d-4a20-9773-cc7f8d430764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsTotalInvestmentScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_e71d8a43-7ce8-412f-84e5-c50cc2875be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_ee7b0f43-767b-482e-a6b3-c5d4ac846f97" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e71d8a43-7ce8-412f-84e5-c50cc2875be2" xlink:to="loc_cvs_TotalInvestmentsTable_ee7b0f43-767b-482e-a6b3-c5d4ac846f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_322f76f3-f8b6-458d-91d4-d4aa480094ea" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_ee7b0f43-767b-482e-a6b3-c5d4ac846f97" xlink:to="loc_cvs_TotalInvestmentsAxis_322f76f3-f8b6-458d-91d4-d4aa480094ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_9a16f55e-4678-4fa9-909b-e38061116cf2" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsAxis_322f76f3-f8b6-458d-91d4-d4aa480094ea" xlink:to="loc_cvs_TotalInvestmentsDomain_9a16f55e-4678-4fa9-909b-e38061116cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_a9c76f51-25a6-49b9-8c2e-8e02a240f7bc" xlink:href="cvs-20210930.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_9a16f55e-4678-4fa9-909b-e38061116cf2" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_a9c76f51-25a6-49b9-8c2e-8e02a240f7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_ace92b43-f8e3-4e85-aea5-03891a41e404" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_9a16f55e-4678-4fa9-909b-e38061116cf2" xlink:to="loc_cvs_MortgageLoansMember_ace92b43-f8e3-4e85-aea5-03891a41e404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_6483fff9-d1e7-4a13-9759-d2317f113414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_9a16f55e-4678-4fa9-909b-e38061116cf2" xlink:to="loc_us-gaap_OtherInvestmentsMember_6483fff9-d1e7-4a13-9759-d2317f113414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_619f0e99-424a-4f6f-b3df-9656cae86175" xlink:href="cvs-20210930.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_ee7b0f43-767b-482e-a6b3-c5d4ac846f97" xlink:to="loc_cvs_TotalInvestmentsLineItems_619f0e99-424a-4f6f-b3df-9656cae86175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_574b8c04-007b-4bf4-a597-fab3db92a035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_619f0e99-424a-4f6f-b3df-9656cae86175" xlink:to="loc_us-gaap_ShortTermInvestments_574b8c04-007b-4bf4-a597-fab3db92a035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_49faf92b-e595-4a26-87c6-ce58d82a07db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_619f0e99-424a-4f6f-b3df-9656cae86175" xlink:to="loc_us-gaap_LongTermInvestments_49faf92b-e595-4a26-87c6-ce58d82a07db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_50d154d0-c424-4698-b92a-7aed3045f094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_619f0e99-424a-4f6f-b3df-9656cae86175" xlink:to="loc_us-gaap_Investments_50d154d0-c424-4698-b92a-7aed3045f094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_ceaaa694-4f3a-477a-99ee-dec744ca43a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2c071bd8-f14d-466a-b149-a3ca40f94211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ceaaa694-4f3a-477a-99ee-dec744ca43a3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2c071bd8-f14d-466a-b149-a3ca40f94211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ee674efb-7109-4029-9926-54afc4f3535b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2c071bd8-f14d-466a-b149-a3ca40f94211" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ee674efb-7109-4029-9926-54afc4f3535b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9aa43fdf-2d07-441a-80b4-836bbbfe08fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ee674efb-7109-4029-9926-54afc4f3535b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9aa43fdf-2d07-441a-80b4-836bbbfe08fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9aa43fdf-2d07-441a-80b4-836bbbfe08fb" xlink:to="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4febc233-700f-462e-982a-99318f936bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4febc233-700f-462e-982a-99318f936bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_7d448d4f-844f-4f11-9d13-abccd017959b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_7d448d4f-844f-4f11-9d13-abccd017959b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_4aded417-278a-4832-b54c-c267be936392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_4aded417-278a-4832-b54c-c267be936392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_e4aeb7d6-3de5-401c-8a83-6dae1f91b399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_e4aeb7d6-3de5-401c-8a83-6dae1f91b399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d3cf0d2d-41b2-444b-b06b-a1263714f251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d3cf0d2d-41b2-444b-b06b-a1263714f251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8d9ec6a0-1298-4bee-8040-78c60c1bc83a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_8d9ec6a0-1298-4bee-8040-78c60c1bc83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_c7ebeb1d-480a-4cac-9cf2-e0a50fdd2e26" xlink:href="cvs-20210930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_c7ebeb1d-480a-4cac-9cf2-e0a50fdd2e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_028e03d5-1e15-4a26-a197-d71d88bbb9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_c24ebdbb-8dfb-4315-b27e-15e63baadb3a" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_028e03d5-1e15-4a26-a197-d71d88bbb9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5323ba8b-9925-4c83-a4e9-c1a9b0b5a4ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2c071bd8-f14d-466a-b149-a3ca40f94211" xlink:to="loc_srt_ProductOrServiceAxis_5323ba8b-9925-4c83-a4e9-c1a9b0b5a4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d308884e-3b68-4fe1-8b41-cb1fdbcedb6f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5323ba8b-9925-4c83-a4e9-c1a9b0b5a4ea" xlink:to="loc_srt_ProductsAndServicesDomain_d308884e-3b68-4fe1-8b41-cb1fdbcedb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_a190709d-3a45-465c-b25f-5a7df484f420" xlink:href="cvs-20210930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d308884e-3b68-4fe1-8b41-cb1fdbcedb6f" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_a190709d-3a45-465c-b25f-5a7df484f420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2c071bd8-f14d-466a-b149-a3ca40f94211" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_8da9d36b-8fc5-4db5-9b59-6ae166455e49" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_8da9d36b-8fc5-4db5-9b59-6ae166455e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_257e9f2b-48a3-4020-ab73-154bdf06fc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_257e9f2b-48a3-4020-ab73-154bdf06fc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_cfc981d4-f201-422d-947a-92bf2cddd3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_cfc981d4-f201-422d-947a-92bf2cddd3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cbe24ddc-5028-403b-88f8-408c47c00b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cbe24ddc-5028-403b-88f8-408c47c00b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_2c88a641-a50f-4c43-880d-1fa23828cd55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d392378f-cf59-4ae1-8e89-5cb958ccf92f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_2c88a641-a50f-4c43-880d-1fa23828cd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_41c4614d-d624-4fbc-8894-a11f259797a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ad30d06b-c533-4274-b10b-59e5859ab105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_41c4614d-d624-4fbc-8894-a11f259797a8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ad30d06b-c533-4274-b10b-59e5859ab105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b3e70b80-7e4e-469e-ba80-8be3c7beff9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ad30d06b-c533-4274-b10b-59e5859ab105" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b3e70b80-7e4e-469e-ba80-8be3c7beff9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bdfab320-d46d-4926-8a86-853505f02da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b3e70b80-7e4e-469e-ba80-8be3c7beff9c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bdfab320-d46d-4926-8a86-853505f02da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_cc3df7aa-83a3-4500-bf9a-7e7dc57792a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bdfab320-d46d-4926-8a86-853505f02da9" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_cc3df7aa-83a3-4500-bf9a-7e7dc57792a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_77ef3bf1-a169-49eb-8d25-a46c39c4fe2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bdfab320-d46d-4926-8a86-853505f02da9" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_77ef3bf1-a169-49eb-8d25-a46c39c4fe2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_5967106e-2e71-45d7-9c97-b9d3c2c52157" xlink:href="cvs-20210930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bdfab320-d46d-4926-8a86-853505f02da9" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_5967106e-2e71-45d7-9c97-b9d3c2c52157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_bb465807-b4e0-47ac-bd6b-ef11481ec0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ad30d06b-c533-4274-b10b-59e5859ab105" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_bb465807-b4e0-47ac-bd6b-ef11481ec0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_bb465807-b4e0-47ac-bd6b-ef11481ec0ec" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_0d99c431-a6d3-4676-a9a1-a32364fba8bd" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_0d99c431-a6d3-4676-a9a1-a32364fba8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_b1a97f59-a444-4c12-b7d6-3bfb838d94f7" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_b1a97f59-a444-4c12-b7d6-3bfb838d94f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_99220582-373d-485f-8f44-083e53917ebd" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_99220582-373d-485f-8f44-083e53917ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_515ae94b-26d0-4aac-8ed0-670e4b7ccbe5" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_515ae94b-26d0-4aac-8ed0-670e4b7ccbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_42fbba5b-b69c-4cf6-965f-293fcd16a2aa" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_42fbba5b-b69c-4cf6-965f-293fcd16a2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_0d5b0fc8-1419-435d-9a97-4c4d36663c48" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_7f143ecf-0ffe-4965-8c74-e589d1945180" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_0d5b0fc8-1419-435d-9a97-4c4d36663c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_bb465807-b4e0-47ac-bd6b-ef11481ec0ec" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5d5ff0c8-7ec1-4935-af0d-77e1de1c7a64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5d5ff0c8-7ec1-4935-af0d-77e1de1c7a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0d6c14d5-7a31-48f7-b3ed-b5bc78f15c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0d6c14d5-7a31-48f7-b3ed-b5bc78f15c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_bbd0d018-e6d6-4a83-bba6-9e4c80ddeaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_bbd0d018-e6d6-4a83-bba6-9e4c80ddeaa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_cfab2cca-6d5e-4dae-8d88-7a2e162b7063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_cfab2cca-6d5e-4dae-8d88-7a2e162b7063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_00a8e2cc-b685-464a-8d17-3971c66fbb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_00a8e2cc-b685-464a-8d17-3971c66fbb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ab6dca7e-5d0e-45d3-acba-479a775ec39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a139c55a-eb22-42d7-a080-09f4e46cef2d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ab6dca7e-5d0e-45d3-acba-479a775ec39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_b9d0d8db-76ae-4b8e-9c78-e063391e659a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_bebfe43d-f527-442c-a801-8eefc1c1d41d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b9d0d8db-76ae-4b8e-9c78-e063391e659a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_bebfe43d-f527-442c-a801-8eefc1c1d41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5733ff07-edd1-42c9-a558-9ada632d1009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_bebfe43d-f527-442c-a801-8eefc1c1d41d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5733ff07-edd1-42c9-a558-9ada632d1009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5733ff07-edd1-42c9-a558-9ada632d1009" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_25cd3b6b-5a45-4c18-9ba3-4d437f8f4604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_25cd3b6b-5a45-4c18-9ba3-4d437f8f4604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_75d6fa79-2a00-4024-bc63-6014efe3b84c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_75d6fa79-2a00-4024-bc63-6014efe3b84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_8773dc5f-1af9-4542-94fe-da7b1ad270c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_8773dc5f-1af9-4542-94fe-da7b1ad270c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_fcf60d0b-bbd7-469b-9083-42a10fdd9d52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_fcf60d0b-bbd7-469b-9083-42a10fdd9d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_61837fae-bfee-45ac-ada1-37c895ac85ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_61837fae-bfee-45ac-ada1-37c895ac85ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_19d01be6-17dd-4b1b-97b1-ccbf924f9caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_19d01be6-17dd-4b1b-97b1-ccbf924f9caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_b9d925ae-ca50-47b0-891e-1497a082ad5e" xlink:href="cvs-20210930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_b9d925ae-ca50-47b0-891e-1497a082ad5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_8d7afdc0-b7af-43b9-a980-dbc2f56740b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b2817a-000a-4297-ac32-a4f37a001375" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_8d7afdc0-b7af-43b9-a980-dbc2f56740b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_53ce674b-e78b-4be6-9b1f-4f931effb2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_bebfe43d-f527-442c-a801-8eefc1c1d41d" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_53ce674b-e78b-4be6-9b1f-4f931effb2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_eaa45e08-87e4-480b-9c92-1b47fd1f3892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_53ce674b-e78b-4be6-9b1f-4f931effb2b7" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_eaa45e08-87e4-480b-9c92-1b47fd1f3892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0af349c7-f0bf-496c-ae21-614d5f641264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_eaa45e08-87e4-480b-9c92-1b47fd1f3892" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0af349c7-f0bf-496c-ae21-614d5f641264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_ab5c9542-1eea-4bcd-871e-aec1684246d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_eaa45e08-87e4-480b-9c92-1b47fd1f3892" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_ab5c9542-1eea-4bcd-871e-aec1684246d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_14caf2c3-7d23-4b1c-8425-f5e8ada14a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_eaa45e08-87e4-480b-9c92-1b47fd1f3892" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_14caf2c3-7d23-4b1c-8425-f5e8ada14a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_8a57e0b8-327b-4e88-b0e8-b8be42386f5e" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_53ce674b-e78b-4be6-9b1f-4f931effb2b7" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_8a57e0b8-327b-4e88-b0e8-b8be42386f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_92504034-fafc-433f-a4e7-7a0b89f90ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_8a57e0b8-327b-4e88-b0e8-b8be42386f5e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_92504034-fafc-433f-a4e7-7a0b89f90ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_898df459-d120-4980-bd0f-7fec7c0df975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_8a57e0b8-327b-4e88-b0e8-b8be42386f5e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_898df459-d120-4980-bd0f-7fec7c0df975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ad4ee5a3-5d55-42f0-a189-c1827d0b9a15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_8a57e0b8-327b-4e88-b0e8-b8be42386f5e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ad4ee5a3-5d55-42f0-a189-c1827d0b9a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f500bd1a-aca9-47a5-b3bb-294f824b2015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_53ce674b-e78b-4be6-9b1f-4f931effb2b7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f500bd1a-aca9-47a5-b3bb-294f824b2015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_79fc5ea1-75a2-424d-913d-510c933169c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f500bd1a-aca9-47a5-b3bb-294f824b2015" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_79fc5ea1-75a2-424d-913d-510c933169c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_5a3945aa-2719-4ba2-950a-38552f2f0b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f500bd1a-aca9-47a5-b3bb-294f824b2015" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_5a3945aa-2719-4ba2-950a-38552f2f0b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f59c106d-117b-4cd7-b57e-c268696baae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f500bd1a-aca9-47a5-b3bb-294f824b2015" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f59c106d-117b-4cd7-b57e-c268696baae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_64eb9094-380b-4b78-95b6-71b0df4452c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_474c1081-2fae-4246-9950-9ff79f814790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_64eb9094-380b-4b78-95b6-71b0df4452c7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_474c1081-2fae-4246-9950-9ff79f814790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f8cf470d-adbe-4a78-b725-5430a464b2e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_474c1081-2fae-4246-9950-9ff79f814790" xlink:to="loc_srt_ProductOrServiceAxis_f8cf470d-adbe-4a78-b725-5430a464b2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c90955e2-af38-4a76-a626-2e620a2767b0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f8cf470d-adbe-4a78-b725-5430a464b2e3" xlink:to="loc_srt_ProductsAndServicesDomain_c90955e2-af38-4a76-a626-2e620a2767b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_315e8adc-b917-49d0-8db3-39cd466f206e" xlink:href="cvs-20210930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c90955e2-af38-4a76-a626-2e620a2767b0" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_315e8adc-b917-49d0-8db3-39cd466f206e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_ea724d11-dfb1-4124-be89-95a06bfa01b4" xlink:href="cvs-20210930.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c90955e2-af38-4a76-a626-2e620a2767b0" xlink:to="loc_cvs_SupportingRemainingProductsMember_ea724d11-dfb1-4124-be89-95a06bfa01b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6acd048d-0f04-4b80-966f-271d3abd5455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_474c1081-2fae-4246-9950-9ff79f814790" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6acd048d-0f04-4b80-966f-271d3abd5455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_06a72bb5-be10-4bbf-9251-a420b0bb2cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6acd048d-0f04-4b80-966f-271d3abd5455" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_06a72bb5-be10-4bbf-9251-a420b0bb2cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3c3befb7-7c5f-47f1-888b-5df604853a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_06a72bb5-be10-4bbf-9251-a420b0bb2cb1" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3c3befb7-7c5f-47f1-888b-5df604853a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_70c643ea-e427-4889-ad7d-7277237cf8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_06a72bb5-be10-4bbf-9251-a420b0bb2cb1" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_70c643ea-e427-4889-ad7d-7277237cf8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_de070762-fe70-4fa5-941a-44d775b8e2df" xlink:href="cvs-20210930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_06a72bb5-be10-4bbf-9251-a420b0bb2cb1" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_de070762-fe70-4fa5-941a-44d775b8e2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c356f14b-a093-4e94-b7fe-e789fbfbd52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_474c1081-2fae-4246-9950-9ff79f814790" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c356f14b-a093-4e94-b7fe-e789fbfbd52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c356f14b-a093-4e94-b7fe-e789fbfbd52b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_d66d9cc9-eec5-47fb-9fb0-d8205dea9f13" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_d66d9cc9-eec5-47fb-9fb0-d8205dea9f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_f603565e-dda4-4d70-92ab-a734e1ba11bb" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_f603565e-dda4-4d70-92ab-a734e1ba11bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_e1fe60da-a151-4aa4-a027-002ac29a844a" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_e1fe60da-a151-4aa4-a027-002ac29a844a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_3192bf8a-0266-4d7f-9630-cc10e685fd18" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_3192bf8a-0266-4d7f-9630-cc10e685fd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_bf96a679-8310-4e67-aa53-35afd0d9989b" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_bf96a679-8310-4e67-aa53-35afd0d9989b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_49a00ff2-d96e-4474-958a-662c3f194169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0c27c3f9-02c2-4488-ac92-98f88637bf11" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_49a00ff2-d96e-4474-958a-662c3f194169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c356f14b-a093-4e94-b7fe-e789fbfbd52b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_63e5c1d4-7cd1-463c-bd46-df2550d754df" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_63e5c1d4-7cd1-463c-bd46-df2550d754df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_a9b0f2c2-2dd2-4d77-9e44-eecd6f92dbad" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_a9b0f2c2-2dd2-4d77-9e44-eecd6f92dbad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_d8ded535-bc25-4f16-be5d-8819a2ab13e0" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_d8ded535-bc25-4f16-be5d-8819a2ab13e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_b3239599-3fa6-42d9-aebe-f8d8677bbb96" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_b3239599-3fa6-42d9-aebe-f8d8677bbb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_aa4d70ea-3ac1-43d6-ad55-b88bdc68bbca" xlink:href="cvs-20210930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_aa4d70ea-3ac1-43d6-ad55-b88bdc68bbca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ecf09dc0-58eb-4665-a10c-fe53d7b02714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_0f667c70-f417-44ce-bff7-73a0af992ff3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ecf09dc0-58eb-4665-a10c-fe53d7b02714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsMortgageLoansDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_38892888-369a-49e6-9925-46aa1bb8567d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_862cf1a7-db67-4334-91ce-f62489b4f252" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_38892888-369a-49e6-9925-46aa1bb8567d" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_862cf1a7-db67-4334-91ce-f62489b4f252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_6489a453-4851-4261-bd98-358c7eab37d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_862cf1a7-db67-4334-91ce-f62489b4f252" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_6489a453-4851-4261-bd98-358c7eab37d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_50d6d818-d4f4-4e86-aa15-7ef3aa51ea2a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_6489a453-4851-4261-bd98-358c7eab37d1" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_50d6d818-d4f4-4e86-aa15-7ef3aa51ea2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_dcbb8658-88af-4a62-b1a9-a1c10c6da673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_50d6d818-d4f4-4e86-aa15-7ef3aa51ea2a" xlink:to="loc_us-gaap_CommercialRealEstateMember_dcbb8658-88af-4a62-b1a9-a1c10c6da673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_843876f0-61c9-4c8b-abca-723b03ba7c3c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_862cf1a7-db67-4334-91ce-f62489b4f252" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_843876f0-61c9-4c8b-abca-723b03ba7c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_a4d9be65-81a7-4370-9df9-d834a7055ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_843876f0-61c9-4c8b-abca-723b03ba7c3c" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_a4d9be65-81a7-4370-9df9-d834a7055ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_1b6010cd-0e1d-45c2-81be-6b99a52cced7" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_843876f0-61c9-4c8b-abca-723b03ba7c3c" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_1b6010cd-0e1d-45c2-81be-6b99a52cced7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_73a71d6c-2d8a-41d1-80cd-952c93c404cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_843876f0-61c9-4c8b-abca-723b03ba7c3c" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_73a71d6c-2d8a-41d1-80cd-952c93c404cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_78932241-066a-40b0-8fa1-7ebe01209939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_81f4b36f-2970-4303-b3a1-3d02c6bf1d7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_78932241-066a-40b0-8fa1-7ebe01209939" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_81f4b36f-2970-4303-b3a1-3d02c6bf1d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_a44a0dc8-0378-4f1b-9fb8-684fcd1e786b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_81f4b36f-2970-4303-b3a1-3d02c6bf1d7a" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_a44a0dc8-0378-4f1b-9fb8-684fcd1e786b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d862314d-dfda-47e8-864e-87553b9eab30" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_a44a0dc8-0378-4f1b-9fb8-684fcd1e786b" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d862314d-dfda-47e8-864e-87553b9eab30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_56c5f6f5-6605-4cfe-9934-f77659ddd97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d862314d-dfda-47e8-864e-87553b9eab30" xlink:to="loc_us-gaap_CommercialRealEstateMember_56c5f6f5-6605-4cfe-9934-f77659ddd97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_e74d0b52-15c3-421e-88a8-e7d133545788" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_81f4b36f-2970-4303-b3a1-3d02c6bf1d7a" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_e74d0b52-15c3-421e-88a8-e7d133545788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_e74d0b52-15c3-421e-88a8-e7d133545788" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_c272eb71-b62c-4017-86b2-bdab96814088" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_c272eb71-b62c-4017-86b2-bdab96814088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_2fbedf7f-389d-4a45-9e07-9e91bd53deeb" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_2fbedf7f-389d-4a45-9e07-9e91bd53deeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_0b582e5a-da5d-4f8d-af80-094b6a336f20" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_0b582e5a-da5d-4f8d-af80-094b6a336f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_0337de41-0725-43ce-83db-6d35fe2213bd" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_0337de41-0725-43ce-83db-6d35fe2213bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_999791dd-60e4-44bb-aabc-899d74eb2e05" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_999791dd-60e4-44bb-aabc-899d74eb2e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_67fc7358-04c1-40cb-8ad0-3d793e207f2b" xlink:href="cvs-20210930.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1dd0032a-2747-4fd3-a60e-ed8b7ccc7075" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_67fc7358-04c1-40cb-8ad0-3d793e207f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_c1fe0549-d994-42b0-b656-a0f083e9de73" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_81f4b36f-2970-4303-b3a1-3d02c6bf1d7a" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_c1fe0549-d994-42b0-b656-a0f083e9de73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_75ec03c1-61a1-4dbb-a65a-fcf8ea3d1f7b" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_c1fe0549-d994-42b0-b656-a0f083e9de73" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_75ec03c1-61a1-4dbb-a65a-fcf8ea3d1f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_11f504df-7b01-458a-aa68-5885602bc966" xlink:href="cvs-20210930.xsd#cvs_Category1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_75ec03c1-61a1-4dbb-a65a-fcf8ea3d1f7b" xlink:to="loc_cvs_Category1Member_11f504df-7b01-458a-aa68-5885602bc966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_0f04b6ca-7928-4c92-8c9a-5774dda6f690" xlink:href="cvs-20210930.xsd#cvs_Category2To4Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_75ec03c1-61a1-4dbb-a65a-fcf8ea3d1f7b" xlink:to="loc_cvs_Category2To4Member_0f04b6ca-7928-4c92-8c9a-5774dda6f690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_a2fd9eb7-cb6d-48bb-988a-90b353f4ef13" xlink:href="cvs-20210930.xsd#cvs_Categories5and6Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_75ec03c1-61a1-4dbb-a65a-fcf8ea3d1f7b" xlink:to="loc_cvs_Categories5and6Member_a2fd9eb7-cb6d-48bb-988a-90b353f4ef13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_064ec7b6-31c2-4d7d-9b36-c8289c7caa73" xlink:href="cvs-20210930.xsd#cvs_Category7Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_75ec03c1-61a1-4dbb-a65a-fcf8ea3d1f7b" xlink:to="loc_cvs_Category7Member_064ec7b6-31c2-4d7d-9b36-c8289c7caa73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_7c5464ab-309d-45da-b1a6-3c43ed2ff12f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_81f4b36f-2970-4303-b3a1-3d02c6bf1d7a" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_7c5464ab-309d-45da-b1a6-3c43ed2ff12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_5a95d565-8ec7-4eb6-80fa-ab4dfa8f88a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_7c5464ab-309d-45da-b1a6-3c43ed2ff12f" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_5a95d565-8ec7-4eb6-80fa-ab4dfa8f88a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_41cdbbdd-d2e6-4ed8-937d-3f1ba3c6d257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_512f728b-33ce-4506-8c21-b0850b2d7c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_41cdbbdd-d2e6-4ed8-937d-3f1ba3c6d257" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_512f728b-33ce-4506-8c21-b0850b2d7c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4a4f86c6-deb8-40cb-b8b9-a8a402377e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_512f728b-33ce-4506-8c21-b0850b2d7c28" xlink:to="loc_us-gaap_InvestmentTypeAxis_4a4f86c6-deb8-40cb-b8b9-a8a402377e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_cebfb96f-db2d-470a-a063-3fd240621799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_4a4f86c6-deb8-40cb-b8b9-a8a402377e54" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_cebfb96f-db2d-470a-a063-3fd240621799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_2ef14ec0-1328-46c5-a9b4-efc31cbb6f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_cebfb96f-db2d-470a-a063-3fd240621799" xlink:to="loc_us-gaap_DebtSecuritiesMember_2ef14ec0-1328-46c5-a9b4-efc31cbb6f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_f06f2063-804e-4cc2-ab68-c4f121996b9d" xlink:href="cvs-20210930.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_cebfb96f-db2d-470a-a063-3fd240621799" xlink:to="loc_cvs_MortgageLoansMember_f06f2063-804e-4cc2-ab68-c4f121996b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_4a8e0c13-171d-48c3-8db2-a331f5d856b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_cebfb96f-db2d-470a-a063-3fd240621799" xlink:to="loc_us-gaap_OtherInvestmentsMember_4a8e0c13-171d-48c3-8db2-a331f5d856b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_706ce3ea-c35c-45e5-9d3d-945b1ffdc7cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_512f728b-33ce-4506-8c21-b0850b2d7c28" xlink:to="loc_srt_ProductOrServiceAxis_706ce3ea-c35c-45e5-9d3d-945b1ffdc7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8514258a-3447-44c7-a733-c27413c09ae0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_706ce3ea-c35c-45e5-9d3d-945b1ffdc7cb" xlink:to="loc_srt_ProductsAndServicesDomain_8514258a-3447-44c7-a733-c27413c09ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_d37faef5-cbf1-460f-9634-8471d7590cf4" xlink:href="cvs-20210930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8514258a-3447-44c7-a733-c27413c09ae0" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_d37faef5-cbf1-460f-9634-8471d7590cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_512f728b-33ce-4506-8c21-b0850b2d7c28" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_542e55ee-3c13-4dbe-9463-2248a01cc347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_542e55ee-3c13-4dbe-9463-2248a01cc347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_b1fcd77d-40df-4e72-b575-cb69024e82c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_b1fcd77d-40df-4e72-b575-cb69024e82c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_b4763d41-573e-4f0b-959e-5b38fd666593" xlink:href="cvs-20210930.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_b4763d41-573e-4f0b-959e-5b38fd666593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_8334970d-4485-4134-a22d-3935cee29ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_8334970d-4485-4134-a22d-3935cee29ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_f71af3c1-9fff-4606-8036-487d59513b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_us-gaap_InvestmentIncomeNet_f71af3c1-9fff-4606-8036-487d59513b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_df4768c2-b851-4062-9960-7cd12a1db1c3" xlink:href="cvs-20210930.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_df4768c2-b851-4062-9960-7cd12a1db1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_65ce98df-06dc-4eeb-884c-e2b651e9e069" xlink:href="cvs-20210930.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e098f7b9-141a-4eb9-a07d-a47446ed6008" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_65ce98df-06dc-4eeb-884c-e2b651e9e069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#InvestmentsRealizedGainsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_2407be02-f828-4795-a2cd-9059a69b67a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_b5849c43-074c-4877-a0e0-292f93ef04bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_2407be02-f828-4795-a2cd-9059a69b67a3" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_b5849c43-074c-4877-a0e0-292f93ef04bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_34cbe115-fbd2-4c94-a7a3-c49f63e2b8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_2407be02-f828-4795-a2cd-9059a69b67a3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_34cbe115-fbd2-4c94-a7a3-c49f63e2b8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_2d6f5bdf-f18f-44dc-a3be-2de22ea16b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_2407be02-f828-4795-a2cd-9059a69b67a3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_2d6f5bdf-f18f-44dc-a3be-2de22ea16b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValue" xlink:type="simple" xlink:href="cvs-20210930.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7f9f2ff2-3479-497a-ab72-d79ea2079b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_a00dd71d-f30b-430c-94d7-cbe60ff02869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7f9f2ff2-3479-497a-ab72-d79ea2079b7d" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_a00dd71d-f30b-430c-94d7-cbe60ff02869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueTables" xlink:type="simple" xlink:href="cvs-20210930.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e4d61ed5-7a2f-4796-8863-405b3c4639f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e41b9942-2cda-463e-9865-cb3c01e3adc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e4d61ed5-7a2f-4796-8863-405b3c4639f2" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e41b9942-2cda-463e-9865-cb3c01e3adc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_363530b3-78e2-4ed6-a746-4ec29cf28a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e4d61ed5-7a2f-4796-8863-405b3c4639f2" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_363530b3-78e2-4ed6-a746-4ec29cf28a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_323ca4b5-bb17-482a-8dd2-6fd46612ff7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e4d61ed5-7a2f-4796-8863-405b3c4639f2" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_323ca4b5-bb17-482a-8dd2-6fd46612ff7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_87d9ae21-a853-4065-a261-95849c58792b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4265076d-51fd-4480-9823-7fc12c53b626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_87d9ae21-a853-4065-a261-95849c58792b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4265076d-51fd-4480-9823-7fc12c53b626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e1926fd-a4f2-4dc7-baba-cae3ce98d1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4265076d-51fd-4480-9823-7fc12c53b626" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e1926fd-a4f2-4dc7-baba-cae3ce98d1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b036bf9c-2bec-4202-9d34-b987da96b22b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6e1926fd-a4f2-4dc7-baba-cae3ce98d1d4" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b036bf9c-2bec-4202-9d34-b987da96b22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_95f31cdb-f06b-4323-bdf1-aecf301a8a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b036bf9c-2bec-4202-9d34-b987da96b22b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_95f31cdb-f06b-4323-bdf1-aecf301a8a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b265b504-dd13-4331-9709-fee86b5337b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4265076d-51fd-4480-9823-7fc12c53b626" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b265b504-dd13-4331-9709-fee86b5337b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b265b504-dd13-4331-9709-fee86b5337b9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_48f1e100-b8e2-4cf4-b7d9-4d6716e80e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_48f1e100-b8e2-4cf4-b7d9-4d6716e80e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_459914ec-5536-4564-8015-5816a8a3b2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_459914ec-5536-4564-8015-5816a8a3b2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_0d2268cb-e9ca-4bef-93e4-5bfb9fbecd2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_0d2268cb-e9ca-4bef-93e4-5bfb9fbecd2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_ac319efc-26dd-4b8f-939d-54564f818a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_ac319efc-26dd-4b8f-939d-54564f818a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_cf8c25d6-72b0-448c-af48-c879ebfb6775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_cf8c25d6-72b0-448c-af48-c879ebfb6775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_7264bbdb-dd38-46c1-a1e3-fc441b8c842b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_7264bbdb-dd38-46c1-a1e3-fc441b8c842b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_47f71d2c-93e8-4509-b29d-7f7994c6e955" xlink:href="cvs-20210930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_47f71d2c-93e8-4509-b29d-7f7994c6e955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_eb1c66a5-3d7b-48d1-9781-ad02a340fa09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e20a685-2b9e-48df-9b58-42a1e13ece0e" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_eb1c66a5-3d7b-48d1-9781-ad02a340fa09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9ff9b61-f531-408c-a628-e6354be7becd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4265076d-51fd-4480-9823-7fc12c53b626" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9ff9b61-f531-408c-a628-e6354be7becd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94191bfb-d687-4673-857a-5a1ef150dfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b9ff9b61-f531-408c-a628-e6354be7becd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94191bfb-d687-4673-857a-5a1ef150dfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_119436be-ef79-4eb5-8299-e6623ce73e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94191bfb-d687-4673-857a-5a1ef150dfd5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_119436be-ef79-4eb5-8299-e6623ce73e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_15040309-4072-49d8-8475-7b1444f70de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94191bfb-d687-4673-857a-5a1ef150dfd5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_15040309-4072-49d8-8475-7b1444f70de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_308091a5-8bd1-498b-9c93-ab581c365cae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94191bfb-d687-4673-857a-5a1ef150dfd5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_308091a5-8bd1-498b-9c93-ab581c365cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4265076d-51fd-4480-9823-7fc12c53b626" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_3fed392f-9d92-41ef-8b55-32cd1375413d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_3fed392f-9d92-41ef-8b55-32cd1375413d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_930fe4c3-1ea7-40e6-a557-f98fdc6b921d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_930fe4c3-1ea7-40e6-a557-f98fdc6b921d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7ae79207-daf4-47a2-80ba-0ae617251cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7ae79207-daf4-47a2-80ba-0ae617251cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_cd6d2844-8310-40a6-83b2-bda6e96a1d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_cd6d2844-8310-40a6-83b2-bda6e96a1d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9e9fc698-d527-4617-a3a3-dccc21a475d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b946ab8e-ac19-4e5b-9e64-676e62e46644" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_9e9fc698-d527-4617-a3a3-dccc21a475d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5c8e42b1-1d1e-4f7f-844e-44f34c350cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_aa88d89e-ca59-41e1-8bf6-11701155620f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5c8e42b1-1d1e-4f7f-844e-44f34c350cfb" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_aa88d89e-ca59-41e1-8bf6-11701155620f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28da8fec-ede4-4825-97ec-8305b0023101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_aa88d89e-ca59-41e1-8bf6-11701155620f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28da8fec-ede4-4825-97ec-8305b0023101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_cac37923-e792-4143-bd7d-ee36b213dbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28da8fec-ede4-4825-97ec-8305b0023101" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_cac37923-e792-4143-bd7d-ee36b213dbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_edc3dddb-1f87-4652-b685-bb1d539fa198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_cac37923-e792-4143-bd7d-ee36b213dbb7" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_edc3dddb-1f87-4652-b685-bb1d539fa198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a4cceaf-84ae-445b-960a-502b1a7256f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_aa88d89e-ca59-41e1-8bf6-11701155620f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a4cceaf-84ae-445b-960a-502b1a7256f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be10da61-2d18-417b-95f3-dc070e6ac9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a4cceaf-84ae-445b-960a-502b1a7256f1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be10da61-2d18-417b-95f3-dc070e6ac9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_af299dd3-346d-488f-843b-920ff311b6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be10da61-2d18-417b-95f3-dc070e6ac9fe" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_af299dd3-346d-488f-843b-920ff311b6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0139d0c3-25ef-4a93-8d40-9c0f705fe4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be10da61-2d18-417b-95f3-dc070e6ac9fe" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0139d0c3-25ef-4a93-8d40-9c0f705fe4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_99fea7fd-925d-4b68-9dd6-7f58790950fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be10da61-2d18-417b-95f3-dc070e6ac9fe" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_99fea7fd-925d-4b68-9dd6-7f58790950fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_7cb389d7-cdf5-4e9e-916a-81c740fa4d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be10da61-2d18-417b-95f3-dc070e6ac9fe" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_7cb389d7-cdf5-4e9e-916a-81c740fa4d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_9190776d-b3f8-4c24-8082-569f1afafbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_aa88d89e-ca59-41e1-8bf6-11701155620f" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_9190776d-b3f8-4c24-8082-569f1afafbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0bcc25bb-ec9d-45ec-88fc-eeed074ff9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_9190776d-b3f8-4c24-8082-569f1afafbd3" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0bcc25bb-ec9d-45ec-88fc-eeed074ff9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_c5e16c35-c42e-43bc-826e-640828bd95fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0bcc25bb-ec9d-45ec-88fc-eeed074ff9cb" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_c5e16c35-c42e-43bc-826e-640828bd95fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d26d0bb9-8015-4ec3-8b83-e38114e28398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_c5e16c35-c42e-43bc-826e-640828bd95fc" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d26d0bb9-8015-4ec3-8b83-e38114e28398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8afba158-f675-4d7c-a71a-603638c3d24c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_c5e16c35-c42e-43bc-826e-640828bd95fc" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8afba158-f675-4d7c-a71a-603638c3d24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6d1d5752-1493-4974-ad8c-53a34d776a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_aa88d89e-ca59-41e1-8bf6-11701155620f" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6d1d5752-1493-4974-ad8c-53a34d776a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_aa0b0b3e-e53e-48d4-b05b-df8e33095d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6d1d5752-1493-4974-ad8c-53a34d776a7c" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_aa0b0b3e-e53e-48d4-b05b-df8e33095d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_a21c8e94-2cc6-4c7d-ae3b-922a6ecfbc93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_aa0b0b3e-e53e-48d4-b05b-df8e33095d3a" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_a21c8e94-2cc6-4c7d-ae3b-922a6ecfbc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_98f045d6-d78b-4820-ad84-9b280e4373e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_aa0b0b3e-e53e-48d4-b05b-df8e33095d3a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_98f045d6-d78b-4820-ad84-9b280e4373e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_bce5a6b5-3b18-4e4b-9e56-515325be6e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6d1d5752-1493-4974-ad8c-53a34d776a7c" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_bce5a6b5-3b18-4e4b-9e56-515325be6e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_7e6ce08a-3266-432d-9cff-48ee5b8b2a4b" xlink:href="cvs-20210930.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_bce5a6b5-3b18-4e4b-9e56-515325be6e24" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_7e6ce08a-3266-432d-9cff-48ee5b8b2a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_98c59df1-62d1-4c69-9a99-0a86a8515048" xlink:href="cvs-20210930.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_bce5a6b5-3b18-4e4b-9e56-515325be6e24" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_98c59df1-62d1-4c69-9a99-0a86a8515048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_1f04c108-99e3-4fea-86d1-ed5641bd9518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_bce5a6b5-3b18-4e4b-9e56-515325be6e24" xlink:to="loc_us-gaap_DebtInstrumentFairValue_1f04c108-99e3-4fea-86d1-ed5641bd9518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_22abab62-53e0-456f-b91c-07211cbfc4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b2cfa37e-a807-498d-9d47-2d5581c11601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_22abab62-53e0-456f-b91c-07211cbfc4d1" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b2cfa37e-a807-498d-9d47-2d5581c11601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_13a6fc89-4b67-4f67-8d0a-370f2f702902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b2cfa37e-a807-498d-9d47-2d5581c11601" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_13a6fc89-4b67-4f67-8d0a-370f2f702902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2b18c16b-027c-47a9-9aeb-821360be4a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_13a6fc89-4b67-4f67-8d0a-370f2f702902" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2b18c16b-027c-47a9-9aeb-821360be4a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_bd91f22a-bb55-446c-8224-f18a671c78de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_2b18c16b-027c-47a9-9aeb-821360be4a4f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_bd91f22a-bb55-446c-8224-f18a671c78de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f28e096-24b0-4098-adb3-519e5909040f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b2cfa37e-a807-498d-9d47-2d5581c11601" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f28e096-24b0-4098-adb3-519e5909040f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d4a4408e-e4ec-43c2-a00b-e696347c666b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f28e096-24b0-4098-adb3-519e5909040f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d4a4408e-e4ec-43c2-a00b-e696347c666b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4daf98af-ee26-4812-8edc-883e3666e60d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d4a4408e-e4ec-43c2-a00b-e696347c666b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4daf98af-ee26-4812-8edc-883e3666e60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_525d828e-a95a-41f7-bf1f-6580ba902997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d4a4408e-e4ec-43c2-a00b-e696347c666b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_525d828e-a95a-41f7-bf1f-6580ba902997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_cf82be65-e13a-4218-82d4-ea877f7c4600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d4a4408e-e4ec-43c2-a00b-e696347c666b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_cf82be65-e13a-4218-82d4-ea877f7c4600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4745bf77-8115-4d84-bc6a-26a5b0395396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b2cfa37e-a807-498d-9d47-2d5581c11601" xlink:to="loc_us-gaap_InvestmentTypeAxis_4745bf77-8115-4d84-bc6a-26a5b0395396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_e56c73a3-21ad-4102-8938-c51b8c852b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_4745bf77-8115-4d84-bc6a-26a5b0395396" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_e56c73a3-21ad-4102-8938-c51b8c852b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_e440b231-3637-4d51-b5ee-87720930e79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e56c73a3-21ad-4102-8938-c51b8c852b3e" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_e440b231-3637-4d51-b5ee-87720930e79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_337a89f3-4346-4ff2-a085-cac63765971d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e56c73a3-21ad-4102-8938-c51b8c852b3e" xlink:to="loc_us-gaap_DebtSecuritiesMember_337a89f3-4346-4ff2-a085-cac63765971d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_3acb2d4a-7719-4909-a13c-214e7e60ef47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e56c73a3-21ad-4102-8938-c51b8c852b3e" xlink:to="loc_us-gaap_EquitySecuritiesMember_3acb2d4a-7719-4909-a13c-214e7e60ef47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_7e2942af-2030-40d9-b142-0370a97f306f" xlink:href="cvs-20210930.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e56c73a3-21ad-4102-8938-c51b8c852b3e" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_7e2942af-2030-40d9-b142-0370a97f306f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_daef5618-57a7-4f06-9886-aec9c127d798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b2cfa37e-a807-498d-9d47-2d5581c11601" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_daef5618-57a7-4f06-9886-aec9c127d798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e39e81a3-01f4-4dc3-9cbb-d69fc974aef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_daef5618-57a7-4f06-9886-aec9c127d798" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e39e81a3-01f4-4dc3-9cbb-d69fc974aef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_19fde89d-3937-4a93-8f19-c24376dbd138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e39e81a3-01f4-4dc3-9cbb-d69fc974aef7" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_19fde89d-3937-4a93-8f19-c24376dbd138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember_9fa8596d-b8b3-4e50-9467-5e79807125ad" xlink:href="cvs-20210930.xsd#cvs_OtherReceivablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e39e81a3-01f4-4dc3-9cbb-d69fc974aef7" xlink:to="loc_cvs_OtherReceivablesMember_9fa8596d-b8b3-4e50-9467-5e79807125ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9619ac2d-fecc-40b3-9697-90e5a68d4903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b2cfa37e-a807-498d-9d47-2d5581c11601" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9619ac2d-fecc-40b3-9697-90e5a68d4903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_e298fe30-196e-41be-8733-84919e2dfbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9619ac2d-fecc-40b3-9697-90e5a68d4903" xlink:to="loc_us-gaap_SeparateAccountAssets_e298fe30-196e-41be-8733-84919e2dfbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Goodwill" xlink:type="simple" xlink:href="cvs-20210930.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f5f561a-415c-4f55-a5a7-de2d42089c08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_58f5b66e-539a-4a08-bf38-6cd1debf11e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f5f561a-415c-4f55-a5a7-de2d42089c08" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_58f5b66e-539a-4a08-bf38-6cd1debf11e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables" xlink:type="simple" xlink:href="cvs-20210930.xsd#GoodwillandOtherIntangiblesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9aedd53-00e0-4030-adf1-0ef5cf92e07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_465f9b2b-636c-451e-b279-fb63c2f551d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9aedd53-00e0-4030-adf1-0ef5cf92e07d" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_465f9b2b-636c-451e-b279-fb63c2f551d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#GoodwillandOtherIntangiblesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_07072342-1257-4582-a36c-4c0688e16bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_aa645d7c-f270-4be1-b40e-42e6354a61bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_07072342-1257-4582-a36c-4c0688e16bd7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_aa645d7c-f270-4be1-b40e-42e6354a61bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d185710a-2df1-4118-8d57-0bfb5ecfb2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_aa645d7c-f270-4be1-b40e-42e6354a61bd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d185710a-2df1-4118-8d57-0bfb5ecfb2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b8817ae8-4d34-46fb-9bb8-9c8db6897d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d185710a-2df1-4118-8d57-0bfb5ecfb2c3" xlink:to="loc_us-gaap_SegmentDomain_b8817ae8-4d34-46fb-9bb8-9c8db6897d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_1b140bc1-235c-4220-aa11-7771b14ed1aa" xlink:href="cvs-20210930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b8817ae8-4d34-46fb-9bb8-9c8db6897d9d" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_1b140bc1-235c-4220-aa11-7771b14ed1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_81c45124-0132-4090-a02d-328bee44a86e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_aa645d7c-f270-4be1-b40e-42e6354a61bd" xlink:to="loc_us-gaap_ReportingUnitAxis_81c45124-0132-4090-a02d-328bee44a86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_e0e8e0e2-6d17-4986-8645-0f4eddb5e491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_81c45124-0132-4090-a02d-328bee44a86e" xlink:to="loc_us-gaap_ReportingUnitDomain_e0e8e0e2-6d17-4986-8645-0f4eddb5e491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember_dda32a6a-21a4-4a3c-a898-cee418b73672" xlink:href="cvs-20210930.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_e0e8e0e2-6d17-4986-8645-0f4eddb5e491" xlink:to="loc_cvs_LongTermCareReportingUnitMember_dda32a6a-21a4-4a3c-a898-cee418b73672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_3120d28c-4df8-43fc-9781-be3991bdc1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_aa645d7c-f270-4be1-b40e-42e6354a61bd" xlink:to="loc_us-gaap_GoodwillLineItems_3120d28c-4df8-43fc-9781-be3991bdc1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_06e5ccda-d718-400d-b7e0-4ae896e5ac04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3120d28c-4df8-43fc-9781-be3991bdc1d0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_06e5ccda-d718-400d-b7e0-4ae896e5ac04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_aa8bbb09-a70d-42e0-88d1-f85c31bd9ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3120d28c-4df8-43fc-9781-be3991bdc1d0" xlink:to="loc_us-gaap_Goodwill_aa8bbb09-a70d-42e0-88d1-f85c31bd9ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c265f91a-d846-4b63-b900-5bfaf9561725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3120d28c-4df8-43fc-9781-be3991bdc1d0" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c265f91a-d846-4b63-b900-5bfaf9561725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#GoodwillandOtherIntangiblesGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6e8b497f-d1e0-4a25-bba4-6fdb2ae11e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_68a6e43a-900c-4db8-809c-5ccdcdefd9df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6e8b497f-d1e0-4a25-bba4-6fdb2ae11e40" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_68a6e43a-900c-4db8-809c-5ccdcdefd9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_43259a69-78f4-4e83-bfb0-6200fcdb7205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_68a6e43a-900c-4db8-809c-5ccdcdefd9df" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_43259a69-78f4-4e83-bfb0-6200fcdb7205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_202fc427-321e-4424-86fb-ac441c6dde5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_43259a69-78f4-4e83-bfb0-6200fcdb7205" xlink:to="loc_us-gaap_SegmentDomain_202fc427-321e-4424-86fb-ac441c6dde5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_d8dc3748-b859-4fe0-8232-f22413617964" xlink:href="cvs-20210930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_202fc427-321e-4424-86fb-ac441c6dde5c" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_d8dc3748-b859-4fe0-8232-f22413617964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_728bfec9-d943-4dec-829b-875fc59374a1" xlink:href="cvs-20210930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_202fc427-321e-4424-86fb-ac441c6dde5c" xlink:to="loc_cvs_PharmacyServicesSegmentMember_728bfec9-d943-4dec-829b-875fc59374a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_5ed4d873-74a5-44e0-b7a4-b77ef3176bf3" xlink:href="cvs-20210930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_202fc427-321e-4424-86fb-ac441c6dde5c" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_5ed4d873-74a5-44e0-b7a4-b77ef3176bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_c501b50d-a202-48f2-a796-fc5f97deb858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_68a6e43a-900c-4db8-809c-5ccdcdefd9df" xlink:to="loc_us-gaap_GoodwillLineItems_c501b50d-a202-48f2-a796-fc5f97deb858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_06b92025-d907-4938-909e-56e3de49ac46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_c501b50d-a202-48f2-a796-fc5f97deb858" xlink:to="loc_us-gaap_GoodwillRollForward_06b92025-d907-4938-909e-56e3de49ac46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_74ec628a-ed7e-4249-b3f2-1a423f5d3665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_06b92025-d907-4938-909e-56e3de49ac46" xlink:to="loc_us-gaap_Goodwill_74ec628a-ed7e-4249-b3f2-1a423f5d3665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_7baadc2a-feae-4666-b4db-c5fcf5056c67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_06b92025-d907-4938-909e-56e3de49ac46" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_7baadc2a-feae-4666-b4db-c5fcf5056c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ac70495e-45c9-4d6b-b789-67a703884677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_06b92025-d907-4938-909e-56e3de49ac46" xlink:to="loc_us-gaap_Goodwill_ac70495e-45c9-4d6b-b789-67a703884677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="simple" xlink:href="cvs-20210930.xsd#HealthCareCostsPayable"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_8e2c3236-2455-4aff-a1de-4f9b96aafdc9" xlink:href="cvs-20210930.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_01862a33-1aa4-4791-834c-6dcd87dff117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_8e2c3236-2455-4aff-a1de-4f9b96aafdc9" xlink:to="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_01862a33-1aa4-4791-834c-6dcd87dff117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="simple" xlink:href="cvs-20210930.xsd#HealthCareCostsPayableTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_be545b59-b7e4-4155-aebb-9b77fa3c512d" xlink:href="cvs-20210930.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_e1878ee4-102d-4d79-84b2-a48298e3bc39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_be545b59-b7e4-4155-aebb-9b77fa3c512d" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_e1878ee4-102d-4d79-84b2-a48298e3bc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_490dc4c4-e6d4-44f3-8c99-3efeeee09a49" xlink:href="cvs-20210930.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_1591e7ad-ed60-499c-90fd-c659d87dc186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_490dc4c4-e6d4-44f3-8c99-3efeeee09a49" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_1591e7ad-ed60-499c-90fd-c659d87dc186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e3ac4dd0-38a3-42ad-801f-909239fcc4da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_1591e7ad-ed60-499c-90fd-c659d87dc186" xlink:to="loc_srt_ProductOrServiceAxis_e3ac4dd0-38a3-42ad-801f-909239fcc4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_96eb5b23-5b69-4910-b5eb-3479bbec7b98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e3ac4dd0-38a3-42ad-801f-909239fcc4da" xlink:to="loc_srt_ProductsAndServicesDomain_96eb5b23-5b69-4910-b5eb-3479bbec7b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_7a0399a3-3f26-49d9-acc1-6d3719769f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_96eb5b23-5b69-4910-b5eb-3479bbec7b98" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_7a0399a3-3f26-49d9-acc1-6d3719769f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1b800ed0-a7bd-46e2-be32-98e9a5c24237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_1591e7ad-ed60-499c-90fd-c659d87dc186" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1b800ed0-a7bd-46e2-be32-98e9a5c24237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_16bf73c5-6101-431e-9a8c-54bbd5dbd7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1b800ed0-a7bd-46e2-be32-98e9a5c24237" xlink:to="loc_us-gaap_SegmentDomain_16bf73c5-6101-431e-9a8c-54bbd5dbd7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_4624d7c0-6dbf-4a07-a7dd-313701f6cfbc" xlink:href="cvs-20210930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_16bf73c5-6101-431e-9a8c-54bbd5dbd7a2" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_4624d7c0-6dbf-4a07-a7dd-313701f6cfbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember_47b83ca5-faeb-419f-95ba-5d9d254a06d1" xlink:href="cvs-20210930.xsd#cvs_CorporateOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_16bf73c5-6101-431e-9a8c-54bbd5dbd7a2" xlink:to="loc_cvs_CorporateOtherMember_47b83ca5-faeb-419f-95ba-5d9d254a06d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_80d2bae3-fdb2-4593-bd83-46484ae129a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_1591e7ad-ed60-499c-90fd-c659d87dc186" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_80d2bae3-fdb2-4593-bd83-46484ae129a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_80d2bae3-fdb2-4593-bd83-46484ae129a8" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f864f023-02dd-49bd-b055-6cdc7a13e863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f864f023-02dd-49bd-b055-6cdc7a13e863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_020d8fd2-7a2f-4c9d-ab5f-1fcf733303ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_020d8fd2-7a2f-4c9d-ab5f-1fcf733303ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_3e95a070-f246-45e6-a130-cd3c7ac98198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_3e95a070-f246-45e6-a130-cd3c7ac98198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_82b51d25-4e0a-410f-9d07-9c9f30e66d06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_82b51d25-4e0a-410f-9d07-9c9f30e66d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_50e85b29-2013-4340-b62b-0e9eb31f7f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_50e85b29-2013-4340-b62b-0e9eb31f7f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_1ddadfdc-d0a3-482a-ad92-aecde567c19c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_50e85b29-2013-4340-b62b-0e9eb31f7f0b" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_1ddadfdc-d0a3-482a-ad92-aecde567c19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_1d88dc13-49af-4396-a212-48ea6e77e747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_50e85b29-2013-4340-b62b-0e9eb31f7f0b" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_1d88dc13-49af-4396-a212-48ea6e77e747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_72011a44-4d53-44b6-a27d-1a13066f3af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_50e85b29-2013-4340-b62b-0e9eb31f7f0b" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_72011a44-4d53-44b6-a27d-1a13066f3af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d7d47fb-5ca0-4258-a97f-34834419fc95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d7d47fb-5ca0-4258-a97f-34834419fc95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_4a6a5caf-a203-411f-ba0f-7d7f7c9fc621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d7d47fb-5ca0-4258-a97f-34834419fc95" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_4a6a5caf-a203-411f-ba0f-7d7f7c9fc621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_1a58332c-585a-46ac-b46f-1a14fa674863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d7d47fb-5ca0-4258-a97f-34834419fc95" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_1a58332c-585a-46ac-b46f-1a14fa674863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_8f27536a-8891-4edf-8835-ad1507229771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d7d47fb-5ca0-4258-a97f-34834419fc95" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_8f27536a-8891-4edf-8835-ad1507229771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_5e6aebf0-62d8-4091-b9f7-b5ed1873d6e1" xlink:href="cvs-20210930.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_5e6aebf0-62d8-4091-b9f7-b5ed1873d6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_ea16312d-52a2-441b-a939-fcfa2b93d2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_ea16312d-52a2-441b-a939-fcfa2b93d2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_352908d7-6e75-4894-83e4-fc9f67aee873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_352908d7-6e75-4894-83e4-fc9f67aee873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_10a1c21d-092e-4914-ac09-38cb94ad1468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f622fb38-ac57-402b-91fc-fd8bbaab6b9d" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_10a1c21d-092e-4914-ac09-38cb94ad1468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_5d2fe156-7c44-412b-bf30-624e6efd0719" xlink:href="cvs-20210930.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_80d2bae3-fdb2-4593-bd83-46484ae129a8" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_5d2fe156-7c44-412b-bf30-624e6efd0719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_abf52695-0658-4e60-ae47-5d8e5e147ab5" xlink:href="cvs-20210930.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_80d2bae3-fdb2-4593-bd83-46484ae129a8" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_abf52695-0658-4e60-ae47-5d8e5e147ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_37758403-90f9-4a6b-8657-620305998bf0" xlink:href="cvs-20210930.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_0569576d-7e8a-48f2-bd17-8d587fb9b107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_37758403-90f9-4a6b-8657-620305998bf0" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_0569576d-7e8a-48f2-bd17-8d587fb9b107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_78546df9-077e-40cd-a105-08bd90852262" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_0569576d-7e8a-48f2-bd17-8d587fb9b107" xlink:to="loc_srt_ProductOrServiceAxis_78546df9-077e-40cd-a105-08bd90852262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47bdca7a-2768-4004-84bb-4e99a72a283b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_78546df9-077e-40cd-a105-08bd90852262" xlink:to="loc_srt_ProductsAndServicesDomain_47bdca7a-2768-4004-84bb-4e99a72a283b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_497742b1-df37-4921-94be-7b4b92b4f7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47bdca7a-2768-4004-84bb-4e99a72a283b" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_497742b1-df37-4921-94be-7b4b92b4f7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_addc72b5-7b4d-4f89-8225-d5001b567003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_0569576d-7e8a-48f2-bd17-8d587fb9b107" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_addc72b5-7b4d-4f89-8225-d5001b567003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_8af23ddc-327a-4caf-8ef3-a14e56ec319d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_addc72b5-7b4d-4f89-8225-d5001b567003" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_8af23ddc-327a-4caf-8ef3-a14e56ec319d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_5bce3286-89c1-4b75-9f16-e85a13bb353b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_addc72b5-7b4d-4f89-8225-d5001b567003" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_5bce3286-89c1-4b75-9f16-e85a13bb353b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Borrowings" xlink:type="simple" xlink:href="cvs-20210930.xsd#Borrowings"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Borrowings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3a3a8550-c0bd-4c02-a84b-23edeae1407f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_64c81572-7307-4b11-a90a-ac1376ba8c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3a3a8550-c0bd-4c02-a84b-23edeae1407f" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_64c81572-7307-4b11-a90a-ac1376ba8c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsTables" xlink:type="simple" xlink:href="cvs-20210930.xsd#BorrowingsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6ba19fc5-50d1-4122-8512-5d9e88d15000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0c1f4575-82c6-4333-a88d-ef8c9e34a0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6ba19fc5-50d1-4122-8512-5d9e88d15000" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0c1f4575-82c6-4333-a88d-ef8c9e34a0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#BorrowingsScheduleofBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1a07e8f7-43de-4d2a-8ed7-9e7af943f3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_875ad796-089c-472d-aaeb-bbf925ad5c53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1a07e8f7-43de-4d2a-8ed7-9e7af943f3f9" xlink:to="loc_us-gaap_DebtInstrumentTable_875ad796-089c-472d-aaeb-bbf925ad5c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a54eb335-e167-4acd-98f4-f1eb39827ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_875ad796-089c-472d-aaeb-bbf925ad5c53" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a54eb335-e167-4acd-98f4-f1eb39827ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_22bd9002-f4e1-4334-b7e1-9166fafefb08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a54eb335-e167-4acd-98f4-f1eb39827ce0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_22bd9002-f4e1-4334-b7e1-9166fafefb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_739b3f8b-f7d5-46c3-84f2-144955b528a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_22bd9002-f4e1-4334-b7e1-9166fafefb08" xlink:to="loc_us-gaap_SeniorNotesMember_739b3f8b-f7d5-46c3-84f2-144955b528a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_d227283b-dc73-4e7b-a36c-52138784be29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_22bd9002-f4e1-4334-b7e1-9166fafefb08" xlink:to="loc_us-gaap_NotesPayableToBanksMember_d227283b-dc73-4e7b-a36c-52138784be29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_b0d7c6a5-10d1-4352-b97f-d63976722eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_22bd9002-f4e1-4334-b7e1-9166fafefb08" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_b0d7c6a5-10d1-4352-b97f-d63976722eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_aadaa5c2-ed75-485f-bddd-e1afcf920d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_875ad796-089c-472d-aaeb-bbf925ad5c53" xlink:to="loc_us-gaap_DebtInstrumentAxis_aadaa5c2-ed75-485f-bddd-e1afcf920d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_aadaa5c2-ed75-485f-bddd-e1afcf920d74" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_de3c8631-0a5a-4910-a672-fc14510a22f2" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_de3c8631-0a5a-4910-a672-fc14510a22f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2021Member_076768b2-efd0-4299-88fe-bddf84c884d7" xlink:href="cvs-20210930.xsd#cvs_FloatingRateNotesDueMarch2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_FloatingRateNotesDueMarch2021Member_076768b2-efd0-4299-88fe-bddf84c884d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_456d09cb-0d4c-4b68-a794-97332bd6d094" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_456d09cb-0d4c-4b68-a794-97332bd6d094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.125June2021Member_5540aa68-f987-4e98-85f1-fba84c57c875" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.125June2021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2.125June2021Member_5540aa68-f987-4e98-85f1-fba84c57c875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_874856ba-2051-442b-904d-e9d6d418adeb" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_874856ba-2051-442b-904d-e9d6d418adeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_61187780-ea9f-41c9-b6ce-9b3bad09d83c" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_61187780-ea9f-41c9-b6ce-9b3bad09d83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_2fbe6d10-d2cb-43b7-a4d6-2c52ca4ab01d" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_2fbe6d10-d2cb-43b7-a4d6-2c52ca4ab01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_2f5ff10a-a5cf-4106-b345-bf919fb8ff71" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_2f5ff10a-a5cf-4106-b345-bf919fb8ff71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_ed657bf1-cc6a-46fa-bd44-77115b1eab02" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_ed657bf1-cc6a-46fa-bd44-77115b1eab02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_195f4c59-bb61-4c9e-b395-cd4064ed3caa" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_195f4c59-bb61-4c9e-b395-cd4064ed3caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_917a13de-5e57-4635-b988-22aa166a7adc" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_917a13de-5e57-4635-b988-22aa166a7adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_05f4798e-d382-46ea-ae2c-c3f4450e3729" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_05f4798e-d382-46ea-ae2c-c3f4450e3729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_d91fdf24-0a37-4875-9fdd-0a5578cc2cb6" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_d91fdf24-0a37-4875-9fdd-0a5578cc2cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_98480b58-641b-49f3-940f-a49d072a686b" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_98480b58-641b-49f3-940f-a49d072a686b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_aa10d701-4a44-49a8-9240-b6f3e3a86914" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_aa10d701-4a44-49a8-9240-b6f3e3a86914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_95ea71dd-c88e-4f12-93ca-391b58114397" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_95ea71dd-c88e-4f12-93ca-391b58114397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_f68bb33e-d104-40d1-8d6c-5f3130f5a0e7" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_f68bb33e-d104-40d1-8d6c-5f3130f5a0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_09a4d6d7-8d4c-4479-82cb-dffaa0341c7e" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_09a4d6d7-8d4c-4479-82cb-dffaa0341c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_6ae4822d-c036-4e5c-a3c0-0ff3835affb5" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_6ae4822d-c036-4e5c-a3c0-0ff3835affb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_eb1d7631-06b0-4bb5-be79-abfd444cadb1" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_eb1d7631-06b0-4bb5-be79-abfd444cadb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_9e3bbb01-956d-41e9-9d6e-92907edc9716" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_9e3bbb01-956d-41e9-9d6e-92907edc9716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member_e13644cf-239f-49ae-a1f3-318e15f20c1b" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.625DueApril2027Member_e13644cf-239f-49ae-a1f3-318e15f20c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_17731dcf-be42-4646-8f4a-3e2edfc417e9" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_17731dcf-be42-4646-8f4a-3e2edfc417e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_27f5da16-358b-48c8-b95e-f7c6fa022839" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_27f5da16-358b-48c8-b95e-f7c6fa022839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_99d58372-db4b-4cd1-9742-d49f983f56c4" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_99d58372-db4b-4cd1-9742-d49f983f56c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_02664356-3153-4906-a5f8-8314e0c680e9" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_02664356-3153-4906-a5f8-8314e0c680e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member_8b9660ad-9574-4ecf-934b-db1fd34113e4" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.75DueApril2030Member_8b9660ad-9574-4ecf-934b-db1fd34113e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_c5d6038c-e426-4870-a108-16f68e1c2db5" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_c5d6038c-e426-4870-a108-16f68e1c2db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member_e6f3b4cc-c1ce-42d8-b867-d2b66e58820e" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes1875DueFebruary2031Member_e6f3b4cc-c1ce-42d8-b867-d2b66e58820e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2125PercentDueAugust2031Member_f5336bd4-190e-4d59-a18b-fb09e9cf850d" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2125PercentDueAugust2031Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes2125PercentDueAugust2031Member_f5336bd4-190e-4d59-a18b-fb09e9cf850d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_743e2337-9881-43ee-9484-5060fa012b55" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_743e2337-9881-43ee-9484-5060fa012b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_f05b3b22-e216-4cb4-904a-b69850db2cf9" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_f05b3b22-e216-4cb4-904a-b69850db2cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_abddb498-d798-47b9-9405-91fbf1f41892" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_abddb498-d798-47b9-9405-91fbf1f41892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_4dc58610-8496-4844-88bc-25b39f358b68" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_4dc58610-8496-4844-88bc-25b39f358b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_bc0debda-7189-4b6e-9f18-828af284c96a" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_bc0debda-7189-4b6e-9f18-828af284c96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member_75956750-4422-426e-9809-d6491be5ccf4" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.125DueApril2040Member_75956750-4422-426e-9809-d6491be5ccf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_9b83656e-f82d-4309-9d18-d9493fb2872d" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_9b83656e-f82d-4309-9d18-d9493fb2872d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_26eca057-e383-4988-ad81-0e8d864aed70" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_26eca057-e383-4988-ad81-0e8d864aed70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_7ef52499-b3cb-4006-993e-93fb98c085ae" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_7ef52499-b3cb-4006-993e-93fb98c085ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_527bbd55-8120-4edd-be56-e07c3bf31057" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_527bbd55-8120-4edd-be56-e07c3bf31057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_54be20f5-2c0b-4dd8-899f-555c6dbed006" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_54be20f5-2c0b-4dd8-899f-555c6dbed006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_179f8ecf-42ee-4445-a9e2-14f7146d345a" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_179f8ecf-42ee-4445-a9e2-14f7146d345a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_4d15fb6e-6706-4e36-b033-02c51844465a" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_4d15fb6e-6706-4e36-b033-02c51844465a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_fd6fc897-92c3-49c0-bfa6-a50d88b88668" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_fd6fc897-92c3-49c0-bfa6-a50d88b88668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_c227e301-1f00-43e2-a576-d20e16417fac" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_c227e301-1f00-43e2-a576-d20e16417fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member_f52b90f4-59a6-4c3e-a688-25e2cf4f2649" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_30155af5-cb82-48a4-a6a0-ad7424f5ac29" xlink:to="loc_cvs_SeniorNotes4.25DueApril2050Member_f52b90f4-59a6-4c3e-a688-25e2cf4f2649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_875ad796-089c-472d-aaeb-bbf925ad5c53" xlink:to="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f983735f-d8b1-4cbf-bc9e-4af1e6c3e766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f983735f-d8b1-4cbf-bc9e-4af1e6c3e766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_0838c302-18bd-42ee-82c9-d7fbb6a8abaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_0838c302-18bd-42ee-82c9-d7fbb6a8abaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_5a6aa1aa-9d11-4f80-b31c-6b3437433067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_FinanceLeaseLiability_5a6aa1aa-9d11-4f80-b31c-6b3437433067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_b2a4536e-8513-4318-8306-1e0892d430d0" xlink:href="cvs-20210930.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_b2a4536e-8513-4318-8306-1e0892d430d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_0ee151e7-3fcb-4644-9e8d-30e81851c833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_0ee151e7-3fcb-4644-9e8d-30e81851c833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_61ccd1e8-a40d-4def-a8d8-3b16cea3937e" xlink:href="cvs-20210930.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_61ccd1e8-a40d-4def-a8d8-3b16cea3937e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_a923a0b6-6634-4724-8c00-ced1a656b0be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_a923a0b6-6634-4724-8c00-ced1a656b0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_690a0570-8110-407f-976d-a9640e5215ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_690a0570-8110-407f-976d-a9640e5215ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f39f1020-8c7f-488b-85ad-70a66557e99d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ce0645-11a3-4764-87b7-f0e9c18b8321" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f39f1020-8c7f-488b-85ad-70a66557e99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#BorrowingsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ee065a5f-c4d1-4639-a662-dedc7505bf73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_086bb192-4044-43e7-a532-70cae51db78e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ee065a5f-c4d1-4639-a662-dedc7505bf73" xlink:to="loc_us-gaap_DebtInstrumentTable_086bb192-4044-43e7-a532-70cae51db78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1997c1cf-5da0-4689-9ee9-b54bcdb09652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_086bb192-4044-43e7-a532-70cae51db78e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1997c1cf-5da0-4689-9ee9-b54bcdb09652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_95beb255-3d44-41bb-a405-fa4ebf9c8405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1997c1cf-5da0-4689-9ee9-b54bcdb09652" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_95beb255-3d44-41bb-a405-fa4ebf9c8405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3751fdb8-b5fd-409c-9b81-8ce561e4dc36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95beb255-3d44-41bb-a405-fa4ebf9c8405" xlink:to="loc_us-gaap_SeniorNotesMember_3751fdb8-b5fd-409c-9b81-8ce561e4dc36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_13c1c373-db30-4810-bad6-0aaaa29fc510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_086bb192-4044-43e7-a532-70cae51db78e" xlink:to="loc_us-gaap_DebtInstrumentAxis_13c1c373-db30-4810-bad6-0aaaa29fc510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_13c1c373-db30-4810-bad6-0aaaa29fc510" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2125PercentDueAugust2031Member_f3be53c1-2157-4869-8389-8144fa3686ad" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes2125PercentDueAugust2031Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:to="loc_cvs_SeniorNotes2125PercentDueAugust2031Member_f3be53c1-2157-4869-8389-8144fa3686ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes43Due2028Member_819015fb-7ff1-4be5-982f-cf1be08aeee5" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes43Due2028Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:to="loc_cvs_SeniorNotes43Due2028Member_819015fb-7ff1-4be5-982f-cf1be08aeee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember_5c8212a4-46b5-4d81-b070-fbde5c8a031a" xlink:href="cvs-20210930.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:to="loc_cvs_OutstandingSeniorNotesMember_5c8212a4-46b5-4d81-b070-fbde5c8a031a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_9e40375e-843a-459b-9bd7-76f7c9730345" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_9e40375e-843a-459b-9bd7-76f7c9730345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_72b6e4ca-7615-4349-8bab-361d1c3fe552" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_72b6e4ca-7615-4349-8bab-361d1c3fe552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_1e62e666-579a-4e4b-846e-185acbbf0682" xlink:href="cvs-20210930.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_73ecc2e3-0dce-4904-9084-1e839dfd87f6" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_1e62e666-579a-4e4b-846e-185acbbf0682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_086bb192-4044-43e7-a532-70cae51db78e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9a3b7b6d-1e29-43e5-9bab-b577ed09575e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9a3b7b6d-1e29-43e5-9bab-b577ed09575e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4b12558a-0b61-48b2-8341-ad16e814ef97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4b12558a-0b61-48b2-8341-ad16e814ef97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_10174390-049c-4fa4-a43e-fe386b9e72c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_10174390-049c-4fa4-a43e-fe386b9e72c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_7776ccb7-fcef-4e76-9970-301bc1ab58dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_7776ccb7-fcef-4e76-9970-301bc1ab58dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_45c2d50f-1936-41f1-a7ac-88c899c79958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_45c2d50f-1936-41f1-a7ac-88c899c79958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_c226fb79-b26b-47fa-8057-3c448ac8c28a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_c226fb79-b26b-47fa-8057-3c448ac8c28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees_b5825cda-ae47-4e83-831c-0a200b522152" xlink:href="cvs-20210930.xsd#cvs_DebtExtinguishmentFees"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_cvs_DebtExtinguishmentFees_b5825cda-ae47-4e83-831c-0a200b522152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b0446085-192f-4d00-b082-01aaefb9a730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_10507438-5457-4f81-88fe-6bda601550ab" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b0446085-192f-4d00-b082-01aaefb9a730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cvs-20210930.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_76dacbdd-ec51-478f-bf86-45d560e740a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b49ee927-dd05-4352-979f-dc213a82ada5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_76dacbdd-ec51-478f-bf86-45d560e740a9" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b49ee927-dd05-4352-979f-dc213a82ada5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#ShareholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_88759ea5-7daf-4c59-b777-b8fdff1ac43d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_e6628c25-79af-4b32-bc1f-92314ec4c9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_88759ea5-7daf-4c59-b777-b8fdff1ac43d" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_e6628c25-79af-4b32-bc1f-92314ec4c9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_892a98ff-61a0-47b3-9ec3-7014eea9242e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_e6628c25-79af-4b32-bc1f-92314ec4c9f5" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_892a98ff-61a0-47b3-9ec3-7014eea9242e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_328c8ee5-9e67-4f0a-b394-54dd6274b2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_892a98ff-61a0-47b3-9ec3-7014eea9242e" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_328c8ee5-9e67-4f0a-b394-54dd6274b2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember_4773259e-3c3a-4500-9fb6-92840e696c5a" xlink:href="cvs-20210930.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_328c8ee5-9e67-4f0a-b394-54dd6274b2e8" xlink:to="loc_cvs_A2016RepurchaseProgramMember_4773259e-3c3a-4500-9fb6-92840e696c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_8e9034fb-5e1b-4b87-a165-a9d05af61513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_e6628c25-79af-4b32-bc1f-92314ec4c9f5" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_8e9034fb-5e1b-4b87-a165-a9d05af61513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c3507509-2271-4931-9dda-54b32fa8bba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_8e9034fb-5e1b-4b87-a165-a9d05af61513" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c3507509-2271-4931-9dda-54b32fa8bba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_b76f5866-f5f0-4cb2-b7de-e3e1074eb33a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_8e9034fb-5e1b-4b87-a165-a9d05af61513" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_b76f5866-f5f0-4cb2-b7de-e3e1074eb33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7b030c0d-3ca7-450a-8a0d-180c73711b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_8e9034fb-5e1b-4b87-a165-a9d05af61513" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7b030c0d-3ca7-450a-8a0d-180c73711b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_424be890-b2a1-446a-998f-c8ab2d11d074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_8e9034fb-5e1b-4b87-a165-a9d05af61513" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_424be890-b2a1-446a-998f-c8ab2d11d074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20210930.xsd#OtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c1a81b7f-6834-4706-be01-110452b61c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_09151703-ac06-4d28-8bf8-498e06440dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c1a81b7f-6834-4706-be01-110452b61c47" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_09151703-ac06-4d28-8bf8-498e06440dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="cvs-20210930.xsd#OtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_86e6369c-3e4c-4347-9d98-009e72bca357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_36d8144a-b116-4924-9daa-da4352fc1340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_86e6369c-3e4c-4347-9d98-009e72bca357" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_36d8144a-b116-4924-9daa-da4352fc1340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#OtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a458b2d5-092a-46f4-a449-f5b228514e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e3acbc5-fdb5-45d9-9809-aed0770a1446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a458b2d5-092a-46f4-a449-f5b228514e7e" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e3acbc5-fdb5-45d9-9809-aed0770a1446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c0799fd5-c3f1-42be-be4a-59c37d858993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e3acbc5-fdb5-45d9-9809-aed0770a1446" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c0799fd5-c3f1-42be-be4a-59c37d858993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c0799fd5-c3f1-42be-be4a-59c37d858993" xlink:to="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_81fe2d6e-669e-400c-b0d0-af0bf42bde42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_81fe2d6e-669e-400c-b0d0-af0bf42bde42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_4dfc214a-ac78-479e-9cee-a60e9e09cae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_4dfc214a-ac78-479e-9cee-a60e9e09cae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_1c890b90-fc55-4e7a-81c4-cd71f5b01e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_1c890b90-fc55-4e7a-81c4-cd71f5b01e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_debc87b2-2a05-454d-95e3-46da4cd95ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_debc87b2-2a05-454d-95e3-46da4cd95ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_d22953ed-00d4-422c-b703-8a33c7d5928a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ee545c1f-4f4b-4312-a410-7ef984ab1e94" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_d22953ed-00d4-422c-b703-8a33c7d5928a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d3afd3aa-443c-4946-b6d3-04b562abe736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8e3acbc5-fdb5-45d9-9809-aed0770a1446" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d3afd3aa-443c-4946-b6d3-04b562abe736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_64f07725-9e66-4724-b9cd-8f81e9612de8" xlink:href="cvs-20210930.xsd#cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d3afd3aa-443c-4946-b6d3-04b562abe736" xlink:to="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_64f07725-9e66-4724-b9cd-8f81e9612de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3dceb808-7e6b-4bd7-b915-ff5827e04ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_64f07725-9e66-4724-b9cd-8f81e9612de8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3dceb808-7e6b-4bd7-b915-ff5827e04ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d401f566-16e1-45d2-a65b-cdc97cbfec0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_64f07725-9e66-4724-b9cd-8f81e9612de8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d401f566-16e1-45d2-a65b-cdc97cbfec0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1d1b33ef-8935-49c8-8a0e-08fb0b399ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_64f07725-9e66-4724-b9cd-8f81e9612de8" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1d1b33ef-8935-49c8-8a0e-08fb0b399ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85e14075-8003-4d70-ad06-7b948301b0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_64f07725-9e66-4724-b9cd-8f81e9612de8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85e14075-8003-4d70-ad06-7b948301b0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_053415f9-ea4b-4545-980f-92083aebc926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_64f07725-9e66-4724-b9cd-8f81e9612de8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_053415f9-ea4b-4545-980f-92083aebc926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_81cf403e-1cdc-41f1-8d4a-a8b8e461875c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d3afd3aa-443c-4946-b6d3-04b562abe736" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_81cf403e-1cdc-41f1-8d4a-a8b8e461875c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_496e42af-9b94-444c-950c-fa8795e87a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d3afd3aa-443c-4946-b6d3-04b562abe736" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_496e42af-9b94-444c-950c-fa8795e87a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_fa481e8e-1b71-49bb-a5a3-91aa1b337aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d3afd3aa-443c-4946-b6d3-04b562abe736" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_fa481e8e-1b71-49bb-a5a3-91aa1b337aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cvs-20210930.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_aba58966-18e8-4436-8b85-9e0a2813ad2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_0c5b38f0-acde-414e-ac4d-c024e20f8cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_aba58966-18e8-4436-8b85-9e0a2813ad2f" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_0c5b38f0-acde-414e-ac4d-c024e20f8cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cvs-20210930.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_32503e08-8deb-4e59-b65b-21c9b387083d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_bb8b8db9-a97b-45c7-8e0f-90e3ee59ffa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_32503e08-8deb-4e59-b65b-21c9b387083d" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_bb8b8db9-a97b-45c7-8e0f-90e3ee59ffa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f60af9c2-e0b5-498a-a15b-d2e8c1eb4bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_971ef054-7fdd-419b-8e77-9b6562caf1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f60af9c2-e0b5-498a-a15b-d2e8c1eb4bc8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_971ef054-7fdd-419b-8e77-9b6562caf1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_7fb32da7-66d3-4daa-992f-a182a6b0466f" xlink:href="cvs-20210930.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f60af9c2-e0b5-498a-a15b-d2e8c1eb4bc8" xlink:to="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_7fb32da7-66d3-4daa-992f-a182a6b0466f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_8d84e47d-e2fc-4221-8c50-8992ae60ac94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_7fb32da7-66d3-4daa-992f-a182a6b0466f" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_8d84e47d-e2fc-4221-8c50-8992ae60ac94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_af112cf3-b546-40bf-970c-d3fdcb3cad12" xlink:href="cvs-20210930.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f60af9c2-e0b5-498a-a15b-d2e8c1eb4bc8" xlink:to="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_af112cf3-b546-40bf-970c-d3fdcb3cad12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ba23da6f-4715-4af2-9e32-546d079c92bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_af112cf3-b546-40bf-970c-d3fdcb3cad12" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ba23da6f-4715-4af2-9e32-546d079c92bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f2c62c99-43b0-4abb-859d-13e25a380d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_af112cf3-b546-40bf-970c-d3fdcb3cad12" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f2c62c99-43b0-4abb-859d-13e25a380d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1b5e1cd7-9d3e-492c-90e8-1ed5536e8388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_af112cf3-b546-40bf-970c-d3fdcb3cad12" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1b5e1cd7-9d3e-492c-90e8-1ed5536e8388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_52f80584-be89-4e2b-85b9-2ac9be10f682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f60af9c2-e0b5-498a-a15b-d2e8c1eb4bc8" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_52f80584-be89-4e2b-85b9-2ac9be10f682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3e6be5d6-7384-455a-81da-7c7df9dded7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_52f80584-be89-4e2b-85b9-2ac9be10f682" xlink:to="loc_us-gaap_EarningsPerShareBasic_3e6be5d6-7384-455a-81da-7c7df9dded7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2ec9f2f9-6014-4518-b741-970ae81df65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_52f80584-be89-4e2b-85b9-2ac9be10f682" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2ec9f2f9-6014-4518-b741-970ae81df65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cvs-20210930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_eb28eeac-2849-4e3c-a917-b71dae105101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9fe997ba-5f33-4618-9b70-649ee7914902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_eb28eeac-2849-4e3c-a917-b71dae105101" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9fe997ba-5f33-4618-9b70-649ee7914902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4aa18650-117a-428a-9bb6-0a00375f52ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberofLeases_3e7ba387-2da4-4f1a-9965-5cdc75ebd249" xlink:href="cvs-20210930.xsd#cvs_GuarantorObligationsNumberofLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4aa18650-117a-428a-9bb6-0a00375f52ee" xlink:to="loc_cvs_GuarantorObligationsNumberofLeases_3e7ba387-2da4-4f1a-9965-5cdc75ebd249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyAuditMethodologySampleSize_3a9deca9-df53-48bd-a47f-120e3bdb9e6c" xlink:href="cvs-20210930.xsd#cvs_LossContingencyAuditMethodologySampleSize"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4aa18650-117a-428a-9bb6-0a00375f52ee" xlink:to="loc_cvs_LossContingencyAuditMethodologySampleSize_3a9deca9-df53-48bd-a47f-120e3bdb9e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_003e922c-dfba-40e0-b493-2d4dd7642928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4aa18650-117a-428a-9bb6-0a00375f52ee" xlink:to="loc_us-gaap_LossContingenciesTable_003e922c-dfba-40e0-b493-2d4dd7642928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_0b70d845-5ef7-4ec6-9777-0fe4b753886e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_003e922c-dfba-40e0-b493-2d4dd7642928" xlink:to="loc_srt_LitigationCaseAxis_0b70d845-5ef7-4ec6-9777-0fe4b753886e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_75f265c1-35f7-456e-9984-3b1f2a294bb1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_0b70d845-5ef7-4ec6-9777-0fe4b753886e" xlink:to="loc_srt_LitigationCaseTypeDomain_75f265c1-35f7-456e-9984-3b1f2a294bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_766e65d3-653e-4387-bc89-b9774bacc4a4" xlink:href="cvs-20210930.xsd#cvs_RadcliffeAndFlaimVAetnaIncEtAlMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_75f265c1-35f7-456e-9984-3b1f2a294bb1" xlink:to="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_766e65d3-653e-4387-bc89-b9774bacc4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d2ed05bc-89d3-4fa8-99f4-665ec69da2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_003e922c-dfba-40e0-b493-2d4dd7642928" xlink:to="loc_us-gaap_LitigationStatusAxis_d2ed05bc-89d3-4fa8-99f4-665ec69da2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_c7f2e2fc-f6d7-4b6b-9cad-21e88cde5799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_d2ed05bc-89d3-4fa8-99f4-665ec69da2f5" xlink:to="loc_us-gaap_LitigationStatusDomain_c7f2e2fc-f6d7-4b6b-9cad-21e88cde5799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_d383ae96-7a38-46de-8c56-e92a531cb9ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_c7f2e2fc-f6d7-4b6b-9cad-21e88cde5799" xlink:to="loc_us-gaap_PendingLitigationMember_d383ae96-7a38-46de-8c56-e92a531cb9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_6ca7395d-c43c-4087-a740-b09cf4600646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_003e922c-dfba-40e0-b493-2d4dd7642928" xlink:to="loc_us-gaap_LossContingenciesLineItems_6ca7395d-c43c-4087-a740-b09cf4600646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_091d7990-9f56-43f9-960d-585c30b6c2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ca7395d-c43c-4087-a740-b09cf4600646" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_091d7990-9f56-43f9-960d-585c30b6c2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReporting" xlink:type="simple" xlink:href="cvs-20210930.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_21781cb8-3437-4853-ac66-086b8b06ca0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_82bc8afb-9af0-40fb-baac-ba2f93add601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_21781cb8-3437-4853-ac66-086b8b06ca0b" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_82bc8afb-9af0-40fb-baac-ba2f93add601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="cvs-20210930.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_46599d28-718d-4232-9b60-a336ab0ce43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_1c626df9-e24c-4a2b-970f-f8b6f8fc080e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_46599d28-718d-4232-9b60-a336ab0ce43f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_1c626df9-e24c-4a2b-970f-f8b6f8fc080e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_b763ade4-5554-41bf-8768-e23bd2b7d1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_46599d28-718d-4232-9b60-a336ab0ce43f" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_b763ade4-5554-41bf-8768-e23bd2b7d1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2725bec8-0376-4656-8685-d05d370f9358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_14787fb3-3bdb-4b4a-976c-b5751ca267db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2725bec8-0376-4656-8685-d05d370f9358" xlink:to="loc_us-gaap_NumberOfOperatingSegments_14787fb3-3bdb-4b4a-976c-b5751ca267db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_410e1daa-e94f-427b-9905-2d6e29af3701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d2c05863-66d7-42b5-a678-b4e07da4aebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_410e1daa-e94f-427b-9905-2d6e29af3701" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d2c05863-66d7-42b5-a678-b4e07da4aebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_81ad6ab8-1bd6-496c-9f57-889c5b2a5260" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d2c05863-66d7-42b5-a678-b4e07da4aebb" xlink:to="loc_srt_ConsolidationItemsAxis_81ad6ab8-1bd6-496c-9f57-889c5b2a5260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_419df8e3-b55f-4a7a-9b22-492a2714404e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_81ad6ab8-1bd6-496c-9f57-889c5b2a5260" xlink:to="loc_srt_ConsolidationItemsDomain_419df8e3-b55f-4a7a-9b22-492a2714404e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_96edf236-db03-4656-963e-e8810c5d903f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_419df8e3-b55f-4a7a-9b22-492a2714404e" xlink:to="loc_us-gaap_OperatingSegmentsMember_96edf236-db03-4656-963e-e8810c5d903f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_d0b011a3-87d5-4eec-93bf-8baacb0a40cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_419df8e3-b55f-4a7a-9b22-492a2714404e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_d0b011a3-87d5-4eec-93bf-8baacb0a40cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_01c2ae85-e3ef-4b31-862e-d079703a7587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_419df8e3-b55f-4a7a-9b22-492a2714404e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_01c2ae85-e3ef-4b31-862e-d079703a7587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0fb81236-2d3e-45de-8771-f67e146eced6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d2c05863-66d7-42b5-a678-b4e07da4aebb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0fb81236-2d3e-45de-8771-f67e146eced6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_189e3f89-2e6e-47ef-8e03-50fcd17ee238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0fb81236-2d3e-45de-8771-f67e146eced6" xlink:to="loc_us-gaap_SegmentDomain_189e3f89-2e6e-47ef-8e03-50fcd17ee238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_3dfcb9e4-f57e-4efc-bec0-a5d8d079d1a2" xlink:href="cvs-20210930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_189e3f89-2e6e-47ef-8e03-50fcd17ee238" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_3dfcb9e4-f57e-4efc-bec0-a5d8d079d1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_5716e651-06db-4ec6-8cc2-c36757d9c0c9" xlink:href="cvs-20210930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_189e3f89-2e6e-47ef-8e03-50fcd17ee238" xlink:to="loc_cvs_PharmacyServicesSegmentMember_5716e651-06db-4ec6-8cc2-c36757d9c0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_0b9133eb-fde6-472b-b616-72dfc87affe4" xlink:href="cvs-20210930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_189e3f89-2e6e-47ef-8e03-50fcd17ee238" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_0b9133eb-fde6-472b-b616-72dfc87affe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_d2c05863-66d7-42b5-a678-b4e07da4aebb" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_e43dd802-e9bc-47c7-906d-e07253a73f4f" xlink:href="cvs-20210930.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_e43dd802-e9bc-47c7-906d-e07253a73f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eaf57fb2-85bc-4966-a44b-fced753b451b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eaf57fb2-85bc-4966-a44b-fced753b451b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_7a064d4b-a063-4457-b85e-48cf6d7da2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:to="loc_us-gaap_NetInvestmentIncome_7a064d4b-a063-4457-b85e-48cf6d7da2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5cd940b9-e0fe-4e7d-a0e3-259a6316ded0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:to="loc_us-gaap_Revenues_5cd940b9-e0fe-4e7d-a0e3-259a6316ded0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_84a94b25-d89d-4f72-945c-0ac5485380c7" xlink:href="cvs-20210930.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_84a94b25-d89d-4f72-945c-0ac5485380c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_57d2288d-6ce0-4b03-85c2-e6fcdd55179f" xlink:href="cvs-20210930.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_8bb737a3-d94a-42ce-9d26-ea088f6d50c8" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_57d2288d-6ce0-4b03-85c2-e6fcdd55179f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20210930.xsd#SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0e3c03e9-503c-419d-81f7-125d2e78ee8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6d61577e-4df3-4c7b-9ce5-f93899ec61ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0e3c03e9-503c-419d-81f7-125d2e78ee8f" xlink:to="loc_us-gaap_OperatingIncomeLoss_6d61577e-4df3-4c7b-9ce5-f93899ec61ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_60b56295-5436-4312-9744-4a0d89cab9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0e3c03e9-503c-419d-81f7-125d2e78ee8f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_60b56295-5436-4312-9744-4a0d89cab9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_9c898bff-b925-41f5-8461-5a2686540758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0e3c03e9-503c-419d-81f7-125d2e78ee8f" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_9c898bff-b925-41f5-8461-5a2686540758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_edc77706-b26f-467b-91bd-ab1f99381040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0e3c03e9-503c-419d-81f7-125d2e78ee8f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_edc77706-b26f-467b-91bd-ab1f99381040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_d0882001-f0d5-4e52-9a63-23c41293da4a" xlink:href="cvs-20210930.xsd#cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0e3c03e9-503c-419d-81f7-125d2e78ee8f" xlink:to="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_d0882001-f0d5-4e52-9a63-23c41293da4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_173a3f45-6a31-492b-8284-5de5e0b15c4d" xlink:href="cvs-20210930.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0e3c03e9-503c-419d-81f7-125d2e78ee8f" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_173a3f45-6a31-492b-8284-5de5e0b15c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_0b05ed39-b334-4bac-8dfd-4a234a6a1a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0e3c03e9-503c-419d-81f7-125d2e78ee8f" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_0b05ed39-b334-4bac-8dfd-4a234a6a1a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6daa26d3-79ce-4372-980c-5d6d835fb8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_0b05ed39-b334-4bac-8dfd-4a234a6a1a82" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6daa26d3-79ce-4372-980c-5d6d835fb8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_abcd8e69-2e6d-4dc8-8ab7-79337306fe63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6daa26d3-79ce-4372-980c-5d6d835fb8e9" xlink:to="loc_us-gaap_SegmentDomain_abcd8e69-2e6d-4dc8-8ab7-79337306fe63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_34f1fa90-a0a1-4f96-b9d3-acee88fa1db3" xlink:href="cvs-20210930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_abcd8e69-2e6d-4dc8-8ab7-79337306fe63" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_34f1fa90-a0a1-4f96-b9d3-acee88fa1db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e868e05f-649c-4122-82da-1c6156fdb222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_0b05ed39-b334-4bac-8dfd-4a234a6a1a82" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e868e05f-649c-4122-82da-1c6156fdb222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_383388c3-2437-41aa-b7b6-1764dee41486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e868e05f-649c-4122-82da-1c6156fdb222" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_383388c3-2437-41aa-b7b6-1764dee41486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_9aba2d2e-af8c-4d72-8ccb-a45e20a5c968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_383388c3-2437-41aa-b7b6-1764dee41486" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_9aba2d2e-af8c-4d72-8ccb-a45e20a5c968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_374f4682-e789-474a-854b-e08be7b7f34e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_0b05ed39-b334-4bac-8dfd-4a234a6a1a82" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_374f4682-e789-474a-854b-e08be7b7f34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a4ee116e-d53d-4624-96b2-1851a5c8f56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_374f4682-e789-474a-854b-e08be7b7f34e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a4ee116e-d53d-4624-96b2-1851a5c8f56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_137a24ef-e09f-4949-8f9c-aac2870de5ac" xlink:href="cvs-20210930.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a4ee116e-d53d-4624-96b2-1851a5c8f56f" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_137a24ef-e09f-4949-8f9c-aac2870de5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_69c4264e-9e49-4f22-adc3-d5d42d752d54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_0b05ed39-b334-4bac-8dfd-4a234a6a1a82" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_69c4264e-9e49-4f22-adc3-d5d42d752d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_f21b8a15-6721-48dd-91ef-9ea2db01d320" xlink:href="cvs-20210930.xsd#cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_69c4264e-9e49-4f22-adc3-d5d42d752d54" xlink:to="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_f21b8a15-6721-48dd-91ef-9ea2db01d320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_60e44ba8-c554-4bd6-a24c-8d251949fc77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_69c4264e-9e49-4f22-adc3-d5d42d752d54" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_60e44ba8-c554-4bd6-a24c-8d251949fc77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>cvs-20210930_g1.jpg
<DESCRIPTION>CVS HEALTH LOGO
<TEXT>
begin 644 cvs-20210930_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  < )T# 2(  A$! Q$!_\0
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M>(O@BW@63PU_PLX3?\([?_V@?#O]N&P_L[S/M.S[=Y()\[9Y>[G;CY3\[?\
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&-FB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>cvs-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cvs="http://www.cvshealth.com/20210930"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20210930.xsd" xlink:type="simple"/>
    <context id="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i01397c0a67fe4cc788c55f7cf5e5d177_I20211027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-10-27</instant>
        </period>
    </context>
    <context id="ifdf12dfa1c48413dbb649aad32495c18_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icc9deb51f5bb4f66aeeede8d66412ffa_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9b9b6ee2abc8442796e1853380c5e295_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if40d51c00c3843f6a2791ae818b66480_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i234d631c1cd74b0aac095889f4187793_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i198519b4ab0741be886e63579724dda2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifd200dc7e8bf44ecaa5ed256c3e815d3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3312e30597dd4849b396d77a190ab38a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib3ded585d03e4dee889ec0a76b1c3773_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2fdf49e58ef74885bcae89152e425b39_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie73ca519535e42989446d84c5cbfd99c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4adcddfef50d4237a36d95774c4b5e7f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie81f391964c947c2b2bd32278edef5e3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i23ba03e375294644884d8e56a4a12ec8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic9750e3f154044e0bf5e620a4abf5bc5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i551bc5b2e45e4537a35491b701e2bc6e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a860e1fdc9241a88d247676226a1743_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic102a7412e044e7dbb913688ea071de1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2054af963ad94d309c02720a2cfbe212_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i92e4947a219a4f35b8b0e727a77bffa0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if831d75953f547bf91c30a4f27bf85e5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i74a27263e55344aa87673203df970d6c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id5ba9d09ff88466f96d748c706ada380_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i22d23b76e1394040af9ea41449e89e30_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib469fa63d0a24fd3b8919d0471ce244c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i86e55f5b316946bca272063c2c239038_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib76c2965654e4d27a7289e7d74a81285_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0f8f1c6e4cf54f67a77ef5861fe75220_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iebdfe2716bb1440b8056abf51feecbc7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if0b07933938d4d1fb52659a2713205d8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5c062bdcf0194ad8ab5933e999439363_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie9c14939d5344d3b8c3ef6eb09b33da0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8781832d43cd4db79f8719e073082c68_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ife449814992e43438e58bd3a5248451e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id2d9c33c5d0445d4b7720d99637d30f0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i427a383940a94623a153c763b01bf61c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i30c3d180e86948ca9c3beded789d010a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0f39afeaa0164b9aaae2c4ad2a9488b3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ide68db09236a41bd9e4db1ad61b5f1a7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ice52c31f671142ff9c5da1e16b8b587c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i086fc8748c444262890e455770e0e120_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1ed26699159f4e319ec98d041d5818f4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4687f5e592964cc2a694fd8d54353d81_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id6540e87000648d19833b26522bbc190_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0b84af36af2c42629e456c37a28e3938_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i56f7b57e38ca4b558784c1d56f0aabcb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8c1b85bddaae456e90d5a5399f3b4816_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i17ed94c211de47da9c0bd88c599e60f2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iab82a09b9c1a400d8e88219f37aea2de_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7ed0ba20d2cd461099ef887e226c3e93_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2e60a7d260c843d980920a5e304ae972_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9a9f6159e4b14b72bff92db8236fd747_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if6a97ebcb6674c2096965c9b22aaffc2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id4ab8d4ce4d04aecb9a84bbfc6849284_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0265118fa568463fb1dfa52b691e2fca_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i59307294db3d4cf4a1ad0f4df554aaf2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i186f27b850c7471dbc106faa8ac8974c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if2aa020f1483426a991754c1bc8e4103_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3d7fc2a5a2924d5991aedae343217836_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i082bfd21f3b045cbb0aaa7fba7f7804d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iac37107e130b46c6b8fd2d7a2c171383_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9adf9f3e2e264684a8989823942612fc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic11ff217d030454db570ea0bc1a32ec6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i64cb0760a3094aa686d8405ae705af26_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i47ef065bc8ca45d686c76f5b4b47492d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i69acde82d8db408eaa9ed7c6287a2301_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ice9b45cfa6034116a0bb3a805bb25deb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i63137494a1854ceeb7bd1ce433103833_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i949dda05f0274cf9b1746bbae441be84_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie19194eb945449b2be88388ede7f8337_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i90f84206f61549279918a09332e58af8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i06e2801f1e8f4d4bb0ba64b129f8714a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i20bf1fd8851f4638bdd00a557c5f447b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie0a7e1350bad4522a8484dd42ae70233_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id069616f8c3a471b9d0a7ef8e5adaa32_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1385ab29305c448a9c67d5770afb048e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ida08eebb482d482f87035620abbf89d6_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i082608aa6b234f278b38aaf17009eb6e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id654c856e0c94aafa2fe19dc04299751_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i48d4429acad1442ca35208e950d6b8a7_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8fff271aac61427a93aace91fe11d093_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if946b6b5938546dcb10f22ed41a68dc9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7dd00683a8f140fba68409bd3564961e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic5ce1bd21a3640a79c7e024cab066d90_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i874e9eeb56a64352a7d096d7ecf784e3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i08cf13c568a64de2a8c45a6b75813fc3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iaae98d9e6fb345029082485700a2a279_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibf4d73e8ce60495e83dd3d579a0a6635_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i85fd60b1e5304049bca379f1eefb23a2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic26c88d8650047d8a0474834e8096a37_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i87af6ecaa93148af93ee60a00e2bc5fc_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icace12a02237438d97c47d5283d91ee4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib368257cbb8a4dcc9f102a7125dff098_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibe896c82eb7d48558a916c2226cdee18_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i619aa996f3d8498ab4f572d7da7b1ff7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibffe81af21c64c838090535f9633ed0a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i20587aa2f9cc43dab807a6fd036d6ec6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7b392878ff634b039bf5f8e8010826e5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i81afc144424c4e4585c0d1c6720651e8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id11218ddb52b4b7889cb60e1b16b1edd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9c2b0a74f321415ab4143fba6052d3fc_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ida30c27c4c6849159ca6711a4c1037d2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idd3c26ba9f894ca9a7da1af89a150bf8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib0d552fb03c44883bdd9e4c09723809d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iccddc7d61a62405bbd6126135b096cc4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iac3c8def758f4306a0225b383df470e6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iba7be38e83d341e093f4c569c8926177_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie66834e318c34f77b62a7489806c5c36_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i04578fac9b784d489a884552dd60834b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2900b425253d40ca9ff265afb5d2e8ee_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifb8d675420f0416490172136b95d4f77_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia4b4ffbeaad7402bafb6efb81912f182_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i64b99e857d05479fbde03dab04aacd4c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2c4351afa1124647b74064aed3c9b1ed_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iea10f7ec17074278bce5534f7460eebe_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib9c67264f8554c16b088c68a6bf79e3e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i741f16a969ec4437b522117aeb1529bd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia94eca1fb7324209b95d6bcfa9878abc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i253d046d1d4543a0a2641f1e7e78877d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7d765d02ede34e5fa56a51625a55c188_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0c3ac878cf024e6d80d9917247d48b26_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9af0cc01cbc54c9f9e8615532da5bb0c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i03ddd201af14457bbc83df4348f9bad1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i412e5ff6392245189b7c9456c23bf31a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia533baf499d04c8ca9ae5911bd795ab9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i290002d5729c495f8ac74f3b19d7d0fb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia3894328a8f1466c8e456c94b93be275_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0ab7ca31512a47f9b1c6b3868a809813_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifdf2284c5d324dbc834c16b94260f82a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia7eccee89ee34209972dbe04829f41a0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i625652e7d45b4702a574e3cc0bc9ee59_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6ff4f742554a4022a187f1fa185cc04e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i77b79029d3d0422f91971672e000f6b6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib390a8745a16401b9768897652fc449c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1d3ec90dc0814b88b58bd914fedc0407_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic247236f845346c988b0332f27fa5573_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id372e9bfe6bb44eeba5d3ea51e988f33_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id61c65f32eec4471868eff06cba27f89_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i05ab8ae673ac4c12938a12847aa81a22_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i713ef3848ad542c18962c0cc34fc33eb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia630bb470ae642f8905431f2e294870b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i25b37ce901e241a68a26af12fa5a391b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1c910bf185e14abb8f843118e080650b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i583100df6a7145b9ad53eb0bc9fc4236_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3f4c6beff36b46b0b7456de5c1600949_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i91168981806a44fcada2dd00fcdacabe_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifa6342f43a2c4bbaa5a4beabc6f6e0d9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i818171c70ff34861b15de5ffb456cd9d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i69d20d815682465bb2bb57dc75692e06_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i713de0630b2c4ae48f9171b5d5051b83_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5eef7665d65c4130b53d504334affcd0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6dd05f21d6b243cb8fde4098a5393a14_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iabd597abb76543afb656b9b04aa8e034_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i05a987898eb94aac864574fe231e3a18_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaf8640ff8c964e05b35cb76754034a11_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0da9396c07ac45aa88b14bb17a63332e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if0b6b6a5a9634ad0b60f62d11118f057_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4b1cb227ce25418f98cdb4c840a209b3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic02cc6173d9844a4af5efdc0fe2df7f5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6984fc17f7d8475f874f4de494cb3c48_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0c255846afcd4865851ce574828f1003_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6bfee72d1a0443d680828612b3a96710_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic576deaca0f04caea39ef63cbd517eeb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2893b2b18b814343a59acf92e7535ee6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4997bd10dafe4ccd9f92c679e0ffd1c1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5772c520e35f4b77b4c2c79644da46dd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1ac823ba7ff34a13a62385beff1f8dba_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia22d065e2388491692af56f354d79db7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4dc4395dff1d4c82a9760c20fceda344_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id3576406107f47d7858dda78d75a6417_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i42ba3552a810439d9832cae42b188533_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9e4cd869c087429386704db934a61115_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2c29ab4601174287b450f53152b36d36_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iea31066dc7804044ae36620bede68059_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8cdc8fa97da54c4a83f3e7c81196ef40_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8aff50c37dc4454689af8f6f2c7cfa70_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia3cbdb53e0614fd69d22b0611082a4fa_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i63014255cc54440493b3c80ebe5cbf20_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib30ff9d3c92d44c69e87a939aee311b7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic8e8ad852fbc47aca12f0dc2b4d1819d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6f5439e4bb5845809fd326a3d2d9535b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia370cae5def349beaf1f0d98272cbc86_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i383e9e49c580468f96d67226826b3701_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2fdbb1d0471e422b94075bd37bc906a7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifa352e072fd64bac9be7da2a91adf04b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic11a639bc0634a7f934934ab6d3ea9e6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i77461fd39fbd4219b11e33a2ae292268_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib8f710bc255b4ddabb067c4df0121ed6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic48a2e72c0a444fd9aa88f429033c37f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id47a917ec1af4c5db06417fff5be5881_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if898d4a04a094d2fbda70a5bce06fbff_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5df45e3a2a5c4b17bf3ad60977af7588_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0d918c713f67448682d7c685dc82da6b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i34039126a3d845358fb813264ce5d92f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icb505e76b20f4068b74c4b35f149f619_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib14d585750a94bcf85c1726868d8ed22_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iad03227c933241798aeed098ed54ba11_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9901c4b8de6e4460ade56fa6d6a6c4df_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifb4ce333dc4b4ac6a6db70a32f589fa0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9d5483cd591a4ba29922131097dcc0a7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id3777a80d7d548dd86f819a7a8c68626_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7cc744230a544ead88ffab3c45d0c454_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8b445faeec3845f6b11c9569be49f9fb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i472a8387964b45ec897885f8bc357e99_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8f347f866918415994fa315bd6128224_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i009f875b81cb4be983f6d06abb32da71_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8ce155a0217b4ef6b1d855626c01d3b7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2ebd9dc275854c4faf090e45cccef77b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8111b2822cf741f59d35a0e165fda8f6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia5082f90c86d41ae9be5d122e912ec22_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib50abeadc51e4faca566c3e8f770d30b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib624b26fc2464997942a122cf2a18d64_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9867d0a744a545c08b139379b67df848_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i15d6678bc52c4b1b9a3992371795d9ba_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic6674a9f6c2a41b19f32aefffb3a2dec_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idac5a4c6d4b94f628ed2cfe21a4d2421_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ife3c76ab2d024ff4a261d3b4e14bdada_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i04744a27d4fd4e3faadf43a927a7eb4a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id3bf41b2dd03474394b5ac3c1e4407b9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i45b3cd0569ac4039b5a66d8ac80b2c19_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4b19f1d9ffbb4fe298e1f449c044db56_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i25970c943ef246bf95009df4317e9dc3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icadb573d19cd422abcc090b691494ecc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8c84847084804557b40086d59812ad68_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6b2e395d22bf48aaa5e44c7091a81e15_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7e829120f1fb4c1a9331bd53efd465d1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib32e95b570724a1f982834c296abc3e8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if97993cdf6bb48d99b74e00b854fff89_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie363563d839a430fa7d79ed6d41e5d06_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie1ea3d7632384fe7b52a58c46f5bc52d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia07ca84334b34916a64718d4f3f0dadb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6a95101c0a2547d68267b540d8eb8935_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0610bf8e796340e4b079b333dbc7453b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i57164e4241fa4481b87fa534a3023d49_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie0aa1900809b484188a9ccdf8c6792cd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifc788eb85be74801ab161654330fe954_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id1d2ef8361434b6e86e6d370a02b1d83_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2c4d3d8eccee408d901f45c189ed9409_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if52efbf3b02a4086a4563b641c39020c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9ea4f28e976a42eaad4bf6503fb394a6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i64e9bda172dd402da851f2556c558b25_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9a81285c245547c79d2a6cf01d1794e0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iac2b3349c830449db89d0000b4259672_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4dc635a1438340608f1c50ba4fdd86c9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i21ee770549c949dcb40ae6f549cc3f40_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i80a6996dadac4e8b8f355582234ddeb6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i97c318d6cbb84ce1af4416e5e9e9e796_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i707fe789ecce4f57bbc13e85dcb9d128_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e088f53c1324f15a6ec9498f86c75ad_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie6144005cd614c8aa06ca2e425c85859_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i84071dd39d474caab85d1a67242c2886_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if27a76e953c04bb392f52d3e05778b01_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4167d58e660348f68004d45412fb002b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i97c60203ad5c46589c94c32f921cb550_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idf502564439b47e698e240fdd68a98f8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i16162ee44bb9440284fbd19d6465d34c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib769dc9c21e142589bdcbe6161dc3506_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib1bcbe85de984034b24a5e4fda18e485_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia73e717be6b54384b3a33a455727136e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia4661486124b4ca28fd4c5ee294a70e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3778b495d7b42c5a45cf242a88722cf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic9ed33a6edcd4234b95ebdec84f83d90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibb8aec5e18a44c75a0b64168efe52403_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1675bac7aaba429694ea0a6a1d6a3574_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7cc96f7ad297439c9bd36cc63d9e3146_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0db856db0a1a4dc6b3fd81758f0ae424_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if24bb6ab7e694ecdb87149237d4c1602_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8d2954c416de4b1e94f5fc8ec55a8415_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7a9dc416181f40ecaf6b337fd9f9f867_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4f12b69dec3e45bc83561d3148a11d4b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia0879481908c44bb974f798733a18941_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i81bd66dcd0c14391b7ca572896fce844_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic20457c673f444f7ad09370f0abc943f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie65d53b92fb04633bf47f5b64fe04237_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1005ea182f234733a5f7f072c2ab891b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i621480d3797b439aa77a9e7253861a59_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib6bef302866f416f9a0761624eade678_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifa59d496a4474b0f95a13c32d9357c35_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifcad87c9dec641918b3c4b3bb560a7de_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2f221174b2cc4c23bf352b6226458e50_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0ccbb0e4dc92472684d9df86f46847c6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie6b89ae1dbe540a4b314a9ffd00f3e91_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib99fbba707114103952918869f5d54e8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4a096f78525a4f118bb1911a1d28e677_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i305483b9eb2c4a8995176a43a6032fc0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ied8e395c6c584b45aadbedeab96bdde0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3e4c260ac59344468042ee0c45e67651_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifacff69d92414346adfc278aca85cbab_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if6bbe3fa4925463a965ddbfa2358fff7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i687923585ac246a3aeff8523198d5758_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if8f440075a474904a22012bf5a0fa634_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i37ba77da999a41fdb1d81252d6c8a441_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i16e95dbb642b48db85e7e5bdff14e6e0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9969a7b4b4034a81bbe819b2eac5c9d6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i42c00a9fab3d4285ae67e62b24f65277_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8be70fee5e364ac0b0e505aa20317bc3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i613b395302204b2d82957489697563c8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6adc5271a0f0419f838168a0b0c93dcf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3be55e2300ee48e49c912324e8d0adb5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib5edd5e4487d4cde9d6f50a2574f3e8c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6b52851fb9b94ea79df46ebaba85d992_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i13f6a29f7e20449ca439559613ffdb02_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie16bfbf4e5d442348e7fbfc7fa8540f6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie54cb4fb85cc4c14ad9a8f690844eb1c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7336d9407ae74018bd8107c29553bc53_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i990fec2baf6c440d8151861169097a2d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6bbb7234989e4a60815b6f61bbb10430_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic54ed38faf1840829ada4f19ee78708b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib458fd6ed94b4ec88122673b72dc2b86_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iaf1830b9927b403fb56106443f7e286a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic16faab668914c0b8f33d98455c26ca8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i299c35c4365f42e1bfcf88ec9516cd24_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i89e754d40a6d447789aba510c1139f8c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i838e7866071a4f15bf5992c7b4d65771_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc3123160602429a9bf38bb156b7b80d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f211351ebd945b59851039aa7cd4aef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f8fc8c9444745159ca710fbe002a038_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i34358d8265934eedae4d1ba649b53da2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4b8c3d6759524f80acd74630696a9506_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i027a56206bf049918acb4cc292f57cf6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6be1325a1fd74472b0c1686a5b8bed29_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40eace95f50e4f4abe9ef0c982f565fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e6dcc78d1204e1a9a491939346531d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e2cf59a412346b49745f23c85ebdae7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e1433ec26e14619bce3f327630539e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad4028c79991465f8affd1c774924434_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i515f5ad673e841cbafd84da71411a3a4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icdf7f501b4a04e6ab02d3946c1b2fcc7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifed08cdcd0ec4c51b9c44843b976a3fb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i141813623d8d47759168dc83deace4b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iebcd200cf0d3431899420614fcc5f00d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaeef2fe72a0e4db78d0c62aa5b990f64_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b884c52dc2140b8ad6a93ffb21a0ca8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if7e1a05886ee4b2fb12e4f8922b90730_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib80106be43ca44388999d7b0f50726e1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf0870a5c62d42d0835c91ab95f6f879_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia4a4db2857ba40af84f29186cfed8c8a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifebe5c48239d4acbbcfb816d06be3231_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41ef632b7d74402987f587828bb58743_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idca40fd7d89b44aeab59a2047d066ca6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i597b415b2bd6471fa91f8a8a2d582e58_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0cf2d7ded1ee4ac3ad8f173a49ca5148_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i930f3c01703c43719b9d884430d891d8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i474200218c78432fae6cc7d8692546d7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i59cbe9d0b1c14573aeee78a7f064a39c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i42c6d3403b9b4becaa9ff959ccfe8f44_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2ebe53271a07413f911296d1d7453a25_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibaaa57ceba5d4481b694b7ba30c13b7b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i72bbd414aabc447686e70f07f2d01a3f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id63cf05999ee4f44a681fc80a55eb52f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i04638c4a1572491dab3ac08e4ad98438_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6a39ccc3c07c44ed8a195c76b9e7e55d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3c637804a3d2436ba9be1a2b270b4e53_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if1067180474044cab8a4d973cdb2842e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i508e18defcad47008f1dab8d4f81dbdb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0563521c632f47179c829933333c3ddf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe7ab3f842154eeea4c328406a7ac83a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifda576b425f044eb953d6a347d279daa_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if06aeed222c24fe2b41407064d3593bd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i49fc9d5b465f44abab9625a29fa0d38b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia2af50b590ac44018a0222d8c3c2f4aa_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0c1da65d86f7414da97ff4e9d8609420_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3c144abf9d6c4c40ae0c2318a533d55b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib513a974552e403ca51acd78fcf5dde8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie6e72b78b8754b94aaada037ca2420ee_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i75c0f2cacc534be690f026d29bdfd858_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7e2a3404bce24924ba593cb3d50a171f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia81d44c8f29a451a8615660915b19be0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9883998841414e459a14949384066c00_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie4aee10007334dc08704544552884bc2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i41c7bdff14cf4b519ad7ee30cc901f32_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5add9eb3c7da468c9b1a2863e2d79bf2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i83f92ecb821d4bf7936caf73110c90ed_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6837264698c94d41988231e4099598b4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibab1f6f3b94e4f5fa5194e624f3698ef_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7db0731152d84288b010f872cd8a99e0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic04e7b60901742bcbc036ef80339246d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2025973837f14d479020bf7cc4499a72_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idfa61eff06aa45fcab009a3adb153755_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i92ad02b987304467b861021d6c699fee_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if6d623b8d6a0424bb2669fd66020aafa_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i94c9a1f84bba4080b2c3d4bef2b71e52_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i501877927dd54fbf93b7f49e999ee841_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2c847c9a44124e7db070cb42a1a63f14_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia9dd3149c06249a287ef6e26045fdd95_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iadba8d3e3d8440528cfcc9c33445f682_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib29de6a09dcd46d9aeb48b72526eef8e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i999f68483084466e9e68712a6eafd08d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2cfde730bc324d93b7009d7ab45141b6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i89494621c37c4c219c62fdca2ec3a02c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icc7910d366b94081aba8f7c036e31370_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4d9073e6b5944376a12e7f42f106f789_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib122074ed9c9464eac823cc8d4819acb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia674f1ddc0d840b0aa42d18120ac12e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i95327e52078a41a89444ec318828a7dd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic836b346282347908809f16a6eb5660c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i34bec3f3434a41b7ab493984748deeae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icc87715012e244f1a0941fc7f486bcb5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8fa629d192414558a844c90838b9c4a1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1ab2e48c06df4ca08a139917417a396f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie971ffe3a7844dc29d629c33684e8d32_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb69f5ffee80421c89348f37e2cb0f86_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf2f0f2fe2f045bda1c2226bbe6a8fd5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43c1eef1a6b448418547a06e29940d6d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idc165d15f6804c64841a910becac3ed9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4c412a5ba874f98870341d7ea31c942_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib297eefdd01042809add61d2dd4010fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7de217ffec6c4548b78c7b2302f20377_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa404aec6f7740709c74a50e423f55c2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i694813f254844fc388cdc57b0282c552_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76a73d6716c549c5a3e574f5997c2627_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i53410c2dbc4c4d39a65c4deba26b6c80_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i23fa0bd51236409caabdfcaa76735c44_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6d4071d9bde54949b0ab30e57b6d131b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie5f20743700e4f5d90d0ace281e6184a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8bd830bd2d0a49eb8ec02b1932b58722_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb2d516d37a44977806647d938c79d40_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7cdd4cdd4ca546788f18be91782db91c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i47fa10c381de44068b970898e3aa4e58_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i96cb72db03134df09fb6aa81f2b1786b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9611cadb797e417db325edf33945b988_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i563011688aa349e7a1f32d722693061e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idc355084ff424474b90262f9ba68cb4a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3904707e6a34e4e8e4ccfc85ced0bef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i07c7bd30fcf945f7bae17c46fe84a1e0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iafea971f2cd6419a915d40ecfdcc6853_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf087794476a45f1bafd4c1e6447c2a8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c049e51c8604a9183951023541454c3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i021c91d03c7945d4a5905a640d27996a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6c135e138975479dbc208139f9ce925f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i147018bb8fcc4e0586edf2dde3e287c4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iaad5be874c394c87a8151ea37f655ba4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iaaa2a9cf9df24d96a4910a7770e327b3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd49134c4a7f487a8cd469c1c1ffbe58_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if687d685f43147b8a54d5058142cdfc7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec2da8685e5443638fdf326121bfbf76_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c964868b4a547e1868068b2b01396dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic0ecb6e4143541d38112288c2c2203a0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iafa9567a6e1242cf9ae54c608091a142_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i612ca748550d489da66896239ad5b1c9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i13473c0ae0c14361aa7e0e5b5809b5bd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie18b978d6a92462cb19e95c291464ff5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i557a10fe4b3943739f83a4f01347a36a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0cd654f81de94c4ba6574ed395d10914_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f6debc0fdc84a0095ae738e034b2ce7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic5b399af8f2c4b1494f420b54c395eab_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i18d84e87420b4fdfb90748e9026f0c49_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if13f0350cddf45ffa223d9ec2d72053a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib46ae0b202514c6ba3af15017b7e230f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9f2877a791e3491f9534edd67ed3e987_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad504c15b51c4049918b0ba3bf6aa35f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic424242c3bba48f9bbc125c6af13010d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib33c9671d5f046d79fce9e9901904688_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c04b19feb064cf1bf23bc7e65f7be4f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icf82daed791d40cd93b600a3e62ef8cc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5aa8d204d59f4f928a510e6900cf939a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i09fb9a5bef7f42428348726a2ff173f1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i685f457f55ed4bfdaf90fab6ce466d85_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60056bc19bb048b59c735005c438169b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a47aa4aaf384bc6a0e156ab09a449c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic0cd80f6244e42fbab3150923c3c3ef6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id865ac262326451daffd0d3a056e96be_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7d357538b6c0474aa7f475e2632e3e77_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0bde8bbc8af2428fb013ae54651523b7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7abda2e513b34485baeda28fdbf8e4a1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic763372116b148e9a5a2904296c53f93_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79f3ba86d6354f07b5df6c1ffa8bbbe1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iafc45f1d336740b0a1a8d911aac65229_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7733f5518c7645c4b56b68cccf6f76ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4652506a76c7489ca73ed1b4e3db819d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1d5e67cc70504729944139279d44d713_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i15df075bc2d04e759bf072636f0fd065_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8616075a3e1f47668b0ea71db5e5caf4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i42ae767186744b45adac05f6feb0c37e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i750ac96cf4c64738af59810ad96e6411_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i23c1f04677c042939927a68bb5fd9f65_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i869431e7abf74749b23dd3a1ed93e1ef_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i05a9eb3fc13543189b612e1898a32241_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2e788b4e17294696828048f3be438c9f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie0f632a81048467cbde9502af1736d39_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0497b7413f024eccab9ca54d54ee0dac_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic0118ee2d69441a7b3e211472508a35b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibc05881978f94525b7d1199de70e7105_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id3ecfefee0e642c0a78fc0131c0449c3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2db04fe0f832449baafb9d23de950513_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i07fb4a28c1654faaa862b3d378de1c6c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib62f2ee98dd644cd9bcc6e7fafb92659_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9dbe9ff3e69946d3a25f666403b2d133_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6af42f85334840f8806360242558dac0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id10cfac743044c0b8d548cd557cd8836_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9597fa0131bc4e9887c9815a6cd88648_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i59e7dd59a3b54a77b96c49edb48d86b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf27f7ccf52044a79068c5b1c21729a4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9b3bd812b24f4f1eb1e8c8d5c0a75877_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i852a5e91e3b9468ba1cb2eb5f74b1b9d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6191e346def74ee2aea270383730ae08_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76f9788e25764f54b73f568ee5806646_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibc41a17f6c774042b9fcf1afc65bbdde_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i137942ee3c634b5389f5afc0f8942bca_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if73d40a8e2434d0fa1ef103cc7698cc3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib6b0b4743e034bb1bc3f258385746efd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i99bd1157dbbe4945af1a81d0c21130ea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie17499a4aa5e4151b918eeea4df0de97_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1d6ac400309247c5b66323fd368436e2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8b0ee41eebc34bd180b2c69788165350_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i99f11726422242bdae9d51047e1fbd8a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f47310960c144eaacb797297d97929d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1d3712df84af449f83452fc8bc0a7e18_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i483ec33bdab247d48a38b7f13570e673_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia618ec5a27694900b1f7ba774ad68e8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff008f8fc0ee406881b35526798fa89d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i19a79677cf9c4a2da09c14598934ad6e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia1ab71b7baae485dba34f4f0eb636d02_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i01e1bcf974684d3f8b8d8a88ddadfd46_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie08be45af7c046aaa32b288f6d0abe62_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iec21c12c0eb1436d803f53d89f62fa05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i72a7a16809e84d3b92e4bad0bac2262d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic5d016793b9b42579b7bc6222e15baf6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i764944fd1b5e42008a5e99c7c609eed9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3c92560f130b45779c8a95a020b233ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27806ca29bf844b3901fae3f691be398_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iad404c84173a424d89258a6896c6cf7e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie935136890474a69910662f38d5b6b95_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i17ee5f6b60d74d7e9832465d6c93a81d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i777d22b7a1214acf87d3902cab5fc684_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i08366cfa41cf4ec09bb0df2075ab0906_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i501701dd672b47b79ce22cd7925e8550_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i35c86118fbc64523a77d011172ead4d3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6bf76349f2134b799b85e620ca017ce1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib2c451a4fe964730babafb480988f0b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaae7c158e8fc423e95ac2bd644820bd4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i950c1c297c4a4358acd09c74ab566982_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i62ccc6e98f4545a181d967e33f10d4df_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i857f5b369f4040fab9b2b410b0a79b73_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if6bba02cee2944fbb480017e52082d76_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i32452f38e22247ae967975fe6e98f407_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia409b9876a544297931507912b72df4f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i75a9c983e179487b80338719c6654c2b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a4406c7b2f34949810aebaf45489f84_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8151e799d1c74f5c833144285cf01c69_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3182ba22cd594ccf9a8ae05b9078606d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib60002bca8e844649c542c4cc7f63f72_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba95d402ec9d49d28efe5abbbf533067_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6773fdec06dc4a40983a54841b13dda4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic4916faa22d44187b36197276e047af9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueAugust2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i73aea79ad2ba4f3fbca099d45fbd99ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueAugust2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibeb8eac0c5ec472ea3a8d59c3be4564c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia10a7bda458947608ba95da5905bd9c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic5a7d1903cee4bbe9e9caaee0f3997ea_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8be68adc97de4b3193304ca21babaad1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic715e236403845808ec274271d922531_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2e414d119b874c97af3d40d143e3f394_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i98d7f42792064db8af2bea27fe4217d6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id9d87dfab2bc4779af52ac27db253497_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id61537d136804380900baa2205811e11_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9f7e8dff237f43d0883eb5f73e112a29_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icbe99d66375e4a84a14ca3cb9bd04463_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i78303eac554f4ebaac80fbdb2ef497d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic2bdbe81b56b433eb0b1abff2a8cf359_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib7ad50bbcb824461968e1e224ceb45eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id19aa5c38de0498ba584e838008334eb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3f0df169cc2a4329a01ff1661c5f6643_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia45c0682f66e4831a5e18003515863b7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i44d5c108e0784a1baefe552607e68fbc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82d31c26e4d44623ae7b535f4961b40a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iaca08c7669e84499a6b53f5fc209d8d1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieaf0c3b289b94b89ba1558094a4e7fbb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic7efa34741b14f12a2e1553830369efd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee85be27a3054609aeaa1f1291e5378b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4027fc5015314a28afdf00ece6eaa61d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia33e18e6e5cf4bca9278bb182bc5c16e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i64ab274ab94e4fb0b97224d1979d31f7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic90e5382382f47f6a02d952c5ef3f35f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie01363b48cc748a8b4849e735b906bcb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i57bd188e01604c998e340453dd1c10bc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib9e00c491a58435bbe46b502dfc86a88_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7771d9a02ba1459fa65a6ed760132976_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1710183e3c7642969f8764f4a6bccb12_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2fe10dd7c524a25a46b3c5a30a4d149_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i498b74e1a6084982a704243062845c72_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf76f8b405534054bff48c947da24a34_I20210818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueAugust2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-18</instant>
        </period>
    </context>
    <context id="iec82b516316744c190f4a9f8856af906_D20210818-20210818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueAugust2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-18</startDate>
            <endDate>2021-08-18</endDate>
        </period>
    </context>
    <context id="ib7001acb1c0940d18c4cb5e7df98ee1e_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i5ec50d6371f84eb3808d2b78b4f8710a_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="ifcbf1d24a625419793f28cc2390b7c49_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i4365454cfaf648c79ea4a5b95d9f8a4f_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ib8e59782bbf940fbb42fef683312041e_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i9f1e3af8e2a7433f93e2da46dedb4bae_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="idc2a92285efd424994eb094e0817bfc3_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i7f0b1fccad9c4d07b2db0f2507871783_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i7898b0b327ab449eb16708ed5b14e472_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i0de59d4f1eeb42f8bbb0fb2fe5621340_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ie44679796a144c26b4b62a377639993f_I20161102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-11-02</instant>
        </period>
    </context>
    <context id="i191becb0a3c544ecaf8184ef7e8acb3d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6197d49ef31446ffacc35056221fecbf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7b734952dace49dab51be5df71c2cdad_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i45de384d4b8f4d4aa79185b3cf224a05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8ddb5c89f1944d7f9dfa198754d529ee_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i33239c1a09204337ad5c55fefd2f9d8c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idf731d8db2514741951a6d08a5bf2340_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i56a02a7778f5400493e2859f84b416f2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if38c0c0626334984872a2e8f0277dc2e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iefa0cb672bf44372a091873f1dfe9120_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibe641cc44c4a46438e0b7bfd4cc3622e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iecd646f2764643b59a88988226c92eff_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id4a67b4c90b54c758612bcb4085bec12_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i12d2dcb1b92e4bcb94f40436329a7dd6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id52f8f655a4e45b28cdd084d28393f28_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i47faa1c1728e4e11a77c17ac0400684b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idedf5740b04f4deea7f8b81566c50b36_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1d8528d81dc241b8800e77a29be29f47_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic1952024433d45cdb011fb1c5362e577_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic976b0752299464f9eb1c2e3a0466f84_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i537c6fd82b2d4484a4285287e0da5e8d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5fcb54914f1448388da80fbfae61bf9b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i89f5412889bb4704867c4db1cb7606ca_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i80de0413731140859ba1fca6bbc151be_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7e05796d442740d6b0e31e64c7579488_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i22587a4dc04645edaa23ee4e6fe5309c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i320caa0f2438447eb917283e43737ae0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia60c00beb57f4d0aa1389f1cbd1b8aa9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i46462aa1e76c440a848f1a6c4854fcbf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4c8056adf6394fb8a935b96c8a1244bc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i73d82d6008cf422f990c1967019b47ae_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i38f0d7cd0319413a864c57d831aa6de9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia5c9058389544d8f9fd0949b2df8c97e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8fa36c1044d245bfa0fdac23491e04fe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5168781fe0f2491a9d873c5536902ff3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia9a54e61594a4ce5afdb32319e63cfe5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7d6fd9a3e6ba4affb174e7bf3606494f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibd3134eb77504bf1a35552d9f49abbce_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifd24288b5c4a41a39c5a91e91a8ef6bf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icb78040186fa4e1aaee57c20ecf08ec1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iaeb02179387b4c138f3d16aecc35f88b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i02e8e4d27b8640368de9694d52106ab1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i38524abcd2514a1fb4737a87a7e66b81_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i744afac31d1c419187429ada2dec85cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5cb66a72330944e6abe3847855220870_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i840219be56704e14b8dd4d1adb3ca119_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia4d9088e966a40a68d31fc31fc7a2d2a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ida4612fe99b04ca2aa41bf1a2e73fe9a_D20120101-20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-12-31</endDate>
        </period>
    </context>
    <context id="i384f03c6d15c44d196ee290093383364_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:RadcliffeAndFlaimVAetnaIncEtAlMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib1c774f4ed3c4faabc1e5df119dd09f8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieb5b7e4050464b31ba5e844cce234bd4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i81f235791bca4dbc853d081abfa4d343_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1620dfc000424fd3b15b25a1ac9a1791_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifc97d958fa084ddc939774b0bc91d620_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8d900d4b1ca34915859e9703c35c8775_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic04e76d8cae84ec2a080a6f0fc22a523_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i307fb82e77314c8895bc793a68fe29dc_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8d22088cdb00442b89bdd1fe6cf8a26b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8b7044360fae43969a13838008e79bb1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iacf5f0e00659493589182745e85a0e36_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iedfff3121ba6469d9e77415864b5a41a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i45a7d151a028477481ac7f32edde55eb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i28069fe437ba40d9b14e06d3899dbf60_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0d7f4151778947ca96d8cb506330110a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8246339cd89c42688813a929c411f371_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i020d373f0ad2415aa7656c159c909537_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0ac023dc2cf14e8aa8be582c9ee42c76_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6a39cfe4d74743ff8499e3d09c93e0c5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i104116dd6efe40a7bb00f658c0ab14e3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0311b59b583f418eaccfec74aac1d61f_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0975e9ea8e5e480faf0a315905252457_D20200731-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-31</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="location">
        <measure>cvs:location</measure>
    </unit>
    <unit id="clinic">
        <measure>cvs:clinic</measure>
    </unit>
    <unit id="people">
        <measure>cvs:people</measure>
    </unit>
    <unit id="patient">
        <measure>cvs:patient</measure>
    </unit>
    <unit id="segment">
        <measure>cvs:Segment</measure>
    </unit>
    <unit id="state">
        <measure>cvs:state</measure>
    </unit>
    <unit id="security">
        <measure>cvs:security</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="store">
        <measure>cvs:store</measure>
    </unit>
    <unit id="member">
        <measure>cvs:member</measure>
    </unit>
    <unit id="claim">
        <measure>cvs:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80L2ZyYWc6MGUyNjA0NWQxYzcyNDMyYWFmNGIwYjljMTA5ZWE4MDQvdGFibGU6Y2M1M2E0MWQzMjgyNGEzYmFlZTcwODFiNGQ3MjRmMjIvdGFibGVyYW5nZTpjYzUzYTQxZDMyODI0YTNiYWVlNzA4MWI0ZDcyNGYyMl8zLTEtMS0xLTA_1c3f9a3d-e1fa-405d-8747-e9d281707d4c">0000064803</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80L2ZyYWc6MGUyNjA0NWQxYzcyNDMyYWFmNGIwYjljMTA5ZWE4MDQvdGFibGU6Y2M1M2E0MWQzMjgyNGEzYmFlZTcwODFiNGQ3MjRmMjIvdGFibGVyYW5nZTpjYzUzYTQxZDMyODI0YTNiYWVlNzA4MWI0ZDcyNGYyMl80LTEtMS0xLTA_e92d698c-6b6d-4dca-8312-299db04fa9bd">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80L2ZyYWc6MGUyNjA0NWQxYzcyNDMyYWFmNGIwYjljMTA5ZWE4MDQvdGFibGU6Y2M1M2E0MWQzMjgyNGEzYmFlZTcwODFiNGQ3MjRmMjIvdGFibGVyYW5nZTpjYzUzYTQxZDMyODI0YTNiYWVlNzA4MWI0ZDcyNGYyMl81LTEtMS0xLTA_dfbedd34-6dc5-4c2b-ac1b-b7d8f0b761c2">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80L2ZyYWc6MGUyNjA0NWQxYzcyNDMyYWFmNGIwYjljMTA5ZWE4MDQvdGFibGU6Y2M1M2E0MWQzMjgyNGEzYmFlZTcwODFiNGQ3MjRmMjIvdGFibGVyYW5nZTpjYzUzYTQxZDMyODI0YTNiYWVlNzA4MWI0ZDcyNGYyMl82LTEtMS0xLTA_2f28591d-93b9-4232-90fb-4af3e969cdd6">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80L2ZyYWc6MGUyNjA0NWQxYzcyNDMyYWFmNGIwYjljMTA5ZWE4MDQvdGFibGU6Y2M1M2E0MWQzMjgyNGEzYmFlZTcwODFiNGQ3MjRmMjIvdGFibGVyYW5nZTpjYzUzYTQxZDMyODI0YTNiYWVlNzA4MWI0ZDcyNGYyMl83LTEtMS0xLTA_d46fde7d-25b4-46dc-a734-2f53b4a7b7fa">false</dei:AmendmentFlag>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0wLTEtMS0w_51df1bf1-ea40-4dda-aacf-0790c85c5f35">http://fasb.org/us-gaap/2021-01-31#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0wLTEtMS0w_ce153847-f1d8-473f-ba33-7838efabea74">http://fasb.org/us-gaap/2021-01-31#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0wLTEtMS0w_d7e8ee36-962e-44b5-9405-217e509268a0">http://fasb.org/us-gaap/2021-01-31#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0wLTEtMS0w_ec68be8b-ec23-4ae8-b389-cfb8e2497555">http://fasb.org/us-gaap/2021-01-31#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i06e2801f1e8f4d4bb0ba64b129f8714a_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi0wLTEtMS0w_b7f503b3-72c7-47e0-954f-75dfffc049a2">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <dei:DocumentType
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N184Nw_37aa6e89-a214-4268-9733-cdb58f9c720b">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDMx_cd1517cd-3033-454a-9f21-cf8769b8176b">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMjU_61057fdd-68f1-4249-89fd-f2ce4ef40344">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDMy_e5ccf0a3-4aa9-4219-ba53-b4420aaae24a">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDMz_d9308d2c-078b-4568-b6e4-b355b469fdd0">001-01011</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDM0_97c2c71d-94b0-41e3-b31e-8dabbb4bb75d">CVS HEALTH CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6NDVjODRiZmVjYzBiNGVkYmE0ZTlkMjY3MTRmNDY2NzgvdGFibGVyYW5nZTo0NWM4NGJmZWNjMGI0ZWRiYTRlOWQyNjcxNGY0NjY3OF8wLTAtMS0xLTA_3d0e855a-6e7b-45da-80d7-0d53dbe197cf">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6NDVjODRiZmVjYzBiNGVkYmE0ZTlkMjY3MTRmNDY2NzgvdGFibGVyYW5nZTo0NWM4NGJmZWNjMGI0ZWRiYTRlOWQyNjcxNGY0NjY3OF8wLTItMS0xLTA_c71a971c-b94f-42b6-b4b4-156d52f4614a">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6YzM3ZmQ5YWJhNTgxNDU2OWIyNWU0NjQ1MGQyOTgyNmMvdGFibGVyYW5nZTpjMzdmZDlhYmE1ODE0NTY5YjI1ZTQ2NDUwZDI5ODI2Y18wLTEtMS0xLTA_af11cd84-b10d-42e5-a927-f953ec52f95b">One CVS Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6YzM3ZmQ5YWJhNTgxNDU2OWIyNWU0NjQ1MGQyOTgyNmMvdGFibGVyYW5nZTpjMzdmZDlhYmE1ODE0NTY5YjI1ZTQ2NDUwZDI5ODI2Y18wLTItMS0xLTA_8eae5ec0-500b-4bc1-8036-6c58200cdce5">Woonsocket,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6YzM3ZmQ5YWJhNTgxNDU2OWIyNWU0NjQ1MGQyOTgyNmMvdGFibGVyYW5nZTpjMzdmZDlhYmE1ODE0NTY5YjI1ZTQ2NDUwZDI5ODI2Y18wLTMtMS0xLTA_50434a68-4543-4520-ada9-b09bd5b29251">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6YzM3ZmQ5YWJhNTgxNDU2OWIyNWU0NjQ1MGQyOTgyNmMvdGFibGVyYW5nZTpjMzdmZDlhYmE1ODE0NTY5YjI1ZTQ2NDUwZDI5ODI2Y18wLTUtMS0xLTA_c2d4b330-fb44-4988-ae90-8b6c39e358fa">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6YzM3ZmQ5YWJhNTgxNDU2OWIyNWU0NjQ1MGQyOTgyNmMvdGFibGVyYW5nZTpjMzdmZDlhYmE1ODE0NTY5YjI1ZTQ2NDUwZDI5ODI2Y18zLTUtMS0xLTA_ab67452e-874f-4134-9456-e42463d35591">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6YzM3ZmQ5YWJhNTgxNDU2OWIyNWU0NjQ1MGQyOTgyNmMvdGFibGVyYW5nZTpjMzdmZDlhYmE1ODE0NTY5YjI1ZTQ2NDUwZDI5ODI2Y18zLTYtMS0xLTA_c29f9a39-eed6-43be-81ad-ca269338a494">765-1500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6ZDQyZGMyZTkzNTRlNGIxNmE1ZGFiNDQ2YTQ5OWZjNWEvdGFibGVyYW5nZTpkNDJkYzJlOTM1NGU0YjE2YTVkYWI0NDZhNDk5ZmM1YV8xLTAtMS0xLTA_29890012-9f8a-4143-82d4-a946473ab7ef">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6ZDQyZGMyZTkzNTRlNGIxNmE1ZGFiNDQ2YTQ5OWZjNWEvdGFibGVyYW5nZTpkNDJkYzJlOTM1NGU0YjE2YTVkYWI0NDZhNDk5ZmM1YV8xLTEtMS0xLTA_19d2abcd-873d-4468-a124-4aee95155be9">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6ZDQyZGMyZTkzNTRlNGIxNmE1ZGFiNDQ2YTQ5OWZjNWEvdGFibGVyYW5nZTpkNDJkYzJlOTM1NGU0YjE2YTVkYWI0NDZhNDk5ZmM1YV8xLTItMS0xLTA_08e6cb02-7dc9-4046-92b6-d50d997c7ed0">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDI4_04748e76-e287-48d9-b64d-7fe3d66e0d2c">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDI5_94dc8fcb-bff5-4e1d-b81d-c1cd59a8c80f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6MDQwZGY2OWE0YzIyNDk4NDg5ZDJlODMzNjAwMjkwNzAvdGFibGVyYW5nZTowNDBkZjY5YTRjMjI0OTg0ODlkMmU4MzM2MDAyOTA3MF8wLTAtMS0xLTA_b06a7aeb-9b26-4a67-bb70-f1da2b5768dc">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6MDQwZGY2OWE0YzIyNDk4NDg5ZDJlODMzNjAwMjkwNzAvdGFibGVyYW5nZTowNDBkZjY5YTRjMjI0OTg0ODlkMmU4MzM2MDAyOTA3MF8xLTMtMS0xLTA_dd8bd117-d5e9-4e40-9526-4e38cad6c29a">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGFibGU6MDQwZGY2OWE0YzIyNDk4NDg5ZDJlODMzNjAwMjkwNzAvdGFibGVyYW5nZTowNDBkZjY5YTRjMjI0OTg0ODlkMmU4MzM2MDAyOTA3MF8yLTMtMS0xLTA_14e9933b-61ae-49ca-af92-4a35381cf667">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18yMDMw_d15d8ab8-9f5b-412f-879d-7e58fb665eec">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i01397c0a67fe4cc788c55f7cf5e5d177_I20211027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xL2ZyYWc6ZmEyMDg3YmM2YTVjNDE0YjlmYTQ5YmY2ZWY2NTk2NTcvdGV4dHJlZ2lvbjpmYTIwODdiYzZhNWM0MTRiOWZhNDliZjZlZjY1OTY1N18xOTgw_55ee4e51-d79f-4c41-91d0-2964754df3a1"
      unitRef="shares">1320058657</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifdf12dfa1c48413dbb649aad32495c18_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMy0xLTEtMS0w_6629c2da-45da-4f8b-98c3-b500e64a61d8"
      unitRef="usd">51853000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc9deb51f5bb4f66aeeede8d66412ffa_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMy0zLTEtMS0w_3bc4243f-4c57-4a98-8808-1b8a3fdd3205"
      unitRef="usd">47738000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b9b6ee2abc8442796e1853380c5e295_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMy01LTEtMS0w_c918ea43-a9a3-4078-95f4-79757f7e14c6"
      unitRef="usd">149765000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if40d51c00c3843f6a2791ae818b66480_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMy03LTEtMS0w_357b1686-db7c-4f80-be6c-0cac04056537"
      unitRef="usd">141096000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:PremiumsEarnedNet
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNC0xLTEtMS0w_d3c2eab5-aaa8-4303-9427-d869214341d6"
      unitRef="usd">18984000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNC0zLTEtMS0w_57f77777-0165-424f-84f0-64df591e6dcf"
      unitRef="usd">17182000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNC01LTEtMS0w_261b5a56-f0d9-4df4-a847-4b8d8ace0939"
      unitRef="usd">56927000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNC03LTEtMS0w_0384e34c-50f5-4b1d-aa87-d20e80b15c0f"
      unitRef="usd">51749000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i198519b4ab0741be886e63579724dda2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNS0xLTEtMS0w_65fbf207-5195-4085-b90d-e5bd0d7f8244"
      unitRef="usd">2711000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd200dc7e8bf44ecaa5ed256c3e815d3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNS0zLTEtMS0w_5b40b59a-7ed1-4de9-bc9c-d7a2bb2c5c1c"
      unitRef="usd">1932000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3312e30597dd4849b396d77a190ab38a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNS01LTEtMS0w_3a24ecac-a74d-4272-8d20-6f4f572d02a7"
      unitRef="usd">7983000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3ded585d03e4dee889ec0a76b1c3773_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNS03LTEtMS0w_97444169-c3d5-4794-92c5-19ab7adbe348"
      unitRef="usd">5757000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNi0xLTEtMS0w_286be67d-3624-4e43-a168-238766c77e79"
      unitRef="usd">246000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNi0zLTEtMS0w_cfc107c3-81f5-4a46-9950-d1c3380a91aa"
      unitRef="usd">204000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNi01LTEtMS0w_94e03f3d-116b-4998-96d8-70305a7b8d72"
      unitRef="usd">832000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNi03LTEtMS0w_11f7d075-55fe-4e7a-aa45-9978baaeb64f"
      unitRef="usd">550000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNy0xLTEtMS0w_79ed0063-2ee9-493d-a3d2-1c8ddab8b2ed"
      unitRef="usd">73794000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNy0zLTEtMS0w_50808680-ce7d-4710-b248-07fd3f06f00b"
      unitRef="usd">67056000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNy01LTEtMS0w_1d52fb95-7b2b-485f-9be1-0e45f1e15127"
      unitRef="usd">215507000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNy03LTEtMS0w_82e12bc2-1d68-491e-877d-7e0b5c60c3b9"
      unitRef="usd">199152000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0xLTEtMS0w_4f37b59e-1475-48ea-af5b-ad0b8ef02466"
      unitRef="usd">45011000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS0zLTEtMS0w_b3e8f63e-4fcd-4e1b-a998-7c791267a7d7"
      unitRef="usd">40940000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS01LTEtMS0w_f3f1e805-01b8-46d4-8e19-84fbcb11423b"
      unitRef="usd">129425000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfOS03LTEtMS0w_620f9bb6-cd83-422c-bfaa-a08433d12b63"
      unitRef="usd">121529000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTAtMS0xLTEtMA_a952b29c-ca51-410f-98fd-20703bf8853c"
      unitRef="usd">16081000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTAtMy0xLTEtMA_82d4fb6a-0ba9-44e0-924a-e5d4619ce03a"
      unitRef="usd">14396000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTAtNS0xLTEtMA_1f05d15d-205f-42d8-a4a7-e3bf49b9e884"
      unitRef="usd">47686000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTAtNy0xLTEtMA_9e557163-ed75-4d5a-9793-a30eb66f29bd"
      unitRef="usd">40534000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtMS0xLTEtNzU3MA_cd93a4d0-cffc-4940-bfa4-daa7a13da6ab"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtMy0xLTEtNzU4Nw_bdfe24f2-d2b6-4a59-994b-0e384e6835ca"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtNS0xLTEtNzYwNQ_226325f1-4e11-41bb-84a1-40d4c491afbb"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtNy0xLTEtNzYyMw_5e595806-cac4-4ec4-b413-997d786a3e2e"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <cvs:OperatingExpensesExcludingGoodwillImpairments
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtMS0xLTEtMA_2ad81d12-ad4c-4c3f-807f-836759305ac5"
      unitRef="usd">9210000000</cvs:OperatingExpensesExcludingGoodwillImpairments>
    <cvs:OperatingExpensesExcludingGoodwillImpairments
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtMy0xLTEtMA_c68f9672-2ffe-48ef-99e0-0b6a64f30160"
      unitRef="usd">8471000000</cvs:OperatingExpensesExcludingGoodwillImpairments>
    <cvs:OperatingExpensesExcludingGoodwillImpairments
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtNS0xLTEtMA_422c92d3-ae11-4848-8d84-7b7dc8cf2382"
      unitRef="usd">27001000000</cvs:OperatingExpensesExcludingGoodwillImpairments>
    <cvs:OperatingExpensesExcludingGoodwillImpairments
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTEtNy0xLTEtMA_b7788215-a856-4448-b9f1-63b8cdfb0b7c"
      unitRef="usd">25702000000</cvs:OperatingExpensesExcludingGoodwillImpairments>
    <us-gaap:CostsAndExpenses
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTItMS0xLTEtMA_43653d76-cc9a-4b4e-8cb5-9a70e617912b"
      unitRef="usd">70733000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTItMy0xLTEtMA_4d03915d-887c-4171-a5ab-9567342768a6"
      unitRef="usd">63807000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTItNS0xLTEtMA_e2b97ffb-ebc7-4ce0-acc6-2375c484fc41"
      unitRef="usd">204543000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTItNy0xLTEtMA_aa233864-3e3f-4903-9a56-06cf233c1c87"
      unitRef="usd">187765000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTMtMS0xLTEtMA_fb515f1e-cbdf-4efe-9e74-f76f969ab6b4"
      unitRef="usd">3061000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTMtMy0xLTEtMA_258fc45e-d586-4789-b0c9-fd2806bd003f"
      unitRef="usd">3249000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTMtNS0xLTEtMA_6e0a3ef2-0648-4854-a19b-cef4fc287b68"
      unitRef="usd">10964000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTMtNy0xLTEtMA_cd62e712-ec73-4ceb-917c-bc57a0a1a9f8"
      unitRef="usd">11387000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTQtMS0xLTEtMA_aef69925-7ffb-4c54-abc6-a1c9b80334eb"
      unitRef="usd">602000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTQtMy0xLTEtMA_dec10a08-58ce-420e-a99a-ca4c2b647417"
      unitRef="usd">731000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTQtNS0xLTEtMA_075f7293-eec6-4b8e-aa5c-7a70928ee7f4"
      unitRef="usd">1895000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTQtNy0xLTEtMA_9b144179-2778-4845-9e90-04ef999806db"
      unitRef="usd">2229000000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTUtMS0xLTEtMA_42471213-bcf0-4d52-a59e-20959a5c1461"
      unitRef="usd">-363000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTUtMy0xLTEtMA_2e95b86c-263d-4ac7-8377-6f96bd3d8f7a"
      unitRef="usd">-766000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTUtNS0xLTEtMA_7d15fd29-e6fb-41ee-b78e-fbdee428475a"
      unitRef="usd">-363000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTUtNy0xLTEtMA_3ad9d89c-ed9f-48e6-a3bf-7bfe79963642"
      unitRef="usd">-766000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTYtMS0xLTEtMA_bffc3088-9334-413a-8836-e492ae9c7f79"
      unitRef="usd">49000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTYtMy0xLTEtMA_c552560c-51d6-4fd0-8fc1-9aa1be8c273d"
      unitRef="usd">54000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTYtNS0xLTEtMA_7c411f78-f92d-42a4-90f0-c0cc958d7b5e"
      unitRef="usd">144000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTYtNy0xLTEtMA_96185fe1-89c2-49a7-b6e2-b017f382a901"
      unitRef="usd">153000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTctMS0xLTEtMA_15fdb3f9-2ddd-499b-b06d-eb96386bb06c"
      unitRef="usd">2145000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTctMy0xLTEtMA_25f734a9-9751-4738-813b-df13a26db504"
      unitRef="usd">1806000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTctNS0xLTEtMA_9ca4569d-a50d-45e5-9a1a-87e4f4e19cee"
      unitRef="usd">8850000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTctNy0xLTEtMA_a8f61203-4f81-4c9e-9f7a-33259de8fb8e"
      unitRef="usd">8545000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTgtMS0xLTEtMA_e7fecc86-fc8c-416c-b863-45fab9d45026"
      unitRef="usd">558000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTgtMy0xLTEtMA_0a2193ae-3eff-498e-b63e-df8aa1071ffc"
      unitRef="usd">587000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTgtNS0xLTEtMA_f8e48888-8dfc-4589-acf1-c92f0318c623"
      unitRef="usd">2248000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMTgtNy0xLTEtMA_e310ec1f-5a12-4017-b416-9140bcc0ce46"
      unitRef="usd">2328000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjEtMS0xLTEtMA_04b7018a-f80d-45cc-abdf-37ba23a50343"
      unitRef="usd">1587000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjEtMy0xLTEtMA_9571d221-6493-4f7a-ae92-2d334e2678e5"
      unitRef="usd">1219000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjEtNS0xLTEtMA_b308433f-42c9-4758-9c00-e08fe0e126b4"
      unitRef="usd">6602000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjEtNy0xLTEtMA_75313df6-2c78-4e32-8331-cc4235bb0bdf"
      unitRef="usd">6217000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjItMS0xLTEtMA_169a6204-5744-4527-9668-42c6fc500796"
      unitRef="usd">-11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjItMy0xLTEtMA_7325229e-a404-4353-8454-6a556879d333"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjItNS0xLTEtMA_5f0bbdc4-f657-40ff-bbce-00e3023babd5"
      unitRef="usd">-2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjItNy0xLTEtMA_3422f3bb-0b94-4497-9721-6aa579ba57d0"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjMtMS0xLTEtMA_9667507d-dd5f-4bd4-b4fd-2039141e179b"
      unitRef="usd">1598000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjMtMy0xLTEtMA_ba8af6f1-5d21-41c8-9aca-79d9c5ef5b3a"
      unitRef="usd">1224000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjMtNS0xLTEtMA_37867f92-1b89-4642-b01d-4c597244e854"
      unitRef="usd">6604000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjMtNy0xLTEtMA_2230d694-a7d3-47ab-88f1-c225eddc69a2"
      unitRef="usd">6206000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjYtMS0xLTEtMA_db9f33a5-0fea-4a12-8cb1-f17153d7e84e"
      unitRef="usdPerShare">1.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjYtMy0xLTEtMA_6fdbec76-7491-4e88-b155-4a4770124752"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjYtNS0xLTEtMA_875e22ed-be5f-4d8f-8c31-229234c6963d"
      unitRef="usdPerShare">5.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjYtNy0xLTEtMA_a34e5024-4de4-498d-8413-b83048538f57"
      unitRef="usdPerShare">4.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjctMS0xLTEtMA_1af2d273-0d24-415e-ac25-3308350b6011"
      unitRef="usdPerShare">1.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjctMy0xLTEtMA_f10d6229-420c-4772-8e77-91917a9408b1"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjctNS0xLTEtMA_9b8f1777-19c8-4eb8-9ee9-6a9a34415aa3"
      unitRef="usdPerShare">4.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjctNy0xLTEtMA_5017157b-d68d-42a3-a7c6-eb0552e5e1f3"
      unitRef="usdPerShare">4.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjktMS0xLTEtMA_aa893404-d8e4-4b83-8757-4e821a499555"
      unitRef="shares">1321000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjktMy0xLTEtMA_15139f95-6329-4a62-87a5-b42e9e1a052f"
      unitRef="shares">1310000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjktNS0xLTEtMA_8e11ae59-2908-4a6a-a91b-6aba52e86a96"
      unitRef="shares">1318000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMjktNy0xLTEtMA_a431a1c5-5e1b-43b9-b42c-513fef60e9f1"
      unitRef="shares">1308000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMzAtMS0xLTEtMA_aeff4377-92e1-429e-bdcf-ce0edd58e4fd"
      unitRef="shares">1329000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMzAtMy0xLTEtMA_3cd277e1-bdfc-46d4-9617-a90ce2c49780"
      unitRef="shares">1315000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMzAtNS0xLTEtMA_c6bd3212-f780-497e-a59a-777dfa1ca689"
      unitRef="shares">1326000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfMzAtNy0xLTEtMA_bf1af7bc-11e0-4c7a-8f65-ea27ea06b580"
      unitRef="shares">1314000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNDEtMS0xLTEtMA_1d1b54c9-99ad-4ad3-96b3-c04f220207e0"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNDEtMy0xLTEtMA_2a65c530-e9ef-4b2b-b06c-a11f77b9c7fa"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNDEtNS0xLTEtMA_b9812c91-bbe6-4ae9-aa6b-f4f19eb9649d"
      unitRef="usdPerShare">1.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xOS9mcmFnOmYxNTM1MTc1ZDFhOTQyNDZhOWU0Yjc5YmIyOTc1OGQwL3RhYmxlOjY0NWY1NThkYjgyNjQ1OWViZWUwMTdkMzYyZmZiOGUxL3RhYmxlcmFuZ2U6NjQ1ZjU1OGRiODI2NDU5ZWJlZTAxN2QzNjJmZmI4ZTFfNDEtNy0xLTEtMA_b304f63f-1093-4fa4-96b2-fc816769dfe3"
      unitRef="usdPerShare">1.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMi0xLTEtMS0w_04b7018a-f80d-45cc-abdf-37ba23a50343"
      unitRef="usd">1587000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMi0zLTEtMS0w_9571d221-6493-4f7a-ae92-2d334e2678e5"
      unitRef="usd">1219000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMi01LTEtMS0w_b308433f-42c9-4758-9c00-e08fe0e126b4"
      unitRef="usd">6602000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMi03LTEtMS0w_75313df6-2c78-4e32-8331-cc4235bb0bdf"
      unitRef="usd">6217000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNC0xLTEtMS0w_70c21c2a-21cb-4674-a8d3-22950d9ab9df"
      unitRef="usd">-73000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNC0zLTEtMS0w_6cfb1ea0-4200-4a76-9d03-5cb2e0581dcd"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNC01LTEtMS0w_6b8ac751-d4f7-42de-8a86-81edd2bcb32e"
      unitRef="usd">-310000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNC03LTEtMS0w_1a70cb79-8825-4e62-b2cb-a55fb71e6a0f"
      unitRef="usd">257000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNS0xLTEtMS0w_de85d0cf-9357-411d-9c7a-c4dfc68063a2"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNS0zLTEtMS0w_fe663bd9-7ff3-40f7-8bf9-b20b7f006d79"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNS01LTEtMS0w_4bb883a3-6919-4b03-ac0d-fdc9e5860b3a"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNS03LTEtMS0w_a9ac12d7-f3d0-4c06-9bc5-e1c70deefe96"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNi0xLTEtMS0w_07112298-0c8f-4429-b3d0-d15591417348"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNi0zLTEtMS0w_715c0fc1-a2a9-44dd-90bf-0514043f6ad9"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNi01LTEtMS0w_3ccafdd4-052e-48b6-bf0a-cfd3ec877044"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNi03LTEtMS0w_1aba967a-ba3a-4b0f-bee7-4ed3eb2f8522"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNy0xLTEtMS0w_d4186b03-ccce-41b2-af53-4d86952c26c5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNy0zLTEtMS0w_da9df924-f0e1-4b36-802d-7e286edd00a8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNy01LTEtMS0w_5f0abcbd-7d46-4b17-95ca-d649db12a62f"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfNy03LTEtMS0w_173149af-a9fd-45d0-af63-a8e094602069"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOC0xLTEtMS0w_69bd7db9-c328-4987-b18e-56e97a7a4d8b"
      unitRef="usd">-93000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOC0zLTEtMS0w_8900a25d-91cb-4f5c-85c4-189b868620f5"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOC01LTEtMS0w_cc20afdd-7ef0-4a8f-a5d6-a0cd1eae977a"
      unitRef="usd">-337000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOC03LTEtMS0w_5cd58f5e-b5a7-4386-9898-97a24f39c682"
      unitRef="usd">236000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOS0xLTEtMS0w_23871e99-c730-4727-8a9f-c98b31c70f55"
      unitRef="usd">1494000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOS0zLTEtMS0w_b9e8ec64-1ccb-4a6d-a0bb-4a9fd1eaa7af"
      unitRef="usd">1261000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOS01LTEtMS0w_c7f53a28-bc60-4a08-92dc-af5f194e5c62"
      unitRef="usd">6265000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfOS03LTEtMS0w_e05eab05-4d94-4df9-9f75-eacf6279111e"
      unitRef="usd">6453000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTAtMS0xLTEtMA_169a6204-5744-4527-9668-42c6fc500796"
      unitRef="usd">-11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTAtMy0xLTEtMA_e44f4d20-53cd-4ba7-b0ca-e208a54ae27f"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTAtNS0xLTEtMA_5f0bbdc4-f657-40ff-bbce-00e3023babd5"
      unitRef="usd">-2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTAtNy0xLTEtMA_3422f3bb-0b94-4497-9721-6aa579ba57d0"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTEtMS0xLTEtMA_9a8444ad-639c-41b4-bc2d-e9a3f8258110"
      unitRef="usd">1505000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTEtMy0xLTEtMA_94fd55ad-9ddc-4905-855c-7322cdabd86a"
      unitRef="usd">1266000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTEtNS0xLTEtMA_3049e63e-f02c-4d8b-91a9-bcc02af210c5"
      unitRef="usd">6267000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yMi9mcmFnOjA2MzIyNjUxYWRhYjQyNGI4NmYzYTA2NDY5ZjVhZGJhL3RhYmxlOjU0MDgxZDJmYjBjNjQ0ZDJiYTM4ZDkxYzRmZWZmZjk2L3RhYmxlcmFuZ2U6NTQwODFkMmZiMGM2NDRkMmJhMzhkOTFjNGZlZmZmOTZfMTEtNy0xLTEtMA_0d5f9a5f-7071-4163-96b9-dc55927bf4a4"
      unitRef="usd">6442000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMi0xLTEtMS0w_33f03c85-46e8-4fbd-b9ab-0667f6426329"
      unitRef="usd">9826000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMi0zLTEtMS0w_5071ef91-838b-4554-bca2-137c7e4bd82a"
      unitRef="usd">7854000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMy0xLTEtMS0w_34b9609d-b8d9-49bf-8294-8a9416925da9"
      unitRef="usd">3015000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMy0zLTEtMS0w_e7dcbb48-8572-4dcc-9979-928a50524f97"
      unitRef="usd">3000000000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNC0xLTEtMS0w_7bb12d66-364f-48ee-b338-7de5623d1717"
      unitRef="usd">25283000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNC0zLTEtMS0w_6d91d08d-b41b-42a4-baa6-4979d6f2acad"
      unitRef="usd">21742000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNS0xLTEtMS0w_2a788bf0-b80d-4388-b3a8-930d644adfb8"
      unitRef="usd">17399000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNS0zLTEtMS0w_ba227147-318e-4452-a44b-0c2df175c0d9"
      unitRef="usd">18496000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNi0xLTEtMS0w_b175ecd7-2479-4226-a2a2-9cbc4518e20f"
      unitRef="usd">5319000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNi0zLTEtMS0w_1ab508db-986b-4fba-8ff9-48e71ae6adaa"
      unitRef="usd">5277000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNy0xLTEtMS0w_4a9fca7f-f36f-4d6b-8f27-dfba13a70fbb"
      unitRef="usd">60842000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNy0zLTEtMS0w_0002787d-41bf-445d-acdb-19bc0fb8bedc"
      unitRef="usd">56369000000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfOC0xLTEtMS0w_e7fda66b-e800-457f-899e-77f3796c77da"
      unitRef="usd">22370000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfOC0zLTEtMS0w_f1555326-7a90-49ee-98f3-ece9cf0d3519"
      unitRef="usd">20812000000</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfOS0xLTEtMS0w_ff3fd2b0-962a-4b57-a2c9-d76aa6ffce9b"
      unitRef="usd">12771000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfOS0zLTEtMS0w_cb0cfdb3-b2aa-4eea-b4e7-0ff284f21d81"
      unitRef="usd">12606000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTAtMS0xLTEtMA_90fccc2d-032c-4919-a9f1-a3ea7c7491ba"
      unitRef="usd">20462000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTAtMy0xLTEtMA_f476af67-cfa1-4306-93ac-0f435c76a6b5"
      unitRef="usd">20729000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTEtMS0xLTEtMA_3a42c68d-9c73-44fe-9903-b4b9e684ba1e"
      unitRef="usd">79121000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTEtMy0xLTEtMA_3ceb42bb-d0f5-488c-8a9c-3cc3eebf2920"
      unitRef="usd">79552000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTItMS0xLTEtMA_1265c818-94ed-4da1-8602-c16ab9c3c10b"
      unitRef="usd">29545000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTItMy0xLTEtMA_92d52a5f-1782-4992-893f-65192bfc58f9"
      unitRef="usd">31142000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:SeparateAccountAssets
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTMtMS0xLTEtMA_13705155-4a00-4368-bbd5-1010661ee18d"
      unitRef="usd">5086000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTMtMy0xLTEtMA_31048ccd-6854-4aef-85d8-8b036a551e02"
      unitRef="usd">4881000000</us-gaap:SeparateAccountAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTQtMS0xLTEtMA_41974607-aabc-4e3c-a734-a85b7a553e9c"
      unitRef="usd">4694000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTQtMy0xLTEtMA_cf471b0f-6cf6-4bc8-aee2-1dd0175c71de"
      unitRef="usd">4624000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTUtMS0xLTEtMA_53292201-7ebe-4576-89db-a494468be340"
      unitRef="usd">234891000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTUtMy0xLTEtMA_da8f6c4e-ab92-4ff2-a436-1ee8e9fdf1b8"
      unitRef="usd">230715000000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTgtMS0xLTEtMA_90c1297e-0a04-41ca-ab0b-bc88f8cb9dc8"
      unitRef="usd">12696000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTgtMy0xLTEtMA_6d4321b0-1938-4bbf-8607-ec25b0a50ecd"
      unitRef="usd">11138000000</us-gaap:AccountsPayableTradeCurrent>
    <cvs:PharmacyClaimsandDiscountsPayableCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTktMS0xLTEtMA_8be28103-3d83-4557-b48a-783154c0ad9d"
      unitRef="usd">17895000000</cvs:PharmacyClaimsandDiscountsPayableCurrent>
    <cvs:PharmacyClaimsandDiscountsPayableCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMTktMy0xLTEtMA_fff9e7b2-a7b8-4ef1-9f63-524966155e0a"
      unitRef="usd">15795000000</cvs:PharmacyClaimsandDiscountsPayableCurrent>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjAtMS0xLTEtMA_9795ff5c-0057-45dd-a8d3-1c48ad18483f"
      unitRef="usd">8877000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjAtMy0xLTEtMA_599bc77d-ee7b-468d-8681-c84bc9ccefa4"
      unitRef="usd">7936000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:OtherPolicyholderFunds
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjEtMS0xLTEtMA_0961f03c-aa1a-4fa1-bfaa-a3a22a2ce3c6"
      unitRef="usd">4444000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:OtherPolicyholderFunds
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjEtMy0xLTEtMA_8366140e-1ab7-4085-b3a3-5b66e95d1451"
      unitRef="usd">4270000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjItMS0xLTEtMA_b0123346-d4f3-415f-b73e-ac7484d67d41"
      unitRef="usd">16140000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjItMy0xLTEtMA_eda0e10f-c328-4b85-8cbd-f8abb26a2b1c"
      unitRef="usd">14243000000</us-gaap:AccruedLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjMtMS0xLTEtMA_0b6facc8-5092-4138-b896-95a302e5ef96"
      unitRef="usd">1287000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjMtMy0xLTEtMA_8ed04520-2f2c-4753-97b0-ccb01d2c2fac"
      unitRef="usd">1557000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjQtMS0xLTEtMA_0b52d326-d109-499e-a7db-1ff4f2bb175e"
      unitRef="usd">1809000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjQtMy0xLTEtMA_e0d43086-ecf6-4a84-a672-4e06e35e7eaf"
      unitRef="usd">1638000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjYtMS0xLTEtMA_11a6354c-713b-4104-8e84-df1059138e24"
      unitRef="usd">1561000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjYtMy0xLTEtMA_25ab5884-3052-4c53-b172-e3e33967c55f"
      unitRef="usd">5440000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjctMS0xLTEtMA_c58b9864-e7ab-4a91-aac8-b126a61b0179"
      unitRef="usd">64709000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjctMy0xLTEtMA_afb50df6-1305-4534-8ff6-b96c588f58fa"
      unitRef="usd">62017000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjgtMS0xLTEtMA_1d47066e-8b6a-4c8c-9612-6f03dd16626e"
      unitRef="usd">18456000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjgtMy0xLTEtMA_114e1636-de43-4955-8002-728211eee9d2"
      unitRef="usd">18757000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjktMS0xLTEtMA_b732eef5-857d-4fa5-9dc4-423e7a2fc7ff"
      unitRef="usd">56832000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMjktMy0xLTEtMA_5d8c119c-efaa-4919-8a68-6261e1955d6e"
      unitRef="usd">59207000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzAtMS0xLTEtMA_2bec0f1a-063e-42c2-861b-40d1b8bcc911"
      unitRef="usd">6329000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzAtMy0xLTEtMA_997014a1-38fa-41b6-8ab6-4a54741be4f5"
      unitRef="usd">6794000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:SeparateAccountsLiability
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzEtMS0xLTEtMA_c81a1f88-d24f-4121-810d-646cb38f2ae9"
      unitRef="usd">5086000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountsLiability
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzEtMy0xLTEtMA_250aafbb-90fd-4991-8999-35983e8ba2f6"
      unitRef="usd">4881000000</us-gaap:SeparateAccountsLiability>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzItMS0xLTEtMA_1151ad1c-f96d-4eb9-a5d6-04fa4664a87d"
      unitRef="usd">6551000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzItMy0xLTEtMA_55b63974-6ba7-419a-87d8-52cdc0c2fdac"
      unitRef="usd">7007000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzMtMS0xLTEtMA_61869863-b7bc-49f8-aefe-8d56a21231c8"
      unitRef="usd">2310000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzMtMy0xLTEtMA_72998eb3-2643-4c67-aec7-a72a12144bda"
      unitRef="usd">2351000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzQtMS0xLTEtMA_50739d3f-cba9-43a5-ae0f-8817b735e854"
      unitRef="usd">160273000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzQtMy0xLTEtMA_0d997dee-7dba-4dd2-bea2-8282f29b5369"
      unitRef="usd">161014000000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzMx_25bb4194-7095-4911-843e-f16ab4744d80"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzMx_b91e5266-54f2-4fb9-b834-a8bd05903adc"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzM1_6719fc3a-436a-4c8a-9c42-0ef14f4ff647"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzM1_99be9ba0-b898-4953-834c-a3e2431253cc"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzU3_18698380-a36a-4ac2-9063-806d0b168906"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzU3_45026aa3-a97e-49df-a33d-b0b7f831c070"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzU3_a5638583-35bb-4136-8041-81434d4ee30a"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2MDA4YzRkZDEzYjQwMzliZmY2MDQwMTgzOTA3Zjg1XzU3_c1b48e0c-c540-4ab7-8880-191b108f0c67"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMS0xLTEtMA_64cbb992-0a07-4f5e-b8a9-3596293c11ad"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzctMy0xLTEtMA_3d18c188-8286-4d4e-b879-c3aacb535b0a"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzI4_625b89c1-cf70-4991-8cad-42a020abfa8a"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzI4_e43dbed3-235f-4618-88c6-003e512ac6d4"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzMy_0591d2c1-0385-49dd-87be-9dd60d606376"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzMy_d1cb71cc-5573-453c-8607-93fc2d51af47"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzU0_70a547b5-e865-499d-ab61-3694718f75eb"
      unitRef="shares">1743000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4Xzc1_8d3a9898-ab08-43ae-9520-afed44210258"
      unitRef="shares">1321000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzEwNw_4cc38f6d-4d66-4d91-bd35-2f523b825836"
      unitRef="shares">1733000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmJkYTI3MmEyZDcxZTQ2NzM4NDc5MGI4NWExZTIxNGI4XzEyOA_e46cfd50-cc35-4f74-99e8-30af3cda67da"
      unitRef="shares">1310000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMS0xLTEtMA_653cd1ac-a893-44b0-8dc6-2ce3c0e56894"
      unitRef="usd">47133000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzgtMy0xLTEtMA_44366385-289f-4163-9957-3eae48376a71"
      unitRef="usd">46513000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzktMC0xLTEtMC90ZXh0cmVnaW9uOmE3ZGU0YzMyOWFkMTQwZmY4NDUzMjk4MmJjODA2NDQxXzI5_cbaf0338-18c1-4073-a9d3-02759490fc44"
      unitRef="shares">422000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzktMC0xLTEtMC90ZXh0cmVnaW9uOmE3ZGU0YzMyOWFkMTQwZmY4NDUzMjk4MmJjODA2NDQxXzQ5_07db744d-3cc5-4ed2-9439-0cd76a49aff3"
      unitRef="shares">423000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzktMS0xLTEtMA_059fdd02-7601-4585-b9f1-8ca47518d373"
      unitRef="usd">28166000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfMzktMy0xLTEtMA_d6073f12-1edb-4f5c-9bdd-03ee4a2f9fd1"
      unitRef="usd">28178000000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDAtMS0xLTEtMA_bcbc131b-f73d-4f85-b02e-8aea0c39055b"
      unitRef="usd">54264000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDAtMy0xLTEtMA_b79c34e8-3750-4439-b995-3ea91e45500f"
      unitRef="usd">49640000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDEtMS0xLTEtMA_cea55f51-d7dc-4ab2-bc62-d2d7148a3723"
      unitRef="usd">1077000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDEtMy0xLTEtMA_16e79d86-b8f4-488f-a28a-612c49cdf1cc"
      unitRef="usd">1414000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDItMS0xLTEtMA_21b9b902-0866-4a5d-b3c2-817c7623ae6d"
      unitRef="usd">74308000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDItMy0xLTEtMA_e771bd4c-df13-4d67-80dc-df297ef5c8bd"
      unitRef="usd">69389000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDMtMS0xLTEtMA_ae9f9e00-90d6-4757-9bc0-1c09c0ff0f0f"
      unitRef="usd">310000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDMtMy0xLTEtMA_d26e2540-b779-4cd0-8a06-f63140d7cfa3"
      unitRef="usd">312000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDQtMS0xLTEtMA_dd65c25b-3f1a-4393-91f5-0e737373a08f"
      unitRef="usd">74618000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDQtMy0xLTEtMA_a52575d7-886f-4214-a487-a9678684bfb1"
      unitRef="usd">69701000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDUtMS0xLTEtMA_4e3544ff-3f98-4db5-85be-22ca1d4eb9c7"
      unitRef="usd">234891000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yNS9mcmFnOmZkMTk2NjBlZDc5NDQ4NjlhOTgyYjI1NDlkMzE0ZWYxL3RhYmxlOmQ3NzQ2YzgxMTgxYzQwMzVhOGY2MzZiOGMxMmVkNmM2L3RhYmxlcmFuZ2U6ZDc3NDZjODExODFjNDAzNWE4ZjYzNmI4YzEyZWQ2YzZfNDUtMy0xLTEtMA_e8d592c7-ec6f-4fad-842a-7cdb848de9f8"
      unitRef="usd">230715000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProceedsFromCustomers
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMy0xLTEtMS0w_e1a92d2b-b94a-408a-b5e6-73d51f922fdc"
      unitRef="usd">209104000000</us-gaap:ProceedsFromCustomers>
    <us-gaap:ProceedsFromCustomers
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMy0zLTEtMS0w_77a0b9bd-152b-42b3-9f43-8312b27fd868"
      unitRef="usd">195554000000</us-gaap:ProceedsFromCustomers>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNC0xLTEtMS0w_b34ee109-bbf6-497a-8ce7-85b5fdebc9fe"
      unitRef="usd">122129000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNC0zLTEtMS0w_e0f33232-5880-4587-803d-eff29684c420"
      unitRef="usd">116590000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNS0xLTEtMS0w_1fb4bb08-d970-43eb-91ee-b1d8a10e5fc1"
      unitRef="usd">46965000000</cvs:PaymentsforInsuranceBenefits>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNS0zLTEtMS0w_d5d83caa-8055-48cd-a937-4c5e4d1364ef"
      unitRef="usd">40221000000</cvs:PaymentsforInsuranceBenefits>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNi0xLTEtMS0w_9ed87b0f-74ef-44ef-9380-01586dc80335"
      unitRef="usd">21840000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNi0zLTEtMS0w_de0de563-c5c4-4900-8dde-b0291ba6c3e2"
      unitRef="usd">22185000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNy0xLTEtMS0w_5ca17c5a-784f-4329-9e47-add3c2f90055"
      unitRef="usd">582000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfNy0zLTEtMS0w_d56b5fdb-2e36-421d-a1fd-1bdec3ee4399"
      unitRef="usd">622000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:InterestPaidNet
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfOC0xLTEtMS0w_5228bf95-91e4-470f-bd8b-1334583fe9df"
      unitRef="usd">2095000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfOC0zLTEtMS0w_d534281f-ef46-4aee-a140-0edd21310f9b"
      unitRef="usd">2517000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfOS0xLTEtMS0w_30192316-2238-4784-b858-8930ca7e0791"
      unitRef="usd">2397000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfOS0zLTEtMS0w_81623df3-e797-44d6-b7a2-1977a6851723"
      unitRef="usd">2365000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTAtMS0xLTEtMA_a9c47c38-e018-4717-84d2-9ddfff107331"
      unitRef="usd">14260000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTAtMy0xLTEtMA_19cd064d-cb35-4b1f-ac3f-93766790dcd0"
      unitRef="usd">12298000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTMtMS0xLTEtMA_8d02e1e9-6b05-4742-9a7a-3cf1fe28d37d"
      unitRef="usd">5559000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTMtMy0xLTEtMA_fcea0f89-d203-47f6-befd-b92d10baec9b"
      unitRef="usd">3790000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTQtMS0xLTEtMA_cd455d9e-5d5d-44e2-aabf-94e935630a81"
      unitRef="usd">7417000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTQtMy0xLTEtMA_be992064-54a1-43ce-846c-e88def1895e0"
      unitRef="usd">6377000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTUtMS0xLTEtMA_11a77352-918c-46e0-9cf1-74670c1ffbce"
      unitRef="usd">1923000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTUtMy0xLTEtMA_f7170f58-50ee-4b5b-9f86-99742acaa055"
      unitRef="usd">1724000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTYtMS0xLTEtMA_784d739e-3661-4a75-9352-bc6e42006e55"
      unitRef="usd">135000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTYtMy0xLTEtMA_d3760cb7-8f09-415a-9802-117d698c7621"
      unitRef="usd">828000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTctMS0xLTEtMA_70b201a2-a17c-47a8-8a64-c16955baf5d7"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTctMy0xLTEtMA_79909922-e9b8-4471-bb81-7877edc43d1f"
      unitRef="usd">834000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTgtMS0xLTEtMA_d89da939-3ae7-4668-b498-77d46f7c0694"
      unitRef="usd">-95000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTgtMy0xLTEtMA_5ebd27eb-e59f-4cb4-8873-eb5ac0d0a6cf"
      unitRef="usd">-5000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTktMS0xLTEtMA_94166b9f-0030-48e1-a281-d71f63d1cdca"
      unitRef="usd">-3821000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMTktMy0xLTEtMA_0b4ea246-4e08-4680-940f-4a8a47d054e6"
      unitRef="usd">-4300000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjMtMS0xLTEtMA_44181e46-04c2-4445-bd1d-2c2e794fd344"
      unitRef="usd">987000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjMtMy0xLTEtMA_d34643cc-7501-4a46-b6b2-a33be045aa9d"
      unitRef="usd">7919000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjQtMS0xLTEtMA_dedbc9c6-ca60-486c-8171-72a0064e9127"
      unitRef="usd">7823000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjQtMy0xLTEtMA_79aba4d2-7ea5-4a40-9443-b8e17416f84c"
      unitRef="usd">10493000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjUtMS0xLTEtMA_444da234-a9a5-4e92-9949-cc8830b28bdb"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjUtMy0xLTEtMA_bd224428-913c-4a96-ac0a-4dbda7ccebd9"
      unitRef="usd">7000000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsOfDividends
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjYtMS0xLTEtMA_839b8242-f5a9-4768-8fee-013e777932ad"
      unitRef="usd">1965000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjYtMy0xLTEtMA_e4f0fa10-4bf1-4766-8331-2d8b96a2a597"
      unitRef="usd">1980000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjctMS0xLTEtMA_158b5783-e1a7-4ce8-a32a-9800b8bef94f"
      unitRef="usd">440000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjctMy0xLTEtMA_7bcaac48-c349-4e5a-95d7-2e07e5d93781"
      unitRef="usd">249000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjgtMS0xLTEtMA_276f0883-ef39-4d13-98bf-5f6c4dea7b10"
      unitRef="usd">161000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjgtMy0xLTEtMA_23e06af9-6b03-462e-a45d-3f23bfa761a4"
      unitRef="usd">75000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjktMS0xLTEtMA_31cdd7a2-0772-4b6e-8f86-97ec6e4d5bf2"
      unitRef="usd">-3000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMjktMy0xLTEtMA_23e49611-2252-4dd5-958c-8885a3436c02"
      unitRef="usd">-33000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzAtMS0xLTEtMA_b0e700fe-1b5b-4537-9587-af8f2c0ce072"
      unitRef="usd">-8525000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzAtMy0xLTEtMA_bdd76422-4a47-4b52-ad2f-a71f557be113"
      unitRef="usd">-4420000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzEtMS0xLTEtMA_b8f7b375-abc7-48cd-9b04-cdd4c438710b"
      unitRef="usd">1914000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzEtMy0xLTEtMA_ce21081d-7b7d-4c89-9af5-e141771a1f25"
      unitRef="usd">3578000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzItMS0xLTEtMA_dc109b49-7e4f-4a4f-99b7-2aa84488247b"
      unitRef="usd">8130000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4adcddfef50d4237a36d95774c4b5e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzItMy0xLTEtMA_f57a4668-24fe-46f9-b46e-32937111b783"
      unitRef="usd">5954000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzMtMS0xLTEtMA_4d40a0d6-5feb-4cf1-850d-4f974529336e"
      unitRef="usd">10044000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie81f391964c947c2b2bd32278edef5e3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjUzZjUwNDAwYmI4MTQ4NzU4Njk2YTBhZGU1NTE2NzA0L3RhYmxlcmFuZ2U6NTNmNTA0MDBiYjgxNDg3NTg2OTZhMGFkZTU1MTY3MDRfMzMtMy0xLTEtMA_72463f01-aad0-4570-8368-7494a965530b"
      unitRef="usd">9532000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ProfitLoss
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMy0xLTEtMS0w_b308433f-42c9-4758-9c00-e08fe0e126b4"
      unitRef="usd">6602000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMy0zLTEtMS0w_75313df6-2c78-4e32-8331-cc4235bb0bdf"
      unitRef="usd">6217000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfNS0xLTEtMS0w_0b243ca8-814d-4c43-a588-d8ef661c96d8"
      unitRef="usd">3397000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfNS0zLTEtMS0w_87a9ca6e-57b8-4656-bdc7-a2de117662e0"
      unitRef="usd">3302000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfNi0xLTEtMS0w_bee35031-6215-4b5e-9c84-6581342ca8dd"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfNi0zLTEtMS0w_f9ff4fa7-cb67-40d1-ab54-2a71e54cae22"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfNy0xLTEtMS0w_beb287b7-a892-414d-beb0-e98574a53b25"
      unitRef="usd">346000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfNy0zLTEtMS0w_1441eb0d-304b-40d4-a90a-8303bf241473"
      unitRef="usd">288000000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfOC0xLTEtMS0w_101e563e-dbad-470a-9a01-e2ee1a6d677b"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfOC0zLTEtMS0w_6973e305-3044-467e-a3d8-1b566bd1e362"
      unitRef="usd">271000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfOS0xLTEtMS0w_2bde3106-79be-42e0-a2f4-9ec6fda0ddc4"
      unitRef="usd">-363000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfOS0zLTEtMS0w_f65d2b1b-d553-4db7-908e-0be7157a3bb4"
      unitRef="usd">-766000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cvs:Deferredincometaxesandothernoncashitems
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTAtMS0xLTEtMA_edb90b83-c327-4f0f-b599-a2badbadd491"
      unitRef="usd">-645000000</cvs:Deferredincometaxesandothernoncashitems>
    <cvs:Deferredincometaxesandothernoncashitems
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTAtMy0xLTEtMA_0207bcff-06c6-4e9c-b6b1-bcc7d708169a"
      unitRef="usd">-25000000</cvs:Deferredincometaxesandothernoncashitems>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTItMS0xLTEtMA_f0ba3c70-919e-4a6d-87b6-705bd4f1077f"
      unitRef="usd">3504000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTItMy0xLTEtMA_f04b98d6-577a-49de-9cbe-254af29fe6db"
      unitRef="usd">3564000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTMtMS0xLTEtMA_3f937569-99d5-481d-b68d-c9b2e20e5011"
      unitRef="usd">-1097000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTMtMy0xLTEtMA_82e37a44-42d9-47d6-819f-fdc849a28c41"
      unitRef="usd">-45000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTQtMS0xLTEtMA_713b6aee-eeea-4b9c-b6c0-7305d6da030a"
      unitRef="usd">32000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTQtMy0xLTEtMA_74e271ce-c10e-4c32-8658-56fab38470ca"
      unitRef="usd">211000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTUtMS0xLTEtMA_4639fc9a-7576-404d-971c-0436e2e4daeb"
      unitRef="usd">3973000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTUtMy0xLTEtMA_dfd82283-64f5-4499-859b-34f1ed0c9aa1"
      unitRef="usd">3495000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTYtMS0xLTEtMA_186ec035-2b59-4ea3-ba6a-ba04bb742d95"
      unitRef="usd">348000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTYtMy0xLTEtMA_d28dbfc5-8175-474c-b5ab-588d203bc895"
      unitRef="usd">-474000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTctMS0xLTEtMA_79542b94-c181-4ab4-92f8-a386f969c64d"
      unitRef="usd">1884000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTctMy0xLTEtMA_36cc494b-6989-40d8-9415-822776de6b0d"
      unitRef="usd">2730000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTgtMS0xLTEtMA_53820a6a-2ef9-4fb8-b427-db946ffd4e39"
      unitRef="usd">14260000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8yOC9mcmFnOjdjYjQxZGMzYjIxMTQ0NjlhN2I1ZmIwYjczOTBhNDY0L3RhYmxlOjkzZThmN2I4NTlmNDQ4NWFiMzhhMzYxYzg0MTEzNGRkL3RhYmxlcmFuZ2U6OTNlOGY3Yjg1OWY0NDg1YWIzOGEzNjFjODQxMTM0ZGRfMTgtMy0xLTEtMA_5c82dfda-44fb-437e-bee5-e62421c11716"
      unitRef="usd">12298000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SharesOutstanding
      contextRef="i23ba03e375294644884d8e56a4a12ec8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS0xLTEtMS0w_ae7ae955-8cee-4a00-9933-c21ea0a7caae"
      unitRef="shares">1733000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="ic9750e3f154044e0bf5e620a4abf5bc5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS0yLTEtMS0w_d174f413-fa0e-4e11-ab68-94ea32f3f8b9"
      unitRef="shares">-423000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i551bc5b2e45e4537a35491b701e2bc6e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS00LTEtMS0w_9fa121f2-d8c4-46e4-b66f-177184da942d"
      unitRef="usd">46513000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic9750e3f154044e0bf5e620a4abf5bc5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS01LTEtMS0w_95207aad-d4e2-4fbb-8d72-bca35abada02"
      unitRef="usd">-28178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a860e1fdc9241a88d247676226a1743_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS02LTEtMS0w_e1de0d1e-ff2f-44a1-943c-7490a0f90f6c"
      unitRef="usd">49640000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic102a7412e044e7dbb913688ea071de1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS03LTEtMS0w_0ed4bfb7-a3ec-47b8-8be7-2cc28607a581"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2054af963ad94d309c02720a2cfbe212_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS04LTEtMS0w_4f1fecee-ba80-469d-8357-b028cf5f1862"
      unitRef="usd">69389000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92e4947a219a4f35b8b0e727a77bffa0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS05LTEtMS0w_cc4f2a8c-8e31-487f-b81e-85eef89c5ca3"
      unitRef="usd">312000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS0xMC0xLTEtMA_78edae45-b127-4909-9949-f3980233ae21"
      unitRef="usd">69701000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="if831d75953f547bf91c30a4f27bf85e5_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNi02LTEtMS0w_cd160d7a-7b6f-4979-8dc1-28932b0f9714"
      unitRef="usd">2223000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i74a27263e55344aa87673203df970d6c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNi04LTEtMS0w_495c8ef8-38a5-4789-9455-c63d8e084a46"
      unitRef="usd">2223000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id5ba9d09ff88466f96d748c706ada380_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNi05LTEtMS0w_09232207-a6ca-4a96-8ac8-48d288d21837"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNi0xMC0xLTEtMA_0cf1d2d7-165c-40fa-9c62-7e754e68cb23"
      unitRef="usd">2224000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i22d23b76e1394040af9ea41449e89e30_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNy03LTEtMS0w_6f300a09-3745-45b5-ac42-2ff3050f4159"
      unitRef="usd">-392000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i74a27263e55344aa87673203df970d6c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNy04LTEtMS0w_e57b86c8-0f27-4e9d-a647-786b655a9581"
      unitRef="usd">-392000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNy0xMC0xLTEtMA_f8b9a0f9-84d0-4c0e-a5b7-de9f2c19a4f6"
      unitRef="usd">-392000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib469fa63d0a24fd3b8919d0471ce244c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOC0xLTEtMS0w_3e0f2938-cc1a-4019-bac0-4531bfdfdc8f"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i86e55f5b316946bca272063c2c239038_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOC00LTEtMS0w_ba871677-b90d-479d-9db2-be26b7fb580f"
      unitRef="usd">214000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i74a27263e55344aa87673203df970d6c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOC04LTEtMS0w_eb5c900e-0860-4fd2-9d5e-f9373f66bec9"
      unitRef="usd">214000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOC0xMC0xLTEtMA_ad3cba20-41ca-452d-9e48-b03a45ad55f9"
      unitRef="usd">214000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="ib76c2965654e4d27a7289e7d74a81285_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS0yLTEtMS0w_a3d36f42-c1ec-4ae6-bca4-0cb4bf194dfd"
      unitRef="shares">1000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="ib76c2965654e4d27a7289e7d74a81285_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS01LTEtMS0w_3e47f73e-e459-43ba-8f5d-51743f0781f9"
      unitRef="usd">76000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i74a27263e55344aa87673203df970d6c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS04LTEtMS0w_06a78138-46b5-44a2-a10e-57eb52dd707a"
      unitRef="usd">76000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS0xMC0xLTEtMA_b257dba3-c443-4f14-bd7f-70e54355ae7f"
      unitRef="usd">76000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="if831d75953f547bf91c30a4f27bf85e5_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTAtNi0xLTEtMA_4c2c4525-e11c-47f0-866b-9a3d48727554"
      unitRef="usd">660000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i74a27263e55344aa87673203df970d6c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTAtOC0xLTEtMA_2ae3a441-6854-4616-88a7-d8d7dcf8bf56"
      unitRef="usd">660000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTAtMTAtMS0xLTA_94292405-4a6f-4fd0-89f5-72cbe27c0467"
      unitRef="usd">660000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="id5ba9d09ff88466f96d748c706ada380_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTEtOS0xLTEtMA_7fc6ad81-78b4-49ff-81e5-549d8e47ad0b"
      unitRef="usd">1000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i861240e950c545b4b063a0bcdf990f14_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTEtMTAtMS0xLTA_0eee7a55-3e0d-496f-87df-5889e4c55923"
      unitRef="usd">1000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i0f8f1c6e4cf54f67a77ef5861fe75220_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItMS0xLTEtMA_eaa8c99d-c372-48f2-80a5-b1449652affb"
      unitRef="shares">1735000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="iebdfe2716bb1440b8056abf51feecbc7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItMi0xLTEtMA_d79af9bc-7b58-45a9-83e2-d1c57a6838eb"
      unitRef="shares">-422000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if0b07933938d4d1fb52659a2713205d8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNC0xLTEtMA_8ff228aa-4d86-461e-9162-15397fc95b7b"
      unitRef="usd">46727000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iebdfe2716bb1440b8056abf51feecbc7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNS0xLTEtMA_a2ccaa98-c808-436e-bc23-a18e347c6aef"
      unitRef="usd">-28102000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5c062bdcf0194ad8ab5933e999439363_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNi0xLTEtMA_ed2b954c-4f61-4947-8173-0d5347235f32"
      unitRef="usd">51203000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie9c14939d5344d3b8c3ef6eb09b33da0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNy0xLTEtMA_06f0e1cd-37e1-4de8-a028-5878808e2a4b"
      unitRef="usd">1022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8781832d43cd4db79f8719e073082c68_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItOC0xLTEtMA_f3d26689-56f4-4421-bea6-3cd6eb3cc270"
      unitRef="usd">70850000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife449814992e43438e58bd3a5248451e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItOS0xLTEtMA_434a5531-771b-4424-af89-42040618ea42"
      unitRef="usd">314000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id2d9c33c5d0445d4b7720d99637d30f0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItMTAtMS0xLTA_3e573a7b-09ab-41c9-9628-c0c4632ad3f3"
      unitRef="usd">71164000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i427a383940a94623a153c763b01bf61c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTMtNi0xLTEtMA_ba38f655-bb40-431a-93de-d23c30738e39"
      unitRef="usd">2783000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i30c3d180e86948ca9c3beded789d010a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTMtOC0xLTEtMA_3fcfee77-98eb-4b17-bdf6-cc22d37f6b23"
      unitRef="usd">2783000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0f39afeaa0164b9aaae2c4ad2a9488b3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTMtOS0xLTEtMA_3b0ff278-5a16-4072-9673-f5a4d462a333"
      unitRef="usd">8000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTMtMTAtMS0xLTA_4313deeb-358c-46c5-a4c0-ac247afb69a4"
      unitRef="usd">2791000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ide68db09236a41bd9e4db1ad61b5f1a7_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTQtNy0xLTEtMA_19b6030b-874a-48eb-b242-b3ecce140dfe"
      unitRef="usd">148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i30c3d180e86948ca9c3beded789d010a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTQtOC0xLTEtMA_8f307786-6a3d-4249-a6f9-de74ef515004"
      unitRef="usd">148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTQtMTAtMS0xLTA_7827b529-bdea-414e-ac81-5e85c9e1ea7b"
      unitRef="usd">148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ice52c31f671142ff9c5da1e16b8b587c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTUtMS0xLTEtMA_e4b7e3e5-8072-465e-a258-673719bcb985"
      unitRef="shares">7000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i086fc8748c444262890e455770e0e120_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTUtNC0xLTEtMA_b48973fa-5b00-4cff-af94-b934b37c3d66"
      unitRef="usd">268000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i30c3d180e86948ca9c3beded789d010a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTUtOC0xLTEtMA_3fdb27d2-1b73-487d-a8a5-a3b9dd83eef0"
      unitRef="usd">268000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTUtMTAtMS0xLTA_a64ec4d6-d47b-4b46-b772-43fe808eb2d3"
      unitRef="usd">268000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="i1ed26699159f4e319ec98d041d5818f4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtMi0xLTEtMA_706373f9-0140-4065-9f3d-5ee06f70df06"
      unitRef="shares">2000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i1ed26699159f4e319ec98d041d5818f4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtNS0xLTEtMA_7a819f02-085e-4718-abf2-7b94f5c7e3e1"
      unitRef="usd">150000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i30c3d180e86948ca9c3beded789d010a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtOC0xLTEtMA_6c58c92e-1ec0-4fd6-9d3c-02e9d95032b3"
      unitRef="usd">150000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtMTAtMS0xLTA_0e9773f7-9d98-4ae0-89c4-57f896271858"
      unitRef="usd">150000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="i427a383940a94623a153c763b01bf61c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTctNi0xLTEtMA_325d9f61-dc43-4190-b488-ec33e47f2fa6"
      unitRef="usd">655000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i30c3d180e86948ca9c3beded789d010a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTctOC0xLTEtMA_99149a54-186d-4426-8eca-833edf62954f"
      unitRef="usd">655000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTctMTAtMS0xLTA_90dd8608-e9ba-433f-b48f-87ab78e28884"
      unitRef="usd">655000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i0f39afeaa0164b9aaae2c4ad2a9488b3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTgtOS0xLTEtMA_89fc906f-9eee-43ce-84c9-2edb863eb160"
      unitRef="usd">-1000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i9dc641daa8c742809a67f93d3416ad2d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTgtMTAtMS0xLTA_c7e911ec-cdeb-4f3c-953b-01cc1c2b5fe4"
      unitRef="usd">-1000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i4687f5e592964cc2a694fd8d54353d81_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktMS0xLTEtMA_d5f594ed-9113-4605-b088-260bc11bc1de"
      unitRef="shares">1742000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="id6540e87000648d19833b26522bbc190_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktMi0xLTEtMA_5a4b074b-11ab-42ef-b0cf-f71cf7ac3621"
      unitRef="shares">-424000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b84af36af2c42629e456c37a28e3938_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNC0xLTEtMA_5ea3be2e-d67b-46af-b75e-45b93159eb93"
      unitRef="usd">46995000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id6540e87000648d19833b26522bbc190_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNS0xLTEtMA_a5e3687d-cd13-4018-8344-29d72d6f0b22"
      unitRef="usd">-28252000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56f7b57e38ca4b558784c1d56f0aabcb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNi0xLTEtMA_903ceb7b-71f7-4131-804c-3311890c460a"
      unitRef="usd">53331000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8c1b85bddaae456e90d5a5399f3b4816_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNy0xLTEtMA_b2d9d240-1890-4871-a87e-b5c651ebc371"
      unitRef="usd">1170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i17ed94c211de47da9c0bd88c599e60f2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktOC0xLTEtMA_7c22cdad-9b02-44fb-a903-a56041bd888a"
      unitRef="usd">73244000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iab82a09b9c1a400d8e88219f37aea2de_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktOS0xLTEtMA_0146145f-7f34-4bbd-95c3-3e9126feedc3"
      unitRef="usd">321000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ed0ba20d2cd461099ef887e226c3e93_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktMTAtMS0xLTA_5760f8c2-823d-4857-825d-4d3584cf72ad"
      unitRef="usd">73565000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i2e60a7d260c843d980920a5e304ae972_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjAtNi0xLTEtMA_aa691208-8564-4c02-8190-77f99291b0a5"
      unitRef="usd">1598000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9a9f6159e4b14b72bff92db8236fd747_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjAtOC0xLTEtMA_dbf85a33-c844-40b8-896f-f1add302b261"
      unitRef="usd">1598000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if6a97ebcb6674c2096965c9b22aaffc2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjAtOS0xLTEtMA_bf7caad8-8914-4d43-94b1-85ce3f8c7353"
      unitRef="usd">-11000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjAtMTAtMS0xLTA_48aab240-64f4-4a73-8fdc-0b839b4fe087"
      unitRef="usd">1587000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id4ab8d4ce4d04aecb9a84bbfc6849284_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjEtNy0xLTEtMA_3d85c8e6-5070-4b29-81d0-09220e743200"
      unitRef="usd">-93000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9a9f6159e4b14b72bff92db8236fd747_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjEtOC0xLTEtMA_9e5df960-bc9e-486a-8f53-0e77e2b33099"
      unitRef="usd">-93000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjEtMTAtMS0xLTA_194423b5-9384-44f3-b8c7-a23a16804afa"
      unitRef="usd">-93000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0265118fa568463fb1dfa52b691e2fca_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjItMS0xLTEtMA_c5399910-2f71-44ec-a183-1eba118aa4a8"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i59307294db3d4cf4a1ad0f4df554aaf2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjItNC0xLTEtMA_05331b88-e255-4dbf-8123-62f8f9e7a21b"
      unitRef="usd">138000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9a9f6159e4b14b72bff92db8236fd747_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjItOC0xLTEtMA_f21ce29d-8749-466e-996e-1754c55cf514"
      unitRef="usd">138000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjItMTAtMS0xLTA_53e73e8d-c80a-4f36-be13-97a74195ac2e"
      unitRef="usd">138000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="i186f27b850c7471dbc106faa8ac8974c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtMi0xLTEtMA_bae16aa4-1ebf-46cd-a62c-af75a994bea5"
      unitRef="shares">2000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i186f27b850c7471dbc106faa8ac8974c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtNS0xLTEtMA_2567cfd5-7634-4093-8d82-13ba8964cc47"
      unitRef="usd">86000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i9a9f6159e4b14b72bff92db8236fd747_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtOC0xLTEtMA_576061dc-12da-4717-969a-4ce874a6abd0"
      unitRef="usd">86000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtMTAtMS0xLTA_d1c09cb0-bbbe-4c80-afca-e5ce96098783"
      unitRef="usd">86000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="i2e60a7d260c843d980920a5e304ae972_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjQtNi0xLTEtMA_835756e1-72fb-4371-932a-f89d3a400305"
      unitRef="usd">665000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i9a9f6159e4b14b72bff92db8236fd747_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjQtOC0xLTEtMA_d86b960b-0f5a-48a9-b99d-b0ba7ff829ff"
      unitRef="usd">665000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjQtMTAtMS0xLTA_d6138027-f06d-4993-ac47-f402f7eb27f8"
      unitRef="usd">665000000</us-gaap:DividendsCommonStock>
    <us-gaap:SharesOutstanding
      contextRef="if2aa020f1483426a991754c1bc8e4103_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtMS0xLTEtMA_69e14c89-bd6e-44b9-98bf-4e35adaf5916"
      unitRef="shares">1743000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i3d7fc2a5a2924d5991aedae343217836_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtMi0xLTEtMA_30ea49d0-0c4c-4253-8deb-c6b8ee4d1ff3"
      unitRef="shares">-422000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i082bfd21f3b045cbb0aaa7fba7f7804d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNC0xLTEtMA_d0c66a66-bc83-4916-a3ae-75e089f30f71"
      unitRef="usd">47133000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d7fc2a5a2924d5991aedae343217836_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNS0xLTEtMA_e93ad5c1-0d07-4d6a-8e38-4a12cc3d1d1a"
      unitRef="usd">-28166000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac37107e130b46c6b8fd2d7a2c171383_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNi0xLTEtMA_02ffcb2b-52b5-4b0a-89eb-b638f5473b69"
      unitRef="usd">54264000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9adf9f3e2e264684a8989823942612fc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNy0xLTEtMA_c06f01cf-8cd9-4d4b-b8f7-d283fb684cb0"
      unitRef="usd">1077000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic11ff217d030454db570ea0bc1a32ec6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtOC0xLTEtMA_44ebb3ba-078f-41c6-8b8d-070f02c1deb2"
      unitRef="usd">74308000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64cb0760a3094aa686d8405ae705af26_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtOS0xLTEtMA_28aaf5b8-04ac-48bd-9f7d-94f7dfad7ac8"
      unitRef="usd">310000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtMTAtMS0xLTA_cbc959c7-270f-4466-ba03-473c420b95d2"
      unitRef="usd">74618000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg4Ng_02fd537f-d763-4274-8780-7a66558f4edb"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg4Ng_03b4edd3-6c78-4aca-b222-6b2c90213dc5"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i7ed0ba20d2cd461099ef887e226c3e93_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg4Ng_46fdfc27-425e-4e22-b9f0-25abae5d1dfa"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="id2d9c33c5d0445d4b7720d99637d30f0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg4Ng_bd50908c-7a63-429a-86ab-a8c3d1a1dd35"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i7ed0ba20d2cd461099ef887e226c3e93_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Mg_4c36ba1f-92db-41ab-ab63-d665392e9b85"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="id2d9c33c5d0445d4b7720d99637d30f0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Mg_583bda1d-7ac2-4dba-ae87-ce195ae5ad84"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Mg_79270ca0-4751-49ca-8301-f452fd21917f"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Mg_e1a9a934-7ce1-497d-9a77-b523c4a909bb"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <us-gaap:CommonStockValue
      contextRef="i7ed0ba20d2cd461099ef887e226c3e93_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Nw_09656635-fc6b-4816-994f-38f800c96d1a"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Nw_1865c2b4-c54d-4afb-9ba9-9aa66a9d43cc"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="id2d9c33c5d0445d4b7720d99637d30f0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Nw_252bb686-a84d-427e-8c1f-059535be1008"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODg5Nw_9de6c227-b34f-4767-865b-5984d2f1c557"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:SharesOutstanding
      contextRef="i47ef065bc8ca45d686c76f5b4b47492d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS0xLTEtMS0w_961e8554-b46a-4b00-a710-ae6b89ca2aaa"
      unitRef="shares">1727000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i69acde82d8db408eaa9ed7c6287a2301_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS0yLTEtMS0w_3c449d66-8194-4b73-b723-40167f9bc6ac"
      unitRef="shares">-425000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice9b45cfa6034116a0bb3a805bb25deb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS00LTEtMS0w_bcf6bb97-2a1f-4b9e-957f-9bdd06a9f486"
      unitRef="usd">45972000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69acde82d8db408eaa9ed7c6287a2301_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS01LTEtMS0w_0e722941-474c-452e-907a-9b9dfdc759d0"
      unitRef="usd">-28235000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i63137494a1854ceeb7bd1ce433103833_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS02LTEtMS0w_6ac96658-13b5-4034-b220-73b141e3f808"
      unitRef="usd">45108000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i949dda05f0274cf9b1746bbae441be84_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS03LTEtMS0w_c5ee1989-6867-41a7-ae00-32a02743a096"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie19194eb945449b2be88388ede7f8337_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS04LTEtMS0w_93d82fbb-5191-4f4c-b83f-08b72fdb01fa"
      unitRef="usd">63864000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90f84206f61549279918a09332e58af8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS05LTEtMS0w_3c8c14f7-24ca-4e46-b16f-9b21a50878ec"
      unitRef="usd">306000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4adcddfef50d4237a36d95774c4b5e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS0xMC0xLTEtMA_7743e1bc-4238-4954-88e5-37ae3cc59c96"
      unitRef="usd">64170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i20bf1fd8851f4638bdd00a557c5f447b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi02LTEtMS0w_6b55e493-0bf6-491f-b808-0bf50bf578a7"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0a7e1350bad4522a8484dd42ae70233_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi04LTEtMS0w_024f2e1f-846c-4ae2-8f94-42293da62071"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id069616f8c3a471b9d0a7ef8e5adaa32_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi0xMC0xLTEtMA_bebec290-7fb8-47ed-ad52-695b1989a76b"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i1385ab29305c448a9c67d5770afb048e_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNy02LTEtMS0w_3b5cbdf0-455c-448d-840b-8418cba01f02"
      unitRef="usd">2007000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ida08eebb482d482f87035620abbf89d6_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNy04LTEtMS0w_b4bd5418-0d05-4f85-ba5f-d873e3b0ff1f"
      unitRef="usd">2007000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i082608aa6b234f278b38aaf17009eb6e_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNy05LTEtMS0w_01202f3b-48ab-4412-a7ad-f1a066b963bf"
      unitRef="usd">5000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNy0xMC0xLTEtMA_aa041094-5507-4ff9-a4a5-8bda4850e1f4"
      unitRef="usd">2012000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id654c856e0c94aafa2fe19dc04299751_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOC03LTEtMS0w_6b800f03-6e5a-4bfc-ab78-0417f5db5b74"
      unitRef="usd">-332000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ida08eebb482d482f87035620abbf89d6_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOC04LTEtMS0w_ecd6448b-a3f2-49a8-b5cc-56f0ea840aaa"
      unitRef="usd">-332000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOC0xMC0xLTEtMA_9505257a-7f1c-4984-acda-8d74a50e6539"
      unitRef="usd">-332000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i48d4429acad1442ca35208e950d6b8a7_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOS0xLTEtMS0w_a7fb3e2d-6ec2-4487-aff3-b113f3ecad1d"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8fff271aac61427a93aace91fe11d093_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOS00LTEtMS0w_eff6e367-ca00-44e0-a822-573f8448fcb4"
      unitRef="usd">208000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ida08eebb482d482f87035620abbf89d6_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOS04LTEtMS0w_f241bda7-57f1-46e4-b62d-c342f53b92c2"
      unitRef="usd">208000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOS0xMC0xLTEtMA_d04691db-4db9-40f8-8590-29afb9be0ce4"
      unitRef="usd">208000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="if946b6b5938546dcb10f22ed41a68dc9_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtMi0xLTEtMA_d2f3618f-ccb2-47ee-8a92-3983dd19fe58"
      unitRef="shares">1000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="if946b6b5938546dcb10f22ed41a68dc9_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtNS0xLTEtMA_2f70f4b2-1c71-4266-869e-ce63c3a83d4c"
      unitRef="usd">53000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="ida08eebb482d482f87035620abbf89d6_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtOC0xLTEtMA_f573c847-9cff-4e3b-928a-edb55caf1bf8"
      unitRef="usd">53000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtMTAtMS0xLTA_daf666e7-1eab-4b7b-9ddd-f6c0424f7a95"
      unitRef="usd">53000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="i1385ab29305c448a9c67d5770afb048e_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTEtNi0xLTEtMA_50465cbd-f27d-4474-86a5-e5fc4337f5bc"
      unitRef="usd">657000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ida08eebb482d482f87035620abbf89d6_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTEtOC0xLTEtMA_55409cff-37a5-42d7-bad4-25f670bae02c"
      unitRef="usd">657000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTEtMTAtMS0xLTA_364fcd35-bc6a-44c9-9c71-8d8f0b96b7cd"
      unitRef="usd">657000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i082608aa6b234f278b38aaf17009eb6e_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTItOS0xLTEtMA_eaf5359c-3344-42bb-b43a-a60973464659"
      unitRef="usd">23000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTItMTAtMS0xLTA_9c1f8ebc-1425-4acc-a839-60579bbe0eec"
      unitRef="usd">23000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i7dd00683a8f140fba68409bd3564961e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtMS0xLTEtMA_97a22150-475c-4077-b690-26c4b72a19b9"
      unitRef="shares">1729000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="ic5ce1bd21a3640a79c7e024cab066d90_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtMi0xLTEtMA_5a7a6f94-71f1-49af-9f5a-c5337e491d60"
      unitRef="shares">-424000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i874e9eeb56a64352a7d096d7ecf784e3_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNC0xLTEtMA_628ff552-edb2-42b5-977f-39188ec396c1"
      unitRef="usd">46180000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5ce1bd21a3640a79c7e024cab066d90_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNS0xLTEtMA_b90fd349-d8e5-43ed-881b-24b77604464e"
      unitRef="usd">-28182000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i08cf13c568a64de2a8c45a6b75813fc3_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNi0xLTEtMA_80c45186-4661-4602-bf1d-4501314c91f8"
      unitRef="usd">46455000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaae98d9e6fb345029082485700a2a279_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNy0xLTEtMA_1249ccfc-1e6c-4e0b-83a9-e76b6c5bfa11"
      unitRef="usd">687000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf4d73e8ce60495e83dd3d579a0a6635_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtOC0xLTEtMA_e5b93d89-67ab-4ac2-b442-05682f3fa5d1"
      unitRef="usd">65140000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i85fd60b1e5304049bca379f1eefb23a2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtOS0xLTEtMA_8a9cf761-48f1-4df7-b1b1-9105cc098216"
      unitRef="usd">334000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic26c88d8650047d8a0474834e8096a37_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtMTAtMS0xLTA_f95e33bd-f305-44a6-87ce-3003f725adfc"
      unitRef="usd">65474000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i87af6ecaa93148af93ee60a00e2bc5fc_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTQtNi0xLTEtMA_4b8d3859-d178-4852-b3a0-0a9867079bb3"
      unitRef="usd">2975000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icace12a02237438d97c47d5283d91ee4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTQtOC0xLTEtMA_cc4525c5-6452-4103-b203-feac79be8f66"
      unitRef="usd">2975000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib368257cbb8a4dcc9f102a7125dff098_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTQtOS0xLTEtMA_de321a85-aabc-4cf1-8b2b-f8decceab33a"
      unitRef="usd">11000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTQtMTAtMS0xLTA_94a6330c-9fa9-4207-a812-cc26912cff0a"
      unitRef="usd">2986000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibe896c82eb7d48558a916c2226cdee18_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTUtNy0xLTEtMA_0aea6f30-5bba-4faa-a013-9d21181290f7"
      unitRef="usd">526000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icace12a02237438d97c47d5283d91ee4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTUtOC0xLTEtMA_65b52d2e-5b2d-4765-9479-1f037c744800"
      unitRef="usd">526000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTUtMTAtMS0xLTA_cf665d34-d7a2-4f57-a34e-89f73a29328b"
      unitRef="usd">526000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i619aa996f3d8498ab4f572d7da7b1ff7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTYtMS0xLTEtMA_fb7aec88-9630-4521-a746-1b15fb90eda3"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibffe81af21c64c838090535f9633ed0a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTYtNC0xLTEtMA_47663ff0-bb33-42e2-8fda-5a986f4f2203"
      unitRef="usd">96000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="icace12a02237438d97c47d5283d91ee4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTYtOC0xLTEtMA_c4aba8c9-aa09-4526-8d82-595553afd176"
      unitRef="usd">96000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTYtMTAtMS0xLTA_ddd93513-0407-4e16-9b08-b72306582aef"
      unitRef="usd">96000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="i20587aa2f9cc43dab807a6fd036d6ec6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctMi0xLTEtMA_0bb5398b-a386-4c1b-aa40-b5891a25a52d"
      unitRef="shares">1000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i20587aa2f9cc43dab807a6fd036d6ec6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctNS0xLTEtMA_9af71cce-2a15-49e5-b13c-b7c0458c9e0a"
      unitRef="usd">53000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="icace12a02237438d97c47d5283d91ee4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctOC0xLTEtMA_21940468-77fa-4319-8b74-1a62f6895dc0"
      unitRef="usd">53000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctMTAtMS0xLTA_356aa2f7-7a89-48b7-8b92-f7e240b8832d"
      unitRef="usd">53000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="i87af6ecaa93148af93ee60a00e2bc5fc_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTgtNi0xLTEtMA_97a913a3-93bc-43df-ad54-122431ce8f59"
      unitRef="usd">662000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="icace12a02237438d97c47d5283d91ee4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTgtOC0xLTEtMA_a658f509-9ca8-42a5-94a0-7e8d2e178dc3"
      unitRef="usd">662000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTgtMTAtMS0xLTA_be2d4def-5d18-4b67-b7e4-5d7b94d86466"
      unitRef="usd">662000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="ib368257cbb8a4dcc9f102a7125dff098_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTktOS0xLTEtMA_ee87af54-a151-47d7-832a-e30194bc6f2a"
      unitRef="usd">-12000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i30bd1f7f73ce41ec9f0b3e420737b5ba_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTktMTAtMS0xLTA_d40c9f3f-ab2c-4fa2-9dad-0d274afa4e24"
      unitRef="usd">-12000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i7b392878ff634b039bf5f8e8010826e5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtMS0xLTEtMA_f69bd105-6257-4186-9b36-195c90a78086"
      unitRef="shares">1732000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i81afc144424c4e4585c0d1c6720651e8_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtMi0xLTEtMA_bdbd385d-1f8d-4b53-9278-ecdb4f1ca047"
      unitRef="shares">-425000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id11218ddb52b4b7889cb60e1b16b1edd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNC0xLTEtMA_bcaaf698-4b3f-4af4-9fcd-bf465e2d066f"
      unitRef="usd">46276000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81afc144424c4e4585c0d1c6720651e8_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNS0xLTEtMA_903d301d-a3f1-4b21-a771-9aec8812fe7e"
      unitRef="usd">-28235000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9c2b0a74f321415ab4143fba6052d3fc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNi0xLTEtMA_8858cc98-2ecb-4b10-af03-2791e6de5d3b"
      unitRef="usd">48768000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida30c27c4c6849159ca6711a4c1037d2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNy0xLTEtMA_e37b813c-415b-4c3e-b32d-686903d01157"
      unitRef="usd">1213000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd3c26ba9f894ca9a7da1af89a150bf8_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtOC0xLTEtMA_a56e8e1e-3d3f-451d-8f0a-a12d2050f501"
      unitRef="usd">68022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib0d552fb03c44883bdd9e4c09723809d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtOS0xLTEtMA_48b4d894-c2d9-49de-8dbf-a762780723b9"
      unitRef="usd">333000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iccddc7d61a62405bbd6126135b096cc4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtMTAtMS0xLTA_bb352f11-9c9a-4540-9e22-aa023cce7d54"
      unitRef="usd">68355000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="iac3c8def758f4306a0225b383df470e6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjEtNi0xLTEtMA_02c126bf-1638-470d-9e5d-6dd9995280f6"
      unitRef="usd">1224000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iba7be38e83d341e093f4c569c8926177_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjEtOC0xLTEtMA_4ee5f70a-986c-4e0c-8a69-dc74c748956a"
      unitRef="usd">1224000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie66834e318c34f77b62a7489806c5c36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjEtOS0xLTEtMA_29cd5bc5-4df0-4639-8b0c-53f42222a1a3"
      unitRef="usd">-5000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjEtMTAtMS0xLTA_6b65127a-5e01-4662-b10f-ab877b8d894d"
      unitRef="usd">1219000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i04578fac9b784d489a884552dd60834b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjItNy0xLTEtMA_7658b002-805b-4029-81f0-655919fdfb63"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iba7be38e83d341e093f4c569c8926177_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjItOC0xLTEtMA_e703f333-71dd-4644-9db1-b0adb7256f93"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjItMTAtMS0xLTA_2db780ad-bc2b-475e-b73e-319a275a3b17"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2900b425253d40ca9ff265afb5d2e8ee_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjMtNC0xLTEtMA_36dd9700-2ab6-4371-9922-e173326f8a6f"
      unitRef="usd">112000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iba7be38e83d341e093f4c569c8926177_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjMtOC0xLTEtMA_0b1b021d-19d7-42f0-b33b-7502e63528a4"
      unitRef="usd">112000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjMtMTAtMS0xLTA_e38dd1c8-f8ce-4187-8a75-2e85a3631793"
      unitRef="usd">112000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="ifb8d675420f0416490172136b95d4f77_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtMi0xLTEtMA_360f5eeb-beba-40ed-8cca-0a920d5a120c"
      unitRef="shares">2000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="ifb8d675420f0416490172136b95d4f77_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtNS0xLTEtMA_3b76e1bd-f0c1-4144-80fd-b209578840b3"
      unitRef="usd">71000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="iba7be38e83d341e093f4c569c8926177_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtOC0xLTEtMA_c8c5388d-9d1a-4e20-87b0-f6e96e06647d"
      unitRef="usd">71000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtMTAtMS0xLTA_e2e27be2-864e-464b-875d-a7b51b4f9d3b"
      unitRef="usd">71000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="iac3c8def758f4306a0225b383df470e6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjUtNi0xLTEtMA_cb40e00f-dda0-40ce-be89-856870c903aa"
      unitRef="usd">664000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="iba7be38e83d341e093f4c569c8926177_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjUtOC0xLTEtMA_a123a1e5-af37-489a-b8c4-54da0702445b"
      unitRef="usd">664000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjUtMTAtMS0xLTA_89454259-1c1e-4072-b2e3-8db10e438d80"
      unitRef="usd">664000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="ie66834e318c34f77b62a7489806c5c36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjYtOS0xLTEtMA_fe9c2db8-b018-498f-9450-201cd2c8871e"
      unitRef="usd">-23000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjYtMTAtMS0xLTA_dec47102-d0fb-4344-854d-0ce206db37e0"
      unitRef="usd">-23000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="ia4b4ffbeaad7402bafb6efb81912f182_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctMS0xLTEtMA_330b411d-f524-48c6-a81e-1400c8cdb0af"
      unitRef="shares">1732000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i64b99e857d05479fbde03dab04aacd4c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctMi0xLTEtMA_b0287672-564a-41d3-bd32-0089b65be989"
      unitRef="shares">-423000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c4351afa1124647b74064aed3c9b1ed_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNC0xLTEtMA_5e486fe4-2705-4eb0-9011-2efff2473d31"
      unitRef="usd">46388000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64b99e857d05479fbde03dab04aacd4c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNS0xLTEtMA_1b5f60bb-10d7-4399-bfbb-a23d0366a7f2"
      unitRef="usd">-28164000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea10f7ec17074278bce5534f7460eebe_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNi0xLTEtMA_65f68640-0384-455a-905d-4ea3fd2cc371"
      unitRef="usd">49328000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib9c67264f8554c16b088c68a6bf79e3e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNy0xLTEtMA_b8c4c0f1-28dc-4d7d-b090-540a79820445"
      unitRef="usd">1255000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i741f16a969ec4437b522117aeb1529bd_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctOC0xLTEtMA_b6418437-81e2-4d88-8ebe-a11f2f57ee28"
      unitRef="usd">68807000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia94eca1fb7324209b95d6bcfa9878abc_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctOS0xLTEtMA_5a49f646-ae09-4f9b-a94a-7bc9722c705e"
      unitRef="usd">305000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie81f391964c947c2b2bd32278edef5e3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctMTAtMS0xLTA_cfe2bf0f-b4bc-4311-91e5-ca4e24cb842d"
      unitRef="usd">69112000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="ic26c88d8650047d8a0474834e8096a37_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk2Ng_160bd428-88a1-449c-8531-a7494fc444e0"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="iccddc7d61a62405bbd6126135b096cc4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk2Ng_b4e88ab2-ec4b-4af8-b96d-a48338470065"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="ie81f391964c947c2b2bd32278edef5e3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk2Ng_d9f91d44-2de2-4ed8-91ff-40d1f4f589ac"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i4adcddfef50d4237a36d95774c4b5e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk2Ng_eb3f53ad-b972-4da1-9dae-8fc9ce404de7"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="ic26c88d8650047d8a0474834e8096a37_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk3Mw_480a1147-9755-4cfd-b7c7-0c5e263de478"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i4adcddfef50d4237a36d95774c4b5e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk3Mw_86217f0f-4801-4833-ba3e-c3e5b62b5c47"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="iccddc7d61a62405bbd6126135b096cc4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk3Mw_bb608600-131a-457e-a2e3-d4f3ed6e9196"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="ie81f391964c947c2b2bd32278edef5e3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk3Mw_e6d3eb4c-435d-492f-8991-ff7e70b0a0cb"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <us-gaap:CommonStockValue
      contextRef="i4adcddfef50d4237a36d95774c4b5e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk4MA_065ef590-7321-4578-8c41-9a8cc78fa684"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="iccddc7d61a62405bbd6126135b096cc4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk4MA_a653534c-e9a0-4db7-8e1f-53fe3a0b8bb9"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic26c88d8650047d8a0474834e8096a37_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk4MA_d759832e-b130-4d83-b44c-057a76204355"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ie81f391964c947c2b2bd32278edef5e3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA5OTUxMTYyODk4MA_d7b252f0-12f1-4d81-8780-2c544eedd414"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i253d046d1d4543a0a2641f1e7e78877d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfOTE2_1a231f0e-4661-4166-93e0-2124f42e83e4"
      unitRef="usd">3000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzNDU_06487801-4ee7-4ac6-a914-ccfd3d0ecce5">Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business&#160; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation (&#x201c;CVS Health&#x201d;), together with its subsidiaries (collectively, the &#x201c;Company&#x201d;), has more than 9,900 retail locations, nearly 1,200 walk-in medical clinics, a leading pharmacy benefits manager with approximately 110 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#x201c;PDP&#x201d;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) continues to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#x2019;s businesses, operating results, cash flows and financial condition, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Quarterly Report on Form 10-Q.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Health Care Benefits segment is one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#x2019; compensation administrative services through its Coventry Health Care Workers&#x2019; Compensation business (&#x201c;Workers&#x2019; Compensation business&#x201d;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d; In addition, the Company has submitted regulatory filings for a January 2022 entrance into the individual public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) in eight states.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Pharmacy Services Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment provides a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#x201c;Covered Entities&#x201d;). The Pharmacy Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of September&#160;30, 2021, the Retail/LTC segment operated more than 9,900 retail locations, nearly 1,200 MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the &#x201c;2020 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#x2019;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#x2019;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net is composed of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for credit losses was $364 million and $358 million as of September&#160;30, 2021 and December&#160;31,&lt;br/&gt;2020, respectively. When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate the Company&#x2019;s revenue by major source in each segment for the three and nine months ended September 30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020   &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice program.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021 and 2020, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Insurer Fee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Since January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#x201c;ACA&#x201d;) has imposed an annual premium-based health insurer fee (the &#x201c;HIF&#x201d;). The HIF, which is payable each September, is not deductible for federal income tax purposes. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was no expense related to the HIF in the three and nine months ended September&#160;30, 2021. In the three and nine months ended September&#160;30, 2020, operating expenses included $255&#160;million and $774 million, respectively, related to the Company&#x2019;s estimated share of the 2020 HIF. The Company paid approximately $1.0&#160;billion, representing the Company&#x2019;s portion of the non tax-deductible HIF in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $16 million and $5 million in the three months ended September&#160;30, 2021 and 2020, respectively, and expensed fees for the use of this network of approximately $35 million and $28 million in the nine months ended September&#160;30, 2021 and 2020, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $20 million and $15 million for pharmaceutical inventory purchases during the three months ended September&#160;30, 2021 and 2020, respectively, and $57 million and $58 million for pharmaceutical inventory purchases during the nine months ended September&#160;30, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Recently Adopted  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows, financial condition or related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other &lt;/span&gt;&lt;/div&gt;comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#x2019;s expected investment yield under the existing guidance.</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfStores
      contextRef="i7d765d02ede34e5fa56a51625a55c188_I20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTgx_004205b2-e550-4007-b080-05ad31b41103"
      unitRef="location">9900</us-gaap:NumberOfStores>
    <cvs:NumberofWalkInMedicalClinics
      contextRef="i7d765d02ede34e5fa56a51625a55c188_I20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMjE2_844cac75-6712-407d-bdca-f4868e85fd3b"
      unitRef="clinic">1200</cvs:NumberofWalkInMedicalClinics>
    <cvs:NumberofPharmacyPlanMembers
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMjk5_a14f1874-8494-408f-bc2f-58333c7221d5"
      unitRef="people">110000000</cvs:NumberofPharmacyPlanMembers>
    <cvs:NumberofPatientsServedperYear
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMzc2_714277c6-5210-402e-99ad-65bf2a826b72"
      unitRef="patient">1000000</cvs:NumberofPatientsServedperYear>
    <cvs:NumberOfPeopleServed
      contextRef="i0c3ac878cf024e6d80d9917247d48b26_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfNDc3_e7c6e029-497f-4101-aac1-e02a12932922"
      unitRef="people">35000000</cvs:NumberOfPeopleServed>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTY0MTI_4ba7673c-9287-489f-b00a-febd8dee6452">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Health Care Benefits segment is one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#x2019; compensation administrative services through its Coventry Health Care Workers&#x2019; Compensation business (&#x201c;Workers&#x2019; Compensation business&#x201d;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d; In addition, the Company has submitted regulatory filings for a January 2022 entrance into the individual public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) in eight states.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Pharmacy Services Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment provides a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#x201c;Covered Entities&#x201d;). The Pharmacy Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of September&#160;30, 2021, the Retail/LTC segment operated more than 9,900 retail locations, nearly 1,200 MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI2Nw_cc2110a0-c7c9-4415-8519-5424dc636492"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates
      contextRef="i9af0cc01cbc54c9f9e8615532da5bb0c_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfNDk0NzgwMjM0MjE2NQ_a36741e3-4202-47dd-bcde-2a3ad28898ce"
      unitRef="state">8</cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates>
    <us-gaap:NumberOfStores
      contextRef="i7d765d02ede34e5fa56a51625a55c188_I20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfNDY1NA_004205b2-e550-4007-b080-05ad31b41103"
      unitRef="location">9900</us-gaap:NumberOfStores>
    <cvs:NumberofWalkInMedicalClinics
      contextRef="i7d765d02ede34e5fa56a51625a55c188_I20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfNDY4OQ_844cac75-6712-407d-bdca-f4868e85fd3b"
      unitRef="clinic">1200</cvs:NumberofWalkInMedicalClinics>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzNTk_e45975ad-1074-4cff-83eb-d63b431ad251">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the &#x201c;2020 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#x2019;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzODg_78420c52-7cf9-4476-8af3-2cea0973bf97">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#x2019;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzODg_f207417a-888c-412d-8c9d-88b99d89d71b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#x2019;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzODM_2d8b385b-0215-4f88-bd4b-03a6e7754da9">Restricted CashRestricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzOTc_ebb1651b-deb2-4a7d-881f-6e668b2ed9ab">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmI3ODE3Yzk4MDczYTRkY2E5NzQ3Mjc4MTk3ZWVjYzA3L3RhYmxlcmFuZ2U6Yjc4MTdjOTgwNzNhNGRjYTk3NDcyNzgxOTdlZWNjMDdfMS0xLTEtMS0w_33f03c85-46e8-4fbd-b9ab-0667f6426329"
      unitRef="usd">9826000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmI3ODE3Yzk4MDczYTRkY2E5NzQ3Mjc4MTk3ZWVjYzA3L3RhYmxlcmFuZ2U6Yjc4MTdjOTgwNzNhNGRjYTk3NDcyNzgxOTdlZWNjMDdfMS0zLTEtMS0w_5071ef91-838b-4554-bca2-137c7e4bd82a"
      unitRef="usd">7854000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmI3ODE3Yzk4MDczYTRkY2E5NzQ3Mjc4MTk3ZWVjYzA3L3RhYmxlcmFuZ2U6Yjc4MTdjOTgwNzNhNGRjYTk3NDcyNzgxOTdlZWNjMDdfMi0xLTEtMS0w_daeafe3e-8b8b-48cf-8986-24bdbddaa401"
      unitRef="usd">218000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmI3ODE3Yzk4MDczYTRkY2E5NzQ3Mjc4MTk3ZWVjYzA3L3RhYmxlcmFuZ2U6Yjc4MTdjOTgwNzNhNGRjYTk3NDcyNzgxOTdlZWNjMDdfMi0zLTEtMS0w_71e6de45-694a-4019-a877-d8a3b70e1a73"
      unitRef="usd">276000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmI3ODE3Yzk4MDczYTRkY2E5NzQ3Mjc4MTk3ZWVjYzA3L3RhYmxlcmFuZ2U6Yjc4MTdjOTgwNzNhNGRjYTk3NDcyNzgxOTdlZWNjMDdfMy0xLTEtMS0w_2b37856a-299d-4fbf-9360-b40ca9ec5793"
      unitRef="usd">10044000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmI3ODE3Yzk4MDczYTRkY2E5NzQ3Mjc4MTk3ZWVjYzA3L3RhYmxlcmFuZ2U6Yjc4MTdjOTgwNzNhNGRjYTk3NDcyNzgxOTdlZWNjMDdfMy0zLTEtMS0w_cc03bc2f-fe2d-487d-b549-5542544bfcfa"
      unitRef="usd">8130000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzNzc_85e2a1ca-8415-47a5-a55a-5c34ccca5bb9">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzODQ_94f3ac13-d8ca-4693-b9d6-3cdf366d59a7">Accounts receivable, net is composed of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfMS0xLTEtMS0w_1f6f5f70-9145-4017-b673-8d2719c178ae"
      unitRef="usd">8398000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfMS0zLTEtMS0w_997eb991-6b2a-4409-bc93-5fce3369285b"
      unitRef="usd">7101000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <cvs:VendorandManufacturerReceivables
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfMi0xLTEtMS0w_90b8b622-f700-4063-800c-7a51887fb7d1"
      unitRef="usd">11727000000</cvs:VendorandManufacturerReceivables>
    <cvs:VendorandManufacturerReceivables
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfMi0zLTEtMS0w_59d94add-f0a9-4aef-b5c0-bea9ae219712"
      unitRef="usd">9815000000</cvs:VendorandManufacturerReceivables>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfMy0xLTEtMS0w_5f214981-4c8e-4bb1-86d6-b0b864ae392c"
      unitRef="usd">2391000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfMy0zLTEtMS0w_76acc15e-484a-40b4-9795-a493c708da5f"
      unitRef="usd">2628000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfNC0xLTEtMS0w_c1eccdaa-6515-4377-9541-1af4787b6fe1"
      unitRef="usd">2767000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfNC0zLTEtMS0w_0060aae0-074f-466d-8464-77cae90e99c2"
      unitRef="usd">2198000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfNS0xLTEtMS0w_4553aacb-0539-44c4-ae77-2bdc97e5bdb7"
      unitRef="usd">25283000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOmJkY2FlOTA4NTgzZDQxYjhhZjAzY2RlMjcxOTM2ODcwL3RhYmxlcmFuZ2U6YmRjYWU5MDg1ODNkNDFiOGFmMDNjZGUyNzE5MzY4NzBfNS0zLTEtMS0w_1118360b-45e0-483c-85b0-f4403a8f0538"
      unitRef="usd">21742000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfOTAyOA_69960806-9e69-40c7-9960-eb4cba858645"
      unitRef="usd">364000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfOTAzNQ_26e5e2c2-07e7-4818-9f00-ea19b34eef25"
      unitRef="usd">358000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzODk_55ac3363-5bd8-4938-9f0d-03d1fb8f852e">When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTY0MDQ_3104779d-7c39-4fa8-9304-067d0bfb6b1e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate the Company&#x2019;s revenue by major source in each segment for the three and nine months ended September 30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020   &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice program.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03ddd201af14457bbc83df4348f9bad1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMy0xLTEtMS0w_c7677a46-28c1-4eb4-85c5-f46a59b3335e"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i412e5ff6392245189b7c9456c23bf31a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMy0zLTEtMS0w_326c8910-d948-4aea-998c-906df6847832"
      unitRef="usd">38867000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia533baf499d04c8ca9ae5911bd795ab9_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMy01LTEtMS0w_5eee6bd7-c812-49cb-b77d-6302ef26ab8e"
      unitRef="usd">19023000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i290002d5729c495f8ac74f3b19d7d0fb_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMy03LTEtMS0w_6ebd10f0-4300-4327-b5dc-c42bf2ebad36"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3894328a8f1466c8e456c94b93be275_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMy05LTEtMS0w_8139a42b-63b9-4993-9dc4-48e2e8c0d38b"
      unitRef="usd">-10857000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ab7ca31512a47f9b1c6b3868a809813_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMy0xMS0xLTEtMA_8d909931-83bd-42f7-bf36-8c68ae9a0122"
      unitRef="usd">47033000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifdf2284c5d324dbc834c16b94260f82a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNC0xLTEtMS0w_966925e2-5dd4-4cbf-9f62-627fbef3878e"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7eccee89ee34209972dbe04829f41a0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNC0zLTEtMS0w_5165c909-7fa0-4776-b887-dfe104eee23a"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i625652e7d45b4702a574e3cc0bc9ee59_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNC01LTEtMS0w_e86984e4-5927-439d-a5fb-f23df7cc4361"
      unitRef="usd">5359000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ff4f742554a4022a187f1fa185cc04e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNC03LTEtMS0w_c00b7e23-5301-4d97-92f2-129913d98370"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77b79029d3d0422f91971672e000f6b6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNC05LTEtMS0w_228afb41-4dac-44eb-a989-eee703e284d0"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib390a8745a16401b9768897652fc449c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNC0xMS0xLTEtMA_1389b602-e8bc-4cc6-9edf-92d99d9f863e"
      unitRef="usd">5359000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d3ec90dc0814b88b58bd914fedc0407_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNS0xLTEtMS0w_8cf8588e-7db9-4241-bda4-0e350875daff"
      unitRef="usd">18959000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic247236f845346c988b0332f27fa5573_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNS0zLTEtMS0w_37941299-7fa8-48f9-9996-7a3c77846838"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id372e9bfe6bb44eeba5d3ea51e988f33_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNS01LTEtMS0w_640ea7f1-829e-4261-8385-f440b6c81929"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id61c65f32eec4471868eff06cba27f89_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNS03LTEtMS0w_8e5addd7-d7d6-480e-8fc1-652995643266"
      unitRef="usd">25000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i05ab8ae673ac4c12938a12847aa81a22_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNS05LTEtMS0w_718c9f46-1d64-4e57-9876-3358fb81985f"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i713ef3848ad542c18962c0cc34fc33eb_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNS0xMS0xLTEtMA_8f23b40a-fa04-436c-87bb-c3c711f394d2"
      unitRef="usd">18984000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ia630bb470ae642f8905431f2e294870b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNi0xLTEtMS0w_4a048e00-0e58-494f-a38b-3b12da4f2acb"
      unitRef="usd">147000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNi0zLTEtMS0w_6ac8a6f1-ecfa-4436-9f7e-28085f117166"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i25b37ce901e241a68a26af12fa5a391b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNi01LTEtMS0w_a3a7dff5-fadf-4c8e-b4f5-240e24da5451"
      unitRef="usd">-33000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i1c910bf185e14abb8f843118e080650b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNi03LTEtMS0w_d0212144-e256-447e-a202-64c5c0727ed6"
      unitRef="usd">132000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNi05LTEtMS0w_feeaa530-be87-40c9-ad0b-d5d4cca491ee"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNi0xMS0xLTEtMA_c09f8661-055d-4347-aece-1b7dd8aaf574"
      unitRef="usd">246000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i583100df6a7145b9ad53eb0bc9fc4236_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNy0xLTEtMS0w_67f07158-da98-483d-bc1b-d88bd34af9c2"
      unitRef="usd">1373000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f4c6beff36b46b0b7456de5c1600949_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNy0zLTEtMS0w_70aeee9e-6931-47e2-aa17-b98f4d237e8c"
      unitRef="usd">179000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91168981806a44fcada2dd00fcdacabe_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNy01LTEtMS0w_c597724e-4dda-4908-b0ad-b86230c5b347"
      unitRef="usd">643000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa6342f43a2c4bbaa5a4beabc6f6e0d9_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNy03LTEtMS0w_aed1140b-ddcb-467c-ad6e-11d59bebdfc8"
      unitRef="usd">14000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i818171c70ff34861b15de5ffb456cd9d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNy05LTEtMS0w_da29dd4d-d746-43ab-826b-7e948c40b53d"
      unitRef="usd">-37000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69d20d815682465bb2bb57dc75692e06_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfNy0xMS0xLTEtMA_aceabe4d-f4e6-4a6f-a5fb-91816e3c7ada"
      unitRef="usd">2172000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="ia630bb470ae642f8905431f2e294870b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfOC0xLTEtMS0w_80a3b066-10c4-4c2f-94cd-09822785ec5c"
      unitRef="usd">20479000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfOC0zLTEtMS0w_c102abfb-e8d1-40f1-9712-f5cf4a5754b8"
      unitRef="usd">39046000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i25b37ce901e241a68a26af12fa5a391b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfOC01LTEtMS0w_8aad4bc0-fe12-4ee8-8a4b-20b90443cd38"
      unitRef="usd">24992000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1c910bf185e14abb8f843118e080650b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfOC03LTEtMS0w_febba8a2-f935-476e-b752-4e961a8771ff"
      unitRef="usd">171000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfOC05LTEtMS0w_8217b983-9c35-4f0d-ae72-b21fdaf16109"
      unitRef="usd">-10894000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfOC0xMS0xLTEtMA_19a09a67-48bc-4d41-8cf9-4541d32aa4a5"
      unitRef="usd">73794000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i713de0630b2c4ae48f9171b5d5051b83_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTEtMy0xLTEtMA_7d8c95f2-680c-4c8e-b171-58c17b7c8851"
      unitRef="usd">23665000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5eef7665d65c4130b53d504334affcd0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTItMy0xLTEtMA_0adce520-62bb-4bd0-b05a-c57a92af56f8"
      unitRef="usd">15202000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6dd05f21d6b243cb8fde4098a5393a14_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTMtMy0xLTEtMA_b5ea04d9-799f-44cf-8ea3-669cb23a5f38"
      unitRef="usd">179000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTQtMy0xLTEtMA_4dcff8b8-1e6f-4454-8a0b-15297acb9d91"
      unitRef="usd">39046000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iabd597abb76543afb656b9b04aa8e034_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTgtMS0xLTEtMA_e54101cc-0f6e-45b0-88e6-591aaf71418c"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i05a987898eb94aac864574fe231e3a18_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTgtMy0xLTEtMA_9d9a698f-0781-4794-acff-5ad4d13ffced"
      unitRef="usd">35505000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf8640ff8c964e05b35cb76754034a11_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTgtNS0xLTEtMA_3d129ca1-0794-4486-a2a8-dce68b9e5cb8"
      unitRef="usd">17608000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0da9396c07ac45aa88b14bb17a63332e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTgtNy0xLTEtMA_458db50d-8a3b-4f36-b995-23fca51e3d55"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0b6b6a5a9634ad0b60f62d11118f057_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTgtOS0xLTEtMA_8b5230db-8c18-49f0-a96e-bb54b9f5d3f5"
      unitRef="usd">-10051000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b1cb227ce25418f98cdb4c840a209b3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTgtMTEtMS0xLTA_77e632f8-fdbe-42f6-8fbe-407a5a140c2e"
      unitRef="usd">43062000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic02cc6173d9844a4af5efdc0fe2df7f5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTktMS0xLTEtMA_42c84ba3-e39f-484d-bf6f-2d3725cfe8fb"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6984fc17f7d8475f874f4de494cb3c48_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTktMy0xLTEtMA_47ba7a1c-dbf5-4ef2-b76f-c9e89108ed1a"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c255846afcd4865851ce574828f1003_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTktNS0xLTEtMA_a47ab361-b2d2-4abd-b698-97e686038a48"
      unitRef="usd">4740000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6bfee72d1a0443d680828612b3a96710_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTktNy0xLTEtMA_30c94a2b-90ed-4fcb-be0a-531db73ca560"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic576deaca0f04caea39ef63cbd517eeb_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTktOS0xLTEtMA_523ee587-01cd-4a4d-864b-c468f2f02cf2"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2893b2b18b814343a59acf92e7535ee6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMTktMTEtMS0xLTA_0e5c06aa-cb4c-4cda-83c3-d0f191ceaee4"
      unitRef="usd">4740000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4997bd10dafe4ccd9f92c679e0ffd1c1_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjAtMS0xLTEtMA_bfe0e1a4-f572-483c-91b6-84b6dfe7a4b4"
      unitRef="usd">17165000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5772c520e35f4b77b4c2c79644da46dd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjAtMy0xLTEtMA_f1304983-0d1b-49ce-86a0-9631283aa5dd"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ac823ba7ff34a13a62385beff1f8dba_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjAtNS0xLTEtMA_df9af2b0-b243-4c7b-8753-cfceb41aa799"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia22d065e2388491692af56f354d79db7_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjAtNy0xLTEtMA_b76ff342-cb1c-4538-8363-e0f59253ce66"
      unitRef="usd">17000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4dc4395dff1d4c82a9760c20fceda344_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjAtOS0xLTEtMA_e110f58d-2d43-47b0-9ad7-432d2a4e8036"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3576406107f47d7858dda78d75a6417_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjAtMTEtMS0xLTA_60cf9da7-23f9-4a8a-b0ab-cf5e3ec5f68e"
      unitRef="usd">17182000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i42ba3552a810439d9832cae42b188533_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjEtMS0xLTEtMA_18d9f52a-ed44-4a13-aa10-a6644f296612"
      unitRef="usd">121000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjEtMy0xLTEtMA_a1d122a5-6a2c-43ac-bfa5-a0b2648b80f9"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i2c29ab4601174287b450f53152b36d36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjEtNS0xLTEtMA_fc4e4fea-bd85-47e6-ad5e-ecc62e571ca8"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjEtNy0xLTEtMA_79c73f1a-7689-4616-8f99-fd365995a444"
      unitRef="usd">83000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iea31066dc7804044ae36620bede68059_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjEtOS0xLTEtMA_706e26f0-04b6-4776-bc31-1244d544ad45"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjEtMTEtMS0xLTA_28db1d3f-bd76-478a-8c9c-c686cad3d768"
      unitRef="usd">204000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8cdc8fa97da54c4a83f3e7c81196ef40_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjItMS0xLTEtMA_e90ccae6-4875-42c0-b894-38690bc6234f"
      unitRef="usd">1412000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8aff50c37dc4454689af8f6f2c7cfa70_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjItMy0xLTEtMA_5369985a-fdc0-45fe-951e-da3abf56125f"
      unitRef="usd">206000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3cbdb53e0614fd69d22b0611082a4fa_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjItNS0xLTEtMA_e60628b5-9afd-4983-ab2d-444451f4dd8e"
      unitRef="usd">377000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63014255cc54440493b3c80ebe5cbf20_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjItNy0xLTEtMA_29ed019b-7773-41ae-8231-5fc1932af81c"
      unitRef="usd">16000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib30ff9d3c92d44c69e87a939aee311b7_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjItOS0xLTEtMA_4c3d0e42-790e-4be4-8be4-3603aafab3f9"
      unitRef="usd">-143000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8e8ad852fbc47aca12f0dc2b4d1819d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjItMTEtMS0xLTA_91602a4c-3a16-41ab-9638-da6d5260b272"
      unitRef="usd">1868000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i42ba3552a810439d9832cae42b188533_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjMtMS0xLTEtMA_709d31e2-873b-41e7-ab1d-62870ae9efa9"
      unitRef="usd">18698000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjMtMy0xLTEtMA_6474a4f2-258a-4a33-8fce-af869173f834"
      unitRef="usd">35711000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c29ab4601174287b450f53152b36d36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjMtNS0xLTEtMA_e521699a-1b72-4409-b687-d92fd8518897"
      unitRef="usd">22725000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjMtNy0xLTEtMA_955581f1-a7aa-4fe0-b7f6-97938938dfd8"
      unitRef="usd">116000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iea31066dc7804044ae36620bede68059_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjMtOS0xLTEtMA_98b3381a-af00-4971-861c-8a016e41d00a"
      unitRef="usd">-10194000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjMtMTEtMS0xLTA_dd871b32-a593-46af-ad96-da06fa9fe359"
      unitRef="usd">67056000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f5439e4bb5845809fd326a3d2d9535b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjYtMy0xLTEtMA_0078c9c6-b5ef-44c5-a1d4-f6260fe0506e"
      unitRef="usd">21473000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia370cae5def349beaf1f0d98272cbc86_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjctMy0xLTEtMA_9682fe74-fd6a-40d4-8eac-905ebeabf562"
      unitRef="usd">14032000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i383e9e49c580468f96d67226826b3701_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjgtMy0xLTEtMA_37481c93-5cba-49ab-8db2-ca39122d08cf"
      unitRef="usd">206000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjk2M2IxMjEwYWRiMzRkYTM5NWM4ODU1NzkyNmU0ZTgxL3RhYmxlcmFuZ2U6OTYzYjEyMTBhZGIzNGRhMzk1Yzg4NTU3OTI2ZTRlODFfMjktMy0xLTEtMA_c7bb5b2a-e7e2-4297-8e55-baca7e147b49"
      unitRef="usd">35711000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fdbb1d0471e422b94075bd37bc906a7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMy0xLTEtMS0w_faea34aa-72a8-4164-a4d4-981bfcad2fa3"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa352e072fd64bac9be7da2a91adf04b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMy0zLTEtMS0w_6e02ea38-0e63-4739-87d2-d6537d70ae35"
      unitRef="usd">113161000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic11a639bc0634a7f934934ab6d3ea9e6_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMy01LTEtMS0w_ac1a5604-939a-4e50-be98-0aea0280d3e7"
      unitRef="usd">55781000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77461fd39fbd4219b11e33a2ae292268_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMy03LTEtMS0w_5b6ed579-38a4-40f4-8522-9682d35326a6"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8f710bc255b4ddabb067c4df0121ed6_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMy05LTEtMS0w_623291e4-7749-4f15-94a5-b3b45db2740d"
      unitRef="usd">-33025000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic48a2e72c0a444fd9aa88f429033c37f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMy0xMS0xLTEtMA_844084a9-13df-41e7-8ef7-fc7a9333fdb8"
      unitRef="usd">135917000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id47a917ec1af4c5db06417fff5be5881_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNC0xLTEtMS0w_2b934f92-1ed9-4016-8fe8-24f24870dd2f"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if898d4a04a094d2fbda70a5bce06fbff_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNC0zLTEtMS0w_e9a892ef-90f6-49c2-93f3-337d068bda19"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5df45e3a2a5c4b17bf3ad60977af7588_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNC01LTEtMS0w_6845a8ee-3b21-455e-8aef-4d932b748c4c"
      unitRef="usd">15255000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d918c713f67448682d7c685dc82da6b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNC03LTEtMS0w_4fa53ef2-23c6-4eb4-bbd1-a0ca75023d78"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34039126a3d845358fb813264ce5d92f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNC05LTEtMS0w_3465906a-2d7d-4cce-9bd0-e681b033c5c5"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb505e76b20f4068b74c4b35f149f619_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNC0xMS0xLTEtMA_5f8481ce-9afd-4be6-9cdf-52a11a294ac9"
      unitRef="usd">15255000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib14d585750a94bcf85c1726868d8ed22_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNS0xLTEtMS0w_53d7ae55-ea79-418a-9f09-78809dc04be9"
      unitRef="usd">56869000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad03227c933241798aeed098ed54ba11_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNS0zLTEtMS0w_879c91a8-d1f0-4c35-b9ca-d4765b6f8cd5"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9901c4b8de6e4460ade56fa6d6a6c4df_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNS01LTEtMS0w_b4fc7e09-7930-4244-828a-693fafbba07e"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb4ce333dc4b4ac6a6db70a32f589fa0_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNS03LTEtMS0w_607f1372-23dc-40ef-b6b3-ae69c9cc5fb5"
      unitRef="usd">58000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d5483cd591a4ba29922131097dcc0a7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNS05LTEtMS0w_039463b5-b991-4742-9272-3c613704bc09"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3777a80d7d548dd86f819a7a8c68626_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNS0xMS0xLTEtMA_3635a0e4-7071-499c-a656-1465bbf04860"
      unitRef="usd">56927000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i7cc744230a544ead88ffab3c45d0c454_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNi0xLTEtMS0w_0ebc7173-d883-42ba-b473-7a6c205452ad"
      unitRef="usd">432000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNi0zLTEtMS0w_e96bad39-080c-4473-84ac-e370c87d46df"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i8b445faeec3845f6b11c9569be49f9fb_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNi01LTEtMS0w_69269f94-0217-49cb-ac2f-5830db95f9f4"
      unitRef="usd">13000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNi03LTEtMS0w_57fece00-1749-4e7f-b6ec-6695bac8d1fd"
      unitRef="usd">387000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i472a8387964b45ec897885f8bc357e99_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNi05LTEtMS0w_02c64a20-9aa3-45df-8a82-c1759da384d4"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNi0xMS0xLTEtMA_0940a4bb-9370-4566-b476-b976716f4639"
      unitRef="usd">832000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f347f866918415994fa315bd6128224_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNy0xLTEtMS0w_2e70ac17-d783-42c1-82c9-c4214c8fd8ff"
      unitRef="usd">4186000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i009f875b81cb4be983f6d06abb32da71_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNy0zLTEtMS0w_88673af7-856f-4dbf-9777-0dbe1467e7aa"
      unitRef="usd">520000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ce155a0217b4ef6b1d855626c01d3b7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNy01LTEtMS0w_eef07f41-f566-4aae-a8fa-c41d79b018c8"
      unitRef="usd">1945000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ebd9dc275854c4faf090e45cccef77b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNy03LTEtMS0w_6a88a787-8ded-4a73-b3ba-b6e9dba0a653"
      unitRef="usd">43000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8111b2822cf741f59d35a0e165fda8f6_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNy05LTEtMS0w_074ff14b-c02e-4b44-b6df-3b9f866e1c54"
      unitRef="usd">-118000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5082f90c86d41ae9be5d122e912ec22_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfNy0xMS0xLTEtMA_c5b4d510-b870-4cf2-ab85-98140a6ab266"
      unitRef="usd">6576000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i7cc744230a544ead88ffab3c45d0c454_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfOC0xLTEtMS0w_76b9c7f3-7fae-498c-bf04-11a7b2e6c859"
      unitRef="usd">61487000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfOC0zLTEtMS0w_395fc2c9-aeb9-4418-9c8d-4c442a50b65b"
      unitRef="usd">113681000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8b445faeec3845f6b11c9569be49f9fb_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfOC01LTEtMS0w_0ed354a2-a5a9-47fa-aab2-12fb661916ee"
      unitRef="usd">72994000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfOC03LTEtMS0w_e194472b-a77e-495a-94c9-d53f462c0f5d"
      unitRef="usd">488000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i472a8387964b45ec897885f8bc357e99_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfOC05LTEtMS0w_73c1f934-7fe0-45a4-8ae2-28207770b738"
      unitRef="usd">-33143000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfOC0xMS0xLTEtMA_648c09e2-19d2-4409-8698-783ad36c5984"
      unitRef="usd">215507000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib50abeadc51e4faca566c3e8f770d30b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTEtMy0xLTEtMA_cbd7feec-915b-4d96-a6c3-a3c7d08754df"
      unitRef="usd">68476000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib624b26fc2464997942a122cf2a18d64_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTItMy0xLTEtMA_08f88d92-fc51-4f97-9ca1-fee7bdd7aefa"
      unitRef="usd">44685000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9867d0a744a545c08b139379b67df848_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTMtMy0xLTEtMA_35573d52-5191-4ab7-8f34-fe25cc538367"
      unitRef="usd">520000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTQtMy0xLTEtMA_2a47b9c2-815d-4986-8dc0-75942c24188e"
      unitRef="usd">113681000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15d6678bc52c4b1b9a3992371795d9ba_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTgtMS0xLTEtMA_568fcf78-093f-4387-840c-01383d1bec9c"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6674a9f6c2a41b19f32aefffb3a2dec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTgtMy0xLTEtMA_e1031ac9-7775-409b-8896-b592b4548781"
      unitRef="usd">104924000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idac5a4c6d4b94f628ed2cfe21a4d2421_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTgtNS0xLTEtMA_6bdb6a1c-6581-4b0d-a4b7-d682d82f2846"
      unitRef="usd">51833000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife3c76ab2d024ff4a261d3b4e14bdada_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTgtNy0xLTEtMA_7095e5f1-7439-40ce-a14b-2ccae33aa340"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04744a27d4fd4e3faadf43a927a7eb4a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTgtOS0xLTEtMA_c4ed8770-26b6-4d55-a100-79638abfa26b"
      unitRef="usd">-30032000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3bf41b2dd03474394b5ac3c1e4407b9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTgtMTEtMS0xLTA_6e115301-34bb-4085-bcf8-efc8b9b7010a"
      unitRef="usd">126725000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45b3cd0569ac4039b5a66d8ac80b2c19_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTktMS0xLTEtMA_f7738b75-cd15-481e-b95e-0e2e661b156c"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b19f1d9ffbb4fe298e1f449c044db56_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTktMy0xLTEtMA_15261519-6b45-4d13-8a91-e771e800b4a8"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25970c943ef246bf95009df4317e9dc3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTktNS0xLTEtMA_4c9d0ef8-312a-4fff-9431-c9cc32cc00e9"
      unitRef="usd">14601000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icadb573d19cd422abcc090b691494ecc_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTktNy0xLTEtMA_e6b193e5-42f4-4f3e-9ed3-f788bd0b6adf"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c84847084804557b40086d59812ad68_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTktOS0xLTEtMA_3628e213-b662-48c6-b5f5-abc9c0b7fe8a"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b2e395d22bf48aaa5e44c7091a81e15_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMTktMTEtMS0xLTA_f5ca1d04-2a42-4d00-9e0a-f79cd22b3437"
      unitRef="usd">14601000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e829120f1fb4c1a9331bd53efd465d1_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjAtMS0xLTEtMA_fcd1ee01-2e70-460a-ac1a-75de7fcd6c0d"
      unitRef="usd">51699000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib32e95b570724a1f982834c296abc3e8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjAtMy0xLTEtMA_8c4be631-79b9-4dab-aa86-bd6f8299c2de"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if97993cdf6bb48d99b74e00b854fff89_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjAtNS0xLTEtMA_7f887175-48d8-48fb-a03a-71fb6f48fd87"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie363563d839a430fa7d79ed6d41e5d06_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjAtNy0xLTEtMA_fb62dc24-9c16-4d7d-a842-fecde0bf6b34"
      unitRef="usd">50000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1ea3d7632384fe7b52a58c46f5bc52d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjAtOS0xLTEtMA_3c823997-483a-406a-81e1-4d0721ce7971"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia07ca84334b34916a64718d4f3f0dadb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjAtMTEtMS0xLTA_6d1e7407-6327-4bec-aaa4-88d8eeccf347"
      unitRef="usd">51749000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i6a95101c0a2547d68267b540d8eb8935_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjEtMS0xLTEtMA_a3b5bced-1117-4905-8825-33b84e9174fe"
      unitRef="usd">341000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjEtMy0xLTEtMA_df7383ab-adae-429f-ad35-4733468e8420"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i0610bf8e796340e4b079b333dbc7453b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjEtNS0xLTEtMA_13a67722-daea-4366-842c-ff3e0de788c7"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjEtNy0xLTEtMA_af78f06b-57f9-481f-89cd-60627632dc7c"
      unitRef="usd">209000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjEtOS0xLTEtMA_5a63839a-6205-40eb-a301-af1bf03b4e78"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjEtMTEtMS0xLTA_f954e24e-e97a-43c6-a8cc-71b986fee162"
      unitRef="usd">550000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57164e4241fa4481b87fa534a3023d49_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjItMS0xLTEtMA_6d0dffdb-3e91-4e4c-bd3f-ed076bcbcd30"
      unitRef="usd">4324000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0aa1900809b484188a9ccdf8c6792cd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjItMy0xLTEtMA_da4d9576-db52-4973-8d0d-b5e56e01b05b"
      unitRef="usd">659000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc788eb85be74801ab161654330fe954_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjItNS0xLTEtMA_6bc10feb-9a27-4aa2-8611-38ee78daefca"
      unitRef="usd">702000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1d2ef8361434b6e86e6d370a02b1d83_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjItNy0xLTEtMA_23b87f76-1d91-4822-b010-9ecc159af12f"
      unitRef="usd">33000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c4d3d8eccee408d901f45c189ed9409_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjItOS0xLTEtMA_1373448d-f3e1-40aa-a296-af97e257d559"
      unitRef="usd">-191000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if52efbf3b02a4086a4563b641c39020c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjItMTEtMS0xLTA_a974e85c-de6b-4a78-80c2-71ec6e33595e"
      unitRef="usd">5527000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i6a95101c0a2547d68267b540d8eb8935_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjMtMS0xLTEtMA_7d02adb0-1023-4ad4-b2ab-626cc9ca44e7"
      unitRef="usd">56364000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjMtMy0xLTEtMA_71df2c0e-26f3-4725-91a7-30b0314893c2"
      unitRef="usd">105583000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0610bf8e796340e4b079b333dbc7453b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjMtNS0xLTEtMA_faaae4b5-7587-45b7-b1ad-aeef6a2a4935"
      unitRef="usd">67136000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjMtNy0xLTEtMA_dcd0935a-34fa-4d13-a509-dbe79e58046d"
      unitRef="usd">292000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjMtOS0xLTEtMA_106d104a-8653-401b-ae17-1441824df338"
      unitRef="usd">-30223000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjMtMTEtMS0xLTA_1e2d6e24-1cae-467b-b205-4b9fd39a68bb"
      unitRef="usd">199152000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9ea4f28e976a42eaad4bf6503fb394a6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjYtMy0xLTEtMA_e749f130-4549-4e00-9e1b-e71a52debe2b"
      unitRef="usd">63109000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i64e9bda172dd402da851f2556c558b25_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjctMy0xLTEtMA_11a60a1d-79f8-4685-bcbc-446dfaf9592e"
      unitRef="usd">41815000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9a81285c245547c79d2a6cf01d1794e0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjgtMy0xLTEtMA_3cd0eac6-cb66-4f76-9253-c0b6cb202cb4"
      unitRef="usd">659000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjQ4MzA4OWQyZjMzODQ1ODE5Y2YwNDYwMmE4ODRiYzE4L3RhYmxlcmFuZ2U6NDgzMDg5ZDJmMzM4NDU4MTljZjA0NjAyYTg4NGJjMThfMjktMy0xLTEtMA_0d068625-e705-4eff-b599-4bb73154b26c"
      unitRef="usd">105583000000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzNzg_840f4e9f-6c1d-493a-b7d4-77d1f0b7e56d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzOTU_cf436098-9d9b-40fc-a69d-7843318dda9c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021 and 2020, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjg5NDUwMzUxZTc1NTQ1MTBiMGRmZjgzYzJkMjgwNWRhL3RhYmxlcmFuZ2U6ODk0NTAzNTFlNzU1NDUxMGIwZGZmODNjMmQyODA1ZGFfMS0xLTEtMS0w_1f6f5f70-9145-4017-b673-8d2719c178ae"
      unitRef="usd">8398000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjg5NDUwMzUxZTc1NTQ1MTBiMGRmZjgzYzJkMjgwNWRhL3RhYmxlcmFuZ2U6ODk0NTAzNTFlNzU1NDUxMGIwZGZmODNjMmQyODA1ZGFfMS0zLTEtMS0w_04b71c9c-b550-444d-91e9-8bb6105f51b7"
      unitRef="usd">7101000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjg5NDUwMzUxZTc1NTQ1MTBiMGRmZjgzYzJkMjgwNWRhL3RhYmxlcmFuZ2U6ODk0NTAzNTFlNzU1NDUxMGIwZGZmODNjMmQyODA1ZGFfMi0xLTEtMS0w_823cba8e-1bb5-49f4-8abb-7f7527ec5d73"
      unitRef="usd">78000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjg5NDUwMzUxZTc1NTQ1MTBiMGRmZjgzYzJkMjgwNWRhL3RhYmxlcmFuZ2U6ODk0NTAzNTFlNzU1NDUxMGIwZGZmODNjMmQyODA1ZGFfMi0zLTEtMS0w_b3975110-d15f-4c8f-b411-6586833b242d"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfMi0xLTEtMS0w_b3975110-d15f-4c8f-b411-6586833b242d"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i4adcddfef50d4237a36d95774c4b5e7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfMi0zLTEtMS0w_d2765690-aec4-4a77-bb49-f02c6bbe1fe3"
      unitRef="usd">73000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfMy0xLTEtMS0w_8d168ce2-be82-4380-8708-7e6ffdf80f95"
      unitRef="usd">286000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfMy0zLTEtMS0w_e2427da8-3570-40ef-861a-658c3264c6ea"
      unitRef="usd">266000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractwithCustomerLiabilityRedemptionandBreakage
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfNC0xLTEtMS0w_7c65040d-3530-477d-b07e-2ea8497068a8"
      unitRef="usd">279000000</cvs:ContractwithCustomerLiabilityRedemptionandBreakage>
    <cvs:ContractwithCustomerLiabilityRedemptionandBreakage
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfNC0zLTEtMS0w_bcd87e5f-0da1-467c-b422-de61f8c35ae2"
      unitRef="usd">264000000</cvs:ContractwithCustomerLiabilityRedemptionandBreakage>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfNS0xLTEtMS0w_823cba8e-1bb5-49f4-8abb-7f7527ec5d73"
      unitRef="usd">78000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ie81f391964c947c2b2bd32278edef5e3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RhYmxlOjViOWVmZjgyY2VjOTRiNzI5MDA1ZWJkOWU3MzIzYjA2L3RhYmxlcmFuZ2U6NWI5ZWZmODJjZWM5NGI3MjkwMDVlYmQ5ZTczMjNiMDZfNS0zLTEtMS0w_34c5abf1-313f-4d3b-b513-937e169958ff"
      unitRef="usd">75000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:HealthCareEntitiesPolicyPolicyTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzNDg_278d1ded-8d2b-45f6-95de-94e3f04e7f5e">Health Insurer FeeSince January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#x201c;ACA&#x201d;) has imposed an annual premium-based health insurer fee (the &#x201c;HIF&#x201d;). The HIF, which is payable each September, is not deductible for federal income tax purposes.</us-gaap:HealthCareEntitiesPolicyPolicyTextBlock>
    <cvs:HealthInsurerFee
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTE4OTk_51f77a18-d457-4dd5-a27c-0b5fe7452572"
      unitRef="usd">0</cvs:HealthInsurerFee>
    <cvs:HealthInsurerFee
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTE4OTk_a2ee9430-e24c-478c-988f-3584a238d09c"
      unitRef="usd">0</cvs:HealthInsurerFee>
    <cvs:HealthInsurerFee
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTE5ODU_3882b728-f3a1-4756-9b3f-196f45d163fd"
      unitRef="usd">255000000</cvs:HealthInsurerFee>
    <cvs:HealthInsurerFee
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTE5OTI_c1fc11ac-b2d3-425a-aad2-b77ec487e0b7"
      unitRef="usd">774000000</cvs:HealthInsurerFee>
    <cvs:PaymentsToHealthInsurerFee
      contextRef="iac2b3349c830449db89d0000b4259672_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMzI5ODUzNDkwMDA3NA_6b4eff88-cfa1-4cc3-ba4f-53d55a52ada5"
      unitRef="usd">1000000000</cvs:PaymentsToHealthInsurerFee>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzNTM_dced6e4f-9bac-426c-860b-9ee2896d98de">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $16 million and $5 million in the three months ended September&#160;30, 2021 and 2020, respectively, and expensed fees for the use of this network of approximately $35 million and $28 million in the nine months ended September&#160;30, 2021 and 2020, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $20 million and $15 million for pharmaceutical inventory purchases during the three months ended September&#160;30, 2021 and 2020, respectively, and $57 million and $58 million for pharmaceutical inventory purchases during the nine months ended September&#160;30, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI0MjI_b370f22d-1f39-49bd-a96e-190ee05a65eb"
      unitRef="usd">16000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI0Mjk_b0acc57b-2c9c-47af-bd50-e376a53ce416"
      unitRef="usd">5000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI1NDY_688bbb7b-822b-4c81-9fcd-d1822898062e"
      unitRef="usd">35000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI1NTM_939b19c4-2c8b-481c-9069-e5e230e6af10"
      unitRef="usd">28000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i4dc635a1438340608f1c50ba4fdd86c9_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI4NDU_e581957c-5e83-4b83-81d5-64b0884fb109"
      unitRef="state">4</us-gaap:NumberOfStatesInWhichEntityOperates>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI4ODM_cb5185bd-0a91-4240-8a19-dd1114b65b2c"
      unitRef="usd">20000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI4OTA_1aae189c-6a48-4200-b4a7-cf90bdd4dde3"
      unitRef="usd">15000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI5OTE_a291f382-010f-4f63-87e5-7aa5d308a442"
      unitRef="usd">57000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTI5OTg_03e918d6-341f-418f-b966-2043fb715f90"
      unitRef="usd">58000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zNy9mcmFnOjQwMTg1OGFjYWNhZDQxYWY5MWQ3ZWQ1YmYxODNhOGJiL3RleHRyZWdpb246NDAxODU4YWNhY2FkNDFhZjkxZDdlZDViZjE4M2E4YmJfMTYzODY_14ab63d0-a5ec-4643-9e90-2a7fec0add21">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Recently Adopted  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows, financial condition or related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other &lt;/span&gt;&lt;/div&gt;comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#x2019;s expected investment yield under the existing guidance.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDkxNg_fd57c260-7369-47fd-9f72-430f1b191665">Investments&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at September&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at September&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;There was no allowance for expected credit losses recorded on available-for-sale debt securities at September&#160;30, 2021 or December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results. At September&#160;30, 2021, debt securities with a fair value of $882 million, gross unrealized capital gains of $101 million and gross unrealized capital losses of $1 million and at December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities at September&#160;30, 2021 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at September&#160;30, 2021 and December&#160;31, 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#x2019;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#x2019;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#x2019;s current prospects for recovery. Unrealized capital losses at September&#160;30, 2021 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of September&#160;30, 2021, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at September&#160;30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting&lt;br/&gt;experience-rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting &lt;br/&gt;remaining products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s mortgage loans are collateralized by commercial real estate.&#160;During the three and nine months ended September&#160;30, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#x2019;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 1 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Represents loans of superior quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 2 to 4 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 5 and 6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represent loans where credit risk is not substantial, but these loans warrant management&#x2019;s close attention.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the Company&#x2019;s assessments at September&#160;30, 2021 and December&#160;31, 2020, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the three and nine months ended September&#160;30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains (losses) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital losses include yield-related impairment losses on debt securities of $3 million in the three months ended September&#160;30, 2021. Net realized capital gains are net of yield-related impairment losses on debt securities of $35 million in the nine months ended September&#160;30, 2021. There were no credit-related losses on debt securities in the three and nine months ended September&#160;30, 2021. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $1 million and $2 million, respectively, in the three months ended September&#160;30, 2020. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $4 million and $44 million, respectively, in the nine months ended September&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net investment income includes $9 million and $28 million for the three and nine months ended September&#160;30, 2021, respectively, and $10 million and $31 million for the three and nine months ended September&#160;30, 2020, respectively, related to investments supporting experience-rated products. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and nine months ended September&#160;30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <cvs:TotalInvestmentsTableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDk3MA_ee596593-77d6-46f5-b719-298012e99a32">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at September&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:TotalInvestmentsTableTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="i21ee770549c949dcb40ae6f549cc3f40_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMi0xLTEtMS0w_250f67dc-648a-41be-bc9d-dacae7913cda"
      unitRef="usd">2859000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i21ee770549c949dcb40ae6f549cc3f40_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMi0zLTEtMS0w_8c1ada5d-9ef1-4f29-96fc-7990c78661c6"
      unitRef="usd">19715000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i21ee770549c949dcb40ae6f549cc3f40_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMi01LTEtMS0w_663814b5-04c0-45b4-8790-9fabe9a60b24"
      unitRef="usd">22574000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i80a6996dadac4e8b8f355582234ddeb6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMi03LTEtMS0w_3a75656b-32b4-4ecf-817d-fc03351eec9c"
      unitRef="usd">2774000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i80a6996dadac4e8b8f355582234ddeb6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMi05LTEtMS0w_2ea01091-0258-4df3-adbd-fa80a1671290"
      unitRef="usd">18414000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i80a6996dadac4e8b8f355582234ddeb6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMi0xMS0xLTEtMA_89929f8c-73e6-4324-9ea8-1cc321143217"
      unitRef="usd">21188000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i97c318d6cbb84ce1af4416e5e9e9e796_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMy0xLTEtMS0w_bb1f7a1a-ace9-4627-bca7-9af8858f525c"
      unitRef="usd">110000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i97c318d6cbb84ce1af4416e5e9e9e796_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMy0zLTEtMS0w_4b5a3d8a-10f5-4e6c-8440-5658e13f1977"
      unitRef="usd">824000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i97c318d6cbb84ce1af4416e5e9e9e796_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMy01LTEtMS0w_67c93395-e0f6-4b8b-8bc8-9f20c0235ad7"
      unitRef="usd">934000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i707fe789ecce4f57bbc13e85dcb9d128_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMy03LTEtMS0w_3578e537-e7ae-4dcd-8c57-a2e142ae6657"
      unitRef="usd">226000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i707fe789ecce4f57bbc13e85dcb9d128_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMy05LTEtMS0w_3fd4a749-fe36-45a2-b727-4c1a0b5fd818"
      unitRef="usd">821000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i707fe789ecce4f57bbc13e85dcb9d128_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfMy0xMS0xLTEtMA_f6c59fde-1ad9-471f-bb75-48336e2f04ac"
      unitRef="usd">1047000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i5e088f53c1324f15a6ec9498f86c75ad_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNC0xLTEtMS0w_d429e606-3f3f-4a93-afe8-d822fc3eadd0"
      unitRef="usd">46000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i5e088f53c1324f15a6ec9498f86c75ad_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNC0zLTEtMS0w_983d2ba8-861b-4b1c-89b5-4a160d00fc75"
      unitRef="usd">1831000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i5e088f53c1324f15a6ec9498f86c75ad_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNC01LTEtMS0w_2023f88d-b224-4541-8534-14b7f7cfa7dc"
      unitRef="usd">1877000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ie6144005cd614c8aa06ca2e425c85859_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNC03LTEtMS0w_8c0970b4-4f70-49de-95f3-13dbea38f2d7"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ie6144005cd614c8aa06ca2e425c85859_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNC05LTEtMS0w_d6365e56-e295-40a7-9d4d-e55d5ae82f62"
      unitRef="usd">1577000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="ie6144005cd614c8aa06ca2e425c85859_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNC0xMS0xLTEtMA_53f3799b-7a1c-44e4-b427-b7ac420e0f4d"
      unitRef="usd">1577000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNS0xLTEtMS0w_9f3c03df-9569-4b46-9e66-237b989ed5df"
      unitRef="usd">3015000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNS0zLTEtMS0w_0dd59856-bf9e-4275-b0c9-c76e6a202e1e"
      unitRef="usd">22370000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNS01LTEtMS0w_dbda76c8-353e-43bc-b6e4-843422c8d8c8"
      unitRef="usd">25385000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNS03LTEtMS0w_e1a95d65-ad75-4aa6-a77e-1092941dfc04"
      unitRef="usd">3000000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNS05LTEtMS0w_31122afc-f7d7-44d3-999a-b19d5a01a926"
      unitRef="usd">20812000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmQ1NzEyYmM5YmM0YjQxY2JiMjgyZDU2MGVjODEwNGUyL3RhYmxlcmFuZ2U6ZDU3MTJiYzliYzRiNDFjYmIyODJkNTYwZWM4MTA0ZTJfNS0xMS0xLTEtMA_181de5f7-f518-4329-8576-4cfe2e4cc830"
      unitRef="usd">23812000000</us-gaap:Investments>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDkzMA_9513acff-8fd8-46cd-90ac-a49e9ffe58b4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at September&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;There was no allowance for expected credit losses recorded on available-for-sale debt securities at September&#160;30, 2021 or December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results. At September&#160;30, 2021, debt securities with a fair value of $882 million, gross unrealized capital gains of $101 million and gross unrealized capital losses of $1 million and at December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMy01LTEtMS0w_e85c06fc-e6ba-4491-bf32-7223a7c6e58d"
      unitRef="usd">2260000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMy03LTEtMS0w_a52b9f03-5363-4b95-bc25-4be231053301"
      unitRef="usd">81000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMy05LTEtMS0w_21e299cd-3819-49a4-a578-a070db3fef36"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMy0xMS0xLTEtMA_3221c993-02d0-4f59-9593-79d27eacb952"
      unitRef="usd">2340000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNC01LTEtMS0w_fded7a7a-30ab-4b0a-b3ec-4d04dacd7ca8"
      unitRef="usd">2939000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNC03LTEtMS0w_081780ab-c529-485e-8652-1964b88cdf3e"
      unitRef="usd">151000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNC05LTEtMS0w_691919a0-bd0d-42f0-9e56-b53f92db294b"
      unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNC0xMS0xLTEtMA_7ed79b94-6680-45f7-b8c8-bfb689287072"
      unitRef="usd">3085000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i84071dd39d474caab85d1a67242c2886_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNS01LTEtMS0w_81571bfd-8de8-4afa-bc56-923958845e8a"
      unitRef="usd">8898000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i84071dd39d474caab85d1a67242c2886_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNS03LTEtMS0w_b160e288-c3ac-4504-897a-f1ddbd6c6207"
      unitRef="usd">757000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i84071dd39d474caab85d1a67242c2886_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNS05LTEtMS0w_64c6f6e3-3829-4715-b0f7-687b16c7e9da"
      unitRef="usd">22000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i84071dd39d474caab85d1a67242c2886_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNS0xMS0xLTEtMA_09d8c658-211c-4708-9c12-3ed6a7c09724"
      unitRef="usd">9633000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNi01LTEtMS0w_47e90fd7-4c46-49cc-8515-9fe141463111"
      unitRef="usd">2736000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNi03LTEtMS0w_69da3434-4aeb-42b1-9dc4-047127a6dcdb"
      unitRef="usd">221000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNi05LTEtMS0w_fb2a1eda-5f78-488e-b9f4-49c54640d40e"
      unitRef="usd">12000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNi0xMS0xLTEtMA_b709bf38-383c-4182-98fe-81bf63a28f1c"
      unitRef="usd">2945000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNy01LTEtMS0w_b67de901-52bf-4391-a9ca-55aa94ede9a5"
      unitRef="usd">849000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNy03LTEtMS0w_46f6c1a3-42a2-43b6-a790-e6a9dcf71f5d"
      unitRef="usd">19000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNy05LTEtMS0w_3b3e4637-76b5-4f7c-bdfb-925fcaa099f7"
      unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfNy0xMS0xLTEtMA_22674af9-b1c0-400e-ac0f-919013e6a9b8"
      unitRef="usd">863000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOC01LTEtMS0w_5a4d55d7-da88-4a0d-8f6b-7d9aebf263e7"
      unitRef="usd">1160000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOC03LTEtMS0w_99ec6363-6834-4067-bb1e-5762aae56233"
      unitRef="usd">57000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOC05LTEtMS0w_0fdd0429-1f0c-4af9-b59b-75e75cd351a0"
      unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOC0xMS0xLTEtMA_c9dc424c-bf54-4c2b-ace6-9e674d894431"
      unitRef="usd">1209000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOS01LTEtMS0w_c4c9c365-f0c6-4d2e-84af-44be7c20462c"
      unitRef="usd">2447000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOS03LTEtMS0w_c26946ff-e9b4-46a3-8a24-9e5a20e05aed"
      unitRef="usd">23000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOS05LTEtMS0w_a9e74c8a-8289-4566-89bc-8696265a2c1a"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfOS0xMS0xLTEtMA_cd8bb2d6-5d96-44c2-99e3-681b7d28e39d"
      unitRef="usd">2468000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="idf502564439b47e698e240fdd68a98f8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTAtNS0xLTEtMA_ee36636c-b16c-4440-9b8d-c5de81a0bf91"
      unitRef="usd">28000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idf502564439b47e698e240fdd68a98f8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTAtNy0xLTEtMA_82f982a2-b30a-46ff-b1eb-7ce8b51fb87e"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idf502564439b47e698e240fdd68a98f8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTAtOS0xLTEtMA_6ee7415e-2fa8-4b6c-8f61-e1d54ab36e0d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idf502564439b47e698e240fdd68a98f8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTAtMTEtMS0xLTA_e65f044c-4391-4ecf-bbbb-1149e9b95621"
      unitRef="usd">31000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTEtNS0xLTEtMA_336ac941-4f8b-4d3b-811e-e2e83531e119"
      unitRef="usd">21317000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTEtNy0xLTEtMA_09adaa2b-c5a1-46a3-a207-e51b751b81e6"
      unitRef="usd">1312000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTEtOS0xLTEtMA_a93f5279-5940-458b-a41b-729d7335df62"
      unitRef="usd">55000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTEtMTEtMS0xLTA_85aeda2e-53d8-446f-a6b9-cc943142aae1"
      unitRef="usd">22574000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTUtNS0xLTEtMA_9be3be62-0cca-4928-bb61-ee85761ab84b"
      unitRef="usd">2341000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTUtNy0xLTEtMA_adf712ad-9fd5-4124-ab11-5de2f9607e57"
      unitRef="usd">128000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTUtOS0xLTEtMA_5ec01bcb-626e-4765-a7ed-5b13cd9d532c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTUtMTEtMS0xLTA_c7586209-c72d-4ae9-a089-08ff20afe3b3"
      unitRef="usd">2469000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTYtNS0xLTEtMA_a13066e1-b0d4-4b42-a724-e9980a959405"
      unitRef="usd">2556000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTYtNy0xLTEtMA_49d5d6ee-9115-4671-a48e-c91f666ed3b3"
      unitRef="usd">172000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTYtOS0xLTEtMA_a3c87522-3ade-4b77-ae85-410daf9157bf"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTYtMTEtMS0xLTA_04a41cee-d05e-4902-985b-133891c4b99c"
      unitRef="usd">2728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTctNS0xLTEtMA_3429ba3e-46ea-4aba-8141-95a2dce27bda"
      unitRef="usd">7879000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTctNy0xLTEtMA_a4d828e4-7f6b-4d76-9945-3af56202294f"
      unitRef="usd">1023000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTctOS0xLTEtMA_e1f9e12b-bc1d-4e2c-8caa-8847ca167d05"
      unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTctMTEtMS0xLTA_4c983864-427d-4fef-b87d-70133d756820"
      unitRef="usd">8894000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTgtNS0xLTEtMA_e9c09ad8-efed-42cb-8951-f9776c584764"
      unitRef="usd">2595000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTgtNy0xLTEtMA_b98256f3-7327-41f2-a7a8-bfaf715baf8f"
      unitRef="usd">324000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTgtOS0xLTEtMA_b794a248-12d9-4909-8aab-eb0aa016b61d"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTgtMTEtMS0xLTA_dfe6e66d-a34c-499c-8c4c-ae3889819981"
      unitRef="usd">2918000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ia73e717be6b54384b3a33a455727136e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTktNS0xLTEtMA_4cd21c00-fd59-4024-a788-12e4c55dd31e"
      unitRef="usd">673000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia73e717be6b54384b3a33a455727136e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTktNy0xLTEtMA_375cad43-9edd-4784-9f5b-a64759934d56"
      unitRef="usd">32000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia73e717be6b54384b3a33a455727136e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTktOS0xLTEtMA_ea912f77-2382-48b7-9d93-c77887294cac"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia73e717be6b54384b3a33a455727136e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMTktMTEtMS0xLTA_9d3f971a-b068-4152-b1a2-8489cae591ca"
      unitRef="usd">705000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjAtNS0xLTEtMA_e54e7894-3f73-4f83-b6aa-9ec857ac0d23"
      unitRef="usd">962000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjAtNy0xLTEtMA_034d7ee0-cb95-420d-9837-9d43e2d8c982"
      unitRef="usd">84000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjAtOS0xLTEtMA_d67e69ba-6d44-4511-b0c4-fcef6fbd6b5f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjAtMTEtMS0xLTA_9fe43176-726f-4b9d-a7bc-020b144d7d50"
      unitRef="usd">1046000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjEtNS0xLTEtMA_6ba7b829-68c1-4ba7-a2d4-e2d742e37fd9"
      unitRef="usd">2369000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjEtNy0xLTEtMA_4cff8454-9b8a-412b-a50e-504d296a1cb7"
      unitRef="usd">36000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjEtOS0xLTEtMA_678b82f1-800b-4aa6-9bae-e0e6b03cbd3d"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjEtMTEtMS0xLTA_a2460ff1-e2cc-4ee1-9449-ac90c3f6b157"
      unitRef="usd">2403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ic9ed33a6edcd4234b95ebdec84f83d90_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjItNS0xLTEtMA_0a51e0da-3727-4fd8-a109-436f5a5ba11c"
      unitRef="usd">21000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic9ed33a6edcd4234b95ebdec84f83d90_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjItNy0xLTEtMA_808f48a7-d01e-4236-9a0a-c581d55e87ff"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic9ed33a6edcd4234b95ebdec84f83d90_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjItOS0xLTEtMA_f0919ef5-838a-401f-9d94-84f8ed61a1f5"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic9ed33a6edcd4234b95ebdec84f83d90_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjItMTEtMS0xLTA_4ca2b6a7-bac8-4290-86f3-db7311c77564"
      unitRef="usd">25000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjMtNS0xLTEtMA_1c67a0e2-8069-44c0-adc5-cf6560d13d26"
      unitRef="usd">19396000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjMtNy0xLTEtMA_361819f4-6bbb-4eed-b680-b51ba0ed2a95"
      unitRef="usd">1803000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjMtOS0xLTEtMA_b54ea77d-3b28-4fd3-a1a1-651467be0200"
      unitRef="usd">11000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmNlZWZhMjdlOGUyZTQxODRhY2JmMGE0NGMwMGQxZTk1L3RhYmxlcmFuZ2U6Y2VlZmEyN2U4ZTJlNDE4NGFjYmYwYTQ0YzAwZDFlOTVfMjMtMTEtMS0xLTA_33147939-7656-4134-af10-cc22f13818bb"
      unitRef="usd">21188000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfMjEx_68526fba-fbe6-459c-aee5-a15bd122d1b5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfMjEx_d3027883-7016-45c2-836e-61f2c888dc79"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDk4_a851fd24-ccd5-4319-9e26-294a6ef61276"
      unitRef="usd">882000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNTM2_88cef85f-925a-448b-95d8-4ff3747f9340"
      unitRef="usd">101000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNTc4_79e7c443-3ee5-4802-a2e5-50f607e86426"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibb8aec5e18a44c75a0b64168efe52403_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNjI5_f7621c21-f7f1-4a94-9fbb-d908c19c6200"
      unitRef="usd">919000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibb8aec5e18a44c75a0b64168efe52403_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNjY3_bd7a7d2b-45ca-46e8-bad9-998c58831561"
      unitRef="usd">135000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibb8aec5e18a44c75a0b64168efe52403_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNjc0_9a711e2f-4d33-4416-9b15-22f0798153ef"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDk4Mg_0d8f0115-6902-4dd6-8381-30d807fa75bd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities at September&#160;30, 2021 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfMi0xLTEtMS0w_eb97941a-7a68-4f44-94f0-0582050bb1cc"
      unitRef="usd">1056000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfMi0zLTEtMS0w_bb3f169e-26b7-4852-be32-a100b96da1bc"
      unitRef="usd">1071000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfMy0xLTEtMS0w_4f004648-672e-4a24-8e72-f5dd9a5a8f3f"
      unitRef="usd">7123000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfMy0zLTEtMS0w_c67b26eb-0c56-4692-9a5e-5dba3e6e1518"
      unitRef="usd">7390000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNC0xLTEtMS0w_11dcac9b-ab31-4e62-bbe9-622af34544c3"
      unitRef="usd">4492000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNC0zLTEtMS0w_65cfa699-fb0a-44ea-b7f0-1804711a92c6"
      unitRef="usd">4718000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNS0xLTEtMS0w_17c2eeff-0dab-45fb-b360-716a55f6e4d9"
      unitRef="usd">4190000000</cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNS0zLTEtMS0w_fbb35d13-07fc-4f30-bc70-8a73adfac05a"
      unitRef="usd">4855000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNi0xLTEtMS0w_882aa935-2582-4ff0-a960-08fb0fedb50a"
      unitRef="usd">849000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNi0zLTEtMS0w_fc20bd4d-7595-4387-8e68-b969000ddb30"
      unitRef="usd">863000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNy0xLTEtMS0w_59ee7266-3b07-406e-b3f6-47fa5f8ad0e7"
      unitRef="usd">1160000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfNy0zLTEtMS0w_fb1a9eed-c70e-4b7f-8107-8546d02c8236"
      unitRef="usd">1209000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfOC0xLTEtMS0w_01517c39-13ec-490a-8f10-a23bc47cb0f9"
      unitRef="usd">2447000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfOC0zLTEtMS0w_37c9415b-201a-423c-a671-3791e72e4f36"
      unitRef="usd">2468000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfOS0xLTEtMS0w_af10c56e-8bb9-455f-880d-9f3ae9217bc7"
      unitRef="usd">21317000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiNzM0YjFhOTk0ODRiMjE4OWRjOGNmMWJkYTY5NzEwL3RhYmxlcmFuZ2U6NGI3MzRiMWE5OTQ4NGIyMTg5ZGM4Y2YxYmRhNjk3MTBfOS0zLTEtMS0w_e247f416-97d2-4abc-b05a-590a12774dd3"
      unitRef="usd">22574000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDg5OA_233f1b8f-fa94-4922-b20d-8936f18a57ec">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at September&#160;30, 2021 and December&#160;31, 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at September&#160;30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting&lt;br/&gt;experience-rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting &lt;br/&gt;remaining products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC0xLTEtMS0w_49a3e297-7e48-4e47-abc9-3229d8e07869"
      unitRef="security">45</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC0zLTEtMS0w_030a3568-bebf-4d74-950b-0af57354b94d"
      unitRef="usd">204000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC01LTEtMS0w_a8c35abb-5008-4562-a130-3c8aa39b7b37"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC03LTEtMS0w_2120bebb-bb55-4f9d-a73f-e5e4b1947755"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC05LTEtMS0w_2c215e83-e7ec-4444-b5a6-42474ece5e1e"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC0xMS0xLTEtMA_cfeae266-eee6-42cc-8277-1288aa27c3f0"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC0xMy0xLTEtMA_f19953bc-1da6-44f0-823d-88fa9bb0721d"
      unitRef="security">47</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC0xNS0xLTEtMA_caf8675e-4b62-4cac-91c0-e2c9270d5fa6"
      unitRef="usd">205000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i69848f4e7b6b4ecc87c357fbbb14fed8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNC0xNy0xLTEtMA_83915881-b8f5-441f-9d97-b081bf3675ba"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS0xLTEtMS0w_f77ba1f9-40c9-43cf-abb4-7fa1ff446f35"
      unitRef="security">234</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS0zLTEtMS0w_ff112a1e-9048-4e83-934e-ae7cebc28caf"
      unitRef="usd">464000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS01LTEtMS0w_de486785-276e-4fbf-a898-d6e74697eac6"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS03LTEtMS0w_6ddf35b3-4b85-4f39-9aad-a10290f93996"
      unitRef="security">1</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS05LTEtMS0w_25e25427-e8d0-4fcc-b2e0-55c8120e6f3a"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS0xMS0xLTEtMA_645dba41-5a28-4911-bf2b-9486a75ff662"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS0xMy0xLTEtMA_1f1bf0be-a911-4d7d-a755-4c65b7d2863b"
      unitRef="security">235</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS0xNS0xLTEtMA_a109aff8-cd83-4235-9b63-527f5fc8f75d"
      unitRef="usd">468000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i6219773cc6094ae6a3a58d0952cbb6fd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNS0xNy0xLTEtMA_7cb162df-1f8e-4a56-a01d-6ee84e63f90c"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i84071dd39d474caab85d1a67242c2886_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi0xLTEtMS0w_3476b2d2-db63-476d-bd6d-8262bbc3df2b"
      unitRef="security">1081</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i84071dd39d474caab85d1a67242c2886_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi0zLTEtMS0w_62f2ef9d-82c0-4360-92f3-32ee74e85a14"
      unitRef="usd">1528000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i84071dd39d474caab85d1a67242c2886_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi01LTEtMS0w_8b272e3a-dd0d-4f0f-a950-824c5aee566f"
      unitRef="usd">19000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i84071dd39d474caab85d1a67242c2886_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi03LTEtMS0w_d419de39-0999-423a-901e-bf39b6f6b2ed"
      unitRef="security">43</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i84071dd39d474caab85d1a67242c2886_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi05LTEtMS0w_5c8c2d47-12a6-4fd5-a0e1-ae1b3eed03e8"
      unitRef="usd">51000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i84071dd39d474caab85d1a67242c2886_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi0xMS0xLTEtMA_6162cf37-d587-49ba-81a2-5f908c9c461a"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i84071dd39d474caab85d1a67242c2886_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi0xMy0xLTEtMA_1ad4224f-7d36-44f5-8eda-c85393d9e479"
      unitRef="security">1124</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i84071dd39d474caab85d1a67242c2886_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi0xNS0xLTEtMA_fff5524c-69fa-4cc1-9917-4048f0309dcf"
      unitRef="usd">1579000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i84071dd39d474caab85d1a67242c2886_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNi0xNy0xLTEtMA_40ed76f6-7896-4d62-a49e-96297df9a4ea"
      unitRef="usd">22000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy0xLTEtMS0w_f1ad2f06-b7ef-4c80-827e-fdd0bc529409"
      unitRef="security">320</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy0zLTEtMS0w_99f1f412-55c3-4f01-b024-0be5a7fa9c38"
      unitRef="usd">568000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy01LTEtMS0w_5b5fbc02-f281-4220-b30b-a00a60fc8d2b"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy03LTEtMS0w_51c7ebb5-a1a4-411f-9e8f-b479e3dc08a9"
      unitRef="security">12</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy05LTEtMS0w_b4e5a8ca-1fc2-4f0a-bc16-108432fc3b31"
      unitRef="usd">21000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy0xMS0xLTEtMA_311d6676-51b3-422c-a352-c153fb49c5c8"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy0xMy0xLTEtMA_539108bb-1d9c-4049-8237-fb78cf3a99fb"
      unitRef="security">332</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy0xNS0xLTEtMA_0f3dab49-3a6d-467e-95bf-d49dccc8aeec"
      unitRef="usd">589000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="if27a76e953c04bb392f52d3e05778b01_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfNy0xNy0xLTEtMA_a669fa73-3dc3-4ef9-8b6b-343f2d0692e6"
      unitRef="usd">12000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC0xLTEtMS0w_ae1b848a-5c5c-4d37-a540-1de7d9907655"
      unitRef="security">122</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC0zLTEtMS0w_575f2f18-7f22-4c80-bfb5-26d2a927d700"
      unitRef="usd">476000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC01LTEtMS0w_b0094fed-d653-48fa-9970-18216b7d9014"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC03LTEtMS0w_3e70b054-645e-4b41-9661-3c7ec512b835"
      unitRef="security">9</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC05LTEtMS0w_9503c65f-df89-4b51-8552-0a22cf2da248"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC0xMS0xLTEtMA_201237a3-b904-44b8-aecd-2417ac2773f7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC0xMy0xLTEtMA_8aad08f8-a522-4e63-812f-d780e451612d"
      unitRef="security">131</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC0xNS0xLTEtMA_3082763b-7e62-48f0-8805-5f6f94330572"
      unitRef="usd">486000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOC0xNy0xLTEtMA_f3faf251-cda8-4b2d-b62b-711cccf749e1"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS0xLTEtMS0w_24a5ff0f-fc15-461e-87a2-f71bc7e2dc64"
      unitRef="security">127</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS0zLTEtMS0w_c5960a0a-087d-4c5c-a75c-acb7b76c8a94"
      unitRef="usd">342000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS01LTEtMS0w_9cfc1925-108a-4b92-bdbb-99a6a8cb9ec9"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS03LTEtMS0w_b29f69cc-ae40-4cb8-951c-50c3a7dbeb26"
      unitRef="security">15</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS05LTEtMS0w_a6d89e1b-7ee4-4ade-b5a4-dd7b129bb0a3"
      unitRef="usd">47000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS0xMS0xLTEtMA_326fc4b4-876d-4fc4-921e-f326ca2e3f39"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS0xMy0xLTEtMA_44aff4fa-1ebc-46a0-8f95-43d8c84af39b"
      unitRef="security">142</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS0xNS0xLTEtMA_076d92aa-3913-4710-87d4-2d89245e3d1a"
      unitRef="usd">389000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfOS0xNy0xLTEtMA_16d36e40-fd27-4221-9810-7b6e00aaa1af"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtMS0xLTEtMA_d5d65c3e-29da-4845-9ae2-f07c11fad06f"
      unitRef="security">312</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtMy0xLTEtMA_0422a551-3635-4cd9-97e7-93a17ecc7442"
      unitRef="usd">652000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtNS0xLTEtMA_ed22c6ab-9f87-46d2-b846-b64c88e4d431"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtNy0xLTEtMA_cfac04b7-4e28-4f35-af2b-134bfa6d5bcc"
      unitRef="security">18</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtOS0xLTEtMA_9612dc92-3c2d-4a35-878a-12d4608804b2"
      unitRef="usd">17000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtMTEtMS0xLTA_925fa759-786f-4283-8421-4d6d32af13b1"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtMTMtMS0xLTA_c10dae5c-9672-4c8d-94df-50d492b3e0a0"
      unitRef="security">330</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtMTUtMS0xLTA_0710a751-440a-4430-ab38-076b3d225b46"
      unitRef="usd">669000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTAtMTctMS0xLTA_f0483d94-88b0-4263-8ebf-ed72acc6173f"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="idf502564439b47e698e240fdd68a98f8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtMS0xLTEtMA_751007f1-f881-476c-9f92-656535fb781d"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="idf502564439b47e698e240fdd68a98f8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtMy0xLTEtMA_51b7e290-049e-4c8b-aeff-4e53455f368b"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="idf502564439b47e698e240fdd68a98f8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtNS0xLTEtMA_1e803c58-8b84-4b16-86bc-9ec898c5f564"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="idf502564439b47e698e240fdd68a98f8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtNy0xLTEtMA_0fcb4243-5c92-423b-89da-8cd67716855b"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="idf502564439b47e698e240fdd68a98f8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtOS0xLTEtMA_f41cef68-c74d-4106-9ae7-30e9dbbd4c13"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="idf502564439b47e698e240fdd68a98f8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtMTEtMS0xLTA_c7761b65-8cc9-442f-a6af-5dc4f08aecc9"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="idf502564439b47e698e240fdd68a98f8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtMTMtMS0xLTA_76db7052-6335-4357-b371-ada2feac9adb"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="idf502564439b47e698e240fdd68a98f8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtMTUtMS0xLTA_7ce6fb19-f9ba-446f-8955-7e0faa2ffd18"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="idf502564439b47e698e240fdd68a98f8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTEtMTctMS0xLTA_a383291a-a3f5-4af9-ada2-bcd4cca9e080"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItMS0xLTEtMA_6750c8f7-9812-471b-b83f-b8e944272262"
      unitRef="security">2243</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItMy0xLTEtMA_c205ad1c-69c1-4cf6-99b5-75dbb82b6efa"
      unitRef="usd">4239000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItNS0xLTEtMA_5a4e4ec0-a869-4849-903d-5494344b135a"
      unitRef="usd">49000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItNy0xLTEtMA_a338ded4-3a37-41b1-a70e-f13985de7b65"
      unitRef="security">100</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItOS0xLTEtMA_55646628-f384-44ce-af37-fffc2163621a"
      unitRef="usd">151000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItMTEtMS0xLTA_fd907f85-e332-464a-aea9-80b557ef5296"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItMTMtMS0xLTA_9d9ccde1-4ff7-444f-929c-a84a86f69f2c"
      unitRef="security">2343</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItMTUtMS0xLTA_9a79c81e-b6ef-402e-a51c-a7bc1b6b5c4e"
      unitRef="usd">4390000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTItMTctMS0xLTA_36804098-9c6c-4438-9562-6c1678d44ca5"
      unitRef="usd">55000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtMS0xLTEtMA_f073dd10-947a-4234-b4a0-e5433c997986"
      unitRef="security">32</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtMy0xLTEtMA_cd651f50-a392-457e-84c7-ee73e91a0fcd"
      unitRef="usd">205000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtNS0xLTEtMA_1ffa0cd8-14b4-4d95-96ec-4dde36ad4d12"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtNy0xLTEtMA_d7b7062d-e2cf-4871-808a-5f3b63af1c94"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtOS0xLTEtMA_62f7cd66-d007-4a4c-890a-4c857851a72d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtMTEtMS0xLTA_1dd13fda-9c54-4ccd-b86c-6c4a8cb48a76"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtMTMtMS0xLTA_50fb8304-9b09-47d7-b225-17a0d2e7595c"
      unitRef="security">32</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtMTUtMS0xLTA_bc98d211-ba48-4f45-bd57-44172f534548"
      unitRef="usd">205000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i16162ee44bb9440284fbd19d6465d34c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTYtMTctMS0xLTA_2cd4fbe3-dbe4-4297-adce-f46b3334d385"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctMS0xLTEtMA_e27e9003-c075-4cff-a99c-877395505023"
      unitRef="security">49</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctMy0xLTEtMA_fb5de1df-9cfc-49f3-ba1d-4f787408c2b8"
      unitRef="usd">83000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctNS0xLTEtMA_5c731271-9e04-45a3-9ba7-e727f331ea10"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctNy0xLTEtMA_fc500533-500e-421a-85f4-138380d5d149"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctOS0xLTEtMA_8bd635da-dbad-41ea-8d76-80c3050f5a5f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctMTEtMS0xLTA_7ac0aa6c-035f-4451-82be-04a4142bf3ae"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctMTMtMS0xLTA_f8ba63a1-2000-49c4-887e-7a7de87d18d4"
      unitRef="security">49</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctMTUtMS0xLTA_166dfaf9-19de-48a2-9add-a4cd42088548"
      unitRef="usd">83000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib769dc9c21e142589bdcbe6161dc3506_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTctMTctMS0xLTA_34fd6c59-f724-4035-8f57-38deb69fcf66"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtMS0xLTEtMA_b845cd2f-cbfa-4bb1-a62a-a2a6c0b01679"
      unitRef="security">145</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtMy0xLTEtMA_fb846737-47e2-40ec-92c8-9e87413cc87e"
      unitRef="usd">155000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtNS0xLTEtMA_6fc6fed8-4a31-4ea0-b6b8-b08383db62f1"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtNy0xLTEtMA_cc4586d7-990e-49d5-ac8c-f655bee30bb5"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtOS0xLTEtMA_f4a00757-273b-4423-b050-36492a6593c8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtMTEtMS0xLTA_ce79757e-3bff-407b-b81a-00e3dafc2a86"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtMTMtMS0xLTA_034555a7-6b38-4745-ba66-f43dc80c0db2"
      unitRef="security">147</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtMTUtMS0xLTA_94afbecc-c76d-482b-bba1-3455638b7814"
      unitRef="usd">155000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i6b9e7773af45416aa21f2d8f06f7abc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTgtMTctMS0xLTA_9b3a2697-8914-4ce1-acaa-bb758fa414dd"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktMS0xLTEtMA_89a0923a-e7d1-4ced-98e0-9b54ba9a9925"
      unitRef="security">41</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktMy0xLTEtMA_67a72ce7-fbf0-47da-a2f9-fe198160487f"
      unitRef="usd">69000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktNS0xLTEtMA_4bebd5c2-0d70-4c79-8ef1-e64536520e90"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktNy0xLTEtMA_de3f369d-3ccd-4844-b412-df0a3abc0b71"
      unitRef="security">5</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktOS0xLTEtMA_260df1e0-921f-42d7-922f-74a794b331de"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktMTEtMS0xLTA_0b6a1f2c-bd3b-4e1f-ad8e-2dd74828d7e8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktMTMtMS0xLTA_f2c9eec0-aa19-460c-8411-ec043e3e1fe5"
      unitRef="security">46</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktMTUtMS0xLTA_971a28da-2566-40c7-a44b-abbab6418347"
      unitRef="usd">74000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib1bcbe85de984034b24a5e4fda18e485_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMTktMTctMS0xLTA_2fb56ede-4006-4486-9483-83b147e36582"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ia73e717be6b54384b3a33a455727136e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtMS0xLTEtMA_4f64912c-c0e5-4f65-b17e-07a29a187e58"
      unitRef="security">23</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ia73e717be6b54384b3a33a455727136e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtMy0xLTEtMA_e03e3954-7334-42b1-8c4d-67ddab045022"
      unitRef="usd">26000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ia73e717be6b54384b3a33a455727136e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtNS0xLTEtMA_a2305228-feb6-4233-bac3-73be1f24d037"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ia73e717be6b54384b3a33a455727136e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtNy0xLTEtMA_8dd50d56-2e5f-453b-9be7-5404f041e2f2"
      unitRef="security">3</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ia73e717be6b54384b3a33a455727136e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtOS0xLTEtMA_b394a292-318d-4dc0-80c1-4e7470e67db2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ia73e717be6b54384b3a33a455727136e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtMTEtMS0xLTA_46c57e76-2cee-4728-bfb4-b97c747018c4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ia73e717be6b54384b3a33a455727136e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtMTMtMS0xLTA_f5f753cf-ec9b-43c9-9076-1865dc7e5c13"
      unitRef="security">26</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ia73e717be6b54384b3a33a455727136e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtMTUtMS0xLTA_1caf5dd7-541e-4991-bbf5-408ebaa71aae"
      unitRef="usd">26000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ia73e717be6b54384b3a33a455727136e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjAtMTctMS0xLTA_248007fe-7753-4430-8b15-1bebacda6e82"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtMS0xLTEtMA_806173ba-bbd4-480b-b4d0-6333aa131226"
      unitRef="security">22</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtMy0xLTEtMA_aa6a9ce2-feef-4444-a6a9-f7a74450a8e3"
      unitRef="usd">75000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtNS0xLTEtMA_df9d701c-a334-4d16-8359-f2cb91a193c0"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtNy0xLTEtMA_ee21e88d-bcda-4433-a2f4-ee93f1a51ae3"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtOS0xLTEtMA_aad7690e-e232-49f9-bfeb-5974f20c025e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtMTEtMS0xLTA_9ffa2896-4914-4240-8af1-c6ccd0712c95"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtMTMtMS0xLTA_7aef05d5-fe3d-45dd-9895-e863600a92c1"
      unitRef="security">22</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtMTUtMS0xLTA_fe9812b6-b173-4e5a-a8af-a79bd4aa8b55"
      unitRef="usd">75000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ia4661486124b4ca28fd4c5ee294a70e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjEtMTctMS0xLTA_632effce-4bee-48cf-9498-53d167e7fea4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItMS0xLTEtMA_50ad818a-31e6-4c32-8a3c-64144a33072a"
      unitRef="security">156</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItMy0xLTEtMA_4c94bc36-2dad-4c9b-a7d2-b90b7eccb4c2"
      unitRef="usd">256000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItNS0xLTEtMA_4096d407-7bbe-46eb-b880-5909743e79ce"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItNy0xLTEtMA_988038e4-f6bb-48f0-b557-f9e3619afad1"
      unitRef="security">49</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItOS0xLTEtMA_a822268f-2b24-415a-a20b-ff78f885bb5e"
      unitRef="usd">41000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItMTEtMS0xLTA_6a1efd79-41e4-48c1-9ed4-eff13bd91af0"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItMTMtMS0xLTA_2fc1213c-3ba3-4021-bef6-f2afb58acc8f"
      unitRef="security">205</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItMTUtMS0xLTA_6f2d370d-82d6-4dbe-89c0-61a911554b7b"
      unitRef="usd">297000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ie3778b495d7b42c5a45cf242a88722cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjItMTctMS0xLTA_64df2be3-798f-47b8-bd08-0638df6b9e2f"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtMS0xLTEtMA_34d4fb87-39df-4e9f-ac20-e9ef62f8bde6"
      unitRef="security">468</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtMy0xLTEtMA_774df60a-adf2-4086-91e0-d38007e9b843"
      unitRef="usd">869000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtNS0xLTEtMA_dd072b3a-e46d-4392-81f5-c156f3ec9433"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtNy0xLTEtMA_4c1fceb7-634f-4040-bdd1-5aa579f850d7"
      unitRef="security">59</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtOS0xLTEtMA_44e2cc18-b8de-403e-9f82-61ad36e0de40"
      unitRef="usd">46000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtMTEtMS0xLTA_e7b70e60-d6d0-4b11-b948-08341bd47241"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtMTMtMS0xLTA_502336e0-050d-48df-b711-341decbc0bfe"
      unitRef="security">527</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtMTUtMS0xLTA_6b5e1fbe-500a-44c8-8b78-fe33320b6aea"
      unitRef="usd">915000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjE4ZTU1NDU1ZjIzMTQxODU4YzBjZTkwZWEwM2I0MjAwL3RhYmxlcmFuZ2U6MThlNTU0NTVmMjMxNDE4NThjMGNlOTBlYTAzYjQyMDBfMjMtMTctMS0xLTA_e89d3123-0939-4123-a508-22782c633482"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMy0xLTEtMS0w_060e493c-ac51-424d-be75-dc7f167f3710"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMy0zLTEtMS0w_fe204396-da41-4975-add3-d67fd2177377"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMy01LTEtMS0w_bc6c01be-ec21-45e5-9af5-f97bed37f669"
      unitRef="usd">22000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMy03LTEtMS0w_de658b29-5cbe-485b-a6ba-6edd77ac9fef"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMy05LTEtMS0w_0a007f5d-f1fc-474e-afcb-1b78efccd5cf"
      unitRef="usd">22000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMy0xMS0xLTEtMA_06f5c6b7-b815-4bc6-a8b3-8e43fd5b362f"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNC0xLTEtMS0w_fc299269-68c4-4534-b87d-18807c236aa3"
      unitRef="usd">6000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNC0zLTEtMS0w_1e4e6a10-436f-478f-8870-3d9026df7c9b"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNC01LTEtMS0w_8c06a953-c799-43ca-b792-8b94f13b339d"
      unitRef="usd">1264000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNC03LTEtMS0w_217a0d47-ae91-4c9b-89da-dfbd28c032db"
      unitRef="usd">11000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNC05LTEtMS0w_d9c65c68-9cb6-4ba3-aefe-a205d05db342"
      unitRef="usd">1270000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNC0xMS0xLTEtMA_a46ca547-30ae-48bc-a705-001afc46bf62"
      unitRef="usd">11000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNS0xLTEtMS0w_5dfb5ff0-0b5e-44e8-9fa6-ecb8f18e93fe"
      unitRef="usd">29000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNS0zLTEtMS0w_0f432a1f-0eed-4a18-a925-5dd011a394b0"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNS01LTEtMS0w_f975433d-438f-43e5-8299-4fdbe5751897"
      unitRef="usd">920000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNS03LTEtMS0w_2bb5e5f4-1db8-43fc-9244-bea323de6ca2"
      unitRef="usd">16000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNS05LTEtMS0w_e659d6a7-9577-4fb8-9912-98ac974a7f04"
      unitRef="usd">949000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNS0xMS0xLTEtMA_4fc3e65c-d657-43da-b351-6ab4a75a6e9b"
      unitRef="usd">17000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNi0xLTEtMS0w_529504b5-6c05-47a5-8468-38f7ac060505"
      unitRef="usd">19000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNi0zLTEtMS0w_dca3953e-493a-40b6-b494-b43970f127d8"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNi01LTEtMS0w_33e72495-48d1-4445-992c-dc34fd9cf273"
      unitRef="usd">586000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNi03LTEtMS0w_5a960fa3-4a3a-45fc-9b5c-71c65bf6d15d"
      unitRef="usd">12000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNi05LTEtMS0w_52cbf82f-51de-426b-a535-8a33b48daeea"
      unitRef="usd">605000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNi0xMS0xLTEtMA_4cb8508b-b221-4f13-90a1-0d80194a2650"
      unitRef="usd">12000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i7cc96f7ad297439c9bd36cc63d9e3146_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNy0xLTEtMS0w_834ee2cc-4276-44cd-8855-218734e54a37"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i7cc96f7ad297439c9bd36cc63d9e3146_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNy0zLTEtMS0w_9e15bb47-1a9e-4b1b-924a-d41ca651fecc"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i0db856db0a1a4dc6b3fd81758f0ae424_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNy01LTEtMS0w_cc0db4b8-4cf3-40b8-947b-79e1e0235be7"
      unitRef="usd">486000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i0db856db0a1a4dc6b3fd81758f0ae424_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNy03LTEtMS0w_96279ea6-048e-43b8-ab5c-d5c60d661e4c"
      unitRef="usd">5000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNy05LTEtMS0w_e5253464-2b88-4228-8c1e-0fa4a217bf98"
      unitRef="usd">486000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i4167d58e660348f68004d45412fb002b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfNy0xMS0xLTEtMA_11fdb03a-a79b-412c-94b2-a5079d54c774"
      unitRef="usd">5000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="if24bb6ab7e694ecdb87149237d4c1602_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOC0xLTEtMS0w_28277044-8f4c-4b87-bd42-7f0bc2193ca3"
      unitRef="usd">6000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="if24bb6ab7e694ecdb87149237d4c1602_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOC0zLTEtMS0w_ad0da237-ed23-4d86-9fca-e6231dfbeda9"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i8d2954c416de4b1e94f5fc8ec55a8415_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOC01LTEtMS0w_0a23df98-cd76-45c9-a1c3-5efc13deee8a"
      unitRef="usd">383000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i8d2954c416de4b1e94f5fc8ec55a8415_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOC03LTEtMS0w_c1141449-e7d5-415f-805e-b52bf17adc1f"
      unitRef="usd">8000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOC05LTEtMS0w_4f98daf7-4739-488b-8c99-af9904363881"
      unitRef="usd">389000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i0ec9ab4c022a4b099a0dcd90654596a2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOC0xMS0xLTEtMA_7f96a888-de80-45f1-aad6-ddc950398a92"
      unitRef="usd">8000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i7a9dc416181f40ecaf6b337fd9f9f867_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOS0xLTEtMS0w_7a3423af-66f6-4b0d-914f-4fd87c3a7551"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i7a9dc416181f40ecaf6b337fd9f9f867_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOS0zLTEtMS0w_5d146aac-8683-4448-820f-407798b36044"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i4f12b69dec3e45bc83561d3148a11d4b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOS01LTEtMS0w_80bc2b25-5852-4ec7-8ff9-5f801d2c15ff"
      unitRef="usd">669000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i4f12b69dec3e45bc83561d3148a11d4b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOS03LTEtMS0w_50c893f2-0545-48e5-a32d-48f0bae0c06e"
      unitRef="usd">2000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOS05LTEtMS0w_5232017a-765f-4ba3-96f2-78e589b2e987"
      unitRef="usd">669000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i97c60203ad5c46589c94c32f921cb550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfOS0xMS0xLTEtMA_f819a9ce-f0fd-4985-a773-9ca0b548c2cb"
      unitRef="usd">2000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMTAtMS0xLTEtMA_da309e68-b732-4ad9-aba4-bb46ca098002"
      unitRef="usd">60000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i4d80e123e8a343c3aea47bf4a325d6f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMTAtMy0xLTEtMA_3f7d7799-74f7-4418-a8c5-9b61c5e0d1a0"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMTAtNS0xLTEtMA_532d7074-7b06-4218-825b-57cc4a1b8a10"
      unitRef="usd">4330000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i1675bac7aaba429694ea0a6a1d6a3574_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMTAtNy0xLTEtMA_b8d342ca-daf4-4f65-aa3b-01cab9c8a34b"
      unitRef="usd">54000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMTAtOS0xLTEtMA_f2c2c878-6d8f-4931-9270-b5cf84f3d390"
      unitRef="usd">4390000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjRiMmU1ODBkOTcwYjQ0ZmM4OTkwOTA3ZDg4MzE1NjQzL3RhYmxlcmFuZ2U6NGIyZTU4MGQ5NzBiNDRmYzg5OTA5MDdkODgzMTU2NDNfMTAtMTEtMS0xLTA_87baf74a-ac42-4055-abee-0c2a2997f9a5"
      unitRef="usd">55000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:ActivityInMortgageLoanPortfolioTableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDk3Mg_4bfa2e2a-23fc-4b21-8d08-28a6bc595a62">During the three and nine months ended September&#160;30, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</cvs:ActivityInMortgageLoanPortfolioTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="ia0879481908c44bb974f798733a18941_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMi0xLTEtMS0w_311519ec-e611-4a0a-8b59-46e1bb1591aa"
      unitRef="usd">53000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="i81bd66dcd0c14391b7ca572896fce844_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMi0zLTEtMS0w_82c21570-d43d-4d6a-b87b-985e90e1b7dc"
      unitRef="usd">31000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="ic20457c673f444f7ad09370f0abc943f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMi01LTEtMS0w_ceb7b14d-6422-44e5-ac5d-b107dd9dc035"
      unitRef="usd">173000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="ie65d53b92fb04633bf47f5b64fe04237_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMi03LTEtMS0w_7297fdac-876e-49a0-b6d3-149851381aa5"
      unitRef="usd">55000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="ia0879481908c44bb974f798733a18941_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMy0xLTEtMS0w_6abcdd87-14cb-4b09-9000-34a730aacd62"
      unitRef="usd">88000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="i81bd66dcd0c14391b7ca572896fce844_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMy0zLTEtMS0w_2096da06-34ec-4288-8e68-a4656221d1f3"
      unitRef="usd">37000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="ic20457c673f444f7ad09370f0abc943f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMy01LTEtMS0w_ad6bf5c1-1f5c-4e67-b84d-08b7e92a6801"
      unitRef="usd">260000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="ie65d53b92fb04633bf47f5b64fe04237_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfMy03LTEtMS0w_74231e54-a613-48f1-a86d-3ced5e1f6699"
      unitRef="usd">114000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="ia0879481908c44bb974f798733a18941_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfNC0xLTEtMS0w_e4df3a33-f5b3-4dd7-a07f-22ee46ab4772"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="i81bd66dcd0c14391b7ca572896fce844_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfNC0zLTEtMS0w_5e91330c-11ff-46c1-8d65-dcb095c39498"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="ic20457c673f444f7ad09370f0abc943f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfNC01LTEtMS0w_0fa5746a-6464-4c5e-b479-1a1ed6578b2c"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="ie65d53b92fb04633bf47f5b64fe04237_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjUyZDA2MjQ5NTkxMjQ4MWM4ODkxMTBjMDYzNWE5ZjI5L3RhYmxlcmFuZ2U6NTJkMDYyNDk1OTEyNDgxYzg4OTExMGMwNjM1YTlmMjlfNC03LTEtMS0w_e5893b0d-6fa5-4563-ad01-28eade9cfb96"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDk2NA_281d8edc-9ae2-4a20-a690-82ab7eb9c24e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the Company&#x2019;s assessments at September&#160;30, 2021 and December&#160;31, 2020, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i1005ea182f234733a5f7f072c2ab891b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy0xLTEtMS0w_76002a62-4bc3-4dc8-b3aa-06ebbe5a9954"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i621480d3797b439aa77a9e7253861a59_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy0zLTEtMS0w_8299976a-0873-44ef-8211-25508e63b2d0"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib6bef302866f416f9a0761624eade678_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy01LTEtMS0w_2bfa048e-00f1-484c-8bbd-cac900920b1a"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ifa59d496a4474b0f95a13c32d9357c35_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy03LTEtMS0w_cb53e6c6-dd6a-462a-a484-0bb6b6c487df"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ifcad87c9dec641918b3c4b3bb560a7de_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy05LTEtMS0w_c4d8f5a8-f986-442d-85ec-4518e0d53a2b"
      unitRef="usd">22000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2f221174b2cc4c23bf352b6226458e50_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy0xMS0xLTEtMA_9d8211b0-5dae-44fa-b23e-1ee157d36f91"
      unitRef="usd">29000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0ccbb0e4dc92472684d9df86f46847c6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMy0xMy0xLTEtMA_e0a89984-24f9-4b67-9b89-a7dbcad07e4a"
      unitRef="usd">51000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie6b89ae1dbe540a4b314a9ffd00f3e91_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC0xLTEtMS0w_9d4fb6b1-996b-4318-bbb4-165015483106"
      unitRef="usd">171000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib99fbba707114103952918869f5d54e8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC0zLTEtMS0w_cfc140eb-37b6-490f-867c-f139222934cd"
      unitRef="usd">44000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4a096f78525a4f118bb1911a1d28e677_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC01LTEtMS0w_75c9c1cf-bc92-4cdc-9ce5-21499d6229dd"
      unitRef="usd">64000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i305483b9eb2c4a8995176a43a6032fc0_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC03LTEtMS0w_33e4def2-3ce4-4f4d-b854-1a474a481168"
      unitRef="usd">73000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ied8e395c6c584b45aadbedeab96bdde0_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC05LTEtMS0w_ecec8125-cbec-4b51-a297-de42d8c4201c"
      unitRef="usd">75000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3e4c260ac59344468042ee0c45e67651_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC0xMS0xLTEtMA_2192b7e1-27ab-4ee7-ae1d-b22dc9981fba"
      unitRef="usd">443000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ifacff69d92414346adfc278aca85cbab_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNC0xMy0xLTEtMA_59ed3d9b-ab57-42cd-bbf4-bf6b7aaab930"
      unitRef="usd">870000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if6bbe3fa4925463a965ddbfa2358fff7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS0xLTEtMS0w_81f80a30-cced-4904-b136-598a696955c0"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i687923585ac246a3aeff8523198d5758_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS0zLTEtMS0w_cc303497-0bf0-402a-b520-fde1e628de67"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if8f440075a474904a22012bf5a0fa634_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS01LTEtMS0w_3f54781c-d318-4a5d-a2d6-2a059f6040e1"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i37ba77da999a41fdb1d81252d6c8a441_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS03LTEtMS0w_09f074ac-5fe3-4425-ae98-e7f3efc13da2"
      unitRef="usd">3000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i16e95dbb642b48db85e7e5bdff14e6e0_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS05LTEtMS0w_c129f10a-8e8f-4043-9267-7ba88a4821ee"
      unitRef="usd">4000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9969a7b4b4034a81bbe819b2eac5c9d6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS0xMS0xLTEtMA_c7f2937f-dd28-4954-a3f2-9454b7d16598"
      unitRef="usd">6000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i42c00a9fab3d4285ae67e62b24f65277_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNS0xMy0xLTEtMA_1a9884bc-4092-4170-b07c-74d3f0af85c2"
      unitRef="usd">13000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i8be70fee5e364ac0b0e505aa20317bc3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi0xLTEtMS0w_b2105793-9905-49ee-86a7-203b835d83a3"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i613b395302204b2d82957489697563c8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi0zLTEtMS0w_d97bda07-c541-4f92-866d-cbf8e022bc0b"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6adc5271a0f0419f838168a0b0c93dcf_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi01LTEtMS0w_c7fcf0c7-379c-4856-80f7-81d4dde3dd92"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3be55e2300ee48e49c912324e8d0adb5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi03LTEtMS0w_f848fea8-7369-4d1a-b0f1-6c67aa355511"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib5edd5e4487d4cde9d6f50a2574f3e8c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi05LTEtMS0w_b4ebe61e-2eca-4086-8541-b3856476cf48"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6b52851fb9b94ea79df46ebaba85d992_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi0xMS0xLTEtMA_39cc2797-9162-42e3-81c7-1bea12636331"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i13f6a29f7e20449ca439559613ffdb02_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNi0xMy0xLTEtMA_b36ea46e-68ff-4ff8-9510-f45e87f6c9e0"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie16bfbf4e5d442348e7fbfc7fa8540f6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy0xLTEtMS0w_b80c5355-41d0-4f60-adbb-56465438adb5"
      unitRef="usd">171000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie54cb4fb85cc4c14ad9a8f690844eb1c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy0zLTEtMS0w_9297707d-cca2-4bcb-bd75-dffce312bc4e"
      unitRef="usd">44000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7336d9407ae74018bd8107c29553bc53_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy01LTEtMS0w_acccb5f7-258c-4386-a66d-5ad5c1180223"
      unitRef="usd">64000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i990fec2baf6c440d8151861169097a2d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy03LTEtMS0w_f002b866-90be-4bd7-8e5e-0a413ac43a87"
      unitRef="usd">76000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6bbb7234989e4a60815b6f61bbb10430_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy05LTEtMS0w_16ca2b60-e0b0-4533-9b4d-7f0827df70db"
      unitRef="usd">101000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic54ed38faf1840829ada4f19ee78708b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy0xMS0xLTEtMA_dabc61af-3a09-4888-be36-d82f06c25d7d"
      unitRef="usd">478000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib458fd6ed94b4ec88122673b72dc2b86_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfNy0xMy0xLTEtMA_84e779eb-22df-43e9-bb92-1212c7e455c6"
      unitRef="usd">934000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iaf1830b9927b403fb56106443f7e286a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTAtMy0xLTEtMA_43d390aa-574a-4b75-a7a3-f061abd36e85"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic16faab668914c0b8f33d98455c26ca8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTAtNS0xLTEtMA_8f55e123-9656-4437-aa48-55644696512b"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i299c35c4365f42e1bfcf88ec9516cd24_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTAtNy0xLTEtMA_939e534c-3455-4924-ab1c-801c77814995"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i89e754d40a6d447789aba510c1139f8c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTAtOS0xLTEtMA_b997f290-0b9c-40f3-ad9f-0b2238ba2af9"
      unitRef="usd">22000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i838e7866071a4f15bf5992c7b4d65771_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTAtMTEtMS0xLTA_b5bcba71-44e3-465a-95ef-c14f3ac9cf81"
      unitRef="usd">37000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ifc3123160602429a9bf38bb156b7b80d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTAtMTMtMS0xLTA_192d2385-2c67-4722-98cb-862449405184"
      unitRef="usd">59000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i5f211351ebd945b59851039aa7cd4aef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTEtMy0xLTEtMA_8d4a164a-ae54-41e1-9149-199eae99803d"
      unitRef="usd">46000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i5f8fc8c9444745159ca710fbe002a038_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTEtNS0xLTEtMA_d94759e7-f3f4-461e-861d-c0cc409b15ba"
      unitRef="usd">96000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i34358d8265934eedae4d1ba649b53da2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTEtNy0xLTEtMA_f113a3a3-abdf-46a4-b5ab-f44ff9148db3"
      unitRef="usd">91000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4b8c3d6759524f80acd74630696a9506_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTEtOS0xLTEtMA_d8c98394-ba79-475d-bca4-4d381e892916"
      unitRef="usd">124000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i027a56206bf049918acb4cc292f57cf6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTEtMTEtMS0xLTA_0a506e1a-346d-4e5c-9950-18ff34dd0b71"
      unitRef="usd">595000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6be1325a1fd74472b0c1686a5b8bed29_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTEtMTMtMS0xLTA_b3442183-ebeb-49c8-8a22-084823ed934b"
      unitRef="usd">952000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i40eace95f50e4f4abe9ef0c982f565fd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTItMy0xLTEtMA_8d21a07d-33ff-4199-bb09-630d9cd831b3"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i1e6dcc78d1204e1a9a491939346531d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTItNS0xLTEtMA_cd5de697-1223-42c3-af37-b921bfc3f5b9"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6e2cf59a412346b49745f23c85ebdae7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTItNy0xLTEtMA_c5f59607-dfe5-422f-a3f5-1ffe688b4ec3"
      unitRef="usd">3000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i5e1433ec26e14619bce3f327630539e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTItOS0xLTEtMA_f1826ca3-ec49-4cc4-9644-08137af19d52"
      unitRef="usd">4000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iad4028c79991465f8affd1c774924434_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTItMTEtMS0xLTA_3c79802e-b76d-412c-9240-192f91a4d199"
      unitRef="usd">29000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i515f5ad673e841cbafd84da71411a3a4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTItMTMtMS0xLTA_e5d3931c-51ec-4aa2-9156-07c50a91dad3"
      unitRef="usd">36000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="icdf7f501b4a04e6ab02d3946c1b2fcc7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTMtMy0xLTEtMA_be7bbf31-12b8-43ee-852e-777abab4b230"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ifed08cdcd0ec4c51b9c44843b976a3fb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTMtNS0xLTEtMA_4de268ad-02e1-4e90-a1b0-fa99d27c5f2e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i141813623d8d47759168dc83deace4b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTMtNy0xLTEtMA_06deb08f-5599-4af5-b086-0dd1b3094ad1"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iebcd200cf0d3431899420614fcc5f00d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTMtOS0xLTEtMA_24053cf9-ca6a-42ba-b324-bc456d37db05"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iaeef2fe72a0e4db78d0c62aa5b990f64_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTMtMTEtMS0xLTA_182afbf1-4b04-43d0-a3eb-3b3a750a82da"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2b884c52dc2140b8ad6a93ffb21a0ca8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTMtMTMtMS0xLTA_c96d70d1-3f8c-46bb-818b-97f6d5883ffe"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if7e1a05886ee4b2fb12e4f8922b90730_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTQtMy0xLTEtMA_b4ffbd3f-f086-45d7-aca3-24dc0fa19cd8"
      unitRef="usd">46000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib80106be43ca44388999d7b0f50726e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTQtNS0xLTEtMA_8feed5d8-f407-4ad6-8248-1bbc92b0f182"
      unitRef="usd">96000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="icf0870a5c62d42d0835c91ab95f6f879_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTQtNy0xLTEtMA_09db6ca9-0d05-4e7d-b422-0197ece27f8e"
      unitRef="usd">94000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia4a4db2857ba40af84f29186cfed8c8a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTQtOS0xLTEtMA_3412f0ef-b732-45a4-9c03-4edf12f72304"
      unitRef="usd">150000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ifebe5c48239d4acbbcfb816d06be3231_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTQtMTEtMS0xLTA_b41b3333-dba3-471c-b18d-6bec524bef02"
      unitRef="usd">661000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i41ef632b7d74402987f587828bb58743_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjgwYzUxNWQwMTA1NzQwZTJiOWQxNjhjOTY0ZWQyZWY2L3RhYmxlcmFuZ2U6ODBjNTE1ZDAxMDU3NDBlMmI5ZDE2OGM5NjRlZDJlZjZfMTQtMTMtMS0xLTA_a35c184b-0bac-4c50-8a2b-3ce2a76fdbfa"
      unitRef="usd">1047000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:InvestmentIncomeTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDkxNA_3b9c14cf-825e-4a90-a1ab-f0c0e9662536">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the three and nine months ended September&#160;30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains (losses) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital losses include yield-related impairment losses on debt securities of $3 million in the three months ended September&#160;30, 2021. Net realized capital gains are net of yield-related impairment losses on debt securities of $35 million in the nine months ended September&#160;30, 2021. There were no credit-related losses on debt securities in the three and nine months ended September&#160;30, 2021. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $1 million and $2 million, respectively, in the three months ended September&#160;30, 2020. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $4 million and $44 million, respectively, in the nine months ended September&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;(2)Net investment income includes $9 million and $28 million for the three and nine months ended September&#160;30, 2021, respectively, and $10 million and $31 million for the three and nine months ended September&#160;30, 2020, respectively, related to investments supporting experience-rated products.</us-gaap:InvestmentIncomeTextBlock>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="idca40fd7d89b44aeab59a2047d066ca6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMi0xLTEtMS0w_7f2ce8a4-1497-4ae3-8036-a648ced8c5cb"
      unitRef="usd">157000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i597b415b2bd6471fa91f8a8a2d582e58_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMi0zLTEtMS0w_abdfa148-08ab-4a53-be16-d1a62957ac7b"
      unitRef="usd">151000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i0cf2d7ded1ee4ac3ad8f173a49ca5148_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMi01LTEtMS0w_b603ad70-6b54-4992-a48a-ee6427a36399"
      unitRef="usd">474000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i930f3c01703c43719b9d884430d891d8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMi03LTEtMS0w_47bbe51a-f7d5-4394-96cd-847ed4b67eec"
      unitRef="usd">441000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i474200218c78432fae6cc7d8692546d7_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMy0xLTEtMS0w_4f7c9a99-4514-4630-8b62-f6de025963d2"
      unitRef="usd">13000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i59cbe9d0b1c14573aeee78a7f064a39c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMy0zLTEtMS0w_d0413e15-c472-46a5-a67a-9fc55b6b3607"
      unitRef="usd">15000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i42c6d3403b9b4becaa9ff959ccfe8f44_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMy01LTEtMS0w_99d38b49-8ab5-45dc-bc0e-debc2d5cc047"
      unitRef="usd">41000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i2ebe53271a07413f911296d1d7453a25_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfMy03LTEtMS0w_838cdfac-bff2-4979-ba84-aa514aad6ddc"
      unitRef="usd">45000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ibaaa57ceba5d4481b694b7ba30c13b7b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNC0xLTEtMS0w_caf779bf-458c-4294-a4f4-0dc11119f2f8"
      unitRef="usd">109000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i72bbd414aabc447686e70f07f2d01a3f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNC0zLTEtMS0w_21c82095-5257-43e0-8837-0667bff60bcd"
      unitRef="usd">37000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="id63cf05999ee4f44a681fc80a55eb52f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNC01LTEtMS0w_dcb0f61b-7863-4f0e-971f-45222ab2a694"
      unitRef="usd">307000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i04638c4a1572491dab3ac08e4ad98438_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNC03LTEtMS0w_94727aec-89a4-4b82-b469-7e563eef7313"
      unitRef="usd">64000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNS0xLTEtMS0w_43fb21dc-f3ee-4a8e-b205-fd5484ab9045"
      unitRef="usd">279000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNS0zLTEtMS0w_5b22bcf7-865e-44e7-bfdc-7c004d777caa"
      unitRef="usd">203000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNS01LTEtMS0w_a8440df8-7bdf-49bf-9ffb-b81ef440ae96"
      unitRef="usd">822000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNS03LTEtMS0w_694812ef-4a18-4a3e-bae8-5e19770d1740"
      unitRef="usd">550000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNi0xLTEtMS0w_30964080-bef8-4752-a854-d77badbd9658"
      unitRef="usd">11000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNi0zLTEtMS0w_59f28413-8ba4-4baf-81f9-77cc74fc542a"
      unitRef="usd">8000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNi01LTEtMS0w_4273a5d8-6f72-4ea7-80ab-9562ada43778"
      unitRef="usd">28000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNi03LTEtMS0w_da97e5a0-da63-4359-bd10-b47b6e24eff2"
      unitRef="usd">25000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNy0xLTEtMS0w_f555691c-5d7a-4bfd-938d-e9390f583685"
      unitRef="usd">268000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNy0zLTEtMS0w_8c13efd8-4b46-486b-b3df-b443b93bf935"
      unitRef="usd">195000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNy01LTEtMS0w_acb93d0b-2d85-4be5-894c-d6b754b5e235"
      unitRef="usd">794000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfNy03LTEtMS0w_b4d04cf5-6d52-474c-ba49-fa1e0c896eb9"
      unitRef="usd">525000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOC0xLTEtMS0w_b4a84a87-b2ab-4116-8b00-0f33abf2e273"
      unitRef="usd">-22000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOC0zLTEtMS0w_4293fa73-91e9-4b9e-8635-ef9974af6fbb"
      unitRef="usd">9000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOC01LTEtMS0w_84268d3a-cabd-4659-bd43-470e026e60eb"
      unitRef="usd">38000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOC03LTEtMS0w_174826e2-8d09-460e-9500-51990e0b9b49"
      unitRef="usd">25000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:InvestmentIncomeNet
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOS0xLTEtMS0w_c4c501b1-1f49-4d04-aabf-a937c86365e4"
      unitRef="usd">246000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOS0zLTEtMS0w_e96e47ae-cd2b-4fe7-b430-422ccc620aa9"
      unitRef="usd">204000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOS01LTEtMS0w_2e771001-9a56-4b57-9c0e-376178bbc158"
      unitRef="usd">832000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOjNlOTZhOWY4ZTFiMjRhZTJiZDEzYTllMjkyNWZmNDU3L3RhYmxlcmFuZ2U6M2U5NmE5ZjhlMWIyNGFlMmJkMTNhOWUyOTI1ZmY0NTdfOS03LTEtMS0w_d7200dcb-39c1-43d7-98ec-b8b5718e6ceb"
      unitRef="usd">550000000</us-gaap:InvestmentIncomeNet>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfMzk1MQ_19fe0f3a-5e63-443f-838e-87fe4046f466"
      unitRef="usd">3000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfMzk1OA_8905d401-799e-45d8-9078-41f4a8aa8cf1"
      unitRef="usd">35000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDAyNQ_2c88994e-fb07-4694-939b-d81b870ba6ca"
      unitRef="usd">0</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDAyNQ_7751eb3d-7eb4-4506-a598-74107bfd1b87"
      unitRef="usd">0</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDIzMw_f897b0d7-7472-4e6f-bf0e-34f3c77831d4"
      unitRef="usd">1000000</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfMTA5OTUxMTYzMjg4Ng_d8004d32-087d-42c0-8433-bf386585e0c2"
      unitRef="usd">2000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDQzOA_af1450da-f99a-4b88-8812-67a827c173ce"
      unitRef="usd">4000000</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDQ0NQ_1b1a7a6e-c81e-4ec1-8f30-fd620b4d24b2"
      unitRef="usd">44000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:InvestmentIncomeNet
      contextRef="i6a39ccc3c07c44ed8a195c76b9e7e55d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDUyMw_f5aa2a67-ff26-4476-952e-5a8d0ae2aa0f"
      unitRef="usd">9000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i3c637804a3d2436ba9be1a2b270b4e53_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDUzMA_77b25e24-745c-44a7-8fce-e8ef1a67f7bf"
      unitRef="usd">28000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="if1067180474044cab8a4d973cdb2842e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDU2Ng_c2566fe6-96a9-4c94-be74-644a2406453e"
      unitRef="usd">10000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i508e18defcad47008f1dab8d4f81dbdb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDU3Mw_e756d3db-c83c-4a95-ba3a-9878c92fc567"
      unitRef="usd">31000000</us-gaap:InvestmentIncomeNet>
    <cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RleHRyZWdpb246NmI3MjkyZjczMmQ4NDM5MzlkMzIwYjM2NTg4OWIwZmJfNDkxMQ_70d86a6c-6646-43cf-8e4f-b1b5172266af">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and nine months ended September&#160;30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMi0xLTEtMS0w_ca68b88d-ad41-4b71-af2f-9a8c04b20094"
      unitRef="usd">668000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMi0zLTEtMS0w_6a262b70-d313-494d-b3ce-03a6ae389323"
      unitRef="usd">905000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMi01LTEtMS0w_c95074c5-b7ce-43d1-b212-5782980d065c"
      unitRef="usd">2935000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMi03LTEtMS0w_ec393c6c-ee3f-4bf5-8353-a3751e7173d8"
      unitRef="usd">2324000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMy0xLTEtMS0w_28d6e07c-132b-4794-bacf-4659163853a0"
      unitRef="usd">19000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMy0zLTEtMS0w_de2661a2-7e9f-4330-975f-36d0a2447cf5"
      unitRef="usd">17000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMy01LTEtMS0w_7dcf3d5d-c822-4455-a8e6-8b91690b1ce0"
      unitRef="usd">61000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfMy03LTEtMS0w_9a8a7dd1-6c14-4053-801d-3bca0d4e1fb1"
      unitRef="usd">60000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfNC0xLTEtMS0w_6dd06608-b77f-4a66-9dae-a20b0fbd2343"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfNC0zLTEtMS0w_48186d50-0df0-4466-8747-4c290dc439ef"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfNC01LTEtMS0w_e475161f-2e66-42c2-8968-8bc9c9811da2"
      unitRef="usd">12000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80MC9mcmFnOjZiNzI5MmY3MzJkODQzOTM5ZDMyMGIzNjU4ODliMGZiL3RhYmxlOmRhNjRmMWUwNzNjODQwNWRhYjhlMWMwNGJjYzQwNzIyL3RhYmxlcmFuZ2U6ZGE2NGYxZTA3M2M4NDA1ZGFiOGUxYzA0YmNjNDA3MjJfNC03LTEtMS0w_05b389cc-c28f-41bf-b3ed-0a00f875b48b"
      unitRef="usd">59000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMjc0NA_ecc791ae-416b-4449-8c69-9de1d0a6dfbe">Fair Value&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#x2019;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#x201c;valuation inputs&#x201d;) that qualifies a financial asset or liability for each level:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Unadjusted quoted prices for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Valuation inputs other than Level 1 that are based on observable market data.&#160;&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Developed from unobservable data, reflecting the Company&#x2019;s assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#x201c;Fair Value&#x201d; in the 2020 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no financial liabilities measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2021 or December&#160;31, 2020. Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2021 and 2020, there were no transfers into or out of Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at September&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets relate to the Company&#x2019;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Separate Accounts financial assets as of September&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $9 million of other payables at September&#160;30, 2021 and $29 million of other receivables at December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i0563521c632f47179c829933333c3ddf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMTQzNQ_5d6ffac6-4f6c-4374-9234-8021243c1fad"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="ibe7ab3f842154eeea4c328406a7ac83a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMTQzNQ_bbce314c-cd4d-4710-870d-7342a5237c24"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMjc0Mw_ce109eb8-0e11-442b-80cf-ef15bda9e158">Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ifda576b425f044eb953d6a347d279daa_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMi0xLTEtMS0w_e1124896-22c3-4021-8760-b79ab1599059"
      unitRef="usd">4953000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if06aeed222c24fe2b41407064d3593bd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMi0zLTEtMS0w_a182c1c5-6ebf-445b-8d5d-bba973f03794"
      unitRef="usd">4873000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i49fc9d5b465f44abab9625a29fa0d38b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMi01LTEtMS0w_70cf2947-11aa-44ae-92fd-ab01ed440d5e"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibe7ab3f842154eeea4c328406a7ac83a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMi03LTEtMS0w_04c0a635-4076-47e6-8390-91b4b0016757"
      unitRef="usd">9826000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia2af50b590ac44018a0222d8c3c2f4aa_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNC0xLTEtMS0w_9d6a0f23-e978-4a30-a334-e0a4b0821a54"
      unitRef="usd">2295000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0c1da65d86f7414da97ff4e9d8609420_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNC0zLTEtMS0w_e76a715f-f8c7-4d54-869e-f158446f30af"
      unitRef="usd">45000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3c144abf9d6c4c40ae0c2318a533d55b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNC01LTEtMS0w_763052af-a37a-43d1-a158-8ee289104fc0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib513a974552e403ca51acd78fcf5dde8_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNC03LTEtMS0w_9ea75b8d-bc94-468a-b925-3b99236a339d"
      unitRef="usd">2340000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie6e72b78b8754b94aaada037ca2420ee_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNS0xLTEtMS0w_02289bcf-aa25-4573-84f8-317ea1513b6e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i75c0f2cacc534be690f026d29bdfd858_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNS0zLTEtMS0w_9437e509-cbdc-4ede-af71-f3b6b04327bf"
      unitRef="usd">3085000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7e2a3404bce24924ba593cb3d50a171f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNS01LTEtMS0w_a3a21f8f-8c8e-4ce4-b400-fb0bd4b02791"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia81d44c8f29a451a8615660915b19be0_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNS03LTEtMS0w_1dd7e92c-dbb4-4a1e-bac2-9a8ff0f66b73"
      unitRef="usd">3085000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9883998841414e459a14949384066c00_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNi0xLTEtMS0w_9dca7528-6325-4821-b911-e4a18c135009"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie4aee10007334dc08704544552884bc2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNi0zLTEtMS0w_cee44ba5-b740-40a6-8c50-c61bf1c2fe1f"
      unitRef="usd">9594000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i41c7bdff14cf4b519ad7ee30cc901f32_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNi01LTEtMS0w_0337c5cf-b391-415f-a5b6-19a1e7466294"
      unitRef="usd">39000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5add9eb3c7da468c9b1a2863e2d79bf2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNi03LTEtMS0w_fef378c8-97ed-4dd9-a992-fbcd2059f849"
      unitRef="usd">9633000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i83f92ecb821d4bf7936caf73110c90ed_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNy0xLTEtMS0w_747f41bf-670c-4258-8211-e75945122445"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6837264698c94d41988231e4099598b4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNy0zLTEtMS0w_4504258f-ad40-4b0c-84f6-76bae10485f5"
      unitRef="usd">2945000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibab1f6f3b94e4f5fa5194e624f3698ef_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNy01LTEtMS0w_6ebf9f82-664b-4c7a-881b-c086288b62e1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7db0731152d84288b010f872cd8a99e0_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfNy03LTEtMS0w_dd513304-2fb5-4b16-b487-f0212bfc7b74"
      unitRef="usd">2945000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic04e7b60901742bcbc036ef80339246d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOC0xLTEtMS0w_052b8fd6-fa93-42ca-a0e3-0a051acc71dc"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2025973837f14d479020bf7cc4499a72_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOC0zLTEtMS0w_fe7cd51b-523a-45ae-9d95-63760a89fada"
      unitRef="usd">863000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idfa61eff06aa45fcab009a3adb153755_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOC01LTEtMS0w_cd29a29e-065c-4a1e-98ad-887fb858b34c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i92ad02b987304467b861021d6c699fee_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOC03LTEtMS0w_66482a56-265e-4d8b-9e58-3c30e428678f"
      unitRef="usd">863000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if6d623b8d6a0424bb2669fd66020aafa_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOS0xLTEtMS0w_597a1f2c-b8a4-4d1b-a504-f7f96bf8c619"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i94c9a1f84bba4080b2c3d4bef2b71e52_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOS0zLTEtMS0w_9cc74f74-10c3-4179-9ab6-edd1c880c4d8"
      unitRef="usd">1209000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i501877927dd54fbf93b7f49e999ee841_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOS01LTEtMS0w_7b6978e0-d7ee-451a-ae49-56c05d91e552"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2c847c9a44124e7db070cb42a1a63f14_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfOS03LTEtMS0w_2523acc6-3739-4cec-9ac4-e678e270b97d"
      unitRef="usd">1209000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia9dd3149c06249a287ef6e26045fdd95_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTAtMS0xLTEtMA_f33435e5-09c2-4928-8e7f-3669974663a1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iadba8d3e3d8440528cfcc9c33445f682_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTAtMy0xLTEtMA_9d0da4de-2c96-4d99-af0d-246fd96c706d"
      unitRef="usd">2468000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib29de6a09dcd46d9aeb48b72526eef8e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTAtNS0xLTEtMA_17e17b98-76be-4dea-92dc-2e8bb0154c2c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i999f68483084466e9e68712a6eafd08d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTAtNy0xLTEtMA_35d6d1cd-2028-4e0c-93d9-c5b7824c4d79"
      unitRef="usd">2468000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2cfde730bc324d93b7009d7ab45141b6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTEtMS0xLTEtMA_537731d5-cb5b-4739-891a-2df502645b8e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i89494621c37c4c219c62fdca2ec3a02c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTEtMy0xLTEtMA_cee14d46-41f0-4c94-a563-3f369bb6ea74"
      unitRef="usd">31000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icc7910d366b94081aba8f7c036e31370_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTEtNS0xLTEtMA_f2f21e30-0075-4598-ad7f-deb8406ce5ef"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4d9073e6b5944376a12e7f42f106f789_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTEtNy0xLTEtMA_7dc7ff2a-254a-48cc-a513-621edac971f7"
      unitRef="usd">31000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifda576b425f044eb953d6a347d279daa_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTItMS0xLTEtMA_9f68cc13-4c45-4bc1-8c1c-592a248db5b2"
      unitRef="usd">2295000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if06aeed222c24fe2b41407064d3593bd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTItMy0xLTEtMA_1967ee62-bff1-4ddb-8d70-cd3ab3633ac6"
      unitRef="usd">20240000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i49fc9d5b465f44abab9625a29fa0d38b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTItNS0xLTEtMA_2944d3b6-7e88-4f55-9600-01db4c1b6c55"
      unitRef="usd">39000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibe7ab3f842154eeea4c328406a7ac83a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTItNy0xLTEtMA_3dbc90e3-db50-4771-b6d2-a7af9d7dbd23"
      unitRef="usd">22574000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ifda576b425f044eb953d6a347d279daa_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTMtMS0xLTEtMA_210030bb-f37e-4234-98c9-fafd988c056c"
      unitRef="usd">107000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if06aeed222c24fe2b41407064d3593bd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTMtMy0xLTEtMA_aa6c672a-bad6-41d3-bc73-02d4f03eda24"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i49fc9d5b465f44abab9625a29fa0d38b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTMtNS0xLTEtMA_3d947c6c-f419-418d-bc14-40e2bdccefe8"
      unitRef="usd">42000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ibe7ab3f842154eeea4c328406a7ac83a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTMtNy0xLTEtMA_70ac57f7-eaee-49f6-a228-079b70e56bdc"
      unitRef="usd">149000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifda576b425f044eb953d6a347d279daa_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTQtMS0xLTEtMA_844a0cce-d3ee-4352-b807-1d38011d0871"
      unitRef="usd">7355000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if06aeed222c24fe2b41407064d3593bd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTQtMy0xLTEtMA_8b0e5f04-40e1-4a5e-a396-1e4f82e02262"
      unitRef="usd">25113000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i49fc9d5b465f44abab9625a29fa0d38b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTQtNS0xLTEtMA_3b3ed289-351c-4e33-af56-5a2d1ea3c0cd"
      unitRef="usd">81000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibe7ab3f842154eeea4c328406a7ac83a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTQtNy0xLTEtMA_61b18d3a-25db-4acc-add4-a93270244761"
      unitRef="usd">32549000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib122074ed9c9464eac823cc8d4819acb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTctMS0xLTEtMA_7e3d80ba-913d-48cf-bc5d-1bbabac94acc"
      unitRef="usd">3985000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia674f1ddc0d840b0aa42d18120ac12e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTctMy0xLTEtMA_458f0139-d30d-47f3-a1c8-5b8db501ab14"
      unitRef="usd">3869000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i95327e52078a41a89444ec318828a7dd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTctNS0xLTEtMA_b4c28d31-8d2b-47f0-97e1-4390c5f5d76a"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0563521c632f47179c829933333c3ddf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTctNy0xLTEtMA_7a8abe23-a1ac-4d5b-a532-d8f882a7951a"
      unitRef="usd">7854000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic836b346282347908809f16a6eb5660c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTktMS0xLTEtMA_b6c9b825-7ec4-4f37-bcaf-05907d82d58f"
      unitRef="usd">2370000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i34bec3f3434a41b7ab493984748deeae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTktMy0xLTEtMA_f3fbe449-22f8-4f81-9af1-123dfb706083"
      unitRef="usd">99000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icc87715012e244f1a0941fc7f486bcb5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTktNS0xLTEtMA_38472441-e339-43df-8ee5-13201174c01e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8fa629d192414558a844c90838b9c4a1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMTktNy0xLTEtMA_383b800d-7efd-4f6c-92cf-0ac37044cac0"
      unitRef="usd">2469000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1ab2e48c06df4ca08a139917417a396f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjAtMS0xLTEtMA_73bf45d6-b11b-42f0-81f2-2dca2f663aec"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie971ffe3a7844dc29d629c33684e8d32_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjAtMy0xLTEtMA_c4919bba-8b03-4fa2-a26c-e0bf603fabac"
      unitRef="usd">2727000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifb69f5ffee80421c89348f37e2cb0f86_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjAtNS0xLTEtMA_03eae8a7-0ff9-4f8d-97f4-3750a975e162"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibf2f0f2fe2f045bda1c2226bbe6a8fd5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjAtNy0xLTEtMA_101eeddf-22c2-475f-bf2c-f76b287db929"
      unitRef="usd">2728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i43c1eef1a6b448418547a06e29940d6d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjEtMS0xLTEtMA_cfef7e41-b34e-4372-a7bd-3a5b72325f2d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idc165d15f6804c64841a910becac3ed9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjEtMy0xLTEtMA_62ee9c0b-183b-43e8-8fdc-51f3fa8bfad2"
      unitRef="usd">8842000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib4c412a5ba874f98870341d7ea31c942_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjEtNS0xLTEtMA_3c3868b9-b7df-4492-93a2-5718ac601a8c"
      unitRef="usd">52000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib297eefdd01042809add61d2dd4010fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjEtNy0xLTEtMA_b4253983-e1d1-441a-9ebb-1218ea4d9f82"
      unitRef="usd">8894000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7de217ffec6c4548b78c7b2302f20377_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjItMS0xLTEtMA_9d2f27ef-1a77-4898-bad8-acb26b8574c0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa404aec6f7740709c74a50e423f55c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjItMy0xLTEtMA_0b3432b3-fcf0-4bce-a518-8e5328472296"
      unitRef="usd">2918000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i694813f254844fc388cdc57b0282c552_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjItNS0xLTEtMA_b3d09ded-6a74-447d-8bc6-59f6c051bcc0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i76a73d6716c549c5a3e574f5997c2627_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjItNy0xLTEtMA_192766cf-4e7b-4451-89f4-fb2ac5f7f522"
      unitRef="usd">2918000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i53410c2dbc4c4d39a65c4deba26b6c80_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjMtMS0xLTEtMA_4aa72ed3-e308-405a-a3f2-f7ca1b16dc4d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i23fa0bd51236409caabdfcaa76735c44_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjMtMy0xLTEtMA_7bb97df2-fc0f-4b90-bd73-ea81cba7d491"
      unitRef="usd">705000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6d4071d9bde54949b0ab30e57b6d131b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjMtNS0xLTEtMA_8be7b672-e169-4bb8-b251-d77b1ee16382"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie5f20743700e4f5d90d0ace281e6184a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjMtNy0xLTEtMA_f6a73c3e-e59c-4eb6-92cf-55d6f0dddc32"
      unitRef="usd">705000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8bd830bd2d0a49eb8ec02b1932b58722_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjQtMS0xLTEtMA_1b6f1bc1-c9f0-4dd0-b86f-828084433eb1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibb2d516d37a44977806647d938c79d40_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjQtMy0xLTEtMA_f9030ed7-9d6e-4795-b956-8f2b7a43cd01"
      unitRef="usd">1046000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7cdd4cdd4ca546788f18be91782db91c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjQtNS0xLTEtMA_d866d9d5-f063-4bf8-8c4f-6ae5de04e1e7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i47fa10c381de44068b970898e3aa4e58_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjQtNy0xLTEtMA_04c08e99-c5ed-4521-8a31-61415ed987e7"
      unitRef="usd">1046000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i96cb72db03134df09fb6aa81f2b1786b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjUtMS0xLTEtMA_13f295d4-1148-46fa-9fac-a7167ef628c4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9611cadb797e417db325edf33945b988_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjUtMy0xLTEtMA_0d5b0cbe-69d0-4b67-8672-d761676f447a"
      unitRef="usd">2403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i563011688aa349e7a1f32d722693061e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjUtNS0xLTEtMA_b1cbbdc0-6152-4d34-93ff-65381d6f40e1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idc355084ff424474b90262f9ba68cb4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjUtNy0xLTEtMA_affc7af2-03dd-415d-87ff-4cc6a6b5d2f7"
      unitRef="usd">2403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib3904707e6a34e4e8e4ccfc85ced0bef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjYtMS0xLTEtMA_0ae2f50b-2d09-4a96-9b71-04e6db06c2ec"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i07c7bd30fcf945f7bae17c46fe84a1e0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjYtMy0xLTEtMA_9ca5cec9-a71c-4baa-8c60-5639a011a332"
      unitRef="usd">24000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iafea971f2cd6419a915d40ecfdcc6853_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjYtNS0xLTEtMA_3b43aeac-150e-441e-aa36-82020b9fc34e"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf087794476a45f1bafd4c1e6447c2a8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjYtNy0xLTEtMA_d5071754-cac1-4642-8dfc-d6a9ce01105e"
      unitRef="usd">25000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib122074ed9c9464eac823cc8d4819acb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjctMS0xLTEtMA_bc58f1fb-ba65-4cf8-b082-6b304a7d2f62"
      unitRef="usd">2370000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia674f1ddc0d840b0aa42d18120ac12e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjctMy0xLTEtMA_799f80f6-26cd-4835-ac07-1388b163c075"
      unitRef="usd">18764000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i95327e52078a41a89444ec318828a7dd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjctNS0xLTEtMA_4d690416-bca5-4aac-96fc-c019d80b6fd0"
      unitRef="usd">54000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0563521c632f47179c829933333c3ddf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjctNy0xLTEtMA_a4601a82-c014-45cf-9665-bfb904794157"
      unitRef="usd">21188000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib122074ed9c9464eac823cc8d4819acb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjgtMS0xLTEtMA_c7f69e3f-b880-4128-92be-fcffbc4743f9"
      unitRef="usd">17000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia674f1ddc0d840b0aa42d18120ac12e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjgtMy0xLTEtMA_7398d120-f391-4f76-8043-9821eec10d3a"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i95327e52078a41a89444ec318828a7dd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjgtNS0xLTEtMA_fb6d2088-fe6f-4924-8353-8e5058baf079"
      unitRef="usd">30000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i0563521c632f47179c829933333c3ddf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjgtNy0xLTEtMA_cd40bc06-dd38-4a75-ae70-54fe898287bc"
      unitRef="usd">47000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib122074ed9c9464eac823cc8d4819acb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjktMS0xLTEtMA_acf4843c-5a02-4afa-a730-92d364abdd5f"
      unitRef="usd">6372000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia674f1ddc0d840b0aa42d18120ac12e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjktMy0xLTEtMA_7e5f39b5-4bd3-467b-b77f-296ded9803cf"
      unitRef="usd">22633000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i95327e52078a41a89444ec318828a7dd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjktNS0xLTEtMA_4e2ef0b5-90df-4e76-a9f7-cfa90f00e244"
      unitRef="usd">84000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0563521c632f47179c829933333c3ddf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjg3NDkwN2E0ZDJkZTQzMDQ4YWY2YWMwZmQwZjlhYjI2L3RhYmxlcmFuZ2U6ODc0OTA3YTRkMmRlNDMwNDhhZjZhYzBmZDBmOWFiMjZfMjktNy0xLTEtMA_1d671840-eb17-4ee5-a5a3-8374cca3b1c5"
      unitRef="usd">29089000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMjc3NQ_1f303984-f111-44b0-a665-0629f58adf3f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at September&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;(1)It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i2c049e51c8604a9183951023541454c3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfNC0xLTEtMS0w_4517e7a4-93d1-44c3-b49f-9465b6f6714d"
      unitRef="usd">934000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i021c91d03c7945d4a5905a640d27996a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfNC0zLTEtMS0w_8fa8fc3a-2d68-4a35-b69f-f944eef607d0"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i6c135e138975479dbc208139f9ce925f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfNC01LTEtMS0w_db4e083c-5780-4f51-8d18-f2103823948a"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i147018bb8fcc4e0586edf2dde3e287c4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfNC03LTEtMS0w_86307a15-230c-403b-8929-6ddf5e11564c"
      unitRef="usd">945000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="iaad5be874c394c87a8151ea37f655ba4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfNC05LTEtMS0w_507354cc-3f69-4c6c-93a1-1c62fa53c7e9"
      unitRef="usd">945000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i2c049e51c8604a9183951023541454c3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfNS0xLTEtMS0w_487294e1-37e2-43a2-8828-eaab54a6ae7c"
      unitRef="usd">50000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i2c049e51c8604a9183951023541454c3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOC0xLTEtMS0w_65d5a294-089e-4031-a584-9949c056291f"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i021c91d03c7945d4a5905a640d27996a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOC0zLTEtMS0w_0dd2db1d-85a5-4caa-84a9-ba613b64cd79"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i6c135e138975479dbc208139f9ce925f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOC01LTEtMS0w_661bb3e7-7799-4e32-afe6-b0c056534985"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i147018bb8fcc4e0586edf2dde3e287c4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOC03LTEtMS0w_e5fe68b6-8c05-4000-9d40-0da4e8f1520c"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="iaad5be874c394c87a8151ea37f655ba4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOC05LTEtMS0w_5f399113-4b87-4d24-8454-a5f3bedb7ad9"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i2c049e51c8604a9183951023541454c3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOS0xLTEtMS0w_6211777b-2b62-47c8-b2c3-d754e45395ee"
      unitRef="usd">334000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i021c91d03c7945d4a5905a640d27996a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOS0zLTEtMS0w_07f655ec-a268-425d-9b21-377be61bb472"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i6c135e138975479dbc208139f9ce925f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOS01LTEtMS0w_e272747a-9005-4bd1-b615-e02697229b7b"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i147018bb8fcc4e0586edf2dde3e287c4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOS03LTEtMS0w_ca448555-7671-4856-a879-36cb77329496"
      unitRef="usd">378000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="iaad5be874c394c87a8151ea37f655ba4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfOS05LTEtMS0w_4ef0d360-1055-4c91-9aa1-b6cf08fb368f"
      unitRef="usd">378000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2c049e51c8604a9183951023541454c3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTAtMS0xLTEtMA_8d7d4509-512f-42c1-b0a3-c1f1cf2ad537"
      unitRef="usd">58393000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i021c91d03c7945d4a5905a640d27996a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTAtMy0xLTEtMA_07b2a5d1-c524-4591-b441-541bfdc79f65"
      unitRef="usd">66960000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6c135e138975479dbc208139f9ce925f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTAtNS0xLTEtMA_334b8d9b-abd4-44d5-8d91-3e525d567f73"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i147018bb8fcc4e0586edf2dde3e287c4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTAtNy0xLTEtMA_dcd8ba32-26eb-4134-a5cf-c5564e6b4a0d"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iaad5be874c394c87a8151ea37f655ba4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTAtOS0xLTEtMA_474269f9-fb65-41c9-adde-e8f1ad49dcdd"
      unitRef="usd">66960000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="iaaa2a9cf9df24d96a4910a7770e327b3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTQtMS0xLTEtMA_e33644a0-ac46-4d0a-a9c0-dd1a1aff12cc"
      unitRef="usd">1047000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ibd49134c4a7f487a8cd469c1c1ffbe58_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTQtMy0xLTEtMA_1db39eb9-47af-4336-b0bd-5acdff237f0e"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="if687d685f43147b8a54d5058142cdfc7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTQtNS0xLTEtMA_ef59e5b0-f84f-4a52-893e-5f0065106441"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="iec2da8685e5443638fdf326121bfbf76_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTQtNy0xLTEtMA_9424406e-00f4-4a48-ae9b-8343623ff799"
      unitRef="usd">1070000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i5c964868b4a547e1868068b2b01396dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTQtOS0xLTEtMA_5e19a9ca-c08f-4741-955d-06c2deb1887d"
      unitRef="usd">1070000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="iaaa2a9cf9df24d96a4910a7770e327b3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTUtMS0xLTEtMA_3aebc571-a0c3-4a52-a1db-f944ad513b6b"
      unitRef="usd">145000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="iaaa2a9cf9df24d96a4910a7770e327b3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTgtMS0xLTEtMA_38cd0cae-9962-4f89-a2a7-089b25e63df5"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ibd49134c4a7f487a8cd469c1c1ffbe58_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTgtMy0xLTEtMA_04eac8c1-b354-467e-b254-f8c744b73a25"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="if687d685f43147b8a54d5058142cdfc7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTgtNS0xLTEtMA_e945b36a-18d5-4f19-88e7-43c0adddbc40"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="iec2da8685e5443638fdf326121bfbf76_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTgtNy0xLTEtMA_e94a1fc9-4b78-4b31-92ec-391c27a41d7a"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i5c964868b4a547e1868068b2b01396dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTgtOS0xLTEtMA_605c1d6c-91f3-4305-99ac-ebdcff43f96b"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="iaaa2a9cf9df24d96a4910a7770e327b3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTktMS0xLTEtMA_0f037744-d232-4c1e-b078-f91f00eeb641"
      unitRef="usd">322000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ibd49134c4a7f487a8cd469c1c1ffbe58_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTktMy0xLTEtMA_ff02b28a-b2ff-4588-bd42-83d20c49fcc7"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="if687d685f43147b8a54d5058142cdfc7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTktNS0xLTEtMA_f8efd463-4dca-4b24-aa71-b31ca02c809e"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="iec2da8685e5443638fdf326121bfbf76_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTktNy0xLTEtMA_9eac2b67-774e-4f8c-a57e-9ff0a2054b00"
      unitRef="usd">371000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i5c964868b4a547e1868068b2b01396dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMTktOS0xLTEtMA_26c738ba-8fa1-4dba-83e0-671bf25f7b08"
      unitRef="usd">371000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iaaa2a9cf9df24d96a4910a7770e327b3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMjAtMS0xLTEtMA_825cc3fe-0ab4-486c-9da8-768b109cc0fd"
      unitRef="usd">64647000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ibd49134c4a7f487a8cd469c1c1ffbe58_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMjAtMy0xLTEtMA_f560d4cc-37a5-4e2e-a957-734a2b4c3b1b"
      unitRef="usd">75940000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if687d685f43147b8a54d5058142cdfc7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMjAtNS0xLTEtMA_1e2a96f3-9992-42c9-82fb-5c5961a33d02"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iec2da8685e5443638fdf326121bfbf76_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMjAtNy0xLTEtMA_fc764dd5-8f15-4e60-99e1-9200e5c57938"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i5c964868b4a547e1868068b2b01396dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjFhZWVlMzZjNjIxNDRjYTVhNTQzZTQyZThiNzUyMGY3L3RhYmxlcmFuZ2U6MWFlZWUzNmM2MjE0NGNhNWE1NDNlNDJlOGI3NTIwZjdfMjAtOS0xLTEtMA_00578a66-e38e-4a95-87ac-564c780bac23"
      unitRef="usd">75940000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMjc1NQ_a95bd28a-7f9b-4152-933d-135f699abd3b">Separate Accounts financial assets as of September&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $9 million of other payables at September&#160;30, 2021 and $29 million of other receivables at December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock>
    <us-gaap:SeparateAccountAssets
      contextRef="ic0ecb6e4143541d38112288c2c2203a0_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi0yLTEtMS0w_d0d463ed-98d1-4dd4-a46f-980344916fb7"
      unitRef="usd">3000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iafa9567a6e1242cf9ae54c608091a142_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi00LTEtMS0w_c19e40e3-f367-4854-bbe2-b9168e91d9c7"
      unitRef="usd">216000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i612ca748550d489da66896239ad5b1c9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi02LTEtMS0w_5cc8c1bb-d6fe-4e90-b68c-03b8aa9587e2"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i13473c0ae0c14361aa7e0e5b5809b5bd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi04LTEtMS0w_1d4116e5-aa21-4909-8bcd-e6c51f0127ba"
      unitRef="usd">219000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie18b978d6a92462cb19e95c291464ff5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi0xMC0xLTEtMA_07b14e20-454a-48f2-8c5d-e5a34306aa30"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i557a10fe4b3943739f83a4f01347a36a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi0xMi0xLTEtMA_0f1b603c-fa4f-4119-b184-857960c4b05b"
      unitRef="usd">186000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i0cd654f81de94c4ba6574ed395d10914_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi0xNC0xLTEtMA_1878e05c-d94e-4b6c-850d-9afc6fce9384"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i0f6debc0fdc84a0095ae738e034b2ce7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMi0xNi0xLTEtMA_0250c6be-fdd9-4f19-a77c-094016d855a7"
      unitRef="usd">188000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic5b399af8f2c4b1494f420b54c395eab_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy0yLTEtMS0w_65211a66-ba7d-47a6-ae70-5ed981de170f"
      unitRef="usd">1214000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i18d84e87420b4fdfb90748e9026f0c49_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy00LTEtMS0w_22a14631-fcd3-4ce2-84f0-351dd89eb015"
      unitRef="usd">3083000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if13f0350cddf45ffa223d9ec2d72053a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy02LTEtMS0w_45d1f1f9-ff4c-4754-a056-e71b6c76e1af"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib46ae0b202514c6ba3af15017b7e230f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy04LTEtMS0w_21c46913-5f2b-4c99-a753-6f35dc8c98de"
      unitRef="usd">4297000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i9f2877a791e3491f9534edd67ed3e987_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy0xMC0xLTEtMA_c5659b30-9853-4357-9813-023ba9fbd7d3"
      unitRef="usd">1465000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iad504c15b51c4049918b0ba3bf6aa35f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy0xMi0xLTEtMA_5a8e5d10-d931-4d4f-817c-07d64a9f97b4"
      unitRef="usd">2634000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic424242c3bba48f9bbc125c6af13010d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy0xNC0xLTEtMA_f60eb9ab-0017-45a5-b5e5-b64e2e3713cf"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib33c9671d5f046d79fce9e9901904688_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfMy0xNi0xLTEtMA_3e14004a-0e2b-42c9-8afe-c19d75216ab4"
      unitRef="usd">4099000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i9c04b19feb064cf1bf23bc7e65f7be4f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC0yLTEtMS0w_5a297af8-bfdb-4353-89e9-a0536ac6704f"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="icf82daed791d40cd93b600a3e62ef8cc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC00LTEtMS0w_1cf94c46-e9b2-4dda-bf9a-2de4b8ad7143"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5aa8d204d59f4f928a510e6900cf939a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC02LTEtMS0w_f23cb1a7-fb44-4068-9dee-118f0b44b8eb"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i09fb9a5bef7f42428348726a2ff173f1_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC04LTEtMS0w_6546d9ca-e40f-44c1-bd24-3b5340213bee"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i685f457f55ed4bfdaf90fab6ce466d85_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC0xMC0xLTEtMA_39618a9d-de16-4451-ae3c-a62af2a25c63"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i60056bc19bb048b59c735005c438169b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC0xMi0xLTEtMA_d402a4c1-5275-49ca-a4f0-d31ec4e36564"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i4a47aa4aaf384bc6a0e156ab09a449c7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC0xNC0xLTEtMA_11151afd-ffa9-4fb7-9405-f727b111a2e4"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic0cd80f6244e42fbab3150923c3c3ef6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNC0xNi0xLTEtMA_9f38a9e9-f268-4516-9a85-ce57d365f9a9"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="id865ac262326451daffd0d3a056e96be_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS0yLTEtMS0w_74a14869-f08f-4f6a-a8b1-a1028ff0bf8c"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i7d357538b6c0474aa7f475e2632e3e77_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS00LTEtMS0w_95d77a20-e81f-4bab-b30f-648dbba7e352"
      unitRef="usd">577000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i0bde8bbc8af2428fb013ae54651523b7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS02LTEtMS0w_6c2d9f7f-9c6e-4f73-9370-c3936db42084"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i7abda2e513b34485baeda28fdbf8e4a1_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS04LTEtMS0w_13af22ba-824e-44d8-8e9a-ed9a9c372277"
      unitRef="usd">577000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic763372116b148e9a5a2904296c53f93_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS0xMC0xLTEtMA_4dac21b7-3a47-46ef-a279-77af429d05ad"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i79f3ba86d6354f07b5df6c1ffa8bbbe1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS0xMi0xLTEtMA_4c6a447c-d7ef-44bc-956d-14af82d883f6"
      unitRef="usd">563000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iafc45f1d336740b0a1a8d911aac65229_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS0xNC0xLTEtMA_943232a9-37b8-4ec2-9621-02a0412f486c"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i7733f5518c7645c4b56b68cccf6f76ff_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNS0xNi0xLTEtMA_f21faad7-4221-4710-af5a-51ba2be4aad1"
      unitRef="usd">563000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ifda576b425f044eb953d6a347d279daa_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi0yLTEtMS0w_43ec6768-2553-4906-bb1f-a7ef90b9511a"
      unitRef="usd">1217000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if06aeed222c24fe2b41407064d3593bd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi00LTEtMS0w_7eb2e03b-2e00-4157-bb32-65997e3b2804"
      unitRef="usd">3878000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i49fc9d5b465f44abab9625a29fa0d38b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi02LTEtMS0w_176b1746-ba89-4b55-8050-e544d405427e"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ibe7ab3f842154eeea4c328406a7ac83a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi04LTEtMS0w_90a1a349-b08f-4efb-a04c-e95c6e64222e"
      unitRef="usd">5095000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib122074ed9c9464eac823cc8d4819acb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi0xMC0xLTEtMA_83db812f-5234-4572-9de4-c9c6bbf4cbc1"
      unitRef="usd">1467000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia674f1ddc0d840b0aa42d18120ac12e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi0xMi0xLTEtMA_d4c2b59f-72f4-46ce-a853-8cf0a3f68ab8"
      unitRef="usd">3385000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i95327e52078a41a89444ec318828a7dd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi0xNC0xLTEtMA_b22e7afe-3249-4fa7-8b2e-0c8e0e535ced"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i0563521c632f47179c829933333c3ddf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RhYmxlOjExMGI1NmUzN2M2NzRhOTNiNWVjODFmNzM5YzU5YTZhL3RhYmxlcmFuZ2U6MTEwYjU2ZTM3YzY3NGE5M2I1ZWM4MWY3MzljNTlhNmFfNi0xNi0xLTEtMA_c34f9646-0b92-4f8b-9ec6-7980165fbdda"
      unitRef="usd">4852000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i4652506a76c7489ca73ed1b4e3db819d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMjY3OQ_ff5198df-c5c0-4025-a4f1-c97f03bd1d72"
      unitRef="usd">9000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i1d5e67cc70504729944139279d44d713_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80My9mcmFnOjEwMzdiMGUzMDk4MjQ2M2NiMWQxMzUzOTgxZGQ0NDc0L3RleHRyZWdpb246MTAzN2IwZTMwOTgyNDYzY2IxZDEzNTM5ODFkZDQ0NzRfMjY4Ng_f8f050f9-566d-4d99-bdd3-c10076a23b84"
      unitRef="usd">29000000</us-gaap:SeparateAccountAssets>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGV4dHJlZ2lvbjozOTdkNGNkZjdjMWQ0ODI1YTk3ZmViYjRjMWZjNGJiM18zMjk4NTM0OTA3MzU0_43c3ad8b-701f-45e5-a1e2-8747f8d0c63a">Goodwill&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is not amortized, but is subject to annual impairment reviews, or more frequent reviews if events or circumstances indicate there may be impairment. Goodwill is evaluated for possible impairment by comparing the fair value of a reporting unit to its carrying value, including the goodwill assigned to that reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated an impairment of the goodwill associated with the LTC reporting unit, as the reporting unit&#x2019;s carrying value exceeded its fair value as of the testing date. The results of the impairment tests of the remaining reporting units indicated that there was no impairment of goodwill as of the testing date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During 2021, the LTC reporting unit has continued to face challenges that have impacted the Company&#x2019;s ability to grow the LTC reporting unit&#x2019;s business at the rate estimated when its 2020 goodwill impairment test was performed. These challenges include lower net facility admissions, net long-term care facility customer losses and the prolonged adverse impact of the COVID-19 pandemic and the emerging new variants, which resulted in more significant declines in occupancy rates experienced by the Company&#x2019;s long-term care facility customers than previously anticipated. During the third quarter of 2021, LTC management updated their 2021 annual forecast and submitted their long-term plan which showed deterioration in the financial results for the remainder of 2021 and beyond. The Company utilized these updated projections in performing its annual impairment test, which indicated that the fair value of the LTC reporting unit was lower than its carrying value, resulting in a $431&#160;million goodwill impairment charge in the third quarter of 2021. The fair value of the LTC reporting unit was determined using a combination of a discounted cash flow method and a market multiple method. As of September&#160;30, 2021, there was no remaining goodwill balance in the LTC reporting unit. The Company also performed an impairment test of the intangible assets of the LTC reporting unit and concluded these assets were not impaired as of September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cumulative goodwill impairments were $6.6&#160;billion and $6.1&#160;billion at September&#160;30, 2021 and December 31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Below is a summary of the changes in the carrying value of goodwill by segment for the nine months ended September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i15df075bc2d04e759bf072636f0fd065_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGV4dHJlZ2lvbjozOTdkNGNkZjdjMWQ0ODI1YTk3ZmViYjRjMWZjNGJiM181NDk3NTU4MTY2NjAz_3de0b2da-ef8d-4745-b200-6c84f50da442"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i8616075a3e1f47668b0ea71db5e5caf4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGV4dHJlZ2lvbjozOTdkNGNkZjdjMWQ0ODI1YTk3ZmViYjRjMWZjNGJiM180OTQ3ODAyMzUzMzIw_45cd995f-b90a-436a-a18f-036ccdd34cc1"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGV4dHJlZ2lvbjozOTdkNGNkZjdjMWQ0ODI1YTk3ZmViYjRjMWZjNGJiM180OTQ3ODAyMzQ2OTI5_0a2fa305-bc07-42db-8056-f882a5522532"
      unitRef="usd">6600000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGV4dHJlZ2lvbjozOTdkNGNkZjdjMWQ0ODI1YTk3ZmViYjRjMWZjNGJiM180OTQ3ODAyMzQ2OTc4_919f9496-2b81-48a2-b273-7475a561a70a"
      unitRef="usd">6100000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGV4dHJlZ2lvbjozOTdkNGNkZjdjMWQ0ODI1YTk3ZmViYjRjMWZjNGJiM18zMjk4NTM0OTA3MzU2_1428aba3-102d-42ee-bb96-79c96e9390c7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Below is a summary of the changes in the carrying value of goodwill by segment for the nine months ended September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i42ae767186744b45adac05f6feb0c37e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18xLTEtMS0xLTg5OTg_20f8e4f6-3535-4903-9f8b-3660e6de46c4"
      unitRef="usd">45130000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i750ac96cf4c64738af59810ad96e6411_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18xLTMtMS0xLTg4MjQ_3687c7e9-eeeb-422a-8359-3c1ce3544ca3"
      unitRef="usd">23615000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i23c1f04677c042939927a68bb5fd9f65_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18xLTUtMS0xLTg5MTQ_e894e86b-729a-40f9-8bd6-6815f438026a"
      unitRef="usd">10807000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18xLTctMS0xLTkwOTA_038d934b-f11e-46bd-9764-901d9abe100d"
      unitRef="usd">79552000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i9af0cc01cbc54c9f9e8615532da5bb0c_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18zLTEtMS0xLTkwNDI_92569ff0-0cae-49ca-9b52-250da5d47ffa"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i869431e7abf74749b23dd3a1ed93e1ef_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18zLTMtMS0xLTg4Njg_baf969e9-3156-489c-8429-500f50071b0f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i05a9eb3fc13543189b612e1898a32241_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18zLTUtMS0xLTg5NjA_c56af83a-1d3d-43a6-8078-7d172d562bec"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY18zLTctMS0xLTkxNDk_7289980f-be53-4f1b-898b-d53a0a43e19d"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i0c3ac878cf024e6d80d9917247d48b26_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY182LTEtMS0xLTkwNjM_60268560-923f-4811-b1f8-9c13dc2ad5e8"
      unitRef="usd">45130000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2e788b4e17294696828048f3be438c9f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY182LTMtMS0xLTg4OTM_b209ce2e-e557-45db-95da-57925c32b9dd"
      unitRef="usd">23615000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7d765d02ede34e5fa56a51625a55c188_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY182LTUtMS0xLTg5ODM_0fbfa77e-f5c5-43da-b80b-5f798888c686"
      unitRef="usd">10376000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMDk5NTExNjI4OTcwL2ZyYWc6Mzk3ZDRjZGY3YzFkNDgyNWE5N2ZlYmI0YzFmYzRiYjMvdGFibGU6YWYyMTA4MWFmOWQ4NDM1N2E0YjgxZWI4MDljY2ViZmMvdGFibGVyYW5nZTphZjIxMDgxYWY5ZDg0MzU3YTRiODFlYjgwOWNjZWJmY182LTctMS0xLTkxNjM_444bb764-ff80-4851-a101-f134d86cb29a"
      unitRef="usd">79121000000</us-gaap:Goodwill>
    <us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMTgwOQ_b5fe14a2-b833-4b90-b849-1cb41498512e">Health Care Costs Payable&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the nine months ended September&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(771)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the nine months ended September&#160;30, 2021 and 2020 in the table above exclude (i) $1 million and $1 million, respectively, for a premium deficiency reserve related to the Company&#x2019;s Medicaid products, (ii) $45 million and $31 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#x2019;s unaudited condensed consolidated balance sheets and (iii) $168 million and $173 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#x2019;s unaudited condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimates of prior years&#x2019; health care costs payable decreased by $771 million and $448 million, respectively, in the nine months ended September&#160;30, 2021 and 2020, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#x2019;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021, the Company&#x2019;s liabilities for the ultimate cost of (i) services rendered to the Company&#x2019;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#x201c;IBNR&#x201d;) plus expected development on reported claims totaled approximately $6.8 billion. Substantially all of the Company&#x2019;s liabilities for IBNR plus expected development on reported claims at September&#160;30, 2021 related to the current year.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMTgxNQ_0b8d09fe-f2d6-466e-8a0f-8301a033ec72">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the nine months ended September&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(771)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the nine months ended September&#160;30, 2021 and 2020 in the table above exclude (i) $1 million and $1 million, respectively, for a premium deficiency reserve related to the Company&#x2019;s Medicaid products, (ii) $45 million and $31 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#x2019;s unaudited condensed consolidated balance sheets and (iii) $168 million and $173 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#x2019;s unaudited condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ie0f632a81048467cbde9502af1736d39_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMi0xLTEtMS0w_a642b422-7446-44f7-b2aa-f55581eece79"
      unitRef="usd">7936000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i0497b7413f024eccab9ca54d54ee0dac_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMi0zLTEtMS0w_1f19c85c-105c-4fd5-9ea2-15e8c8a37366"
      unitRef="usd">6879000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ie0f632a81048467cbde9502af1736d39_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMy0xLTEtMS0w_97d090a3-0090-4a77-8240-3fb40a17bf7a"
      unitRef="usd">10000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i0497b7413f024eccab9ca54d54ee0dac_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMy0zLTEtMS0w_ce185657-a7f0-4b5b-bee9-7461afdfe301"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ie0f632a81048467cbde9502af1736d39_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfNC0xLTEtMS0w_fc315a9f-c77d-4bcb-be12-f54aaa13ae25"
      unitRef="usd">7926000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i0497b7413f024eccab9ca54d54ee0dac_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfNC0zLTEtMS0w_839d540e-0c53-4bcb-8123-3315b1a71b24"
      unitRef="usd">6874000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfNS0xLTEtMS0w_7b37ba2f-405a-43eb-9fdd-1f5187f500b4"
      unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfNS0zLTEtMS0w_c770dd20-f317-462b-8079-624d9422ed74"
      unitRef="usd">444000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfNy0xLTEtMS0w_2c77bc32-0b89-40dc-9cf7-91b2cda525c1"
      unitRef="usd">48243000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfNy0zLTEtMS0w_f7f16c22-25c7-4d38-965f-c050249a9d0b"
      unitRef="usd">40777000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfOC0xLTEtMS0w_029b22e9-d5cd-4414-b5e7-151c6d0abb23"
      unitRef="usd">-771000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfOC0zLTEtMS0w_88829a82-658d-477d-af4c-975559b8df99"
      unitRef="usd">-448000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfOS0xLTEtMS0w_a8427918-bf89-41b8-b006-a26be0e9d11b"
      unitRef="usd">47472000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfOS0zLTEtMS0w_8771738d-d41b-4e2c-8df8-1093cf604cdf"
      unitRef="usd">40329000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTEtMS0xLTEtMA_402e6700-3f57-4a92-a7e3-118a020f61ad"
      unitRef="usd">39887000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTEtMy0xLTEtMA_cb583b12-ae81-46ce-9568-4cebc8158629"
      unitRef="usd">34198000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTItMS0xLTEtMA_741ebbb4-175e-4994-b295-65c2e0e80a31"
      unitRef="usd">6639000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTItMy0xLTEtMA_7470be55-d33b-4f97-9c32-ef944073775d"
      unitRef="usd">5865000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTMtMS0xLTEtMA_dd31d35c-46fc-48d8-bd35-d6b1b62eb486"
      unitRef="usd">46526000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTMtMy0xLTEtMA_d4b08d1a-7472-432d-9244-8cfb4114b217"
      unitRef="usd">40063000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ic0118ee2d69441a7b3e211472508a35b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTQtMS0xLTEtMA_4ea9ee96-a4f5-41ff-9e5c-33ae6f15729c"
      unitRef="usd">1000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ibc05881978f94525b7d1199de70e7105_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTQtMy0xLTEtMA_00d850b3-6e8e-42b4-b22e-0fbdcb847793"
      unitRef="usd">1000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ic0118ee2d69441a7b3e211472508a35b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTUtMS0xLTEtMA_29079a5c-e4ab-49c4-b16c-b56e87aec47b"
      unitRef="usd">8873000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ibc05881978f94525b7d1199de70e7105_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTUtMy0xLTEtMA_6fbc9997-fa8d-4deb-a83d-766bbb04857d"
      unitRef="usd">7585000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ic0118ee2d69441a7b3e211472508a35b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTYtMS0xLTEtMA_a3d9102c-33ec-4180-a80c-9c0e5ea99ee0"
      unitRef="usd">4000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ibc05881978f94525b7d1199de70e7105_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTYtMy0xLTEtMA_b8c132ef-372f-4ba9-8fa5-3abf9406b595"
      unitRef="usd">8000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ic0118ee2d69441a7b3e211472508a35b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTctMS0xLTEtMA_036c40c2-8458-460c-b94c-0392a983fef7"
      unitRef="usd">8877000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ibc05881978f94525b7d1199de70e7105_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RhYmxlOmI0ZmViODIzM2YzOTQzNDFiYjNiZDU1ZGQ4OWE0Njc2L3RhYmxlcmFuZ2U6YjRmZWI4MjMzZjM5NDM0MWJiM2JkNTVkZDg5YTQ2NzZfMTctMy0xLTEtMA_b9a8b974-fd39-4104-9a26-555f1dc04020"
      unitRef="usd">7593000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ic0118ee2d69441a7b3e211472508a35b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMjc2_4ea9ee96-a4f5-41ff-9e5c-33ae6f15729c"
      unitRef="usd">1000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ibc05881978f94525b7d1199de70e7105_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMjgz_00d850b3-6e8e-42b4-b22e-0fbdcb847793"
      unitRef="usd">1000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i9af0cc01cbc54c9f9e8615532da5bb0c_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMzkw_f7ee8a04-37ee-4983-a3f1-52ee4478ca3e"
      unitRef="usd">45000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="id3ecfefee0e642c0a78fc0131c0449c3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMzk3_b3316eae-f60a-4ea4-b68d-19b3d94e4d4e"
      unitRef="usd">31000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i2db04fe0f832449baafb9d23de950513_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfNjAx_a6350169-bfa4-4e97-bad1-46d64ecc3d9f"
      unitRef="usd">168000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i07fb4a28c1654faaa862b3d378de1c6c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfNjA4_f18d3c49-c13b-4a07-9a78-b083256eb148"
      unitRef="usd">173000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="ibddf2383b27440dfa62ff0b279e63601_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfODc4_029b22e9-d5cd-4414-b5e7-151c6d0abb23"
      unitRef="usd">-771000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="ic7e65dc4013e4f6db79b5de991f4c232_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfODg1_88829a82-658d-477d-af4c-975559b8df99"
      unitRef="usd">-448000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80Ni9mcmFnOmFhNTZhNTAwZThhZjQ0ZjViODllMTQ1YjQ4OGNhY2I3L3RleHRyZWdpb246YWE1NmE1MDBlOGFmNDRmNWI4OWUxNDViNDg4Y2FjYjdfMTY1OA_f004ef9f-b7d7-41a3-bc8d-b497aad8682b"
      unitRef="usd">6800000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8zMjk4NTM0ODkwNTI0_23259b07-902b-46fa-ac2c-e9ff8aa3af76">Borrowings&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings at September&#160;30, 2021 and December&#160;31, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.35% senior notes due March 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Floating rate notes due March 2021 (0.950% at December 31, 2020)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due May 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5.45% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.7% senior notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;7,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1.875% senior notes due February 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due September 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;58,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;65,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;(818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;(909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;58,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;(1,561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;(5,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;56,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;59,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021 Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On August 18, 2021, the Company issued $1.0&#160;billion aggregate principal amount of 2.125% unsecured senior notes due September 15, 2031 for total proceeds of $987&#160;million, net of discounts, underwriting fees and offering expenses. The net proceeds of this offering were used for the purchase of senior notes in connection with the Company&#x2019;s cash tender offer in August 2021 as described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Early Extinguishments of Debt&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, the Company purchased approximately $2.0&#160;billion of its outstanding 4.3% senior notes due 2028 through a cash tender offer. In connection with the purchase of such senior notes, the Company paid a premium of $332&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $26&#160;million of unamortized deferred financing costs and incurred $5&#160;million in fees, for a total loss on early extinguishment of debt of $363&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8zMjk4NTM0ODkwNTI2_a30df100-f62d-41c5-be8a-e308c8717bfa">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings at September&#160;30, 2021 and December&#160;31, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.35% senior notes due March 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Floating rate notes due March 2021 (0.950% at December 31, 2020)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due May 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5.45% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.7% senior notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;7,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1.875% senior notes due February 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due September 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;58,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;65,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;(818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;(909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;58,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;(1,561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;(5,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;56,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;59,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib62f2ee98dd644cd9bcc6e7fafb92659_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81LTAtMS0xLTEzMTAvdGV4dHJlZ2lvbjoxODNlMjkxODQ0ODY0YTYzYWNlNzJiZmRhNWMwMjAzYl80_92fbf718-05ca-4caa-9cca-ad0e0f721988"
      unitRef="number">0.0335</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib62f2ee98dd644cd9bcc6e7fafb92659_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81LTEtMS0xLTEzMTA_6ad7c7fc-c2fd-42c6-bf7c-6a8d6faa3194"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9dbe9ff3e69946d3a25f666403b2d133_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81LTMtMS0xLTEzMTA_ae2a825b-1328-4a72-aac9-6da86151be3a"
      unitRef="usd">2038000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6af42f85334840f8806360242558dac0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl82LTAtMS0xLTEzMTAvdGV4dHJlZ2lvbjoyOGVjZmM2OGEzZTU0OGFhYWEwMTgyOGE2MmE0MzQ2MV82Ng_630eed45-4d00-4aed-b67e-61e1a05f8869"
      unitRef="number">0.00950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id10cfac743044c0b8d548cd557cd8836_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl82LTEtMS0xLTEzMTA_4fbd08e4-456a-4405-a532-b74886e69a66"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6af42f85334840f8806360242558dac0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl82LTMtMS0xLTEzMTA_ef8cb4b6-721f-4924-aad3-a2c7fa110f50"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9597fa0131bc4e9887c9815a6cd88648_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl83LTAtMS0xLTEzMTAvdGV4dHJlZ2lvbjo2YWEzMjAxNzhmMTc0MDE2YTY2NmRkODJjMDI4NTgyOF80_a7c1d924-4583-441d-b7c2-bca883b9ce28"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9597fa0131bc4e9887c9815a6cd88648_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl83LTEtMS0xLTEzMTA_e47843e7-d1f5-44d2-b55b-a8fd9e588785"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i59e7dd59a3b54a77b96c49edb48d86b0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl83LTMtMS0xLTEzMTA_d62e4a56-1d2b-4e5b-83c2-aaa7f7c580c3"
      unitRef="usd">222000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iaf27f7ccf52044a79068c5b1c21729a4_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl84LTAtMS0xLTEzMTAvdGV4dHJlZ2lvbjpmNmU1MTc0MWJkOTY0MmE0ODQzY2QxNTE2NzY2Y2NhM180_fc9e8ffe-452d-41dc-935e-9f87455bd3f3"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iaf27f7ccf52044a79068c5b1c21729a4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl84LTEtMS0xLTEzMTA_c4f8112e-512c-4327-ace5-088e43114fa6"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9b3bd812b24f4f1eb1e8c8d5c0a75877_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl84LTMtMS0xLTEzMTA_f11e08ad-b7e8-4ee3-ae04-6dd14e270f85"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i852a5e91e3b9468ba1cb2eb5f74b1b9d_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl85LTAtMS0xLTEzMTAvdGV4dHJlZ2lvbjowMDhiYWQ2NzIyMGU0ZDcwYjI5YmRmN2ZkZDZhMGU0N180_32dc4296-08e9-4f51-aaae-fb1c8640c9ae"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i852a5e91e3b9468ba1cb2eb5f74b1b9d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl85LTEtMS0xLTEzMTA_7a5f30e1-6cea-490a-9751-194b538136bb"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6191e346def74ee2aea270383730ae08_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl85LTMtMS0xLTEzMTA_28de9102-6849-4f68-a5de-38adce3fa4d8"
      unitRef="usd">203000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i76f9788e25764f54b73f568ee5806646_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMC0wLTEtMS0xMzEwL3RleHRyZWdpb246M2QzOWMyMTIxMjMzNGQwYjhhZWY4N2NlNTA5ZjFkYjNfNA_4196023b-9e74-48c9-9710-c69f2d9b35a0"
      unitRef="number">0.0545</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i76f9788e25764f54b73f568ee5806646_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMC0xLTEtMS0xMzEw_2a1d240f-1acd-4eb5-acce-74d9a439547b"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibc41a17f6c774042b9fcf1afc65bbdde_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMC0zLTEtMS0xMzEw_d0483a62-c27d-4373-9159-ef924e7e2a7a"
      unitRef="usd">187000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i137942ee3c634b5389f5afc0f8942bca_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMS0wLTEtMS0xMzEwL3RleHRyZWdpb246YTljNDg2NGMxYWI2NDQ2Zjk4OGViNzA4MmY4ZjFjY2NfNA_b53b1912-9fcf-4923-8a63-a0963b00cd62"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i137942ee3c634b5389f5afc0f8942bca_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMS0xLTEtMS0xMzEw_020187b4-1106-44cb-95a5-fe778f9f98f3"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if73d40a8e2434d0fa1ef103cc7698cc3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMS0zLTEtMS0xMzEw_4b0d4cd8-202d-40fb-8639-b013bab52af8"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib6b0b4743e034bb1bc3f258385746efd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMi0wLTEtMS0xMzEwL3RleHRyZWdpb246Zjk2ODUwOTAyZWJjNDI4Mzg2ZTZiMTE4ODNiZjA2Y2JfNA_8c8eec0c-a586-4dc1-a35e-bf1006b94ce1"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib6b0b4743e034bb1bc3f258385746efd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMi0xLTEtMS0xMzEw_4f0b05fb-dbbe-41a6-90f0-02e5f55602ba"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i99bd1157dbbe4945af1a81d0c21130ea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMi0zLTEtMS0xMzEw_89b0144f-8c34-4560-b6ba-5acfd11ace09"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie17499a4aa5e4151b918eeea4df0de97_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMy0wLTEtMS0xMzEwL3RleHRyZWdpb246N2M4YzJmMzhiMmNhNGExNDgzOTRjOGU3Y2UyMjE5OTZfNA_ddeb41c7-8061-4218-a941-465c0a5a35be"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie17499a4aa5e4151b918eeea4df0de97_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMy0xLTEtMS0xMzEw_47c6f7dc-ad34-49d8-87ad-9e8ce3530796"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1d6ac400309247c5b66323fd368436e2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xMy0zLTEtMS0xMzEw_f81bc442-b0ff-42d3-9962-8eca0a970d2b"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8b0ee41eebc34bd180b2c69788165350_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNC0wLTEtMS0xMzEwL3RleHRyZWdpb246ZDNjNWM4MjA2MTU3NDIwZjhhZjViNTA0NTY5ODMzMGRfNA_e211cb40-1496-435a-a4d1-006f1a942410"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8b0ee41eebc34bd180b2c69788165350_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNC0xLTEtMS0xMzEw_e9103ef3-6ba9-4125-b38f-5e29681164ae"
      unitRef="usd">399000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i99f11726422242bdae9d51047e1fbd8a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNC0zLTEtMS0xMzEw_453a5eeb-44d4-425b-8166-5d29922b7500"
      unitRef="usd">399000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7f47310960c144eaacb797297d97929d_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNS0wLTEtMS0xMzEwL3RleHRyZWdpb246OGJhZjE3ZGMyYmUyNDU0ZjkwZjJmNzdjZTIxN2NiNDZfNA_d81ec0d4-acb8-48ad-9e82-8a1f6e8d5c3c"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7f47310960c144eaacb797297d97929d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNS0xLTEtMS0xMzEw_21a0d154-bd14-42a5-862c-dea4a219d5b5"
      unitRef="usd">2336000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1d3712df84af449f83452fc8bc0a7e18_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNS0zLTEtMS0xMzEw_80201db1-3647-4768-8885-af22dff3159b"
      unitRef="usd">2336000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i483ec33bdab247d48a38b7f13570e673_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNi0wLTEtMS0xMzEwL3RleHRyZWdpb246Yzc5MWNkMWZkNTczNGM2MWFiM2NiM2RkMGUxNjcwMjFfNA_84069088-cad3-4757-ae62-1649597617e8"
      unitRef="number">0.028</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i483ec33bdab247d48a38b7f13570e673_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNi0xLTEtMS0xMzEw_6a038c98-3354-4b02-9ee9-5b8bb1beabc6"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia618ec5a27694900b1f7ba774ad68e8e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNi0zLTEtMS0xMzEw_20c2a428-8907-4d58-a01d-5012fe81703b"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iff008f8fc0ee406881b35526798fa89d_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNy0wLTEtMS0xMzEwL3RleHRyZWdpb246YjY5YWJjNzUzN2Y2NDQ5Nzk4NmM5ZGM4NzlhZmRiNzNfNA_810cf834-535f-4643-a711-8a3b452f3c35"
      unitRef="number">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iff008f8fc0ee406881b35526798fa89d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNy0xLTEtMS0xMzEw_e9181ae3-e3b4-484b-9954-ed8813f6b44d"
      unitRef="usd">414000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i19a79677cf9c4a2da09c14598934ad6e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xNy0zLTEtMS0xMzEw_0e834866-b4b6-4c76-aad5-736b0b085bc2"
      unitRef="usd">414000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia1ab71b7baae485dba34f4f0eb636d02_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xOC0wLTEtMS0xMzEwL3RleHRyZWdpb246MjViODA2OTAzODdmNDIzYTg3YmM2NTkxMGFmNjI4NDdfMTA5OTUxMTYyNzgxMg_55d8f079-aefa-49a4-821b-424f84183989"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia1ab71b7baae485dba34f4f0eb636d02_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xOC0xLTEtMS0xMzEw_fd88d2e8-1fd3-4d83-ac8f-f89532da4210"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i01e1bcf974684d3f8b8d8a88ddadfd46_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xOC0zLTEtMS0xMzEw_c6527246-d6ce-41a3-b325-30e1dfa4884c"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie08be45af7c046aaa32b288f6d0abe62_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xOS0wLTEtMS0xMzEwL3RleHRyZWdpb246MDRjNWE1MjgxZjQzNGFiMGE1YzY0NzA4Y2M2OWFjNTdfMTA5OTUxMTYyNzgxMg_c9c1ffb3-be8e-4f63-834f-1bbb47e58c5c"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie08be45af7c046aaa32b288f6d0abe62_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xOS0xLTEtMS0xMzEw_a3fb8828-d33d-45d3-8969-82c764ce88a3"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iec21c12c0eb1436d803f53d89f62fa05_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8xOS0zLTEtMS0xMzEw_a37858e1-65b5-44db-b42b-a9a56e093917"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i72a7a16809e84d3b92e4bad0bac2262d_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMC0wLTEtMS0xMzEwL3RleHRyZWdpb246ZDNmZjBiNGI1OTQ4NDg2M2E3OGZhZDBjYTY3N2ZjNjFfNA_a37fe543-39a0-4d3d-bd6f-82333a003893"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i72a7a16809e84d3b92e4bad0bac2262d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMC0xLTEtMS0xMzEw_cd69c6e1-c921-4c0b-b6cc-2f7f4cb01dad"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic5d016793b9b42579b7bc6222e15baf6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMC0zLTEtMS0xMzEw_5ba786dd-c4c9-4f0c-af20-5232d016357f"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i764944fd1b5e42008a5e99c7c609eed9_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMS0wLTEtMS0xMzEwL3RleHRyZWdpb246YzhmZmYyNmQwNzgwNDRlOTg0YTI1YzM1OGM3N2IzNDBfNA_a98e3c80-35d0-4029-bda7-6c91aa19666c"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i764944fd1b5e42008a5e99c7c609eed9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMS0xLTEtMS0xMzEw_275ad229-8ab2-498d-b3df-004182e3cb22"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3c92560f130b45779c8a95a020b233ed_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMS0zLTEtMS0xMzEw_8f7ee85b-3bd7-4576-807c-81aab70c8512"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i27806ca29bf844b3901fae3f691be398_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMi0wLTEtMS0xMzEwL3RleHRyZWdpb246YTIzZmY5ZWM5ZTA3NDhlODk3MDU1YjE1MWYxZDY2N2NfNA_2982779e-9fc1-4171-9de0-80ddffc3622f"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i27806ca29bf844b3901fae3f691be398_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMi0xLTEtMS0xMzEw_01cfe7e6-fa16-4ddd-8b14-8f78a59e12b7"
      unitRef="usd">950000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iad404c84173a424d89258a6896c6cf7e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMi0zLTEtMS0xMzEw_d4c10852-64b7-4c93-9520-d6a9df6ce20a"
      unitRef="usd">950000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie935136890474a69910662f38d5b6b95_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMy0wLTEtMS0xMzEwL3RleHRyZWdpb246YjZjYWFmMjVkNGQ1NGNiOThjNzNhMDQ2Yjc3MTAzNDBfNA_87f9a12b-6a7a-48d7-9925-2349bb41c639"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie935136890474a69910662f38d5b6b95_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMy0xLTEtMS0xMzEw_03ce9900-c3f4-40b6-a54e-1b68e7fac6bc"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i17ee5f6b60d74d7e9832465d6c93a81d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yMy0zLTEtMS0xMzEw_82c3b65a-3fdb-499c-90d4-9d0c5ca79aaa"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i777d22b7a1214acf87d3902cab5fc684_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNC0wLTEtMS0xMzEwL3RleHRyZWdpb246ZDcxNGI3MTYwZjgxNDRiZmFmODQzYzM3YjA5ZjllNGVfNA_91c3cdf4-500b-49a7-8c6f-9117ce72313e"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i777d22b7a1214acf87d3902cab5fc684_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNC0xLTEtMS0xMzEw_e28142e3-30d4-40b1-acd6-4196351622cf"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i08366cfa41cf4ec09bb0df2075ab0906_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNC0zLTEtMS0xMzEw_75f84f0a-0f88-4c35-a36c-e2dd59f0c66a"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i501701dd672b47b79ce22cd7925e8550_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNS0wLTEtMS0xMzEwL3RleHRyZWdpb246YTJjZjkxZGM1ZjU3NDI4MTkwN2I0ZWM2ZjA2NzE3MzhfNA_3ff281ac-855f-478b-8901-d261b6cbf36d"
      unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i501701dd672b47b79ce22cd7925e8550_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNS0xLTEtMS0xMzEw_1dcb56db-8599-4acd-a85f-0e7f1f5c34cc"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i35c86118fbc64523a77d011172ead4d3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNS0zLTEtMS0xMzEw_57abf0d6-8933-4c13-93b2-a1c6bae89946"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6bf76349f2134b799b85e620ca017ce1_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNi0wLTEtMS0xMzEwL3RleHRyZWdpb246YWVjYTEyMWM5YzdmNGMwOGE3MGIzNTVhZWI2MGIzMmNfNA_fbf5a635-3d57-4ee5-bcc0-ba1af27abd0b"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6bf76349f2134b799b85e620ca017ce1_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNi0xLTEtMS0xMzEw_d7c89865-96b0-4531-8c3a-094f0e640395"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib2c451a4fe964730babafb480988f0b2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNi0zLTEtMS0xMzEw_0b64fa7f-ab79-4b97-a54c-1feb10bfb924"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iaae7c158e8fc423e95ac2bd644820bd4_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNy0wLTEtMS0xMzEwL3RleHRyZWdpb246ZDJhOTU5M2NmNzExNDI3Y2FjMzc1OTdlZjU1ZjYzZDRfNA_e9e470ae-739d-4dde-a76b-a929b3fe6d4c"
      unitRef="number">0.0625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iaae7c158e8fc423e95ac2bd644820bd4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNy0xLTEtMS0xMzEw_09200d0f-cfc1-486f-bbaf-9104c0f5cff7"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i950c1c297c4a4358acd09c74ab566982_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yNy0zLTEtMS0xMzEw_9472e30a-cc9e-4f73-a6dc-4efefcda2857"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i62ccc6e98f4545a181d967e33f10d4df_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yOC0wLTEtMS0xMzEwL3RleHRyZWdpb246NjM1YzkzZTZmZTQwNDQwMDkyYTkxYjI4ZGUwOTg1NjZfNA_7bcca18f-10c2-414e-a265-e7ebe99f8a06"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i62ccc6e98f4545a181d967e33f10d4df_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yOC0xLTEtMS0xMzEw_2d2c2bf2-02f1-4b7a-a378-9dfe4e6be579"
      unitRef="usd">2250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i857f5b369f4040fab9b2b410b0a79b73_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yOC0zLTEtMS0xMzEw_c53f5a9b-2a8d-440f-9a97-e57adab6d869"
      unitRef="usd">2250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if6bba02cee2944fbb480017e52082d76_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yOS0wLTEtMS0xMzEwL3RleHRyZWdpb246MDlhZWU5N2FjZWRmNGFmNWJlNmM0NDUwZTlmZWYyNGVfNA_178a6dfe-dbee-4d54-862c-1c5135596366"
      unitRef="number">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if6bba02cee2944fbb480017e52082d76_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yOS0xLTEtMS0xMzEw_23fce254-5bad-48b2-9df8-2866cd184d96"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i32452f38e22247ae967975fe6e98f407_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8yOS0zLTEtMS0xMzEw_711faedb-6823-4609-ac69-dcec20d5af39"
      unitRef="usd">7050000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia409b9876a544297931507912b72df4f_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMC0wLTEtMS0xMzEwL3RleHRyZWdpb246ODVkMmExZDkyMGMwNDgwMGJlNmEwNWI5NDJiOWU5NjFfNA_7b769033-6daf-4771-8f0d-1a40830e34b0"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia409b9876a544297931507912b72df4f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMC0xLTEtMS0xMzEw_758278ce-d819-4f4e-b2ef-fe4734efbf54"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i75a9c983e179487b80338719c6654c2b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMC0zLTEtMS0xMzEw_12dd6aa0-4cdb-4a1c-860f-773d8a139672"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7a4406c7b2f34949810aebaf45489f84_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMS0wLTEtMS0xMzEwL3RleHRyZWdpb246ODQ0ODNjM2NlZmYxNDA4MmFmY2VmOTE1MjQxMmZiNzhfNA_cc99a98d-7bfe-4a3d-9ee3-a4f8b8e10652"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7a4406c7b2f34949810aebaf45489f84_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMS0xLTEtMS0xMzEw_ec4ca56b-e981-4fc2-b9a0-31e1b2e937d5"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8151e799d1c74f5c833144285cf01c69_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMS0zLTEtMS0xMzEw_e9b08a25-b3b8-4b47-99ef-cb20b9d56a0f"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3182ba22cd594ccf9a8ae05b9078606d_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMi0wLTEtMS0xMzEwL3RleHRyZWdpb246YjJjYjU0OWJiYTc2NGYyODg2NjBjNzVkMjJhYmE4MzZfNA_4a89ce83-0a2a-4404-a535-584295c1a049"
      unitRef="number">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3182ba22cd594ccf9a8ae05b9078606d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMi0xLTEtMS0xMzEw_c6ddc586-4dd5-41a4-9ac8-74cffc39f92d"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib60002bca8e844649c542c4cc7f63f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMi0zLTEtMS0xMzEw_74521df4-7f63-41ad-b1fa-8a5974666323"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iba95d402ec9d49d28efe5abbbf533067_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMy0wLTEtMS0xMzEwL3RleHRyZWdpb246ZDgxYjZlMTA0ODQyNDg5ZGJkMmQ0YWQwNTIzYzViODNfNA_12033622-adf2-407c-ba1b-c0a441fef014"
      unitRef="number">0.01875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iba95d402ec9d49d28efe5abbbf533067_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMy0xLTEtMS0xMzEw_2ab3fe54-c642-4a50-804a-17e82d7210a6"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6773fdec06dc4a40983a54841b13dda4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zMy0zLTEtMS0xMzEw_989fc6ae-fb61-4132-8452-63ed56f85a3a"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic4916faa22d44187b36197276e047af9_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNC0wLTEtMS0xNzA2L3RleHRyZWdpb246N2RjY2YzMDU0NjQ2NDZmOGE0NmJjYzU1NDU3NDc3NTZfMTA5OTUxMTYyNzgyMQ_390d8049-94b2-43d0-9e16-87e040b340b4"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic4916faa22d44187b36197276e047af9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNC0xLTEtMS0xNzE1_0e8bf54a-3f16-44e8-bf4c-5012965df96b"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i73aea79ad2ba4f3fbca099d45fbd99ca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNC0zLTEtMS0xNzIy_1dd3eb93-aeea-4c4d-8d34-c8736696d80b"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibeb8eac0c5ec472ea3a8d59c3be4564c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNC0wLTEtMS0xMzEwL3RleHRyZWdpb246MWI4YTIxMjU1ODlhNDY1ZjhjNzRmZWY0MzA3ZmJkYTVfNA_710b3925-9c09-4d42-94ff-0790b35d0011"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibeb8eac0c5ec472ea3a8d59c3be4564c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNC0xLTEtMS0xMzEw_5e2ec58c-8ca1-4535-93da-577156f5e45a"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia10a7bda458947608ba95da5905bd9c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNC0zLTEtMS0xMzEw_07f5b40a-3188-4245-ab16-55bd0910fcbb"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic5a7d1903cee4bbe9e9caaee0f3997ea_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNS0wLTEtMS0xMzEwL3RleHRyZWdpb246YzgzODYyYjkzNjAwNGMxZWI5YWUxZDc0NTE3MGUxM2VfNA_e077eebd-62be-4d91-89fd-c775557995b2"
      unitRef="number">0.06625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic5a7d1903cee4bbe9e9caaee0f3997ea_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNS0xLTEtMS0xMzEw_fb8fe3bc-d04f-4ba1-9401-15e2b74ec133"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8be68adc97de4b3193304ca21babaad1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNS0zLTEtMS0xMzEw_467a7034-8972-40bd-8f3c-5173b99e74b9"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic715e236403845808ec274271d922531_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNi0wLTEtMS0xMzEwL3RleHRyZWdpb246NjhjNDY0Yjk3OGU4NDI5NzkxMTllNzU3MDNmZTEwYWNfNA_e37e0542-5bad-4548-8ec1-e2e367c32a6a"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic715e236403845808ec274271d922531_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNi0xLTEtMS0xMzEw_4d973a00-de36-470f-83a3-2866d3bbda89"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2e414d119b874c97af3d40d143e3f394_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNi0zLTEtMS0xMzEw_699c66f5-ee67-4725-8ba8-b6acdb233c14"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i98d7f42792064db8af2bea27fe4217d6_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNy0wLTEtMS0xMzEwL3RleHRyZWdpb246NDVhNjA4ZGE2MDIwNGI0NDllMmYxNjlmMTg1OGQ0YmRfNA_37a77a32-3fe0-4af0-8a22-31cdc08dfafa"
      unitRef="number">0.0478</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i98d7f42792064db8af2bea27fe4217d6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNy0xLTEtMS0xMzEw_3b24f32a-76c9-415a-9cf6-eea17361bd4b"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id9d87dfab2bc4779af52ac27db253497_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zNy0zLTEtMS0xMzEw_9a4a7867-b9d8-4184-ac5a-8e67d5abf4bd"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id61537d136804380900baa2205811e11_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zOC0wLTEtMS0xMzEwL3RleHRyZWdpb246MjU0NGMyYzM2OGU4NGEzYTg2MGVhY2ZhMWYyNTBhMThfNA_5eece932-c91c-4739-b178-8daf7b5e20cc"
      unitRef="number">0.06125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id61537d136804380900baa2205811e11_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zOC0xLTEtMS0xMzEw_71013fcd-f718-4128-b9d8-0755ddacde7a"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9f7e8dff237f43d0883eb5f73e112a29_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zOC0zLTEtMS0xMzEw_85884adb-ed3e-46e4-aae0-6e44a75e1f96"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icbe99d66375e4a84a14ca3cb9bd04463_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zOS0wLTEtMS0xMzEwL3RleHRyZWdpb246YmQxYmZhZDIzODlkNGRkMWI1YTZiZWU3ODg4N2QwZGJfNA_18b6df4a-0d50-41c0-93c3-0531d8ca1889"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icbe99d66375e4a84a14ca3cb9bd04463_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zOS0xLTEtMS0xMzEw_460b4938-f96c-49de-abb4-b5b38324756d"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i78303eac554f4ebaac80fbdb2ef497d2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl8zOS0zLTEtMS0xMzEw_82b9473d-84c7-41e3-b92a-95c1d1edf083"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic2bdbe81b56b433eb0b1abff2a8cf359_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80MC0wLTEtMS0xMzEwL3RleHRyZWdpb246NzI0YzQ1YzFhY2JmNDQ0ZTlhMjM2MjZiMWJhZWRjNzZfNA_edd603d2-4221-4272-bea0-89965cfaba7b"
      unitRef="number">0.027</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic2bdbe81b56b433eb0b1abff2a8cf359_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80MC0xLTEtMS0xMzEw_abe4f6cc-c9e8-4edf-952f-657926ccd3c4"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib7ad50bbcb824461968e1e224ceb45eb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80MC0zLTEtMS0xMzEw_3e012232-9089-42e6-b14a-71821ebf105e"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id19aa5c38de0498ba584e838008334eb_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80MS0wLTEtMS0xMzEwL3RleHRyZWdpb246M2EzYTIwNzdkNTY0NDdkNmFhNjU4MzAwMDhiNzBjMzRfNA_3430e50a-4e8c-4d3f-b11c-f1f392802d43"
      unitRef="number">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id19aa5c38de0498ba584e838008334eb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80MS0xLTEtMS0xMzEw_23748e96-c204-4469-a2c6-27c2e6a19f95"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3f0df169cc2a4329a01ff1661c5f6643_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80MS0zLTEtMS0xMzEw_da57fb8f-1d90-4e7d-91c4-9ba238680802"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia45c0682f66e4831a5e18003515863b7_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Mi0wLTEtMS0xMzEwL3RleHRyZWdpb246ZDM4Nzc0OTQ0YTdmNDAwMWFlOGNiZTY1MDE1ZWRiYzRfNA_27f6bd2e-40f8-4e91-9cbf-361e888c6340"
      unitRef="number">0.045</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia45c0682f66e4831a5e18003515863b7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Mi0xLTEtMS0xMzEw_b2bffb3b-ff0c-45b6-a9ab-19fbaa585777"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i44d5c108e0784a1baefe552607e68fbc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Mi0zLTEtMS0xMzEw_de492c4e-1c8f-40d4-a4c4-ac02a44ab155"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i82d31c26e4d44623ae7b535f4961b40a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80My0wLTEtMS0xMzEwL3RleHRyZWdpb246MjY2NmVlYjYzNmU2NDNiMzlmYjczNDBiMDNlYTM3MTBfNA_24fc195b-de1d-445f-bf0f-653a46fbf922"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i82d31c26e4d44623ae7b535f4961b40a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80My0xLTEtMS0xMzEw_d4959907-40ff-45d9-bb2d-19899166c3ca"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iaca08c7669e84499a6b53f5fc209d8d1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80My0zLTEtMS0xMzEw_3b4b1d57-ada6-4d99-85e0-7ae20cdcbe63"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ieaf0c3b289b94b89ba1558094a4e7fbb_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80NC0wLTEtMS0xMzEwL3RleHRyZWdpb246ODMyYzc3MmM0YTRjNDY3ZGJiYTI4NTkxYmQ2NTAwOWVfNA_ad172e0c-4f69-430c-b045-60ac9ec1ac4d"
      unitRef="number">0.053</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ieaf0c3b289b94b89ba1558094a4e7fbb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80NC0xLTEtMS0xMzEw_c8bd60ce-7409-47b2-8de1-1ad7308e3a21"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic7efa34741b14f12a2e1553830369efd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80NC0zLTEtMS0xMzEw_1d180e7b-0ee9-4ab1-8f0e-e5a8d4f68c68"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iee85be27a3054609aeaa1f1291e5378b_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80NS0wLTEtMS0xMzEwL3RleHRyZWdpb246MDczNTYwYzVjMDg3NGQ5ZGFlNmUyZGE3YzQwZjY4MjFfNA_88313b26-9cdd-4d63-9e93-4ed77b6f28cc"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iee85be27a3054609aeaa1f1291e5378b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80NS0xLTEtMS0xMzEw_f76f3ad9-5c9a-4426-b544-11d1ec606702"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4027fc5015314a28afdf00ece6eaa61d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80NS0zLTEtMS0xMzEw_4b81d870-54c5-448c-b36f-a574e0628f1b"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia33e18e6e5cf4bca9278bb182bc5c16e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Ni0wLTEtMS0xMzEwL3RleHRyZWdpb246MDMwYzhkYmI3YTliNDZiN2JhNmNmZjkzNmIwZWRlM2VfNA_8cb1e888-5f2f-40ae-a50a-b07e7263b19a"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia33e18e6e5cf4bca9278bb182bc5c16e_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Ni0xLTEtMS0xMzEw_267c9648-78df-4d7e-ac55-c3b43d9e4c60"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i64ab274ab94e4fb0b97224d1979d31f7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Ni0zLTEtMS0xMzEw_56722df6-479a-4ead-a0f8-f3082d15bbe1"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic90e5382382f47f6a02d952c5ef3f35f_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Ny0wLTEtMS0xMzEwL3RleHRyZWdpb246YjkyMmM1MmU3ZmEwNDMyMGJiODk0NzdlMmY3ODM1ZGRfNA_ed21b581-6ffa-4271-8589-4a092e00346e"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic90e5382382f47f6a02d952c5ef3f35f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Ny0xLTEtMS0xMzEw_d4ca8494-fc43-4070-b87d-748e0a5cf9a1"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie01363b48cc748a8b4849e735b906bcb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80Ny0zLTEtMS0xMzEw_456837d4-e9aa-43b9-abbf-53d1b4325ebf"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i57bd188e01604c998e340453dd1c10bc_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80OC0wLTEtMS0xMzEwL3RleHRyZWdpb246ZGE3MTE3NTA5M2MzNGNlYThlYTA0NmNlMjVmMDIwZDVfNA_5f750f04-00ce-4b10-a6c8-7da15b5c7d2f"
      unitRef="number">0.0505</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i57bd188e01604c998e340453dd1c10bc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80OC0xLTEtMS0xMzEw_fda9fdd0-756c-4513-86a8-aac052509eee"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib9e00c491a58435bbe46b502dfc86a88_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80OC0zLTEtMS0xMzEw_2277babf-2934-4a78-9ba6-4581cc2ab397"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7771d9a02ba1459fa65a6ed760132976_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80OS0wLTEtMS0xMzEwL3RleHRyZWdpb246MmUwYjVkNGI1NmMzNDNmZTlmOTYzMmQ3YzI3NzM4N2FfNA_1e71d92c-e830-4c2e-8aed-fed4bb58413f"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7771d9a02ba1459fa65a6ed760132976_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80OS0xLTEtMS0xMzEw_c7c219bd-3b4d-444d-aad3-8e3cee3caea5"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1710183e3c7642969f8764f4a6bccb12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl80OS0zLTEtMS0xMzEw_5d8aec9c-6973-4cc7-b06b-ed3f5c63eb25"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81MC0xLTEtMS0xMzEw_1f8e53a5-c8bd-47a7-b17f-d009e6547981"
      unitRef="usd">1207000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81MC0zLTEtMS0xMzEw_b5cd7b3d-a09c-46f2-9ad4-dd8e8dffea70"
      unitRef="usd">1083000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib2fe10dd7c524a25a46b3c5a30a4d149_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81MS0xLTEtMS0xMzEw_ae5e6983-1fe7-4eca-85fb-64f806b7e803"
      unitRef="usd">321000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i498b74e1a6084982a704243062845c72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81MS0zLTEtMS0xMzEw_e7da1c09-adca-4a0b-81e7-096d1a232094"
      unitRef="usd">326000000</us-gaap:DebtInstrumentCarryingAmount>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81Mi0xLTEtMS0xMzEw_fd3b970c-232a-49ea-bf0f-9d356d5904f6"
      unitRef="usd">58987000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81Mi0zLTEtMS0xMzEw_5523b4e9-d5ec-4076-a7eb-4d758ad049fc"
      unitRef="usd">65318000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81My0xLTEtMS0xMzEw_76a2576d-cf4a-444c-b8f4-f187cb7e400c"
      unitRef="usd">224000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81My0zLTEtMS0xMzEw_b38356aa-4753-4b4d-b9aa-9e8edb735e56"
      unitRef="usd">238000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81NC0xLTEtMS0xMzEw_534b25a2-d809-4b29-8710-527b0fe524d3"
      unitRef="usd">818000000</cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet>
    <cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81NC0zLTEtMS0xMzEw_ff7223a6-6f59-4488-a82d-961909a312a4"
      unitRef="usd">909000000</cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81NS0xLTEtMS0xMzEw_3a818d5d-c99e-4d71-8b9d-bf5cd44197b1"
      unitRef="usd">58393000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81NS0zLTEtMS0xMzEw_b32d671a-c197-4b01-bd35-79f24326d16b"
      unitRef="usd">64647000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81OC0xLTEtMS0xMzEw_aeda3ab0-cf10-487e-8d82-450bd8f50223"
      unitRef="usd">1561000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81OC0zLTEtMS0xMzEw_ba1ccbc8-8810-4a7f-95b2-8438a31e0dce"
      unitRef="usd">5440000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81OS0xLTEtMS0xMzEw_5924c1b6-d0e6-4175-839f-484e35f64927"
      unitRef="usd">56832000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ie73ca519535e42989446d84c5cbfd99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGFibGU6NWVlNTU3NDgwMjllNDI0NmE3NDcyZjkxNjZhM2I3MDYvdGFibGVyYW5nZTo1ZWU1NTc0ODAyOWU0MjQ2YTc0NzJmOTE2NmEzYjcwNl81OS0zLTEtMS0xMzEw_a85ead01-54e6-4358-a369-32759091ec8c"
      unitRef="usd">59207000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iaf76f8b405534054bff48c947da24a34_I20210818"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NDkz_1cd6eafb-cf93-4b69-b681-81f52cc601dc"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iaf76f8b405534054bff48c947da24a34_I20210818"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTA4_6908df96-12ff-4627-8346-49113f3668e7"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="iec82b516316744c190f4a9f8856af906_D20210818-20210818"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTcx_0ae49e88-c293-45bd-839d-60e4a1a6fe00"
      unitRef="usd">987000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ib7001acb1c0940d18c4cb5e7df98ee1e_D20210801-20210831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTIy_f20a2998-f6ef-4323-9a32-eaa84607f73d"
      unitRef="usd">2000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5ec50d6371f84eb3808d2b78b4f8710a_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTM3_24d7b24c-1dc6-4615-898d-11ef2ad022bf"
      unitRef="number">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="ib7001acb1c0940d18c4cb5e7df98ee1e_D20210801-20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTg2_bdab15b6-9bf0-44aa-86dd-012697b56165"
      unitRef="usd">-332000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="ib7001acb1c0940d18c4cb5e7df98ee1e_D20210801-20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTk5_24112595-c71d-4521-8253-3560cbabd930"
      unitRef="usd">26000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="ib7001acb1c0940d18c4cb5e7df98ee1e_D20210801-20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NjEy_ab649c3b-ea9a-4e65-ab65-cb52194552e7"
      unitRef="usd">5000000</cvs:DebtExtinguishmentFees>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib7001acb1c0940d18c4cb5e7df98ee1e_D20210801-20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NTU4_955624d4-9ca8-43ef-9688-4e43cfd28a8b"
      unitRef="usd">-363000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ifcbf1d24a625419793f28cc2390b7c49_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NjI1_4d090376-78a5-489a-9097-b298fbd586d8"
      unitRef="usd">6000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i4365454cfaf648c79ea4a5b95d9f8a4f_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjM3NjUy_9ebd55aa-96ea-47c9-bff7-bd26c4315fa3"
      unitRef="usd">723000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib8e59782bbf940fbb42fef683312041e_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4NzEz_ba50144d-68f3-4e02-ba94-e98caa119d21"
      unitRef="number">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i9f1e3af8e2a7433f93e2da46dedb4bae_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4NzIw_a1d77ee0-464e-4a68-bd66-f1e1ba9202c8"
      unitRef="usd">2300000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idc2a92285efd424994eb094e0817bfc3_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4NzM1_d95601f1-fd96-4c4f-b884-5681007346b0"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i7f0b1fccad9c4d07b2db0f2507871783_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4NzQy_bc2812cc-2c10-4b24-9d61-17ff080145c2"
      unitRef="usd">3000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7898b0b327ab449eb16708ed5b14e472_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4NzU3_81825dea-e2f6-43ed-8139-a6223525acfc"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="i0de59d4f1eeb42f8bbb0fb2fe5621340_D20200801-20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4NzY0_89635dff-6e1f-4650-8114-dc66027195d1"
      unitRef="usd">-706000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i0de59d4f1eeb42f8bbb0fb2fe5621340_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4Nzc5_8cc3ed47-1522-42cf-a48f-840f2c53253b"
      unitRef="usd">47000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="i0de59d4f1eeb42f8bbb0fb2fe5621340_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4Nzkz_c3686bd0-bfe1-495c-8bc1-6f90826bac4c"
      unitRef="usd">13000000</cvs:DebtExtinguishmentFees>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0de59d4f1eeb42f8bbb0fb2fe5621340_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8xMTg1L2ZyYWc6MTczMDE3M2FlOWI4NDI3NTljZDk4YWE4OGYwYTQxNTEvdGV4dHJlZ2lvbjoxNzMwMTczYWU5Yjg0Mjc1OWNkOThhYTg4ZjBhNDE1MV8xMDk5NTExNjI4ODA3_df967558-380b-4451-865c-016f7e7331a5"
      unitRef="usd">-766000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfMTMxOQ_81ee366f-25b6-4289-9aa4-f32aed617c30">Shareholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2, 2016, CVS Health&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) authorized the 2016 share repurchase program (&#x201c;2016 Repurchase Program&#x201d;) for up to&#160;$15.0 billion of the Company&#x2019;s common shares. The 2016 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2016 Repurchase Program can be modified or terminated by the Board at any time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021 and 2020, the Company did not repurchase any shares of its common stock. At September&#160;30, 2021, the Company had remaining authorization to repurchase an aggregate of up to approximately $13.9 billion of its common shares under the 2016 Repurchase Program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;The quarterly cash dividend declared by the Board was $0.50 per share in each of the three-month periods ended September&#160;30, 2021 and 2020. Cash dividends declared by the Board were $1.50 per share in each of the nine-month periods ended September&#160;30, 2021 and 2020. CVS Health has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#x2019;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ie44679796a144c26b4b62a377639993f_I20161102"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfMTk3_922a2736-cc7c-4ab8-8fef-51aed1dc1363"
      unitRef="usd">15000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfNjI4_327f2bc6-5503-4360-b079-7b9125da842e"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfNjI4_82fbaf21-64a5-45e3-ac78-36154054e0d4"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i191becb0a3c544ecaf8184ef7e8acb3d_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfNzcy_03ddb333-143b-4fdd-a1b5-7f7f56b01399"
      unitRef="usd">13900000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfODk4_1ee9794f-5caf-4b92-ad99-8da21f46e48f"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfODk4_3dddc327-dcdc-41e2-a2b3-04fc7794f95d"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfMTAwNQ_1689aaef-f210-42c9-8fa3-931073004229"
      unitRef="usdPerShare">1.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV80OS9mcmFnOjA0MGU4MjRhYTEzNTQ0ODU4ZjJiNTdiNDU3NWVmM2FiL3RleHRyZWdpb246MDQwZTgyNGFhMTM1NDQ4NThmMmI1N2I0NTc1ZWYzYWJfMTAwNQ_a631876a-78fa-4e4f-8fd2-8d91445a83df"
      unitRef="usdPerShare">1.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RleHRyZWdpb246ODE2MzAwOTEyNTdiNGYwOGFkNWU3NGYwNzg4MWVhNDNfMTAyMw_1098dc44-a89a-4abd-a61a-aed83913b6fa">Other Comprehensive Income&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income for the three and nine months ended September&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$(73), $83, $(346), $278 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(14), $(10), $(15), $47 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $0, $0, $(7) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(20), $(4), $(29), $(14) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $0, $0, and $(8) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $0, $1 and $7 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of period accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of period accumulated other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;(3)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RleHRyZWdpb246ODE2MzAwOTEyNTdiNGYwOGFkNWU3NGYwNzg4MWVhNDNfMTAyNQ_9117faa7-4c69-4095-9bea-059b09762a99">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income for the three and nine months ended September&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$(73), $83, $(346), $278 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(14), $(10), $(15), $47 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $0, $0, $(7) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(20), $(4), $(29), $(14) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $0, $0, and $(8) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $0, $1 and $7 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of period accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of period accumulated other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;(3)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6197d49ef31446ffacc35056221fecbf_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMy0xLTEtMS0w_bccdb420-67e5-443e-ac9a-3e23ceab7994"
      unitRef="usd">977000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b734952dace49dab51be5df71c2cdad_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMy0zLTEtMS0w_208d623f-ebe9-4e38-abb9-c82754dac9eb"
      unitRef="usd">987000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i45de384d4b8f4d4aa79185b3cf224a05_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMy01LTEtMS0w_96648d2b-e9be-4934-8a11-9e7fba35112a"
      unitRef="usd">1214000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8ddb5c89f1944d7f9dfa198754d529ee_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMy03LTEtMS0w_021e3c82-fc3b-442b-a1ec-b104d7ab1868"
      unitRef="usd">774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i33239c1a09204337ad5c55fefd2f9d8c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC0wLTEtMS0wL3RleHRyZWdpb246OTgxMDkyZDMwNWU4NGY0ZWE5M2E3ZDNiYjdmMDM0NzBfNjQ_8822f829-4f94-4d3b-898d-5e947232321c"
      unitRef="usd">-73000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="idf731d8db2514741951a6d08a5bf2340_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC0wLTEtMS0wL3RleHRyZWdpb246OTgxMDkyZDMwNWU4NGY0ZWE5M2E3ZDNiYjdmMDM0NzBfNjg_579eae9d-8c0d-4c33-9c83-1d1833b98e39"
      unitRef="usd">83000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i56a02a7778f5400493e2859f84b416f2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC0wLTEtMS0wL3RleHRyZWdpb246OTgxMDkyZDMwNWU4NGY0ZWE5M2E3ZDNiYjdmMDM0NzBfNzI_d743918c-350f-42ab-9ca5-2ee99c718d86"
      unitRef="usd">-346000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if38c0c0626334984872a2e8f0277dc2e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC0wLTEtMS0wL3RleHRyZWdpb246OTgxMDkyZDMwNWU4NGY0ZWE5M2E3ZDNiYjdmMDM0NzBfNzY_96813989-eabf-4383-af99-d77334838f0e"
      unitRef="usd">278000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i33239c1a09204337ad5c55fefd2f9d8c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC0xLTEtMS0w_d076ed1e-eca0-44ba-977b-7df5b29910fa"
      unitRef="usd">-61000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="idf731d8db2514741951a6d08a5bf2340_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC0zLTEtMS0w_7d7b1baa-c3ce-44bd-9c50-1a34ba355121"
      unitRef="usd">52000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i56a02a7778f5400493e2859f84b416f2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC01LTEtMS0w_e0c105b0-ba3c-4fcc-a794-bef7f3743770"
      unitRef="usd">-297000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if38c0c0626334984872a2e8f0277dc2e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNC03LTEtMS0w_85597734-786e-4f12-b890-a69e5e696d23"
      unitRef="usd">218000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i33239c1a09204337ad5c55fefd2f9d8c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS0wLTEtMS0wL3RleHRyZWdpb246MzJiYzY1OGFlOWRkNDdmNDlkMjVmOWFjZGJmMGJmM2FfNzA_f3c54b9c-ac5f-455a-8477-614877e05b9e"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="idf731d8db2514741951a6d08a5bf2340_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS0wLTEtMS0wL3RleHRyZWdpb246MzJiYzY1OGFlOWRkNDdmNDlkMjVmOWFjZGJmMGJmM2FfNzQ_76b8022d-a527-406d-926c-ab617b1b4f02"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i56a02a7778f5400493e2859f84b416f2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS0wLTEtMS0wL3RleHRyZWdpb246MzJiYzY1OGFlOWRkNDdmNDlkMjVmOWFjZGJmMGJmM2FfNzg_e534ea61-846a-4ad1-8c8d-3e6b686b5f2e"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="if38c0c0626334984872a2e8f0277dc2e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS0wLTEtMS0wL3RleHRyZWdpb246MzJiYzY1OGFlOWRkNDdmNDlkMjVmOWFjZGJmMGJmM2FfODI_89336955-5ab9-4c7f-8311-73eea95c876d"
      unitRef="usd">47000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i33239c1a09204337ad5c55fefd2f9d8c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS0xLTEtMS0w_c1d4b052-4ed4-4b4c-92f9-68b9e7107066"
      unitRef="usd">12000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="idf731d8db2514741951a6d08a5bf2340_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS0zLTEtMS0w_6342ba77-4ed8-4362-902a-8196722e6d6f"
      unitRef="usd">8000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i56a02a7778f5400493e2859f84b416f2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS01LTEtMS0w_6bd3a9a6-1272-4bec-8d53-6726d56fe5e9"
      unitRef="usd">13000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if38c0c0626334984872a2e8f0277dc2e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNS03LTEtMS0w_5777da12-265e-426a-bbe3-d00554cc5872"
      unitRef="usd">-39000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i33239c1a09204337ad5c55fefd2f9d8c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNi0xLTEtMS0w_44ed1293-a93d-43b2-8444-84c6c065a77d"
      unitRef="usd">-73000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idf731d8db2514741951a6d08a5bf2340_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNi0zLTEtMS0w_fa93d64c-8945-41dd-af8e-c6f1931a7d09"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i56a02a7778f5400493e2859f84b416f2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNi01LTEtMS0w_7fbb1e1f-706c-4cda-8743-1b306c7a15bd"
      unitRef="usd">-310000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if38c0c0626334984872a2e8f0277dc2e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNi03LTEtMS0w_69539672-c330-46cd-8f04-fe435e783e51"
      unitRef="usd">257000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iefa0cb672bf44372a091873f1dfe9120_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNy0xLTEtMS0w_d7d21d65-9008-4344-b958-1d742865706f"
      unitRef="usd">904000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe641cc44c4a46438e0b7bfd4cc3622e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNy0zLTEtMS0w_eb90b377-22fd-454a-8378-78156cb0e8fb"
      unitRef="usd">1031000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iefa0cb672bf44372a091873f1dfe9120_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNy01LTEtMS0w_7af04df6-84e2-4702-82d0-fcb86a3a648b"
      unitRef="usd">904000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe641cc44c4a46438e0b7bfd4cc3622e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfNy03LTEtMS0w_29416be9-7e9a-466c-bf5e-f76a8f0cecda"
      unitRef="usd">1031000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iecd646f2764643b59a88988226c92eff_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTAtMS0xLTEtMA_5f141332-db93-4a90-9d51-08ada834fe07"
      unitRef="usd">6000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id4a67b4c90b54c758612bcb4085bec12_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTAtMy0xLTEtMA_2e22417d-d6a3-4b10-824f-669fdddd44f3"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i12d2dcb1b92e4bcb94f40436329a7dd6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTAtNS0xLTEtMA_5fce2da4-3a28-4e5c-af9e-077bd5c5c8be"
      unitRef="usd">7000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id52f8f655a4e45b28cdd084d28393f28_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTAtNy0xLTEtMA_59629fcc-10a5-495b-a318-bb9e3b78b0f6"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i47faa1c1728e4e11a77c17ac0400684b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTEtMS0xLTEtMA_05c291f7-19b3-415f-ad94-79b4799f94c6"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="idedf5740b04f4deea7f8b81566c50b36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTEtMy0xLTEtMA_47d018d5-e505-4ed2-94d7-93cc0339498d"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1d8528d81dc241b8800e77a29be29f47_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTEtNS0xLTEtMA_da54f601-4b43-434c-a9f6-fbdbed16b81d"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic1952024433d45cdb011fb1c5362e577_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTEtNy0xLTEtMA_829b2e06-1891-49d8-8d73-cbfcceee7428"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i47faa1c1728e4e11a77c17ac0400684b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTMtMS0xLTEtMA_990d3cea-d48c-40b1-8936-82d8771c34c7"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idedf5740b04f4deea7f8b81566c50b36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTMtMy0xLTEtMA_158c30eb-7493-472c-9ba5-57218591e3c9"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1d8528d81dc241b8800e77a29be29f47_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTMtNS0xLTEtMA_39ded0b9-cc99-4174-bc6c-3a36106ceee5"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic1952024433d45cdb011fb1c5362e577_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTMtNy0xLTEtMA_19dc5e7e-76c3-4b6f-953d-7897a9216a4f"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic976b0752299464f9eb1c2e3a0466f84_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTQtMS0xLTEtMA_682c834c-1987-4132-8144-3cf24632acc0"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i537c6fd82b2d4484a4285287e0da5e8d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTQtMy0xLTEtMA_ae0627c2-0b90-4097-858b-01f07541804f"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic976b0752299464f9eb1c2e3a0466f84_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTQtNS0xLTEtMA_480ea90a-f897-4cae-833a-02de97addd9e"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i537c6fd82b2d4484a4285287e0da5e8d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTQtNy0xLTEtMA_57e3a781-67e0-4af2-af13-8e61da83e92c"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5fcb54914f1448388da80fbfae61bf9b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTctMS0xLTEtMA_240529bf-ac4a-4679-96e5-45d08588ef0b"
      unitRef="usd">241000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i89f5412889bb4704867c4db1cb7606ca_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTctMy0xLTEtMA_d387b3ea-aed6-4160-8019-431b6d249c2b"
      unitRef="usd">267000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80de0413731140859ba1fca6bbc151be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTctNS0xLTEtMA_fe4fafda-7947-4159-a093-24d8e7b11a9c"
      unitRef="usd">248000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7e05796d442740d6b0e31e64c7579488_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTctNy0xLTEtMA_4447c333-2ae2-4972-8e6a-8e75c30e9606"
      unitRef="usd">279000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i22587a4dc04645edaa23ee4e6fe5309c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM4ZDgwYjdmOWE2NjRmYjM5Njg5MWUwNjI0M2QyNjE2XzU1_c30d2be7-0fbf-400a-b5ac-4661eb556411"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i320caa0f2438447eb917283e43737ae0_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM4ZDgwYjdmOWE2NjRmYjM5Njg5MWUwNjI0M2QyNjE2XzU5_db692759-990e-407e-88cd-66be36f85cba"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia60c00beb57f4d0aa1389f1cbd1b8aa9_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM4ZDgwYjdmOWE2NjRmYjM5Njg5MWUwNjI0M2QyNjE2XzYz_f8046566-2b4d-4f10-9833-1a116dfe0d2f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i46462aa1e76c440a848f1a6c4854fcbf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjM4ZDgwYjdmOWE2NjRmYjM5Njg5MWUwNjI0M2QyNjE2XzY3_ed223937-06a5-4a8b-9a6e-b918cf82a7ac"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i22587a4dc04645edaa23ee4e6fe5309c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtMS0xLTEtMA_f4566d99-26a2-41f0-8fd9-bb3abde9d1b0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i320caa0f2438447eb917283e43737ae0_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtMy0xLTEtMA_be6e3c66-fdfe-4737-98da-f04560fcb0e1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia60c00beb57f4d0aa1389f1cbd1b8aa9_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtNS0xLTEtMA_9144392a-ceb4-43b2-9043-67d3d02dbf97"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i46462aa1e76c440a848f1a6c4854fcbf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTgtNy0xLTEtMA_fe41d19d-1c7b-4eca-b075-65cd179e52d7"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i22587a4dc04645edaa23ee4e6fe5309c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktMC0xLTEtMC90ZXh0cmVnaW9uOmY4NGQxYjE2NmFiNTRmZDliZTJhMTYyZTExYmM2ZmZhXzcw_5b291621-c670-4dd2-bcc9-3c4c781c73d9"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i320caa0f2438447eb917283e43737ae0_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktMC0xLTEtMC90ZXh0cmVnaW9uOmY4NGQxYjE2NmFiNTRmZDliZTJhMTYyZTExYmM2ZmZhXzc0_04c7ecf9-4ce3-4921-bf84-5c06b0473adf"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ia60c00beb57f4d0aa1389f1cbd1b8aa9_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktMC0xLTEtMC90ZXh0cmVnaW9uOmY4NGQxYjE2NmFiNTRmZDliZTJhMTYyZTExYmM2ZmZhXzc4_3624f564-20b8-43db-b146-e8410cafb7fc"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i46462aa1e76c440a848f1a6c4854fcbf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktMC0xLTEtMC90ZXh0cmVnaW9uOmY4NGQxYjE2NmFiNTRmZDliZTJhMTYyZTExYmM2ZmZhXzgy_1a1c4122-0f7c-49cb-8be4-6b99b48aeeb0"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i22587a4dc04645edaa23ee4e6fe5309c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktMS0xLTEtMA_233bf244-2c14-4733-bcc3-ff68ba8cbae3"
      unitRef="usd">15000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i320caa0f2438447eb917283e43737ae0_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktMy0xLTEtMA_c9823881-33df-41e2-a5d9-731cf4952eac"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia60c00beb57f4d0aa1389f1cbd1b8aa9_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktNS0xLTEtMA_b4d378b7-f4d4-4253-bb0d-518fd6503a12"
      unitRef="usd">22000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i46462aa1e76c440a848f1a6c4854fcbf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMTktNy0xLTEtMA_97af32d8-d3af-4b23-ac0c-65d122a2eef4"
      unitRef="usd">10000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i22587a4dc04645edaa23ee4e6fe5309c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjAtMS0xLTEtMA_05faaa86-f76f-439c-945b-0f3b8f149a56"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i320caa0f2438447eb917283e43737ae0_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjAtMy0xLTEtMA_6f1eb972-78f3-4fb4-aabb-b8b9e53f35e3"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia60c00beb57f4d0aa1389f1cbd1b8aa9_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjAtNS0xLTEtMA_2764b696-8a08-491f-b304-af466b90ec52"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i46462aa1e76c440a848f1a6c4854fcbf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjAtNy0xLTEtMA_a862867d-3eca-4d20-a961-245fc0e6bf3b"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c8056adf6394fb8a935b96c8a1244bc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjEtMS0xLTEtMA_97bdb363-ff3a-4b4c-b905-70c455b2fed5"
      unitRef="usd">226000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73d82d6008cf422f990c1967019b47ae_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjEtMy0xLTEtMA_9443abe1-72ed-45e4-b200-ddf5911ccddd"
      unitRef="usd">264000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c8056adf6394fb8a935b96c8a1244bc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjEtNS0xLTEtMA_e23c8c0c-3f79-406f-a43d-21ca1b93097b"
      unitRef="usd">226000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73d82d6008cf422f990c1967019b47ae_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjEtNy0xLTEtMA_78599408-b634-4e11-a459-17761c68d57d"
      unitRef="usd">264000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i38f0d7cd0319413a864c57d831aa6de9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjQtMS0xLTEtMA_9fa0de12-f15e-4eae-841e-9bcfb3f2bbc5"
      unitRef="usd">-54000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5c9058389544d8f9fd0949b2df8c97e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjQtMy0xLTEtMA_5d02324a-24d2-4ed4-82cc-e45a853602a9"
      unitRef="usd">-39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8fa36c1044d245bfa0fdac23491e04fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjQtNS0xLTEtMA_0205ea2b-d211-4c9c-846e-d439e16e4dd9"
      unitRef="usd">-55000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5168781fe0f2491a9d873c5536902ff3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjQtNy0xLTEtMA_5b205f66-4e04-4578-8c37-6bf189561655"
      unitRef="usd">-38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia9a54e61594a4ce5afdb32319e63cfe5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjE0NTNjZTU2MTlmNjQzZjRiZWZlYmU3ZDNjMjQ2NTRkXzU1_bf00ba5a-e9a5-4ed4-9453-095b86ce5f5e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i7d6fd9a3e6ba4affb174e7bf3606494f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjE0NTNjZTU2MTlmNjQzZjRiZWZlYmU3ZDNjMjQ2NTRkXzU5_033f252d-e38b-4abc-bf2d-d9df1ab885b0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ibd3134eb77504bf1a35552d9f49abbce_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjE0NTNjZTU2MTlmNjQzZjRiZWZlYmU3ZDNjMjQ2NTRkXzYz_b684e7a2-a597-4b59-8a86-727d0b9476d4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ifd24288b5c4a41a39c5a91e91a8ef6bf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjE0NTNjZTU2MTlmNjQzZjRiZWZlYmU3ZDNjMjQ2NTRkXzcx_ccddf74a-606a-44de-842c-8b97cd6cacd0"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia9a54e61594a4ce5afdb32319e63cfe5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtMS0xLTEtMA_792135b7-dd49-4544-a075-f9387ce06468"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7d6fd9a3e6ba4affb174e7bf3606494f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtMy0xLTEtMA_9fa2e411-bfa8-4962-9a14-e585ffed65fb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibd3134eb77504bf1a35552d9f49abbce_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtNS0xLTEtMA_bcd99a79-1e37-4d9d-9291-71025e91c06b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ifd24288b5c4a41a39c5a91e91a8ef6bf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjUtNy0xLTEtMA_9f97843d-207b-4a0c-b55f-765a083b7068"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ia9a54e61594a4ce5afdb32319e63cfe5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA0MTc1ZWEzNDA2NTRmN2ViYjY1NGI5NTdhM2JiZDJiXzY4_d1b13d9c-a921-4791-8fbf-50c8d41a1f7d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i7d6fd9a3e6ba4affb174e7bf3606494f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA0MTc1ZWEzNDA2NTRmN2ViYjY1NGI5NTdhM2JiZDJiXzcy_3f6e7de7-b119-4a93-bbf5-5c1865a26ae3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ibd3134eb77504bf1a35552d9f49abbce_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA0MTc1ZWEzNDA2NTRmN2ViYjY1NGI5NTdhM2JiZDJiXzc2_777562f9-2d84-447e-a25f-9092785d32c5"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ifd24288b5c4a41a39c5a91e91a8ef6bf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA0MTc1ZWEzNDA2NTRmN2ViYjY1NGI5NTdhM2JiZDJiXzgz_2a7ca8c1-95cf-48ad-9d2f-030bf2b1dd2b"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia9a54e61594a4ce5afdb32319e63cfe5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtMS0xLTEtMA_1c356969-c540-4d6b-a121-48288badff90"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7d6fd9a3e6ba4affb174e7bf3606494f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtMy0xLTEtMA_d022dc6b-aa1f-47d6-a0ac-0f05f50581c3"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibd3134eb77504bf1a35552d9f49abbce_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtNS0xLTEtMA_62174c98-e084-4870-900b-e1e392b810b0"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ifd24288b5c4a41a39c5a91e91a8ef6bf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjYtNy0xLTEtMA_edb375fa-ff44-43da-92fb-586929a4cfab"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia9a54e61594a4ce5afdb32319e63cfe5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjctMS0xLTEtMA_694c92c3-7fdb-4fa7-82db-1beb086feeef"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7d6fd9a3e6ba4affb174e7bf3606494f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjctMy0xLTEtMA_37b032ad-23c2-43fe-8b3d-42a81440497a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibd3134eb77504bf1a35552d9f49abbce_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjctNS0xLTEtMA_dcdef228-f6d8-4f58-92d8-18820e84ff15"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifd24288b5c4a41a39c5a91e91a8ef6bf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjctNy0xLTEtMA_20b64d92-fde7-4ca2-aa10-5478c14110bf"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icb78040186fa4e1aaee57c20ecf08ec1_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjgtMS0xLTEtMA_3ac81044-1db0-410f-80fc-52137e54ca9a"
      unitRef="usd">-54000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaeb02179387b4c138f3d16aecc35f88b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjgtMy0xLTEtMA_7c63208e-72d6-4825-8c80-aacc52174e3a"
      unitRef="usd">-39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icb78040186fa4e1aaee57c20ecf08ec1_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjgtNS0xLTEtMA_bf385afd-6350-4f33-9107-2ff3005470ff"
      unitRef="usd">-54000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaeb02179387b4c138f3d16aecc35f88b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMjgtNy0xLTEtMA_65ad627b-0b50-40cc-9683-b47f335966ea"
      unitRef="usd">-39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i02e8e4d27b8640368de9694d52106ab1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzAtMS0xLTEtMA_4b9c5016-e3f3-422c-b071-8c1498be523b"
      unitRef="usd">1170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i38524abcd2514a1fb4737a87a7e66b81_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzAtMy0xLTEtMA_a49e0441-c9b6-4f66-a22f-4d8f29847f7f"
      unitRef="usd">1213000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i744afac31d1c419187429ada2dec85cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzAtNS0xLTEtMA_a735cc75-e1c8-411c-960a-1f97738f40af"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5cb66a72330944e6abe3847855220870_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzAtNy0xLTEtMA_6f01702c-ae46-4c0b-8b92-011275b039d1"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id4ab8d4ce4d04aecb9a84bbfc6849284_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzEtMS0xLTEtMA_3d85c8e6-5070-4b29-81d0-09220e743200"
      unitRef="usd">-93000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzEtMy0xLTEtMA_6d0ede36-87d1-488d-b39c-a10588fbb4ac"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzEtNS0xLTEtMA_435fd22b-304d-474a-a3ed-d99faa107bc4"
      unitRef="usd">-337000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzEtNy0xLTEtMA_304cf154-2f69-4d46-bbeb-e897c841a1c8"
      unitRef="usd">236000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i840219be56704e14b8dd4d1adb3ca119_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzItMS0xLTEtMA_a5649950-6822-4933-be98-6b7be2ba2731"
      unitRef="usd">1077000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia4d9088e966a40a68d31fc31fc7a2d2a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzItMy0xLTEtMA_3e3a63ca-137b-4903-b818-82c8198d28b5"
      unitRef="usd">1255000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i840219be56704e14b8dd4d1adb3ca119_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzItNS0xLTEtMA_d8380852-b67c-4962-9695-a84624a532d9"
      unitRef="usd">1077000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia4d9088e966a40a68d31fc31fc7a2d2a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RhYmxlOmM2YTkwZTllN2I5MjQyNzZhNzk0MTMxZGRmNGZkZmU5L3RhYmxlcmFuZ2U6YzZhOTBlOWU3YjkyNDI3NmE3OTQxMzFkZGY0ZmRmZTlfMzItNy0xLTEtMA_528fe796-9c27-4275-a480-4ff0090593fc"
      unitRef="usd">1255000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i4c8056adf6394fb8a935b96c8a1244bc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81Mi9mcmFnOjgxNjMwMDkxMjU3YjRmMDhhZDVlNzRmMDc4ODFlYTQzL3RleHRyZWdpb246ODE2MzAwOTEyNTdiNGYwOGFkNWU3NGYwNzg4MWVhNDNfNjY5_b1caf58b-5ef4-4788-ae4a-6d03db4154bb"
      unitRef="usd">11000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RleHRyZWdpb246ZjliZTY2YTIxNzkxNDhkYjkxMzUzNmQ1NGVhNzk5M2ZfNzYw_2a3d9d1c-aaec-47b9-af35-5c7946c85d13">Earnings Per Share&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share is computed using the two-class method. Stock appreciation rights and options to purchase 8 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share in each of the three and nine-month periods ended September&#160;30, 2021, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, stock appreciation rights and options to purchase 17 million and 16 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and nine months ended September&#160;30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share for the respective periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RleHRyZWdpb246ZjliZTY2YTIxNzkxNDhkYjkxMzUzNmQ1NGVhNzk5M2ZfMTM1_4f01645c-4064-4f89-a1c6-b03c597aa458"
      unitRef="shares">8000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RleHRyZWdpb246ZjliZTY2YTIxNzkxNDhkYjkxMzUzNmQ1NGVhNzk5M2ZfMTM1_65607586-288c-49c1-a1c4-21ea8cf2a3c6"
      unitRef="shares">8000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RleHRyZWdpb246ZjliZTY2YTIxNzkxNDhkYjkxMzUzNmQ1NGVhNzk5M2ZfNTAw_26fbab07-5aea-42aa-92d0-bf392b313917"
      unitRef="shares">17000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RleHRyZWdpb246ZjliZTY2YTIxNzkxNDhkYjkxMzUzNmQ1NGVhNzk5M2ZfNTA3_186ccc15-8a56-47f9-a447-9e94bc99ea40"
      unitRef="shares">16000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RleHRyZWdpb246ZjliZTY2YTIxNzkxNDhkYjkxMzUzNmQ1NGVhNzk5M2ZfNzk0_783904ed-fe66-44e0-834f-e8e984a68ed6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share for the respective periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfNi0xLTEtMS0w_8c08a933-40c1-4e1d-959d-13fe2521eb59"
      unitRef="usd">1598000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfNi0zLTEtMS0w_1ea8efb2-2d47-434d-a862-1587bd2ae860"
      unitRef="usd">1224000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfNi01LTEtMS0w_83c753c4-93e9-4074-a429-b1821518f47f"
      unitRef="usd">6604000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfNi03LTEtMS0w_6fa3200d-add9-42ef-9196-6d411c4dfa07"
      unitRef="usd">6206000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfOS0xLTEtMS0w_aa893404-d8e4-4b83-8757-4e821a499555"
      unitRef="shares">1321000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfOS0zLTEtMS0w_15139f95-6329-4a62-87a5-b42e9e1a052f"
      unitRef="shares">1310000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfOS01LTEtMS0w_8e11ae59-2908-4a6a-a91b-6aba52e86a96"
      unitRef="shares">1318000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfOS03LTEtMS0w_a431a1c5-5e1b-43b9-b42c-513fef60e9f1"
      unitRef="shares">1308000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTAtMS0xLTEtMA_d75f28b6-5933-4d96-a5ef-6cad2abeec16"
      unitRef="shares">8000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTAtMy0xLTEtMA_7a1088bc-928b-410a-9103-354093f6a1a7"
      unitRef="shares">5000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTAtNS0xLTEtMA_71f5b656-acef-4b15-a1cd-7a2fa42f65b4"
      unitRef="shares">8000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTAtNy0xLTEtMA_6e3e3a88-acfd-4cf8-b28a-465ecb50837e"
      unitRef="shares">6000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTEtMS0xLTEtMA_aeff4377-92e1-429e-bdcf-ce0edd58e4fd"
      unitRef="shares">1329000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTEtMy0xLTEtMA_3cd277e1-bdfc-46d4-9617-a90ce2c49780"
      unitRef="shares">1315000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTEtNS0xLTEtMA_c6bd3212-f780-497e-a59a-777dfa1ca689"
      unitRef="shares">1326000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTEtNy0xLTEtMA_bf1af7bc-11e0-4c7a-8f65-ea27ea06b580"
      unitRef="shares">1314000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTQtMS0xLTEtMA_4a6d78c9-98ee-41b2-ac3f-a459c24e94c8"
      unitRef="usdPerShare">1.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTQtMy0xLTEtMA_930b9546-8c9d-4875-91ac-9b959ec61ba5"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTQtNS0xLTEtMA_b13b0d80-559b-4267-9f46-5acb5ffb3457"
      unitRef="usdPerShare">5.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTQtNy0xLTEtMA_815a2300-8593-40b2-a550-371deea65147"
      unitRef="usdPerShare">4.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTUtMS0xLTEtMA_d0e836bd-44b0-40e3-bc91-ab307c39d6d7"
      unitRef="usdPerShare">1.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTUtMy0xLTEtMA_ecc0d294-6d9e-4e84-bb98-1340097c3ee2"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTUtNS0xLTEtMA_73242c83-a1ab-46ae-a7b4-c8f8b370027e"
      unitRef="usdPerShare">4.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81NS9mcmFnOmY5YmU2NmEyMTc5MTQ4ZGI5MTM1MzZkNTRlYTc5OTNmL3RhYmxlOjE5YWViNGRiOWJjYjRkOTFhMjJkYzY0MDFjODgxZTQ5L3RhYmxlcmFuZ2U6MTlhZWI0ZGI5YmNiNGQ5MWEyMmRjNjQwMWM4ODFlNDlfMTUtNy0xLTEtMA_7a610ec8-f699-4175-9c64-2c85edd578e6"
      unitRef="usdPerShare">4.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81OC9mcmFnOjY0M2Y3NDA2Njc1OTQxMTJhYTRiMThlOTU1MDVjYWYyL3RleHRyZWdpb246NjQzZjc0MDY2NzU5NDExMmFhNGIxOGU5NTUwNWNhZjJfMjgyMzY_1457f91f-e69f-43c2-9abe-d23a5149001d">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;COVID-19&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic continues to evolve. The Company believes COVID-19&#x2019;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#x2019;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company&#x2019;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#x2019;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lease Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#x2019;s Stores and Linens &#x2018;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#x2019;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#x2019;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of September&#160;30, 2021, the Company guaranteed 72 such store leases (excluding the lease guarantees related to Linens &#x2018;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2030. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#x2019;s assessments generally are based on a formula relating to the Company&#x2019;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#x201c;Penn Treaty&#x201d;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#x2019;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#x2019;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the U.S. Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;), state insurance and health and welfare departments, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the U.S. Department of Justice (the &#x201c;DOJ&#x201d;), &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;state attorneys general, the U.S. Drug Enforcement Administration (the &#x201c;DEA&#x201d;) and other governmental authorities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#x2019;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#x2019;s financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#x2019;s financial position. Substantial unanticipated verdicts, fines and rulings, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Usual and Customary Pricing Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#x2019;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;PBM Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is facing multiple lawsuits, including by a State Attorney General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#x201c;CIDs&#x201d;) and other requests for documents and information from, and is being investigated by, Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Behnke v. CVS Caremark Corporation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#x2019;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#x2019;s PBM. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Controlled Substances Litigation, Audits and Subpoenas&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information. In June 2021, prior to the start of the New York State Court bellwether trial, the Company reached a settlement with Nassau and Suffolk Counties for an immaterial amount.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations in connection with an investigation concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The Company has been providing documents and information in response to this subpoena.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Prescription Processing Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ex rel.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Bassan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; v. Omnicare, Inc. and CVS Health Corp. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#x2019;s Office for the Southern District of New York (the &#x201c;SDNY&#x201d;) filed a complaint-in-intervention in this previously sealed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#x2019;s Omnicare pharmacies&#x2019; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2016, the Company received a CID from the U.S. Attorney&#x2019;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#x2019;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Provider Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#x201c;out-of-network providers&#x201d;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#x2019;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;CMS Actions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS regularly audits the Company&#x2019;s performance to determine its compliance with CMS&#x2019;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#x2019;s and other companies&#x2019; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#x2019; medical records to determine whether those records support the related diagnosis codes that determine the members&#x2019; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#x201c;RADV&#x201d;) audits of various Medicare Advantage plans, including certain of the Company&#x2019;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#x2019;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#x201c;HHS-OIG&#x201d;) also is auditing the Company&#x2019;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately 200 members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#x2019;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#x2019;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#x2019;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#x2019;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, HHS-OIG or otherwise, including audits of the Company&#x2019;s minimum medical loss ratio (&#x201c;MLR&#x201d;) rebates, methodology and/or reports, could be material and could adversely affect the Company&#x2019;s operating results, cash flows and/or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Medicare and Medicaid CIDs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#x2019;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stockholder Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#x2019;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;City of Miami Fire Fighters&#x2019; and Police Officers&#x2019; Retirement Trust, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;et al. (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Anarkat&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;), was dismissed with prejudice in February 2021. Plaintiffs have appealed that decision to the First Circuit after their motion for reconsideration was denied. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;In re CVS Health Corp. Securities Act Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Waterford&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;In re CVS Health Corp. Securities Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;City of Warren&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Freundlich&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;) have been stayed pending the outcome of the First Circuit appeal. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August and September 2020, two ERISA class actions were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna Inc. (&#x201c;Aetna&#x201d;), and several current and former executives, directors and/or members of Aetna&#x2019;s Compensation and Talent Management Committee: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Radcliffe v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flaim v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#x2019;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#x2019;s LTC business unit. The district court consolidated the actions and the Company is defending itself against these claims. In October 2021, the consolidated case was dismissed without prejudice. Plaintiffs may seek leave to file an amended complaint. The Company also received a related document request pursuant to ERISA &#xa7; 104(b), to which the Company has responded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Legal and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#x2019;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#x2019;s operating results. The Company will continue to defend contract awards it receives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#x2019;s and the rest of the health care and related benefits industry&#x2019;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#x2019; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a leading national health care services company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#x2019;s businesses, changes to or clarifications of the Company&#x2019;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit against the Company, whether sealed or unsealed, or in any future &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <cvs:GuarantorObligationsNumberofLeases
      contextRef="i2fdf49e58ef74885bcae89152e425b39_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81OC9mcmFnOjY0M2Y3NDA2Njc1OTQxMTJhYTRiMThlOTU1MDVjYWYyL3RleHRyZWdpb246NjQzZjc0MDY2NzU5NDExMmFhNGIxOGU5NTUwNWNhZjJfMjAxNA_cfabef9b-f90e-4e1f-a803-9636c3a1721d"
      unitRef="store">72</cvs:GuarantorObligationsNumberofLeases>
    <cvs:LossContingencyAuditMethodologySampleSize
      contextRef="ida4612fe99b04ca2aa41bf1a2e73fe9a_D20120101-20121231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81OC9mcmFnOjY0M2Y3NDA2Njc1OTQxMTJhYTRiMThlOTU1MDVjYWYyL3RleHRyZWdpb246NjQzZjc0MDY2NzU5NDExMmFhNGIxOGU5NTUwNWNhZjJfMTgwNjg_a92adda0-a6a7-4776-87a4-d7d643a1afdf"
      unitRef="member">200</cvs:LossContingencyAuditMethodologySampleSize>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i384f03c6d15c44d196ee290093383364_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV81OC9mcmFnOjY0M2Y3NDA2Njc1OTQxMTJhYTRiMThlOTU1MDVjYWYyL3RleHRyZWdpb246NjQzZjc0MDY2NzU5NDExMmFhNGIxOGU5NTUwNWNhZjJfMjI0NTg_746191ee-7c4e-44aa-a969-c6908c1f96fd"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMzQzMA_e0988b15-8344-4019-be9f-70a81872e947">Segment ReportingThe Company has three operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#x2019;s segments maintain separate financial information, and the Company&#x2019;s chief operating decision maker (the &#x201c;CODM&#x201d;) evaluates the segments&#x2019; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#x2019;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#x2019;s business nor reflect the Company&#x2019;s underlying business performance. See the reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#x2019;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total revenues of the Pharmacy Services segment include approximately $2.8 billion and $2.5 billion of retail co-payments for the three months ended  September&#160;30, 2021 and 2020, respectively, and $9.0 billion and $8.5 billion of retail co-payments for the nine months ended September&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#x201c;PSS members&#x201d;) enrolled in Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; elect to pick up maintenance prescriptions at one of the Company&#x2019;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are reconciliations of consolidated operating income to adjusted operating income for the three and nine months ended September&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition purchase price adjustment outside of measurement period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on divestiture of subsidiary &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three and nine months ended September 30, 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:8.68pt"&gt;During the three and nine months ended September 30, 2021, the goodwill impairment charge relates to the LTC reporting unit within the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statement of operations for the nine months ended September&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment. &lt;/span&gt;&lt;/div&gt;(5)During the three and nine months ended September 30, 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#x2019; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations within the Health Care Benefits segment.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfNDE_8bdec9bd-d467-4952-ace1-6ed30f95e9b9"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMzQyNg_3909d17d-00e3-44e7-80ad-b35fd5771fb8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total revenues of the Pharmacy Services segment include approximately $2.8 billion and $2.5 billion of retail co-payments for the three months ended  September&#160;30, 2021 and 2020, respectively, and $9.0 billion and $8.5 billion of retail co-payments for the nine months ended September&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#x201c;PSS members&#x201d;) enrolled in Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; elect to pick up maintenance prescriptions at one of the Company&#x2019;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia630bb470ae642f8905431f2e294870b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMy0xLTEtMS0w_6e9f5b6b-f205-476b-8494-eef344ce8072"
      unitRef="usd">20311000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMy0zLTEtMS0w_96a11781-629d-4b06-89fe-573637c0e036"
      unitRef="usd">36851000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25b37ce901e241a68a26af12fa5a391b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMy01LTEtMS0w_2daf23cf-f245-45b5-aa42-5a4131b1de83"
      unitRef="usd">16347000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c910bf185e14abb8f843118e080650b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMy03LTEtMS0w_e8930c54-c93e-44af-b8d3-f7afeebd8b2a"
      unitRef="usd">39000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMy0xMS0xLTEtMA_8bb0a90a-79aa-437a-ae58-5be9a7900689"
      unitRef="usd">73548000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1c774f4ed3c4faabc1e5df119dd09f8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNC0xLTEtMS0w_35bc5233-8623-4d32-960f-4ac8402a80dc"
      unitRef="usd">21000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb5b7e4050464b31ba5e844cce234bd4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNC0zLTEtMS0w_410d89e3-b911-46b3-93da-c16d2d1c3c52"
      unitRef="usd">2195000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81f235791bca4dbc853d081abfa4d343_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNC01LTEtMS0w_fc06756a-67d3-4688-b6f2-18ee2e02ff41"
      unitRef="usd">8678000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNC05LTEtMS0w_9f514e3f-1801-4e37-b191-1ce28b128996"
      unitRef="usd">-10894000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ia630bb470ae642f8905431f2e294870b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNS0xLTEtMS0w_4a048e00-0e58-494f-a38b-3b12da4f2acb"
      unitRef="usd">147000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNS0zLTEtMS0w_6ac8a6f1-ecfa-4436-9f7e-28085f117166"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i25b37ce901e241a68a26af12fa5a391b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNS01LTEtMS0w_a3a7dff5-fadf-4c8e-b4f5-240e24da5451"
      unitRef="usd">-33000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i1c910bf185e14abb8f843118e080650b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNS03LTEtMS0w_d0212144-e256-447e-a202-64c5c0727ed6"
      unitRef="usd">132000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNS05LTEtMS0w_feeaa530-be87-40c9-ad0b-d5d4cca491ee"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNS0xMS0xLTEtMA_c09f8661-055d-4347-aece-1b7dd8aaf574"
      unitRef="usd">246000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i1620dfc000424fd3b15b25a1ac9a1791_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNi0xLTEtMS0w_0c7408fc-8845-4091-aa91-d178d5ad0e1c"
      unitRef="usd">20479000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifc97d958fa084ddc939774b0bc91d620_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNi0zLTEtMS0w_bae5b639-b37b-43bc-ac06-82e642ebae6b"
      unitRef="usd">39046000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8d900d4b1ca34915859e9703c35c8775_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNi01LTEtMS0w_95392129-c03d-4f29-8965-6a9a4ba7228d"
      unitRef="usd">24992000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1c910bf185e14abb8f843118e080650b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNi03LTEtMS0w_07ed4d20-e5fa-4a33-8593-7d47a4611a80"
      unitRef="usd">171000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNi05LTEtMS0w_af2a7715-62b3-46cf-9b3f-c5c74ad1cdd6"
      unitRef="usd">-10894000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNi0xMS0xLTEtMA_5bf2616f-77c3-4061-b2f2-58632071e446"
      unitRef="usd">73794000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia630bb470ae642f8905431f2e294870b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNy0xLTEtMS0w_07a944af-c9f6-487b-ad40-8a500b711a3a"
      unitRef="usd">1106000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNy0zLTEtMS0w_23658bea-a7d9-4d90-af44-f4545751d301"
      unitRef="usd">1773000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i25b37ce901e241a68a26af12fa5a391b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNy01LTEtMS0w_c34059bd-cc09-435f-8663-6f3bf2ae6607"
      unitRef="usd">1723000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i1c910bf185e14abb8f843118e080650b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNy03LTEtMS0w_e2ac92bd-63f8-4d19-94e3-679f077331d3"
      unitRef="usd">-343000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="id9d40a5659954943bd8d178c2899a6e3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNy05LTEtMS0w_03b3f4da-305f-493c-a061-0f398050f7b3"
      unitRef="usd">-186000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfNy0xMS0xLTEtMA_9b23f0e4-08eb-498b-a025-66672a3afc89"
      unitRef="usd">4073000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42ba3552a810439d9832cae42b188533_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTAtMS0xLTEtMA_59d1d263-d181-4ce9-8df5-d1f153cab33a"
      unitRef="usd">18557000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTAtMy0xLTEtMA_1d9809f5-e350-4b78-adce-c343a9c6f139"
      unitRef="usd">33492000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c29ab4601174287b450f53152b36d36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTAtNS0xLTEtMA_907a12d2-8d05-4724-9df7-95cd4b0e0458"
      unitRef="usd">14770000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTAtNy0xLTEtMA_2515b483-152a-45a6-8f3e-240c057edf6e"
      unitRef="usd">33000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTAtMTEtMS0xLTA_ce42a07e-d1c0-43e9-a80c-58e3f98dbaf0"
      unitRef="usd">66852000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic04e76d8cae84ec2a080a6f0fc22a523_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTEtMS0xLTEtMA_f3cb30bc-6793-48e3-af0c-5b64e5bc9934"
      unitRef="usd">20000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i307fb82e77314c8895bc793a68fe29dc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTEtMy0xLTEtMA_4e18eb03-f30e-47f3-afa5-6128d4e2a376"
      unitRef="usd">2219000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d22088cdb00442b89bdd1fe6cf8a26b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTEtNS0xLTEtMA_bc974854-426e-46c0-ad03-cd67ed91589c"
      unitRef="usd">7955000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea31066dc7804044ae36620bede68059_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTEtOS0xLTEtMA_0e3b6960-a257-40ab-b353-4c7d160a50b0"
      unitRef="usd">-10194000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i42ba3552a810439d9832cae42b188533_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTItMS0xLTEtMA_18d9f52a-ed44-4a13-aa10-a6644f296612"
      unitRef="usd">121000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTItMy0xLTEtMA_a1d122a5-6a2c-43ac-bfa5-a0b2648b80f9"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i2c29ab4601174287b450f53152b36d36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTItNS0xLTEtMA_fc4e4fea-bd85-47e6-ad5e-ecc62e571ca8"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTItNy0xLTEtMA_79c73f1a-7689-4616-8f99-fd365995a444"
      unitRef="usd">83000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iea31066dc7804044ae36620bede68059_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTItOS0xLTEtMA_706e26f0-04b6-4776-bc31-1244d544ad45"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTItMTEtMS0xLTA_cfc107c3-81f5-4a46-9950-d1c3380a91aa"
      unitRef="usd">204000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i8b7044360fae43969a13838008e79bb1_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTMtMS0xLTEtMA_acc036da-c8de-4d33-9985-aaa3993b6156"
      unitRef="usd">18698000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iacf5f0e00659493589182745e85a0e36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTMtMy0xLTEtMA_d9651373-c3c0-4e15-a28c-fe5086d6a0c5"
      unitRef="usd">35711000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iedfff3121ba6469d9e77415864b5a41a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTMtNS0xLTEtMA_4090e3a4-9ba2-468b-b7af-baf7ccf6fe05"
      unitRef="usd">22725000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTMtNy0xLTEtMA_09279d01-73a5-467c-b617-0bc8db000a88"
      unitRef="usd">116000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iea31066dc7804044ae36620bede68059_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTMtOS0xLTEtMA_6d82e080-7e4e-432f-9877-79de9ff06397"
      unitRef="usd">-10194000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTMtMTEtMS0xLTA_bad30cb8-7078-44f7-a542-568fcced4f11"
      unitRef="usd">67056000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i42ba3552a810439d9832cae42b188533_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTQtMS0xLTEtMA_2d8ce8cf-5c8d-451e-a514-11d4ef52b82a"
      unitRef="usd">1080000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTQtMy0xLTEtMA_845ab551-d738-4e35-a98f-23d422230cf9"
      unitRef="usd">1619000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i2c29ab4601174287b450f53152b36d36_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTQtNS0xLTEtMA_0364ffc3-b5c6-4d5f-8df7-31441ec4f4a3"
      unitRef="usd">1412000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i57fd13efc20e41d5b7d29a45e1db9047_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTQtNy0xLTEtMA_d05b5798-a5e0-488a-bd05-916fa97c002d"
      unitRef="usd">-303000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iea31066dc7804044ae36620bede68059_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTQtOS0xLTEtMA_8140246e-7ac0-40fd-9c99-7da417a037e5"
      unitRef="usd">-186000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTQtMTEtMS0xLTA_2dbb4eaf-2c24-4dbe-bf60-9518615360b7"
      unitRef="usd">3622000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7cc744230a544ead88ffab3c45d0c454_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTgtMS0xLTEtMA_6de5e315-ce27-4442-a515-3e63f099f9dc"
      unitRef="usd">60993000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTgtMy0xLTEtMA_2bc4615a-fe53-4371-a694-aa3bdb30b0a6"
      unitRef="usd">105909000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b445faeec3845f6b11c9569be49f9fb_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTgtNS0xLTEtMA_6155e72c-81e2-4299-a7ee-b1e41c426abf"
      unitRef="usd">47672000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTgtNy0xLTEtMA_34b31357-281b-49ae-a60b-9a29917a93da"
      unitRef="usd">101000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTgtMTEtMS0xLTA_6bf77804-a3e8-4017-aac0-923786856ce3"
      unitRef="usd">214675000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45a7d151a028477481ac7f32edde55eb_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTktMS0xLTEtMA_eb32e0dd-c16d-4feb-91b2-95b53e1f0ddb"
      unitRef="usd">62000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28069fe437ba40d9b14e06d3899dbf60_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTktMy0xLTEtMA_d0d2d5df-4787-4b02-b8b6-b027c4e99ace"
      unitRef="usd">7772000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d7f4151778947ca96d8cb506330110a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTktNS0xLTEtMA_480ebb67-ebb1-4388-926b-5ebb9540a75a"
      unitRef="usd">25309000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i472a8387964b45ec897885f8bc357e99_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMTktOS0xLTEtMA_434f887a-2832-46c6-bfdb-bfa7ac301dd2"
      unitRef="usd">-33143000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i7cc744230a544ead88ffab3c45d0c454_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjAtMS0xLTEtMA_e4936f2a-0f80-4a7c-987b-6e958ee38576"
      unitRef="usd">432000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjAtMy0xLTEtMA_e96bad39-080c-4473-84ac-e370c87d46df"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i8b445faeec3845f6b11c9569be49f9fb_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjAtNS0xLTEtMA_69269f94-0217-49cb-ac2f-5830db95f9f4"
      unitRef="usd">13000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjAtNy0xLTEtMA_57fece00-1749-4e7f-b6ec-6695bac8d1fd"
      unitRef="usd">387000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i472a8387964b45ec897885f8bc357e99_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjAtOS0xLTEtMA_02c64a20-9aa3-45df-8a82-c1759da384d4"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjAtMTEtMS0xLTA_94e03f3d-116b-4998-96d8-70305a7b8d72"
      unitRef="usd">832000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i9af0cc01cbc54c9f9e8615532da5bb0c_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjEtMS0xLTEtMA_67264a3b-368e-4132-b2f7-6874ba25ff75"
      unitRef="usd">61487000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i869431e7abf74749b23dd3a1ed93e1ef_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjEtMy0xLTEtMA_f01b6cf5-c90e-4292-ba8f-1754ea574472"
      unitRef="usd">113681000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i05a9eb3fc13543189b612e1898a32241_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjEtNS0xLTEtMA_70af9416-8d16-4db0-be76-33c9580b0680"
      unitRef="usd">72994000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjEtNy0xLTEtMA_2f91f078-a19f-4ccc-b739-a889cc5b667d"
      unitRef="usd">488000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i472a8387964b45ec897885f8bc357e99_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjEtOS0xLTEtMA_c80ece34-5d00-41c2-83ac-cfb0a4f36e81"
      unitRef="usd">-33143000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjEtMTEtMS0xLTA_ceeabcdf-126e-4e8d-b33e-a512dd691116"
      unitRef="usd">215507000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i7cc744230a544ead88ffab3c45d0c454_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjItMS0xLTEtMA_82d6306f-ed3e-438f-ba00-61aa03d1264d"
      unitRef="usd">4502000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjItMy0xLTEtMA_8c930c16-84b3-454d-b37f-210a762a1f04"
      unitRef="usd">5035000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i8b445faeec3845f6b11c9569be49f9fb_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjItNS0xLTEtMA_50c5087b-2bbb-4122-a96b-28e71218571e"
      unitRef="usd">5166000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic23bb8e83bc240c59e3d1ad0d2fd59b3_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjItNy0xLTEtMA_9701e8bb-0e5e-4f0d-b22b-4a0c69592bb6"
      unitRef="usd">-1015000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i472a8387964b45ec897885f8bc357e99_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjItOS0xLTEtMA_4977f141-000d-4ae5-a1f6-efef4a3c253a"
      unitRef="usd">-523000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjItMTEtMS0xLTA_1924aa10-3a74-4e92-8861-1dae4218bde9"
      unitRef="usd">13165000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a95101c0a2547d68267b540d8eb8935_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjUtMS0xLTEtMA_a774a704-a443-44bf-9447-eabeb798e8d5"
      unitRef="usd">55972000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjUtMy0xLTEtMA_da149e04-09c6-4eaa-b0d8-154df9b62b39"
      unitRef="usd">98233000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0610bf8e796340e4b079b333dbc7453b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjUtNS0xLTEtMA_50b95ed4-43d9-4600-94a7-e951afd13722"
      unitRef="usd">44314000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjUtNy0xLTEtMA_e5c93692-55cf-4790-9b0d-b5675ca26d0c"
      unitRef="usd">83000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjUtMTEtMS0xLTA_67c7e61a-1a3e-445a-b90d-a210fef395a5"
      unitRef="usd">198602000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8246339cd89c42688813a929c411f371_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjYtMS0xLTEtMA_6f9fda40-45c1-41eb-8a7a-974aebf04259"
      unitRef="usd">51000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i020d373f0ad2415aa7656c159c909537_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjYtMy0xLTEtMA_90b04d5d-8846-44d4-ab39-281d42424f20"
      unitRef="usd">7350000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ac023dc2cf14e8aa8be582c9ee42c76_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjYtNS0xLTEtMA_b2ee14c7-f59e-4365-95f5-d663d819aea4"
      unitRef="usd">22822000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjYtOS0xLTEtMA_2ce09ea4-3555-42f0-a6a6-4bff41b50fd5"
      unitRef="usd">-30223000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i6a95101c0a2547d68267b540d8eb8935_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjctMS0xLTEtMA_80f85948-933c-4a46-ae64-1455f26d5550"
      unitRef="usd">341000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjctMy0xLTEtMA_df7383ab-adae-429f-ad35-4733468e8420"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i0610bf8e796340e4b079b333dbc7453b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjctNS0xLTEtMA_13a67722-daea-4366-842c-ff3e0de788c7"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjctNy0xLTEtMA_af78f06b-57f9-481f-89cd-60627632dc7c"
      unitRef="usd">209000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjctOS0xLTEtMA_5a63839a-6205-40eb-a301-af1bf03b4e78"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjctMTEtMS0xLTA_11f7d075-55fe-4e7a-aa45-9978baaeb64f"
      unitRef="usd">550000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="id3ecfefee0e642c0a78fc0131c0449c3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjgtMS0xLTEtMA_d95553ad-6d83-422c-9845-105d8492f291"
      unitRef="usd">56364000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6a39cfe4d74743ff8499e3d09c93e0c5_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjgtMy0xLTEtMA_1c308964-49a9-4ad5-bbfa-dc01fd106a7f"
      unitRef="usd">105583000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i104116dd6efe40a7bb00f658c0ab14e3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjgtNS0xLTEtMA_269d8fbf-0125-4e78-b759-0c97a89f4490"
      unitRef="usd">67136000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjgtNy0xLTEtMA_674fea92-6a37-4a6a-b72a-415fde8a14c3"
      unitRef="usd">292000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjgtOS0xLTEtMA_51c53097-e6b7-4a94-9911-9a2cf1e3f4d5"
      unitRef="usd">-30223000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjgtMTEtMS0xLTA_d9690697-70c4-451b-9785-acb09136366c"
      unitRef="usd">199152000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i6a95101c0a2547d68267b540d8eb8935_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjktMS0xLTEtMA_5aae679b-f215-4f02-ba60-52622f1c98e8"
      unitRef="usd">6035000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjktMy0xLTEtMA_b998bcff-7b5a-4e64-ae6d-91402c9a9899"
      unitRef="usd">4127000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i0610bf8e796340e4b079b333dbc7453b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjktNS0xLTEtMA_43a12775-a7f9-4b7d-89bf-2eec9e18196e"
      unitRef="usd">4371000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ie70680faaa2f4a2c974efeca0ef112a0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjktNy0xLTEtMA_7da122b9-8c7f-4b44-ac22-1d6b057cfcf9"
      unitRef="usd">-931000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i3e64f2f48e3b4e25ae7610d25ad7bfd2_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjktOS0xLTEtMA_0a52d716-9cff-4ad5-98a9-94f3d9d6e593"
      unitRef="usd">-539000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjhiYmQ3OGIwMGU5NTRjZjFhNzExMWYwMmU1YWFlMmY0L3RhYmxlcmFuZ2U6OGJiZDc4YjAwZTk1NGNmMWE3MTExZjAyZTVhYWUyZjRfMjktMTEtMS0xLTA_b4d33d5b-3afc-4a73-a50c-78e1492d7f9f"
      unitRef="usd">13063000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="iacbda50f486e4f3dbd7bb393b8f18ea0_D20210701-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMTczOQ_0eb0d5a2-09e8-440c-a646-2eadaeaf1a53"
      unitRef="usd">2800000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i9e4cd869c087429386704db934a61115_D20200701-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMTc0Ng_b61f7c6d-a1af-42ed-82eb-ad0970513f53"
      unitRef="usd">2500000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i72246c7d83514be490bbc2e567422bb8_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMTgyOA_68ed2989-19ae-4f6d-b8db-5e7b581faa66"
      unitRef="usd">9000000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i1a019fded32d496a8ccec04117f6e40d_D20200101-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMTgzNQ_cb3c8039-3781-48d6-9e8a-7c9bf3b10776"
      unitRef="usd">8500000000</cvs:NetRevenuesRetailCoPayments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMzQyMg_e503137d-b6e5-43c2-b63d-e6d40d30064d">&lt;div style="margin-bottom:0.3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are reconciliations of consolidated operating income to adjusted operating income for the three and nine months ended September&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition purchase price adjustment outside of measurement period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on divestiture of subsidiary &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three and nine months ended September 30, 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:8.68pt"&gt;During the three and nine months ended September 30, 2021, the goodwill impairment charge relates to the LTC reporting unit within the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statement of operations for the nine months ended September&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment. &lt;/span&gt;&lt;/div&gt;(5)During the three and nine months ended September 30, 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#x2019; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations within the Health Care Benefits segment.</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMi0xLTEtMS0w_fb515f1e-cbdf-4efe-9e74-f76f969ab6b4"
      unitRef="usd">3061000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMi0zLTEtMS0w_258fc45e-d586-4789-b0c9-fd2806bd003f"
      unitRef="usd">3249000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMi01LTEtMS0w_6e0a3ef2-0648-4854-a19b-cef4fc287b68"
      unitRef="usd">10964000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMi03LTEtMS0w_cd62e712-ec73-4ceb-917c-bc57a0a1a9f8"
      unitRef="usd">11387000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMy0xLTEtMS0w_920a91e5-5811-4d73-8722-7dc51087af51"
      unitRef="usd">561000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMy0zLTEtMS0w_28a9be3b-48fc-4788-aa6d-1d7555fa2981"
      unitRef="usd">587000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMy01LTEtMS0w_a46c5586-8bec-410c-abe0-5c0f417f79ea"
      unitRef="usd">1730000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfMy03LTEtMS0w_c287d3e4-8386-4132-bddf-6e44f52f9918"
      unitRef="usd">1751000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNC0xLTEtMS0w_20b2d44f-b126-46b0-a5f1-03d3e1436267"
      unitRef="usd">20000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNC0zLTEtMS0w_54f22c88-10ba-4b77-a010-dab447e48c08"
      unitRef="usd">57000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNC01LTEtMS0w_afbc6a7a-a1f0-4ce4-b8de-9a76e54abdf5"
      unitRef="usd">101000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNC03LTEtMS0w_13b22aa5-63d5-4b37-adb1-beac1daa8ed2"
      unitRef="usd">196000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS0xLTEtMS03NjY3_3d00fe2a-0c74-4bcd-89ef-e03684a8084d"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS0zLTEtMS03Njgx_666f3b01-8f39-4046-8cc8-6a51fbff8d16"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS01LTEtMS03Njk1_8590df23-4f0f-483e-a4e9-01b4d73bb326"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS03LTEtMS03NzE1_23831557-3ecb-454a-8704-b9d629044461"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS0xLTEtMS00MDgx_16106766-036a-4d3f-b78b-8d3d6512a096"
      unitRef="usd">0</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS01LTEtMS00MTI4_f878ac64-a134-4d80-bfe8-7fc3f818f7cd"
      unitRef="usd">61000000</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS0zLTEtMS0w_11cfbb6b-1668-4c96-924f-970bee6e8e8a"
      unitRef="usd">271000000</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNS03LTEtMS0w_3e797961-d989-4b3e-bbdd-8bef4e0455a2"
      unitRef="usd">271000000</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i234d631c1cd74b0aac095889f4187793_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNy0xLTEtMS0w_9b23f0e4-08eb-498b-a025-66672a3afc89"
      unitRef="usd">4073000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i6f4bfd825f554697a8ed63658be8f81a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNy0zLTEtMS0w_2dbb4eaf-2c24-4dbe-bf60-9518615360b7"
      unitRef="usd">3622000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic05cb4705856461a984cc82a102d1b81_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNy01LTEtMS0w_1924aa10-3a74-4e92-8861-1dae4218bde9"
      unitRef="usd">13165000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i54db0af044a5418995f25a45c0b53ec0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RhYmxlOjMzMjZlN2NhZDNkZjQ4ZmRiMTM4NGVjZTMyYzFjNjY1L3RhYmxlcmFuZ2U6MzMyNmU3Y2FkM2RmNDhmZGIxMzg0ZWNlMzJjMWM2NjVfNy03LTEtMS0w_b4d33d5b-3afc-4a73-a50c-78e1492d7f9f"
      unitRef="usd">13063000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i0311b59b583f418eaccfec74aac1d61f_D20210601-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMTA5OTUxMTYzMzE1Mw_c51b5cb8-1448-4dc6-8f37-32a66733708d"
      unitRef="usd">61000000</cvs:ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i0975e9ea8e5e480faf0a315905252457_D20200731-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV82MS9mcmFnOmEwNWIwMzc1YzNmNjRkYTJhMzFhNDBjNDRkYWIyMWUwL3RleHRyZWdpb246YTA1YjAzNzVjM2Y2NGRhMmEzMWE0MGM0NGRhYjIxZTBfMzI5ODUzNDg4OTQ5Nw_58528beb-1b74-4650-9258-246cef5daedc"
      unitRef="usd">850000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNC0xLTEtMA_d0c66a66-bc83-4916-a3ae-75e089f30f71"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNC0xLTEtMA_d0c66a66-bc83-4916-a3ae-75e089f30f71"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS00LTEtMS0w_9fa121f2-d8c4-46e4-b66f-177184da942d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS00LTEtMS0w_9fa121f2-d8c4-46e4-b66f-177184da942d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNC0xLTEtMA_8ff228aa-4d86-461e-9162-15397fc95b7b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNC0xLTEtMA_8ff228aa-4d86-461e-9162-15397fc95b7b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTUtNC0xLTEtMA_b48973fa-5b00-4cff-af94-b934b37c3d66"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTUtNC0xLTEtMA_b48973fa-5b00-4cff-af94-b934b37c3d66"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjItNC0xLTEtMA_05331b88-e255-4dbf-8123-62f8f9e7a21b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjItNC0xLTEtMA_05331b88-e255-4dbf-8123-62f8f9e7a21b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNC0xLTEtMA_5ea3be2e-d67b-46af-b75e-45b93159eb93"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNC0xLTEtMA_5ea3be2e-d67b-46af-b75e-45b93159eb93"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOC00LTEtMS0w_ba871677-b90d-479d-9db2-be26b7fb580f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOC00LTEtMS0w_ba871677-b90d-479d-9db2-be26b7fb580f"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1Nw_b247c82e-4cdd-438b-8461-629d8e081d94" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1Nw_b247c82e-4cdd-438b-8461-629d8e081d94" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common stock and capital surplus includes the par value of common stock of $17 million as of September&#160;30, 2021, June&#160;30, 2021, March&#160;31, 2021 and December&#160;31, 2020.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNC0xLTEtMA_d0c66a66-bc83-4916-a3ae-75e089f30f71"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1Nw_b247c82e-4cdd-438b-8461-629d8e081d94"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS00LTEtMS0w_9fa121f2-d8c4-46e4-b66f-177184da942d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1Nw_b247c82e-4cdd-438b-8461-629d8e081d94"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNC0xLTEtMA_8ff228aa-4d86-461e-9162-15397fc95b7b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1Nw_b247c82e-4cdd-438b-8461-629d8e081d94"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTUtNC0xLTEtMA_b48973fa-5b00-4cff-af94-b934b37c3d66"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1Nw_b247c82e-4cdd-438b-8461-629d8e081d94"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjItNC0xLTEtMA_05331b88-e255-4dbf-8123-62f8f9e7a21b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1Nw_b247c82e-4cdd-438b-8461-629d8e081d94"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNC0xLTEtMA_5ea3be2e-d67b-46af-b75e-45b93159eb93"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1Nw_b247c82e-4cdd-438b-8461-629d8e081d94"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOC00LTEtMS0w_ba871677-b90d-479d-9db2-be26b7fb580f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1Nw_b247c82e-4cdd-438b-8461-629d8e081d94"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNC0xLTEtMA_628ff552-edb2-42b5-977f-39188ec396c1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNC0xLTEtMA_628ff552-edb2-42b5-977f-39188ec396c1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTYtNC0xLTEtMA_47663ff0-bb33-42e2-8fda-5a986f4f2203"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTYtNC0xLTEtMA_47663ff0-bb33-42e2-8fda-5a986f4f2203"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjMtNC0xLTEtMA_36dd9700-2ab6-4371-9922-e173326f8a6f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjMtNC0xLTEtMA_36dd9700-2ab6-4371-9922-e173326f8a6f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNC0xLTEtMA_5e486fe4-2705-4eb0-9011-2efff2473d31"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNC0xLTEtMA_5e486fe4-2705-4eb0-9011-2efff2473d31"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS00LTEtMS0w_bcf6bb97-2a1f-4b9e-957f-9bdd06a9f486"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS00LTEtMS0w_bcf6bb97-2a1f-4b9e-957f-9bdd06a9f486"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOS00LTEtMS0w_eff6e367-ca00-44e0-a822-573f8448fcb4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOS00LTEtMS0w_eff6e367-ca00-44e0-a822-573f8448fcb4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNC0xLTEtMA_bcaaf698-4b3f-4af4-9fcd-bf465e2d066f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNC0xLTEtMA_bcaaf698-4b3f-4af4-9fcd-bf465e2d066f"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OQ_7436366d-7ad1-482d-9dca-49b1e4c4ff23" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OQ_7436366d-7ad1-482d-9dca-49b1e4c4ff23" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common stock and capital surplus includes the par value of common stock of $17 million as of  September 30, 2020, June 30, 2020, March 31, 2020 and December 31, 2019.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNC0xLTEtMA_628ff552-edb2-42b5-977f-39188ec396c1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OQ_7436366d-7ad1-482d-9dca-49b1e4c4ff23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTYtNC0xLTEtMA_47663ff0-bb33-42e2-8fda-5a986f4f2203"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OQ_7436366d-7ad1-482d-9dca-49b1e4c4ff23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjMtNC0xLTEtMA_36dd9700-2ab6-4371-9922-e173326f8a6f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OQ_7436366d-7ad1-482d-9dca-49b1e4c4ff23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNC0xLTEtMA_5e486fe4-2705-4eb0-9011-2efff2473d31"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OQ_7436366d-7ad1-482d-9dca-49b1e4c4ff23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS00LTEtMS0w_bcf6bb97-2a1f-4b9e-957f-9bdd06a9f486"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OQ_7436366d-7ad1-482d-9dca-49b1e4c4ff23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfOS00LTEtMS0w_eff6e367-ca00-44e0-a822-573f8448fcb4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OQ_7436366d-7ad1-482d-9dca-49b1e4c4ff23"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNC0xLTEtMA_bcaaf698-4b3f-4af4-9fcd-bf465e2d066f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OQ_7436366d-7ad1-482d-9dca-49b1e4c4ff23"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS0yLTEtMS0w_d174f413-fa0e-4e11-ab68-94ea32f3f8b9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS0yLTEtMS0w_d174f413-fa0e-4e11-ab68-94ea32f3f8b9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItMi0xLTEtMA_d79af9bc-7b58-45a9-83e2-d1c57a6838eb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItMi0xLTEtMA_d79af9bc-7b58-45a9-83e2-d1c57a6838eb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS0yLTEtMS0w_a3d36f42-c1ec-4ae6-bca4-0cb4bf194dfd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS0yLTEtMS0w_a3d36f42-c1ec-4ae6-bca4-0cb4bf194dfd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktMi0xLTEtMA_5a4b074b-11ab-42ef-b0cf-f71cf7ac3621"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktMi0xLTEtMA_5a4b074b-11ab-42ef-b0cf-f71cf7ac3621"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNS0xLTEtMA_a5e3687d-cd13-4018-8344-29d72d6f0b22"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNS0xLTEtMA_a5e3687d-cd13-4018-8344-29d72d6f0b22"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtMi0xLTEtMA_706373f9-0140-4065-9f3d-5ee06f70df06"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtMi0xLTEtMA_706373f9-0140-4065-9f3d-5ee06f70df06"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS01LTEtMS0w_95207aad-d4e2-4fbb-8d72-bca35abada02"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS01LTEtMS0w_95207aad-d4e2-4fbb-8d72-bca35abada02"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNS0xLTEtMA_e93ad5c1-0d07-4d6a-8e38-4a12cc3d1d1a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNS0xLTEtMA_e93ad5c1-0d07-4d6a-8e38-4a12cc3d1d1a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtMi0xLTEtMA_30ea49d0-0c4c-4253-8deb-c6b8ee4d1ff3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtMi0xLTEtMA_30ea49d0-0c4c-4253-8deb-c6b8ee4d1ff3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtNS0xLTEtMA_2567cfd5-7634-4093-8d82-13ba8964cc47"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtNS0xLTEtMA_2567cfd5-7634-4093-8d82-13ba8964cc47"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtNS0xLTEtMA_7a819f02-085e-4718-abf2-7b94f5c7e3e1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtNS0xLTEtMA_7a819f02-085e-4718-abf2-7b94f5c7e3e1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS01LTEtMS0w_3e47f73e-e459-43ba-8f5d-51743f0781f9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS01LTEtMS0w_3e47f73e-e459-43ba-8f5d-51743f0781f9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNS0xLTEtMA_a2ccaa98-c808-436e-bc23-a18e347c6aef"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNS0xLTEtMA_a2ccaa98-c808-436e-bc23-a18e347c6aef"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtMi0xLTEtMA_bae16aa4-1ebf-46cd-a62c-af75a994bea5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtMi0xLTEtMA_bae16aa4-1ebf-46cd-a62c-af75a994bea5"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of September&#160;30, 2021, June&#160;30, 2021, March&#160;31, 2021 and December&#160;31, 2020. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS0yLTEtMS0w_d174f413-fa0e-4e11-ab68-94ea32f3f8b9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItMi0xLTEtMA_d79af9bc-7b58-45a9-83e2-d1c57a6838eb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS0yLTEtMS0w_a3d36f42-c1ec-4ae6-bca4-0cb4bf194dfd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktMi0xLTEtMA_5a4b074b-11ab-42ef-b0cf-f71cf7ac3621"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTktNS0xLTEtMA_a5e3687d-cd13-4018-8344-29d72d6f0b22"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtMi0xLTEtMA_706373f9-0140-4065-9f3d-5ee06f70df06"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfNS01LTEtMS0w_95207aad-d4e2-4fbb-8d72-bca35abada02"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtNS0xLTEtMA_e93ad5c1-0d07-4d6a-8e38-4a12cc3d1d1a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjYtMi0xLTEtMA_30ea49d0-0c4c-4253-8deb-c6b8ee4d1ff3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtNS0xLTEtMA_2567cfd5-7634-4093-8d82-13ba8964cc47"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTYtNS0xLTEtMA_7a819f02-085e-4718-abf2-7b94f5c7e3e1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfOS01LTEtMS0w_3e47f73e-e459-43ba-8f5d-51743f0781f9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMTItNS0xLTEtMA_a2ccaa98-c808-436e-bc23-a18e347c6aef"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOjhjNTA4NzgxZGM1YjQ4ZTY5NTliNDU2YjA3YmI2NGFlL3RhYmxlcmFuZ2U6OGM1MDg3ODFkYzViNDhlNjk1OWI0NTZiMDdiYjY0YWVfMjMtMi0xLTEtMA_bae16aa4-1ebf-46cd-a62c-af75a994bea5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA0OQ_96d41939-2304-4c31-a144-20bbd77304a1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtMi0xLTEtMA_5a7a6f94-71f1-49af-9f5a-c5337e491d60"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtMi0xLTEtMA_5a7a6f94-71f1-49af-9f5a-c5337e491d60"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctNS0xLTEtMA_9af71cce-2a15-49e5-b13c-b7c0458c9e0a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctNS0xLTEtMA_9af71cce-2a15-49e5-b13c-b7c0458c9e0a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtNS0xLTEtMA_3b76e1bd-f0c1-4144-80fd-b209578840b3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtNS0xLTEtMA_3b76e1bd-f0c1-4144-80fd-b209578840b3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtMi0xLTEtMA_d2f3618f-ccb2-47ee-8a92-3983dd19fe58"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtMi0xLTEtMA_d2f3618f-ccb2-47ee-8a92-3983dd19fe58"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctMi0xLTEtMA_0bb5398b-a386-4c1b-aa40-b5891a25a52d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctMi0xLTEtMA_0bb5398b-a386-4c1b-aa40-b5891a25a52d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNS0xLTEtMA_b90fd349-d8e5-43ed-881b-24b77604464e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNS0xLTEtMA_b90fd349-d8e5-43ed-881b-24b77604464e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctMi0xLTEtMA_b0287672-564a-41d3-bd32-0089b65be989"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctMi0xLTEtMA_b0287672-564a-41d3-bd32-0089b65be989"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtMi0xLTEtMA_360f5eeb-beba-40ed-8cca-0a920d5a120c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtMi0xLTEtMA_360f5eeb-beba-40ed-8cca-0a920d5a120c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNS0xLTEtMA_1b5f60bb-10d7-4399-bfbb-a23d0366a7f2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNS0xLTEtMA_1b5f60bb-10d7-4399-bfbb-a23d0366a7f2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtNS0xLTEtMA_2f70f4b2-1c71-4266-869e-ce63c3a83d4c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtNS0xLTEtMA_2f70f4b2-1c71-4266-869e-ce63c3a83d4c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS01LTEtMS0w_0e722941-474c-452e-907a-9b9dfdc759d0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS01LTEtMS0w_0e722941-474c-452e-907a-9b9dfdc759d0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNS0xLTEtMA_903d301d-a3f1-4b21-a771-9aec8812fe7e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNS0xLTEtMA_903d301d-a3f1-4b21-a771-9aec8812fe7e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtMi0xLTEtMA_bdbd385d-1f8d-4b53-9278-ecdb4f1ca047"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtMi0xLTEtMA_bdbd385d-1f8d-4b53-9278-ecdb4f1ca047"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS0yLTEtMS0w_3c449d66-8194-4b73-b723-40167f9bc6ac"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS0yLTEtMS0w_3c449d66-8194-4b73-b723-40167f9bc6ac"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of September 30, 2020, June 30, 2020, March 31, 2020 and December 31, 2019. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtMi0xLTEtMA_5a7a6f94-71f1-49af-9f5a-c5337e491d60"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctNS0xLTEtMA_9af71cce-2a15-49e5-b13c-b7c0458c9e0a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtNS0xLTEtMA_3b76e1bd-f0c1-4144-80fd-b209578840b3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtMi0xLTEtMA_d2f3618f-ccb2-47ee-8a92-3983dd19fe58"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTctMi0xLTEtMA_0bb5398b-a386-4c1b-aa40-b5891a25a52d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTMtNS0xLTEtMA_b90fd349-d8e5-43ed-881b-24b77604464e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctMi0xLTEtMA_b0287672-564a-41d3-bd32-0089b65be989"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjQtMi0xLTEtMA_360f5eeb-beba-40ed-8cca-0a920d5a120c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjctNS0xLTEtMA_1b5f60bb-10d7-4399-bfbb-a23d0366a7f2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMTAtNS0xLTEtMA_2f70f4b2-1c71-4266-869e-ce63c3a83d4c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS01LTEtMS0w_0e722941-474c-452e-907a-9b9dfdc759d0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtNS0xLTEtMA_903d301d-a3f1-4b21-a771-9aec8812fe7e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfMjAtMi0xLTEtMA_bdbd385d-1f8d-4b53-9278-ecdb4f1ca047"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNS0yLTEtMS0w_3c449d66-8194-4b73-b723-40167f9bc6ac"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA1OA_5cd3b027-afaa-4df0-abc2-9f066fbaa03b"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi04LTEtMS0w_024f2e1f-846c-4ae2-8f94-42293da62071"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi04LTEtMS0w_024f2e1f-846c-4ae2-8f94-42293da62071"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi02LTEtMS0w_6b55e493-0bf6-491f-b808-0bf50bf578a7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi02LTEtMS0w_6b55e493-0bf6-491f-b808-0bf50bf578a7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi0xMC0xLTEtMA_bebec290-7fb8-47ed-ad52-695b1989a76b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi0xMC0xLTEtMA_bebec290-7fb8-47ed-ad52-695b1989a76b"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA2MA_c3424baa-b3bf-46e8-ba70-dcb721cc4745" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA2MA_c3424baa-b3bf-46e8-ba70-dcb721cc4745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-13, </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 326), which resulted in a decrease to retained earnings of $3&#160;million during the three months ended March 31, 2020.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi04LTEtMS0w_024f2e1f-846c-4ae2-8f94-42293da62071"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA2MA_c3424baa-b3bf-46e8-ba70-dcb721cc4745"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi02LTEtMS0w_6b55e493-0bf6-491f-b808-0bf50bf578a7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA2MA_c3424baa-b3bf-46e8-ba70-dcb721cc4745"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RhYmxlOmUxYTBmNjBhOTIwNjRlM2Y5NjcwZDg4NTEyZWQyMTViL3RhYmxlcmFuZ2U6ZTFhMGY2MGE5MjA2NGUzZjk2NzBkODg1MTJlZDIxNWJfNi0xMC0xLTEtMA_bebec290-7fb8-47ed-ad52-695b1989a76b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjQyYTJlZDRmNGU0ODRjZGNiNzk3NDdhMWVlY2EwYzU1L3NlYzo0MmEyZWQ0ZjRlNDg0Y2RjYjc5NzQ3YTFlZWNhMGM1NV8zMS9mcmFnOmIwMjBmMjYxYmNmODQzYTA5N2I3MWViMTExMWMxMjg1L3RleHRyZWdpb246YjAyMGYyNjFiY2Y4NDNhMDk3YjcxZWIxMTExYzEyODVfMTA2MA_c3424baa-b3bf-46e8-ba70-dcb721cc4745"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834078310712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 27, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,320,058,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834075468376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 18,984<span></span>
</td>
<td class="nump">$ 17,182<span></span>
</td>
<td class="nump">$ 56,927<span></span>
</td>
<td class="nump">$ 51,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="nump">832<span></span>
</td>
<td class="nump">550<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">73,794<span></span>
</td>
<td class="nump">67,056<span></span>
</td>
<td class="nump">215,507<span></span>
</td>
<td class="nump">199,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">$ 45,011<span></span>
</td>
<td class="nump">$ 40,940<span></span>
</td>
<td class="nump">$ 129,425<span></span>
</td>
<td class="nump">$ 121,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Cost, Product and Service [Extensible List]</a></td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="nump">$ 16,081<span></span>
</td>
<td class="nump">$ 14,396<span></span>
</td>
<td class="nump">$ 47,686<span></span>
</td>
<td class="nump">$ 40,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">431<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">431<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OperatingExpensesExcludingGoodwillImpairments', window );">Operating expenses</a></td>
<td class="nump">9,210<span></span>
</td>
<td class="nump">8,471<span></span>
</td>
<td class="nump">27,001<span></span>
</td>
<td class="nump">25,702<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">70,733<span></span>
</td>
<td class="nump">63,807<span></span>
</td>
<td class="nump">204,543<span></span>
</td>
<td class="nump">187,765<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">3,061<span></span>
</td>
<td class="nump">3,249<span></span>
</td>
<td class="nump">10,964<span></span>
</td>
<td class="nump">11,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">602<span></span>
</td>
<td class="nump">731<span></span>
</td>
<td class="nump">1,895<span></span>
</td>
<td class="nump">2,229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">363<span></span>
</td>
<td class="nump">766<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="nump">766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="num">(49)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="num">(144)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax provision</a></td>
<td class="nump">2,145<span></span>
</td>
<td class="nump">1,806<span></span>
</td>
<td class="nump">8,850<span></span>
</td>
<td class="nump">8,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">558<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="nump">2,248<span></span>
</td>
<td class="nump">2,328<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,587<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
<td class="nump">6,602<span></span>
</td>
<td class="nump">6,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 1,598<span></span>
</td>
<td class="nump">$ 1,224<span></span>
</td>
<td class="nump">$ 6,604<span></span>
</td>
<td class="nump">$ 6,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share attributable to CVS Health:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share attributable to CVS Health, basic (in dollars per share)</a></td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 5.01<span></span>
</td>
<td class="nump">$ 4.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share attributable to CVS Health, diluted (in dollars per share)</a></td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 4.98<span></span>
</td>
<td class="nump">$ 4.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average basic shares outstanding (in shares)</a></td>
<td class="nump">1,321<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">1,318<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted shares outstanding (in shares)</a></td>
<td class="nump">1,329<span></span>
</td>
<td class="nump">1,315<span></span>
</td>
<td class="nump">1,326<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 51,853<span></span>
</td>
<td class="nump">$ 47,738<span></span>
</td>
<td class="nump">$ 149,765<span></span>
</td>
<td class="nump">$ 141,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 2,711<span></span>
</td>
<td class="nump">$ 1,932<span></span>
</td>
<td class="nump">$ 7,983<span></span>
</td>
<td class="nump">$ 5,757<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingExpensesExcludingGoodwillImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses, Excluding Goodwill Impairments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingExpensesExcludingGoodwillImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BenefitsLossesAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BenefitsLossesAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123410239&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834172906808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,587<span></span>
</td>
<td class="nump">$ 1,219<span></span>
</td>
<td class="nump">$ 6,602<span></span>
</td>
<td class="nump">$ 6,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized investment gains (losses)</a></td>
<td class="num">(73)<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="num">(310)<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net cash flow hedges</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and other postretirement benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(93)<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="num">(337)<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">1,494<span></span>
</td>
<td class="nump">1,261<span></span>
</td>
<td class="nump">6,265<span></span>
</td>
<td class="nump">6,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Comprehensive (income) loss attributable to noncontrolling interests</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to CVS Health</a></td>
<td class="nump">$ 1,505<span></span>
</td>
<td class="nump">$ 1,266<span></span>
</td>
<td class="nump">$ 6,267<span></span>
</td>
<td class="nump">$ 6,442<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834076632920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 9,826<span></span>
</td>
<td class="nump">$ 7,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">3,015<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">25,283<span></span>
</td>
<td class="nump">21,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">17,399<span></span>
</td>
<td class="nump">18,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,319<span></span>
</td>
<td class="nump">5,277<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">60,842<span></span>
</td>
<td class="nump">56,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">22,370<span></span>
</td>
<td class="nump">20,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,771<span></span>
</td>
<td class="nump">12,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">20,462<span></span>
</td>
<td class="nump">20,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">79,121<span></span>
</td>
<td class="nump">79,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">29,545<span></span>
</td>
<td class="nump">31,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">5,086<span></span>
</td>
<td class="nump">4,881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">4,694<span></span>
</td>
<td class="nump">4,624<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">234,891<span></span>
</td>
<td class="nump">230,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">12,696<span></span>
</td>
<td class="nump">11,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PharmacyClaimsandDiscountsPayableCurrent', window );">Pharmacy claims and discounts payable</a></td>
<td class="nump">17,895<span></span>
</td>
<td class="nump">15,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable</a></td>
<td class="nump">8,877<span></span>
</td>
<td class="nump">7,936<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPolicyholderFunds', window );">Policyholders&#8217; funds</a></td>
<td class="nump">4,444<span></span>
</td>
<td class="nump">4,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">16,140<span></span>
</td>
<td class="nump">14,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="nump">1,287<span></span>
</td>
<td class="nump">1,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,809<span></span>
</td>
<td class="nump">1,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1,561<span></span>
</td>
<td class="nump">5,440<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">64,709<span></span>
</td>
<td class="nump">62,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">18,456<span></span>
</td>
<td class="nump">18,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">56,832<span></span>
</td>
<td class="nump">59,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">6,329<span></span>
</td>
<td class="nump">6,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="nump">5,086<span></span>
</td>
<td class="nump">4,881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="nump">6,551<span></span>
</td>
<td class="nump">7,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">2,310<span></span>
</td>
<td class="nump">2,351<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">160,273<span></span>
</td>
<td class="nump">161,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital', window );">Common stock, par value $0.01: 3,200 shares authorized; 1,743 shares issued and 1,321 shares outstanding at September&#160;30, 2021 and 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and capital surplus</a></td>
<td class="nump">47,133<span></span>
</td>
<td class="nump">46,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost: 422 shares at September&#160;30, 2021 and 423 shares at December&#160;31,&#160;2020</a></td>
<td class="num">(28,166)<span></span>
</td>
<td class="num">(28,178)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">54,264<span></span>
</td>
<td class="nump">49,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="nump">74,308<span></span>
</td>
<td class="nump">69,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">74,618<span></span>
</td>
<td class="nump">69,701<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 234,891<span></span>
</td>
<td class="nump">$ 230,715<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PharmacyClaimsandDiscountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Claims and Discounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PharmacyClaimsandDiscountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of par value plus amounts in excess of par value or issuance value for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStocksIncludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPolicyholderFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPolicyholderFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834080213256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">3,200,000,000<span></span>
</td>
<td class="nump">3,200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">1,743,000,000<span></span>
</td>
<td class="nump">1,733,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">1,321,000,000<span></span>
</td>
<td class="nump">1,310,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">422,000,000<span></span>
</td>
<td class="nump">423,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834076917992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCustomers', window );">Cash receipts from customers</a></td>
<td class="nump">$ 209,104<span></span>
</td>
<td class="nump">$ 195,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies', window );">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</a></td>
<td class="num">(122,129)<span></span>
</td>
<td class="num">(116,590)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsforInsuranceBenefits', window );">Insurance benefits paid</a></td>
<td class="num">(46,965)<span></span>
</td>
<td class="num">(40,221)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToSuppliersAndEmployees', window );">Cash paid to other suppliers and employees</a></td>
<td class="num">(21,840)<span></span>
</td>
<td class="num">(22,185)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromInterestAndDividendsReceived', window );">Interest and investment income received</a></td>
<td class="nump">582<span></span>
</td>
<td class="nump">622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="num">(2,095)<span></span>
</td>
<td class="num">(2,517)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="num">(2,397)<span></span>
</td>
<td class="num">(2,365)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">14,260<span></span>
</td>
<td class="nump">12,298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales and maturities of investments</a></td>
<td class="nump">5,559<span></span>
</td>
<td class="nump">3,790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(7,417)<span></span>
</td>
<td class="num">(6,377)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(1,923)<span></span>
</td>
<td class="num">(1,724)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions (net of cash acquired)</a></td>
<td class="num">(135)<span></span>
</td>
<td class="num">(828)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(3,821)<span></span>
</td>
<td class="num">(4,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">987<span></span>
</td>
<td class="nump">7,919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(7,823)<span></span>
</td>
<td class="num">(10,493)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities', window );">Derivative settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(1,965)<span></span>
</td>
<td class="num">(1,980)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">440<span></span>
</td>
<td class="nump">249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes related to net share settlement of equity awards</a></td>
<td class="num">(161)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(8,525)<span></span>
</td>
<td class="num">(4,420)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">1,914<span></span>
</td>
<td class="nump">3,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">8,130<span></span>
</td>
<td class="nump">5,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">10,044<span></span>
</td>
<td class="nump">9,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Reconciliation of net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">6,602<span></span>
</td>
<td class="nump">6,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract', window );"><strong>Adjustments required to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,397<span></span>
</td>
<td class="nump">3,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">431<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">346<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of subsidiary</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(271)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">363<span></span>
</td>
<td class="nump">766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_Deferredincometaxesandothernoncashitems', window );">Deferred income taxes and other noncash items</a></td>
<td class="num">(645)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(3,504)<span></span>
</td>
<td class="num">(3,564)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">1,097<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(211)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable and pharmacy claims and discounts payable</a></td>
<td class="nump">3,973<span></span>
</td>
<td class="nump">3,495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="nump">348<span></span>
</td>
<td class="num">(474)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">1,884<span></span>
</td>
<td class="nump">2,730<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">$ 14,260<span></span>
</td>
<td class="nump">$ 12,298<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_Deferredincometaxesandothernoncashitems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_Deferredincometaxesandothernoncashitems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsforInsuranceBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Insurance Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsforInsuranceBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToSuppliersAndEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to suppliers for goods and services provided and to employees for services provided.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToSuppliersAndEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash receipts from customers during the current period which are usually for sales of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInterestAndDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for dividends and interest on the entity's equity and debt investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3337-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInterestAndDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834083892744">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Total CVS Health Shareholders&#8217; Equity</div></th>
<th class="th">
<div>Total CVS Health Shareholders&#8217; Equity </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Common Stock</div></th>
<th class="th" colspan="2"><div>Treasury Stock</div></th>
<th class="th" colspan="2"><div>Common Stock Including Capital Surplus</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,727<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 64,170<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="nump">$ 63,864<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 45,972<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 45,108<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="nump">$ 1,019<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,012<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2,007<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,007<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(332)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(332)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">208<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">208<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">53<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(657)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(657)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(657)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Mar. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,729<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">65,474<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">65,140<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,182)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,180<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">46,455<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,727<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">64,170<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="nump">63,864<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">45,972<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">45,108<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,217<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">236<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,732<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,112<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">68,807<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,164)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,388<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">49,328<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,255<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Mar. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,729<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Mar. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">65,474<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">65,140<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,182)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,180<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">46,455<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,986<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2,975<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,975<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">526<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">96<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">96<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchases of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(53)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(662)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(662)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(662)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,732<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">68,355<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">68,022<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,276<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">48,768<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,219<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,224<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,224<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">112<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">112<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(664)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(664)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(664)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(23)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,732<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,112<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">68,807<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,164)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,388<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">49,328<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,255<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,733<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,701<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">69,389<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,178)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">49,640<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,224<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,223<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(392)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(392)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(392)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">214<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">76<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(660)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(660)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(660)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,735<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71,164<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">70,850<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,102)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,727<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">51,203<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,733<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,701<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">69,389<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,178)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">49,640<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,602<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(337)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Sep. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,743<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Sep. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">74,618<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">74,308<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,166)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">47,133<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">54,264<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,735<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71,164<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">70,850<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,102)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,727<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">51,203<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,791<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2,783<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,783<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">148<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">268<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchases of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(150)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(655)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(655)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(655)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,742<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">73,565<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">73,244<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,252)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,995<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">53,331<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,587<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,598<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,598<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(93)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">138<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">138<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">86<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(665)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(665)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(665)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Sep. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,743<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Sep. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 74,618<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,308<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,166)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 47,133<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 54,264<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,077<span></span>
</td>
<td class="nump">$ 310<span></span>
</td>
</tr>
<tr><td colspan="17"></td></tr>
<tr><td colspan="17"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of September 30, 2020, June 30, 2020, March 31, 2020 and December 31, 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 326), which resulted in a decrease to retained earnings of $3&#160;million during the three months ended March 31, 2020.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Common stock and capital surplus includes the par value of common stock of $17 million as of  September 30, 2020, June 30, 2020, March 31, 2020 and December 31, 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of September&#160;30, 2021, June&#160;30, 2021, March&#160;31, 2021 and December&#160;31, 2020.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Common stock and capital surplus includes the par value of common stock of $17 million as of September&#160;30, 2021, June&#160;30, 2021, March&#160;31, 2021 and December&#160;31, 2020.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling interest, Other Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834083867016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity (Parentheticals) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">Accounting Standards Update 2016-13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesHeldinTrust', window );">Treasury shares held in trust (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueSharesHeldInTrust', window );">Treasury share held in trust</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Decrease in retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (54,264)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (49,640)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">Accounting Standards Update 2016-13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Decrease in retained earnings</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesHeldinTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Held in Trust</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesHeldinTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueSharesHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Shares Held In Trust</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueSharesHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834069528104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (&#8220;CVS Health&#8221;), together with its subsidiaries (collectively, the &#8220;Company&#8221;), has more than 9,900 retail locations, nearly 1,200 walk-in medical clinics, a leading pharmacy benefits manager with approximately 110 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) continues to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, the Company has submitted regulatory filings for a January 2022 entrance into the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Pharmacy Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of September&#160;30, 2021, the Retail/LTC segment operated more than 9,900 retail locations, nearly 1,200 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the &#8220;2020 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net is composed of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,742&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $364 million and $358 million as of September&#160;30, 2021 and December&#160;31,<br/>2020, respectively. When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue by major source in each segment for the three and nine months ended September 30, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,479&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,992&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,894)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,794&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,051)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,681&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,143)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,681&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020   </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,032)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021 and 2020, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Insurer Fee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Since January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) has imposed an annual premium-based health insurer fee (the &#8220;HIF&#8221;). The HIF, which is payable each September, is not deductible for federal income tax purposes. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was no expense related to the HIF in the three and nine months ended September&#160;30, 2021. In the three and nine months ended September&#160;30, 2020, operating expenses included $255&#160;million and $774 million, respectively, related to the Company&#8217;s estimated share of the 2020 HIF. The Company paid approximately $1.0&#160;billion, representing the Company&#8217;s portion of the non tax-deductible HIF in 2020.</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $16 million and $5 million in the three months ended September&#160;30, 2021 and 2020, respectively, and expensed fees for the use of this network of approximately $35 million and $28 million in the nine months ended September&#160;30, 2021 and 2020, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $20 million and $15 million for pharmaceutical inventory purchases during the three months ended September&#160;30, 2021 and 2020, respectively, and $57 million and $58 million for pharmaceutical inventory purchases during the nine months ended September&#160;30, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other </span></div>comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the existing guidance.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834070856728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at September&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.106%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,385&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at September&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">There was no allowance for expected credit losses recorded on available-for-sale debt securities at September&#160;30, 2021 or December&#160;31, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At September&#160;30, 2021, debt securities with a fair value of $882 million, gross unrealized capital gains of $101 million and gross unrealized capital losses of $1 million and at December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at September&#160;30, 2021 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,574&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at September&#160;30, 2021 and December&#160;31, 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at September&#160;30, 2021 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of September&#160;30, 2021, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at September&#160;30, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,330&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,390&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the three and nine months ended September&#160;30, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at September&#160;30, 2021 and December&#160;31, 2020, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three and nine months ended September&#160;30, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital losses include yield-related impairment losses on debt securities of $3 million in the three months ended September&#160;30, 2021. Net realized capital gains are net of yield-related impairment losses on debt securities of $35 million in the nine months ended September&#160;30, 2021. There were no credit-related losses on debt securities in the three and nine months ended September&#160;30, 2021. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $1 million and $2 million, respectively, in the three months ended September&#160;30, 2020. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $4 million and $44 million, respectively, in the nine months ended September&#160;30, 2020. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net investment income includes $9 million and $28 million for the three and nine months ended September&#160;30, 2021, respectively, and $10 million and $31 million for the three and nine months ended September&#160;30, 2020, respectively, related to investments supporting experience-rated products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and nine months ended September&#160;30, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834069657656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#8217;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#8220;Fair Value&#8221; in the 2020 Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no financial liabilities measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2021 or December&#160;31, 2020. Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,240&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,574&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,549&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,372&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,633&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2021 and 2020, there were no transfers into or out of Level 3.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at September&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.284%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Separate Accounts financial assets as of September&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.243%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,095&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $9 million of other payables at September&#160;30, 2021 and $29 million of other receivables at December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834069596344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is not amortized, but is subject to annual impairment reviews, or more frequent reviews if events or circumstances indicate there may be impairment. Goodwill is evaluated for possible impairment by comparing the fair value of a reporting unit to its carrying value, including the goodwill assigned to that reporting unit.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated an impairment of the goodwill associated with the LTC reporting unit, as the reporting unit&#8217;s carrying value exceeded its fair value as of the testing date. The results of the impairment tests of the remaining reporting units indicated that there was no impairment of goodwill as of the testing date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2021, the LTC reporting unit has continued to face challenges that have impacted the Company&#8217;s ability to grow the LTC reporting unit&#8217;s business at the rate estimated when its 2020 goodwill impairment test was performed. These challenges include lower net facility admissions, net long-term care facility customer losses and the prolonged adverse impact of the COVID-19 pandemic and the emerging new variants, which resulted in more significant declines in occupancy rates experienced by the Company&#8217;s long-term care facility customers than previously anticipated. During the third quarter of 2021, LTC management updated their 2021 annual forecast and submitted their long-term plan which showed deterioration in the financial results for the remainder of 2021 and beyond. The Company utilized these updated projections in performing its annual impairment test, which indicated that the fair value of the LTC reporting unit was lower than its carrying value, resulting in a $431&#160;million goodwill impairment charge in the third quarter of 2021. The fair value of the LTC reporting unit was determined using a combination of a discounted cash flow method and a market multiple method. As of September&#160;30, 2021, there was no remaining goodwill balance in the LTC reporting unit. The Company also performed an impairment test of the intangible assets of the LTC reporting unit and concluded these assets were not impaired as of September 30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative goodwill impairments were $6.6&#160;billion and $6.1&#160;billion at September&#160;30, 2021 and December 31, 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Below is a summary of the changes in the carrying value of goodwill by segment for the nine months ended September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834069605848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract', window );"><strong>Health Care and Other Insurance Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock', window );">Health Care Costs Payable</a></td>
<td class="text">Health Care Costs Payable<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the nine months ended September&#160;30, 2021 and 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(771)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,472&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,329&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,526&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,063&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,873&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,585&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,877&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,593&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the nine months ended September&#160;30, 2021 and 2020 in the table above exclude (i) $1 million and $1 million, respectively, for a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $45 million and $31 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets and (iii) $168 million and $173 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $771 million and $448 million, respectively, in the nine months ended September&#160;30, 2021 and 2020, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, the Company&#8217;s liabilities for the ultimate cost of (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#8220;IBNR&#8221;) plus expected development on reported claims totaled approximately $6.8 billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at September&#160;30, 2021 related to the current year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Care and Other Insurance Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareandOtherInsuranceLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI http://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834070838904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings</a></td>
<td class="text">Borrowings<div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings at September&#160;30, 2021 and December&#160;31, 2020: </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.35% senior notes due March 2021</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Floating rate notes due March 2021 (0.950% at December 31, 2020)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.125% senior notes due May 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5.45% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.5% senior notes due July 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.75% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.7% senior notes due March 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">7,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1.875% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.125% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">58,987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">65,318&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(818)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">58,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(1,561)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(5,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">56,832&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">59,207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 18, 2021, the Company issued $1.0&#160;billion aggregate principal amount of 2.125% unsecured senior notes due September 15, 2031 for total proceeds of $987&#160;million, net of discounts, underwriting fees and offering expenses. The net proceeds of this offering were used for the purchase of senior notes in connection with the Company&#8217;s cash tender offer in August 2021 as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company purchased approximately $2.0&#160;billion of its outstanding 4.3% senior notes due 2028 through a cash tender offer. In connection with the purchase of such senior notes, the Company paid a premium of $332&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $26&#160;million of unamortized deferred financing costs and incurred $5&#160;million in fees, for a total loss on early extinguishment of debt of $363&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834069378296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2016, CVS Health&#8217;s Board of Directors (the &#8220;Board&#8221;) authorized the 2016 share repurchase program (&#8220;2016 Repurchase Program&#8221;) for up to&#160;$15.0 billion of the Company&#8217;s common shares. The 2016 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2016 Repurchase Program can be modified or terminated by the Board at any time.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021 and 2020, the Company did not repurchase any shares of its common stock. At September&#160;30, 2021, the Company had remaining authorization to repurchase an aggregate of up to approximately $13.9 billion of its common shares under the 2016 Repurchase Program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div>The quarterly cash dividend declared by the Board was $0.50 per share in each of the three-month periods ended September&#160;30, 2021 and 2020. Cash dividends declared by the Board were $1.50 per share in each of the nine-month periods ended September&#160;30, 2021 and 2020. CVS Health has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834193747544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive Income</a></td>
<td class="text">Other Comprehensive Income<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income for the three and nine months ended September&#160;30, 2021 and 2020:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$(73), $83, $(346), $278 pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(297)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(14), $(10), $(15), $47 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $0, $0, $(7) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(20), $(4), $(29), $(14) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $0, $0, and $(8) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $0, $1 and $7 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive income </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div>(3)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834071552728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the two-class method. Stock appreciation rights and options to purchase 8 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share in each of the three and nine-month periods ended September&#160;30, 2021, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, stock appreciation rights and options to purchase 17 million and 16 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and nine months ended September&#160;30, 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834070829576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. The Company believes COVID-19&#8217;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company&#8217;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#8217;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of September&#160;30, 2021, the Company guaranteed 72 such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2030. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), state insurance and health and welfare departments, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the U.S. Department of Justice (the &#8220;DOJ&#8221;), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">state attorneys general, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including by a State Attorney General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;) and other requests for documents and information from, and is being investigated by, Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information. In June 2021, prior to the start of the New York State Court bellwether trial, the Company reached a settlement with Nassau and Suffolk Counties for an immaterial amount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations in connection with an investigation concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The Company has been providing documents and information in response to this subpoena.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed a complaint-in-intervention in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#8217;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#8220;HHS-OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately 200 members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, HHS-OIG or otherwise, including audits of the Company&#8217;s minimum medical loss ratio (&#8220;MLR&#8221;) rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">), was dismissed with prejudice in February 2021. Plaintiffs have appealed that decision to the First Circuit after their motion for reconsideration was denied. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Waterford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In re CVS Health Corp. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">City of Warren</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Freundlich</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) have been stayed pending the outcome of the First Circuit appeal. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, two ERISA class actions were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna Inc. (&#8220;Aetna&#8221;), and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The district court consolidated the actions and the Company is defending itself against these claims. In October 2021, the consolidated case was dismissed without prejudice. Plaintiffs may seek leave to file an amended complaint. The Company also received a related document request pursuant to ERISA &#167; 104(b), to which the Company has responded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health care services company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834069292072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment ReportingThe Company has three operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,479&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,992&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,894)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,794&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,487&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,143)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,152&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(539)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $2.8 billion and $2.5 billion of retail co-payments for the three months ended  September&#160;30, 2021 and 2020, respectively, and $9.0 billion and $8.5 billion of retail co-payments for the nine months ended September&#160;30, 2021 and 2020, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three and nine months ended September&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,073&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,165&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,063&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September 30, 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:8.68pt">During the three and nine months ended September 30, 2021, the goodwill impairment charge relates to the LTC reporting unit within the Retail/LTC segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statement of operations for the nine months ended September&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment. </span></div>(5)During the three and nine months ended September 30, 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations within the Health Care Benefits segment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834076722792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, the Company has submitted regulatory filings for a January 2022 entrance into the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Pharmacy Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of September&#160;30, 2021, the Retail/LTC segment operated more than 9,900 retail locations, nearly 1,200 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the &#8220;2020 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text">Restricted CashRestricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable, Allowance for Credit Losses</a></td>
<td class="text">When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Contract Balances</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock', window );">Health Insurer Fee</a></td>
<td class="text">Health Insurer FeeSince January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) has imposed an annual premium-based health insurer fee (the &#8220;HIF&#8221;). The HIF, which is payable each September, is not deductible for federal income tax purposes.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Related Party Transactions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $16 million and $5 million in the three months ended September&#160;30, 2021 and 2020, respectively, and expensed fees for the use of this network of approximately $35 million and $28 million in the nine months ended September&#160;30, 2021 and 2020, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $20 million and $15 million for pharmaceutical inventory purchases during the three months ended September&#160;30, 2021 and 2020, respectively, and $57 million and $58 million for pharmaceutical inventory purchases during the nine months ended September&#160;30, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements Recently Adopted and Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other </span></div>comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the existing guidance.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for all health care policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareEntitiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834065886840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Reconciliation of cash and cash equivalents</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of accounts receivable, net</a></td>
<td class="text">Accounts receivable, net is composed of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,742&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue by major source in each segment for the three and nine months ended September 30, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,479&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,992&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,894)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,794&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,051)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,681&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,143)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,681&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020   </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,032)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of receivables and contract liabilities from contracts with customers</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021 and 2020, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834167117592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsTableTextBlock', window );">Schedule of Total Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at September&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.106%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,385&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Debt Securities Available For Sale</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at September&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">There was no allowance for expected credit losses recorded on available-for-sale debt securities at September&#160;30, 2021 or December&#160;31, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At September&#160;30, 2021, debt securities with a fair value of $882 million, gross unrealized capital gains of $101 million and gross unrealized capital losses of $1 million and at December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Amortized Cost and Fair Value of Debt Securities by Contractual Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at September&#160;30, 2021 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,574&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock', window );">Schedule of Debt Securities In An Unrealized Capital Loss Position</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at September&#160;30, 2021 and December&#160;31, 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at September&#160;30, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,330&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,390&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock', window );">Schedule of Activity in Mortgage Loan Portfolio</a></td>
<td class="text">During the three and nine months ended September&#160;30, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock', window );">Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at September&#160;30, 2021 and December&#160;31, 2020, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeTextBlock', window );">Schedule of Net Investment Income</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three and nine months ended September&#160;30, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital losses include yield-related impairment losses on debt securities of $3 million in the three months ended September&#160;30, 2021. Net realized capital gains are net of yield-related impairment losses on debt securities of $35 million in the nine months ended September&#160;30, 2021. There were no credit-related losses on debt securities in the three and nine months ended September&#160;30, 2021. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $1 million and $2 million, respectively, in the three months ended September&#160;30, 2020. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $4 million and $44 million, respectively, in the nine months ended September&#160;30, 2020. </span></div>(2)Net investment income includes $9 million and $28 million for the three and nine months ended September&#160;30, 2021, respectively, and $10 million and $31 million for the three and nine months ended September&#160;30, 2020, respectively, related to investments supporting experience-rated products.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock', window );">Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and nine months ended September&#160;30, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Table representing activities in mortgage loan portfolio during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ActivityInMortgageLoanPortfolioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item includes total investments, both current and long-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834067821352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text">Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2021 and December&#160;31, 2020 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,240&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,574&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,549&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,372&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,633&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair Value, by Balance Sheet Grouping</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at September&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.284%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div>(1)It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock', window );">Schedule of Fair Value of Separate Accounts by Major Category of Investment</a></td>
<td class="text">Separate Accounts financial assets as of September&#160;30, 2021 and December&#160;31, 2020 were as follows:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.243%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,095&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $9 million of other payables at September&#160;30, 2021 and $29 million of other receivables at December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of asset supporting separate account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124504833&amp;loc=d3e7104-158389<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834070879736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Change in goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Below is a summary of the changes in the carrying value of goodwill by segment for the nine months ended September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834071633960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract', window );"><strong>Health Care and Other Insurance Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the nine months ended September&#160;30, 2021 and 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(771)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,472&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,329&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,526&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,063&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,873&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,585&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,877&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,593&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the nine months ended September&#160;30, 2021 and 2020 in the table above exclude (i) $1 million and $1 million, respectively, for a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $45 million and $31 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets and (iii) $168 million and $173 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Care and Other Insurance Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareandOtherInsuranceLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834071172568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Summary of Company's Borrowings</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings at September&#160;30, 2021 and December&#160;31, 2020: </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.35% senior notes due March 2021</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Floating rate notes due March 2021 (0.950% at December 31, 2020)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.125% senior notes due May 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5.45% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.5% senior notes due July 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.75% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.7% senior notes due March 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">7,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1.875% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.125% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">58,987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">65,318&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(818)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7.75pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">58,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(1,561)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(5,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">56,832&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">59,207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834069315656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income for the three and nine months ended September&#160;30, 2021 and 2020:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$(73), $83, $(346), $278 pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(297)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(14), $(10), $(15), $47 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $0, $0, $(7) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(20), $(4), $(29), $(14) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $0, $0, and $(8) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $0, $1 and $7 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive income </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div>(3)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834071179592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834069637144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summarized Financial Information Of Segments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,479&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,992&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,894)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,794&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,487&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,143)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,152&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(539)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $2.8 billion and $2.5 billion of retail co-payments for the three months ended  September&#160;30, 2021 and 2020, respectively, and $9.0 billion and $8.5 billion of retail co-payments for the nine months ended September&#160;30, 2021 and 2020, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Earnings to Net Income</a></td>
<td class="text"><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three and nine months ended September&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,073&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,165&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,063&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September 30, 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:8.68pt">During the three and nine months ended September 30, 2021, the goodwill impairment charge relates to the LTC reporting unit within the Retail/LTC segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statement of operations for the nine months ended September&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment. </span></div>(5)During the three and nine months ended September 30, 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations within the Health Care Benefits segment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834077943384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br> people in Millions, patient in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>patient </div>
<div>clinic </div>
<div>people </div>
<div>location </div>
<div>state</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>Segment </div>
<div>patient </div>
<div>clinic </div>
<div>people </div>
<div>state </div>
<div>location</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofPharmacyPlanMembers', window );">Number of pharmacy plan members | people</a></td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofPatientsServedperYear', window );">Number of patients served per year | patient</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthInsurerFee', window );">Health insurer fee</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 255,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 774,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsToHealthInsurerFee', window );">Payments to HIF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party transaction, expenses from transactions with related party</a></td>
<td class="nump">16,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="nump">28,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty', window );">Related party transaction, other revenues from transactions with related party</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="nump">$ 57,000,000<span></span>
</td>
<td class="nump">$ 58,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember', window );">Heartland Healthcare Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which entity operates | state</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of stores | location</a></td>
<td class="nump">9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofWalkInMedicalClinics', window );">Number of walk in medical clinics | clinic</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfPeopleServed', window );">Number of people served | people</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates', window );">Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthInsurerFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthInsurerFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfPeopleServed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of People Served</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfPeopleServed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofPatientsServedperYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Patients Served per Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofPatientsServedperYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofPharmacyPlanMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Pharmacy Plan Members</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofPharmacyPlanMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofWalkInMedicalClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Walk In Medical Clinics</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofWalkInMedicalClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsToHealthInsurerFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Health Insurer Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsToHealthInsurerFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834082401384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 9,826<span></span>
</td>
<td class="nump">$ 7,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash (included in other assets)</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash in the statements of cash flows</a></td>
<td class="nump">$ 10,044<span></span>
</td>
<td class="nump">$ 8,130<span></span>
</td>
<td class="nump">$ 9,532<span></span>
</td>
<td class="nump">$ 5,954<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834069298312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 8,398<span></span>
</td>
<td class="nump">$ 7,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_VendorandManufacturerReceivables', window );">Vendor and manufacturer receivables</a></td>
<td class="nump">11,727<span></span>
</td>
<td class="nump">9,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAtCarryingValue', window );">Premium receivables</a></td>
<td class="nump">2,391<span></span>
</td>
<td class="nump">2,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">2,767<span></span>
</td>
<td class="nump">2,198<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total accounts receivable, net</a></td>
<td class="nump">25,283<span></span>
</td>
<td class="nump">21,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="nump">$ 364<span></span>
</td>
<td class="nump">$ 358<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VendorandManufacturerReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vendor and Manufacturer Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VendorandManufacturerReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834075202840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 73,548<span></span>
</td>
<td class="nump">$ 66,852<span></span>
</td>
<td class="nump">$ 214,675<span></span>
</td>
<td class="nump">$ 198,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="nump">832<span></span>
</td>
<td class="nump">550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">73,794<span></span>
</td>
<td class="nump">67,056<span></span>
</td>
<td class="nump">215,507<span></span>
</td>
<td class="nump">199,152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember', window );">Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">47,033<span></span>
</td>
<td class="nump">43,062<span></span>
</td>
<td class="nump">135,917<span></span>
</td>
<td class="nump">126,725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember', window );">Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">5,359<span></span>
</td>
<td class="nump">4,740<span></span>
</td>
<td class="nump">15,255<span></span>
</td>
<td class="nump">14,601<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PremiumsMember', window );">Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">18,984<span></span>
</td>
<td class="nump">17,182<span></span>
</td>
<td class="nump">56,927<span></span>
</td>
<td class="nump">51,749<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,172<span></span>
</td>
<td class="nump">1,868<span></span>
</td>
<td class="nump">6,576<span></span>
</td>
<td class="nump">5,527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">20,479<span></span>
</td>
<td class="nump">18,698<span></span>
</td>
<td class="nump">61,487<span></span>
</td>
<td class="nump">56,364<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember', window );">Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">39,046<span></span>
</td>
<td class="nump">35,711<span></span>
</td>
<td class="nump">113,681<span></span>
</td>
<td class="nump">105,583<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">24,992<span></span>
</td>
<td class="nump">22,725<span></span>
</td>
<td class="nump">72,994<span></span>
</td>
<td class="nump">67,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">20,311<span></span>
</td>
<td class="nump">18,557<span></span>
</td>
<td class="nump">60,993<span></span>
</td>
<td class="nump">55,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">432<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">20,479<span></span>
</td>
<td class="nump">18,698<span></span>
</td>
<td class="nump">61,487<span></span>
</td>
<td class="nump">56,364<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">18,959<span></span>
</td>
<td class="nump">17,165<span></span>
</td>
<td class="nump">56,869<span></span>
</td>
<td class="nump">51,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">1,373<span></span>
</td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">4,186<span></span>
</td>
<td class="nump">4,324<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">36,851<span></span>
</td>
<td class="nump">33,492<span></span>
</td>
<td class="nump">105,909<span></span>
</td>
<td class="nump">98,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">39,046<span></span>
</td>
<td class="nump">35,711<span></span>
</td>
<td class="nump">113,681<span></span>
</td>
<td class="nump">105,583<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Pharmacy network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">23,665<span></span>
</td>
<td class="nump">21,473<span></span>
</td>
<td class="nump">68,476<span></span>
</td>
<td class="nump">63,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Mail choice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">15,202<span></span>
</td>
<td class="nump">14,032<span></span>
</td>
<td class="nump">44,685<span></span>
</td>
<td class="nump">41,815<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="nump">659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">38,867<span></span>
</td>
<td class="nump">35,505<span></span>
</td>
<td class="nump">113,161<span></span>
</td>
<td class="nump">104,924<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="nump">659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">16,347<span></span>
</td>
<td class="nump">14,770<span></span>
</td>
<td class="nump">47,672<span></span>
</td>
<td class="nump">44,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="num">(33)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">24,992<span></span>
</td>
<td class="nump">22,725<span></span>
</td>
<td class="nump">72,994<span></span>
</td>
<td class="nump">67,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">19,023<span></span>
</td>
<td class="nump">17,608<span></span>
</td>
<td class="nump">55,781<span></span>
</td>
<td class="nump">51,833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">5,359<span></span>
</td>
<td class="nump">4,740<span></span>
</td>
<td class="nump">15,255<span></span>
</td>
<td class="nump">14,601<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">643<span></span>
</td>
<td class="nump">377<span></span>
</td>
<td class="nump">1,945<span></span>
</td>
<td class="nump">702<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(10,894)<span></span>
</td>
<td class="num">(10,194)<span></span>
</td>
<td class="num">(33,143)<span></span>
</td>
<td class="num">(30,223)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(10,857)<span></span>
</td>
<td class="num">(10,051)<span></span>
</td>
<td class="num">(33,025)<span></span>
</td>
<td class="num">(30,032)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">$ (37)<span></span>
</td>
<td class="num">$ (143)<span></span>
</td>
<td class="num">$ (118)<span></span>
</td>
<td class="num">$ (191)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PremiumsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PremiumsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834081247832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Receivables and Contracted Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables (included in accounts receivable, net)</a></td>
<td class="nump">$ 8,398<span></span>
</td>
<td class="nump">$ 7,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities (included in accrued expenses)</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834069578568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Contract Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangeinContractwithCustomerLiabilityRollForward', window );"><strong>Change in Contract with Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, beginning of the period</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance', window );">Rewards earnings and gift card issuances</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractwithCustomerLiabilityRedemptionandBreakage', window );">Redemption and breakage</a></td>
<td class="num">(279)<span></span>
</td>
<td class="num">(264)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, end of the period</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangeinContractwithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Contract with Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangeinContractwithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractwithCustomerLiabilityRedemptionandBreakage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer Liability Redemption and Breakage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractwithCustomerLiabilityRedemptionandBreakage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834077422280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Total Investment Schedule (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">$ 3,015<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">22,370<span></span>
</td>
<td class="nump">20,812<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">25,385<span></span>
</td>
<td class="nump">23,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember', window );">Debt securities available for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">2,859<span></span>
</td>
<td class="nump">2,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">19,715<span></span>
</td>
<td class="nump">18,414<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">22,574<span></span>
</td>
<td class="nump">21,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">824<span></span>
</td>
<td class="nump">821<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">934<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">1,831<span></span>
</td>
<td class="nump">1,577<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">$ 1,877<span></span>
</td>
<td class="nump">$ 1,577<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834078236664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">$ 21,317<span></span>
</td>
<td class="nump">$ 19,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1,312<span></span>
</td>
<td class="nump">1,803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">22,574<span></span>
</td>
<td class="nump">21,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for credit losses recorded</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">882<span></span>
</td>
<td class="nump">919<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,260<span></span>
</td>
<td class="nump">2,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,340<span></span>
</td>
<td class="nump">2,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,939<span></span>
</td>
<td class="nump">2,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">3,085<span></span>
</td>
<td class="nump">2,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">8,898<span></span>
</td>
<td class="nump">7,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">757<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">9,633<span></span>
</td>
<td class="nump">8,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,736<span></span>
</td>
<td class="nump">2,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,945<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">849<span></span>
</td>
<td class="nump">673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">863<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="nump">962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,209<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,447<span></span>
</td>
<td class="nump">2,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,468<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834077564648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities by Maturity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet', window );">Less than one year</a></td>
<td class="nump">$ 1,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet', window );">One year through five years</a></td>
<td class="nump">7,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet', window );">After five years through ten years</a></td>
<td class="nump">4,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet', window );">Greater than ten years</a></td>
<td class="nump">4,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">21,317<span></span>
</td>
<td class="nump">$ 19,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than one year</a></td>
<td class="nump">1,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">One year through five years</a></td>
<td class="nump">7,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">After five years through ten years</a></td>
<td class="nump">4,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than ten years</a></td>
<td class="nump">4,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">22,574<span></span>
</td>
<td class="nump">21,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">849<span></span>
</td>
<td class="nump">673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">863<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="nump">962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">1,209<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,447<span></span>
</td>
<td class="nump">2,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 2,468<span></span>
</td>
<td class="nump">$ 2,403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834077286040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>security</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">2,243<span></span>
</td>
<td class="nump">468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">2,343<span></span>
</td>
<td class="nump">527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 4,239<span></span>
</td>
<td class="nump">$ 869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">4,390<span></span>
</td>
<td class="nump">915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 204<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 464<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">468<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">1,081<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">1,124<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 1,528<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">1,579<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">320<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">332<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 568<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">589<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 476<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">486<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 342<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">389<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">312<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">330<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 652<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">669<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834080135960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">1,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">4,390<span></span>
</td>
<td class="nump">$ 915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">486<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">389<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">669<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">1,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">4,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834173330728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Mortgage Loans (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans', window );">New mortgage loans</a></td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid', window );">Mortgage loans fully repaid</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateForeclosures', window );">Mortgage loans foreclosed</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pertains to amount of mortgage loans fully repaid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateLoansFullyRepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateForeclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateForeclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateNewMortgageLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834077600920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Mortgage Loans Credit Ratings Indicator (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 934<span></span>
</td>
<td class="nump">$ 1,047<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">870<span></span>
</td>
<td class="nump">952<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2017 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2017 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2017 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2017 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">478<span></span>
</td>
<td class="nump">661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">443<span></span>
</td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Column G))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category2To4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category2To4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Categories5and6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Categories5and6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834080005560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Net Investment Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 279<span></span>
</td>
<td class="nump">$ 203<span></span>
</td>
<td class="nump">$ 822<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInvestmentExpense', window );">Investment expenses</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentIncomeExcludingCapitalGainsorLosses', window );">Net investment income (excluding net realized capital gains or losses)</a></td>
<td class="nump">268<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="nump">794<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized capital gains (losses)</a></td>
<td class="num">(22)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="nump">832<span></span>
</td>
<td class="nump">550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Yield-related impairment loss</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Credit-related impairment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="nump">441<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 109<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentIncomeExcludingCapitalGainsorLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Income, Excluding Capital Gains or Losses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentIncomeExcludingCapitalGainsorLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInvestmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to the generation of investment income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInvestmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834069445384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Realized Gains (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales</a></td>
<td class="nump">$ 668<span></span>
</td>
<td class="nump">$ 905<span></span>
</td>
<td class="nump">$ 2,935<span></span>
</td>
<td class="nump">$ 2,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Gross realized capital gains</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Gross realized capital losses</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834079358872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Measurement on a Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 22,574<span></span>
</td>
<td class="nump">$ 21,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,340<span></span>
</td>
<td class="nump">2,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">3,085<span></span>
</td>
<td class="nump">2,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,633<span></span>
</td>
<td class="nump">8,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,945<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">863<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,209<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,468<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">9,826<span></span>
</td>
<td class="nump">7,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">22,574<span></span>
</td>
<td class="nump">21,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">32,549<span></span>
</td>
<td class="nump">29,089<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">4,953<span></span>
</td>
<td class="nump">3,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,295<span></span>
</td>
<td class="nump">2,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">7,355<span></span>
</td>
<td class="nump">6,372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">4,873<span></span>
</td>
<td class="nump">3,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">20,240<span></span>
</td>
<td class="nump">18,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">25,113<span></span>
</td>
<td class="nump">22,633<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,340<span></span>
</td>
<td class="nump">2,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,295<span></span>
</td>
<td class="nump">2,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">3,085<span></span>
</td>
<td class="nump">2,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">3,085<span></span>
</td>
<td class="nump">2,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,633<span></span>
</td>
<td class="nump">8,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,594<span></span>
</td>
<td class="nump">8,842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,945<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,945<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">863<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">863<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,209<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,209<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,468<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,468<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834076723576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Carrying Value and Fair Value Classified by Level (Details) - Nonrecurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">$ 934<span></span>
</td>
<td class="nump">$ 1,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">58,393<span></span>
</td>
<td class="nump">64,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 1 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">66,960<span></span>
</td>
<td class="nump">75,940<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 2 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 3 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">945<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">378<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Total | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">945<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">378<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">$ 66,960<span></span>
</td>
<td class="nump">$ 75,940<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts With Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of mortgage loans held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgagesHeldForSaleFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834078753704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Separate Accounts Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 5,086<span></span>
</td>
<td class="nump">$ 4,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">5,095<span></span>
</td>
<td class="nump">4,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other Payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4,297<span></span>
</td>
<td class="nump">4,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,217<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,214<span></span>
</td>
<td class="nump">1,465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,878<span></span>
</td>
<td class="nump">3,385<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,083<span></span>
</td>
<td class="nump">2,634<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cvs_CommonAndCollectiveTrustsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cvs_CommonAndCollectiveTrustsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834078582104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 431<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">79,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Cumulative goodwill impairments</a></td>
<td class="nump">6,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember', window );">Long-Term Care Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 10,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,807<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834078839784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles - Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="num">$ (431)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(431)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="nump">79,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="nump">45,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember', window );">Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="nump">23,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="nump">$ 10,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834077316776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of the period, net</a></td>
<td class="nump">$ 7,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of the period, net</a></td>
<td class="nump">8,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember', window );">Corporate / Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, beginning of the period</a></td>
<td class="nump">7,936<span></span>
</td>
<td class="nump">6,879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Less: Reinsurance recoverables</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of the period, net</a></td>
<td class="nump">7,926<span></span>
</td>
<td class="nump">6,874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Add: Components of incurred health care costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">48,243<span></span>
</td>
<td class="nump">40,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(771)<span></span>
</td>
<td class="num">(448)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred health care costs</a></td>
<td class="nump">47,472<span></span>
</td>
<td class="nump">40,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="nump">39,887<span></span>
</td>
<td class="nump">34,198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="nump">6,639<span></span>
</td>
<td class="nump">5,865<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total claims paid</a></td>
<td class="nump">46,526<span></span>
</td>
<td class="nump">40,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Add: Premium deficiency reserve</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of the period, net</a></td>
<td class="nump">8,873<span></span>
</td>
<td class="nump">7,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Add: Reinsurance recoverables</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, end of the period</a></td>
<td class="nump">8,877<span></span>
</td>
<td class="nump">7,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Premium deficiency reserve</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumDeficiencyReserveLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumDeficiencyReserveLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834081259704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Incurred but not reported (IBNR) claims liability, net</a></td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Decrease in prior years' healthcare costs payable</a></td>
<td class="num">$ (771)<span></span>
</td>
<td class="num">$ (448)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671321-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671317-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834076148648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Schedule of Borrowings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Aug. 18, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liabilities</a></td>
<td class="nump">$ 1,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LongtermDebtGrossAndLeaseObligation', window );">Total debt principal</a></td>
<td class="nump">58,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premiums</a></td>
<td class="nump">224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet', window );">Debt discounts and deferred financing costs</a></td>
<td class="num">(818)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(909)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Long-term debt and lease obligation</a></td>
<td class="nump">58,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="num">(1,561)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">$ 56,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.35% senior notes due March 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due May 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.45% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due July 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due November 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.7% senior notes due March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.8% senior notes due June 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4% senior notes due December 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.375% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.625% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due November 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5% senior notes due December 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.1% senior notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due July 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.875% senior notes due June 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3% senior notes due August 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.625% senior notes due April 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.25% senior notes due June 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.3% senior notes due August 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.3% senior notes due March 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.25% senior notes due August 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.75% senior notes due April 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.75% senior notes due August 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.875% senior notes due February 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% senior notes due September 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.875% senior notes due July 2035</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.625% senior notes due June 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.75% senior notes due December 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.78% senior notes due March 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.125% senior notes due September 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due April 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.7% senior notes due August 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.75% senior notes due May 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.5% senior notes due May 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due November 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.3% senior notes due December 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due March 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.125% senior notes due July 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due August 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.05% senior notes due March 2048</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.25% senior notes due April 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Floating Rate Notes | Floating rate notes due March 2021 (0.950% at December 31, 2020)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other Debt Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongtermDebtGrossAndLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Gross And Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongtermDebtGrossAndLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.125June2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.125June2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.625DueApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.625DueApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.75DueApril2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.75DueApril2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1875DueFebruary2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1875DueFebruary2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2125PercentDueAugust2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2125PercentDueAugust2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueApril2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueApril2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.25DueApril2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.25DueApril2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834078596008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 18, 2021</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 987,000,000<span></span>
</td>
<td class="nump">$ 7,919,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 363,000,000<span></span>
</td>
<td class="nump">$ 766,000,000<span></span>
</td>
<td class="nump">$ 363,000,000<span></span>
</td>
<td class="nump">$ 766,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost', window );">Premium paid in excess of debt principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 706,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of deferred debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtExtinguishmentFees', window );">Debt Extinguishment Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">766,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% senior notes due September 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">$ 987,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Notes, 4.3%, Due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost', window );">Premium paid in excess of debt principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of deferred debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtExtinguishmentFees', window );">Debt Extinguishment Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 363,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Outstanding Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4% senior notes due December 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 723,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.7% senior notes due March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.1% senior notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtExtinguishmentFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Extinguishment Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtExtinguishmentFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2125PercentDueAugust2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2125PercentDueAugust2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes43Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes43Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_OutstandingSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_OutstandingSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834083526712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Nov. 02, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember', window );">2016 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 13,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834077845416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">$ 73,565<span></span>
</td>
<td class="nump">$ 71,164<span></span>
</td>
<td class="nump">$ 69,701<span></span>
</td>
<td class="nump">$ 68,355<span></span>
</td>
<td class="nump">$ 65,474<span></span>
</td>
<td class="nump">$ 64,170<span></span>
</td>
<td class="nump">$ 69,701<span></span>
</td>
<td class="nump">$ 64,170<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(93)<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="num">(392)<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="num">(332)<span></span>
</td>
<td class="num">(337)<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">74,618<span></span>
</td>
<td class="nump">73,565<span></span>
</td>
<td class="nump">71,164<span></span>
</td>
<td class="nump">69,112<span></span>
</td>
<td class="nump">68,355<span></span>
</td>
<td class="nump">65,474<span></span>
</td>
<td class="nump">74,618<span></span>
</td>
<td class="nump">69,112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Net unrealized investment gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
<td class="nump">987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
<td class="nump">774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(297)<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(73)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(310)<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">904<span></span>
</td>
<td class="nump">977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,031<span></span>
</td>
<td class="nump">987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">904<span></span>
</td>
<td class="nump">1,031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="num">(73)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(346)<span></span>
</td>
<td class="nump">278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Net cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">226<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Amount expected to be reclassified</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Pension and OPEB plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">AOCI Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">1,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,414<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,019<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">$ 1,077<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,255<span></span>
</td>
<td class="nump">$ 1,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,077<span></span>
</td>
<td class="nump">$ 1,255<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834080202056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of EPS (in shares)</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumeratorForEarningsPerShareCalculationAbstract', window );"><strong>Numerator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 1,598<span></span>
</td>
<td class="nump">$ 1,224<span></span>
</td>
<td class="nump">$ 6,604<span></span>
</td>
<td class="nump">$ 6,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares, basic (in shares)</a></td>
<td class="nump">1,321<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">1,318<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted shares outstanding (in shares)</a></td>
<td class="nump">1,329<span></span>
</td>
<td class="nump">1,315<span></span>
</td>
<td class="nump">1,326<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share, basic (in dollars per share)</a></td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 5.01<span></span>
</td>
<td class="nump">$ 4.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share, diluted (in dollars per share)</a></td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 4.98<span></span>
</td>
<td class="nump">$ 4.72<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DenominatorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Denominator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DenominatorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumeratorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Numerator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumeratorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834167117592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2012 </div>
<div>member</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>store</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_GuarantorObligationsNumberofLeases', window );">Guarantor obligations, number of leases | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LossContingencyAuditMethodologySampleSize', window );">Sample size | member</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_RadcliffeAndFlaimVAetnaIncEtAlMember', window );">Radcliffe and Flaim v. Aetna Inc., et al | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of claims | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_GuarantorObligationsNumberofLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Number of Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_GuarantorObligationsNumberofLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LossContingencyAuditMethodologySampleSize">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Audit Methodology Sample Size</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LossContingencyAuditMethodologySampleSize</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_RadcliffeAndFlaimVAetnaIncEtAlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_RadcliffeAndFlaimVAetnaIncEtAlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834069556808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834078879432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">$ 73,548<span></span>
</td>
<td class="nump">$ 66,852<span></span>
</td>
<td class="nump">$ 214,675<span></span>
</td>
<td class="nump">$ 198,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="nump">832<span></span>
</td>
<td class="nump">550<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">73,794<span></span>
</td>
<td class="nump">67,056<span></span>
</td>
<td class="nump">215,507<span></span>
</td>
<td class="nump">199,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">4,073<span></span>
</td>
<td class="nump">3,622<span></span>
</td>
<td class="nump">13,165<span></span>
</td>
<td class="nump">13,063<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">20,479<span></span>
</td>
<td class="nump">18,698<span></span>
</td>
<td class="nump">61,487<span></span>
</td>
<td class="nump">56,364<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember', window );">Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">39,046<span></span>
</td>
<td class="nump">35,711<span></span>
</td>
<td class="nump">113,681<span></span>
</td>
<td class="nump">105,583<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">24,992<span></span>
</td>
<td class="nump">22,725<span></span>
</td>
<td class="nump">72,994<span></span>
</td>
<td class="nump">67,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">20,311<span></span>
</td>
<td class="nump">18,557<span></span>
</td>
<td class="nump">60,993<span></span>
</td>
<td class="nump">55,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">432<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">20,479<span></span>
</td>
<td class="nump">18,698<span></span>
</td>
<td class="nump">61,487<span></span>
</td>
<td class="nump">56,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,106<span></span>
</td>
<td class="nump">1,080<span></span>
</td>
<td class="nump">4,502<span></span>
</td>
<td class="nump">6,035<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">36,851<span></span>
</td>
<td class="nump">33,492<span></span>
</td>
<td class="nump">105,909<span></span>
</td>
<td class="nump">98,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">39,046<span></span>
</td>
<td class="nump">35,711<span></span>
</td>
<td class="nump">113,681<span></span>
</td>
<td class="nump">105,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,773<span></span>
</td>
<td class="nump">1,619<span></span>
</td>
<td class="nump">5,035<span></span>
</td>
<td class="nump">4,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NetRevenuesRetailCoPayments', window );">Copayments</a></td>
<td class="nump">2,800<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">8,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">16,347<span></span>
</td>
<td class="nump">14,770<span></span>
</td>
<td class="nump">47,672<span></span>
</td>
<td class="nump">44,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="num">(33)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">24,992<span></span>
</td>
<td class="nump">22,725<span></span>
</td>
<td class="nump">72,994<span></span>
</td>
<td class="nump">67,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,723<span></span>
</td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">5,166<span></span>
</td>
<td class="nump">4,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(10,894)<span></span>
</td>
<td class="num">(10,194)<span></span>
</td>
<td class="num">(33,143)<span></span>
</td>
<td class="num">(30,223)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(10,894)<span></span>
</td>
<td class="num">(10,194)<span></span>
</td>
<td class="num">(33,143)<span></span>
</td>
<td class="num">(30,223)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">(186)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="num">(523)<span></span>
</td>
<td class="num">(539)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,195<span></span>
</td>
<td class="nump">2,219<span></span>
</td>
<td class="nump">7,772<span></span>
</td>
<td class="nump">7,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">8,678<span></span>
</td>
<td class="nump">7,955<span></span>
</td>
<td class="nump">25,309<span></span>
</td>
<td class="nump">22,822<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">$ (343)<span></span>
</td>
<td class="num">$ (303)<span></span>
</td>
<td class="num">$ (1,015)<span></span>
</td>
<td class="num">$ (931)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NetRevenuesRetailCoPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Revenues, Retail CoPayments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NetRevenuesRetailCoPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139834073683528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (GAAP measure)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,061<span></span>
</td>
<td class="nump">$ 3,249<span></span>
</td>
<td class="nump">$ 10,964<span></span>
</td>
<td class="nump">$ 11,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">561<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="nump">1,730<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Acquisition-related integration costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">431<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">431<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod', window );">Acquisition purchase price adjustment outside of measurement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(271)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="num">(271)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,073<span></span>
</td>
<td class="nump">$ 3,622<span></span>
</td>
<td class="nump">13,165<span></span>
</td>
<td class="nump">13,063<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod', window );">Receipt related purchase price adjustment from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits | Discontinued Operations, Disposed of by Sale | Coventry Health Care Workers Compensation business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Purchase Price Adjustment, Outside of Measurement Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>74
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M3&!8)-(8P/U*"/VV,>-(-7Y._P)02P,$%     @ TS5C4R,*&XLT"    R,
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M/#3./%ZBQS(F"MEGG;-B13V?1L2RC(9\VA$4?9N@H'?3 HHI"]OJ\'[4Q+K
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MRS]Y_]NLJF9WRQ]OR^&HG-<$PC_-9M7C+_4'?)G-?U_><'O_7U!+ P04
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MS%-%B5X*D\V60"H/\E0SFK^H+;9)SO#X9!4@,H@%W@V/$E%O@A6.K_BPR@H
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MJY"CN[1FBI&R,\<D-(B<F/M<!3.S%\'[K@_J>1LJ#12U$F2-1(9R^J%RA:G
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M!W:^RPG>J:W+75;HZRP__VK^&N4WCH/<BDC_:&MCL+4;HY7AG3F15Y '_Z'
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MZCM/G;,JEFD3_=5#:.4,N,&G=DH#IF^5Q=G(7,53T-U6P=Z[)^QS+1$[ANI
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M^F$O]4=3[OC'M)9E R_-'Y$#(+VE ?A^59:-^8,VL+^N]OI_ 5!+ P04
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M0#5T6N$X%)'8@Q_(X^14CX%WQ%Y"S5<$8(<R$08"J#\@[P4XH_XKA0L.0;@
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MT!CV?AI0-<74HO7?&T4N=VJ-'0@G!C.D*4J\)&%GC-:V0"X'W0MLK+3M:SH
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M&+U\B30O.0EH*Q>/&6BC'3J8Y'[)@"MK6(43,UN1=2T];22N__QT>_-R^DJ
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M# 7]#(7#858;1@! 0W2^C7!"#"/#C7!B ^HL&!WI<)#7'8@#TDZMD46Y@3B
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MC7K7N-XQ=90]4"C82V629EP!^7T)-#0$ ME>"(Q#.CFOSWD'IG>#%7.6*OA
MC8O5,$;QN'5 Q0QH4)5)MH)15^:\ZJ)7J829]>K.1%0RM8/SJ+;>6IJ][AGH
M)ZIQ=XW2/81YQ^ (2<'6''<R!X:8L5=JI0$J$_CPAFBW0KV3HMSNX'#P(!;7
M^#*$0@^U$N9QU_0]CU,&SC8SRN:; '7K?!NTZ%T&\Z(YDDS3SDCTPM [*/-M
M6EMH''20\.T%A "X1.U0H%YR, 6S[D\Z,7\-NV#DTGZ<AUU7#?L<RYVT)C(<
M L%U",*FE/92:GEL,FJ#CDACR>VGV!M+\3R:3NH](*HT/DAB/3%ZPL<Q(-"\
MA(.V=:$],IZB>8Q)%SDS=N!ZPR0BCB$@N>_K<*5O*W&#\9P\#&^XSC5UZW_$
MQ=B+_C<N!O$_Y*)/_B4RQE$;M3MT:['HW/T45&[M#1<L=B;TZAJH?=M>HEU6
M=T='\>H&#O;Y+>,*MND-J'I0E,R0K&ZUJ@<M]O8F:26T%H7]NZ,IT-<(P/>-
M  #K!S- >[5X\1=02P,$%     @ U#5C4S79EC!K P  V@<  !D   !X;"]W
M;W)K<VAE971S+W-H965T,34N>&ULI551;]LV$/XK!ZW8.B"P;#EIT\8V$"<=
MNH=V0;QU#\,>:.DD$1%)]4C%\7Y]CZ2LR$L3#-B+3>KNON^[X_&XV!FZLS6B
M@P?5:+M,:N?:]VEJ\QJ5L!/3HF9+:4@)QUNJ4ML2BB($J2;-IM,WJ1)2)ZM%
M^'9#JX7I7",UWA#83BE!^S4V9K=,9LGAPZVL:N<_I*M%*RK<H/NCO2'>I0-*
M(15J*XT&PG*97,[>KT^]?W#X(G%G1VOPF6R-N?.;7XME,O6"L,'<>03!?_=X
MA4WC@5C&UQXS&2A]X'A]0/\EY,ZY;(7%*]/\*0M7+Y/S! HL1=>X6[/[B'T^
M9QXO-XT-O["+OADSYIUU1O7!O%=2QW_QT-=A%' ^?28@ZP.RH#L2!977PHG5
M@LP.R'LSFE^$5$,TBY/:'\K&$5LEQ[G5IA:$M6D*)/L3?/C:2;=?I(Z1O3W-
M>Y1U1,F>07D'GXQVM84/NL#B.#YE18.L["!KG;T(N,%V O/I"633;/8"WGQ(
M<Q[PYL_@Q<3@K\NM=<2=\/<+F*<#YFG //V?I?OO*#_^<)[-WE[T6!!,<(MM
M1WG-G6?A-PV?S3VJ+1)DOCBS-R=P]64#'U$TKN[C+:R-H ),"=>2N/T-67CM
M:@3OD$TO@CFL9Q<_@^A<;4C^@P5X'P\*-E#30 TMF8J$@M<]1/!ZE 8WT3Z
M\KB K@5GX-7L;#*%K6P:?PM9DR>Y,JH5>C\(SHU2; VT=@*_'W0\98 624EG
MQS">!LN2,QU)ME"24>!XA'A[_*_)=%4-PA-NI1:NU^2''%\KNL,CB!/.6]X+
MA\T>-%;&25YSF4AH*\)881>1YSQD*%B>U.U?KKI(N3"&M1//CH#-0^G(Z^7L
M<Z%ABZ!,(4O)A(SF?$%TH-_N0UGB\0L'H3:<^ 2N.Y*Z"E;-'<@ X;ZBOZ_
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M1#1,0-]G6KO-@@5L;YZ7_P)02P,$%     @ U#5C4RK(S[+M P  DPD  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3<N>&ULQ59+;^,X#/XKA#''C.TXCZ9!
M$J!INY@Y3%%,=F<.BSTH,A,+U<,KR4WGWR\E/YH";='%'O9@2Z+)CQ]%BO+J
M9.R#JQ ]/"FIW3JIO*^76>9XA8JYU-2HZ<O!6,4\+>TQ<[5%5D8C);,BS^>9
M8D(GFU64W=O-RC1>"HWW%ERC%+._MBC-:9V,DU[P71PK'P399E6S(^[0_U'?
M6UIE THI%&HGC :+AW5R-5YNIT$_*OP0>')G<PB1[(UY"(NOY3K) R&4R'U
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M:;IV?<;;SA@L\)71$9$9/XEX*B4;7V70-YC4,@H($&A+T M.D=$2N[+..SK
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MRTE]1U O"4G5C^ +[P^>I('$1/)*_4R<UH6]3VT_;# 8L2P#S@:$!NX.V:M
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M9 05@4HHMG/GF"0U-;FYZ=S.PF'A1]I^@)B!@E]O>VQ?GQ$./D3<0D)+C%.
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M'\F9M[\37N>R')%_3$*GDIY=V.1Y=90AC&>B8B=SZ)SFQE;-%KR7:-_ 'SA
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M]65->VMN]?&-DK!\GS9OD) Y*1P+RC;7=\UNMG:<?/:+ !J]NB>!4!CE/::
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M0M9 T A8V^#Z74%[)))F$,T*<.>5;">.#AN@U0'BZP5PV'G%QK&'7[(5WON
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M8X@+YY(V&9O-:X=9OLERD.LN[6F>[PG7<<6%:5X*7YM9%FT,(D':'0= 6S.
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MW!UDX(CGMB50GEEDB<BBJ7;W84Y]N;8%O#@@;ABT+=0=$!82:,?SZ7ZD>S!
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MMX'CND;_T1/;P*,SJ(^G1*-@EIRQR@.ZJF5RZZLY?6_@%@N>NT376A5-;DU
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;,59:X_;N!7]*\1T4,P
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M:,'-K5%1]8RO-RC7;H@M)9J1Z):E^2R"L@!S7DB)'QL[%]L/[?@?4$L#!!0
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M./AX)2EGZG+QV'9+B!)"<=)%I2&*8"8D[\)6(0QK)9#KK6,D/QO)HT;^T_)
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MM4+@N4%(.@Q912%=PQQ3B EED"D\*%S4%C/70J0+U7)Z+40"18Z  0%0R(
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M=]Q;G]#S477[OS+5V_/ --UM P)7)-FY'% )==7/JXE5I6^)2V7I\_/#G)Y
MU,Z ]E=*V>W$!6@>U?$?4$L#!!0    ( -0U8U-D\R^X4P,  !<-   9
M>&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;+57T6Z;,!3]%0OUH976@DT(I$HB
MK8FF56JU:EFWAVD/3G*3H!J<V4ZR_?ULH$""05.JOB08SKGWW&O[8(8'+E[D
M!D"A/PE+Y<C9*+6]=5VYV$!"Y0W?0JJ?K+A(J-)#L7;E5@!=9J2$N<3S^FY"
MX]09#[-[3V(\Y#O%XA2>!)*[)*'B[QTP?A@YV'F]\35>;Y2YX8Z'6[J&&:CG
M[9/0([>,LHP32&7,4R1@-7(^XML)\0PA0WR/X2!KU\B4,N?\Q0SNER/',XJ
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M1,FM)P*'F*X/,#JWE]Q?),$<%]9Z 64->8L9Q(+;Q<))@L<Q8EL^<8@)&^@
MM^O ;=?GKD_B[JDJ-L6^AWG@T;S:!OMZ>+/)RZ!]NML6ST6+OZJ_/2MP-T_/
MJ<L<B);;2^ASZ3+'A73_/4V_'D1);OBZ(H#;A9W;SRC,XYELMR@18EA2 OA>
MV/E^@3 +S.1<Z+Q*!!G3#7PO[-:,DS*+B2-CK[87*+/ =744ZTN-"$J%8>Y
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M]?[PBQQW==?5N\/+1Y5O53,$]'^_K^ON]<WP(Q^G7W6Y_C]02P,$%     @
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MLH^K(8OKKNAHD=OS_$EHO!UL<X5_""!- ,XOA-"[CA&H_CF&OP%02P,$%
M  @ U#5C4Y_U?.NS!@  E3(  !D   !X;"]W;W)K<VAE971S+W-H965T-#(N
M>&ULO9M=;]LV%(;_"F'TH@6V6OPFBR3 ZFQ8@!8($G2[&':AVHPC5+8RB4E:
MH#]^DNSZZ)-2080W\=<YU.%KYCEZ+>KL.<N_%/?&6/1UE^Z+\\6]M0_OELMB
M?6]V<?$V>S#[\I.[+-_%MGR9;Y?%0V[B39VT2Y<DBL1R%R?[Q<59_=YU?G&6
M/=HTV9OK'!6/NUV<?WMOTNSY?($7/]ZX2;;WMGIC>7'V$&_-K;&?'J[S\M7R
M-,HFV9E]D61[E)N[\\5O^-T*1[S*J$/^2LQST7B.JKE\SK(OU8NKS?DBJDHR
MJ5G;:HRX?'@R*Y.FU5!E(?\=1UV<#EHE-I__&/V/>O;E;#['A5EEZ=_)QMZ?
M+]0";<Q=_)C:F^SY3W.<45W@.DN+^B]Z/L9&"[1^+&RV.R:7%>R2_>$Q_GI4
MHI& V4@".2:0N0GTF$#KB1XJJZ=U&=OXXBS/GE%>19>C54]J;>KL<C;)OOH>
M;VU>?IJ4>?;B:O]D"EM^,;9 OZ*/66ZWY=>'/F3QOD"KW&P2BVYBF^RW!;K:
M;Y)U;+,<O;XT-D[2XDV9L\IV.Y.ODSA%-Z;\\WMA8VO*#S[=7J+7K]Z@5RC9
MHX])FI9?6W&VM&75U;&7ZV.%[P\5DI$*;\W#6T2C7Q")"!Y(7[G3+\VZ3,=U
M>M1.7Y9:G00C)\%(/1X=&:\C4;D2F[/^YT,9CJZLV17_.@Y&3P>C]<'8U,'2
MZF!#VAWR19U?_<\^76C*SI9/38'Z,3AB\A34JHR=*F/.RE;E;+=9_@UAQS3Y
M:3#^\IJ*T\&$IZ:'?-[0B^..I ,A>EA0>2I+SA.4()LAYIBH.HVH7EY5?3J8
M]E15]R13,NK(VH_1G SKBB,@7#1'V<04B*-XOT'",5_< "=^>7DQ8 <33X&/
M S35P[0C\$ ,%2," Z2PFU*GI2M=,P6R8!9 6& /YK["\IYHW87K#&D7!IS"
M;E#U^UU[(" +E@$$!>Q@Y2NHZJ]4B4?T @)A-X(JO=!W-*LS$: 'B5Y>/ )4
M(=A3O., ,Y8::9S3N.'2E6ZR!Q&  Z$!] -X$/=YR0S]V/S%1X BQ$V1MH+S
M>@T!%! 10$0 !G&?B\P04<Y>A, -XN9&=Q&ZN@D!*A =X'P=<$'=)QLSSMBC
MN=)1H 9U4V/"VU   0WA;AKVQMO?T)Y:K.=O!F)&3FHH@(2Z05)).K>;4, $
M#>!T*'"#^GH=VG<RW7,;9TB[," ,=1.FJ^YDPZ& $1K ]E#@"_4U/K3O:OI+
M>"!F9 DS8!%SLZ@M\KR>Q( Y+(#_84 FYNM_6-_;=)>R,Z1=&#",N1G67<JN
MML4:/Z\$,$$,N,1\31";-D'.D'9A0# V98*P=LT0B,,"F" &%&*^)HCU39#H
M8F$@1H]A 8C%IGP2UG,[&P?8\  ^B0-]N*]/XBZ?=)#7&=(N##C%IZQ46]W)
MSL:!-#R E>* (.YKI7C?2O66\$#,V!+FC=^+I]Q64^1YG8T#<W@ M\6!3-S7
M;7&7VSK*/-N0<6 8GS)D[:7LZFP<\,,#&#(!7!*^ADRX#-GQY_[9GDT P<24
M9\/*-4,@C@C@V0102/AZ-M'W8U)T%>W':#8B*1!+3'DVK.9V-@&P$2&N3C4N
M3WE?GYKV;,Z0=F' *3'EV=KJ3G8V :01 3R;  0)7\\F^GY,=J^E#,3HD=\1
M)>!*3GFVILCS.IL$YL@ GDT"F:2O9Y,#UZ,Z,CM#VH4!P^249VLO95=GDX ?
M&<"S2>"2]/5L<MJS.4/:A0'!Y*1G<PK:N"0>P+-)H)#T]6QRX,)5U-T;,!3$
MQT0%9LE)UR;G]C8%N%$!7)L"_BA?UZ;ZEHR0CL#NF'9IP"HUZ=OD3W4W!;11
M 7R; @PI7]^F^IY,\J[( Y?)R,@9F@)FJ4GC)G^VO2D CPI@W!3@2?D:-]5W
M95U_[ QI%];8^#-IW.3<]J: 0"J <=. )NUKW/2T<7.&M L#B&DWQ*[S),M=
M4P3FZ #.30.'M*]STP-7TJ3J:MH/$F+DQ%<#M;2;6K6J<QN<!N#H .9- X&T
MKWG3?6=&=%?A?@P=V:^I@5;:3:N>P),=3@-P=(BMAHV]AMZ;#8>NN76=Q4 0
MUWQ89QPU]QNZR=51>N;&PZBQ\S *L?4P:NP]C+PW'T9]F];]S6<HAHQLF\51
M8_MAY.9:;V4[]R%&C8V(48B=B%%C*V+DO1?Q.()P-#UWS*&X9>.6@>J&C8]Q
MODW*.:;FKLR)WE:^,#_< G%X8;.'^BZ"SYFUV:Y^>F_BC<FK@/+SNRRS/UY4
M-R:<[D2Y^!]02P,$%     @ U#5C4ZU'>:* !   QQ,  !D   !X;"]W;W)K
M<VAE971S+W-H965T-#,N>&ULQ5AM;ZLV%/XK5G0_M-)MP0;R4J61VI!ME=:M
M:G4W3=,^4#A)K N8V4[3[M?/!@J),=QVNU*_). \Y^4YY_@<Q_,]XU_%%D"B
MYRS-Q>5H*V5QX3@BWD(6B7-60*Y^63.>15*]\HTC"@Y14@IEJ4-<=^QD$<U'
MBWFY=L<7<[:3*<WACB.QR[*(OUQ#RO:7(SQZ7;BGFZW4"\YB7D0;> #YI;CC
MZLUIM"0T@UQ0EB,.Z\O1%;Y8$:(%2L1O%/;BX!EI*H^,?=4O-\GER-4>00JQ
MU"HB]?4$2TA3K4GY\7>M=-38U(*'SZ_:?RC)*S*/D8 E2W^GB=Q>CJ8CE, Z
MVJ7RGNU_@II0H/7%+!7E)]I7V(D_0O%.2);5PLJ#C.;5=_1<!^) 0.FQ"Y!:
M@)@"?1:\6L![JP6_%O#?:B&H!4KJ3L6]#%P8R6@QYVR/N$8K;?JAC'XIK>)%
M<UTH#Y*K7ZF2DXN;_ F$5)F7 IVA7U1EMBOJ,689H),09$13<:H07QY"=/+I
M%'U"-$>W-$U5ML7<D<H5K="):[/7E5G28]9#MRR76X%6>0*)13X<EI\-R#LJ
M!$T<R&L<KLF@P@<HSI'G?D;$)=CBS_+MXJZ-SO^SOOK/UH^"X35%X97ZO#Y]
MJATENQ006W?+X3.ZAX)Q"0FZRMA.%<YG]/B"EI&$#>,OZ,^?E39T(R$3?PWX
MXC>^^*4O?H\O/W(FA"JVQ@M:>F$KN4K1N%2D&^33@DQF<^?I,(T6C.L=8\(N
M9DK(,6;5Q02!VV".F 8-TV"0Z4&DX5D- @'6C54I"0XLGV%LL+1@I@9)"X08
MF)4-$]A)CAN2XT&2NL-TDHE.X#E.=PG--RA7 #7Q4OJ/*K X*JB,4K11$T\@
MQE&JB@'$J2TNXXZS9&P06G8Q>!88@>EB)C/?"$P7$_0%9M($9O+-P/3P/AE@
M/;&DR*C591=C[(JPB_#,6NA"^AA/&\;3]Y>"C>.T:]H?&QPM&-?(6MC%3#US
M7W<QO?MZUO"<#?+\@T*:G'%((]TS:59$E)>,=5IM?&?=;!ALNPB#1VC1813Z
MJ@OQ?3M3[+:G"7>0ZY)#0N5[R-8*#]UP#;86B-'PPF]K65D@?70/#D]XD.[#
MKM"C4/<MW;(YA3R&,UYR+SA+=K$4 S,0D]80^?")C-OC ?:^S\ZM]0RTGJ4%
M@ETSNUU,9U99,![NR6][]L##AX\0'B42$.\XE=0<Q\<ZVRF/@X]/93N.\? \
M?L?Q"ENF9S QTVD#=79K%^1/S!EK _E]&6VG+!X>L[<JN!OU#UCUH\C\XW*L
MLAUC>/KQ"6V'#1Z>-N]):'<"8'/2V##FB<F"\;&930NFY_Q VFE#AJ?-KW(+
M_(#K4#Y)V]0)_O!\DK;S$_*]\EEK&A^U4K/?6D">L8E#&\8U0"L+:&P.5.?@
M8B(#OBEOA 2*=>"JOZ/-:G/K=%7>M1CKU_ABB2WK(;Y857=*K?KJBNLVXAM]
M>$YAK4RYYQ-5>KRZ-:I>)"O*:Y%')B7+RL<M1 EP#5"_KQF3KR_:0'-WM_@7
M4$L#!!0    ( -0U8U-Z> ?0N@(  %T(   9    >&PO=V]R:W-H965T<R]S
M:&5E=#0T+GAM;*56R6[;,!3\%4+((0'::+42![* >&F:@P$C1MI#T0,M/5M$
M*%$E:3OMUY>D9-61%,-(+Q:7F7F<Q^4YVC/^(C( B5YS6HB1E4E9WMFV2#+(
ML;AF)11J9LUXCJ7J\HTM2@XX-:2<VI[CA':.26'%D1E;\#AB6TE) 0N.Q#;/
M,?\]!LKV(\NU#@-/9)-)/6#'48DWL 3Y7"ZXZMF-2DIR* 1A!>*P'EGW[MTL
MU'@#^$9@+X[:2#M9,?:B.X_IR'+T@H!"(K4"5I\=3(!2+:26\:O6M)J0FGC<
M/JA_,=Z5EQ46,&'T.TEE-K)N+93"&F^I?&+[KU#[&6B]A%%A?M&^PH:^A9*M
MD"ROR6H%.2FJ+WZM\W!$4#K]!*\F>&U"\ [!KPG^N1&"FA"<&V%0$XQUN_)N
M$C?%$L<19WO$-5JIZ8;)OF&K?)%"GY.EY&J6*)Z,'XL="*DV7@KT&3T!IN0/
MI.A!G3"!+J<@,:'B2DT]+Z?H\N(*72!2H#FA5&VSB&RIUJ"5[*2.-Z[B>>_$
M\]&<%3(3:%:DD/;PIZ?YPQ-\6WEO$N =$C#V3@HNH;Q&OO,)>8[G]JQG<C[=
MZ;/S?]%G'X[^)AE^<QI\H^>?<1I^W*^$Y.HB_SPA'#3"@1$.WA%><)8 I *M
M.<N1P!1ZSTXE$AH1_<+MXC"\C>S=\7YT,4-G\!8S[6*\H=\"S7I OA<TH#<^
M!XW/P4F?#YP)H=[/^AHEN"024[31UZG/<*4V.%J#.VSY[8'<M.QV(:';,ML#
M<?JMAHW5\"-6J1KMW]RPF^^6U2[";SGM(MR6R*P+&0Q;3NVC]S('OC&%2J"$
M;0M9799FM*F%]Z8$M,;'[MW$[1F?JMI9E;I_\E7AG6.^T4\KA;4*Y5S?J"WA
M53&K.I*5YK5>,:G>?M/,5/T'K@%J?LV8/'1T@.8?1?P74$L#!!0    ( -0U
M8U.UZ71I"0H  *%7   9    >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;,U<
M76_;.!;]*X(Q#S- )^:7)&J0!)BF6^P [6R1;&<?%ON@V$PB5+8\DIQT@/GQ
M*RFV+RU^B#;SP)?63B[I*Y[<PZMC'EV^5/6WYDF(-OJ^*M?-U>RI;3>_S.?-
MXDFL\N:BVHAU]YN'JE[E;?>V?IPWFUKDRV'0JIP3A)+Y*B_6L^O+X6=?ZNO+
M:MN6Q5I\J:-FNUKE]5_O15F]7,WP;/^#V^+QJ>U_,+^^W.2/XDZT7S=?ZN[=
M_##+LEB)=5-4ZZ@6#U>S7_$O-YCQ?L00\D<A7AKI==1?RWU5?>O?_+:\FJ$^
M)5&*1=O/D7?_/8L;49;]5%TB?^YFG1T^M!\HO][/_G&X^NYJ[O-&W%3E?XIE
M^W0UX[-H*1[R;=G>5B__%+LKBOOY%E79#/]&+[M8-(L6VZ:M5KO!70:K8OWZ
M?_Y]MQ+2 ,P, \AN '$=0'<#Z'"AKYD-E_4A;_/KR[IZB>H^NINM?S&LS3"Z
MNYIBW>-XU];=;XMN7'O],2_JZ(^\W(KHY^BSR)MM+3J8VJA?XNA6++9U7:P?
MH_=Y4S31CQ]$FQ=E\U,7_/7N0_3C#S]%/T3%.OI<E&6'2G,Y;[ND^JGGBUT"
M[U\3((8$[L3F(J+H7400P9KA-_;A'\2B&XZ'X>AX^+Q;BL-ZD,-ZD&$^.KD>
M[Z)?FT:T392OE]&G(K\ORJ(M1+-?I66_1+! ?=3OU;H>K=A_/W4?$/W6BE7S
M/TMZ]) >'=)CQLN];Z.F_XPA%]UROTZ0#!/T5?Q\34B<LLOYL[RJFBB,.3]$
M'67'#MDQ:W9?+^XNHL?J6=3KX6_(E.C1Y/%A\CA$9))#>HDO,J\3Q/*:4X9&
MP&B"6)+I<4D/N:76W.[:O!7-NVBU71>+8I/OEJM?F$W5OUGD9<?D]\OBN6C4
M,C[Z3'[X3!XB7-DAO<P7KDQ!@B(>C^!2@TA*#&6$$9 RFBZD155OJKI#SJV.
ML$3Y.$1H,' P)K[@[&:0%SY+*!VAHXGB/&,&>("$L9V%NP:B:P_6CK@ >V(6
M)"[ P#CVQB56"R)CXZK11F%3V0 %8SL'WXJF6'8;3]'1V:JJV\>N$_WY/E]\
MZQ;,#2M@5)P&B170+^;>6'&U.A*EA-2@%,4&I(!]L9U^;ZK52M2+LX$B0*4$
MA0@4 38FV!>HW0PR!IB@;(24+@JQ1 \5D1IB.QG_JWT2=93W2W<:1$"GA 8)
M$1 SL?>U+A Q7=_&QQ#IHA U0 2\3.R\?"N6HKN]OR]%U-W,/XBZ=@8)N)4D
M08($C$SL3:X+2*G:TN$Q1&H,,= = 3(F=C(^K(;M2H$\218B%!0XE]K;UX_%
M.E\/Y%Y*.>5M]-!G_CRH#8.^ )G<]YEH;V>1@L?XELD:<GP)P,K4SLHW>?,T
MK->B?R'^W!9=VEUKH<]19=Z,DV2<IAJ5\MC0C%+@9^K=+%.U#=9J IHPLRA
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M$&5TD= 3T-4<K396%7X4S96EP>:75(P,M7.@\X52=KMQ 9H_L\$O4$L#!!0
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M3Z-SY,CDY7'FBIFFKP$!.N"&T &$Z, BC(XMBK1-8 +#G/9\4)N8PPR'.PD
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MMW4&/> E0K*H "L%41#G_\E+48@*0/&T U !0%T!N #@KH!! 1CL P[UP2D
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MY[]]Y!>2;;.3]"63DD79VPTE/N5I _7YBBG+%1?IX7SY"]3T/U!+ P04
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M3J%OE49Y^9<\5UC/&9'5(9=I7 NK$<1A4OT/OM2!.!&@70*L%F!0P.X0X+4
M'RI@UP+V4 &G%G"&"KBU@#M4P*L%O*%1FM0"DZ$6IK7 M)P.5?[*Y,\#&5Q?
M9NDSR0JTTE9\*&=0*:UR'B;%9/\D,_5KJ.3D]0>Y$QF9I;$JE5TQAY\$\9-5
M&@OR\US(((SR7\@%^?QI3G[^Z1?R$PD3\CZ,(C51\\NQ5",H](Q7M;7;RAKK
ML,;)^S21NYPLDK58(_)+L_S4(#]6GA_=9R_NWS*CPD]B_Y9PZPUA%J/(>&9F
M\5\/B5%\;A9_'V1*G':*+X8/WD+$[X8/'A._'SYX3'SY_R+O?[?OK8G CW7
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M2L_[+Y2QV9V7'C32@U;I>YJEG.4Y^!I\<+4E^PZ9@964W,BT<T6P%5..?JU
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MYZ#1-6+8MF[RP7@'=U]KC2?#!YC^)<5O4$L#!!0    ( -0U8U.DQ]G,N <
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ U#5C4W7#M>&^!   W"<   \
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M8>R;A4*AV?TX;??#N@__ %!+ P04    " #4-6-3F!M:GOL!  #+(P  &@
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MHM[M3^I=IL]#+M>>KS5>_R>IGL[GYNOE+\NOG7B_:"\X)_AWY_$O4$L#!!0
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M              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
M  @ TS5C4ZTK]D\X!0  9!4  !@              ("!#0@  'AL+W=O<FMS
M:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( -,U8U.[[\[ % <  -L@   8
M              " @7L-  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"
M% ,4    " #3-6-37VI8JB0$   ##P  &               @('%%   >&PO
M=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ TS5C4ZF_001B!P
MQ!\  !@              ("!'QD  'AL+W=O<FMS:&5E=',O<VAE970T+GAM
M;%!+ 0(4 Q0    ( -,U8U-#IO9H P,  (H*   8              " @;<@
M  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " #3-6-3(PH;
MBS0(   #(P  &               @('P(P  >&PO=V]R:W-H965T<R]S:&5E
M=#8N>&UL4$L! A0#%     @ TS5C4P=R1B1%%   ,H0  !@
M ("!6BP  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( -,U
M8U.2FY%8@0,  (8-   8              " @=5   !X;"]W;W)K<VAE971S
M+W-H965T."YX;6Q02P$"% ,4    " #4-6-3H+?Q1VX9  !I30  &
M        @(&,1   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%
M  @ U#5C4Y'5=(=S#@  T2X  !D              ("!,%X  'AL+W=O<FMS
M:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " #4-6-3M4#C7\\(   -&@
M&0              @(':;   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+
M 0(4 Q0    ( -0U8U/Y6I3J @8   L/   9              " @>!U  !X
M;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ U#5C4]0\=AF'
M!0  '0\  !D              ("!&7P  'AL+W=O<FMS:&5E=',O<VAE970Q
M,RYX;6Q02P$"% ,4    " #4-6-37&1_K9(&  !F%   &0
M@('7@0  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( -0U
M8U,UV98P:P,  -H'   9              " @:"(  !X;"]W;W)K<VAE971S
M+W-H965T,34N>&UL4$L! A0#%     @ U#5C4UMWT&[W!   A0X  !D
M         ("!0HP  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
M    " #4-6-3*LC/LNT#  "3"0  &0              @(%PD0  >&PO=V]R
M:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( -0U8U,CMTU_IB,  /5Q
M   9              " @925  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL
M4$L! A0#%     @ U#5C4RJJ,?WT"P  E",  !D              ("!<;D
M 'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " #4-6-3"N]H
M;P,3  !].0  &0              @(&<Q0  >&PO=V]R:W-H965T<R]S:&5E
M=#(P+GAM;%!+ 0(4 Q0    ( -0U8U/,8(PWRP@  + 9   9
M  " @=;8  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @
MU#5C4QW-9QQB#   *RL  !D              ("!V.$  'AL+W=O<FMS:&5E
M=',O<VAE970R,BYX;6Q02P$"% ,4    " #4-6-3JES-_30&  #5$@  &0
M            @(%Q[@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4
M Q0    ( -0U8U.Q@@C)O (  -D%   9              " @=ST  !X;"]W
M;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ U#5C4U]N >9"!
MPPH  !D              ("!S_<  'AL+W=O<FMS:&5E=',O<VAE970R-2YX
M;6Q02P$"% ,4    " #4-6-3LA7 QN8$  !2#@  &0              @(%(
M_   >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( -0U8U-W
M"3/N"@4  (L.   9              " @64! 0!X;"]W;W)K<VAE971S+W-H
M965T,C<N>&UL4$L! A0#%     @ U#5C4X/P3-<  P  N08  !D
M     ("!I@8! 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -0U8U/98O>#W H  $%-   9              "
M@8<? 0!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ U#5C
M4WA'-,5] @  G 8  !D              ("!FBH! 'AL+W=O<FMS:&5E=',O
M<VAE970S-"YX;6Q02P$"% ,4    " #4-6-3EX+RD=$"  !@!P  &0
M        @(%.+0$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0
M   ( -0U8U-D\R^X4P,  !<-   9              " @58P 0!X;"]W;W)K
M<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ U#5C4V_>-3YJ!@  BR0
M !D              ("!X#,! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q0
M2P$"% ,4    " #4-6-3O,Y^CE4$  #@$P  &0              @(&!.@$
M>&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( -0U8U-!*8 &
MP@D  .%%   9              " @0T_ 0!X;"]W;W)K<VAE971S+W-H965T
M,SDN>&UL4$L! A0#%     @ U#5C4X];G23/!@  HB\  !D
M ("!!DD! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " #4
M-6-3;\:#X<L"  !_"   &0              @($,4 $ >&PO=V]R:W-H965T
M<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( -0U8U.?]7SKLP8  )4R   9
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M970T-BYX;6Q02P$"% ,4    " #4-6-3 ^?;=VP%  # )0  &0
M    @(%[< $ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    (
M -0U8U,BY@J)/@,  #P,   9              " @1YV 0!X;"]W;W)K<VAE
M971S+W-H965T-#@N>&UL4$L! A0#%     @ U#5C4\TG"U61 P  \ X  !D
M             ("!DWD! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"
M% ,4    " #4-6-3">[J=OD$  #X%   &0              @(%;?0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( -0U8U/>,AFAP (
M -@&   9              " @8N" 0!X;"]W;W)K<VAE971S+W-H965T-3$N
M>&UL4$L! A0#%     @ U#5C4Z#22ML=#0  7FD  !D              ("!
M@H4! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " #4-6-3
MU7)G:!4%  "-&@  &0              @('6D@$ >&PO=V]R:W-H965T<R]S
M:&5E=#4S+GAM;%!+ 0(4 Q0    ( -0U8U,SHK+T&@,   8*   9
M      " @2*8 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%
M  @ U#5C4U9\^!O>!P  1B\  !D              ("!<YL! 'AL+W=O<FMS
M:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " #4-6-3FV!MT^,#   R#@
M&0              @(&(HP$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+
M 0(4 Q0    ( -0U8U.B!UOGP0(  $8'   9              " @:*G 0!X
M;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ U#5C4XTM.1<"
M @  5P0  !D              ("!FJH! 'AL+W=O<FMS:&5E=',O<VAE970U
M."YX;6Q02P$"% ,4    " #4-6-3I,?9S+@'   4+   &0
M@('3K $ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( -0U
M8U/'QY;^<P0  )X0   9              " @<*T 0!X;"]W;W)K<VAE971S
M+W-H965T-C N>&UL4$L! A0#%     @ U#5C4[V^"4K_ @  B0\   T
M         ( !;+D! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #4-6-3EXJ[
M',     3 @  "P              @ &6O $ 7W)E;',O+G)E;'-02P$"% ,4
M    " #4-6-3=<.UX;X$  #<)P  #P              @ %_O0$ >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ U#5C4Y@;6I[[ 0  RR,  !H
M     ( !:L(! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ U#5C4W32QF+> 0  6B,  !,              ( !G<0! %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&     $0 1 "3$@  K,8!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>687</ContextCount>
  <ElementCount>392</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>129</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>14</UnitCount>
  <MyReports>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2110102 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2121103 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2126104 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2130105 - Disclosure - Health Care Costs Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayable</Role>
      <ShortName>Health Care Costs Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2134106 - Disclosure - Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Borrowings</Role>
      <ShortName>Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2138107 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2140108 - Disclosure - Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncome</Role>
      <ShortName>Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2143109 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2146110 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2148111 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Investments</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2322303 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/FairValue</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2327304 - Disclosure - Goodwill and Other Intangibles (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables</Role>
      <ShortName>Goodwill and Other Intangibles (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2331305 - Disclosure - Health Care Costs Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableTables</Role>
      <ShortName>Health Care Costs Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/HealthCareCostsPayable</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2335306 - Disclosure - Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsTables</Role>
      <ShortName>Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Borrowings</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2341307 - Disclosure - Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</Role>
      <ShortName>Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncome</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2344308 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2349309 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SegmentReporting</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails</Role>
      <ShortName>Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails</Role>
      <ShortName>Significant Accounting Policies - Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails</Role>
      <ShortName>Significant Accounting Policies - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Receivables and Contracted Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2412407 - Disclosure - Investments - Total Investment Schedule (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails</Role>
      <ShortName>Investments - Total Investment Schedule (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2413408 - Disclosure - Investments - Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails</Role>
      <ShortName>Investments - Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2414409 - Disclosure - Investments - Debt Securities by Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails</Role>
      <ShortName>Investments - Debt Securities by Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2415410 - Disclosure - Investments - Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails</Role>
      <ShortName>Investments - Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2416411 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails</Role>
      <ShortName>Investments - Unrealized Loss Position Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2417412 - Disclosure - Investments - Mortgage Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails</Role>
      <ShortName>Investments - Mortgage Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2418413 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails</Role>
      <ShortName>Investments - Mortgage Loans Credit Ratings Indicator (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2419414 - Disclosure - Investments - Net Investment Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails</Role>
      <ShortName>Investments - Net Investment Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2420415 - Disclosure - Investments - Realized Gains (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails</Role>
      <ShortName>Investments - Realized Gains (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2423416 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails</Role>
      <ShortName>Fair Value - Measurement on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2424417 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails</Role>
      <ShortName>Fair Value - Carrying Value and Fair Value Classified by Level (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2425418 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails</Role>
      <ShortName>Fair Value - Separate Accounts Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2428419 - Disclosure - Goodwill and Other Intangibles - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangibles - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2429420 - Disclosure - Goodwill and Other Intangibles - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails</Role>
      <ShortName>Goodwill and Other Intangibles - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2432421 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails</Role>
      <ShortName>Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2433422 - Disclosure - Health Care Costs Payable - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails</Role>
      <ShortName>Health Care Costs Payable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2436423 - Disclosure - Borrowings - Schedule of Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails</Role>
      <ShortName>Borrowings - Schedule of Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2437424 - Disclosure - Borrowings - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsNarrativeDetails</Role>
      <ShortName>Borrowings - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2439425 - Disclosure - Shareholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityDetails</Role>
      <ShortName>Shareholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/ShareholdersEquity</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2442426 - Disclosure - Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails</Role>
      <ShortName>Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2445427 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShareTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2447428 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/CommitmentsandContingencies</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2450429 - Disclosure - Segment Reporting - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2451430 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails</Role>
      <ShortName>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cvs-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2452431 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails</Role>
      <ShortName>Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="cvs-20210930.htm">cvs-20210930.htm</File>
    <File>a09302021ex151.htm</File>
    <File>a09302021ex311.htm</File>
    <File>a09302021ex312.htm</File>
    <File>a09302021ex321.htm</File>
    <File>a09302021ex322.htm</File>
    <File>cvs-20210930.xsd</File>
    <File>cvs-20210930_cal.xml</File>
    <File>cvs-20210930_def.xml</File>
    <File>cvs-20210930_lab.xml</File>
    <File>cvs-20210930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cvs-20210930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>79
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cvs-20210930.htm": {
   "axisCustom": 3,
   "axisStandard": 23,
   "contextCount": 687,
   "dts": {
    "calculationLink": {
     "local": [
      "cvs-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cvs-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cvs-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 587,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 5,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 10
   },
   "keyCustom": 62,
   "keyStandard": 330,
   "memberCustom": 78,
   "memberStandard": 49,
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.cvshealth.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110102 - Disclosure - Investments",
     "role": "http://www.cvshealth.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121103 - Disclosure - Fair Value",
     "role": "http://www.cvshealth.com/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126104 - Disclosure - Goodwill",
     "role": "http://www.cvshealth.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130105 - Disclosure - Health Care Costs Payable",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayable",
     "shortName": "Health Care Costs Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134106 - Disclosure - Borrowings",
     "role": "http://www.cvshealth.com/role/Borrowings",
     "shortName": "Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138107 - Disclosure - Shareholders' Equity",
     "role": "http://www.cvshealth.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140108 - Disclosure - Other Comprehensive Income",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncome",
     "shortName": "Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143109 - Disclosure - Earnings Per Share",
     "role": "http://www.cvshealth.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146110 - Disclosure - Commitments and Contingencies",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148111 - Disclosure - Segment Reporting",
     "role": "http://www.cvshealth.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Investments (Tables)",
     "role": "http://www.cvshealth.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322303 - Disclosure - Fair Value (Tables)",
     "role": "http://www.cvshealth.com/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327304 - Disclosure - Goodwill and Other Intangibles (Tables)",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables",
     "shortName": "Goodwill and Other Intangibles (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331305 - Disclosure - Health Care Costs Payable (Tables)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableTables",
     "shortName": "Health Care Costs Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335306 - Disclosure - Borrowings (Tables)",
     "role": "http://www.cvshealth.com/role/BorrowingsTables",
     "shortName": "Borrowings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341307 - Disclosure - Other Comprehensive Income (Tables)",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables",
     "shortName": "Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344308 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.cvshealth.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349309 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.cvshealth.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberofPharmacyPlanMembers",
      "reportCount": 1,
      "unitRef": "people",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails",
     "shortName": "Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
     "shortName": "Significant Accounting Policies - Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:VendorandManufacturerReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
     "shortName": "Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i0ab7ca31512a47f9b1c6b3868a809813_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails",
     "shortName": "Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ie73ca519535e42989446d84c5cbfd99c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Significant Accounting Policies - Contract Balances (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
     "shortName": "Significant Accounting Policies - Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412407 - Disclosure - Investments - Total Investment Schedule (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails",
     "shortName": "Investments - Total Investment Schedule (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413408 - Disclosure - Investments - Debt Securities (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
     "shortName": "Investments - Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414409 - Disclosure - Investments - Debt Securities by Maturity (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
     "shortName": "Investments - Debt Securities by Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415410 - Disclosure - Investments - Unrealized Loss Position (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
     "shortName": "Investments - Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InventoryNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416411 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
     "shortName": "Investments - Unrealized Loss Position Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ia0879481908c44bb974f798733a18941_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417412 - Disclosure - Investments - Mortgage Loans (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
     "shortName": "Investments - Mortgage Loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ia0879481908c44bb974f798733a18941_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ib458fd6ed94b4ec88122673b72dc2b86_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418413 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
     "shortName": "Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ib458fd6ed94b4ec88122673b72dc2b86_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419414 - Disclosure - Investments - Net Investment Income (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
     "shortName": "Investments - Net Investment Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420415 - Disclosure - Investments - Realized Gains (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails",
     "shortName": "Investments - Realized Gains (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423416 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)",
     "role": "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
     "shortName": "Fair Value - Measurement on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FinancialLiabilitiesFairValueDisclosure",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ibe7ab3f842154eeea4c328406a7ac83a_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2c049e51c8604a9183951023541454c3_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424417 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "role": "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
     "shortName": "Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2c049e51c8604a9183951023541454c3_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425418 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)",
     "role": "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
     "shortName": "Fair Value - Separate Accounts Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ibe7ab3f842154eeea4c328406a7ac83a_I20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428419 - Disclosure - Goodwill and Other Intangibles - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
     "shortName": "Goodwill and Other Intangibles - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ie73ca519535e42989446d84c5cbfd99c_I20201231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ie73ca519535e42989446d84c5cbfd99c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429420 - Disclosure - Goodwill and Other Intangibles - Goodwill (Details)",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
     "shortName": "Goodwill and Other Intangibles - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i42ae767186744b45adac05f6feb0c37e_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ie73ca519535e42989446d84c5cbfd99c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432421 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
     "shortName": "Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i9af0cc01cbc54c9f9e8615532da5bb0c_D20210101-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433422 - Disclosure - Health Care Costs Payable - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
     "shortName": "Health Care Costs Payable - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436423 - Disclosure - Borrowings - Schedule of Borrowings (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
     "shortName": "Borrowings - Schedule of Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437424 - Disclosure - Borrowings - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
     "shortName": "Borrowings - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i0de59d4f1eeb42f8bbb0fb2fe5621340_D20200801-20200831",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439425 - Disclosure - Shareholders' Equity (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityDetails",
     "shortName": "Shareholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i7ed0ba20d2cd461099ef887e226c3e93_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442426 - Disclosure - Other Comprehensive Income (Details)",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
     "shortName": "Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i33239c1a09204337ad5c55fefd2f9d8c_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445427 - Disclosure - Earnings Per Share (Details)",
     "role": "http://www.cvshealth.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvs:GuarantorObligationsNumberofLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "store",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447428 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i2fdf49e58ef74885bcae89152e425b39_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvs:GuarantorObligationsNumberofLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "store",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450429 - Disclosure - Segment Reporting - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails",
     "shortName": "Segment Reporting - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451430 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
     "shortName": "Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ia630bb470ae642f8905431f2e294870b_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:AdjustedOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452431 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
     "shortName": "Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i234d631c1cd74b0aac095889f4187793_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i47ef065bc8ca45d686c76f5b4b47492d_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i6808fad4fe0f444295a5dbced96ba433_D20200101-20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "cvs:TreasuryStockSharesHeldinTrust",
       "cvs:TreasuryStockSharesHeldinTrust",
       "cvs:TreasuryStockSharesHeldinTrust",
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i4adcddfef50d4237a36d95774c4b5e7f_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldinTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "cvs:TreasuryStockSharesHeldinTrust",
       "cvs:TreasuryStockSharesHeldinTrust",
       "cvs:TreasuryStockSharesHeldinTrust",
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "i4adcddfef50d4237a36d95774c4b5e7f_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldinTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Significant Accounting Policies",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210930.htm",
      "contextRef": "ic05cb4705856461a984cc82a102d1b81_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 129,
   "tag": {
    "cvs_A2016RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Repurchase Program [Member]",
        "label": "2016 Repurchase Program [Member]",
        "terseLabel": "2016 Repurchase Program"
       }
      }
     },
     "localname": "A2016RepurchaseProgramMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ActivityInMortgageLoanPortfolioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table representing activities in mortgage loan portfolio during the period.",
        "label": "Activity in mortgage loan portfolio [Table Text Block]",
        "verboseLabel": "Schedule of Activity in Mortgage Loan Portfolio"
       }
      }
     },
     "localname": "ActivityInMortgageLoanPortfolioTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_AdjustedOperatingIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Operating Income (Loss)",
        "label": "Adjusted Operating Income (Loss)",
        "terseLabel": "Adjusted operating income (loss)"
       }
      }
     },
     "localname": "AdjustedOperatingIncomeLoss",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]",
        "label": "Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]",
        "terseLabel": "Adjustments required to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "label": "Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "negatedTerseLabel": "Acquisition purchase price adjustment outside of measurement period"
       }
      }
     },
     "localname": "BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_Categories5and6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Categories 5 and 6",
        "label": "Categories 5 and 6 [Member]",
        "terseLabel": "Categories 5 and 6"
       }
      }
     },
     "localname": "Categories5and6Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 1 [Member].",
        "label": "Category 1 [Member]",
        "terseLabel": "Category 1"
       }
      }
     },
     "localname": "Category1Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category2To4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].",
        "label": "Category 2 to 4 [Member]",
        "terseLabel": "Category 2 to 4"
       }
      }
     },
     "localname": "Category2To4Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Category 7",
        "label": "Category 7 [Member]",
        "terseLabel": "Category 7"
       }
      }
     },
     "localname": "Category7Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ChangeinContractwithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Contract with Customer, Liability [Roll Forward]",
        "label": "Change in Contract with Customer, Liability [Roll Forward]",
        "terseLabel": "Change in Contract with Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ChangeinContractwithCustomerLiabilityRollForward",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]",
        "label": "Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of effects from acquisitions:"
       }
      }
     },
     "localname": "ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]",
        "label": "Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]",
        "terseLabel": "Changes in Accumulated Other Comprehensive Income (Loss) by Component"
       }
      }
     },
     "localname": "ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_CommonAndCollectiveTrustsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.",
        "label": "Common and Collective Trusts [Member]",
        "terseLabel": "Common/collective trusts"
       }
      }
     },
     "localname": "CommonAndCollectiveTrustsMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.",
        "label": "Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance",
        "terseLabel": "Rewards earnings and gift card issuances"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ContractwithCustomerLiabilityRedemptionandBreakage": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer Liability Redemption and Breakage",
        "label": "Contract with Customer Liability Redemption and Breakage",
        "negatedTerseLabel": "Redemption and breakage"
       }
      }
     },
     "localname": "ContractwithCustomerLiabilityRedemptionandBreakage",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_CorporateOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate / Other [Member]",
        "label": "Corporate / Other [Member]",
        "terseLabel": "Corporate / Other"
       }
      }
     },
     "localname": "CorporateOtherMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CoventryHealthCareWorkersCompensationBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coventry Health Care Workers Compensation Business [Member]",
        "label": "Coventry Health Care Workers Compensation Business [Member]",
        "terseLabel": "Coventry Health Care Workers Compensation business"
       }
      }
     },
     "localname": "CoventryHealthCareWorkersCompensationBusinessMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "label": "Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "terseLabel": "Credit-related impairment loss"
       }
      }
     },
     "localname": "CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtAndEquitySecuritiesAvailableForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)",
        "label": "Debt And Equity Securities Available For Sale [Member]",
        "terseLabel": "Debt securities available for sale"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesAvailableForSaleMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DebtExtinguishmentFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Extinguishment Fees",
        "label": "Debt Extinguishment Fees",
        "terseLabel": "Debt Extinguishment Fees"
       }
      }
     },
     "localname": "DebtExtinguishmentFees",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net",
        "label": "Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Debt discounts and deferred financing costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Amortized Cost, Net",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "label": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Debt securities, maturity, without single maturity date, unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date, fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_Deferredincometaxesandothernoncashitems": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Deferred income taxes and other noncash items",
        "terseLabel": "Deferred income taxes and other noncash items"
       }
      }
     },
     "localname": "Deferredincometaxesandothernoncashitems",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DenominatorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominator For Earnings Per Share Calculation [Abstract]",
        "label": "Denominator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Denominator for earnings per share calculation:"
       }
      }
     },
     "localname": "DenominatorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method",
        "label": "ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares (in shares)"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method",
        "label": "ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FloatingRateNotesDueMarch2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Notes Due March 2021 [Member]",
        "label": "Floating Rate Notes Due March 2021 [Member]",
        "terseLabel": "Floating rate notes due March 2021 (0.950% at December 31, 2020)"
       }
      }
     },
     "localname": "FloatingRateNotesDueMarch2021Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FrontStoreRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Front Store Revenue [Member]",
        "label": "Front Store Revenue [Member]",
        "terseLabel": "Front Store"
       }
      }
     },
     "localname": "FrontStoreRevenueMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_GuarantorObligationsNumberofLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantor Obligations, Number of Leases",
        "label": "Guarantor Obligations, Number of Leases",
        "terseLabel": "Guarantor obligations, number of leases"
       }
      }
     },
     "localname": "GuarantorObligationsNumberofLeases",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_HealthCareBenefitsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Benefits Segment [Member]",
        "label": "Health Care Benefits Segment [Member]",
        "terseLabel": "Health Care Benefits"
       }
      }
     },
     "localname": "HealthCareBenefitsSegmentMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HealthCareandOtherInsuranceLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care and Other Insurance Liabilities [Abstract]",
        "label": "Health Care and Other Insurance Liabilities [Abstract]",
        "terseLabel": "Health Care and Other Insurance Liabilities [Abstract]"
       }
      }
     },
     "localname": "HealthCareandOtherInsuranceLiabilitiesAbstract",
     "nsuri": "http://www.cvshealth.com/20210930",
     "xbrltype": "stringItemType"
    },
    "cvs_HealthInsurerFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.",
        "label": "Health Insurer Fee",
        "terseLabel": "Health insurer fee"
       }
      }
     },
     "localname": "HealthInsurerFee",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_HeartlandHealthcareServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Heartland Healthcare Services [Member]",
        "label": "Heartland Healthcare Services [Member]",
        "terseLabel": "Heartland Healthcare Services"
       }
      }
     },
     "localname": "HeartlandHealthcareServicesMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States",
        "label": "Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States",
        "terseLabel": "Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States"
       }
      }
     },
     "localname": "IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts With Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts With Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts liabilities with a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts liabilities without a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithoutFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentIncomeExcludingCapitalGainsorLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Income, Excluding Capital Gains or Losses",
        "label": "Investment Income, Excluding Capital Gains or Losses",
        "totalLabel": "Net investment income (excluding net realized capital gains or losses)"
       }
      }
     },
     "localname": "InvestmentIncomeExcludingCapitalGainsorLosses",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "terseLabel": "Benefit costs recorded in other insurance liabilities"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LongTermCareReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Care Reporting Unit [Member]",
        "label": "Long-Term Care Reporting Unit [Member]",
        "terseLabel": "Long-Term Care Reporting Unit"
       }
      }
     },
     "localname": "LongTermCareReportingUnitMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_LongtermDebtGrossAndLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Gross And Lease Obligation",
        "label": "Long-term Debt, Gross And Lease Obligation",
        "totalLabel": "Total debt principal"
       }
      }
     },
     "localname": "LongtermDebtGrossAndLeaseObligation",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LossContingencyAuditMethodologySampleSize": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Audit Methodology Sample Size",
        "label": "Loss Contingency, Audit Methodology Sample Size",
        "terseLabel": "Sample size"
       }
      }
     },
     "localname": "LossContingencyAuditMethodologySampleSize",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_MortgageLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.",
        "label": "Mortgage Loans [Member]",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis].",
        "label": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]",
        "terseLabel": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCreditQualityIndicatorAxis",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain].",
        "label": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]",
        "terseLabel": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCreditQualityIndicatorDomain",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_MortgageLoansOnRealEstateLoansFullyRepaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertains to amount of mortgage loans fully repaid.",
        "label": "Mortgage Loans on Real Estate, Loans Fully Repaid",
        "terseLabel": "Mortgage loans fully repaid"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLoansFullyRepaid",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "label": "Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "terseLabel": "Mortgage Loans On Real Estate, Year Of Origination [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationAxis",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "label": "Mortgage Loans On Real Estate, Year Of Origination [Domain]",
        "terseLabel": "Mortgage Loans On Real Estate, Year Of Origination [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationDomain",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_NetRevenuesRetailCoPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Revenues, Retail CoPayments",
        "label": "Net Revenues, Retail CoPayments",
        "terseLabel": "Copayments"
       }
      }
     },
     "localname": "NetRevenuesRetailCoPayments",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling interest, Other Period Increase (Decrease)",
        "label": "Noncontrolling interest, Other Period Increase (Decrease)",
        "terseLabel": "Other increases (decreases) in noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollinginterestOtherPeriodIncreaseDecrease",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NumberOfPeopleServed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of People Served",
        "label": "Number Of People Served",
        "terseLabel": "Number of people served"
       }
      }
     },
     "localname": "NumberOfPeopleServed",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofPatientsServedperYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Patients Served per Year",
        "label": "Number of Patients Served per Year",
        "terseLabel": "Number of patients served per year"
       }
      }
     },
     "localname": "NumberofPatientsServedperYear",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofPharmacyPlanMembers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Pharmacy Plan Members",
        "label": "Number of Pharmacy Plan Members",
        "terseLabel": "Number of pharmacy plan members"
       }
      }
     },
     "localname": "NumberofPharmacyPlanMembers",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofWalkInMedicalClinics": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Walk In Medical Clinics",
        "label": "Number of Walk In Medical Clinics",
        "terseLabel": "Number of walk in medical clinics"
       }
      }
     },
     "localname": "NumberofWalkInMedicalClinics",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumeratorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator For Earnings Per Share Calculation [Abstract]",
        "label": "Numerator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Numerator for earnings per share calculation:"
       }
      }
     },
     "localname": "NumeratorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OperatingExpensesExcludingGoodwillImpairments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Expenses, Excluding Goodwill Impairments",
        "label": "Operating Expenses, Excluding Goodwill Impairments",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesExcludingGoodwillImpairments",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherAssetBackedSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.",
        "label": "Other Asset-Backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "OtherAssetBackedSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherInsuranceLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Current",
        "label": "Other Insurance Liabilities, Current",
        "terseLabel": "Other insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesCurrent",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherInsuranceLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Noncurrent",
        "label": "Other Insurance Liabilities, Noncurrent",
        "terseLabel": "Other long-term insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesNoncurrent",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Receivables",
        "label": "Other Receivables [Member]",
        "terseLabel": "Other Receivables"
       }
      }
     },
     "localname": "OtherReceivablesMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OutstandingSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding Senior Notes [Member]",
        "label": "Outstanding Senior Notes [Member]",
        "terseLabel": "Outstanding Senior Notes"
       }
      }
     },
     "localname": "OutstandingSeniorNotesMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PaymentsToHealthInsurerFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Health Insurer Fee",
        "label": "Payments to Health Insurer Fee",
        "terseLabel": "Payments to HIF"
       }
      }
     },
     "localname": "PaymentsToHealthInsurerFee",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PaymentsforInsuranceBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Insurance Benefits",
        "label": "Payments for Insurance Benefits",
        "negatedTerseLabel": "Insurance benefits paid"
       }
      }
     },
     "localname": "PaymentsforInsuranceBenefits",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies",
        "label": "Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies",
        "negatedTerseLabel": "Cash paid for inventory and prescriptions dispensed by retail network pharmacies"
       }
      }
     },
     "localname": "PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PharmacyClaimsandDiscountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Claims and Discounts Payable, Current",
        "label": "Pharmacy Claims and Discounts Payable, Current",
        "terseLabel": "Pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "PharmacyClaimsandDiscountsPayableCurrent",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PharmacyRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Revenue [Member]",
        "label": "Pharmacy Revenue [Member]",
        "terseLabel": "Pharmacy"
       }
      }
     },
     "localname": "PharmacyRevenueMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PharmacyServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Services Segment [Member]",
        "label": "Pharmacy Services Segment [Member]",
        "terseLabel": "Pharmacy Services"
       }
      }
     },
     "localname": "PharmacyServicesSegmentMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PremiumDeficiencyReserveLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.",
        "label": "Premium Deficiency Reserve Liability",
        "terseLabel": "Add: Premium deficiency reserve",
        "verboseLabel": "Premium deficiency reserve"
       }
      }
     },
     "localname": "PremiumDeficiencyReserveLiability",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "label": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues",
        "verboseLabel": "Revenues from external customers"
       }
      }
     },
     "localname": "PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums [Member]",
        "label": "Premiums [Member]",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.",
        "label": "Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]",
        "verboseLabel": "Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities"
       }
      }
     },
     "localname": "ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_RadcliffeAndFlaimVAetnaIncEtAlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Radcliffe and Flaim v. Aetna Inc., et al",
        "label": "Radcliffe and Flaim v. Aetna Inc., et al [Member]",
        "terseLabel": "Radcliffe and Flaim v. Aetna Inc., et al"
       }
      }
     },
     "localname": "RadcliffeAndFlaimVAetnaIncEtAlMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "label": "Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "terseLabel": "Receipt related purchase price adjustment from acquisition"
       }
      }
     },
     "localname": "ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_RetailLongTermCareSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail Long-Term Care Segment [Member]",
        "label": "Retail Long-Term Care Segment [Member]",
        "terseLabel": "Retail/ LTC"
       }
      }
     },
     "localname": "RetailLongTermCareSegmentMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SalesChannelOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Channel, Other [Member]",
        "label": "Sales Channel, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "SalesChannelOtherMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.",
        "label": "Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]",
        "verboseLabel": "Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator"
       }
      }
     },
     "localname": "ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_SeniorNotes13DueAugust2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.3%, Due August 2027",
        "label": "Senior Notes, 1.3%, Due August 2027 [Member]",
        "terseLabel": "1.3% senior notes due August 2027"
       }
      }
     },
     "localname": "SeniorNotes13DueAugust2027Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes175DueAugust2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.75%, Due August 2030",
        "label": "Senior Notes, 1.75%, Due August 2030 [Member]",
        "terseLabel": "1.75% senior notes due August 2030"
       }
      }
     },
     "localname": "SeniorNotes175DueAugust2030Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes1875DueFebruary2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.875%, Due February 2031",
        "label": "Senior Notes, 1.875%, Due February 2031 [Member]",
        "terseLabel": "1.875% senior notes due February 2031"
       }
      }
     },
     "localname": "SeniorNotes1875DueFebruary2031Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.125June2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.125%, June 2021 [Member]",
        "label": "Senior Notes, 2.125%, June 2021 [Member]",
        "terseLabel": "2.125% senior notes due June 2021"
       }
      }
     },
     "localname": "SeniorNotes2.125June2021Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.625DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "label": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "terseLabel": "2.625% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes2.625DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.75DueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.75%, Due December 2022 [Member]",
        "label": "Senior Notes, 2.75%, Due December 2022 [Member]",
        "terseLabel": "2.75% senior notes due December 2022"
       }
      }
     },
     "localname": "SeniorNotes2.75DueDecember2022Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.75DueNovember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.75%, Due November 2022 [Member]",
        "label": "Senior Notes, 2.75%, Due November 2022 [Member]",
        "terseLabel": "2.75% senior notes due November 2022"
       }
      }
     },
     "localname": "SeniorNotes2.75DueNovember2022Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.875DueJune2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "label": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "terseLabel": "2.875% senior notes due June 2026"
       }
      }
     },
     "localname": "SeniorNotes2.875DueJune2026Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.8DueJune2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "label": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "terseLabel": "2.8% senior notes due June 2023"
       }
      }
     },
     "localname": "SeniorNotes2.8DueJune2023Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2125PercentDueAugust2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.125 Percent, Due August 2031",
        "label": "Senior Notes, 2.125 Percent, Due August 2031 [Member]",
        "terseLabel": "2.125% senior notes due September 2031"
       }
      }
     },
     "localname": "SeniorNotes2125PercentDueAugust2031Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes27DueAugust2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.7%, Due August 2040",
        "label": "Senior Notes, 2.7%, Due August 2040 [Member]",
        "terseLabel": "2.7% senior notes due August 2040"
       }
      }
     },
     "localname": "SeniorNotes27DueAugust2040Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.25DueAugust2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "label": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "terseLabel": "3.25% senior notes due August 2029"
       }
      }
     },
     "localname": "SeniorNotes3.25DueAugust2029Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.35DueMarch2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.35%, Due March 2021 [Member]",
        "label": "Senior Notes, 3.35%, Due March 2021 [Member]",
        "terseLabel": "3.35% senior notes due March 2021"
       }
      }
     },
     "localname": "SeniorNotes3.35DueMarch2021Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.375DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "label": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "terseLabel": "3.375% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes3.375DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.5DueJuly2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.5%, Due July 2022 [Member]",
        "label": "Senior Notes, 3.5%, Due July 2022 [Member]",
        "terseLabel": "3.5% senior notes due July 2022"
       }
      }
     },
     "localname": "SeniorNotes3.5DueJuly2022Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.5DueNovember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "label": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "terseLabel": "3.5% senior notes due November 2024"
       }
      }
     },
     "localname": "SeniorNotes3.5DueNovember2024Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.625DueApril2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.625%, Due April 2027 [Member]",
        "label": "Senior Notes, 3.625%, Due April 2027 [Member]",
        "terseLabel": "3.625% senior notes due April 2027"
       }
      }
     },
     "localname": "SeniorNotes3.625DueApril2027Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.75DueApril2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.75%, Due April 2030 [Member]",
        "label": "Senior Notes, 3.75%, Due April 2030 [Member]",
        "terseLabel": "3.75% senior notes due April 2030"
       }
      }
     },
     "localname": "SeniorNotes3.75DueApril2030Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.7DueMarch2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.7%, Due March 2023 [Member]",
        "label": "Senior Notes, 3.7%, Due March 2023 [Member]",
        "terseLabel": "3.7% senior notes due March 2023"
       }
      }
     },
     "localname": "SeniorNotes3.7DueMarch2023Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueAugust2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "label": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "terseLabel": "3.875% senior notes due August 2047"
       }
      }
     },
     "localname": "SeniorNotes3.875DueAugust2047Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueJuly2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "label": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "terseLabel": "3.875% senior notes due July 2025"
       }
      }
     },
     "localname": "SeniorNotes3.875DueJuly2025Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3DueAugust2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3%, Due August 2026 [Member]",
        "label": "Senior Notes, 3%, Due August 2026 [Member]",
        "terseLabel": "3% senior notes due August 2026"
       }
      }
     },
     "localname": "SeniorNotes3DueAugust2026Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueApril2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due April 2040 [Member]",
        "label": "Senior Notes, 4.125%, Due April 2040 [Member]",
        "terseLabel": "4.125% senior notes due April 2040"
       }
      }
     },
     "localname": "SeniorNotes4.125DueApril2040Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueJune2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due June 2021 [Member]",
        "label": "Senior Notes, 4.125%, Due June 2021 [Member]",
        "terseLabel": "4.125% senior notes due June 2021"
       }
      }
     },
     "localname": "SeniorNotes4.125DueJune2021Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueMay2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due May 2021 [Member]",
        "label": "Senior Notes, 4.125%, Due May 2021 [Member]",
        "terseLabel": "4.125% senior notes due May 2021"
       }
      }
     },
     "localname": "SeniorNotes4.125DueMay2021Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueNovember2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents senior notes due 2042 with a coupon rate of 4.125%.",
        "label": "Senior Notes, 4.125%, Due November 2042 [Member]",
        "terseLabel": "4.125% senior notes due November 2042"
       }
      }
     },
     "localname": "SeniorNotes4.125DueNovember2042Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.1DueMarch2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "label": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "terseLabel": "4.1% senior notes due March 2025"
       }
      }
     },
     "localname": "SeniorNotes4.1DueMarch2025Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.25DueApril2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.25%, Due April 2050 [Member]",
        "label": "Senior Notes, 4.25%, Due April 2050 [Member]",
        "terseLabel": "4.25% senior notes due April 2050"
       }
      }
     },
     "localname": "SeniorNotes4.25DueApril2050Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.3DueMarch2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "label": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "terseLabel": "4.3% senior notes due March 2028"
       }
      }
     },
     "localname": "SeniorNotes4.3DueMarch2028Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.5DueMay2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "label": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "terseLabel": "4.5% senior notes due May 2042"
       }
      }
     },
     "localname": "SeniorNotes4.5DueMay2042Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.75DueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.75%, Due December 2022 [Member]",
        "label": "Senior Notes, 4.75%, Due December 2022 [Member]",
        "terseLabel": "4.75% senior notes due December 2022"
       }
      }
     },
     "localname": "SeniorNotes4.75DueDecember2022Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.75DueMarch2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "label": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "terseLabel": "4.75% senior notes due March 2044"
       }
      }
     },
     "localname": "SeniorNotes4.75DueMarch2044Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.78DueMarch2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "label": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "terseLabel": "4.78% senior notes due March 2038"
       }
      }
     },
     "localname": "SeniorNotes4.78DueMarch2038Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.875DueJuly2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "label": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "terseLabel": "4.875% senior notes due July 2035"
       }
      }
     },
     "localname": "SeniorNotes4.875DueJuly2035Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes43Due2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.3%, Due 2028",
        "label": "Senior Notes, 4.3%, Due 2028 [Member]",
        "terseLabel": "Senior Notes, 4.3%, Due 2028"
       }
      }
     },
     "localname": "SeniorNotes43Due2028Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4DueDecember2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4%, Due December 2023 [Member]",
        "label": "Senior Notes, 4%, Due December 2023 [Member]",
        "terseLabel": "4% senior notes due December 2023"
       }
      }
     },
     "localname": "SeniorNotes4DueDecember2023Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.05DueMarch2048Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "label": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "terseLabel": "5.05% senior notes due March 2048"
       }
      }
     },
     "localname": "SeniorNotes5.05DueMarch2048Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.125DueJuly2045Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "label": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "terseLabel": "5.125% senior notes due July 2045"
       }
      }
     },
     "localname": "SeniorNotes5.125DueJuly2045Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.3DueDecember2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "label": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "terseLabel": "5.3% senior notes due December 2043"
       }
      }
     },
     "localname": "SeniorNotes5.3DueDecember2043Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.45DueJune2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents senior notes due 2021 with a coupon rate of 5.45%.",
        "label": "Senior Notes, 5.45%, Due June 2021 [Member]",
        "terseLabel": "5.45% senior notes due June 2021"
       }
      }
     },
     "localname": "SeniorNotes5.45DueJune2021Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.75DueMay2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "label": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "terseLabel": "5.75% senior notes due May 2041"
       }
      }
     },
     "localname": "SeniorNotes5.75DueMay2041Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5DueDecember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5%, Due December 2024 [Member]",
        "label": "Senior Notes, 5%, Due December 2024 [Member]",
        "terseLabel": "5% senior notes due December 2024"
       }
      }
     },
     "localname": "SeniorNotes5DueDecember2024Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.125DueSeptember2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "label": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "terseLabel": "6.125% senior notes due September 2039"
       }
      }
     },
     "localname": "SeniorNotes6.125DueSeptember2039Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.25DueJune2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "label": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "terseLabel": "6.25% senior notes due June 2027"
       }
      }
     },
     "localname": "SeniorNotes6.25DueJune2027Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.625DueJune2036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "label": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "terseLabel": "6.625% senior notes due June 2036"
       }
      }
     },
     "localname": "SeniorNotes6.625DueJune2036Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.75DueDecember2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "label": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "terseLabel": "6.75% senior notes due December 2037"
       }
      }
     },
     "localname": "SeniorNotes6.75DueDecember2037Member",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SupportingExperienceRatedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supporting discontinued and experience-rated products.",
        "label": "Supporting Experience Rated Products [Member]",
        "terseLabel": "Supporting experience-rated products"
       }
      }
     },
     "localname": "SupportingExperienceRatedProductsMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SupportingRemainingProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities in an unrealized capital loss position supporting remaining products.",
        "label": "Supporting Remaining Products [Member]",
        "terseLabel": "Supporting remaining products"
       }
      }
     },
     "localname": "SupportingRemainingProductsMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Axis]",
        "terseLabel": "Total Investments [Axis]"
       }
      }
     },
     "localname": "TotalInvestmentsAxis",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Domain]",
        "terseLabel": "Total Investments [Domain]"
       }
      }
     },
     "localname": "TotalInvestmentsDomain",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Line Items]",
        "terseLabel": "Total Investments [Line Items]"
       }
      }
     },
     "localname": "TotalInvestmentsLineItems",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Table]",
        "terseLabel": "Total Investments [Table]"
       }
      }
     },
     "localname": "TotalInvestmentsTable",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes total investments, both current and long-term.",
        "label": "Total Investments [Table Text Block]",
        "verboseLabel": "Schedule of Total Investments"
       }
      }
     },
     "localname": "TotalInvestmentsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchases of treasury shares, net of ESPP issuances (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockSharesHeldinTrust": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Held in Trust",
        "label": "Treasury Stock, Shares, Held in Trust",
        "terseLabel": "Treasury shares held in trust (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesHeldinTrust",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchase of treasury shares, net of ESPP issuances"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TreasuryStockValueSharesHeldInTrust": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Shares Held In Trust",
        "label": "Treasury Stock, Value, Shares Held In Trust",
        "terseLabel": "Treasury share held in trust"
       }
      }
     },
     "localname": "TreasuryStockValueSharesHeldInTrust",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_VendorandManufacturerReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor and Manufacturer Receivables",
        "label": "Vendor and Manufacturer Receivables",
        "terseLabel": "Vendor and manufacturer receivables"
       }
      }
     },
     "localname": "VendorandManufacturerReceivables",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_YearOfOriginationPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Five [Member]",
        "label": "Year Of Origination, Period Five [Member]",
        "terseLabel": "2017"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Four [Member]",
        "label": "Year Of Origination, Period Four [Member]",
        "terseLabel": "2018"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFourMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period One [Member]",
        "label": "Year Of Origination, Period One [Member]",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "YearOfOriginationPeriodOneMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Three [Member]",
        "label": "Year Of Origination, Period Three [Member]",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "YearOfOriginationPeriodThreeMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Two [Member]",
        "label": "Year Of Origination, Period Two [Member]",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "YearOfOriginationPeriodTwoMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPriorToPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Prior To Period Five [Member]",
        "label": "Year Of Origination, Prior To Period Five [Member]",
        "terseLabel": "Prior"
       }
      }
     },
     "localname": "YearOfOriginationPriorToPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "label": "Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "terseLabel": "Yield-related impairment loss"
       }
      }
     },
     "localname": "YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20210930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r132",
      "r176",
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r202",
      "r206",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r327",
      "r329",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r132",
      "r176",
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r202",
      "r206",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r327",
      "r329",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r137",
      "r145",
      "r151",
      "r258",
      "r434",
      "r435",
      "r436",
      "r443",
      "r444",
      "r472",
      "r475",
      "r477",
      "r478",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r137",
      "r145",
      "r151",
      "r258",
      "r434",
      "r435",
      "r436",
      "r443",
      "r444",
      "r472",
      "r475",
      "r477",
      "r478",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r137",
      "r145",
      "r151",
      "r258",
      "r434",
      "r435",
      "r436",
      "r443",
      "r444",
      "r472",
      "r475",
      "r477",
      "r478",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "auth_ref": [
      "r683",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate, Type of Property [Axis]",
        "terseLabel": "Real Estate, Type of Property [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]",
        "terseLabel": "Mortgage Loans on Real Estate [Line Items]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "auth_ref": [
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate [Domain]",
        "terseLabel": "Real Estate [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateScheduleTable": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]",
        "terseLabel": "Mortgage Loans on Real Estate [Table]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateScheduleTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r209",
      "r407",
      "r409",
      "r558",
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r209",
      "r407",
      "r409",
      "r558",
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "Accounting Standards Update 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r138",
      "r139",
      "r140",
      "r141",
      "r223",
      "r224",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r316",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r443",
      "r444",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r521",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r15",
      "r39"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r11",
      "r28",
      "r214",
      "r215"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net",
        "totalLabel": "Total accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r59",
      "r64",
      "r73",
      "r74",
      "r75",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Pension and OPEB plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r54",
      "r64",
      "r73",
      "r74",
      "r75",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r64",
      "r73",
      "r74",
      "r75",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r56",
      "r57",
      "r58",
      "r64",
      "r73",
      "r74",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r31",
      "r62",
      "r63",
      "r64",
      "r614",
      "r653",
      "r657"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r61",
      "r64",
      "r73",
      "r74",
      "r75",
      "r134",
      "r135",
      "r136",
      "r458",
      "r648",
      "r649",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r138",
      "r139",
      "r140",
      "r141",
      "r151",
      "r223",
      "r224",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r316",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r441",
      "r442",
      "r443",
      "r444",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r521",
      "r559",
      "r560",
      "r561",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r217",
      "r261",
      "r263",
      "r264"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r118",
      "r293",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of EPS (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r61",
      "r64",
      "r73",
      "r74",
      "r75",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r129",
      "r184",
      "r197",
      "r204",
      "r253",
      "r317",
      "r318",
      "r319",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r328",
      "r330",
      "r331",
      "r451",
      "r460",
      "r495",
      "r525",
      "r527",
      "r578",
      "r612"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r52",
      "r129",
      "r253",
      "r317",
      "r318",
      "r319",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r328",
      "r330",
      "r331",
      "r451",
      "r460",
      "r495",
      "r525",
      "r527"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r480"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r230"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r232",
      "r235",
      "r598"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r232",
      "r234",
      "r597"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r232",
      "r236",
      "r599"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r232",
      "r233",
      "r596"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r237",
      "r600"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r225",
      "r228",
      "r270",
      "r585"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value",
        "totalLabel": "Total",
        "verboseLabel": "Debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]",
        "terseLabel": "Number of Securities"
       }
      }
     },
     "localname": "AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BenefitsLossesAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Benefits, Losses and Expenses [Abstract]",
        "verboseLabel": "Operating costs:"
       }
      }
     },
     "localname": "BenefitsLossesAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Acquisition-related integration costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r9",
      "r36",
      "r120"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r17",
      "r121",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r110",
      "r120",
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period",
        "totalLabel": "Total cash, cash equivalents and restricted cash in the statements of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r110",
      "r504"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r389",
      "r390",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r237",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage Backed Securities [Member]",
        "terseLabel": "Commercial mortgage-backed securities"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialRealEstateMember": {
     "auth_ref": [
      "r269",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property that is solely used for business purposes.",
        "label": "Commercial Real Estate [Member]",
        "terseLabel": "Commercial Real Estate"
       }
      }
     },
     "localname": "CommercialRealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r301",
      "r302",
      "r303",
      "r312",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock).",
        "label": "Common Stock Including Additional Paid in Capital [Member]",
        "terseLabel": "Common Stock Including Capital Surplus"
       }
      }
     },
     "localname": "CommonStockIncludingAdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r134",
      "r135",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r27",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r27",
      "r527"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStocksIncludingAdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r29",
      "r388"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of par value plus amounts in excess of par value or issuance value for common stock issued.",
        "label": "Common Stocks, Including Additional Paid in Capital",
        "terseLabel": "Common stock, par value $0.01: 3,200 shares authorized; 1,743 shares issued and 1,321 shares outstanding at September\u00a030, 2021 and 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and capital surplus"
       }
      }
     },
     "localname": "CommonStocksIncludingAdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r69",
      "r71",
      "r72",
      "r83",
      "r591",
      "r627"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to CVS Health"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r69",
      "r71",
      "r82",
      "r449",
      "r464",
      "r590",
      "r626"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r81",
      "r90",
      "r589",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r124",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of receivables and contract liabilities from contracts with customers"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r394",
      "r396",
      "r408"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables",
        "verboseLabel": "Trade receivables (included in accounts receivable, net)"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r394",
      "r395",
      "r408"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "periodEndLabel": "Contract liabilities, end of the period",
        "periodStartLabel": "Contract liabilities, beginning of the period",
        "terseLabel": "Contract liabilities (included in accrued expenses)"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r407",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r407",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r206",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate/ Other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r86",
      "r558"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r126",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r349",
      "r356",
      "r357",
      "r359",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Borrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r22",
      "r24",
      "r25",
      "r128",
      "r132",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r361",
      "r362",
      "r363",
      "r364",
      "r516",
      "r579",
      "r580",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r25",
      "r360",
      "r580",
      "r608"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "cvs_LongtermDebtGrossAndLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r332",
      "r361",
      "r362",
      "r514",
      "r516",
      "r517"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r347",
      "r361",
      "r362",
      "r492"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r43",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r44",
      "r128",
      "r132",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r361",
      "r362",
      "r363",
      "r364",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r44",
      "r128",
      "r132",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r358",
      "r361",
      "r362",
      "r363",
      "r364",
      "r384",
      "r385",
      "r386",
      "r387",
      "r513",
      "r514",
      "r516",
      "r517",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r345",
      "r513",
      "r517"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premiums"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r229",
      "r270",
      "r278",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for credit losses recorded"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r245",
      "r276",
      "r281"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Fair Value, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r245",
      "r276"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "terseLabel": "Unrealized Losses, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions": {
     "auth_ref": [
      "r274"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions",
        "terseLabel": "Number of Securities, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r245",
      "r276",
      "r281"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "verboseLabel": "Fair Value, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r245",
      "r276"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "verboseLabel": "Unrealized Losses, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
     "auth_ref": [
      "r274"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
        "terseLabel": "Number of Securities, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Gain",
        "terseLabel": "Gross realized capital gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Loss",
        "terseLabel": "Gross realized capital losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Debt Securities Available For Sale"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r241",
      "r272",
      "r281"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r242",
      "r273"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss",
        "totalLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r243",
      "r274"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "totalLabel": "Number of Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r118",
      "r179"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r407",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Sale [Member]",
        "terseLabel": "Discontinued Operations, Disposed of by Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r388",
      "r603"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedTerseLabel": "Common stock dividends"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r227",
      "r417",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, US [Member]",
        "terseLabel": "U.S. corporate securities"
       }
      }
     },
     "localname": "DomesticCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share attributable to CVS Health:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r84",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r152",
      "r155",
      "r161",
      "r162",
      "r163",
      "r167",
      "r168",
      "r478",
      "r479",
      "r592",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings per share, basic (in dollars per share)",
        "verboseLabel": "Net income per share attributable to CVS Health, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r84",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r155",
      "r161",
      "r162",
      "r163",
      "r167",
      "r168",
      "r478",
      "r479",
      "r592",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings per share, diluted (in dollars per share)",
        "verboseLabel": "Net income per share attributable to CVS Health, diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r164",
      "r165",
      "r166",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r73",
      "r74",
      "r75",
      "r134",
      "r135",
      "r136",
      "r139",
      "r148",
      "r150",
      "r170",
      "r258",
      "r383",
      "r388",
      "r434",
      "r435",
      "r436",
      "r443",
      "r444",
      "r477",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r511",
      "r648",
      "r649",
      "r650",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r37",
      "r109",
      "r252",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r18",
      "r23",
      "r248",
      "r609",
      "r678",
      "r679",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r347",
      "r361",
      "r362",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Aggregate principal of debt extinguished"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r480",
      "r481",
      "r482",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r480",
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r480",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r347",
      "r361",
      "r362",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r425",
      "r481",
      "r531",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r347",
      "r361",
      "r362",
      "r480",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r480",
      "r481",
      "r483",
      "r484",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r347",
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).",
        "label": "Fair Value, Inputs, Level 1, 2 and 3 [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "FairValueInputsLevel12And3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r347",
      "r417",
      "r418",
      "r423",
      "r425",
      "r481",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r347",
      "r361",
      "r362",
      "r417",
      "r418",
      "r423",
      "r425",
      "r481",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r347",
      "r361",
      "r362",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r425",
      "r481",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r347",
      "r361",
      "r362",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r425",
      "r531",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r480",
      "r481",
      "r483",
      "r484",
      "r485",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r486",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r519",
      "r520"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "cvs_LongtermDebtGrossAndLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r238",
      "r239",
      "r249",
      "r250",
      "r251",
      "r262",
      "r265",
      "r266",
      "r267",
      "r268",
      "r275",
      "r277",
      "r280",
      "r281",
      "r358",
      "r381",
      "r468",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial liabilities at fair value on a recurring basis"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r227",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation not domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, Non-US [Member]",
        "terseLabel": "Foreign securities"
       }
      }
     },
     "localname": "ForeignCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r118",
      "r459"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Gain on sale of subsidiary"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r118",
      "r365",
      "r366"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r365",
      "r366"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.",
        "label": "Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost",
        "negatedTerseLabel": "Premium paid in excess of debt principal"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r282",
      "r284",
      "r527",
      "r577"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance, end of the period",
        "periodStartLabel": "Balance, beginning of the period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r285",
      "r287"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Cumulative goodwill impairments"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r118",
      "r283",
      "r286",
      "r290"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill impairment",
        "terseLabel": "Goodwill impairment",
        "verboseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareEntitiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for all health care policies.",
        "label": "Health Care Entities, Policy [Policy Text Block]",
        "terseLabel": "Health Insurer Fee"
       }
      }
     },
     "localname": "HealthCareEntitiesPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HealthInsuranceProductLineMember": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product line consisting of insurance against loss by illness or injury.",
        "label": "Health Insurance Product Line [Member]",
        "terseLabel": "Health Insurance Product Line"
       }
      }
     },
     "localname": "HealthInsuranceProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r79",
      "r184",
      "r196",
      "r200",
      "r203",
      "r206",
      "r574",
      "r587",
      "r594",
      "r629"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income tax provision"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r130",
      "r149",
      "r150",
      "r182",
      "r440",
      "r445",
      "r446",
      "r630"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "negatedTerseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable and pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInsuranceLiabilities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in insurance liability balances during the period.",
        "label": "Increase (Decrease) in Insurance Liabilities",
        "terseLabel": "Health care costs payable and other insurance liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Shareholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r163"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r292",
      "r294"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r77",
      "r178",
      "r512",
      "r515",
      "r593"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r107",
      "r114",
      "r122"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "negatedTerseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Amount expected to be reclassified"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r176",
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r202",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r10",
      "r50",
      "r527"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsorLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Gross investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInvestmentExpense": {
     "auth_ref": [
      "r89",
      "r631"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsorLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to the generation of investment income.",
        "label": "Investment Income, Investment Expense",
        "negatedLabel": "Investment expenses"
       }
      }
     },
     "localname": "InvestmentIncomeInvestmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r87",
      "r88"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "totalLabel": "Net investment income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeTextBlock": {
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table Text Block]",
        "verboseLabel": "Schedule of Net Investment Income"
       }
      }
     },
     "localname": "InvestmentIncomeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r620"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "verboseLabel": "Schedule of Amortized Cost and Fair Value of Debt Securities by Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r248",
      "r575",
      "r601",
      "r681",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r40",
      "r129",
      "r198",
      "r253",
      "r317",
      "r318",
      "r319",
      "r322",
      "r323",
      "r324",
      "r326",
      "r328",
      "r330",
      "r331",
      "r452",
      "r460",
      "r461",
      "r495",
      "r525",
      "r526"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r34",
      "r129",
      "r253",
      "r495",
      "r527",
      "r582",
      "r617"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r42",
      "r129",
      "r253",
      "r317",
      "r318",
      "r319",
      "r322",
      "r323",
      "r324",
      "r326",
      "r328",
      "r330",
      "r331",
      "r452",
      "r460",
      "r461",
      "r495",
      "r525",
      "r526",
      "r527"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r636",
      "r639"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Health care costs payable, end of the period",
        "periodStartLabel": "Health care costs payable, beginning of the period"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liability for Claims and Claims Adjustment Expense [Line Items]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.",
        "label": "Liability for Claims and Claims Adjustment Expense [Table]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "terseLabel": "Acquisition"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Less: Claims paid"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r638"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r637"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Add: Components of incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": {
     "auth_ref": [
      "r607",
      "r636",
      "r639"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "periodEndLabel": "Health care costs payable, end of the period, net",
        "periodStartLabel": "Health care costs payable, beginning of the period, net",
        "terseLabel": "Health care costs payable"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "negatedTerseLabel": "Current portion of long-term debt",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Long-term debt and lease obligation"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-term Investments",
        "terseLabel": "Long-term",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r44",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r49",
      "r129",
      "r253",
      "r317",
      "r322",
      "r323",
      "r324",
      "r330",
      "r331",
      "r495",
      "r581",
      "r616"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstate": {
     "auth_ref": [
      "r682"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateForeclosures": {
     "auth_ref": [
      "r684"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure",
        "terseLabel": "Mortgage loans foreclosed"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateForeclosures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateNewMortgageLoans": {
     "auth_ref": [
      "r684"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan",
        "terseLabel": "New mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNewMortgageLoans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgagesHeldForSaleFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of mortgage loans held-for-sale.",
        "label": "Mortgages Held-for-sale, Fair Value Disclosure",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgagesHeldForSaleFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r110",
      "r116",
      "r119"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r8",
      "r67",
      "r70",
      "r75",
      "r80",
      "r119",
      "r129",
      "r138",
      "r143",
      "r144",
      "r145",
      "r146",
      "r149",
      "r150",
      "r159",
      "r184",
      "r196",
      "r200",
      "r203",
      "r206",
      "r253",
      "r317",
      "r318",
      "r319",
      "r322",
      "r323",
      "r324",
      "r326",
      "r328",
      "r330",
      "r331",
      "r479",
      "r495",
      "r588",
      "r623"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to CVS Health"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r67",
      "r70",
      "r75",
      "r149",
      "r150",
      "r455",
      "r463"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Comprehensive (income) loss attributable to noncontrolling interests",
        "negatedTerseLabel": "Net (income) loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r146",
      "r152",
      "r153",
      "r160",
      "r163",
      "r184",
      "r196",
      "r200",
      "r203",
      "r206"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income attributable to CVS Health"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentIncome": {
     "auth_ref": [
      "r625"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.",
        "label": "Net Investment Income",
        "terseLabel": "Net investment income (loss)",
        "verboseLabel": "Net investment income"
       }
      }
     },
     "localname": "NetInvestmentIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r145",
      "r151",
      "r167",
      "r223",
      "r224",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r316",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r441",
      "r442",
      "r443",
      "r444",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r521",
      "r559",
      "r560",
      "r561",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements Recently Adopted and Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r388",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Other Payables"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableToBanksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a bank.",
        "label": "Notes Payable to Banks [Member]",
        "terseLabel": "Floating Rate Notes"
       }
      }
     },
     "localname": "NotesPayableToBanksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which entity operates"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStores": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of stores.",
        "label": "Number of Stores",
        "terseLabel": "Number of stores"
       }
      }
     },
     "localname": "NumberOfStores",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r184",
      "r196",
      "r200",
      "r203",
      "r206"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (GAAP measure)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r519"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r519"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r518"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r51",
      "r527"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r449",
      "r450",
      "r457"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r64",
      "r73",
      "r74",
      "r505",
      "r507",
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "OCI before Reclass, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r64",
      "r73",
      "r74",
      "r76",
      "r505",
      "r507",
      "r511"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "verboseLabel": "Other Comprehensive income (loss) before reclassifications, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r55",
      "r62"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r68",
      "r71",
      "r73",
      "r74",
      "r76",
      "r81",
      "r383",
      "r505",
      "r510",
      "r511",
      "r589",
      "r624"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive Income (loss)",
        "totalLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r60",
      "r62"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax": {
     "auth_ref": [
      "r62",
      "r65",
      "r66",
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax",
        "terseLabel": "Amounts reclassified, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r240",
      "r271",
      "r417",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other Debt Obligations"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPolicyholderFunds": {
     "auth_ref": [
      "r621"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.",
        "label": "Other Policyholder Funds",
        "terseLabel": "Policyholders\u2019 funds"
       }
      }
     },
     "localname": "OtherPolicyholderFunds",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total CVS Health Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r115",
      "r638"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "totalLabel": "Total claims paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash outflow or inflow from derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.",
        "label": "Payments for (Proceeds from) Derivative Instrument, Financing Activities",
        "negatedTerseLabel": "Derivative settlements"
       }
      }
     },
     "localname": "PaymentsForProceedsFromDerivativeInstrumentFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r94",
      "r97"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Payments for taxes related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions (net of cash acquired)"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToSuppliersAndEmployees": {
     "auth_ref": [
      "r105",
      "r106",
      "r113"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to suppliers for goods and services provided and to employees for services provided.",
        "label": "Payments to Suppliers and Employees",
        "negatedTerseLabel": "Cash paid to other suppliers and employees"
       }
      }
     },
     "localname": "PaymentsToSuppliersAndEmployees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r633"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "verboseLabel": "Benefit costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r26",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r26",
      "r527"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r586",
      "r622",
      "r634",
      "r658"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAtCarryingValue": {
     "auth_ref": [
      "r619"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.",
        "label": "Premiums Receivable, Net",
        "terseLabel": "Premium receivables"
       }
      }
     },
     "localname": "PremiumsReceivableAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCustomers": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash receipts from customers during the current period which are usually for sales of goods and services.",
        "label": "Proceeds from Customers",
        "terseLabel": "Cash receipts from customers"
       }
      }
     },
     "localname": "ProceedsFromCustomers",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of subsidiary"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromInterestAndDividendsReceived": {
     "auth_ref": [
      "r104",
      "r112"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for dividends and interest on the entity's equity and debt investments during the current period.",
        "label": "Proceeds from Interest and Dividends Received",
        "terseLabel": "Interest and investment income received"
       }
      }
     },
     "localname": "ProceedsFromInterestAndDividendsReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r100",
      "r103"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r91",
      "r92",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from sales"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r98",
      "r429"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r8",
      "r67",
      "r70",
      "r75",
      "r108",
      "r129",
      "r138",
      "r149",
      "r150",
      "r184",
      "r196",
      "r200",
      "r203",
      "r206",
      "r253",
      "r317",
      "r318",
      "r319",
      "r322",
      "r323",
      "r324",
      "r326",
      "r328",
      "r330",
      "r331",
      "r449",
      "r454",
      "r456",
      "r463",
      "r464",
      "r479",
      "r495",
      "r594"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r19",
      "r20",
      "r297",
      "r527",
      "r602",
      "r618"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "terseLabel": "Net realized capital gains (losses)"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r216",
      "r220",
      "r221",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r35",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r64",
      "r73",
      "r74",
      "r76",
      "r505",
      "r509",
      "r511"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r196",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Operating Earnings to Net Income"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r16",
      "r129",
      "r253",
      "r317",
      "r322",
      "r323",
      "r324",
      "r330",
      "r331",
      "r368",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]",
        "terseLabel": "Redeemable preferred securities"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": {
     "auth_ref": [
      "r605",
      "r635",
      "r636",
      "r639"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.",
        "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments",
        "periodEndLabel": "Add: Reinsurance recoverables",
        "periodStartLabel": "Less: Reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r424",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Related party transaction, expenses from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.",
        "label": "Related Party Transaction, Other Revenues from Transactions with Related Party",
        "terseLabel": "Related party transaction, other revenues from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r424",
      "r522",
      "r524",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResidentialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r227",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by residential real estate mortgage loans.",
        "label": "Residential Mortgage Backed Securities [Member]",
        "terseLabel": "Residential mortgage-backed securities"
       }
      }
     },
     "localname": "ResidentialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r14",
      "r21",
      "r123",
      "r686"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash (included in other assets)"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r30",
      "r388",
      "r437",
      "r527",
      "r615",
      "r652",
      "r657"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedTerseLabel": "Decrease in retained earnings",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r134",
      "r135",
      "r136",
      "r139",
      "r148",
      "r150",
      "r258",
      "r434",
      "r435",
      "r436",
      "r443",
      "r444",
      "r477",
      "r648",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r175",
      "r176",
      "r195",
      "r201",
      "r202",
      "r209",
      "r210",
      "r212",
      "r406",
      "r407",
      "r558"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r125",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Contract Balances"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r78",
      "r129",
      "r175",
      "r176",
      "r195",
      "r201",
      "r202",
      "r209",
      "r210",
      "r212",
      "r253",
      "r317",
      "r318",
      "r319",
      "r322",
      "r323",
      "r324",
      "r326",
      "r328",
      "r330",
      "r331",
      "r495",
      "r594"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Mail choice"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Pharmacy network"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of accounts receivable, net"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r64",
      "r510",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Reconciliation of cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r44",
      "r132",
      "r361",
      "r363",
      "r384",
      "r385",
      "r386",
      "r387",
      "r513",
      "r514",
      "r517",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Summary of Company's Borrowings"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Separate Account Investment [Line Items]",
        "terseLabel": "Fair Value, Separate Account Investment [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable": {
     "auth_ref": [
      "r606",
      "r660",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table]",
        "terseLabel": "Fair Value, Separate Account Investment [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock": {
     "auth_ref": [
      "r606",
      "r660",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Separate Accounts by Major Category of Investment"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r288",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r288",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Change in goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Net Investment Income [Line Items]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "auth_ref": [
      "r87",
      "r88",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r184",
      "r187",
      "r199",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summarized Financial Information Of Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).",
        "label": "Schedule of Unrealized Loss on Investments [Table Text Block]",
        "verboseLabel": "Schedule of Debt Securities In An Unrealized Capital Loss Position"
       }
      }
     },
     "localname": "ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r171",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r212",
      "r299",
      "r300",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r171",
      "r173",
      "r174",
      "r184",
      "r188",
      "r200",
      "r204",
      "r205",
      "r206",
      "r207",
      "r209",
      "r211",
      "r212",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountAssets": {
     "auth_ref": [
      "r611",
      "r659",
      "r660",
      "r663"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset at fair value held for benefit of separate account policyholder.",
        "label": "Separate Account Asset",
        "terseLabel": "Separate accounts assets"
       }
      }
     },
     "localname": "SeparateAccountAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountsLiability": {
     "auth_ref": [
      "r613",
      "r659",
      "r661",
      "r662",
      "r664"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.",
        "label": "Separate Account, Liability",
        "terseLabel": "Separate accounts liabilities"
       }
      }
     },
     "localname": "SeparateAccountsLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Shares outstanding, balance at end of period (in shares)",
        "periodStartLabel": "Shares outstanding, balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.",
        "label": "Short-Duration Insurance and Deposit Contracts [Text Block]",
        "terseLabel": "Health Care Costs Payable"
       }
      }
     },
     "localname": "ShortDurationInsuranceAndDepositContractsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r23",
      "r583",
      "r584",
      "r610"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Investments",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": {
     "auth_ref": [
      "r641",
      "r642"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net",
        "terseLabel": "Incurred but not reported (IBNR) claims liability, net"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r6",
      "r171",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r212",
      "r288",
      "r298",
      "r299",
      "r300",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r47",
      "r73",
      "r74",
      "r75",
      "r134",
      "r135",
      "r136",
      "r139",
      "r148",
      "r150",
      "r170",
      "r258",
      "r383",
      "r388",
      "r434",
      "r435",
      "r436",
      "r443",
      "r444",
      "r477",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r511",
      "r648",
      "r649",
      "r650",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r170",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r26",
      "r27",
      "r383",
      "r388",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Stock option activity, stock awards and other (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r47",
      "r383",
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock option activity, stock awards and other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r26",
      "r27",
      "r383",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock repurchased during period (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r27",
      "r32",
      "r33",
      "r129",
      "r219",
      "r253",
      "r495",
      "r527"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total CVS Health shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r74",
      "r129",
      "r134",
      "r135",
      "r136",
      "r139",
      "r148",
      "r253",
      "r258",
      "r388",
      "r434",
      "r435",
      "r436",
      "r443",
      "r444",
      "r447",
      "r448",
      "r462",
      "r477",
      "r495",
      "r505",
      "r506",
      "r511",
      "r649",
      "r650",
      "r715"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r127",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r388",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Reconciliation of net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r637"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r637"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "terseLabel": "Prior years",
        "verboseLabel": "Decrease in prior years' healthcare costs payable"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r238",
      "r239",
      "r249",
      "r250",
      "r251",
      "r358",
      "r381",
      "r468",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r46",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r46",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r46",
      "r389",
      "r392"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost: 422 shares at September\u00a030, 2021 and 423 shares at December\u00a031,\u00a02020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r138",
      "r139",
      "r140",
      "r141",
      "r151",
      "r223",
      "r224",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r316",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r441",
      "r442",
      "r443",
      "r444",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r521",
      "r559",
      "r560",
      "r561",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates type of cost from product sold and service rendered.",
        "label": "Cost, Product and Service [Extensible Enumeration]",
        "terseLabel": "Cost, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r131",
      "r417",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r417",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "States, municipalities and political subdivisions"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r154",
      "r163"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average diluted shares outstanding (in shares)",
        "totalLabel": "Weighted average diluted shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r152",
      "r163"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average basic shares outstanding (in shares)",
        "verboseLabel": "Weighted average shares, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write off of deferred debt issuance cost"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 14
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3337-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL6283291-111563"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504833&loc=d3e7104-158389"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.14)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671317-158438"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671321-158438"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6484091&loc=d3e19268-158472"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124505678&loc=SL117422397-158474"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124505678&loc=SL117422401-158474"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "http://asc.fasb.org/topic&trid=2303980"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Column G))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 6))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29)",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r697": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r698": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r699": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r700": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r701": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r702": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r703": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r704": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r705": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r706": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r707": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r708": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r709": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r710": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>80
<FILENAME>0000064803-21-000034-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000064803-21-000034-xbrl.zip
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M^1!KZ$')RN7L)\+/X. 9X6>?O]J&GTO4/",RHV/HS_NX2<DCXI5Y_!!B\5#
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M95W%!#&);WR?N:\2&Z]_OX6,L51F^ODM6T3XZ%I^>K(?P8[_!E!+ P04
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M;Z4=9;8VI"T73I3 "DU['1A[AIQBPUSW!IJMSK]L")R PU!:BCU+@*(R;6?
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M)M(>R;\WRE4K6WYG?5"H5&/MJ)FA12&;Z-/1"QMS3O-ERPT'+F8L+(ER* J
M3%J;37?G<I< Z+_<!G/Y_8NVO*SVCVV.N:G6]QQP.'8!3#;^#(44<IDV(1/I
M2%;W#]6M+*O="98!4PW(7"7E:7L1G'87YAY;".12]W"$[F19[4ZPK1BP#WW5
M/?2I/0(5+B;J1E48\J\V(9Y'7[+=7[?IKF?%4CWH-&G6.76/9!K&):16XOZ-
MB=TO1]X)T( V#0M6MC@>*.>21FJC$JP*7O7]V2N@M[<<>2> 8N\CAT5FK7%J
M14AY/'2*8_Q&"[2+B+<]0'>\''DG@/=IMXHZ=7W& M548N@IN4'DBJ:T?X!O
M<SGR3B!M4PFQ8F;L$4*7 20$$AL6 ZA>M;K=!R2WM_GTIKJ[:E&/8BERKA"X
MD38/"90EU&I7[6#V 9IM;CZ]N<;=X#1L>:E<80@9;B/C56NNO2&\V+9^^>#,
M9#'$!J$+J#UF+14'=.:)4:$,2]X*QMQU?Z#;\N;3F\*'V0F-O';)4$*B@ FP
MM! X<6JT-_CL>CGRYB"3#M:RHWH-0,4QFV4KC3APK;GL#61;V7QZ8SFJ=*M!
MHI<<8. BPW(WZM&]2\J<]@:5G6P^O3&9EZHB&M82 C1#'G]/]P8Z#D'!SQ<2
MS:9<^):T%/?JRDPY G*G[%.#F! \B9:N5[82KFWE\OL7;7_>ZDT;C8;-=7_F
M85\2AY1R@SP2>M-![Y)&;J 1@F#_4-W6O-7VL91<,96F(LA@JB.)A&%Y8BK6
M>R#</RQW-6^U?6QS$(N]]9;5(?K -DAV2*'E)D5X!]@NXKJ)(XW,G5R:#7M2
MD"E635,7-W./>S@F9C%OM7V@:Z0A3:CV; B$+-!+2]:,F\3>V_X!O=5YJQV,
MW-X=(_<4M8)B'D([E%PZU9S=PBXBWO8 W?V\U?8!3Z$,C\&IDRID8\'0N'8+
MN5J=[I;>.\"W/&^U?4B;9$K8L/>:04(FZ:7C\,QQ6F/EUQ6GY2.YQ7FK3;7S
M'J%5X[0$"A0<"A8--D)M2Z&6Z+@WT&QUWFI3>TS$F"*:24D"TA!)I0:/$JM$
M-]L;<&8T;[4AZ$B3!&[0<XH0R]"A$?(T8Q]*LGS5IF4?H-OVO-6FAA;GH*DI
M7#92C864IYW/&#2&W"SM#3XSF+?:%&26-55AZDB@3#Q,W<A>2!Q+D+X_J6H[
M\U8;0D6"E9+Z4'73;2R8Q:8](C502Y-7VY\<M9MYJPVAI&JFS6KDFF!J C(>
MIAISD4!U^*SMH;2K*\":%<U[*]@AASK-=13)F*U#"WYM*]NUK5Q^WZ?MSUN]
M:8/6L+$&K<)-/..TAB%#](%:!RV5%&G0N[7]0W5;\U;;Q])KG6;2<T3-T%N3
MFH: 1L)0M6C>PQ&ZJWFK[6,;H#3LK#1<+-@ E1%AZ :S&@;HLG_8SF+^9?M
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M[W_NQW;^R>G9'?]Q!+;3Q^.T)P^^.#L]&0_U$L1?A[^K9PV83XS/[/R;1S8
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MQ<JYF*_5%ET6H+I-'5R'JG6(5J39(!@4CR-$!5B*5%D-RR6:SCF&6DT;!@@
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MA8Q1(D_1D6-*^914\!:0BB8IU)?T@M\YO6 *7?(REVF[)&'KO.8BT7\M2B&
M+Y9@[U -[U^T(AEK/21.X2)HIZVP#&R6/H&TP;7@M&:35/5VND6SK*5 8B1@
MR0,&'Y-33& Y+Z.C;'#.>SJ9/?YK,HY'8;8Q.5W\ST/X$^JX-J+PO039IQ?_
M27)LB<]CX(PW4'J!"4@AH'=A/L,.4F)$]HMPN.N$<WWA<%?CW,R8A;32"XJ^
M6,RH1<Z,?G-)2\W:X+>:):7[]U?S1@(Q .,R0=;1&^<5&43'*7H34LQ%RLY$
MRCJ1WDBD[/HB9?6)E'%N4Q)1EWPU&B^3X!R,4(SXI6IPN]IF2?)V6@8&IJSE
MSMCL0 GE3>3<N9@,2X:ST\"[$\Z-R$==PHDRA9PR,8VD002&)"72)LD#*R>W
M9 N,83/3C/=O%$7T##)1?RL%R=(C9N^BD'/NK[AL 76Y@6B?CB>'XTF99UFV
MTQ:1MS"3/:"P@9<9%(AHM? R2F-CXD&'Q5+5.Y7G7>GGT6AP(LS147GP3^(Y
M.-E]?G)Z#_KQ[ 9GKYS]7NYPN9>EP$2DY&R,&B!$YT/0R>2B]$*K%K0_+]W3
MR)/.)D?EC>=(V$JCP7@R+ZR0RU*M'J7U4E96ODY=&_0E4S=+DX/R"%\?I;SP
M "VA7"[ZY'*623L'.DH4*FNM@5$<&[EL017'@P=#C1TE,(/(5DD)%H@-6%8R
M%P*$4K;L);<7#,^'8RR[^9MD@><2N7LX7*SWVA[_CJ.W;8%%Y"QD# 8D,?W
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M(R,P)!\!$B++R%/F3(9@M+,A+,H>Q>)"H<:I4-HS#P;D?!H]A0Y!9J&LM,J
M3KF+(WXPA#4%?/WQN_E=K@' II@&YWSD7)GH?0('Y"$X6AY9$)Q+EK#YIJ'#
M0YWV(7$#SI7^XBH!5]R[4NV9$&)F,;D6=(.\OGA64[BN>%KF+^IL4J$Q &.2
M.0$F**^U%#)'J2U(G43S[4.'AUKSD)XE,@PI$7$ <AV6>1%T24!PK:1BS;</
M3?07<&, -L4^.)<Y-T*#$(+"RHC)1<49F,2SC[;C#ZW 0XW9R Q&DOYK%CA
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M.R.,3@P,YA:<I[I.V1L7ZJ\T"?3Z1:>Q8,,':DP[2$QH'$8BE9!E)B[!*-(
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M;-Z;\80X2?:H5Q;_Y_WB70-S/+ESU[UHKG)[0H\_;U[Z4'WE\3])A5 ZYE:
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MP/0R$Y\+[&+SB&\8Z*]6]_L-!"]]FUR612QG?YO[Y;,_?JM!X9W+BN#RH?1
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M!CCQ?JN3ELHX(R!&%%WY2:M,U-;%\A.5?1;,5"1@,E',JLH[%JND?&319"L
MEIZ(1X;S!F49:]H8Z33\O,",>$,,)EF? 5) 5"D*I8-,EJLHNW*-EFGXA32
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M.8\G!^2M!<5,^@UYYIC&)MJRYFXZ5A?LRY<U][$Q?+WFOKTX^/*>!Y[<&23
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MZIYO3U'E[G15HU);N<:!A,F333DOZ8J\"D'-1%#[D_$"EIQ"ZJ4 Y[0!9ED
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M.X9QE JB)AX8,0PTB@@<<BXI(2\M#[DM:,'JAF)U 7YWP>IC8G5BNUQ@Q6/
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M:8$"\$<%^%AN8XZICIJ#H#GF: 1) #<<+"-!!VP0)[$".-[ _8X"\)6=JR\
M?TR 3R:C!8Q-X!J(1BH#W(#1V((PUB1_6@E3U8E. -_ @%X!^,H.E1> /RK
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M,,0DGX-Y#QK9"(ACAAB-PGB]LUM2FS84WJL)+A1X/RZ\QR$%ZIR)WK.$9Q*
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ME]#DK^E%^6NU.53[@TA,8;7":JNK=U)8;596&ZM(;U04C@4P5A-@,>:2K50
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M=WGP]7UR<2S#FH%$FN=#%1@4HP$B%L8RR9A7Z/OZZHX9]#"WJLR@M9M!5N/
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M]8-7VAM--5 3)# A%%BF%4CIF8C2(:'9SNXMU7 >=F"D1"=J".0%2(<"Y-4
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M UEE0]0L[NPRMJB&:25"44/(/NHA^0+9A4!V8C/$.F,<4^ H2QY R+5WN)=
M I*!>TUE+@].6,FV6)V(N,JU2#I[U/N]%]IF$'QCT&WD^G[]$].;W"O) B,7
M'<[UA[^8GM^VSDNUJ/?WU]!&Q]UC\_6?UN#DI-O.S_%EM_<ZF^LWDYCK6??T
M+'3Z)@^RL-A,+#9UPIY($9'*PB/2Q&(>TZ0Y; 0>A6,^&&EQ;LLH%G",K40Q
MZHCB1]L5*2A^;!2/M0BA 0D3JU9I%)@@ 9()/=!(J(U&)G9F.[NR)J'(+0ME
M;&.AGE4=E+_;_YG8K*T,4G9DYV6@J0/Q%#OOI2& I"3 K B@JM+F,N0JPI[;
M2'9VY\D**Y&+&F/X$8OT% P_+H:G5 33 B<3$9XP[#T'S94#I10WE%'A4,9P
M34"\#6>F;Q3HN>W0="G0LWK=,7\9CL)E<W+9Y=ZD'K$H2(1B )R[K#!.9>8R
M"2:J2!QR <G$9:K)R0*<HE*@9[.8H5X%>@HS+( 9)G-'O12,D'Q^1>8F3 2,
M)Q&,Q)%S:0/&-!?H862-"O3,&TNIO0IJ=5POF'[((B@KHN90%^6]FL\)"7F3
M)S>,[(7^H-=R>8<GOSY/U&73"+"VF:F9\_+_OQC;\J]K,U:=8CI^^@\3[WR5
M'D8WD>1P=CP/P_^F?[?/LX%>?'4GIO,A_&4&X46,P97S?[-1YXLI4:6BM%1R
M,-8EZE3.@[:(@?.>.4:5Q,A627-X[KKPLX)PC4)!6TPLRTV9+<12;V(9:S(7
MTBJBL =II0?FE 9M(H> &982&YRF22ZGRN7-3E8U)99M"$\]N[<0:YA!8W 2
M&C9\:'4Z.7[5C=4?SBJ8;5F6S0R,&21UAF/-*0^,:*49$S[)L230HM?:O=_/
M1(D)Q:LBRL)[,_'>_E15%)?$LV4:9&"Y1&SZH;650(Q1C"E%F+0Y2H7IW(F_
M)0FGOB!GQB<)'4/DR#-"I:'":RYE$M66!QDSR+$N(%\GD$]T_>;25*UK"(L!
MF(@:+!,!*-%48HRM5'1GES<UW\!N6ANF7T)ZZ;O*Y9ZZ<WC;3VDRCN^>VW:X
MUI[S>8>U>\3_L\('M#'K XD^,AVX"E$F5<"M,T%IS$F2A-Q278G E8;AROHP
MT_HP78G7,V20%\!CL,GYC1A4$@+ HI:,IT6"BE!5U4)LP6&U!8!LQ7&W0K>%
M;A?O<RL<J<9:,*>9=,02ZRDA4@6?)'J@0Y^[T.TZT>W$N3W"!(T(@S$> >,2
M@:))G4NF<R$ASFG>Q-!-3LG&L&TEYG\9F/2EZ;^^]7GWW]6/X7W8WB^[U_=T
M]>(W+5]8SK(_Z_9;^3D\K4[1M3Z'7[^T_.#D"F$3GQK=*QI_Q-AT6^>#NS\R
M<4<NS?'06SY1D#PF/OTH)G^>7#?".3,? MA>,)_ Q#36IZ;]Q5ST=WZ9NJ73
M5@<FG]^WMW[G#<;X:#<XG#F)E+J]ZMC-TS1?0R^_*XW)U&8LC9->YN)_M1@Q
M)'@666"*.>^L3*I(&AR",\AQ_CYG:^RGSWW-9SJ?==-OG9PLF7ZK<%2=]ARE
MT)AVX_4@_6%4%=/LWF;JE4Y)>>N4?/;WZ\9_@FD/3M)M]<Y&3^M.R-9FV+<;
M8VR"[$I7;8%>YK9 M;^?G]YTS+EOI7OX^<ZQGIK>AX3Z3.7?G$NZ'GI%PV.B
MK*@_W4+;G/7#TZM??KWJR=/J5 .I/O3KZ.HC=LU?\ WM5]\W?'G,-D_0D'%&
MT9S1-X]>?E*]],U2-GQ-LB>"WOTR>H+O?.U[E\7HB63D09?]_FM4L<<9[/TN
M^X.(V0_#X/K&6V_Q.(:S:#G*6O\(%</LK/27QD%ZVTF_\2(!WE=ZXG4X2R"W
MH=>@J#DEF.[YF%;J;5W?>77!IZU!^C+WPV?QO:5UOS/4CFD4[>\6+IIPAF=0
MA?6>(CDZM:@;OD]GMDUZ<&@6\&Q$5/ZO!* DUMJM"D19(W2&":#=TW!5MZ.*
MR9^-$J4;]J+1/0L9= OH)E@Z36Y0!9C#\<R99Q-MTX)_M]WBQH3OEEQ7M]>-
MK<$?W?ZF!.4^7;X[/CE-[V&'Q^W3P^=_LL-_7K8.+D].TE6^OKW\@ Z.7UP>
M_O[7IV^#<D?'A^VCW]_2MQ\_X*-_WJ(T3OSVG_W+H]_3^S^^_'CT_,\TA@/T
M[O>_XG5 [C7Z\MY2I!BE$1AQN9@N5Z =0A"0B@$%3(1E.[NB*=#<(;GZI<$4
M'MI0'EIZ<\7"0P_BH<MK'I*<8NJC .*D A8H&18%=HX1RJU%UL?,0P3/W16U
M?IDZZR+I]OS'\_Y@&#_LY;2=WK"<7V_D-H25N MU\0@>7?1C\H34?8H\#V=I
M-HS\QYS-94Z[:727TV'SDH:Z4N$\::3T>SOD7_8Z?F_"5F4IFV$I.WP](:F1
M)8PZHT!AED_4, J&*P5>A2@$=EIXE4_44%VGI:QDEJ^U!BV07CRDQ^I42:.=
M$0&XM$F="B[ >B?!$!\PED*0@"I(U\I+7J0Z70?M\7NWZ[^TVNU&Z_3,M'I9
MIVY9[<=5EI"^>OK[UP^_>,2S<DYK,C(7 N4HN<""8)Z+I0303C$07&'*2!(8
MWN_L,GJS/'3I2[$Q*%VPB+B[2VY![R+0.U8,4<?(HI'@K)# D,=@+&= C,2!
M,V<"(77L?;MM\8JJ-PO87!$]W>^X)'H)52Q-.&QT3?HE4<_4EEZP1$F;O!.E
M"; <A$A_0A"TXC*M(]16%3V8J)&K4J(/]1,.!:6+1^E8(&#&<$*E!XJ8S0*!
M@='(@**(VD@2;"7=V25J[JH[):#P\("":74:"6?]-,6K_I?GMM_R+=.[*'&%
M)>UD?,=C2<;)/LI1YW4RSU'\[;R?QEU\EIDHZ>C9A'!(-@E<T #>&@_)A@:T
M278*) 1LA!<RE\2IG\]2H@XUK,)<P/H88!WK!Z$E#13QK!\8,"$#&.I5+KHN
MA/4X4$&2?I#S=(\K<84'HRU/]BP=@NFU+QIIH.DFSEO]DZM.ES[8AVU.;(7W
M\GA]J3(1];-Q0N*B%U-F.8K/DU$*(\W"2)-Y#\3Z0#$2(+4-P$A 8$ADH(,3
MT1ODO6,[NU3<;&)3X@X;@]S'ZT95D+M@Y$YL5@CNB<46/.<4D@4E:*0"(!LD
MYM)0FP\!2%&GB.&VQ2*>AQAZO:H5U3"]MNJIG3,LN[D?6R-9I4JU;0W"Z</Z
M4FV':[-X:>$^]Y]>66=HG,HVR32594:&J>Q2*&J6\P''4VVE@K<:647!42*!
M113!<JV3QK F!RP\TWAG5[!YFDJ5H$2-D;MX:5&0^XC('9?]2L:0UL4(2#@!
M+&@'5E@,UCGI)5)8:+.S.U<WN!*I>'@EWJJ91F[N-'$R)ZGL437>=LO85KLZ
MI=.L#O1T8R-473?ZC=CKGC:,^[^DPZM*8P\\QW-?YVJ5UUBHW-0UGQ)[SJ5;
MJ0YYN=#ZG.L?5;8OLK(F!WAN]L:Y,ME?UQ8K*]9,*]94<XB(K*%.(M!8!V!&
M>%#2"DCVM9Y%C*2,55,<=+,L<%&;&P'HY1[?*8!^#$!/-() S&J5"WU+:8!I
MGY/I;0#"F8E$QR"\K0 M:@+HA:K0NNN-_<[GT!ET>W-V5%]#1JI_S_2;S#1A
MK4)),U'25.\!&C657&C0VG-@N06?%2K-:6U)("APA''NZ(G*,>%-AO7C;9@5
MY"X4N6,QH4B@TN2L&^)SS:PD*Q36$:)WBFE#E&,)N;<$HC=DMZSN<N*HVA ;
MQK!*R&)Y!WEN$DYEB:.KL.)>99'"/#,QSY^3FD%B:H4) 4((R8VQ523=(9 4
M<2^\0129Y,;<+$)0@A(; =F%Y^46R#X.9"=ZWK! )'8!'$8!F,N%[017P$4T
MEJK$ORYO?N%-S-.MNU"XWN<X,Q=59XB\X75V8I)S["X:[O^S]^7/;>7&NO\*
M2_>^5WE5@@=+ VAX4JKRV,Z-;L5+,DY2SB]3C6W$B4QZ2,I+_OH''%(694NV
M:%+4(85)+-/<=$XWOJ\7-+I/:?AFO@D6A]/+[VQIBKYOA+R<*ZI1UTK4]?=+
MTQ&-<CDX8E9;PX!#9*Y0&>.@3)()(J4N:>IL*^G=8T3W92>D(?H[$7WAC,0<
M44I4S$#6#, YAMIYIB"+%'G!.HF*:' M>7%'P%P,&PLT2>5FIY\Y)_-:W^%H
M>C:A44C+U3GW+-/1KT3'\;E&_G*AD$94*Q'5ZV770Z IED5I)KUV#!(IYLE0
M^<'!>UL3KUT/D[6[([1TQWZG.U;8&VD(7A_!2ZZ&Q.AST R%+:Z&A<"\)L\T
M8I1<^8 5P>7YEO>XHPV2=7V'>Q'\W'4ZXW(ZMG'3]W)3N+2-XC1([X %@8(!
M>6!.9F2DT&1G7# 0:^D%XI?LU!(;>X/MNTYL-&QO#-L7?H<R(8 #SXQ#5_NJ
M(7,@BALBI;4F)N-YP;8\M(KW"-OW8;CH\YM. UK5_UN,XER,YE9%!7%\5C,F
MY_=TXZFT^S;D;?,"VAORWZYC5];^X[+T7RY6_D\?_SY-L5B 3_OLGQ9_X_Z5
MN/_79;].*Y2\IHEDRH7[LT?F05H6BZ]G<HZ0E"M^'1Q*LS;Y;QQ:=YQV:B3;
M2';'/>Q&LK='LA<.MBY6,N9(# K!,E V,9^29LE(D"((884I)"L/I=M4=O[N
M2;;SSW^8U7VX\G<<OCOZ8_=C?A]^\L/1IWNZ_.(6P2F[>08I%4^Z3C*@T<?J
M5H_&L_+MLW$%9DRC^9R#42<AFI5_Y.&(1F%(I^5*RQ/SX9Y_.!O161R6U__?
M@VMN[)J[/K_?Q45![7[P=CQO#_!PDDX+$-^E']\/X^SDG$Z6/K70,+_X"/ER
MJ6>SZS^RI,=0KCU-ML^*G>#-95$L_ZQ7V[$,2)(I0H8$Q=N,P5MGP9)(*1 /
M6O^BQ,'YATXFYW?PEGXM$)LD^C>C7&[P(9V^IX_3@Q\NR>'-<,26A?ZYO*Z5
M2LZW)I4YR I;CR==M_B'!=II4M]5KHEZ<RV#DTFU5O_U;?T(50\KQO2A NKQ
M)T ]7@;4GSX!ZN=/@/KC#W1TU?JXTW5LKUS'C__Q\V!1@_!X/'F[D-;@6J#W
MYKJOUL:%#FKCDFZ(P<GXM&A^VO6QMC\.GOY^-IQ][/W]_>'OGRCYVFM]0Y-?
M"PU4,_A9UYE/E]Z9L NZ[<QFN853>CM-#\\?_!B'T[>G]/'A<-1=2/>A'Q??
MON#H^@L^,YG=[YN_?$$_#_B<@A;)K<5O7KS\H'OI,S=@\9I^8(6\]F7^0%S_
MT:]\K7F@M.G1MW[]-86P\6NU#SC:'DG@Z]_JX/I7O_=;!7^@G=[XU[H'(#<O
M@G*Q0F]>7^5BU<U6Y3=2T]_<9C(W?^L*WRKT%^^](JLPI[WM1,_X+1J?'SF8
MS29#?S:GX>I$?#*W-VB=M:X %ZK\S$?'[@W?K]W)^/WG&XH[I9+G9V]\FG3S
M7:I[,.T"F_'9K,1#HWH7&U+,)S'!19)NA;#UQLFR;?HN-Q/PX_&;-TL3];;N
M8=WL*KM)@+7(MN\7^IC>#F=TVO?+_/EL\O;T;/HI<MCH)>@'\@87<47FH6*-
MR0?XI?=:9T#.0],_R,]<[ ;G9<6^JN4+9Y,[#)E6 ?0.+C^QW>77/XO\MS2C
M\F3L+/%3FHS*E5]?H[COTG@4PMF;L].:SN@$TI4-=8_J),9).DFC:5E;W3/'
M71?C>RNJ5^-B& =SV5PXUO6?5V1^NN?G&Q*?Y8!N)K:=DLSS\:CNS$W&IZ?5
MI9VOE7*-:?J5'BE[<-_=BOCJ"KA"]U?'24*N$RAM/S135X9F^P/V15CQ2;<W
M6\?K2Z*Y:[?CKG4ZW%=_;77LWXAN[K22YI->NR]\6(/28?BVE+^R*7@\FMOC
M<A6GM9_\]Z9>=KJ<]F9P^8E.NQ/ -!L\22%U*2PE#@>UCF:=H\#KE7%ML5KI
M<S&M6*PTS_5]5J\DE2>NDK):.C  B! Q:4- 0J: OQQ7\0JIQ!IE2G.B>W&1
M8.Q+-=)_GOV\J$9Z<_S^V6\_O7GVV^L/K]\\?_/BR5__\_K5(_U<'JOR.X;/
M7CW]\.R?SSX\^^U7<5&-=/+;\U>/X/E_?JU53.+U;W^%?[UZK9^_.AT^?_)W
M^?JW1^KUFV/Y_'_^=/I%-5)Y_[,GOZH73_[T[]?_^4=Y_\GI\]_^+5[\\Y@_
M?_6OX;,G<?CZM]?\]3__D9\OCQRD9"DYK1F6Q<N .&?.*<6"%(DXV4"4ZD$>
MJ];N4+(J/#91SGG_X'K]Z> K\1J<U3RI+#1P@,1]ULE(7N!:'OF@K\?K->>"
M&S;7Q.;'3]B,PD(&H<HZJ8W/DA",O*FG<1(IF55&[PZ.0'Z)S)4/ .]9C77O
M2ZAOAN7OK:#N;X'TFB['%?716A26\C*!+O]7EI0&)[SE(DD?3-J,OU'SX(O$
MQSS9<3P*IV=5FB_'DWJ)RYO2K\:74T7G6:)&A*L1(?]$A"X7YU%DR2*&.JD]
M ?/&9":L%<6_) <R%B(TAUKLDI?2R.P^D-E*#:77]\8:K?6<UL0%K6G)+5%D
M$9*LA^T\PV@E\Z%8,?(4B<N#(XF'PGYY#J27+EYCM/O :"L0FB(T/(D<@Y,@
MJ'8N FNLD=)0B6Y4<\]VEL?D)QY+(B8>16(YR\P 2)00505FP7'BV?%L0G'/
MW*&!#1\:;F36R&Q[9!8$EV1!R%2=,QN]=T(9Q$3<%@B(1F8[2V;J$YGQ%,%G
M;QFI%!A8CPQ]LDR&((LMLZ2Q&RH&8NW.5HW+&I?=%9=)7N=V.J,H.HB*N\"E
M+9&F#-DG*63CLIWE,OC$99!%3G5?SQ-R!L9%ADI;YKG$D'46:$J :=RA0M?(
MK)%9K^Y[!3)S,H$#2U(X@JRT1\^3E9:L]3D3OY[,&E_=/5_I3WP5 F1)&!@F
M)1B@S<QCB2M1EX6-+NA ZN!(B2^GLS6RZ@=H&UE]DZR258&T<%KI!-*A S 1
MH2QNGZ-SH7E>.\MD'YX]ONB0C"E2 LV\D):!XW5,-3B6E4,NE:+B97>^E^5?
M#J[K*9UMJ,5[GPFLME@=?OT(T(YU?;[9?7?G.>2/_>C-W23<NI\W+34)-PG?
MMC.:48EH=7%&LX82+#L1%"\QM"R/2]2E/^_AK-;R2E].QGDX^\MXVIOVH;OA
M60Z7-EM#++B)EICU)A>_TCJ&,13UH%/2\^RL@-J=7UY1%MPPUUAM9R6\ JM9
M(&FE44EK!4"$UE@EN8H%'3R:T%BM'ZRVM%/A=,"4D2FD.NL,2[0,6K-@5,3$
M$0A,8[4^8RYJ3RYRES,BF#H$*EK 8+FA2 KY#3#78+496%TDU+F32DIN&9E
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MD"9A.$UM+N]J_/3W2TW5P-NDDF98-__ Z$)/4B,S5MD2_P3O4!\<K=V=I>T
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M8)DSKCP*"2V0(1]Y,R"-WO9+PG>12&[TMK4,PE(B.8JBK^ Y\]ZGPFK(&>5
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M5S;*ANX=1O?%?,FDK,?:HZ@P>$%W4(EY)2,S:*I%YT)H6Q-J4FQJ_DH#=P_
M'560QI/+Z""0(QNI^.OH2&CN\U><\P;NOH-[^22*-@F32*RXYB7VUL4[Q\R)
MD9!1<LVSYN+@R. AERU=OC_H]CQJ+;/G*@ @*A^C2Q"XL[+._?E*9JT!N \
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M%I@K(A.Z'\5_KT*>;Y1;S4,\G3["#397*&ZA&/:?O*5*XN);2K3@K.A:0TP
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M"7G@<5%^XQ.$TLX&=,V/^1;,"='L5%S&5"Z27?S@;&K-9K=;^/WIG7Z<%)U
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M57EQ\.M5F.]9STI[3DM'BMG!?<!F]NL7_.#3VQ X&D2.DJ #<A=@DAC)+)'
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MI0XJ)2-Y68?;A)[.5M4>N8\E62L5V"X*8]:Y"+]['!LA7FB)\<G<HS:+]3<
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M!U\//[]\'<L\W^T_BWG_%?W\K]?/I_CWI[="9"J"D>V-BY!])![).*%*Z:R
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MD(O/T;/^Q!T>%O2:W^@U>[3;O$7N]"1>YMD4'OJ=<73_V>]O!:.@M8U$A^)
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M\"2 ,IEGRD/F5> ?@,!S8X7GGAEO& @03EH7LN5)2R%34I75;[O4=P,.-,E
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M:TCGD*!S:SEG B57QQ!H[4.RS9*^#"-084$)7UBZ900T<&(Y"KX("@$ C?-
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M1HL_[0EVU>B[1:]%">6GCK+-<VK;#/"-XGE84M&_3>XVC;.789^JTSXB^4P
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M%STHQV)):J9+!P)K,L5MH?=\<'@(P_B('12/PN_KI=9,6LVX#"@KN<T)35T
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MZ]0O7YL)_4YY_3J%UYO"N:.EF<A_-TVW5MNQ87TFJP*X KAM4U@!7 %< ?R
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M4F=P_0BKVD]MM)]F^'XS_/>@OP_#:C\MB71QBG3..$6])) 0E"(RNT2\$9F
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MO&1$>8[&N6.,A,P#<:C/>Z-RUIJO+(6J,D!;&.!^U?>:0G5'N)X'!UEF(=,
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M8"18Y9DLF%=\:<ND8GX=,5]S>5J+\GDNCPW<<!">I$03D9EFXITJ1S!E5!Y
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MI&A *16((=CDG'+*V'648_\$LXRV@W>LOGP9SD?2X*:A>A%=;]E5UK5!*JT
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MQC.0O[G(WPKGY9#R7P9UMV3GE]RB:>!T%=7>^ SDK!C[9&T6R4_,M+<OYO[
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MUC?2,_FROQ^=EM^VDX".^/]\+]]17V:#_LGQ8WOPZV^O?_FU_'EP_"]\\NC
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M+8=&E]3-!?0:C/8!Z#L#]%(/,4[:6E5 Z]8 ?>DG_;R#6K)*KMB$*0Y WP-
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ML$KY-3I^OQ/W7(?N<J&[X']3Q!J3JT;$&'6K#!Q%T#4)FVUT"HTI4O?(N37
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M))7=V#*;,EP[/+1#=W6A6Y6ITK!N6DH%6RMJ;4ILJ3V]EM9@#QM: =3.PX;
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MRTT6/H$PP>8J0=LC0<_]I6N][F?/J0V))Y*DU 1D],3*Z(C4ELL@N+<Q/DZ
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MTM"(4()KOPZ<_U[=-U&]L3<=#UL(:]6%\Z3 NW)&C#D:F02"1D91BTX2HWC
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M:^2L+?+05$_K@Q\9\TD9%X/5$;$JF!6"0G"<E;)B+K)*4Y\&JY=I*BCM-!6
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M-7)%R:P4$E%KC050T4"0P>=H[7>2<E8,_W@,7^857H:HO2@AC$@N0&5.K(M
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MYT7T_'%XMO_'FR]['T$$P>>][\<<QGFRM[.7Q<GY[MD1+)4.GG-D\W%";EU
M%M87V1@T,X0YF2X%=JW!27LOL,"*"UA_P;7ESC,#%QO'+X:H]PN6SJU_H]J
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MO>(H1<Y$5)I%03:VJ;AU&<3[8O?G4"/[=6[8^;/JV,NX31\-8*W>(HG)8N^
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ME.KGFM!#M\UZQ"-\W(-\#FZY@^[ MAIN08.RGQ5>J#*/GEG_LB7$,*911QX
MM;7DF$D=HI&&!Y%[EEE'KFY?-IM)T!FV4>@.T.B*6C0_O&C^_G+6=<>=\0(3
MB2)+#'%*/7)8$91#$$:[*"AS&]MDDZC+9^+KI.@GP^U@K=%<0#Q00;@E"30S
MIJQ65D4IG297=S:KN7WMN7VJB%MN(N:<(&^<!+-<2F0I32@WLZ-&@SJN<LQQ
MDQ)6<_NZ</M=-+[GW";K&0G$<V*(5IP:&RP%SM7"NZN;GM7LON[L/N.%LXH)
M[Y5 D7B-."'9[L86D6248CIQ; N[<W+9$5>S^]-A=^!H*:VBC&'#>03U/3(
M>RT$I5@K?'4_M)K=UY[=9]QL"8.:#AJ\C1RDN\<NMTB@"!-"E7"8F4 RN\->
MKQ&[/X>C3Y6;XFHWQ H.0*T3A-U!ND  ZT0'[B,/F-OHG;&:.Y>\U-Q0S:]Q
MSJG.<[PO5'H]EQP40*/442(!NX.XHP9I$C#"!H1/5)R!7;FQ;2X;' ]2SO:9
MUZ=>O6=!)NY2T%0D(;@TRNH8))-"NZB3)G:E53EK?KTIO\YH$0''$)E$6H5<
M_D@'Y%BNW4JPT#HYQZW?V.:T+BJ_+DQ[)SDY&(P&KF#+A>226*.Y]YH"$=!
MLD/PQJ50:OZ] _Z=,?HY$RE0ZA##/"">^Z99%G-72)/R 0/E/-_89NQR*<=:
MX*XO[RYC[?/@L$V8<RLXT<:(1(7E NQ!P:+'*RWW6G/L33EVYM OYCX1P1%-
MTB >P'AW+CH4M5%>Y_KH7F]L4W:YX\/#B=SGDUP0YT[^7"^MH''#O*5JNB\8
M;$KH#ETK3C(\;I<2N'9+^U\/N$!/QK32'#0OXZ*0"O-(N-,A\$!L<,Q;0LS5
M>=.U6W>]Q</;60>*!0T<A#A&4E.*N&$,N6@TDDZY2)VEBE5N7759I;N96W=U
MS/; ,: :=FO877W)+1X,UCH:*2W'5NK 2/+Y_\K20.W5">HU[*X][,YHY9%9
M"8(4$9:[L!D,L*N)1IIZ38P.5#M1<F7$J@H)UK#[V&#WNM;[,\3=.W!LU/KN
MTP7>V8I(FFFL!45.*C]J8BV-0%9S2;D5C 93Z[LU\-; >U_ 6VN\3QAXIQJO
MH#I%920RGBK$J0+,Y3H?WTZPN5@8EOQ3TWB+'_M?A:3&S;#*/_?=28S>N)/8
MT3+_FV_[=54O9:+'N-[LA-@9O$#YFU4#E;[&FFQL_T+NIE':==[^V]RJZ"U9
M5N'FS9Y'P0$ Q4;_%% P]PEHM<X!J&"1J^>$Z(#,)XT1&[97;@,<A!^;G48G
M#N _7V/54G'\1/@!7@<0;@$O\]L!&>&9_>I3X9HRJ/X _I-O[.>01O<T]JJN
M[5N/D"[HLZ(+;_LGC=3JGC5.8CA>0!C-D0!LQ&^G>>=O3Q.- [@]AWUMY[P\
MU<,E@^YT?N<->WK:ZWX#:3Z(K?-*!"S3F)1[C86T(4EF>'+:&B:<D5Y;0CEW
M?B4&W5@S^!L&^0I6\0TLXK_S&OYAFYT<PC[H_A[_GMFS'>"]SO$>C)+071CN
M20YR/W:]HA7__3>\(YPZRN7^SFNZ^_WEV?[!Z_.]@]#<^^/P;/^/-U_V0&?(
MG_>^'W,8Y\G>SE[:^WPHCASQ-@GMD(B)(ZZTSCGF%LF 67"<".[R*=$%O6J!
M]5KP8;, %]#7P'[;'./8,6P $'*_W_7-0HIGS<%)HPE4=HG:@;J[(^PKK)*O
M'!%X!S:J06BC7;;J I*-QK,W; .;^^KO3(+-SK!0^>/ NO^Y,.J* CG+;<LD
M#QI[4-.PHY3%* 1.DE/L1<5L<$\,+P<E$],KQK!3W";.@]<N6J\XT[DG=B+X
MJO? (X7GH.X3Y7DHY3I$TLH'3)CD#E]\#]@%PG"2+)>,<ZZ=8\E&'T/$"4?%
M1LU/+^W$@F_6"M\7K\Y-5_7GJW1S>9(/$_Q0FF0)D4>2.TE7#P#=<]"+@V:O
MB(*&BYV8,B=>%#/5U:M3.WY.!8U+NDE%$=O_XWK_VKZO'R\4?.%9);^LKY\U
MP^!D;%_/W#4R</#T%NM@>8:#JV^9,6-\S"+L_@-C!7NHOH"H,__FX5901"V-
M@2<>N>8^>*>,XLJ2&+T%)!)'0FR,;SKI3?'V."+7B_8+L@EF^,*VSNQY?^-?
M<PO1;G;0[*I?7+"KM^W'RBQ5%P$^?W/GJZP6KK+9NA.PN];;Y]&.%/_1Q#TT
MDIPK2 Z>U\I>VUXNV-+_*_;>GP#(',##?V]U_9<'5J_VWH_4J_:A.&Q_H'MP
M[^Z!%[L'[_BG/]["?W?)[O=/7_8._@;5RHO]@[WV1?7JT^=6\]/!(3T\>/L-
MQO5M;^?DR^%G4-.^?_B^UWY']O[X)[MRQ"[]E/:^'YX=4<N""<0C"Q( U"MG
M@"&80,(KPT$=%H&PBU(6>TH=A[<)!0J8"9J&P"5UG@JL&/<;C0@:ZVE&DMXP
M;FR/%[P!*]XH2WY9.;HV("Z4:#\=T3Q;V]XQ</8(&2G0Z>B;[/.@]\"(B^%N
MLDP@I!K]DR+^^D6\#K,D&_9SE:$L] 9G753D<J,=!R?=L-4H#LQB$L6LS^9U
M*0ZH?B5F3XO(RP;4Z;#G3RR8:%>:2N7%_=6GY"]A-KV$[0U-$%$@U]Y/_!&O
MOU6J0.YL^*HL2IGH?KK(SY7RLC96TWVS=7[>$4^82"Z H[$$JREI8&OB)7*8
M>6&4M5SH'_CA%Q(!93Q(1CSQ08'N;:W'1FAM$B=:*<.6[/=6$\%=$X$4$BNA
M):):YVBF)YD(.*(D6NT30+^7&]OZDN5\I2E=H5+1I &6VOF+ CQG$;"J.QR
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M(\* "@P@4(QT-:ZK&G]J_'EBKJL:?VZ&/[/'=!GEU&N&++$.<6DCLLIQY$%
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M"ZOVQ]#V+&@%,\55UQCP?H^#LPC80<# *;L"']3F[&;DPV"A 035/QUFI$A
MR9UR^*_PXM#UFZ$)>!3++OO6,.]XX_>NFY#N>R"'$2S\!P8 VU]^DK]U@,<J
M\HC6G^3'G9TTX4-^:/R_(7 H@%QJ C^5EE#.=K[TAJ<#?[Y9'K9K>_T3VVKU
MMQIO.T"1,%9@@SR.LQ.8DBVG&_.IEO$8SX%0<V4G^*F?QS0_3Z#7K\U0?CT>
M[^$8&2\]:3*Y\L1&U[4FM)V'6M@*C,S,?M45P$;M,NK\*E#@8!F:%:OW(KSD
M=-CK#^&5&88R4G3B&=S:/1TA_FAD^='-"A^JIP(ZY;=UQY@Y&7!H J[U"]=O
M-3[FY2CH/[-; )>]\77P:+BOC,X##'0&HW<!F,(%$^5C##PPR\V%(#59MSY,
MH0U\#?? >$];UL-B9^SO#H]/JMT>+P_,W)_ 7.!MQSW BSR;;'NT.\UT/K=!
M942=\P5+/GO5F<TO_[]ALU<]JP_7]-,YT$@J=X]EW?BU_<;HL5=L=5ZJ9)NM
M_*RV_1++19,7G%9%PC*NACR%BK"J(<Z3UP1>%PP.+NS.3VES0BM]L"&;">Q)
M((XQ,D]EX025@4SZ0UC6F7F-!<&""35S*31;Q%Z>3;/_!3[8P?Q"CK2+:XVW
MB#@8S_MX.H@9'"H+F^'-1K9UYI=B0B:A<?6)Y[R.%V/B*21NHM Q*:ZU<-Y&
M;8B@D5/AF#EZN\@5_';OS=C,\E_[+T;XW.WM3T=?'6;NIH+@_;7QR=R_@?7R
MV][+(Y_ FDK&H61PCBN!I64U9LA()CVS1%&PK[87>%4J"ISA@'[CE_AM+!*F
MJ#4'$Z M5+1UE6RH9$+1C5P653W0-'L%I[-2U6I:!XHD:+0CQ6G8L?"^_,RL
M]\ 3JT_E2'-Y%2BKH!CE\F8Q#OJ_P@N:H)/F6]OV&VB6[1%VY3'/8'?![-%$
M>@7&*&9XJS$OR!?Z;BZ<>N8YYVB,SB_*"H!N^=M9,PQ.Q@[+F;LJ_]$+/+W%
M.IC-<'#U+3,N*0_H%'OW[W<MV@6]8/3-_GO2FSJ@CB-R@$=?D$TPV!>V=6;/
M^QO_FIL3V -H=@$OSOUJY>JF9OE/S>P+9KE1QAO&%)7<<1J$D<D(RI,@SGF9
M\'J9Y2,</&^\ =$%Z W<VB^B;#,K5E_B /2VPEHC&RW+H_UB6>UU.^@?($ P
MH$"E^CL+C^S2SJSQ5[?;>A1Z[X<BKH_':Y#R&K0L6$_Q6[-?3"O06T"WK*S'
MHMIFUQM(U=#-OX[-L4H=R\*PNA TT$ZQH<IZ MK\ A>TNV#?C'X?GF:L.P6%
MV/>:#BYH@:4+,%2TFY%I-J?;@%!M9O0""W]0C:*@ER^RM%D9KJ< ;OY\U%]Z
M:ES!U/J5HZ+53''6 I\^9[($,.(NF(O52V$,%>S.*<@V^[6;IV4>15VH],$X
M4G[@6EB'LHJ563W2Y:K!9\=9GDRKVSE&!5&+&V"RKL5 S\.<?C,UZ6>'#3_-
M>5\FVJ>=TG#C&#1HL/[!?B@&>]'ZNV.; "S42O 4-.\N5&5G716P6^WFL-T?
MZ]Z51Z'LP$@O*AKE^"J89.6"F [WU6AC1T0  ^N>S8T7GE%4+9^=$WFL7_."
M9H4^.S12ZL?JHM%+&@/[+<)SWW?;$\HK$K(/U-2RO?$N3.?X[]W]B498C0Y4
MURZL<I'9\)).%UBMVT-@;*3F8.+ 096[)$Y(!Y1Y(! PYBT0*<C0,-W]QLM7
M+]?%=O\A]X.YF$-VE5;Z5^QT^N>MK\!-%@S),6,4#W _&VEYK;(%$ZZ@W?*$
MQ@$(,&"C/3"HN[TOC9?%-7SA@86-,J'#0PMC#_KS>ODOL *MZ+,^T (K-U,C
MQ;_-/+]\0W[[-9-B+YY4ND]AVFPQP+=Y=!$>EUU>E4H-NERW&FS%AR/K><[(
M/HV#HEJ,;..*O(>]8HX")>2(ULCNF7UE?EVWZ&!@(01;&9NSBY%ML='292_1
M]++\)T@9GY4HHN:=J2?%@!OK>#,*7K%^!X7VFNVBRE5]H6$ATW  .S''40Y6
M^O04<#&'VI8%0+ 6!]E;EHVD;@>> $O4!6+(CRK(-T*"T7MG4;+RC.7ASPT^
MOSM^.\WZZ!Q?3I!B"I(5\E;V8F%J.W'#32S ..KJL]A9N,!!N,@=6 3%Q'&X
M.7&^%GNPF3&PE'S*5)%7\Z?&Z&"A]WPTQC'U78;'6;_1!0Z[)!2R,Z,)FW#2
MS&9&CK*VYIT$F7I@QH5 6N<SB-KNEHT")CFQK91',2_]Y]!XI.%G3ACF]Q06
MZ8&@SE0W@\%C:-Z<6YFI=9V5B)GG5GL*1D41&A/W]=<X1N89]VG%O2-!6Y2$
M,;6-WODHD+:('5@%/R\ %^H7H1NG?NXBMP&C/F<RSR@SJZ!.Z:5=J:K]2ZIJ
M16*9DE%_I)R>9N5TL\#(Y9<W^U.=S<,-QWDL8[4!WC?L92*J?-:;#:#L49#%
M-]K%W]$_:9XVVLUO,R]/L(7="\K*C.#L3]"AN)BZ8P5J#L0FBLL,E-G*R3\F
MEA%>75SC2KB-6>$"><\J=>?56H<(X)1#_J"B7@$K&;] 3&74'%NM4PB#.ZN9
MS&Q:?LCTQ5. F8QJBH_-HH&4^ G,MI(V4\PJ4\K/:&0;?@P"\Q-L9\?E&(:F
M;\U/7C"WF;EDUR>HF9D\ICINH;/9A9K$^( 1,\C8 -(SOQ@@-O:^5HIX 9NQ
M2C59\'7AU&7C&<UQP*9LW-]3;/IK&MI9DZG]/*H[(Q^*&ZG9*8'<$MH $BD,
M7G2AR0_ 2IVL G>K4&/V5<^'M"9":[)00.(]UQST1G],0XT7 F!P7792P7][
M\6LSGLU&Q I>9+E:G@_TU1V"*(^;(WZO(JG]TU@88_%C1_!0/=F=+TJBN?*,
MWGUMRC2(_*JXJ"H(W(75+9+_OVW[]+?1G\W0> \LUO190Q[IQ*]VWX]UX7&(
M=ZK3S2AZ^2-8D6D$<<#>(QER/YE%B^<^F?K.9$09A?X<PE;"\'_)OX_FN;/_
MYW2>:[F1H_CZ )"A$\\GIO?F=(-W>L/CQNL.[*^O0/QE:#<[H,&-T@_FYOOZ
MY<3&F8K2N9B]'0Y.NE7_RG5!UA\NT'\68<=TF0H[3SIR;F84R.J/GP!O.\LX
M%/)Z-?U@#FUR<*U(K P,U:/FEFH)F!@YKBH;9:22YNA?CK@V<\)+\36,Q.MT
M#-DT*=R;[9[38>^T"Z9B#M9F=LN*? D"5NZ-V9E-G!$CN*WFD=6'&+\44,TZ
MV/2B\<.FHGX.@D]SX"B/&BZ.WV(;K,Z<M&';]CB.+)O*,,N>_<:P T*[ OD,
M.B4I!E;I/-J+ZMHDV0&&GV-(<$.OVZX\,UG!R?]M=NX82ZZ4VU<@*YC98)RT
M'Q+A)KM<A7D'E0EYVFM^S1LX.&GVPF3'BX53F49EN5U.4X(?*PNN1,9'%N@\
M<;MN.*]V:V3E%O?BCP3UC^1Q,:S V)UFR(PX(*7,7H.1]PWDT8PBZ[O]07]J
M'E1>@7Z<,,6(J;*O90 J93/S.XAQVPNM;..,N D$O ?F>A1@-LL<E9LC<[3O
M#6'K"C-UIS6@1YLQ7HR2E0':\ZPF#9H7[)6S$\>*;;2ZL#+CX/-D:<<K/E+S
M1PL[XY^9>(4NV%M?;6M8V4/%_PLZ>P]& S> ;=4LIMS7V.J>5I;1))=I/.99
MVJQ<+C.#Z%89!:/I5^0R^[1R\UFYN60.C.;F)[FD,(AN=JF.5Z#"XPM3@A^J
MY(7+=X^,INL]9/.RL9UOGABDV7]8IE*"$B.[;"M'>R:P?\GC?KV-S[PU\6 !
ME#>_-L.P>&ZF^2SV^#@SQB!>Y9!?X,!Z% SS^IN/IX-)7N)9$^ !UCV&"^DA
MMI-W8X0P54QZA$.#\YF4R$:UTGY6&,\M=IA$EH#/NF=3K)KQ= P[%<-U%S$0
M$-K$UUDH+ONE<@N\_+[Y7V#O(DRO0K*15 8,AX>&\PDM33T;HR%>D3M;^54'
M>08IEI1,.W++]29!J=,X2U\S*%\Y2K//?5#QX9B\1X\?@<LDS2?G3HV>-1H5
M+%0./I? 1S/$:6;LC.ME8NH7'LN;W)]-5X*K*K5LFLVYM.MV2N;3_*WW4_&1
MMZXSCL*%!CPQDTOEWQV/:]BJY%Z=F7 U5S*\/ID)"Y,/?II,<"'YP#)N@F=<
M!BNX=]@2P4(BV!H-3Z#DCI,/?KC8)]VSK&&#K.TV^@!<@_+PK@?1OCD7[9AF
M%'\>AN/1Z8O+^<&;V=G8.Z_"3_TX&+2J]IPEDZ\8-%5N9;<*%X%%XP>CP':E
M?(W3D6: =*SS3=&@Q,A@:',B_;I1F?SB&:UTFCBYU<BNVGRT:.0OFF:&EYC$
MK()[(6D:9C>GUUZ,.KDYA_G$]O$@;EOY9A +V8!JC; B/R["GY75.0D+PT9/
M5/>)=35&_?ZP?SK*7(4;*ND .G<3>+D_[$W,M9+T5:XJUM(T<6"46#&CA\.,
MCGMVY/6:W9"R]C]<CC0G ";YE9-=F5<D'H&R4!V\"UFK+G-\42+K^:J-[0_]
ML8KY:M@'U+7%#0NK"BLZ==2N_QSG+8CB]1QQWL@#6[X;Y:R&)I@8.892N8*R
M)3;6)RMCO'!/T1="%7B;2T[/D9)A<ZR(@\(9C^.E/->)Y.W%04[S/3VQO;:M
MLE6 ^*I84*7%C+)VJJ3LT!L>ERASUC* [W)P<(PKL(%YX(WA9-/\9-/ !O8Q
M'[V97#PZ!Q$ \T8:1$78_8DK>.(RR;DL)30YJ.SAZ5RSG1K+^@W.3ZM,F]-6
M5A[A^WE/20NV?!2SVIQ8Y%4RR)S'>OQ5 <(<:!_G%TV"4M-W5OH8S*:;TQCF
M?$4P_)*5/S?XG!<P'%01I#FO4/6Z',3J%L]*UGO\Q"LVSG(I#OQ,-Z!S733X
MFB,%LDP6-C^VTJP,Z8\7_)'CP5^_[S8N!&C>SN'C<M.;Z#) [:#.C#0[0N_A
M[._/42*;N<NP>R&AN4#D[&47Q BH44!)G1&U-/*ZGI:$9G^U>_F!%R/9 OO%
M+WPZB@@/F_,.T0(/[XMK_N7(-=_X8^QRGO<1#UVVR/N3@UEC=^A5'#K5H3(&
M%D#+?Y15+VJ/*U;D3-_TRIPM5\-:#'-@?)3-,0*XG$M7T H>/\:(\8F*_\_>
MVS>W<2-[HU^%I7N>IY(JP@$&F!D@V:LJQW:RWAO9WMB[*><?%UXEVA2IPQ?;
M\J>_W<"\D2)MR:)D2IX]=1Q)',Y@@.Y?OW>_Q]2HQ7GKW*MA9MC-\NN >[T
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M@2&GEY5,"&$Z1@4PH5I57@_(T[JU8T3O#@C**#3^!39=TN RFO;C\?-_#6+
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M:I^$]ZE2TE*96-KTRJ?VX:06(-V,B>1 TY6S:O.%315 E;#;?*5.G8#W(--
M)E73GN;!M3;X(+6Q?'@ZQ9>N.*W)OIW[SLYLSBY,@=/%=(HQC46JN<#+.\V4
MFC>O_.3MVU=5-=T5-MO7=:K'FI)M"\#>I=6A (&EFAM]AA T&U45=CK]L8FV
MKC^TSE"<N#8V^\.JV;T.>V?8\JRF@%AM6C7$3NV-HC%?TTU*P<"$FJ;,H^ZJ
M&MVH]7:X9=R^>4+VQ*M@(J2F=*?Z+;S#6I^P&'M9G+1YT9V03B?&A%^,S;.B
MM]QMN.0.H-A:8BUJ8YNC,FVOF:WY075_GDU90G7SA-4,H<^%::J\\KH->^Q)
M6\G8-EHS;-KAU.F^NIJVT'6W;ZQFZC9L2,_JG&T35AI&OENC[(J<6TK%YZX6
MI[?)@%_J"16?72>BUW6O37@/872%Y#H?7&C[LZGJX4* X7+O\U.'M2^\TOZ3
M]6=S((Y>HF)V5WRHN-RJAP=F+*;TC(W@Z6>1\]"$P$J.NHX^GGBTHT?QLT@0
M52.,2MEL.@(UZ9BUS)LWER<>JELJQ17\+TCY4<JQ;"3,:%%C;\3A1IU<2=]Y
M$&^XQ!!TG4=1T]ZIMZ"4CN9)C<66A[8>Q("Y[O-%TTBK"_<;RTP[0;.JZV5M
MX;5*;FQ+:,Z;^KU:,G7*]RKI$+MZQ6!8\^U&!*/==5:I1.9\!0)AM;'?XW"
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MV84+Z2J^(5,W2 HCM\1$YO.!6T;5-27F'NOC!'-GL^G)R(Q2,T1XS1H,5QH
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M?!+O \\;/QC\=1*I>%21S7PX "/]9 O5(F1=I%)<@IW.7/S2=AI%D0F;#/>
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M(R@\&.!AZR_.5!GAB86QMYUC7B>1Y40OW0@OB .B8?>!M>;>Q1-#6(OO-U_
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M_&6OQ-#FW?GZ7?W2+GVM4D,KI>:+I9MK!C+\0A;Z8_/%=<_+7X"'OO4E()(
MNZ97JNW[8>7#[ II@)'H0?G7<GP^X"RM,4'HV=EL^C%:=/#1E62X*G.OO)8^
M]T+2H&'G.<L5S;,\$WE9YT?Q*D@%/UQC"-B+V=1Z[^8HR!^WV_D\U%+=W_F
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M$_@,Y<>O&96%#X'M+V,OYK]6'@7?3OBMAL Q+P9\+,(H$:; -QPV 4P :KP
M?C&W\5^"/0G3A+-WA:5PRO_]$=D?+'%@Q7R,UWSMI@KZ=<$B6'+P)+#O"Q;$
MI(S.!\]=VI85DJF-A7E)(5F2>69]),%6RE:OQ*'#W1F]V#%^!6P#((K@IKQ(
M@7^'[\@^C!\GH,+B.'0\D")7>/% L^4*+I_N)(V!(G&,\W?\%$EQX'OXM.W.
MO<"+DRB3-1"LC[_^Z]-/]\I8>+8=QPOX[^&[@2NXGOT4P$B>(R0L3K)3 GR4
MWUAB>_[[?W[[6,B@"&\37A@H6_B;OV@2L\!A^ 9;^$$UE8+@PI.-U,@&BFV?
M%=+]?V'T.XOB7+JYL .9LGD6BP25X*#IZ18S.2@Q.4)TM  78<P5S4/$0!G!
M/O'XXKG)++?^RM_*[3-Y_1581^BGR>&O'#((KRV(NKQ)B_*?LVBM2)[8_01
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M4?MC%<-%W@9/W"S Q2;EE #(W!Q+;>!;P1(=$CL1 N;QSS*GHQ!1T"4>SQN
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MMOZ::ERD4WZS_OLTUUO,53'''9FK(DNJ?)E[*"XS686N=CC60+G"U0XR7>U
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M"DX: ]!A4'@2?N\D\?L,;_#%F;? )\)G%M@!S"0($R$)X1?S!4N8*"3,F05
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MV+N2S.@=?Q5-'->.01.#N\-@51-'8Y,8W%L&CT5#(0W=7_ZBAAXW+$XC!G>
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MOY(S 9<22\3T%C)=5X\Q??]X,C#6FX-V\Y?[(8#*$G3&*DJ#6J!HR;4)"E&
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M6+ @AKD+D9TPJH)O8U4OC4%CT!A4!=^H"KZ?)HIEU@Y2]\5&(1NV(D"H+I4
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MX-?:!OYR=.H$[NT].K'$V:F-^K.$Q R&<4E(,A1FX_*/8\ "JK:OJT<^AD'
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M;&$LW[OV4EALM'J$SY%U[+^I]VS['!A3^$T$ -3V/"\)WQ!NI1=$;.HS)T?
MU';@E3,;_P!@;+W+RZ8HV(M%%'[WYG;"_&7^LH23!\>PYZ!8^33@*3>% 6$6
ML1"GBX7O,=3'@+((?D"$"@%BR-]X41?AI+4-3CNM8>S W:!RD2I>Z0#./&=F
M!T]<+47LF07IGB^NVHMRW;6K-2*NJX1%?N JFT2<H6IF@\Z;,!:45!+JO*>(
M 9@B? @^"IBP9'8D"NP[OCB&=]DP#U0Y#DS4A@GRT8#OL-TE.>Z*WC<"C.>R
M_.=BFRSD) ,?;N6HW>!)&-,+74DHT6O.DLAS8GA[!O<5):91.!<^>T&:L(_
M!<\1CU()GT:-G2^52]]G.X#I<\%+XVSB\?J-,$D&4IS"FOAL2SH6Y8E]]V).
MLIRDP$2[O"+8\+UL)C"0%^!7A6F:H.(&@G@QGU;$GNP(\;(S''XQ $#ZH5-,
M%ZEROTD5$.IG#Z@R7Z\$OYA=V1%&L?#B);/\[=G^!0N=IG[F7 !FP.IB49S
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MW.=C&97"X"G,[$'@8)QKJWV6_1YZP%*?(GN>ZYT)V)9<OWZ E_F9T<"MRO"
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M3-TS2!S1=@8XPV#RS32P6SC&)(T!62/KXDK\<9LV*U$Y0A^H\YKXE_Q1Y"#
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M^'(^((])*.1OY&6#4L%2&O/5TJ[/V7]),'9+KE2:9OZ>LF.O4U,D*]% ^6_
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MGP(O*/2R5ME0)T&X# AA((KQC]E#Z:V"*J58>$1/Y\\DPDFO N4QF^JK"9E
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MU]J[P^8$-FQZ.^PU3:T?)9]Q1CC34VG1-%#!#]\%_BW"J7U%'#6.$&UU;?Q
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ME/(8'R*P>GA2'LB@'X@T?MMG*'0X06K@!.X YCF1]5F9&H4#_1DFA>4E0/9
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MY\LETK_Y7?@TT>B5,2A :T>$LF(@,!]!^A*1)2>B9#U5W&.(W04W\BGAIK?
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M.[I7EY_7/R(%$7_YP_\#4$L#!!0    ( -0U8U-#K8\E/78   XU!0 4
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M5WPOHE[#@;UOY5>!_1AFPS10Y&4K:S*MS15019")6J("+I27,M 6%,5!"+"
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M=:B)Y2J#YS*#YBQY*;GQZ13C:P\LZY1R_ ]"NZ9&\CZ<.7F;>75Q=&)YI4,
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M'2R5I";?7*,&GV4&KW3DI>1D4W^]O=8A>!9^1"_B;T.'-9.1NX#JO2_7@:?
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MY-H]^#*?G!,\N]9!+@VI6H':KK)Z!PB!DT\HN4.NBV")C_:O!T<Z,:H;B'.
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M7M]N^50U&)UQM9XF&.5K$T<RLYS( 7@R7)N2HQ!]3-8MP)ZK6="2KPZ7U0_
M6U?NW0%@5V-A*\3C&!!-B=U=:?9@I8-9L1VH=%(Z1WZ>H-.4@(8 T48#W!J5
M$157KD_BS)'49HOY<5RM&4-&'VU)JZ):%]=Q^]ET<0F;OE->?:W=6->IHB$&
MD05"*"[51N2B7A1&"$JC8$$G;_KD38Q!>7@CIS')=U6H#T-=DGGKA<\W>SZ<
MAVG"7S[AJD##RYQ73(3S.J?SV:JRR:NOM\3WK9O!\+Q7*U):591Q M Z#\JJ
M $ZK",A<1!MMD;L]"7A$5O AYO=<[;(GJ#T=FEZ, OPV?%Y7O=P%]N&,OMV!
M'\<4?(JZ])!MT%D1>MN9(^ 'A<BYH1U)2]H7C%#@313 G>9T0+E"-M7IZ^\6
MF_2$U7<,_XVC<*]G=)@MYU^_Q9/^.9O_BXZSVAJ'F%EA70<AUWW"I U"82&9
M^%)[;7MPA?R $))PEF748>,%TF!D[A%#']F0[47I['!\C*W">/7M^DL,"_S?
M_^/_ U!+ P04    " #4-6-31__R*<0.  !^#P  $P   &-V<RTR,#(Q,#DS
M,%]G,2YJ<&>=EGLX5&O?QQ?&:9 F(:&)1#4..\="9E=;2-@1(2)2QFF29&28
M'"?&(><B3844)N=#"..X2YKP4#,T!J&#R<Q.8S&G=SS7\[[O/^\?[_-\U[VN
MM:[KOG]K_3[W]W>O=0L_"AG ]M.G'$X!8F)B@+_H (33P$E 7$QLJ_U+$I(2
M6Y*"0"0DI:6DI;=.&5DY61D9J(RT-%0!"I63%TE:=INB@ORVK?NMAVR%;T6)
MFKR,M(S\ORUA+P"3 32 ,@DQ;4 <)B8!$Q,. '  $),4^Z> ?TE,7 (B*25*
M"2HG&M"R792^A(2X*%E)"$34&R_J!R PR1U:AX]+*9V])*T=N=,X,?>QS+X3
M#61EUS&6CDG ]219J(KJ+K7=^W7U#AP\9&IF;G'DJ.7)/VQ/V=D[G'8[Y^YQ
MWM/+._!RT)6KP:B0J!O1-V,PL;>24U+3\'?2,_+R"PJ+BN_=+WE27E'YM.K9
M\^K&IN:6UK;VEQU]_0.#0\-_O7XS/O&/R:D/'ZFTN?F%SXM+RU^^?F/__7/M
M%V<=W-C<XA(#),3^6_\G%TS$)2[R "*]Q24F'K,U  :1U#HLM>/X6>E+D4K:
MQHDR.T_D/FX@R^XS<64I!UP?@ZKHF,[M9V^A_9/L_P>6]!^1_0_8_W+1 'D)
M,9%Y$C  "? 5A$!2AQ @7_#GXYOO=:DR_EKYA<[P;D88ZW\):GE/FM[K\MM,
MY^<PF(:7IER;F(=+6<]E-'ADLAF=3-=M \F5K:0%!>U9RON(&Z5H7>1V%<:%
M,P "DC':.0IH9<(++%/S*#S5)H%L^@NP::"D:C@'0C9_04+M *O._/%3-_M(
M((ST>5_97PW5M83)$V@-M-F&:<ZRPIN3LMN.4_P>;<H+HED;3U%9_0&?UG*<
MASGH-)O=K*O;62UF:)3W-_>@.&?C<=;?A,E84LSTV@CG=R&0?(>'"F=3R\'7
M4@2+Q.BOK<VTH&1;H[0'#Q Y99GO#\R1%71MH@.3U>,GA("DH8C_23"N'D\V
M4/489S*QY^=QZC4YV[PKR5R=L6K$L9GLEV\/[#$6_ZEUP_V06H7+8,Y')8XT
M&\W;*;VPE[64J%&2@']:D'_Q@T[.#4L??0QP _5 2N;^LKSSSL-[F*(W;(+A
M<'(=S62N+L6TL,-%#@R<&\PNKJA]=R&D/RH*)ID#27&\/ESWYICM1;C)D)V$
MY:1?J,6W'@GB'=Y1QB8O-/G--90MS;7&6='QE$76K)UA36N'10P&1P[&A<D)
M@6TC;"E-W?VL,^?5@UX1R/DVB>JQ#[U.1N?S,"Z_II.Q77NZLQ8HX!&7^;17
M7.M@&UW60SSC%<)W_!=\!:WB3:=2HB/&*;)%;^8_A(T59AQ'8]1V=9X:>S;3
M6V/QJ:>Q Q03 HR\BXI^2O%X@?(TUCR9BUE,P5T6O/-K11_F<>OWS[8MSZB#
MJ5CT"YXR/P^)RJ'B%U13<5?N72X='IE[7+MQ]G@-.E=_.1M3[M>JJ*^F$>MG
M"%>R.?+)M^DQH4KQYJN-0A[W"W9(]=C<F0C#<VPO[:K=9@6QC-*DY&($IQL5
MTL7\N8GGA(J<*IC%.H@N[M_]-'BV*@0A(&N4NL9W_X5 ^+-I+9]JWNR](Q5@
M5_)D)K']P:B?,E9'5 XI"<9V#/0NL'2P!)YDYGA,5SW<PK&EH?[AQ+O)%S2[
ME#=,4V)[-GV*.:-0^S;W&:*K?D-B;I@9%<40 J#>AP&7%%BD8I:U4V5([MUM
M"Q'5WHN)G^6/%29MYB*NG2CA(C@W11GY?L6IXQC9M\[<JDIO1DMB*$,/]^8/
MW3+=',B=GG98'.#4']<:XJ0YHNE)8I=#;T][BI->:_3#TC^?TXOP;%V=7(F7
M0MP&H_ )3=:KVRJAX+VAHFQVQ7AI"(TV.DCC- P207U%9OYSK%4[2$)7HKZS
M.+35UR6;<+GDBE-T?Z=4ZMOID[EJ\=R3V,ZV:S:S_#LXQA.ZC2BSPH3AB[\5
MSWVF2[+00Q0H!84R">&TJ=(T AQ@W1.?A[5'%T>@/M5:UUWM-_2KY1)";5E-
MG'91( 9TY7JQF,OI*SPYC7PG\_(Y_@G-F/YQL8'\>XJEN^4?*>B\?[RQ[68V
M8@TMD"D35;KV%#)\5@93U]]M.+Y6BMZ).85 T;A.R2OLD-:)V#N:Y9"4PMW:
MZB@H^?TSOWN&&\[&Y0.'W)<V2J@D>+FUW\YV/\/8_3X)+BF/OKJ5G*Y4,SOP
M='SQP>[)M8AU)Y+"+*BEQT2S.SF;_"Q3(9!)5%D5:+;>7TC+%\"8%OVWW$?+
MAAX8&*'#?J2..)G6Z-U[_\?7)O53K*C<MK12SG-^C31/I0-.7<$0& 2,BHL"
MKN^=$J[/"L=_A+7BMX<AF[HHS2O<F#S9GZVQ<2^G<PIXHM4+ 4!-KCMF1""[
MGT5T!</9W^=FDWBJT?SZ&TQU5S"&3XI!M7EW>\7,\%\@3;!]=O"]M-J:US[$
MW_EEUE9LY)P>3R,V6@C($8?I<!!?=T$PJD37K2K'7/MREQQ@?=J\[WULDVIT
M=&%;F@_^;&*3P2_\W]3-]AZC^O4J%?(PSN7GK[KE-DX$OUH(!(KJ\4!Q<HLB
MP:]U/4>@A>F<5R5$$SI'$>2;G#T&.?VBCT&M=CN&%*[O7 CM1]P;TXEM,SD<
M- .I03C,8-5%GO9\AS=05LJY5U!$!>O(>2% 2 ! I\HOFU5]+CO .I=N)S='
M7X]Y34M'J[2>#(N'5NHU=TJ4;UCE6:AG-%;XPSM/EFR4"Z!S[*;YXI4)KCS8
M/V_7YWN2?--RN9_KU77\V?"\KWG<]SBN7!R*;J_M69E9,;HWI:;AD'C]/AW8
MS_5^(] BJO<PUJ"!K9C1%<V^R.44O9R8"ITE_(:9=?4-&'8[5$FC'_ZMS?PO
MQA-;'9=[W:X#O%_LV95 UJRG$,!+"682S-GTAEH,?KYP36#(6K\3+?LK-)VD
MP]T9U$J.&/U\ C)QYGBVSGY/H]\? 0D/4#B6JX'J'''E*]<(),PK%U7JW>D)
MIEHC']-PE[PD4.$U(1X'(XL5#P0SUU>!I5-_VDE#LHTX=_DO!(>Q$-&,]290
MD%#:S]Z8'IENJZS8?6V[SRSX3! =QCT6UV=BZ6[Z^6]23PR85]^][NS2[]?6
MMA+'J,N 0W",^]TZD_D#!L\Q(]XLQ60S9./W#ZUWNQ_24 4;9P</U2K]".2"
M2:.9 ..\R%JR".ZRG%.<  H3U=PB:#'GMQ/3V;NI_R<X?=KIO--D57B IJ4F
MPB7T7M&/4ZB4_&F=]VJ.*GLBP_*. OPKSI;+-OBIL@<?/J\S?;F[,!8"&1);
M"'#"P2RN=5LZ5ND2&S&_E,-:&!*H%0]89I,J,0\IYY327A8:+M\E/(/H#'SK
M%5\^*J&PV;.'81,"9'O*-S"/*2IOG.=&X\BO+.!*/<&OC"Z"CO'EF*M]=/VN
M?0,E6$;M1;B.:ER-?<&E,98=E?QG8V-X4%8Z_E=(QN*@_]< K=?NOO"S?5V!
MI==^Z'K65M?I5)3$N[ETW+**Z#1Y*P2"_*AN9"'0,$MF(LD792<2^BNI"7^C
M@OI]9M]%=L_' .A"EC$&D'2'5E=;APJ@-:*9>=L@L@3/TY^8&MI44!R^J!Q[
M9<Q,=JR$.I"('4'U\>AN!9D_@$9C!-!_W6+*U/U<WWB9D?^'SE#/A1$PWYB\
M%'KDL3OWQL;+TL[PU;C5>+?N=:0TA;=#@O-FC'?4HK\FCO"493LP7=F$'XJ[
M<3 ]?G'TI;^SW_+1VSNH1PPR!5DXLFX/HQC)6L7A.];H>R?UHU<UP/8!,T2I
M&:[1JW\[SE#&\?9;"?N5=^YR/^ '9![%9]E>F[M^:^>A./M/W<53=#PMTH)P
M?RDFJ<C/UZW*^?H2L2F)4.HQY?+B.1P_NPO'^$3,/"\$U*WMNY7RR1[=<EU3
M5^.U'5I4=] \7R-,3X]M_%&480Y-",Q+ZCF)9#R"LQS+5#D=_.QF>-JF/*=;
MLYNU^T)/:F71,0YG:9>\-MU'H4\ODZG_J- _IX43AB8%5Y<77'I^\)G!_I>4
M!QC2P-'",_O#;&U'4\'=OC>F_-ZND.H<UY'0,"0C?[:UZC8/]@QK,AZAYR+^
M;8?E#/4CIO7(&N'NLC'<X.%1=YW7^@\]%?+;=S@G4/A).$:IGQ*244)LTLN)
MILA[@\CA'@UKCRE'E>+89R.!C\D0-^;A^)HWQD4P1]-47KU:GHY<"ET(/%IS
M[?N\=N"<>\!T:.BKK/;BP=I5RUZ*X8OG$U7FE<BKDJKF+>M$7W<*7K0321("
MC<-#E(^!G(,3"0I8'Y;H#V\ZC12_CZMO,5#TSO^SU)WKRV<N#A/53Q!D,T>A
M6A[QO0U6]N2YI_R2GA 4CM':P$L0 JDX5HU >1-S0:!\R6W^=<E/+N3[T[5O
M249-@<R$X\@O QNQ"V^7S39-;&]5+>DMK:\L<JT$DW"6/4G1$[S *IX;3L(%
MNR3BIE7/"V33O@\%]FVN)Y->/$4M-G:@&"6(9X%%=@>U!>STFV%2]N5K'X6
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M+VVLW\0C%?E<A)B'D:M,URA0N^W0%Q"[/H=N1.(HC*C /#8A<9/)IL;+I;R
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MNDQXLE@MDV>QB=*M#LH$UXD)U]GCTVI9N[??DURSHDZ*+6W1B@KG5'+L,4?
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M!R X!F9/;5"/@]7FX]J_:3Q'U5&!7WF;CE]ESVUW(DVR_%.V%$7PQG^WTKO
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MH;WGC71>5T UJ9IO'F+D<A9R2 5!$/%(6>NZ2Q=W/9>YD3+:N5&CY\/#3\U
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ME!?QZG>#M*M3OQ4C,Y_^X2$NX=)O5>:(1[_]GHZ=V8I"+(L#U53G,>$AXZZ
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MF#H1]%SI2BRQ2SVC?J@FDTV-@\O#$9V4P?0/8B.NG0>L%5\S/UA?J W,N&O
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M?,"W8ZF!(1V8M!KI@7F;=J5AJH;2H-7@!NQT *T28=,2>T 8E-)\Y!B5X7H
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M5W"LY-DQ5](MY38LYEWYN8%F&B^9-RPT+S)_ P_MMRG])N_-LU^G ^F1]PE
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M"=# /.J(C?-.M4/[H'O4<_.,NCOM4/1X7]IU:<^VBA]W+:IIGA8%3A1$151
MG',""ZPWHTK&1412+A1WC$\YGF)JK_F^P9]_F_ S0-J]Y?W@&=I8<D/&O\WA
MB?+#-#7\^#I-KR^K>;%AX>F5[MU:/LXW\_O*[KNC9=UB)$J*-"4Y@IG$&&),
M8_URZW\B%0N%&1?2[B-^?OBIO=A["8$1T;E+RQD NU_J_K ,_$([(N+4G>6R
MXKU[LYP9>K3.+)?5.NS+TG%5OT9WIH>>1J1H=I%9E$J>1!RF2"B(*4U@$>41
MY)1A1A@N:&3M*KX\S=1>Y.-.8FW[1B.Q7S^V(UB=?!P]P!K5N?$2IYX-[(X
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MK_MJ=Y>'"5]8+3=:8GW!_7RIWS59;JKBJ75I[0]+OI:TE.]D_=\9RXHLHX6
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M":X?00P&[!@.+BTXJ"4_\'7M75U "P^,]!ZEB]QPMC^O& SOD0XO#HLYSY=
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MF [P-L"@XN+X)UR>]/[WW?)9SV12EVZR,$PQ2B7$A!.(DCB&.(XXY)E$'/,
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MJ\7LV;O/C3YKXYP;(Q\#9A<$]89A9(JL[1JA"NFLQYX;(1^/,'$3Y#/.G39
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MI(> W#"KK![!Z<7F#M:#0FZW2UFZZ)K(&#1=MJF/T=&?*EE2.0*4IK\?&E^
M>51_!$?3<?#G:F0533_0>L[+##)IXDR.#_A.<S]>[NIMZ5\IIU^OQ%%F^==2
MR$\*TV.7[S8;;<([6N3%77E4?%]EEG%*A @BR-(D@0C'"E(62)CP+%9ID"$1
M.&6+O5HWMXBS<<ZH#QTO-"L/RPS*D8^@<;)J5EV["4H_!V\,#)CRWIL#TTSD
MV+O/WN80_%XZ"48I81P%_K%W$P98^-8["L/!M=A5\#!(SPJ#W$A%KT3Q?OWX
MN%Z5ZJZ+*"0X2U$(>68Z!4L402I(!B.1$!S+*$IPTB,4/S?63 /LRL)*RQF(
MQF['0H)ST%H6#O1%:J)"@<:\*U #55KHL2Z@Q7^_=0#G!IHV[]_BZDF>O^VS
M[GG]VXU\S'>/1F&(YW+%G[_(LO'IOMGL0C(NI%(4ID&HU^2A(% S@_Y/("7'
M/$W3V+I98N=H<XOIKH7X"ZBM!F)O-MA4=MMGG[MQCC2.H5(:6(%BB%!J8NTL
MA0$EE"G"(Y3*Q3>Y8>O)D3X>=<3E]20P=Q=,>(5N["V)&K.#L:"V]M#@VR=Z
M]O417E&<J#CB[D&:HD&3#-3Q?_WE*_0/E>+@=@WD]R?)S<]JM]5Q&>"F,Z)^
M!>9[:<%'FJ^V<E76S)OF#P7XP6P7R>_T\6FI5Q(BW^@[U'\J=OP!T**Z#7@R
MNP5%8>Y2_OE'<U]]I?FE,4A^SXNM^>O>LJ?ESBQ*MAKB)WIDUE,%?K5@V<C#
M(1(]]EH_S3JR]*2-9#W-+74=W?>8K*C#VIWCB@[[BP8+T%Z2!6_*E[*,XQ@I
MB# 3$&4D@%A1#C,L(Y(Q1A+D5*YA/?+LWMM'0J&7U?9["\%V3(-=@#\*N"._
M;ZYOWG^ZT*QN7)%4.X3&$CCM&/VMQ$GM0&D1%K6\0=_VOB\;$WQ:F:*(E9YR
MDSO*9$*%"@4D"H40,4(AHZ&$$4]23M*$IQGOL;_0.NA,-QJ.+'3MZ=N&L!T+
M#0=L*GW.RC[P0V/ICR8ZLL&N1_->"TP\=^UM&W'B=KT6SI_VZ;6YJ'>#WF:C
MXT3B?T$$#B7)$HAD$$"4* $I1T9I(D1Z^9RD-,Y<(IZVP>86Y!QO4%Z=:2\"
M?M /2/7KRYVMW2&WXQ5?0(Y,*\=[EU=UTY"KXZXA7GOP=B+BNPGOY0&G[L+;
MZ?J9-KS=U_1CE"_5@E['K=OG.[TP+DPCV?6JC(;JZJ@R97_TMU*K]OBZA4*I
M2M,P@#PEW/0&CR#-C(@YB3"-$QFJV$J_W*=1<V.HVC;P9(P#VX/E5V!=KLHV
MM6-E$<WQ!VJM\\WQ#=PXS,LDVW'=U%,W,B<VLU;:!>Z.9ZU:2W]Y,6MW)[/V
MX@;^"-0GS%Z)UHMADQ*R3RA?$[?7>_<C^%_6JWN]<GL\5.$7BT!*)5$6P5@)
MS=<1DQ '*(:48D5IPD*)N%U^I664^655C)%0<_VC7BWMS71CTG-H,HI%RIB"
M,8ZD*=<5$&.6FC4\24,4*AV8N[S]!F(YQ<MLC^1P].Q>*P,Q&?DM<?AB?;+X
M8CF3?8OS7KG[W#B34G&+HZ^9M>VC?9NX:PY6^N&Y7HFO<O,M-\6H-ZJN2Z7+
M0ZEJ<:='*,[_Z>>UR7HMXHP'A)(8RDA$$.$D@XR9<@&4$LT(B2+,J76=3^/F
M1B9[2X^JQ0OP>V6LX\$DKY-H1TUO-34C<UK/6>G16=X_?)Y[TGLT<.)N]OZA
M?<W#HXS1,S?\C>9+DXC[N-Y\I4OYU92)EJ6C/TNVK?OJZ']=*\UJ'_-O\NYA
ML][=/]S)U7])NBGVU:>+D-* *9E @2@U6ILII H',(E3%N$((QHY24AYLVQN
MU%T:#)1)(S\;0\&V,AQLY:KZC6->V=L46N:=WV)B1B9N8SDX.'(%]DY"M=Y
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MZ02*<<"DB"!%)(2(8*Q_4D:$F>,TX#CFV.I(Y>FMY_9HWSI)AIR!JGNEW1^
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M)3GZ ^B4:;!!I24%T'KY9'OS-DX<;YI;?;[O;O8VOR^_&D9Q<%?4[6MYR-.
M"@)%9.IM>8 @86$"(Q4F69#P1,3*)?0Z/\S<6/-@):C,[-D/^ *HMEO;0Z$:
M?7O;&:4>F]QM('C>Z#X[U,2;W6WNGFYXMW[:C0B*S79Q7+19W*R^2+K\4!@!
MTJ;2O"S@7.A5%TE%&$/$4J778YH><&847+B(DC!,*"+<AA3LAYP;0;RHL"^
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MC3I>GY3YJ15=OM](D6^_E HTQ:NCV%B*$+$H@9(A6F6DF2(13'!"DHQ@D:C
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M<<@RR$)33\]%"AGE' 8H$$C&82BS=/%42I9\W>JWXGA@O1YD/,C>4?U/+J\
MD_?Y:F6*EM8*;!\DJ&SH":4DR'3ZE5"2A$(4(P)9S -(..,Q05$:<E5#^6$E
MQ@:R&6("&*4.3'T :)>8ZP/)R"_BSF?0.3_VVDFO*;#]S2?-<KUVZ74BZ^3O
M_5X '[Z;PK1=7CR8H.%&F1J!ZT=3K[9 "A&>1 QR&28089[J*#M5D*4DB*.
M4AQ;'<;O'FIN+XGK^_N-O#=9X*=-ON+Y$UV:)U:8FA^Y]\(UW=X"M=VC[ ?
MD1_NET8:V(R95Z RU-\CWPV&5Q)H&6Y26NAV^S516%S1\Q3B9LVE%,5';62I
M7BN+[?5*_)Q_RX5^QQ5?2A%B*1:,)"GB!$-LFC6AT*AZJ"R!C&,:8!8G4>84
M6]H./#=::6PMJ^KSXZ*2\M3*IC;;\62B[2S8<<P8V([,.(W)P#PMX 7(>[/!
MERYPW8\?.B+E]_2A[>#3'CYTA.3D[*'K]3TK#?/5VDBD-$,L:,0"FFI&"H-
M+WXQTTL10A(8DTS%,L&!)$Z'A%X/,#<B^JRG<[W:ZO&69C67UV8ZEIR?P&C'
M,$/ &7N'<+OF?SRLE_JK5/P+^/#W7=D,9KO=Y&RW+8\4;M?@%7B-&QZ+_2X
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M )1(0I8K;DY\GZ(8&AU&ZM7:L3'VB0*>\:EK7*.&QV(<KYN0=U76&&L-CV:
M1E3#<\GB_ZB&1Q/\?@4U[-;P5#J>WQ?3[7*9I9)\;W-V][+,%CO.US,10H$%
M4YV,J"K@P1 0"!' 0<!<Z :"0V1P.$-S6BV>&?[LQ82NGPM58'7 <U&\15Y7
MYA>+>UXYT$XVN"D(>LQO ].!CN*7EBH8I_\ >'<1P-;ZOQ=@Z47UMVG.JVC]
M7@"@2>'WTFWM>.=5)5JRX%XC>B_^+*<H/QP*">\O*VWHR7:UDM?5WH@[8\P7
MA"JM<A>K@[E)!"+L!X 1)E  8^)Y6JH8M@T;6\I;VM9BH]A:J/1H[!H!Z)GO
M[$BBRR]E#'^=BZ$Q0=H&W"J36C-N4,JU#>DA-UL?OQV)3Q8O<IE<M,-XR)-L
MR])\?LM8D;;23$WVD$_H,MW0K"Q\P4D8> @R@$2LFL4A 0CG$>"<1,AGD(G
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MY)UG"FLK'MHAM+&]8RBEP^A-4J)9%ZM]7IG:QVT;8.2))ZA]Y-[!3;I)67E
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M@REYD=OHQ,1$BTF0R^A4T$QS$E/0Q)L7J$S&H*QNX[[O0^78R;E-D-9,31U
M\$/M/WVQ_'IC$V5AP(9H6?8YUB&<A05';!AI%'@N=<EM@':?EK%OP"9P.E+D
M_?2+?X=KF,XQ7TUE?Y;2Q?G%K"[R LLT3=>3;*,MUGB&MK8;-P%8A,)9]+H
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MFSI.PET4W#QXKJI^H!;+7PX\N9&[()/1(6564PM9/?X9>%M84%DZQ1%ELCM
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MWK-TV8WI^:(^]JW/%GES4[Q\__;MU<CTB8:4<G*"A>04T[7<-UBKF9 %,A<
M)MUQKQ]L8W78ZN,.5S@%]$ZDF?&[5]QC=+.K=N%3H!=9@6%)U,' F39:L-(Q
M7\O-%;=*%[,O G==?-R)>:, L(E>^L#?3?(O;>)==MY$%!\])%G[IB>F WG^
M407'$CJR45![H?(. #QL]9T0&'YT!)Y ,R-?OT]S^,BFFX#6 4 XII)S=,;K
MPFC3<:8Q8E%29\=WF1ERT.*[A;/YGQMZ0RBF __DQ;1V(ICGU8U<YXG*(1IB
MA!F(Y&-)M1D;K9F5*"*$C,*W>>5]B)K=T/:G>#TY6AE]W*:WH^/3;71\$X=Z
M>&[HI"2(06M+0E.T54HL+"!PAG1\1X\\"N-V.,WV7G@W;/W03QSM%=+!*7;_
MV5'S9+2E$]CE.D0<##(/EARAXJ0E(69E&R6J'/;X^Z=XTCA.#;W,GQSF+3!#
MS%$K15X/^=]:>LF\CH8%0_YWU+Z :-7ZXF1OO^)/\4 R@L('A?K)FS;=;ZQS
M6<IRANMI@MGJ-I>M^@G=67.TID)/\7[2SD*E:!\SSXSL0MH#'LGSX"HP=$I"
MD,9!:=-Z>(S.0AB- !<Y,QJ0W*PZ4\Q ]?>Y+\H@A[NAE__?=A;:!Q??Z2RT
MC]0[, MOS)>@B^(W_&/;4[>>[,O%G+Y,E_MZ4W]09$8?N6>R2$VVB@86N42Z
M4ASY6K;($MH\O.U%9B>(.P /=ZL6FRFG ^1]H-_[5@AP57WI>(JUI6.2Y,[K
M[$V=01?KG!+#5>;6FC8^R4/4C(NCALJ_VRGB6$UT@*9OPGE?'2LR>%=__U1-
M$\F%%>JJ'--+2?0'5F0J3$<2$%FBM?= L#E[;\O=N4+#U5M_G[QQ\78\"N[7
M7 ^LD@YP]E#%0=8Y)!V(9%M'*)%C%6)$!M*;P#%S#(W;5;[>J^#G5-6PQ]Q\
M1XJY Z \BOZ7U>%934E"KZ?D$_L<HC7.,6G 5=-3LN E9RX)JXVP/$";(,B.
M!'9B3!V(@UV/I".4TE]JTK_C+$_G'Y9D/DRX3LH$.KLCIMJ*6VQF"A5F. JO
MBI<F[O+^_O0JG1P[QV%D8&'V!(O+)+QK=EYMV0E9\U1;_(.6=/4:'Y@7)C.1
ML(2HK=8I[HN-AY?JI!!U8( ,(-8.+JH;#ZD;AB99.B]2L2S+^IJJB73 I)@%
M108@YT8VLF?N4C)N <+ 5\]18NX )G=;<]WHJ/0"RS1-UY/BLLL$>B:3P2H>
MJ'D=GCF.3DICZPM$$^!\G[9QZP4&AM+ JA@Z(V+HQY;WTX_S*;$%\_6-$,AB
M1HSB(0\I3W_>,(\D>] \T /(_66^3?LE?8MJIR0K4^WZ&9G7HM#]Y"!%HU3.
M;6IL'Z?IV-/H%UA-5V_*VYL;>9Z?E/H'$O0OLYHNA*9HRUUAP1'9.I(HR)ZO
M'=\$7=8Y"8UMNIT?0_7(P<AAT'7W)#N9&@<L"3WI\=;JF#OE<3?6L6<YN6FF
M((F%1[H#G6:0:P,^&9,)7GA]-V.N^V/O/7ZL9L0[_%2S+K:?__7RO]\VADL9
MR56U+&5#&R-A8%$3XZBD=(5+!&C3<GTG\KH]R/;!R[UXY>"*Z<#DWY[.=T1V
MCRN(/.I2:BZ/"+5Y)IW]W',R98-"+:0"T>91>#?ZQ@U.-<); ]5T +AO&46D
MG;N\9.XDN2^)697(I8F860R*0.%R!@A99MEF1,!35(T;V&H$KL'4T .D8'5&
M)F7]H^;\?(99?3)_AR2F:2+G]>&_OV1Z$@.G_P7!8N&:Z6 % U<\@V!2XBJ:
M5H/HCJ%ZW*A9*TB>2HT=0/8=)B0.XFQK.M_8?!HS]Z48%F6=]"*\9"%#9"8
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M_AFW&</;D]QB5H7 P+RRQ PWB<4D@ DODM9@:1^UR7=]DJQQVW(TPM=PBN@
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MW;[)#8/5MDKL *^T\>#CQV7-_R.=O2E;O_[.)L2 A6,=TPFUJEK6H*DC8;H
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M.\"&E?SHY]7;Y2(AYM6FQ&M6'Z'^NJ1K_=WVBG\.GZ;DH/\5IO-5O>YQ52O
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ML,;&02IH'] \WL8TR!E'LH]A<B2;)Z[A^G#]Y4L=-C+_^.M?7W YPWG"]]7
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MI.1%9Z=-;*-*=N]GVF;_C97)""*8.'CY;KG(U^GJ[?(#+K_.TLV%;9E)*#%
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MAZN' Y&>ILW1+1*X=E",)=JR31 L#V"8--(EF85JHR?WV>6T8953P;*9W#K
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M:*KZ^<];_4RJ^77X,JMZ\GL-O?IMGBZO,UF&KZ^752A_#U>W(XXO@A<RL&C
M&*FJ"TU\3HQ!PLR#T2:RB$V4W;$[[VDXSCC*\*2R[. B'D;O+9D7QK.:&L7
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M]T^JG&EFE72@536M2PT N8)@8@ZF5E6Q1JD09U,8-%X@Y3"N=P>>-R'A;5F
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MZ?[\5&W&BQ(4W=".%$A<-Z*)$8(.$CP/H;HX-FS/!1_IV(RS_VF3"[H\(A,
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M,S R,#(Q97@Q-3$N:'1M4$L! A0#%     @ U#5C4[U7C%00"   J"4  !(
M             ( !B ,  &$P.3,P,C R,65X,S$Q+FAT;5!+ 0(4 Q0    (
M -0U8U,BT&Y\' @  ,8E   2              "  <@+  !A,#DS,#(P,C%E
M>#,Q,BYH=&U02P$"% ,4    " #4-6-3"K_$+=H$  #Z$@  $@
M    @ $4%   83 Y,S R,#(Q97@S,C$N:'1M4$L! A0#%     @ U#5C4\>V
M\FWF!   7Q,  !(              ( !'AD  &$P.3,P,C R,65X,S(R+FAT
M;5!+ 0(4 Q0    ( -0U8U,T#2XO<= # +JH-P 0              "  30>
M  !C=G,M,C R,3 Y,S N:'1M4$L! A0#%     @ U#5C4\D,3K%6%P  ,Q !
M !               ( !T^X# &-V<RTR,#(Q,#DS,"YX<V102P$"% ,4
M" #4-6-3Z14(RD L  "MQ@$ %               @ %7!@0 8W9S+3(P,C$P
M.3,P7V-A;"YX;6Q02P$"% ,4    " #4-6-30ZV/)3UV   .-04 %
M        @ '),@0 8W9S+3(P,C$P.3,P7V1E9BYX;6Q02P$"% ,4    " #4
M-6-31__R*<0.  !^#P  $P              @ $XJ00 8W9S+3(P,C$P.3,P
M7V<Q+FIP9U!+ 0(4 Q0    ( -0U8U-M3Y<Z/1T! )_,"P 4
M  "  2VX! !C=G,M,C R,3 Y,S!?;&%B+GAM;%!+ 0(4 Q0    ( -0U8U,H
MA-9%XJL  $K.!P 4              "  9S5!0!C=G,M,C R,3 Y,S!?<')E
:+GAM;%!+!08     #  ,  4#  "P@08    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
